:begin
CREATE CONSTRAINT UNIQUE_IMPORT_NAME FOR (node:`UNIQUE IMPORT LABEL`) REQUIRE (node.`UNIQUE IMPORT ID`) IS UNIQUE;
:commit
CALL db.awaitIndexes(300);
:begin
UNWIND [{_id:56, properties:{bel:"deg(p(HGNC:\"NFKBIA\",pmod(Ph)))"}}, {_id:79, properties:{bel:"deg(a(GO:\"neuron projection\"))"}}, {_id:88, properties:{bel:"deg(a(MESH:\"Nerve Fibers\"))"}}, {_id:96, properties:{bel:"deg(p(HGNC:\"APP\"))"}}, {_id:111, properties:{bel:"deg(a(GO:\"synapse\"))"}}, {_id:117, properties:{bel:"deg(p(MGI:\"App\"))"}}, {_id:232, properties:{bel:"deg(a(MESH:\"neuromelanin\"))"}}, {_id:250, properties:{bel:"deg(a(MESH:\"Dopaminergic Neurons\"))"}}, {_id:469, properties:{bel:"deg(complex(GO:\"proteasome complex\"))"}}, {_id:899, properties:{bel:"deg(p(HGNC:\"CLDN5\"))"}}, {_id:908, properties:{bel:"deg(a(MESH:\"Endothelial Cells\"))"}}, {_id:1139, properties:{bel:"deg(a(GO:\"basement membrane\"))"}}, {_id:1163, properties:{bel:"deg(p(HGNC:\"IKBKG\"))"}}, {_id:1228, properties:{bel:"deg(p(MGI:\"Ocln\"))"}}, {_id:1244, properties:{bel:"deg(a(MESH:\"Eosinophils\"))"}}, {_id:1402, properties:{bel:"deg(p(HGNC:\"TRAF2\"))"}}, {_id:1404, properties:{bel:"deg(p(HGNC:\"TRAF6\"))"}}, {_id:2259, properties:{bel:"deg(a(CELL:\"natural killer cell\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Degradation;
UNWIND [{_id:316, properties:{name:"FOXP3", namespace:"HGNC", bel:"g(HGNC:\"FOXP3\",var(\"?\"))"}}, {_id:344, properties:{name:"rs11248060", namespace:"dbSNP", bel:"g(dbSNP:\"rs11248060\")", pure:true}}, {_id:345, properties:{name:"rs356229", namespace:"dbSNP", bel:"g(dbSNP:\"rs356229\")", pure:true}}, {_id:346, properties:{name:"rs3129882", namespace:"dbSNP", bel:"g(dbSNP:\"rs3129882\")", pure:true}}, {_id:347, properties:{name:"rs2823357", namespace:"dbSNP", bel:"g(dbSNP:\"rs2823357\")", pure:true}}, {_id:348, properties:{name:"rs1491942", namespace:"dbSNP", bel:"g(dbSNP:\"rs1491942\")", pure:true}}, {_id:349, properties:{name:"rs1724425", namespace:"dbSNP", bel:"g(dbSNP:\"rs1724425\")", pure:true}}, {_id:350, properties:{name:"rs4538475", namespace:"dbSNP", bel:"g(dbSNP:\"rs4538475\")", pure:true}}, {_id:351, properties:{name:"rs11711441", namespace:"dbSNP", bel:"g(dbSNP:\"rs11711441\")", pure:true}}, {_id:434, properties:{name:"SNCA", namespace:"HGNC", bel:"g(HGNC:\"SNCA\",var(\"?\"))"}}, {_id:442, properties:{name:"LRRK2", namespace:"HGNC", bel:"g(HGNC:\"LRRK2\",var(\"?\"))"}}, {_id:443, properties:{name:"Lrrk2", namespace:"MGI", bel:"g(MGI:\"Lrrk2\",var(\"?\"))"}}, {_id:464, properties:{name:"PRKN", namespace:"HGNC", bel:"g(HGNC:\"PRKN\",var(\"?\"))"}}, {_id:501, properties:{name:"HLA-DRB1", namespace:"HGNC", bel:"g(HGNC:\"HLA-DRB1\",var(\"?\"))"}}, {_id:502, properties:{name:"HLA-DRB5", namespace:"HGNC", bel:"g(HGNC:\"HLA-DRB5\",var(\"?\"))"}}, {_id:526, properties:{name:"HLA-DQB1", namespace:"HGNC", bel:"g(HGNC:\"HLA-DQB1\",var(\"?\"))"}}, {_id:529, properties:{name:"HLA-DRB3", namespace:"HGNC", bel:"g(HGNC:\"HLA-DRB3\",var(\"?\"))"}}, {_id:531, properties:{name:"HLA-A", namespace:"HGNC", bel:"g(HGNC:\"HLA-A\",var(\"?\"))"}}, {_id:580, properties:{name:"PINK1", namespace:"HGNC", bel:"g(HGNC:\"PINK1\",var(\"?\"))"}}, {_id:1684, properties:{namespace:"HGNC", bel:"g(HGNC:\"MX1\")", name:"MX1", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Gene;
UNWIND [{_id:1685, properties:{name:"ISG20", bel:"g(HGNC:\"ISG20\")", namespace:"HGNC", pure:true}}, {_id:1686, properties:{name:"ZCCHC3", bel:"g(HGNC:\"ZCCHC3\")", namespace:"HGNC", pure:true}}, {_id:1860, properties:{name:"rs76904798", namespace:"dbSNP", bel:"g(dbSNP:\"rs76904798\")", pure:true}}, {_id:1865, properties:{name:"S100 calcium binding proteins", bel:"g(GFAM:\"S100 calcium binding proteins\")", namespace:"GFAM", pure:true}}, {_id:2397, properties:{name:"FOXP3", namespace:"HGNC", bel:"g(HGNC:\"FOXP3\")", pure:true}}, {_id:2399, properties:{name:"SNCA", namespace:"HGNC", bel:"g(HGNC:\"SNCA\")", pure:true}}, {_id:2400, properties:{name:"LRRK2", namespace:"HGNC", bel:"g(HGNC:\"LRRK2\")", pure:true}}, {_id:2401, properties:{name:"Lrrk2", namespace:"MGI", bel:"g(MGI:\"Lrrk2\")", pure:true}}, {_id:2402, properties:{name:"PRKN", namespace:"HGNC", bel:"g(HGNC:\"PRKN\")", pure:true}}, {_id:2403, properties:{name:"HLA-DRB1", namespace:"HGNC", bel:"g(HGNC:\"HLA-DRB1\")", pure:true}}, {_id:2404, properties:{name:"HLA-DRB5", namespace:"HGNC", bel:"g(HGNC:\"HLA-DRB5\")", pure:true}}, {_id:2405, properties:{name:"HLA-DQB1", namespace:"HGNC", bel:"g(HGNC:\"HLA-DQB1\")", pure:true}}, {_id:2406, properties:{name:"HLA-DRB3", namespace:"HGNC", bel:"g(HGNC:\"HLA-DRB3\")", pure:true}}, {_id:2407, properties:{name:"HLA-A", namespace:"HGNC", bel:"g(HGNC:\"HLA-A\")", pure:true}}, {_id:2408, properties:{name:"PINK1", namespace:"HGNC", bel:"g(HGNC:\"PINK1\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Gene;
UNWIND [{_id:148, properties:{bel:"list(p(HGNC:\"SNCA\"),p(PFAM:\"ubiquitin\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:List;
UNWIND [{_id:54, properties:{bel:"pmod(Ph)", type:"pho"}}, {_id:211, properties:{bel:"pmod(Ub)", type:"ubi"}}, {_id:215, properties:{bel:"pmod(GO:\"protein oxidation\")", name:"protein oxidation", namespace:"GO"}}, {_id:217, properties:{bel:"pmod(FIXME:\"protein nitration\")", name:"protein nitration", namespace:"FIXME"}}, {_id:229, properties:{namespace:"FIXME", bel:"pmod(FIXME:\"protein misfolding\")", name:"protein misfolding"}}, {_id:511, properties:{bel:"pmod(Ph,S,129)", position:129, amino_acid:"S", type:"pho"}}, {_id:517, properties:{bel:"pmod(Ph,Y,39)", position:39, amino_acid:"Y", type:"pho"}}, {_id:619, properties:{bel:"pmod(GO:\"protein sulfation\")", name:"protein sulfation", namespace:"GO"}}, {_id:829, properties:{bel:"pmod(Ph,Y,231)", position:231, amino_acid:"Y", type:"pho"}}, {_id:1363, properties:{name:"post-translational protein modification", bel:"pmod(GO:\"post-translational protein modification\")", namespace:"GO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:ProteinModification;
UNWIND [{_id:201, properties:{name:"nucleus", bel:"toLoc(GO:\"nucleus\")", namespace:"GO"}}, {_id:605, properties:{name:"intracellular", namespace:"GO", bel:"toLoc(GO:\"intracellular\")"}}, {_id:827, properties:{name:"cell body", namespace:"GO", bel:"toLoc(GO:\"cell body\")"}}, {_id:1125, properties:{name:"Brain", bel:"toLoc(MESH:\"Brain\")", namespace:"MESH"}}, {_id:1224, properties:{namespace:"MESH", bel:"toLoc(MESH:\"Parenchymal Tissue\")", name:"Parenchymal Tissue"}}, {_id:1330, properties:{name:"Blood", bel:"toLoc(MESH:\"Blood\")", namespace:"MESH"}}, {_id:1394, properties:{namespace:"FIXME", bel:"toLoc(FIXME:\"damaged mitochondria\")", name:"damaged mitochondria"}}, {_id:1462, properties:{name:"cytosol", bel:"toLoc(GO:\"cytosol\")", namespace:"GO"}}, {_id:1771, properties:{name:"neuron", namespace:"CELL", bel:"toLoc(CELL:\"neuron\")"}}, {_id:2319, properties:{namespace:"MESH", bel:"toLoc(MESH:\"Central Nervous System\")", name:"Central Nervous System"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:ToLocation;
UNWIND [{_id:40, properties:{bel:"sec(a(CHEBI:\"reactive oxygen species\"))"}}, {_id:160, properties:{bel:"sec(p(HGNC:\"IL1A\"))"}}, {_id:161, properties:{bel:"sec(p(HGNC:\"TNF\"))"}}, {_id:177, properties:{bel:"sec(a(MESH:\"Cytokines\"))"}}, {_id:179, properties:{bel:"sec(a(MESH:\"Chemokines\"))"}}, {_id:187, properties:{bel:"sec(p(HGNC:\"IL1B\"))"}}, {_id:206, properties:{bel:"sec(p(GFAM:\"Neurotrophins\"))"}}, {_id:269, properties:{bel:"sec(p(HGNC:\"IFNG\"))"}}, {_id:272, properties:{bel:"sec(p(HGNC:\"IL4\"))"}}, {_id:444, properties:{bel:"sec(a(CHEBI:\"dopamine\"))"}}, {_id:507, properties:{bel:"sec(p(HGNC:\"IL5\"))"}}, {_id:600, properties:{bel:"sec(a(CHEBI:\"neurotoxin\"))"}}, {_id:638, properties:{bel:"sec(p(HGNC:\"IL10\"))"}}, {_id:1370, properties:{bel:"sec(p(MGI:\"Tnf\"))"}}, {_id:1371, properties:{bel:"sec(p(MGI:\"Il1b\"))"}}, {_id:1372, properties:{bel:"sec(p(MGI:\"Il6\"))"}}, {_id:1412, properties:{bel:"sec(p(MGI:\"Ifnb1\"))"}}, {_id:1413, properties:{bel:"sec(p(MGI:\"Il12b\"))"}}, {_id:1415, properties:{bel:"sec(p(MGI:\"Il13\"))"}}, {_id:1416, properties:{bel:"sec(p(MGI:\"Cxcl1\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:CellSecretion;
UNWIND [{_id:1418, properties:{bel:"sec(p(MGI:\"Ccl2\"))"}}, {_id:1419, properties:{bel:"sec(p(MGI:\"Ccl4\"))"}}, {_id:2256, properties:{bel:"sec(p(HGNC:\"TGFB1\"))"}}, {_id:2299, properties:{bel:"sec(p(MGI:\"Pla2g2d\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:CellSecretion;
UNWIND [{_id:61, properties:{bel:"products(a(CHEBI:\"peroxynitrite\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Products;
UNWIND [{_id:446, properties:{name:"Lrrk2", bel:"r(MGI:\"Lrrk2\")", namespace:"MGI", pure:true}}, {_id:452, properties:{name:"LRRK2", bel:"r(HGNC:\"LRRK2\")", namespace:"HGNC", pure:true}}, {_id:821, properties:{namespace:"HGNC", bel:"r(HGNC:\"ACE2\")", name:"ACE2", pure:true}}, {_id:835, properties:{name:"TMPRSS2", bel:"r(HGNC:\"TMPRSS2\")", namespace:"HGNC", pure:true}}, {_id:837, properties:{namespace:"HGNC", bel:"r(HGNC:\"NRP1\")", name:"NRP1", pure:true}}, {_id:842, properties:{namespace:"HGNC", bel:"r(HGNC:\"CCL7\")", name:"CCL7", pure:true}}, {_id:843, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL32\")", name:"IL32", pure:true}}, {_id:844, properties:{namespace:"HGNC", bel:"r(HGNC:\"CCL2\")", name:"CCL2", pure:true}}, {_id:845, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL18\")", name:"IL18", pure:true}}, {_id:846, properties:{name:"CXCL8", bel:"r(HGNC:\"CXCL8\")", namespace:"HGNC", pure:true}}, {_id:849, properties:{namespace:"HGNC", bel:"r(HGNC:\"NPPB\")", name:"NPPB", pure:true}}, {_id:850, properties:{namespace:"HGNC", bel:"r(HGNC:\"VCAN\")", name:"VCAN", pure:true}}, {_id:876, properties:{name:"TMPRSS4", bel:"r(HGNC:\"TMPRSS4\")", namespace:"HGNC", pure:true}}, {_id:877, properties:{namespace:"HGNC", bel:"r(HGNC:\"CTSL\")", name:"CTSL", pure:true}}, {_id:878, properties:{name:"TPCN2", bel:"r(HGNC:\"TPCN2\")", namespace:"HGNC", pure:true}}, {_id:885, properties:{name:"APOA1", bel:"r(HGNC:\"APOA1\")", namespace:"HGNC", pure:true}}, {_id:886, properties:{name:"APOA2", bel:"r(HGNC:\"APOA2\")", namespace:"HGNC", pure:true}}, {_id:965, properties:{name:"STAT1", bel:"r(HGNC:\"STAT1\")", namespace:"HGNC", pure:true}}, {_id:966, properties:{name:"STAT2", bel:"r(HGNC:\"STAT2\")", namespace:"HGNC", pure:true}}, {_id:967, properties:{namespace:"HGNC", bel:"r(HGNC:\"IRF7\")", name:"IRF7", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:968, properties:{namespace:"HGNC", bel:"r(HGNC:\"CCL5\")", name:"CCL5", pure:true}}, {_id:969, properties:{name:"CXCL10", bel:"r(HGNC:\"CXCL10\")", namespace:"HGNC", pure:true}}, {_id:970, properties:{namespace:"HGNC", bel:"r(HGNC:\"MX1\")", name:"MX1", pure:true}}, {_id:971, properties:{name:"IFNA1", bel:"r(HGNC:\"IFNA1\")", namespace:"HGNC", pure:true}}, {_id:972, properties:{name:"IFNB1", bel:"r(HGNC:\"IFNB1\")", namespace:"HGNC", pure:true}}, {_id:973, properties:{namespace:"HGNC", bel:"r(HGNC:\"IFNG\")", name:"IFNG", pure:true}}, {_id:974, properties:{namespace:"HGNC", bel:"r(HGNC:\"TNF\")", name:"TNF", pure:true}}, {_id:975, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL6\")", name:"IL6", pure:true}}, {_id:976, properties:{name:"NLRP1", bel:"r(HGNC:\"NLRP1\")", namespace:"HGNC", pure:true}}, {_id:977, properties:{name:"NLRP3", bel:"r(HGNC:\"NLRP3\")", namespace:"HGNC", pure:true}}, {_id:978, properties:{name:"NLRC4", bel:"r(HGNC:\"NLRC4\")", namespace:"HGNC", pure:true}}, {_id:979, properties:{name:"PYCARD", bel:"r(HGNC:\"PYCARD\")", namespace:"HGNC", pure:true}}, {_id:980, properties:{name:"CASP1", bel:"r(HGNC:\"CASP1\")", namespace:"HGNC", pure:true}}, {_id:981, properties:{name:"IFIT3", bel:"r(HGNC:\"IFIT3\")", namespace:"HGNC", pure:true}}, {_id:982, properties:{namespace:"HGNC", bel:"r(HGNC:\"OAS2\")", name:"OAS2", pure:true}}, {_id:983, properties:{namespace:"HGNC", bel:"r(HGNC:\"TLR3\")", name:"TLR3", pure:true}}, {_id:984, properties:{namespace:"HGNC", bel:"r(HGNC:\"TLR7\")", name:"TLR7", pure:true}}, {_id:985, properties:{namespace:"HGNC", bel:"r(HGNC:\"C3\")", name:"C3", pure:true}}, {_id:986, properties:{namespace:"HGNC", bel:"r(HGNC:\"C1QA\")", name:"C1QA", pure:true}}, {_id:987, properties:{namespace:"HGNC", bel:"r(HGNC:\"C1QB\")", name:"C1QB", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:988, properties:{name:"CAPN1", bel:"r(HGNC:\"CAPN1\")", namespace:"HGNC", pure:true}}, {_id:989, properties:{name:"CAPN2", bel:"r(HGNC:\"CAPN2\")", namespace:"HGNC", pure:true}}, {_id:990, properties:{name:"PAIP2", bel:"r(HGNC:\"PAIP2\")", namespace:"HGNC", pure:true}}, {_id:991, properties:{name:"SEMA3C", bel:"r(HGNC:\"SEMA3C\")", namespace:"HGNC", pure:true}}, {_id:992, properties:{namespace:"HGNC", bel:"r(HGNC:\"DLG1\")", name:"DLG1", pure:true}}, {_id:993, properties:{namespace:"HGNC", bel:"r(HGNC:\"CDK5\")", name:"CDK5", pure:true}}, {_id:994, properties:{name:"CASP3", bel:"r(HGNC:\"CASP3\")", namespace:"HGNC", pure:true}}, {_id:995, properties:{namespace:"HGNC", bel:"r(HGNC:\"BCL2\")", name:"BCL2", pure:true}}, {_id:996, properties:{namespace:"HGNC", bel:"r(HGNC:\"BAX\")", name:"BAX", pure:true}}, {_id:1133, properties:{namespace:"MGI", bel:"r(MGI:\"Il6\")", name:"Il6", pure:true}}, {_id:1134, properties:{namespace:"MGI", bel:"r(MGI:\"Tnf\")", name:"Tnf", pure:true}}, {_id:1135, properties:{namespace:"MGI", bel:"r(MGI:\"Ccl2\")", name:"Ccl2", pure:true}}, {_id:1136, properties:{name:"Q9WVQ8", namespace:"UNIPROT", bel:"r(UNIPROT:\"Q9WVQ8\")", pure:true}}, {_id:1137, properties:{name:"A0A1U7RE37", namespace:"UNIPROT", bel:"r(UNIPROT:\"A0A1U7RE37\")", pure:true}}, {_id:1143, properties:{namespace:"MGI", bel:"r(MGI:\"Mmp9\")", name:"Mmp9", pure:true}}, {_id:1149, properties:{namespace:"MGI", bel:"r(MGI:\"Nrp1\")", name:"Nrp1", pure:true}}, {_id:1150, properties:{namespace:"MGI", bel:"r(MGI:\"Bsg\")", name:"Bsg", pure:true}}, {_id:1155, properties:{namespace:"HGNC", bel:"r(HGNC:\"BSG\")", name:"BSG", pure:true}}, {_id:1274, properties:{name:"IFITM1", bel:"r(HGNC:\"IFITM1\")", namespace:"HGNC", pure:true}}, {_id:1275, properties:{name:"IFITM2", bel:"r(HGNC:\"IFITM2\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1276, properties:{namespace:"HGNC", bel:"r(HGNC:\"HLA-A\")", name:"HLA-A", pure:true}}, {_id:1277, properties:{namespace:"HGNC", bel:"r(HGNC:\"HLA-B\")", name:"HLA-B", pure:true}}, {_id:1278, properties:{namespace:"HGNC", bel:"r(HGNC:\"HLA-C\")", name:"HLA-C", pure:true}}, {_id:1279, properties:{namespace:"HGNC", bel:"r(HGNC:\"HLA-E\")", name:"HLA-E", pure:true}}, {_id:1280, properties:{namespace:"HGNC", bel:"r(HGNC:\"HLA-F\")", name:"HLA-F", pure:true}}, {_id:1281, properties:{namespace:"HGNC", bel:"r(HGNC:\"HLA-G\")", name:"HLA-G", pure:true}}, {_id:1284, properties:{name:"HLA-DPA1", bel:"r(HGNC:\"HLA-DPA1\")", namespace:"HGNC", pure:true}}, {_id:1285, properties:{namespace:"HGNC", bel:"r(HGNC:\"B2M\")", name:"B2M", pure:true}}, {_id:1286, properties:{name:"HLA-DRB3", bel:"r(HGNC:\"HLA-DRB3\")", namespace:"HGNC", pure:true}}, {_id:1287, properties:{name:"IFNGR1", bel:"r(HGNC:\"IFNGR1\")", namespace:"HGNC", pure:true}}, {_id:1288, properties:{name:"HLA-DQB1", bel:"r(HGNC:\"HLA-DQB1\")", namespace:"HGNC", pure:true}}, {_id:1289, properties:{namespace:"HGNC", bel:"r(HGNC:\"CD44\")", name:"CD44", pure:true}}, {_id:1290, properties:{name:"PARP9", bel:"r(HGNC:\"PARP9\")", namespace:"HGNC", pure:true}}, {_id:1293, properties:{namespace:"HGNC", bel:"r(HGNC:\"ALDOC\")", name:"ALDOC", pure:true}}, {_id:1294, properties:{name:"LDHAP7", bel:"r(HGNC:\"LDHAP7\")", namespace:"HGNC", pure:true}}, {_id:1295, properties:{namespace:"HGNC", bel:"r(HGNC:\"LDHA\")", name:"LDHA", pure:true}}, {_id:1296, properties:{name:"SEMA5B", bel:"r(HGNC:\"SEMA5B\")", namespace:"HGNC", pure:true}}, {_id:1297, properties:{name:"TMEM145", bel:"r(HGNC:\"TMEM145\")", namespace:"HGNC", pure:true}}, {_id:1298, properties:{name:"PPFIA4", bel:"r(HGNC:\"PPFIA4\")", namespace:"HGNC", pure:true}}, {_id:1299, properties:{name:"CD300A", bel:"r(HGNC:\"CD300A\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1300, properties:{namespace:"HGNC", bel:"r(HGNC:\"STC1\")", name:"STC1", pure:true}}, {_id:1301, properties:{name:"NDRG1", bel:"r(HGNC:\"NDRG1\")", namespace:"HGNC", pure:true}}, {_id:1302, properties:{name:"ADRA1D", bel:"r(HGNC:\"ADRA1D\")", namespace:"HGNC", pure:true}}, {_id:1303, properties:{namespace:"HGNC", bel:"r(HGNC:\"OAS1\")", name:"OAS1", pure:true}}, {_id:1304, properties:{name:"BFSP2", bel:"r(HGNC:\"BFSP2\")", namespace:"HGNC", pure:true}}, {_id:1305, properties:{namespace:"HGNC", bel:"r(HGNC:\"IFI6\")", name:"IFI6", pure:true}}, {_id:1306, properties:{name:"CMPK2", bel:"r(HGNC:\"CMPK2\")", namespace:"HGNC", pure:true}}, {_id:1307, properties:{namespace:"HGNC", bel:"r(HGNC:\"NKD1\")", name:"NKD1", pure:true}}, {_id:1308, properties:{name:"SLC15A2", bel:"r(HGNC:\"SLC15A2\")", namespace:"HGNC", pure:true}}, {_id:1309, properties:{name:"FOXE3", bel:"r(HGNC:\"FOXE3\")", namespace:"HGNC", pure:true}}, {_id:1374, properties:{namespace:"MGI", bel:"r(MGI:\"Il1a\")", name:"Il1a", pure:true}}, {_id:1375, properties:{name:"Il12b", bel:"r(MGI:\"Il12b\")", namespace:"MGI", pure:true}}, {_id:1376, properties:{name:"Il12a", bel:"r(MGI:\"Il12a\")", namespace:"MGI", pure:true}}, {_id:1377, properties:{namespace:"MGI", bel:"r(MGI:\"Ccl4\")", name:"Ccl4", pure:true}}, {_id:1378, properties:{name:"Cxcl1", bel:"r(MGI:\"Cxcl1\")", namespace:"MGI", pure:true}}, {_id:1379, properties:{namespace:"MGI", bel:"r(MGI:\"Ccl3\")", name:"Ccl3", pure:true}}, {_id:1437, properties:{name:"Parp1", bel:"r(MGI:\"Parp1\")", namespace:"MGI", pure:true}}, {_id:1438, properties:{namespace:"MGI", bel:"r(MGI:\"Mmp8\")", name:"Mmp8", pure:true}}, {_id:1439, properties:{name:"Hmgn1", bel:"r(MGI:\"Hmgn1\")", namespace:"MGI", pure:true}}, {_id:1440, properties:{name:"Nfkbid", bel:"r(MGI:\"Nfkbid\")", namespace:"MGI", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1479, properties:{namespace:"HGNC", bel:"r(HGNC:\"SPP1\")", name:"SPP1", pure:true}}, {_id:1480, properties:{name:"COL8A2", bel:"r(HGNC:\"COL8A2\")", namespace:"HGNC", pure:true}}, {_id:1481, properties:{name:"CHI3L1", bel:"r(HGNC:\"CHI3L1\")", namespace:"HGNC", pure:true}}, {_id:1482, properties:{name:"SLC11A1", bel:"r(HGNC:\"SLC11A1\")", namespace:"HGNC", pure:true}}, {_id:1483, properties:{name:"TREM2", bel:"r(HGNC:\"TREM2\")", namespace:"HGNC", pure:true}}, {_id:1484, properties:{name:"SASH3", bel:"r(HGNC:\"SASH3\")", namespace:"HGNC", pure:true}}, {_id:1485, properties:{name:"NPAS4", bel:"r(HGNC:\"NPAS4\")", namespace:"HGNC", pure:true}}, {_id:1486, properties:{namespace:"HGNC", bel:"r(HGNC:\"EGR3\")", name:"EGR3", pure:true}}, {_id:1487, properties:{namespace:"HGNC", bel:"r(HGNC:\"EGR2\")", name:"EGR2", pure:true}}, {_id:1488, properties:{namespace:"HGNC", bel:"r(HGNC:\"ARC\")", name:"ARC", pure:true}}, {_id:1489, properties:{name:"NR4A3", bel:"r(HGNC:\"NR4A3\")", namespace:"HGNC", pure:true}}, {_id:1509, properties:{namespace:"HGNC", bel:"r(HGNC:\"FURIN\")", name:"FURIN", pure:true}}, {_id:1510, properties:{namespace:"HGNC", bel:"r(HGNC:\"CTSB\")", name:"CTSB", pure:true}}, {_id:1513, properties:{namespace:"HGNC", bel:"r(HGNC:\"LY6E\")", name:"LY6E", pure:true}}, {_id:1520, properties:{namespace:"MGI", bel:"r(MGI:\"Sdc4\")", name:"Sdc4", pure:true}}, {_id:1522, properties:{name:"P0DTC9", namespace:"UNIPROT", bel:"r(UNIPROT:\"P0DTC9\")", pure:true}}, {_id:1531, properties:{namespace:"HGNC", bel:"r(HGNC:\"CD68\")", name:"CD68", pure:true}}, {_id:1532, properties:{name:"ITGB5", bel:"r(HGNC:\"ITGB5\")", namespace:"HGNC", pure:true}}, {_id:1533, properties:{namespace:"HGNC", bel:"r(HGNC:\"CD47\")", name:"CD47", pure:true}}, {_id:1534, properties:{namespace:"HGNC", bel:"r(HGNC:\"MSR1\")", name:"MSR1", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1535, properties:{namespace:"HGNC", bel:"r(HGNC:\"CALR\")", name:"CALR", pure:true}}, {_id:1536, properties:{name:"C3AR1", bel:"r(HGNC:\"C3AR1\")", namespace:"HGNC", pure:true}}, {_id:1537, properties:{name:"FCGR3A", bel:"r(HGNC:\"FCGR3A\")", namespace:"HGNC", pure:true}}, {_id:1541, properties:{name:"ISG15", bel:"r(HGNC:\"ISG15\")", namespace:"HGNC", pure:true}}, {_id:1542, properties:{namespace:"HGNC", bel:"r(HGNC:\"GFAP\")", name:"GFAP", pure:true}}, {_id:1584, properties:{name:"Q1LZX8", namespace:"UNIPROT", bel:"r(UNIPROT:\"Q1LZX8\")", pure:true}}, {_id:1585, properties:{name:"Q14UF1", namespace:"UNIPROT", bel:"r(UNIPROT:\"Q14UF1\")", pure:true}}, {_id:1586, properties:{namespace:"HGNC", bel:"r(HGNC:\"AXL\")", name:"AXL", pure:true}}, {_id:1596, properties:{namespace:"HGNC", bel:"r(HGNC:\"CCL3\")", name:"CCL3", pure:true}}, {_id:1597, properties:{name:"CXCL3", bel:"r(HGNC:\"CXCL3\")", namespace:"HGNC", pure:true}}, {_id:1598, properties:{name:"IFIT1", bel:"r(HGNC:\"IFIT1\")", namespace:"HGNC", pure:true}}, {_id:1599, properties:{namespace:"HGNC", bel:"r(HGNC:\"EGR1\")", name:"EGR1", pure:true}}, {_id:1600, properties:{name:"IFI27", bel:"r(HGNC:\"IFI27\")", namespace:"HGNC", pure:true}}, {_id:1601, properties:{namespace:"HGNC", bel:"r(HGNC:\"BST2\")", name:"BST2", pure:true}}, {_id:1602, properties:{namespace:"HGNC", bel:"r(HGNC:\"CHD1\")", name:"CHD1", pure:true}}, {_id:1603, properties:{name:"HIST1H2BD", bel:"r(HGNC:\"HIST1H2BD\")", namespace:"HGNC", pure:true}}, {_id:1604, properties:{name:"HIST1H2AH", bel:"r(HGNC:\"HIST1H2AH\")", namespace:"HGNC", pure:true}}, {_id:1605, properties:{name:"INO80", bel:"r(HGNC:\"INO80\")", namespace:"HGNC", pure:true}}, {_id:1614, properties:{name:"SLC16A2", bel:"r(HGNC:\"SLC16A2\")", namespace:"HGNC", pure:true}}, {_id:1615, properties:{name:"SLC41A3", bel:"r(HGNC:\"SLC41A3\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1616, properties:{name:"SLC16A10", bel:"r(HGNC:\"SLC16A10\")", namespace:"HGNC", pure:true}}, {_id:1617, properties:{name:"SLC44A1", bel:"r(HGNC:\"SLC44A1\")", namespace:"HGNC", pure:true}}, {_id:1618, properties:{name:"SLC35C2", bel:"r(HGNC:\"SLC35C2\")", namespace:"HGNC", pure:true}}, {_id:1619, properties:{name:"CAMK2D", bel:"r(HGNC:\"CAMK2D\")", namespace:"HGNC", pure:true}}, {_id:1620, properties:{name:"ERBB2", bel:"r(HGNC:\"ERBB2\")", namespace:"HGNC", pure:true}}, {_id:1621, properties:{name:"C1QL1", bel:"r(HGNC:\"C1QL1\")", namespace:"HGNC", pure:true}}, {_id:1622, properties:{name:"SYPL1", bel:"r(HGNC:\"SYPL1\")", namespace:"HGNC", pure:true}}, {_id:1626, properties:{namespace:"HGNC", bel:"r(HGNC:\"AQP4\")", name:"AQP4", pure:true}}, {_id:1656, properties:{name:"IFI44", bel:"r(HGNC:\"IFI44\")", namespace:"HGNC", pure:true}}, {_id:1657, properties:{name:"IFI35", bel:"r(HGNC:\"IFI35\")", namespace:"HGNC", pure:true}}, {_id:1658, properties:{name:"IFI30", bel:"r(HGNC:\"IFI30\")", namespace:"HGNC", pure:true}}, {_id:1659, properties:{name:"IFI44L", bel:"r(HGNC:\"IFI44L\")", namespace:"HGNC", pure:true}}, {_id:1660, properties:{namespace:"HGNC", bel:"r(HGNC:\"MX2\")", name:"MX2", pure:true}}, {_id:1661, properties:{name:"IFIT2", bel:"r(HGNC:\"IFIT2\")", namespace:"HGNC", pure:true}}, {_id:1662, properties:{name:"IFIT5", bel:"r(HGNC:\"IFIT5\")", namespace:"HGNC", pure:true}}, {_id:1663, properties:{name:"ISG20", bel:"r(HGNC:\"ISG20\")", namespace:"HGNC", pure:true}}, {_id:1664, properties:{namespace:"HGNC", bel:"r(HGNC:\"OAS3\")", name:"OAS3", pure:true}}, {_id:1665, properties:{namespace:"HGNC", bel:"r(HGNC:\"OASL\")", name:"OASL", pure:true}}, {_id:1666, properties:{name:"CXCL16", bel:"r(HGNC:\"CXCL16\")", namespace:"HGNC", pure:true}}, {_id:1667, properties:{name:"CXCL1", bel:"r(HGNC:\"CXCL1\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1668, properties:{name:"CXCL2", bel:"r(HGNC:\"CXCL2\")", namespace:"HGNC", pure:true}}, {_id:1669, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL15\")", name:"IL15", pure:true}}, {_id:1670, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL7\")", name:"IL7", pure:true}}, {_id:1678, properties:{name:"APOBEC3B", bel:"r(HGNC:\"APOBEC3B\")", namespace:"HGNC", pure:true}}, {_id:1679, properties:{name:"APOBEC3C", bel:"r(HGNC:\"APOBEC3C\")", namespace:"HGNC", pure:true}}, {_id:1680, properties:{name:"APOBEC3D", bel:"r(HGNC:\"APOBEC3D\")", namespace:"HGNC", pure:true}}, {_id:1681, properties:{name:"APOBEC3G", bel:"r(HGNC:\"APOBEC3G\")", namespace:"HGNC", pure:true}}, {_id:1682, properties:{name:"APOBEC3F", bel:"r(HGNC:\"APOBEC3F\")", namespace:"HGNC", pure:true}}, {_id:1687, properties:{name:"SLC1A2", bel:"r(HGNC:\"SLC1A2\")", namespace:"HGNC", pure:true}}, {_id:1688, properties:{name:"SLC7A10", bel:"r(HGNC:\"SLC7A10\")", namespace:"HGNC", pure:true}}, {_id:1689, properties:{name:"SLC18A3", bel:"r(HGNC:\"SLC18A3\")", namespace:"HGNC", pure:true}}, {_id:1690, properties:{name:"SLC6A1", bel:"r(HGNC:\"SLC6A1\")", namespace:"HGNC", pure:true}}, {_id:1691, properties:{name:"SLC4A10", bel:"r(HGNC:\"SLC4A10\")", namespace:"HGNC", pure:true}}, {_id:1692, properties:{name:"SLCO1C1", bel:"r(HGNC:\"SLCO1C1\")", namespace:"HGNC", pure:true}}, {_id:1693, properties:{namespace:"HGNC", bel:"r(HGNC:\"SYNPR\")", name:"SYNPR", pure:true}}, {_id:1694, properties:{namespace:"HGNC", bel:"r(HGNC:\"SYT1\")", name:"SYT1", pure:true}}, {_id:1695, properties:{name:"TUBB4A", bel:"r(HGNC:\"TUBB4A\")", namespace:"HGNC", pure:true}}, {_id:1816, properties:{name:"IL12B", bel:"r(HGNC:\"IL12B\")", namespace:"HGNC", pure:true}}, {_id:1817, properties:{name:"CXCL11", bel:"r(HGNC:\"CXCL11\")", namespace:"HGNC", pure:true}}, {_id:1818, properties:{name:"DDX58", bel:"r(HGNC:\"DDX58\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1819, properties:{name:"LAMP3", bel:"r(HGNC:\"LAMP3\")", namespace:"HGNC", pure:true}}, {_id:1820, properties:{name:"CD40LG", bel:"r(HGNC:\"CD40LG\")", namespace:"HGNC", pure:true}}, {_id:1821, properties:{name:"S100A12", bel:"r(HGNC:\"S100A12\")", namespace:"HGNC", pure:true}}, {_id:1889, properties:{name:"IL17A", bel:"r(HGNC:\"IL17A\")", namespace:"HGNC", pure:true}}, {_id:1890, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL10\")", name:"IL10", pure:true}}, {_id:1960, properties:{name:"ABCC4", bel:"r(HGNC:\"ABCC4\")", namespace:"HGNC", pure:true}}, {_id:1961, properties:{name:"SLC16A1", bel:"r(HGNC:\"SLC16A1\")", namespace:"HGNC", pure:true}}, {_id:1962, properties:{namespace:"HGNC", bel:"r(HGNC:\"LRP8\")", name:"LRP8", pure:true}}, {_id:1963, properties:{namespace:"HGNC", bel:"r(HGNC:\"OCLN\")", name:"OCLN", pure:true}}, {_id:1964, properties:{name:"CLDN14", bel:"r(HGNC:\"CLDN14\")", namespace:"HGNC", pure:true}}, {_id:1965, properties:{name:"CLDN3", bel:"r(HGNC:\"CLDN3\")", namespace:"HGNC", pure:true}}, {_id:1966, properties:{name:"CLDN24", bel:"r(HGNC:\"CLDN24\")", namespace:"HGNC", pure:true}}, {_id:1967, properties:{name:"CLDN22", bel:"r(HGNC:\"CLDN22\")", namespace:"HGNC", pure:true}}, {_id:1968, properties:{namespace:"HGNC", bel:"r(HGNC:\"KRT8\")", name:"KRT8", pure:true}}, {_id:1969, properties:{name:"AQP11", bel:"r(HGNC:\"AQP11\")", namespace:"HGNC", pure:true}}, {_id:1970, properties:{name:"CLDN15", bel:"r(HGNC:\"CLDN15\")", namespace:"HGNC", pure:true}}, {_id:1971, properties:{name:"MARVELD2", bel:"r(HGNC:\"MARVELD2\")", namespace:"HGNC", pure:true}}, {_id:1972, properties:{name:"CLDN9", bel:"r(HGNC:\"CLDN9\")", namespace:"HGNC", pure:true}}, {_id:1973, properties:{namespace:"HGNC", bel:"r(HGNC:\"CDH5\")", name:"CDH5", pure:true}}, {_id:1974, properties:{namespace:"HGNC", bel:"r(HGNC:\"JAM2\")", name:"JAM2", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1975, properties:{namespace:"HGNC", bel:"r(HGNC:\"TFRC\")", name:"TFRC", pure:true}}, {_id:1976, properties:{name:"SLC7A3", bel:"r(HGNC:\"SLC7A3\")", namespace:"HGNC", pure:true}}, {_id:1977, properties:{namespace:"HGNC", bel:"r(HGNC:\"JAM3\")", name:"JAM3", pure:true}}, {_id:1978, properties:{namespace:"HGNC", bel:"r(HGNC:\"F11R\")", name:"F11R", pure:true}}, {_id:1979, properties:{name:"SLC7A5", bel:"r(HGNC:\"SLC7A5\")", namespace:"HGNC", pure:true}}, {_id:1980, properties:{namespace:"HGNC", bel:"r(HGNC:\"WWC2\")", name:"WWC2", pure:true}}, {_id:1981, properties:{name:"CLDN2", bel:"r(HGNC:\"CLDN2\")", namespace:"HGNC", pure:true}}, {_id:1982, properties:{name:"PECAM1", bel:"r(HGNC:\"PECAM1\")", namespace:"HGNC", pure:true}}, {_id:1984, properties:{bel:"r(HGNC:\"CLDN18\",var(\"tv2a\"))", name:"CLDN18", namespace:"HGNC"}}, {_id:1985, properties:{name:"CLDN19", bel:"r(HGNC:\"CLDN19\")", namespace:"HGNC", pure:true}}, {_id:1986, properties:{name:"CLDN20", bel:"r(HGNC:\"CLDN20\")", namespace:"HGNC", pure:true}}, {_id:1987, properties:{name:"CLDN23", bel:"r(HGNC:\"CLDN23\")", namespace:"HGNC", pure:true}}, {_id:1988, properties:{name:"CLDN5", bel:"r(HGNC:\"CLDN5\")", namespace:"HGNC", pure:true}}, {_id:1989, properties:{name:"CLDN7", bel:"r(HGNC:\"CLDN7\")", namespace:"HGNC", pure:true}}, {_id:1990, properties:{name:"CLDN10", namespace:"HGNC", bel:"r(HGNC:\"CLDN10\",var(\"?\"))"}}, {_id:1991, properties:{namespace:"HGNC", bel:"r(HGNC:\"TJP1\")", name:"TJP1", pure:true}}, {_id:1992, properties:{namespace:"HGNC", bel:"r(HGNC:\"LSR\")", name:"LSR", pure:true}}, {_id:1993, properties:{namespace:"HGNC", bel:"r(HGNC:\"MUC1\")", name:"MUC1", pure:true}}, {_id:1994, properties:{namespace:"HGNC", bel:"r(HGNC:\"MCAM\")", name:"MCAM", pure:true}}, {_id:1995, properties:{name:"CLDN17", bel:"r(HGNC:\"CLDN17\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:1996, properties:{name:"AQP10", bel:"r(HGNC:\"AQP10\")", namespace:"HGNC", pure:true}}, {_id:1997, properties:{name:"MUC1", namespace:"HGNC", bel:"r(HGNC:\"MUC1\",var(\"?\"))"}}, {_id:1998, properties:{name:"CLCN7", bel:"r(HGNC:\"CLCN7\")", namespace:"HGNC", pure:true}}, {_id:1999, properties:{name:"CLDN25", namespace:"HGNC", bel:"r(HGNC:\"CLDN25\",var(\"?\"))"}}, {_id:2000, properties:{namespace:"HGNC", bel:"r(HGNC:\"TJP2\")", name:"TJP2", pure:true}}, {_id:2001, properties:{namespace:"HGNC", bel:"r(HGNC:\"INSR\")", name:"INSR", pure:true}}, {_id:2002, properties:{namespace:"HGNC", bel:"r(HGNC:\"LRP1\")", name:"LRP1", pure:true}}, {_id:2003, properties:{name:"SLC2A1", bel:"r(HGNC:\"SLC2A1\")", namespace:"HGNC", pure:true}}, {_id:2004, properties:{name:"SLC7A1", bel:"r(HGNC:\"SLC7A1\")", namespace:"HGNC", pure:true}}, {_id:2005, properties:{namespace:"HGNC", bel:"r(HGNC:\"CDH1\")", name:"CDH1", pure:true}}, {_id:2006, properties:{name:"KRT18", bel:"r(HGNC:\"KRT18\")", namespace:"HGNC", pure:true}}, {_id:2007, properties:{namespace:"HGNC", bel:"r(HGNC:\"FN1\")", name:"FN1", pure:true}}, {_id:2008, properties:{name:"ABCB1", bel:"r(HGNC:\"ABCB1\")", namespace:"HGNC", pure:true}}, {_id:2009, properties:{name:"MFSD2A", bel:"r(HGNC:\"MFSD2A\")", namespace:"HGNC", pure:true}}, {_id:2010, properties:{name:"CLDN4", bel:"r(HGNC:\"CLDN4\")", namespace:"HGNC", pure:true}}, {_id:2011, properties:{name:"CLDN8", bel:"r(HGNC:\"CLDN8\")", namespace:"HGNC", pure:true}}, {_id:2012, properties:{name:"CLDN11", bel:"r(HGNC:\"CLDN11\")", namespace:"HGNC", pure:true}}, {_id:2013, properties:{name:"CLDN12", namespace:"HGNC", bel:"r(HGNC:\"CLDN12\",var(\"?\"))"}}, {_id:2014, properties:{namespace:"HGNC", bel:"r(HGNC:\"TJP3\")", name:"TJP3", pure:true}}, {_id:2015, properties:{name:"ABCA1", bel:"r(HGNC:\"ABCA1\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2016, properties:{name:"ABCA7", bel:"r(HGNC:\"ABCA7\")", namespace:"HGNC", pure:true}}, {_id:2017, properties:{name:"ABCG2", bel:"r(HGNC:\"ABCG2\")", namespace:"HGNC", pure:true}}, {_id:2018, properties:{namespace:"HGNC", bel:"r(HGNC:\"AGER\")", name:"AGER", pure:true}}, {_id:2019, properties:{name:"RARB", namespace:"HGNC", bel:"r(HGNC:\"RARB\",var(\"?\"))"}}, {_id:2020, properties:{namespace:"HGNC", bel:"r(HGNC:\"RXRA\")", name:"RXRA", pure:true}}, {_id:2021, properties:{namespace:"HGNC", bel:"r(HGNC:\"RXRB\")", name:"RXRB", pure:true}}, {_id:2022, properties:{name:"KRT19", bel:"r(HGNC:\"KRT19\")", namespace:"HGNC", pure:true}}, {_id:2023, properties:{namespace:"HGNC", bel:"r(HGNC:\"VIM\")", name:"VIM", pure:true}}, {_id:2024, properties:{namespace:"HGNC", bel:"r(HGNC:\"APOE\")", name:"APOE", pure:true}}, {_id:2025, properties:{name:"CTNNB1", bel:"r(HGNC:\"CTNNB1\")", namespace:"HGNC", pure:true}}, {_id:2026, properties:{namespace:"HGNC", bel:"r(HGNC:\"VEGFA\")", name:"VEGFA", pure:true}}, {_id:2027, properties:{namespace:"HGNC", bel:"r(HGNC:\"VWF\")", name:"VWF", pure:true}}, {_id:2028, properties:{namespace:"HGNC", bel:"r(HGNC:\"MCAT\")", name:"MCAT", pure:true}}, {_id:2033, properties:{name:"MUC1", namespace:"HGNC", bel:"r(HGNC:\"MUC1\",var(\"tva\"))"}}, {_id:2035, properties:{name:"MUC1", namespace:"HGNC", bel:"r(HGNC:\"MUC1\",var(\"tvb\"))"}}, {_id:2037, properties:{name:"B3GAT1", bel:"r(HGNC:\"B3GAT1\")", namespace:"HGNC", pure:true}}, {_id:2039, properties:{namespace:"HGNC", bel:"r(HGNC:\"ICOS\")", name:"ICOS", pure:true}}, {_id:2041, properties:{name:"SLC3A2", bel:"r(HGNC:\"SLC3A2\")", namespace:"HGNC", pure:true}}, {_id:2044, properties:{name:"CXCR3", bel:"r(HGNC:\"CXCR3\")", namespace:"HGNC", pure:true}}, {_id:2046, properties:{namespace:"HGNC", bel:"r(HGNC:\"CCR4\")", name:"CCR4", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2048, properties:{namespace:"HGNC", bel:"r(HGNC:\"GZMA\")", name:"GZMA", pure:true}}, {_id:2049, properties:{name:"IL2RA", bel:"r(HGNC:\"IL2RA\")", namespace:"HGNC", pure:true}}, {_id:2050, properties:{name:"IL2RB", bel:"r(HGNC:\"IL2RB\")", namespace:"HGNC", pure:true}}, {_id:2052, properties:{namespace:"HGNC", bel:"r(HGNC:\"GZMB\")", name:"GZMB", pure:true}}, {_id:2053, properties:{namespace:"HGNC", bel:"r(HGNC:\"GZMK\")", name:"GZMK", pure:true}}, {_id:2054, properties:{namespace:"HGNC", bel:"r(HGNC:\"PRF1\")", name:"PRF1", pure:true}}, {_id:2055, properties:{namespace:"HGNC", bel:"r(HGNC:\"CCR7\")", name:"CCR7", pure:true}}, {_id:2056, properties:{namespace:"HGNC", bel:"r(HGNC:\"CD27\")", name:"CD27", pure:true}}, {_id:2057, properties:{namespace:"HGNC", bel:"r(HGNC:\"CD28\")", name:"CD28", pure:true}}, {_id:2058, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL7R\")", name:"IL7R", pure:true}}, {_id:2059, properties:{namespace:"HGNC", bel:"r(HGNC:\"SELL\")", name:"SELL", pure:true}}, {_id:2060, properties:{name:"THEMIS", bel:"r(HGNC:\"THEMIS\")", namespace:"HGNC", pure:true}}, {_id:2061, properties:{name:"CNOT6L", bel:"r(HGNC:\"CNOT6L\")", namespace:"HGNC", pure:true}}, {_id:2062, properties:{name:"ZFP36", bel:"r(HGNC:\"ZFP36\")", namespace:"HGNC", pure:true}}, {_id:2063, properties:{name:"ZFP36L2", bel:"r(HGNC:\"ZFP36L2\")", namespace:"HGNC", pure:true}}, {_id:2064, properties:{name:"HLA-DRB1", bel:"r(HGNC:\"HLA-DRB1\")", namespace:"HGNC", pure:true}}, {_id:2065, properties:{name:"HLA-DQA1", bel:"r(HGNC:\"HLA-DQA1\")", namespace:"HGNC", pure:true}}, {_id:2067, properties:{name:"KLRD1", bel:"r(HGNC:\"KLRD1\")", namespace:"HGNC", pure:true}}, {_id:2068, properties:{name:"ITGB2", bel:"r(HGNC:\"ITGB2\")", namespace:"HGNC", pure:true}}, {_id:2069, properties:{namespace:"HGNC", bel:"r(HGNC:\"ITGAL\")", name:"ITGAL", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2070, properties:{namespace:"HGNC", bel:"r(HGNC:\"AOAH\")", name:"AOAH", pure:true}}, {_id:2071, properties:{namespace:"HGNC", bel:"r(HGNC:\"GZMH\")", name:"GZMH", pure:true}}, {_id:2072, properties:{namespace:"HGNC", bel:"r(HGNC:\"NKG7\")", name:"NKG7", pure:true}}, {_id:2073, properties:{name:"KLRG1", bel:"r(HGNC:\"KLRG1\")", namespace:"HGNC", pure:true}}, {_id:2074, properties:{namespace:"HGNC", bel:"r(HGNC:\"GNLY\")", name:"GNLY", pure:true}}, {_id:2075, properties:{namespace:"HGNC", bel:"r(HGNC:\"ZEB2\")", name:"ZEB2", pure:true}}, {_id:2076, properties:{name:"KLRC2", bel:"r(HGNC:\"KLRC2\")", namespace:"HGNC", pure:true}}, {_id:2077, properties:{name:"KLRC3", bel:"r(HGNC:\"KLRC3\")", namespace:"HGNC", pure:true}}, {_id:2078, properties:{name:"TYROBP", bel:"r(HGNC:\"TYROBP\")", namespace:"HGNC", pure:true}}, {_id:2079, properties:{namespace:"HGNC", bel:"r(HGNC:\"LYN\")", name:"LYN", pure:true}}, {_id:2080, properties:{name:"IKZF2", bel:"r(HGNC:\"IKZF2\")", namespace:"HGNC", pure:true}}, {_id:2081, properties:{name:"SMAD7", bel:"r(HGNC:\"SMAD7\")", namespace:"HGNC", pure:true}}, {_id:2082, properties:{namespace:"HGNC", bel:"r(HGNC:\"SKI\")", name:"SKI", pure:true}}, {_id:2083, properties:{namespace:"HGNC", bel:"r(HGNC:\"SKIL\")", name:"SKIL", pure:true}}, {_id:2084, properties:{namespace:"HGNC", bel:"r(HGNC:\"LMNA\")", name:"LMNA", pure:true}}, {_id:2085, properties:{name:"GADD45B", bel:"r(HGNC:\"GADD45B\")", namespace:"HGNC", pure:true}}, {_id:2086, properties:{name:"ITGA4", bel:"r(HGNC:\"ITGA4\")", namespace:"HGNC", pure:true}}, {_id:2087, properties:{namespace:"HGNC", bel:"r(HGNC:\"GAB2\")", name:"GAB2", pure:true}}, {_id:2088, properties:{namespace:"HGNC", bel:"r(HGNC:\"KLF7\")", name:"KLF7", pure:true}}, {_id:2089, properties:{name:"MAP3K1", bel:"r(HGNC:\"MAP3K1\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2090, properties:{namespace:"HGNC", bel:"r(HGNC:\"ID3\")", name:"ID3", pure:true}}, {_id:2091, properties:{namespace:"HGNC", bel:"r(HGNC:\"LEF1\")", name:"LEF1", pure:true}}, {_id:2092, properties:{namespace:"HGNC", bel:"r(HGNC:\"ETS1\")", name:"ETS1", pure:true}}, {_id:2093, properties:{name:"HIST1H1C", bel:"r(HGNC:\"HIST1H1C\")", namespace:"HGNC", pure:true}}, {_id:2094, properties:{name:"HIST1H1D", bel:"r(HGNC:\"HIST1H1D\")", namespace:"HGNC", pure:true}}, {_id:2095, properties:{name:"HIST1H1E", bel:"r(HGNC:\"HIST1H1E\")", namespace:"HGNC", pure:true}}, {_id:2097, properties:{name:"RUNX1", bel:"r(HGNC:\"RUNX1\")", namespace:"HGNC", pure:true}}, {_id:2098, properties:{name:"RUNX2", bel:"r(HGNC:\"RUNX2\")", namespace:"HGNC", pure:true}}, {_id:2099, properties:{name:"RUNX3", bel:"r(HGNC:\"RUNX3\")", namespace:"HGNC", pure:true}}, {_id:2104, properties:{name:"ITGB1", bel:"r(HGNC:\"ITGB1\")", namespace:"HGNC", pure:true}}, {_id:2105, properties:{namespace:"HGNC", bel:"r(HGNC:\"FYN\")", name:"FYN", pure:true}}, {_id:2109, properties:{name:"Chemokine ligands", namespace:"GFAM", bel:"r(GFAM:\"Chemokine ligands\")", pure:true}}, {_id:2110, properties:{name:"CCL19", bel:"r(HGNC:\"CCL19\")", namespace:"HGNC", pure:true}}, {_id:2111, properties:{name:"CCL20", bel:"r(HGNC:\"CCL20\")", namespace:"HGNC", pure:true}}, {_id:2112, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL11\")", name:"IL11", pure:true}}, {_id:2113, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL33\")", name:"IL33", pure:true}}, {_id:2114, properties:{namespace:"HGNC", bel:"r(HGNC:\"ATM\")", name:"ATM", pure:true}}, {_id:2115, properties:{namespace:"HGNC", bel:"r(HGNC:\"CNR1\")", name:"CNR1", pure:true}}, {_id:2116, properties:{namespace:"HGNC", bel:"r(HGNC:\"CTSC\")", name:"CTSC", pure:true}}, {_id:2117, properties:{name:"HMGB2", bel:"r(HGNC:\"HMGB2\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2118, properties:{name:"ICAM1", bel:"r(HGNC:\"ICAM1\")", namespace:"HGNC", pure:true}}, {_id:2119, properties:{name:"NOTCH1", bel:"r(HGNC:\"NOTCH1\")", namespace:"HGNC", pure:true}}, {_id:2120, properties:{name:"SYT11", bel:"r(HGNC:\"SYT11\")", namespace:"HGNC", pure:true}}, {_id:2121, properties:{name:"ANAPC16", bel:"r(HGNC:\"ANAPC16\")", namespace:"HGNC", pure:true}}, {_id:2122, properties:{name:"ANAPC5", bel:"r(HGNC:\"ANAPC5\")", namespace:"HGNC", pure:true}}, {_id:2123, properties:{name:"ANAPC7", bel:"r(HGNC:\"ANAPC7\")", namespace:"HGNC", pure:true}}, {_id:2124, properties:{name:"CCNE1", bel:"r(HGNC:\"CCNE1\")", namespace:"HGNC", pure:true}}, {_id:2125, properties:{name:"CDC26", bel:"r(HGNC:\"CDC26\")", namespace:"HGNC", pure:true}}, {_id:2126, properties:{namespace:"HGNC", bel:"r(HGNC:\"CDK2\")", name:"CDK2", pure:true}}, {_id:2127, properties:{namespace:"HGNC", bel:"r(HGNC:\"CDK4\")", name:"CDK4", pure:true}}, {_id:2128, properties:{name:"CDKN2B", bel:"r(HGNC:\"CDKN2B\")", namespace:"HGNC", pure:true}}, {_id:2129, properties:{namespace:"HGNC", bel:"r(HGNC:\"EED\")", name:"EED", pure:true}}, {_id:2130, properties:{name:"H2AFZ", bel:"r(HGNC:\"H2AFZ\")", namespace:"HGNC", pure:true}}, {_id:2131, properties:{name:"HIST1H3H", bel:"r(HGNC:\"HIST1H3H\")", namespace:"HGNC", pure:true}}, {_id:2132, properties:{name:"HIST1H4E", bel:"r(HGNC:\"HIST1H4E\")", namespace:"HGNC", pure:true}}, {_id:2133, properties:{name:"IGFBP7", bel:"r(HGNC:\"IGFBP7\")", namespace:"HGNC", pure:true}}, {_id:2134, properties:{namespace:"HGNC", bel:"r(HGNC:\"UBB\")", name:"UBB", pure:true}}, {_id:2135, properties:{namespace:"HGNC", bel:"r(HGNC:\"CSF1\")", name:"CSF1", pure:true}}, {_id:2136, properties:{name:"GDF15", bel:"r(HGNC:\"GDF15\")", namespace:"HGNC", pure:true}}, {_id:2137, properties:{name:"IGF2R", bel:"r(HGNC:\"IGF2R\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2138, properties:{namespace:"HGNC", bel:"r(HGNC:\"IL1B\")", name:"IL1B", pure:true}}, {_id:2139, properties:{name:"IL6ST", bel:"r(HGNC:\"IL6ST\")", namespace:"HGNC", pure:true}}, {_id:2140, properties:{name:"IQGAP1", bel:"r(HGNC:\"IQGAP1\")", namespace:"HGNC", pure:true}}, {_id:2141, properties:{name:"TNFRSF11B", bel:"r(HGNC:\"TNFRSF11B\")", namespace:"HGNC", pure:true}}, {_id:2146, properties:{name:"LMNB1", bel:"r(HGNC:\"LMNB1\")", namespace:"HGNC", pure:true}}, {_id:2147, properties:{name:"CDKN1A", bel:"r(HGNC:\"CDKN1A\")", namespace:"HGNC", pure:true}}, {_id:2193, properties:{name:"PRDM1", bel:"r(HGNC:\"PRDM1\")", namespace:"HGNC", pure:true}}, {_id:2195, properties:{name:"SMAD3", bel:"r(HGNC:\"SMAD3\")", namespace:"HGNC", pure:true}}, {_id:2196, properties:{name:"SNAI1", bel:"r(HGNC:\"SNAI1\")", namespace:"HGNC", pure:true}}, {_id:2197, properties:{name:"SMURF1", bel:"r(HGNC:\"SMURF1\")", namespace:"HGNC", pure:true}}, {_id:2199, properties:{namespace:"HGNC", bel:"r(HGNC:\"HES1\")", name:"HES1", pure:true}}, {_id:2200, properties:{namespace:"HGNC", bel:"r(HGNC:\"DLL1\")", name:"DLL1", pure:true}}, {_id:2201, properties:{name:"HIF1A", bel:"r(HGNC:\"HIF1A\")", namespace:"HGNC", pure:true}}, {_id:2203, properties:{name:"PF4V1", bel:"r(HGNC:\"PF4V1\")", namespace:"HGNC", pure:true}}, {_id:2204, properties:{namespace:"HGNC", bel:"r(HGNC:\"PF4\")", name:"PF4", pure:true}}, {_id:2205, properties:{name:"TREML1", bel:"r(HGNC:\"TREML1\")", namespace:"HGNC", pure:true}}, {_id:2207, properties:{name:"F13A1", bel:"r(HGNC:\"F13A1\")", namespace:"HGNC", pure:true}}, {_id:2208, properties:{name:"GP1BA", bel:"r(HGNC:\"GP1BA\")", namespace:"HGNC", pure:true}}, {_id:2209, properties:{name:"GP1BB", bel:"r(HGNC:\"GP1BB\")", namespace:"HGNC", pure:true}}, {_id:2210, properties:{name:"TNFSF9", bel:"r(HGNC:\"TNFSF9\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2212, properties:{namespace:"HGNC", bel:"r(HGNC:\"WASL\")", name:"WASL", pure:true}}, {_id:2213, properties:{namespace:"HGNC", bel:"r(HGNC:\"ID2\")", name:"ID2", pure:true}}, {_id:2214, properties:{name:"TNFAIP3", bel:"r(HGNC:\"TNFAIP3\")", namespace:"HGNC", pure:true}}, {_id:2216, properties:{namespace:"HGNC", bel:"r(HGNC:\"RORA\")", name:"RORA", pure:true}}, {_id:2217, properties:{namespace:"HGNC", bel:"r(HGNC:\"PER1\")", name:"PER1", pure:true}}, {_id:2218, properties:{name:"NRIP1", bel:"r(HGNC:\"NRIP1\")", namespace:"HGNC", pure:true}}, {_id:2220, properties:{name:"IGKV1-12", bel:"r(HGNC:\"IGKV1-12\")", namespace:"HGNC", pure:true}}, {_id:2221, properties:{name:"IGKV1-17", bel:"r(HGNC:\"IGKV1-17\")", namespace:"HGNC", pure:true}}, {_id:2222, properties:{name:"CX3CR1", bel:"r(HGNC:\"CX3CR1\")", namespace:"HGNC", pure:true}}, {_id:2223, properties:{name:"FCGR1B", bel:"r(HGNC:\"FCGR1B\")", namespace:"HGNC", pure:true}}, {_id:2224, properties:{name:"HDAC9", bel:"r(HGNC:\"HDAC9\")", namespace:"HGNC", pure:true}}, {_id:2225, properties:{name:"CD180", bel:"r(HGNC:\"CD180\")", namespace:"HGNC", pure:true}}, {_id:2226, properties:{namespace:"HGNC", bel:"r(HGNC:\"MNDA\")", name:"MNDA", pure:true}}, {_id:2227, properties:{namespace:"HGNC", bel:"r(HGNC:\"SELP\")", name:"SELP", pure:true}}, {_id:2231, properties:{name:"VCAM1", bel:"r(HGNC:\"VCAM1\")", namespace:"HGNC", pure:true}}, {_id:2232, properties:{name:"TGFB1", bel:"r(HGNC:\"TGFB1\")", namespace:"HGNC", pure:true}}, {_id:2297, properties:{name:"FOXP3", bel:"r(HGNC:\"FOXP3\")", namespace:"HGNC", pure:true}}, {_id:2330, properties:{name:"ACTR2", bel:"r(HGNC:\"ACTR2\")", namespace:"HGNC", pure:true}}, {_id:2332, properties:{name:"ATP6AP2", bel:"r(HGNC:\"ATP6AP2\")", namespace:"HGNC", pure:true}}, {_id:2335, properties:{name:"ERMP1", bel:"r(HGNC:\"ERMP1\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:2336, properties:{name:"CHST14", bel:"r(HGNC:\"CHST14\")", namespace:"HGNC", pure:true}}, {_id:2351, properties:{name:"Cxcl10", bel:"r(MGI:\"Cxcl10\")", namespace:"MGI", pure:true}}, {_id:2352, properties:{namespace:"MGI", bel:"r(MGI:\"B2m\")", name:"B2m", pure:true}}, {_id:2353, properties:{name:"H2-D1", bel:"r(MGI:\"H2-D1\")", namespace:"MGI", pure:true}}, {_id:2354, properties:{name:"H2-K1", bel:"r(MGI:\"H2-K1\")", namespace:"MGI", pure:true}}, {_id:2355, properties:{name:"Cd300lf", bel:"r(MGI:\"Cd300lf\")", namespace:"MGI", pure:true}}, {_id:2356, properties:{name:"Trem2", bel:"r(MGI:\"Trem2\")", namespace:"MGI", pure:true}}, {_id:2357, properties:{name:"Sall3", bel:"r(MGI:\"Sall3\")", namespace:"MGI", pure:true}}, {_id:2358, properties:{name:"Adrb1", bel:"r(MGI:\"Adrb1\")", namespace:"MGI", pure:true}}, {_id:2416, properties:{name:"CLDN18", namespace:"HGNC", bel:"r(HGNC:\"CLDN18\")", pure:true}}, {_id:2417, properties:{name:"CLDN10", namespace:"HGNC", bel:"r(HGNC:\"CLDN10\")", pure:true}}, {_id:2418, properties:{name:"CLDN25", namespace:"HGNC", bel:"r(HGNC:\"CLDN25\")", pure:true}}, {_id:2419, properties:{name:"CLDN12", namespace:"HGNC", bel:"r(HGNC:\"CLDN12\")", pure:true}}, {_id:2420, properties:{name:"RARB", namespace:"HGNC", bel:"r(HGNC:\"RARB\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Rna;
UNWIND [{_id:11, properties:{bel:"act(p(HGNC:\"IL1B\"))"}}, {_id:24, properties:{bel:"act(complex(GO:\"NF-kappaB complex\"))"}}, {_id:45, properties:{bel:"act(p(HGNC:\"NOS2\"))"}}, {_id:92, properties:{bel:"act(p(HGNC:\"PTGS1\"))"}}, {_id:94, properties:{bel:"act(p(HGNC:\"PTGS2\"))"}}, {_id:174, properties:{bel:"act(p(GFAM:\"Toll like receptors\"))"}}, {_id:238, properties:{bel:"act(a(MESH:\"Antigen-Presenting Cells\"))"}}, {_id:326, properties:{bel:"act(p(HGNC:\"CASP3\"))"}}, {_id:361, properties:{bel:"act(p(HGNC:\"TLR4\"))"}}, {_id:371, properties:{bel:"act(p(MGI:\"Snca\"))"}}, {_id:414, properties:{bel:"act(p(HGNC:\"SOD1\"))"}}, {_id:420, properties:{bel:"act(p(MGI:\"Rag2\"))"}}, {_id:451, properties:{bel:"act(p(HGNC:\"IFNG\"))"}}, {_id:456, properties:{bel:"act(p(HGNC:\"LRRK2\"))"}}, {_id:467, properties:{name:"ubiquitin-ubiquitin ligase activity", bel:"act(p(HGNC:\"PRKN\"),ma(GO:\"ubiquitin-ubiquitin ligase activity\"))", namespace:"GO"}}, {_id:474, properties:{bel:"act(p(HGNC:\"PRKN\"))"}}, {_id:480, properties:{bel:"act(p(MGI:\"Tnf\"))"}}, {_id:481, properties:{bel:"act(p(HGNC:\"SNCA\"))"}}, {_id:493, properties:{bel:"act(p(HGNC:\"ITGA4\"))"}}, {_id:567, properties:{bel:"act(complex(GO:\"mitochondrial respiratory chain complex I\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Activity;
UNWIND [{_id:587, properties:{bel:"act(p(HGNC:\"LRRK2\"),ma(GO:\"kinase activity\"))", name:"kinase activity", namespace:"GO"}}, {_id:588, properties:{namespace:"GO", bel:"act(p(HGNC:\"LRRK2\"),ma(GO:\"GTPase activity\"))", name:"GTPase activity"}}, {_id:627, properties:{bel:"act(p(HGNC:\"SDC3\"))"}}, {_id:630, properties:{bel:"act(p(HGNC:\"SDC1\"))"}}, {_id:631, properties:{bel:"act(p(HGNC:\"SDC2\"))"}}, {_id:674, properties:{bel:"act(complex(GO:\"NLRP3 inflammasome complex\"))"}}, {_id:759, properties:{bel:"act(complex(GO:\"creatine kinase complex\"))"}}, {_id:953, properties:{bel:"act(p(HGNC:\"ACE2\"))"}}, {_id:961, properties:{bel:"act(p(UNIPROT:\"P0DTC2\"))"}}, {_id:1017, properties:{bel:"act(p(HGNC:\"ADAMTS13\"))"}}, {_id:1056, properties:{bel:"act(p(HGNC:\"C3\"))"}}, {_id:1166, properties:{bel:"act(p(HGNC:\"IKBKG\"))"}}, {_id:1193, properties:{bel:"act(p(HGNC:\"RELA\"))"}}, {_id:1198, properties:{bel:"act(p(MGI:\"Rela\"))"}}, {_id:1205, properties:{bel:"act(p(MGI:\"Ikbkg\"))"}}, {_id:1206, properties:{bel:"act(p(MGI:\"Casp3\"))"}}, {_id:1273, properties:{bel:"act(p(HGNC:\"SDC4\"))"}}, {_id:1385, properties:{bel:"act(p(MGI:\"Lrrk2\"),ma(GO:\"kinase activity\"))", name:"kinase activity", namespace:"GO"}}, {_id:1390, properties:{bel:"act(p(MGI:\"Lrrk2\"))"}}, {_id:1450, properties:{bel:"act(p(HGNC:\"GBA\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Activity;
UNWIND [{_id:1451, properties:{namespace:"GO", bel:"act(p(HGNC:\"GBA\"),ma(GO:\"glucosylceramidase activity\"))", name:"glucosylceramidase activity"}}, {_id:1587, properties:{bel:"act(p(HGNC:\"NRP1\"))"}}, {_id:1591, properties:{bel:"act(p(UNIPROT:\"Q14UF1\"))"}}, {_id:1608, properties:{bel:"act(p(GFAM:\"Mitogen-activated protein kinases\"))"}}, {_id:1673, properties:{bel:"act(p(HGNC:\"IFIH1\"))"}}, {_id:1675, properties:{bel:"act(p(HGNC:\"DDX58\"))"}}, {_id:1732, properties:{bel:"act(a(GO:\"lysosome\"))"}}, {_id:1733, properties:{bel:"act(p(HGNC:\"CD68\"))"}}, {_id:1737, properties:{bel:"act(p(HGNC:\"IL6\"))"}}, {_id:1738, properties:{bel:"act(p(HGNC:\"TNF\"))"}}, {_id:1784, properties:{bel:"act(p(HGNC:\"LEP\"))"}}, {_id:1861, properties:{bel:"act(p(HGNC:\"PINK1\"))"}}, {_id:1908, properties:{bel:"act(p(HGNC:\"STIP1\"))"}}, {_id:1939, properties:{bel:"act(complex(GO:\"inflammasome complex\"))"}}, {_id:2143, properties:{bel:"act(p(HGNC:\"GLB1\"))"}}, {_id:2160, properties:{bel:"act(p(HGNC:\"TH\"))"}}, {_id:2228, properties:{bel:"act(p(HGNC:\"ICAM1\"))"}}, {_id:2229, properties:{bel:"act(p(HGNC:\"VCAM1\"))"}}, {_id:2249, properties:{bel:"act(p(HGNC:\"TGFB1\"))"}}, {_id:2274, properties:{bel:"act(p(GFAM:\"Purinergic receptors P2X\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Activity;
UNWIND [{_id:2325, properties:{bel:"act(complex(p(HGNC:\"CD3D\"),p(HGNC:\"CD3E\"),p(HGNC:\"CD3G\")))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Activity;
UNWIND [{_id:22, properties:{bel:"complex(p(HGNC:\"AGER\"),p(HGNC:\"APP\"))", pure:true}}, {_id:23, properties:{namespace:"GO", bel:"complex(GO:\"NF-kappaB complex\")", name:"NF-kappaB complex", pure:true}}, {_id:98, properties:{bel:"complex(p(GFAM:\"C1q domain containing\"),p(HGNC:\"APCS\"),p(HGNC:\"APP\"))", pure:true}}, {_id:225, properties:{bel:"complex(a(MESH:\"T-Lymphocytes\"),p(MGI:\"Snca\",pmod(FIXME:\"protein nitration\")))", pure:true}}, {_id:233, properties:{name:"MHC class II protein complex", bel:"complex(GO:\"MHC class II protein complex\")", namespace:"GO", pure:true}}, {_id:246, properties:{name:"IgG immunoglobulin complex", bel:"complex(GO:\"IgG immunoglobulin complex\")", namespace:"GO", pure:true}}, {_id:247, properties:{bel:"complex(a(MESH:\"Dopaminergic Neurons\"),complex(GO:\"IgG immunoglobulin complex\"))", pure:true}}, {_id:254, properties:{bel:"complex(a(MESH:\"Microglia\"),p(GFAM:\"C1q domain containing\"))", pure:true}}, {_id:255, properties:{bel:"complex(a(MESH:\"neuromelanin\"),p(GFAM:\"C1q domain containing\"))", pure:true}}, {_id:279, properties:{name:"alpha-beta T cell receptor complex", bel:"complex(GO:\"alpha-beta T cell receptor complex\")", namespace:"GO", pure:true}}, {_id:400, properties:{name:"MHC class I protein complex", bel:"complex(GO:\"MHC class I protein complex\")", namespace:"GO", pure:true}}, {_id:423, properties:{bel:"complex(p(HGNC:\"FAS\"),p(HGNC:\"FASLG\"))", pure:true}}, {_id:432, properties:{namespace:"GO", bel:"complex(GO:\"Fc receptor complex\")", name:"Fc receptor complex", pure:true}}, {_id:468, properties:{namespace:"GO", bel:"complex(GO:\"proteasome complex\")", name:"proteasome complex", pure:true}}, {_id:488, properties:{bel:"complex(p(HGNC:\"CD28\"),p(HGNC:\"CD80\"))", pure:true}}, {_id:490, properties:{bel:"complex(p(HGNC:\"CD28\"),p(HGNC:\"CD86\"))", pure:true}}, {_id:523, properties:{bel:"complex(g(HGNC:\"HLA-DRB1\",var(\"?\")),p(HGNC:\"SNCA\"))", pure:true}}, {_id:524, properties:{bel:"complex(g(HGNC:\"HLA-DRB5\",var(\"?\")),p(HGNC:\"SNCA\"))", pure:true}}, {_id:527, properties:{bel:"complex(g(HGNC:\"HLA-DQB1\",var(\"?\")),p(HGNC:\"SNCA\"))", pure:true}}, {_id:530, properties:{bel:"complex(g(HGNC:\"HLA-DRB3\",var(\"?\")),p(HGNC:\"SNCA\"))", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Complex;
UNWIND [{_id:532, properties:{bel:"complex(g(HGNC:\"HLA-A\",var(\"?\")),p(HGNC:\"SNCA\"))", pure:true}}, {_id:566, properties:{bel:"complex(GO:\"mitochondrial respiratory chain complex I\")", name:"mitochondrial respiratory chain complex I", namespace:"GO", pure:true}}, {_id:610, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(HGNC:\"APP\",frag(\"1_42\")))", pure:true}}, {_id:615, properties:{bel:"complex(p(GO:\"external side of plasma membrane\"),p(HGNC:\"APP\",frag(\"1_42\")))", pure:true}}, {_id:617, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(HGNC:\"TF\"))", pure:true}}, {_id:624, properties:{bel:"complex(a(CHEBI:\"sodium chlorate\"),p(HGNC:\"SDC3\"))", pure:true}}, {_id:625, properties:{bel:"complex(a(CHEBI:\"sodium chlorate\"),p(HGNC:\"SDC4\"))", pure:true}}, {_id:632, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(HGNC:\"SNCA\"))", pure:true}}, {_id:633, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(HGNC:\"MAPT\"))", pure:true}}, {_id:673, properties:{name:"NLRP3 inflammasome complex", bel:"complex(GO:\"NLRP3 inflammasome complex\")", namespace:"GO", pure:true}}, {_id:702, properties:{name:"IgM immunoglobulin complex", bel:"complex(GO:\"IgM immunoglobulin complex\")", namespace:"GO", pure:true}}, {_id:758, properties:{namespace:"GO", bel:"complex(GO:\"creatine kinase complex\")", name:"creatine kinase complex", pure:true}}, {_id:776, properties:{bel:"complex(a(TAX:\"Severe acute respiratory syndrome coronavirus 2\"),p(HGNC:\"ACE2\"))", pure:true}}, {_id:1008, properties:{namespace:"GO", bel:"complex(GO:\"fibrinogen complex\")", name:"fibrinogen complex", pure:true}}, {_id:1032, properties:{bel:"complex(a(CHEBI:\"deoxyribonucleic acid\"),p(HGNC:\"MPO\"))", pure:true}}, {_id:1035, properties:{bel:"complex(a(MESH:\"Antithrombins\"),p(HGNC:\"F2\"))", pure:true}}, {_id:1048, properties:{bel:"complex(a(MESH:\"eculizumab\"),p(HGNC:\"C5\"))", pure:true}}, {_id:1052, properties:{bel:"complex(a(NCIT:\"Ravulizumab\"),p(HGNC:\"C5\"))", pure:true}}, {_id:1079, properties:{bel:"complex(a(TAX:\"Severe acute respiratory syndrome coronavirus 2\"),p(HGNC:\"SDC4\"))", pure:true}}, {_id:1084, properties:{bel:"complex(p(HGNC:\"SDC4\",var(\"p.CBD_del\")),p(HGNC:\"SDC4\",var(\"p.HSA_del\")))", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Complex;
UNWIND [{_id:1093, properties:{bel:"complex(p(HGNC:\"SDC4\"),p(UNIPROT:\"P0DTC2\",frag(\"14_685\")))", pure:true}}, {_id:1106, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(HGNC:\"APOE\",var(\"p.His158Cys\"),var(\"p.Ser112Cys\")))", pure:true}}, {_id:1107, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Cys\")))", pure:true}}, {_id:1108, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Arg\")))", pure:true}}, {_id:1140, properties:{namespace:"GO", bel:"complex(GO:\"collagen type IV trimer\")", name:"collagen type IV trimer", pure:true}}, {_id:1268, properties:{bel:"complex(a(CHEBI:\"heparan sulfate\"),p(UNIPROT:\"P0DTC2\"))", pure:true}}, {_id:1269, properties:{bel:"complex(p(HGNC:\"ACE2\"),p(UNIPROT:\"P0DTC2\"))", pure:true}}, {_id:1272, properties:{bel:"complex(a(GO:\"plasma membrane\"),p(UNIPROT:\"P0DTC2\",var(\"p.D614G\"),var(\"p.D950N\"),var(\"p.L452R\"),var(\"p.P681R\"),var(\"p.R158G\"),var(\"p.T19R\"),var(\"p.T478K\"),var(\"p.del156EF157\")))", pure:true}}, {_id:1337, properties:{namespace:"GO", bel:"complex(GO:\"curli\")", name:"curli", pure:true}}, {_id:1347, properties:{namespace:"GO", bel:"complex(GO:\"GABA receptor complex\")", name:"GABA receptor complex", pure:true}}, {_id:1387, properties:{bel:"complex(p(MGI:\"Lrrk2\"),p(MGI:\"Traf6\"))", pure:true}}, {_id:1441, properties:{bel:"complex(p(MGI:\"Park7\"),p(MGI:\"Rela\"))", pure:true}}, {_id:1447, properties:{bel:"complex(p(HGNC:\"S100A8\"),p(HGNC:\"S100A9\"))", pure:true}}, {_id:1774, properties:{bel:"complex(a(MESH:\"Neuroglia\"),a(MESH:\"Neurons\"))", pure:true}}, {_id:1792, properties:{bel:"complex(p(HGNC:\"IL12A\"),p(HGNC:\"IL12B\"))", pure:true}}, {_id:1938, properties:{namespace:"GO", bel:"complex(GO:\"inflammasome complex\")", name:"inflammasome complex", pure:true}}, {_id:2248, properties:{bel:"complex(p(HGNC:\"LRRC32\"),p(HGNC:\"TGFB1\"))", pure:true}}, {_id:2269, properties:{bel:"complex(complex(GO:\"MHC class II protein complex\"),p(HGNC:\"LAG3\"))", pure:true}}, {_id:2281, properties:{bel:"complex(p(MGI:\"Ccl25\"),p(MGI:\"Ccr9\"))", pure:true}}, {_id:2324, properties:{bel:"complex(p(HGNC:\"CD3D\"),p(HGNC:\"CD3E\"),p(HGNC:\"CD3G\"))", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Complex;
UNWIND [{_id:200, properties:{name:"cytoplasm", namespace:"GO", bel:"fromLoc(GO:\"cytoplasm\")"}}, {_id:604, properties:{namespace:"GO", bel:"fromLoc(GO:\"extracellular region\")", name:"extracellular region"}}, {_id:826, properties:{namespace:"GO", bel:"fromLoc(GO:\"axon\")", name:"axon"}}, {_id:1124, properties:{name:"Blood", namespace:"MESH", bel:"fromLoc(MESH:\"Blood\")"}}, {_id:1212, properties:{bel:"fromLoc(MESH:\"Blood Vessels\")", name:"Blood Vessels", namespace:"MESH"}}, {_id:1329, properties:{namespace:"MESH", bel:"fromLoc(MESH:\"Gastrointestinal Tract\")", name:"Gastrointestinal Tract"}}, {_id:1393, properties:{name:"cytosol", namespace:"GO", bel:"fromLoc(GO:\"cytosol\")"}}, {_id:1461, properties:{namespace:"FIXME", bel:"fromLoc(FIXME:\"damaged mitochondria\")", name:"damaged mitochondria"}}, {_id:1770, properties:{name:"neuron", namespace:"CELL", bel:"fromLoc(CELL:\"neuron\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:FromLocation;
UNWIND [{_id:5, properties:{namespace:"GO", bel:"bp(GO:\"microglial cell activation\")", name:"microglial cell activation"}}, {_id:15, properties:{namespace:"GO", bel:"bp(GO:\"glial cell activation\")", name:"glial cell activation"}}, {_id:16, properties:{namespace:"GO", bel:"bp(GO:\"astrocyte activation\")", name:"astrocyte activation"}}, {_id:17, properties:{namespace:"GO", bel:"bp(GO:\"inflammatory response\")", name:"inflammatory response"}}, {_id:19, properties:{name:"cytokine-mediated signaling pathway", bel:"bp(GO:\"cytokine-mediated signaling pathway\")", namespace:"GO"}}, {_id:34, properties:{name:"complement-dependent cytotoxicity", bel:"bp(GO:\"complement-dependent cytotoxicity\")", namespace:"GO"}}, {_id:39, properties:{name:"Oxidative Stress", namespace:"MESH", bel:"bp(MESH:\"Oxidative Stress\")"}}, {_id:47, properties:{namespace:"GO", bel:"bp(GO:\"aging\")", name:"aging"}}, {_id:70, properties:{bel:"bp(GO:\"cytokine production involved in inflammatory response\")", name:"cytokine production involved in inflammatory response", namespace:"GO"}}, {_id:74, properties:{name:"cognition", bel:"bp(GO:\"cognition\")", namespace:"GO"}}, {_id:76, properties:{namespace:"FIXME", bel:"bp(FIXME:\"response to tissue injury\")", name:"response to tissue injury"}}, {_id:82, properties:{bel:"bp(GO:\"production of molecular mediator involved in inflammatory response\")", name:"production of molecular mediator involved in inflammatory response", namespace:"GO"}}, {_id:83, properties:{namespace:"GO", bel:"bp(GO:\"neutrophil chemotaxis\")", name:"neutrophil chemotaxis"}}, {_id:84, properties:{namespace:"GO", bel:"bp(GO:\"monocyte chemotaxis\")", name:"monocyte chemotaxis"}}, {_id:99, properties:{namespace:"GO", bel:"bp(GO:\"cytokine production\")", name:"cytokine production"}}, {_id:106, properties:{name:"cell death", bel:"bp(GO:\"cell death\")", namespace:"GO"}}, {_id:119, properties:{name:"phagocytosis", namespace:"GO", bel:"bp(GO:\"phagocytosis\")"}}, {_id:122, properties:{name:"Motor Activity", namespace:"MESH", bel:"bp(MESH:\"Motor Activity\")"}}, {_id:125, properties:{namespace:"FIXME", bel:"bp(FIXME:\"microglial priming\")", name:"microglial priming"}}, {_id:138, properties:{name:"cellular response to misfolded protein", bel:"bp(GO:\"cellular response to misfolded protein\")", namespace:"GO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:139, properties:{bel:"bp(GO:\"negative regulation of adaptive immune response\")", name:"negative regulation of adaptive immune response", namespace:"GO"}}, {_id:140, properties:{name:"microglial cell mediated cytotoxicity", bel:"bp(GO:\"microglial cell mediated cytotoxicity\")", namespace:"GO"}}, {_id:142, properties:{namespace:"GO", bel:"bp(GO:\"lymphocyte chemotaxis\")", name:"lymphocyte chemotaxis"}}, {_id:156, properties:{name:"immune response", namespace:"GO", bel:"bp(GO:\"immune response\")"}}, {_id:162, properties:{bel:"bp(GO:\"maintenance of permeability of blood-brain barrier\")", name:"maintenance of permeability of blood-brain barrier", namespace:"GO"}}, {_id:165, properties:{namespace:"GO", bel:"bp(GO:\"T cell extravasation\")", name:"T cell extravasation"}}, {_id:166, properties:{namespace:"FIXME", bel:"bp(FIXME:\"B cell extravasation\")", name:"B cell extravasation"}}, {_id:167, properties:{namespace:"GO", bel:"bp(GO:\"lymphocyte migration\")", name:"lymphocyte migration"}}, {_id:169, properties:{name:"Homeostasis", namespace:"MESH", bel:"bp(MESH:\"Homeostasis\")"}}, {_id:170, properties:{namespace:"GO", bel:"bp(GO:\"innate immune response\")", name:"innate immune response"}}, {_id:175, properties:{namespace:"GO", bel:"bp(GO:\"chemokine production\")", name:"chemokine production"}}, {_id:176, properties:{bel:"bp(GO:\"microglial cell activation involved in immune response\")", name:"microglial cell activation involved in immune response", namespace:"GO"}}, {_id:180, properties:{namespace:"GO", bel:"bp(GO:\"adaptive immune response\")", name:"adaptive immune response"}}, {_id:181, properties:{namespace:"GO", bel:"bp(GO:\"neuron cellular homeostasis\")", name:"neuron cellular homeostasis"}}, {_id:186, properties:{namespace:"GO", bel:"bp(GO:\"cellular extravasation\")", name:"cellular extravasation"}}, {_id:188, properties:{namespace:"GO", bel:"bp(GO:\"endothelial cell activation\")", name:"endothelial cell activation"}}, {_id:192, properties:{name:"lymphocyte migration into lymphoid organs", bel:"bp(GO:\"lymphocyte migration into lymphoid organs\")", namespace:"GO"}}, {_id:193, properties:{namespace:"GO", bel:"bp(GO:\"lymphocyte activation\")", name:"lymphocyte activation"}}, {_id:197, properties:{namespace:"FIXME", bel:"bp(FIXME:\"response to brain injury\")", name:"response to brain injury"}}, {_id:198, properties:{name:"T cell activation", namespace:"GO", bel:"bp(GO:\"T cell activation\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:199, properties:{name:"Neuroprotection", namespace:"MESH", bel:"bp(MESH:\"Neuroprotection\")"}}, {_id:208, properties:{namespace:"GO", bel:"bp(GO:\"response to misfolded protein\")", name:"response to misfolded protein"}}, {_id:209, properties:{name:"antigen processing and presentation", bel:"bp(GO:\"antigen processing and presentation\")", namespace:"GO"}}, {_id:213, properties:{namespace:"GO", bel:"bp(GO:\"Lewy body formation\")", name:"Lewy body formation"}}, {_id:222, properties:{namespace:"FIXME", bel:"bp(FIXME:\"alpha-synuclein aggregation\")", name:"alpha-synuclein aggregation"}}, {_id:223, properties:{name:"neuron death", namespace:"GO", bel:"bp(GO:\"neuron death\")"}}, {_id:226, properties:{name:"B cell chemotaxis", namespace:"GO", bel:"bp(GO:\"B cell chemotaxis\")"}}, {_id:227, properties:{name:"T cell chemotaxis", namespace:"GO", bel:"bp(GO:\"T cell chemotaxis\")"}}, {_id:228, properties:{namespace:"FIXME", bel:"bp(FIXME:\"lymphocyte infiltration\")", name:"lymphocyte infiltration"}}, {_id:236, properties:{namespace:"GO", bel:"bp(GO:\"monocyte activation\")", name:"monocyte activation"}}, {_id:239, properties:{namespace:"GO", bel:"bp(GO:\"humoral immune response\")", name:"humoral immune response"}}, {_id:240, properties:{namespace:"GO", bel:"bp(GO:\"leukocyte mediated immunity\")", name:"leukocyte mediated immunity"}}, {_id:249, properties:{name:"Antigen-Antibody Reactions", bel:"bp(MESH:\"Antigen-Antibody Reactions\")", namespace:"MESH"}}, {_id:252, properties:{name:"opsonization", namespace:"GO", bel:"bp(GO:\"opsonization\")"}}, {_id:253, properties:{namespace:"GO", bel:"bp(GO:\"complement activation\")", name:"complement activation"}}, {_id:259, properties:{name:"Lymphocyte Count", namespace:"MESH", bel:"bp(MESH:\"Lymphocyte Count\")"}}, {_id:281, properties:{name:"T-helper 1 cell extravasation", bel:"bp(GO:\"T-helper 1 cell extravasation\")", namespace:"GO"}}, {_id:282, properties:{name:"T-helper 17 cell extravasation", bel:"bp(GO:\"T-helper 17 cell extravasation\")", namespace:"GO"}}, {_id:285, properties:{name:"Autoimmunity", namespace:"MESH", bel:"bp(MESH:\"Autoimmunity\")"}}, {_id:286, properties:{namespace:"GO", bel:"bp(GO:\"leukocyte homeostasis\")", name:"leukocyte homeostasis"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:304, properties:{bel:"bp(FIXME:\"suppressor activity of regulatory T cell\")", name:"suppressor activity of regulatory T cell", namespace:"FIXME"}}, {_id:305, properties:{namespace:"FIXME", bel:"bp(FIXME:\"effector T cell response\")", name:"effector T cell response"}}, {_id:306, properties:{bel:"bp(GO:\"T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell\")", name:"T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell", namespace:"GO"}}, {_id:322, properties:{namespace:"GO", bel:"bp(GO:\"viral genome replication\")", name:"viral genome replication"}}, {_id:323, properties:{namespace:"GO", bel:"bp(GO:\"viral release from host cell\")", name:"viral release from host cell"}}, {_id:327, properties:{bel:"bp(GO:\"granzyme-mediated apoptotic signaling pathway\")", name:"granzyme-mediated apoptotic signaling pathway", namespace:"GO"}}, {_id:329, properties:{namespace:"GO", bel:"bp(GO:\"cell redox homeostasis\")", name:"cell redox homeostasis"}}, {_id:330, properties:{name:"cell migration", namespace:"GO", bel:"bp(GO:\"cell migration\")"}}, {_id:334, properties:{namespace:"GO", bel:"bp(GO:\"macrophage chemotaxis\")", name:"macrophage chemotaxis"}}, {_id:335, properties:{namespace:"GO", bel:"bp(GO:\"microglial cell migration\")", name:"microglial cell migration"}}, {_id:336, properties:{name:"adaptive immune effector response", bel:"bp(GO:\"adaptive immune effector response\")", namespace:"GO"}}, {_id:337, properties:{namespace:"MESH", bel:"bp(MESH:\"Antigen Presentation\")", name:"Antigen Presentation"}}, {_id:352, properties:{namespace:"GO", bel:"bp(GO:\"neuron apoptotic process\")", name:"neuron apoptotic process"}}, {_id:355, properties:{namespace:"GO", bel:"bp(GO:\"mitochondrial transport\")", name:"mitochondrial transport"}}, {_id:357, properties:{namespace:"GO", bel:"bp(GO:\"cellular respiration\")", name:"cellular respiration"}}, {_id:359, properties:{name:"proteasomal protein catabolic process", bel:"bp(GO:\"proteasomal protein catabolic process\")", namespace:"GO"}}, {_id:367, properties:{name:"cell adhesion molecule production", bel:"bp(GO:\"cell adhesion molecule production\")", namespace:"GO"}}, {_id:373, properties:{namespace:"GO", bel:"bp(GO:\"leukocyte chemotaxis\")", name:"leukocyte chemotaxis"}}, {_id:374, properties:{name:"cell activation involved in immune response", bel:"bp(GO:\"cell activation involved in immune response\")", namespace:"GO"}}, {_id:377, properties:{name:"cell proliferation", namespace:"GO", bel:"bp(GO:\"cell proliferation\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:396, properties:{namespace:"GO", bel:"bp(GO:\"locomotory behavior\")", name:"locomotory behavior"}}, {_id:401, properties:{bel:"bp(GO:\"CD8-positive, alpha-beta T cell activation\")", name:"CD8-positive, alpha-beta T cell activation", namespace:"GO"}}, {_id:404, properties:{name:"CD4-CD8 Ratio", namespace:"MESH", bel:"bp(MESH:\"CD4-CD8 Ratio\")"}}, {_id:407, properties:{namespace:"GO", bel:"bp(GO:\"memory T cell activation\")", name:"memory T cell activation"}}, {_id:410, properties:{name:"DNA Breaks, Single-Stranded", bel:"bp(MESH:\"DNA Breaks, Single-Stranded\")", namespace:"MESH"}}, {_id:416, properties:{name:"cell adhesion", namespace:"GO", bel:"bp(GO:\"cell adhesion\")"}}, {_id:417, properties:{name:"diapedesis", bel:"bp(GO:\"diapedesis\")", namespace:"GO"}}, {_id:424, properties:{namespace:"GO", bel:"bp(GO:\"T cell proliferation\")", name:"T cell proliferation"}}, {_id:425, properties:{name:"regulation of T cell proliferation", bel:"bp(GO:\"regulation of T cell proliferation\")", namespace:"GO"}}, {_id:435, properties:{namespace:"GO", bel:"bp(GO:\"homeostatic process\")", name:"homeostatic process"}}, {_id:438, properties:{name:"autophagy", bel:"bp(GO:\"autophagy\")", namespace:"GO"}}, {_id:439, properties:{name:"T cell homeostasis", namespace:"GO", bel:"bp(GO:\"T cell homeostasis\")"}}, {_id:445, properties:{namespace:"GO", bel:"bp(GO:\"macrophage activation\")", name:"macrophage activation"}}, {_id:455, properties:{name:"cytokine secretion", namespace:"GO", bel:"bp(GO:\"cytokine secretion\")"}}, {_id:463, properties:{name:"Transcriptional Activation", bel:"bp(MESH:\"Transcriptional Activation\")", namespace:"MESH"}}, {_id:470, properties:{namespace:"PW", bel:"bp(PW:\"ubiquitination pathway\")", name:"ubiquitination pathway"}}, {_id:472, properties:{name:"mitophagy", bel:"bp(GO:\"mitophagy\")", namespace:"GO"}}, {_id:475, properties:{namespace:"PTS", bel:"bp(PTS:\"nigrostriatal pathway\")", name:"nigrostriatal pathway"}}, {_id:479, properties:{namespace:"GO", bel:"bp(GO:\"neurotrophin production\")", name:"neurotrophin production"}}, {_id:483, properties:{namespace:"GO", bel:"bp(GO:\"lymphocyte proliferation\")", name:"lymphocyte proliferation"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:484, properties:{name:"mitotic cell cycle", namespace:"GO", bel:"bp(GO:\"mitotic cell cycle\")"}}, {_id:522, properties:{namespace:"FIXME", bel:"bp(FIXME:\"alpha-synuclein fibrillation\")", name:"alpha-synuclein fibrillation"}}, {_id:548, properties:{name:"nigrostriatal dopaminergic pathway", bel:"bp(PTS:\"nigrostriatal dopaminergic pathway\")", namespace:"PTS"}}, {_id:568, properties:{namespace:"FIXME", bel:"bp(FIXME:\"alpha-synuclein fibrillization\")", name:"alpha-synuclein fibrillization"}}, {_id:572, properties:{bel:"bp(GO:\"anterograde axonal transport of mitochondrion\")", name:"anterograde axonal transport of mitochondrion", namespace:"GO"}}, {_id:573, properties:{name:"energy homeostasis", namespace:"GO", bel:"bp(GO:\"energy homeostasis\")"}}, {_id:581, properties:{name:"mitochondrial-derived vesicle formation", bel:"bp(FIXME:\"mitochondrial-derived vesicle formation\")", namespace:"FIXME"}}, {_id:583, properties:{name:"mitochondrial antigen presentation", bel:"bp(FIXME:\"mitochondrial antigen presentation\")", namespace:"FIXME"}}, {_id:591, properties:{name:"bacterial-type DNA replication", bel:"bp(GO:\"bacterial-type DNA replication\")", namespace:"GO"}}, {_id:593, properties:{namespace:"GO", bel:"bp(GO:\"vesicle-mediated transport\")", name:"vesicle-mediated transport"}}, {_id:594, properties:{name:"mitochondria homeostasis pathway", bel:"bp(PW:\"mitochondria homeostasis pathway\")", namespace:"PW"}}, {_id:595, properties:{name:"translation", namespace:"GO", bel:"bp(GO:\"translation\")"}}, {_id:596, properties:{bel:"bp(GO:\"regulation of microtubule cytoskeleton organization\")", name:"regulation of microtubule cytoskeleton organization", namespace:"GO"}}, {_id:598, properties:{name:"lysosomal protein catabolic process", bel:"bp(GO:\"lysosomal protein catabolic process\")", namespace:"GO"}}, {_id:616, properties:{namespace:"GO", bel:"bp(GO:\"amyloid fibril formation\")", name:"amyloid fibril formation"}}, {_id:636, properties:{bel:"bp(FIXME:\"tau fibrillation\")", name:"tau fibrillation", namespace:"FIXME"}}, {_id:637, properties:{bel:"bp(GO:\"CD4-positive, alpha-beta T cell activation\")", name:"CD4-positive, alpha-beta T cell activation", namespace:"GO"}}, {_id:639, properties:{namespace:"GO", bel:"bp(GO:\"T cell mediated immunity\")", name:"T cell mediated immunity"}}, {_id:659, properties:{bel:"bp(GO:\"active induction of innate immune response in host by virus\")", name:"active induction of innate immune response in host by virus", namespace:"GO"}}, {_id:660, properties:{bel:"bp(GO:\"cytokine production involved in immune response\")", name:"cytokine production involved in immune response", namespace:"GO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:677, properties:{name:"pro-inflammatory cytokine mediated pathway", bel:"bp(PW:\"pro-inflammatory cytokine mediated pathway\")", namespace:"PW"}}, {_id:770, properties:{name:"blood coagulation", namespace:"GO", bel:"bp(GO:\"blood coagulation\")"}}, {_id:774, properties:{namespace:"GO", bel:"bp(GO:\"viral entry into host cell\")", name:"viral entry into host cell"}}, {_id:785, properties:{name:"apoptotic process", namespace:"GO", bel:"bp(GO:\"apoptotic process\")"}}, {_id:793, properties:{namespace:"FIXME", bel:"bp(FIXME:\"Lymphocyte cuffing\")", name:"Lymphocyte cuffing"}}, {_id:799, properties:{name:"Viral Load", namespace:"MESH", bel:"bp(MESH:\"Viral Load\")"}}, {_id:808, properties:{namespace:"GO", bel:"bp(GO:\"granuloma formation\")", name:"granuloma formation"}}, {_id:818, properties:{namespace:"FIXME", bel:"bp(FIXME:\"T-cell infiltration\")", name:"T-cell infiltration"}}, {_id:819, properties:{name:"Cytopathogenic Effect, Viral", bel:"bp(MESH:\"Cytopathogenic Effect, Viral\")", namespace:"MESH"}}, {_id:820, properties:{name:"Viral Tropism", namespace:"MESH", bel:"bp(MESH:\"Viral Tropism\")"}}, {_id:822, properties:{namespace:"GO", bel:"bp(GO:\"neuron projection development\")", name:"neuron projection development"}}, {_id:832, properties:{namespace:"FIXME", bel:"bp(FIXME:\"nuclear condensation\")", name:"nuclear condensation"}}, {_id:833, properties:{namespace:"GO", bel:"bp(GO:\"programmed cell death\")", name:"programmed cell death"}}, {_id:836, properties:{name:"induction by virus of host cell-cell fusion", bel:"bp(GO:\"induction by virus of host cell-cell fusion\")", namespace:"GO"}}, {_id:838, properties:{namespace:"GO", bel:"bp(GO:\"cellular response to virus\")", name:"cellular response to virus"}}, {_id:839, properties:{name:"cellular response to cytokine stimulus", bel:"bp(GO:\"cellular response to cytokine stimulus\")", namespace:"GO"}}, {_id:840, properties:{name:"RNA processing", namespace:"GO", bel:"bp(GO:\"RNA processing\")"}}, {_id:841, properties:{namespace:"GO", bel:"bp(GO:\"cytoskeleton organization\")", name:"cytoskeleton organization"}}, {_id:848, properties:{name:"p38MAPK cascade", namespace:"GO", bel:"bp(GO:\"p38MAPK cascade\")"}}, {_id:852, properties:{namespace:"GO", bel:"bp(GO:\"blood vessel remodeling\")", name:"blood vessel remodeling"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:854, properties:{name:"ion transport", namespace:"GO", bel:"bp(GO:\"ion transport\")"}}, {_id:855, properties:{namespace:"GO", bel:"bp(GO:\"transmembrane transport\")", name:"transmembrane transport"}}, {_id:856, properties:{name:"cilium assembly", namespace:"GO", bel:"bp(GO:\"cilium assembly\")"}}, {_id:857, properties:{namespace:"GO", bel:"bp(GO:\"cell junction assembly\")", name:"cell junction assembly"}}, {_id:861, properties:{namespace:"GO", bel:"bp(GO:\"cerebrospinal fluid secretion\")", name:"cerebrospinal fluid secretion"}}, {_id:888, properties:{namespace:"GO", bel:"bp(GO:\"lipid biosynthetic process\")", name:"lipid biosynthetic process"}}, {_id:890, properties:{name:"intermembrane lipid transfer activity", bel:"bp(GO:\"intermembrane lipid transfer activity\")", namespace:"GO"}}, {_id:909, properties:{namespace:"FIXME", bel:"bp(FIXME:\"endothelial cell mummification\")", name:"endothelial cell mummification"}}, {_id:910, properties:{name:"focal basement membrane duplication", bel:"bp(FIXME:\"focal basement membrane duplication\")", namespace:"FIXME"}}, {_id:943, properties:{name:"cell division", namespace:"GO", bel:"bp(GO:\"cell division\")"}}, {_id:944, properties:{name:"organelle fission", namespace:"GO", bel:"bp(GO:\"organelle fission\")"}}, {_id:945, properties:{namespace:"GO", bel:"bp(GO:\"cellular metabolic process\")", name:"cellular metabolic process"}}, {_id:947, properties:{name:"type I interferon signaling pathway", bel:"bp(GO:\"type I interferon signaling pathway\")", namespace:"GO"}}, {_id:948, properties:{namespace:"GO", bel:"bp(GO:\"viral transcription\")", name:"viral transcription"}}, {_id:949, properties:{name:"electron transport coupled proton transport", bel:"bp(GO:\"electron transport coupled proton transport\")", namespace:"GO"}}, {_id:950, properties:{bel:"bp(GO:\"mitochondrial electron transport, cytochrome c to oxygen\")", name:"mitochondrial electron transport, cytochrome c to oxygen", namespace:"GO"}}, {_id:951, properties:{bel:"bp(GO:\"mitochondrial electron transport, NADH to ubiquinone\")", name:"mitochondrial electron transport, NADH to ubiquinone", namespace:"GO"}}, {_id:952, properties:{namespace:"GO", bel:"bp(GO:\"cellular response to hypoxia\")", name:"cellular response to hypoxia"}}, {_id:955, properties:{name:"regulation of vascular permeability", bel:"bp(GO:\"regulation of vascular permeability\")", namespace:"GO"}}, {_id:1000, properties:{bel:"bp(GO:\"interleukin-1-mediated signaling pathway\")", name:"interleukin-1-mediated signaling pathway", namespace:"GO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:1001, properties:{bel:"bp(GO:\"interleukin-6-mediated signaling pathway\")", name:"interleukin-6-mediated signaling pathway", namespace:"GO"}}, {_id:1011, properties:{name:"fibrinolysis", namespace:"GO", bel:"bp(GO:\"fibrinolysis\")"}}, {_id:1024, properties:{name:"vasoconstriction", namespace:"GO", bel:"bp(GO:\"vasoconstriction\")"}}, {_id:1025, properties:{name:"coagulation", namespace:"GO", bel:"bp(GO:\"coagulation\")"}}, {_id:1026, properties:{namespace:"GO", bel:"bp(GO:\"platelet activation\")", name:"platelet activation"}}, {_id:1038, properties:{name:"epithelial cell apoptotic process", bel:"bp(GO:\"epithelial cell apoptotic process\")", namespace:"GO"}}, {_id:1045, properties:{name:"viral RNA genome replication", bel:"bp(GO:\"viral RNA genome replication\")", namespace:"GO"}}, {_id:1053, properties:{name:"Survival", bel:"bp(MESH:\"Survival\")", namespace:"MESH"}}, {_id:1064, properties:{name:"sensory perception of sweet taste", bel:"bp(GO:\"sensory perception of sweet taste\")", namespace:"GO"}}, {_id:1065, properties:{name:"sensory perception of bitter taste", bel:"bp(GO:\"sensory perception of bitter taste\")", namespace:"GO"}}, {_id:1066, properties:{name:"sensory perception of salty taste", bel:"bp(GO:\"sensory perception of salty taste\")", namespace:"GO"}}, {_id:1067, properties:{name:"sensory perception of sour taste", bel:"bp(GO:\"sensory perception of sour taste\")", namespace:"GO"}}, {_id:1068, properties:{namespace:"GO", bel:"bp(GO:\"sensory perception of taste\")", name:"sensory perception of taste"}}, {_id:1078, properties:{name:"transduction", namespace:"GO", bel:"bp(GO:\"transduction\")"}}, {_id:1110, properties:{name:"Cell Survival", namespace:"MESH", bel:"bp(MESH:\"Cell Survival\")"}}, {_id:1118, properties:{name:"amyloid-beta 1-42 aggregation", bel:"bp(FIXME:\"amyloid-beta 1-42 aggregation\")", namespace:"FIXME"}}, {_id:1123, properties:{namespace:"MESH", bel:"bp(MESH:\"Capillary Permeability\")", name:"Capillary Permeability"}}, {_id:1129, properties:{name:"apoptotic chromosome condensation", bel:"bp(GO:\"apoptotic chromosome condensation\")", namespace:"GO"}}, {_id:1223, properties:{namespace:"GO", bel:"bp(GO:\"endothelial cell proliferation\")", name:"endothelial cell proliferation"}}, {_id:1230, properties:{name:"endothelial cell apoptotic process", bel:"bp(GO:\"endothelial cell apoptotic process\")", namespace:"GO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:1250, properties:{bel:"bp(GO:\"blood coagulation, fibrin clot formation\")", name:"blood coagulation, fibrin clot formation", namespace:"GO"}}, {_id:1282, properties:{bel:"bp(GO:\"antigen processing and presentation of peptide antigen via MHC class I\")", name:"antigen processing and presentation of peptide antigen via MHC class I", namespace:"GO"}}, {_id:1283, properties:{name:"type II interferon signaling pathway", bel:"bp(PW:\"type II interferon signaling pathway\")", namespace:"PW"}}, {_id:1310, properties:{bel:"bp(GO:\"phosphate-containing compound metabolic process\")", name:"phosphate-containing compound metabolic process", namespace:"GO"}}, {_id:1311, properties:{name:"cellular response to interferon-gamma", bel:"bp(GO:\"cellular response to interferon-gamma\")", namespace:"GO"}}, {_id:1322, properties:{name:"activation of innate immune response", bel:"bp(GO:\"activation of innate immune response\")", namespace:"GO"}}, {_id:1324, properties:{name:"CpG Islands", namespace:"MESH", bel:"bp(MESH:\"CpG Islands\")"}}, {_id:1326, properties:{name:"toll-like receptor signaling pathway", bel:"bp(GO:\"toll-like receptor signaling pathway\")", namespace:"GO"}}, {_id:1327, properties:{name:"intestinal epithelial structure maintenance", bel:"bp(GO:\"intestinal epithelial structure maintenance\")", namespace:"GO"}}, {_id:1335, properties:{namespace:"GO", bel:"bp(GO:\"neuronal signal transduction\")", name:"neuronal signal transduction"}}, {_id:1336, properties:{namespace:"GO", bel:"bp(GO:\"tryptophan catabolic process\")", name:"tryptophan catabolic process"}}, {_id:1348, properties:{name:"gastric motility", namespace:"GO", bel:"bp(GO:\"gastric motility\")"}}, {_id:1349, properties:{namespace:"GO", bel:"bp(GO:\"gastric acid secretion\")", name:"gastric acid secretion"}}, {_id:1350, properties:{name:"synaptic transmission, GABAergic", bel:"bp(GO:\"synaptic transmission, GABAergic\")", namespace:"GO"}}, {_id:1355, properties:{namespace:"GO", bel:"bp(GO:\"excitatory synapse disassembly\")", name:"excitatory synapse disassembly"}}, {_id:1356, properties:{name:"modification of synaptic structure", bel:"bp(GO:\"modification of synaptic structure\")", namespace:"GO"}}, {_id:1357, properties:{name:"neuron-neuron synaptic transmission", bel:"bp(GO:\"neuron-neuron synaptic transmission\")", namespace:"GO"}}, {_id:1361, properties:{namespace:"GO", bel:"bp(GO:\"chemical synaptic transmission\")", name:"chemical synaptic transmission"}}, {_id:1365, properties:{name:"stress-activated MAPK cascade", bel:"bp(GO:\"stress-activated MAPK cascade\")", namespace:"GO"}}, {_id:1392, properties:{namespace:"FIXME", bel:"bp(FIXME:\"mitochondrial quality control\")", name:"mitochondrial quality control"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:1396, properties:{namespace:"GO", bel:"bp(GO:\"protein ubiquitination\")", name:"protein ubiquitination"}}, {_id:1397, properties:{name:"mitochondrial protein catabolic process", bel:"bp(GO:\"mitochondrial protein catabolic process\")", namespace:"GO"}}, {_id:1398, properties:{namespace:"FIXME", bel:"bp(FIXME:\"mitochondrial function\")", name:"mitochondrial function"}}, {_id:1405, properties:{name:"JNK cascade", namespace:"GO", bel:"bp(GO:\"JNK cascade\")"}}, {_id:1407, properties:{bel:"bp(HP:\"Abnormality of mitochondrial metabolism\")", name:"Abnormality of mitochondrial metabolism", namespace:"HP"}}, {_id:1408, properties:{namespace:"GO", bel:"bp(GO:\"antimicrobial humoral response\")", name:"antimicrobial humoral response"}}, {_id:1420, properties:{name:"cGAS/STING signaling pathway", bel:"bp(FIXME:\"cGAS/STING signaling pathway\")", namespace:"FIXME"}}, {_id:1454, properties:{name:"I-kappaB kinase/NF-kappaB signaling", bel:"bp(GO:\"I-kappaB kinase/NF-kappaB signaling\")", namespace:"GO"}}, {_id:1458, properties:{namespace:"FIXME", bel:"bp(FIXME:\"alpha-synuclein redistribution\")", name:"alpha-synuclein redistribution"}}, {_id:1459, properties:{namespace:"MESH", bel:"bp(MESH:\"Cytotoxicity, Immunologic\")", name:"Cytotoxicity, Immunologic"}}, {_id:1465, properties:{namespace:"FIXME", bel:"bp(FIXME:\"meningeal lymphatic drainage\")", name:"meningeal lymphatic drainage"}}, {_id:1478, properties:{name:"gliogenesis", namespace:"GO", bel:"bp(GO:\"gliogenesis\")"}}, {_id:1490, properties:{namespace:"GO", bel:"bp(GO:\"defense response to virus\")", name:"defense response to virus"}}, {_id:1491, properties:{name:"cholesterol biosynthetic process", bel:"bp(GO:\"cholesterol biosynthetic process\")", namespace:"GO"}}, {_id:1492, properties:{namespace:"GO", bel:"bp(GO:\"calcium ion transport\")", name:"calcium ion transport"}}, {_id:1493, properties:{namespace:"GO", bel:"bp(GO:\"regulation of cell size\")", name:"regulation of cell size"}}, {_id:1499, properties:{namespace:"GO", bel:"bp(GO:\"MHC protein binding\")", name:"MHC protein binding"}}, {_id:1500, properties:{bel:"bp(GO:\"interleukin-4-mediated signaling pathway\")", name:"interleukin-4-mediated signaling pathway", namespace:"GO"}}, {_id:1523, properties:{namespace:"GO", bel:"bp(GO:\"postsynaptic density\")", name:"postsynaptic density"}}, {_id:1524, properties:{name:"interferon mediated signaling pathway", bel:"bp(PW:\"interferon mediated signaling pathway\")", namespace:"PW"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:1526, properties:{name:"actin cytoskeleton organization", bel:"bp(GO:\"actin cytoskeleton organization\")", namespace:"GO"}}, {_id:1538, properties:{name:"microglia-mediated phagocytosis", bel:"bp(FIXME:\"microglia-mediated phagocytosis\")", namespace:"FIXME"}}, {_id:1547, properties:{namespace:"GO", bel:"bp(GO:\"iron ion homeostasis\")", name:"iron ion homeostasis"}}, {_id:1548, properties:{namespace:"GO", bel:"bp(GO:\"copper ion homeostasis\")", name:"copper ion homeostasis"}}, {_id:1549, properties:{namespace:"GO", bel:"bp(GO:\"zinc ion homeostasis\")", name:"zinc ion homeostasis"}}, {_id:1551, properties:{bel:"bp(GO:\"regulation of reactive oxygen species metabolic process\")", name:"regulation of reactive oxygen species metabolic process", namespace:"GO"}}, {_id:1552, properties:{name:"extracellular matrix organization", bel:"bp(GO:\"extracellular matrix organization\")", namespace:"GO"}}, {_id:1557, properties:{bel:"bp(GO:\"vascular endothelial growth factor signaling pathway\")", name:"vascular endothelial growth factor signaling pathway", namespace:"GO"}}, {_id:1558, properties:{bel:"bp(GO:\"endoplasmic reticulum unfolded protein response\")", name:"endoplasmic reticulum unfolded protein response", namespace:"GO"}}, {_id:1559, properties:{name:"Endoplasmic Reticulum Stress", bel:"bp(MESH:\"Endoplasmic Reticulum Stress\")", namespace:"MESH"}}, {_id:1560, properties:{name:"reactive oxygen species metabolic process", bel:"bp(GO:\"reactive oxygen species metabolic process\")", namespace:"GO"}}, {_id:1561, properties:{name:"Body Temperature", namespace:"MESH", bel:"bp(MESH:\"Body Temperature\")"}}, {_id:1564, properties:{namespace:"GO", bel:"bp(GO:\"antioxidant activity\")", name:"antioxidant activity"}}, {_id:1576, properties:{namespace:"MESH", bel:"bp(MESH:\"Protein Carbonylation\")", name:"Protein Carbonylation"}}, {_id:1578, properties:{name:"lipid damage", namespace:"FIXME", bel:"bp(FIXME:\"lipid damage\")"}}, {_id:1579, properties:{name:"protein damage", namespace:"FIXME", bel:"bp(FIXME:\"protein damage\")"}}, {_id:1580, properties:{namespace:"FIXME", bel:"bp(FIXME:\"peak body temperature\")", name:"peak body temperature"}}, {_id:1606, properties:{name:"cell activation", namespace:"GO", bel:"bp(GO:\"cell activation\")"}}, {_id:1609, properties:{name:"activation of MAPK activity", bel:"bp(GO:\"activation of MAPK activity\")", namespace:"GO"}}, {_id:1610, properties:{namespace:"GO", bel:"bp(GO:\"cell-cell signaling\")", name:"cell-cell signaling"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:1611, properties:{namespace:"GO", bel:"bp(GO:\"cell junction organization\")", name:"cell junction organization"}}, {_id:1612, properties:{namespace:"GO", bel:"bp(GO:\"cellular ion homeostasis\")", name:"cellular ion homeostasis"}}, {_id:1613, properties:{namespace:"GO", bel:"bp(GO:\"fatty acid homeostasis\")", name:"fatty acid homeostasis"}}, {_id:1623, properties:{namespace:"GO", bel:"bp(GO:\"DNA hypermethylation\")", name:"DNA hypermethylation"}}, {_id:1624, properties:{name:"neurogenesis", namespace:"GO", bel:"bp(GO:\"neurogenesis\")"}}, {_id:1625, properties:{name:"axonogenesis", namespace:"GO", bel:"bp(GO:\"axonogenesis\")"}}, {_id:1671, properties:{bel:"bp(GO:\"type III interferon signaling pathway\")", name:"type III interferon signaling pathway", namespace:"GO"}}, {_id:1676, properties:{name:"DNA demethylation", namespace:"GO", bel:"bp(GO:\"DNA demethylation\")"}}, {_id:1677, properties:{name:"p38 MAPK signaling pathway", bel:"bp(PW:\"p38 MAPK signaling pathway\")", namespace:"PW"}}, {_id:1683, properties:{namespace:"GO", bel:"bp(GO:\"DNA hypomethylation\")", name:"DNA hypomethylation"}}, {_id:1697, properties:{bel:"bp(GO:\"induction by virus of host apoptotic process\")", name:"induction by virus of host apoptotic process", namespace:"GO"}}, {_id:1707, properties:{namespace:"FIXME", bel:"bp(FIXME:\"fibrinogen leakage\")", name:"fibrinogen leakage"}}, {_id:1729, properties:{namespace:"FIXME", bel:"bp(FIXME:\"perivascular extravasation\")", name:"perivascular extravasation"}}, {_id:1730, properties:{namespace:"FIXME", bel:"bp(FIXME:\"thorny ramifications\")", name:"thorny ramifications"}}, {_id:1735, properties:{bel:"bp(FIXME:\"infiltration of CD68+/TMEM119− cells\")", name:"infiltration of CD68+/TMEM119− cells", namespace:"FIXME"}}, {_id:1757, properties:{bel:"bp(GO:\"nuclear fragmentation involved in apoptotic nuclear change\")", name:"nuclear fragmentation involved in apoptotic nuclear change", namespace:"GO"}}, {_id:1758, properties:{namespace:"GO", bel:"bp(GO:\"glial cell apoptotic process\")", name:"glial cell apoptotic process"}}, {_id:1766, properties:{name:"axon guidance", namespace:"GO", bel:"bp(GO:\"axon guidance\")"}}, {_id:1767, properties:{namespace:"GO", bel:"bp(GO:\"neuron projection maintenance\")", name:"neuron projection maintenance"}}, {_id:1768, properties:{namespace:"GO", bel:"bp(GO:\"mechanosensory behavior\")", name:"mechanosensory behavior"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:1776, properties:{name:"interferon-gamma-mediated signaling pathway", bel:"bp(GO:\"interferon-gamma-mediated signaling pathway\")", namespace:"GO"}}, {_id:1777, properties:{bel:"bp(GO:\"tumor necrosis factor-mediated signaling pathway\")", name:"tumor necrosis factor-mediated signaling pathway", namespace:"GO"}}, {_id:1778, properties:{bel:"bp(PW:\"nuclear factor kappa B signaling pathway\")", name:"nuclear factor kappa B signaling pathway", namespace:"PW"}}, {_id:1788, properties:{bel:"bp(GO:\"interleukin-18-mediated signaling pathway\")", name:"interleukin-18-mediated signaling pathway", namespace:"GO"}}, {_id:1793, properties:{bel:"bp(GO:\"interleukin-27-mediated signaling pathway\")", name:"interleukin-27-mediated signaling pathway", namespace:"GO"}}, {_id:1802, properties:{name:"regulation of interferon-alpha production", bel:"bp(GO:\"regulation of interferon-alpha production\")", namespace:"GO"}}, {_id:1814, properties:{namespace:"GO", bel:"bp(GO:\"neutrophil activation\")", name:"neutrophil activation"}}, {_id:1815, properties:{namespace:"GO", bel:"bp(GO:\"neutrophil degranulation\")", name:"neutrophil degranulation"}}, {_id:1847, properties:{name:"olfactory behavior", namespace:"GO", bel:"bp(GO:\"olfactory behavior\")"}}, {_id:1848, properties:{name:"memory", bel:"bp(GO:\"memory\")", namespace:"GO"}}, {_id:1850, properties:{namespace:"GO", bel:"bp(GO:\"amyloid-beta metabolic process\")", name:"amyloid-beta metabolic process"}}, {_id:1852, properties:{name:"myelination", namespace:"GO", bel:"bp(GO:\"myelination\")"}}, {_id:1853, properties:{namespace:"FIXME", bel:"bp(FIXME:\"neural circuit dynamics\")", name:"neural circuit dynamics"}}, {_id:1854, properties:{namespace:"GO", bel:"bp(GO:\"regulation of myelination\")", name:"regulation of myelination"}}, {_id:1855, properties:{name:"synapsis", bel:"bp(GO:\"synapsis\")", namespace:"GO"}}, {_id:1857, properties:{namespace:"GO", bel:"bp(GO:\"calcium ion homeostasis\")", name:"calcium ion homeostasis"}}, {_id:1862, properties:{name:"function of regulatory T cells", bel:"bp(FIXME:\"function of regulatory T cells\")", namespace:"FIXME"}}, {_id:1864, properties:{name:"T cell mediated cytotoxicity", bel:"bp(GO:\"T cell mediated cytotoxicity\")", namespace:"GO"}}, {_id:1866, properties:{namespace:"GO", bel:"bp(GO:\"oxidative phosphorylation\")", name:"oxidative phosphorylation"}}, {_id:1871, properties:{name:"natural killer cell mediated cytotoxicity", bel:"bp(GO:\"natural killer cell mediated cytotoxicity\")", namespace:"GO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:1883, properties:{name:"dysregulation of proteasomal genes", bel:"bp(FIXME:\"dysregulation of proteasomal genes\")", namespace:"FIXME"}}, {_id:1884, properties:{name:"mitochondrial genome maintenance", bel:"bp(GO:\"mitochondrial genome maintenance\")", namespace:"GO"}}, {_id:1888, properties:{namespace:"GO", bel:"bp(GO:\"cellular senescence\")", name:"cellular senescence"}}, {_id:1894, properties:{namespace:"GO", bel:"bp(GO:\"regulation of immune response\")", name:"regulation of immune response"}}, {_id:1898, properties:{name:"DNA repair", bel:"bp(GO:\"DNA repair\")", namespace:"GO"}}, {_id:1902, properties:{namespace:"GO", bel:"bp(GO:\"B cell proliferation\")", name:"B cell proliferation"}}, {_id:1913, properties:{name:"response to ATP", namespace:"GO", bel:"bp(GO:\"response to ATP\")"}}, {_id:1921, properties:{namespace:"GO", bel:"bp(GO:\"immune system process\")", name:"immune system process"}}, {_id:1923, properties:{name:"motor behavior", namespace:"GO", bel:"bp(GO:\"motor behavior\")"}}, {_id:1932, properties:{namespace:"FIXME", bel:"bp(FIXME:\"hyaline membrane formation\")", name:"hyaline membrane formation"}}, {_id:1947, properties:{namespace:"GO", bel:"bp(GO:\"intussusceptive angiogenesis\")", name:"intussusceptive angiogenesis"}}, {_id:1955, properties:{namespace:"GO", bel:"bp(GO:\"leukocyte activation\")", name:"leukocyte activation"}}, {_id:1959, properties:{namespace:"MESH", bel:"bp(MESH:\"Telomere Shortening\")", name:"Telomere Shortening"}}, {_id:2029, properties:{namespace:"GO", bel:"bp(GO:\"lipid metabolic process\")", name:"lipid metabolic process"}}, {_id:2096, properties:{bel:"bp(FIXME:\"RUNX1-regulated transcription related to myeloid differentiation\")", name:"RUNX1-regulated transcription related to myeloid differentiation", namespace:"FIXME"}}, {_id:2103, properties:{name:"T cell receptor signaling pathway", bel:"bp(GO:\"T cell receptor signaling pathway\")", namespace:"GO"}}, {_id:2107, properties:{name:"cell cycle", bel:"bp(GO:\"cell cycle\")", namespace:"GO"}}, {_id:2108, properties:{name:"DNA replication", namespace:"GO", bel:"bp(GO:\"DNA replication\")"}}, {_id:2145, properties:{namespace:"MESH", bel:"bp(MESH:\"Cell Nucleus Size\")", name:"Cell Nucleus Size"}}, {_id:2151, properties:{name:"protein oxidation", namespace:"GO", bel:"bp(GO:\"protein oxidation\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:2156, properties:{bel:"bp(REACTOME:\"Senescence-Associated Secretory Phenotype (SASP)\")", name:"Senescence-Associated Secretory Phenotype (SASP)", namespace:"REACTOME"}}, {_id:2157, properties:{name:"fatty acid biosynthetic process", bel:"bp(GO:\"fatty acid biosynthetic process\")", namespace:"GO"}}, {_id:2158, properties:{bel:"bp(PW:\"adenosine monophosphate-activated protein kinase (AMPK) signaling pathway\")", name:"adenosine monophosphate-activated protein kinase (AMPK) signaling pathway", namespace:"PW"}}, {_id:2173, properties:{name:"Organ Size", namespace:"MESH", bel:"bp(MESH:\"Organ Size\")"}}, {_id:2175, properties:{namespace:"FIXME", bel:"bp(FIXME:\"cerebrospinal fluid volume\")", name:"cerebrospinal fluid volume"}}, {_id:2177, properties:{namespace:"FIXME", bel:"bp(FIXME:\"frontal pole thickness\")", name:"frontal pole thickness"}}, {_id:2178, properties:{name:"superior frontal gyrus thickness", bel:"bp(FIXME:\"superior frontal gyrus thickness\")", namespace:"FIXME"}}, {_id:2179, properties:{name:"middle temporal gyrus thickness", bel:"bp(FIXME:\"middle temporal gyrus thickness\")", namespace:"FIXME"}}, {_id:2180, properties:{name:"superior temporal gyrus thickness", bel:"bp(FIXME:\"superior temporal gyrus thickness\")", namespace:"FIXME"}}, {_id:2182, properties:{bel:"bp(FIXME:\"brainstem volume\")", name:"brainstem volume", namespace:"FIXME"}}, {_id:2183, properties:{name:"amygdala volume", namespace:"FIXME", bel:"bp(FIXME:\"amygdala volume\")"}}, {_id:2188, properties:{namespace:"GO", bel:"bp(GO:\"platelet degranulation\")", name:"platelet degranulation"}}, {_id:2190, properties:{namespace:"GO", bel:"bp(GO:\"immunoglobulin production\")", name:"immunoglobulin production"}}, {_id:2191, properties:{namespace:"GO", bel:"bp(GO:\"megakaryocyte development\")", name:"megakaryocyte development"}}, {_id:2192, properties:{namespace:"GO", bel:"bp(GO:\"T cell differentiation\")", name:"T cell differentiation"}}, {_id:2194, properties:{bel:"bp(GO:\"transforming growth factor beta receptor signaling pathway\")", name:"transforming growth factor beta receptor signaling pathway", namespace:"GO"}}, {_id:2198, properties:{namespace:"GO", bel:"bp(GO:\"regulation of angiogenesis\")", name:"regulation of angiogenesis"}}, {_id:2202, properties:{bel:"bp(PW:\"platelet-derived growth factor signaling pathway\")", name:"platelet-derived growth factor signaling pathway", namespace:"PW"}}, {_id:2206, properties:{name:"hemostasis", bel:"bp(GO:\"hemostasis\")", namespace:"GO"}}, {_id:2211, properties:{name:"negative regulation of immune response", bel:"bp(GO:\"negative regulation of immune response\")", namespace:"GO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:2215, properties:{name:"circadian regulation of gene expression", bel:"bp(GO:\"circadian regulation of gene expression\")", namespace:"GO"}}, {_id:2219, properties:{name:"B cell activation", namespace:"GO", bel:"bp(GO:\"B cell activation\")"}}, {_id:2230, properties:{namespace:"GO", bel:"bp(GO:\"heterotypic cell-cell adhesion\")", name:"heterotypic cell-cell adhesion"}}, {_id:2233, properties:{name:"entry of bacterium into host cell", bel:"bp(GO:\"entry of bacterium into host cell\")", namespace:"GO"}}, {_id:2237, properties:{namespace:"GO", bel:"bp(GO:\"nervous system process\")", name:"nervous system process"}}, {_id:2247, properties:{bel:"bp(GO:\"regulation of regulatory T cell differentiation\")", name:"regulation of regulatory T cell differentiation", namespace:"GO"}}, {_id:2252, properties:{name:"regulatory T cell differentiation", bel:"bp(GO:\"regulatory T cell differentiation\")", namespace:"GO"}}, {_id:2253, properties:{bel:"bp(GO:\"positive regulation of T cell differentiation\")", name:"positive regulation of T cell differentiation", namespace:"GO"}}, {_id:2254, properties:{bel:"bp(GO:\"CD4-positive, alpha-beta T cell proliferation\")", name:"CD4-positive, alpha-beta T cell proliferation", namespace:"GO"}}, {_id:2257, properties:{namespace:"MESH", bel:"bp(MESH:\"Tumor Microenvironment\")", name:"Tumor Microenvironment"}}, {_id:2270, properties:{name:"myeloid dendritic cell activation", bel:"bp(GO:\"myeloid dendritic cell activation\")", namespace:"GO"}}, {_id:2291, properties:{namespace:"GO", bel:"bp(GO:\"NIK/NF-kappaB signaling\")", name:"NIK/NF-kappaB signaling"}}, {_id:2305, properties:{bel:"bp(GO:\"T-helper 17 cell differentiation\")", name:"T-helper 17 cell differentiation", namespace:"GO"}}, {_id:2306, properties:{namespace:"GO", bel:"bp(GO:\"dendritic cell proliferation\")", name:"dendritic cell proliferation"}}, {_id:2329, properties:{name:"Cell Size", namespace:"MESH", bel:"bp(MESH:\"Cell Size\")"}}, {_id:2331, properties:{bel:"bp(GO:\"viral entry via permeabilization of endosomal membrane\")", name:"viral entry via permeabilization of endosomal membrane", namespace:"GO"}}, {_id:2334, properties:{namespace:"GO", bel:"bp(GO:\"endosomal lumen acidification\")", name:"endosomal lumen acidification"}}, {_id:2370, properties:{namespace:"FIXME", bel:"bp(FIXME:\"parenchymal dissociation\")", name:"parenchymal dissociation"}}, {_id:2371, properties:{namespace:"FIXME", bel:"bp(FIXME:\"myocyte vacuolization\")", name:"myocyte vacuolization"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:BiologicalProcess;
UNWIND [{_id:427, properties:{bel:"frag(\"?_*\")", range:"?_*"}}, {_id:504, properties:{bel:"frag(\"31_45\")", range:"31_45"}}, {_id:508, properties:{bel:"frag(\"32_46\")", range:"32_46"}}, {_id:510, properties:{bel:"frag(\"116_140\")", range:"116_140"}}, {_id:513, properties:{bel:"frag(\"121_135\")", range:"121_135"}}, {_id:515, properties:{bel:"frag(\"126_140\")", range:"126_140"}}, {_id:520, properties:{bel:"frag(\"?\")", range:"?"}}, {_id:533, properties:{bel:"frag(\"36_45\")", range:"36_45"}}, {_id:535, properties:{bel:"frag(\"37_45\")", range:"37_45"}}, {_id:537, properties:{bel:"frag(\"37_46\")", range:"37_46"}}, {_id:602, properties:{bel:"frag(\"1_42\")", range:"1_42"}}, {_id:919, properties:{bel:"frag(\"319_541\")", range:"319_541"}}, {_id:921, properties:{bel:"frag(\"16_685\")", range:"16_685"}}, {_id:1049, properties:{bel:"frag(\"678_751\")", range:"678_751"}}, {_id:1089, properties:{bel:"frag(\"14_685\")", range:"14_685"}}, {_id:1094, properties:{bel:"frag(\"680_685\")", range:"680_685"}}, {_id:1167, properties:{bel:"frag(\"1_83\")", range:"1_83"}}, {_id:1169, properties:{bel:"frag(\"84_419\")", range:"84_419"}}, {_id:1171, properties:{bel:"frag(\"1_205\")", range:"1_205"}}, {_id:1173, properties:{bel:"frag(\"206_419\")", range:"206_419"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Fragment;
UNWIND [{_id:1175, properties:{bel:"frag(\"1_231\")", range:"1_231"}}, {_id:1177, properties:{bel:"frag(\"232_419\")", range:"232_419"}}, {_id:1179, properties:{bel:"frag(\"1_304\")", range:"1_304"}}, {_id:1181, properties:{bel:"frag(\"305_419\")", range:"305_419"}}, {_id:1183, properties:{bel:"frag(\"1_313\")", range:"1_313"}}, {_id:1185, properties:{bel:"frag(\"314_419\")", range:"314_419"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Fragment;
UNWIND [{_id:2316, properties:{name:"MIR106B", bel:"m(HGNC:\"MIR106B\")", namespace:"HGNC", pure:true}}, {_id:2317, properties:{name:"MIR25", bel:"m(HGNC:\"MIR25\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:MicroRna;
UNWIND [{_id:0, properties:{namespace:"MESH", bel:"path(MESH:\"Craniocerebral Trauma\")", name:"Craniocerebral Trauma"}}, {_id:1, properties:{name:"Inflammation", namespace:"MESH", bel:"path(MESH:\"Inflammation\")"}}, {_id:2, properties:{name:"ischemia", bel:"path(DO:\"ischemia\")", namespace:"DO"}}, {_id:3, properties:{namespace:"DO", bel:"path(DO:\"coronary artery disease\")", name:"coronary artery disease"}}, {_id:7, properties:{namespace:"DO", bel:"path(DO:\"Alzheimer's disease\")", name:"Alzheimer's disease"}}, {_id:18, properties:{name:"dementia", bel:"path(DO:\"dementia\")", namespace:"DO"}}, {_id:27, properties:{namespace:"FIXME", bel:"path(FIXME:\"dystrophic neurite\")", name:"dystrophic neurite"}}, {_id:28, properties:{namespace:"MESH", bel:"path(MESH:\"Illness Behavior\")", name:"Illness Behavior"}}, {_id:36, properties:{name:"brain infarction", namespace:"DO", bel:"path(DO:\"brain infarction\")"}}, {_id:37, properties:{namespace:"MESH", bel:"path(MESH:\"Nerve Degeneration\")", name:"Nerve Degeneration"}}, {_id:38, properties:{name:"vascular disease", namespace:"DO", bel:"path(DO:\"vascular disease\")"}}, {_id:41, properties:{namespace:"DO", bel:"path(DO:\"cerebrovascular disease\")", name:"cerebrovascular disease"}}, {_id:48, properties:{namespace:"HP", bel:"path(HP:\"chronic inflammation\")", name:"chronic inflammation"}}, {_id:49, properties:{name:"Brain Injuries", namespace:"MESH", bel:"path(MESH:\"Brain Injuries\")"}}, {_id:50, properties:{namespace:"MESH", bel:"path(MESH:\"Brain Injury, Chronic\")", name:"Brain Injury, Chronic"}}, {_id:63, properties:{name:"neurotoxicity", namespace:"FIXME", bel:"path(FIXME:\"neurotoxicity\")"}}, {_id:65, properties:{namespace:"DO", bel:"path(DO:\"amyotrophic lateral sclerosis\")", name:"amyotrophic lateral sclerosis"}}, {_id:66, properties:{bel:"path(HP:\"Abnormality of mitochondrial metabolism\")", name:"Abnormality of mitochondrial metabolism", namespace:"HP"}}, {_id:67, properties:{namespace:"DO", bel:"path(DO:\"Parkinson's disease\")", name:"Parkinson's disease"}}, {_id:71, properties:{bel:"path(ADO:\"neuroinflammation\")", name:"neuroinflammation", namespace:"ADO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:77, properties:{namespace:"MESH", bel:"path(MESH:\"Brain Injuries, Traumatic\")", name:"Brain Injuries, Traumatic"}}, {_id:81, properties:{name:"Stroke", bel:"path(MESH:\"Stroke\")", namespace:"MESH"}}, {_id:86, properties:{namespace:"MESH", bel:"path(MESH:\"Wallerian Degeneration\")", name:"Wallerian Degeneration"}}, {_id:89, properties:{namespace:"DO", bel:"path(DO:\"neurodegenerative disease\")", name:"neurodegenerative disease"}}, {_id:121, properties:{name:"Fever", bel:"path(MESH:\"Fever\")", namespace:"MESH"}}, {_id:124, properties:{namespace:"MESH", bel:"path(MESH:\"Disease Progression\")", name:"Disease Progression"}}, {_id:126, properties:{namespace:"MESH", bel:"path(MESH:\"Plaque, Amyloid\")", name:"Plaque, Amyloid"}}, {_id:127, properties:{name:"Delirium", namespace:"MESH", bel:"path(MESH:\"Delirium\")"}}, {_id:128, properties:{namespace:"FIXME", bel:"path(FIXME:\"systemic inflammation\")", name:"systemic inflammation"}}, {_id:129, properties:{namespace:"MESH", bel:"path(MESH:\"Cognitive Dysfunction\")", name:"Cognitive Dysfunction"}}, {_id:130, properties:{name:"obesity", bel:"path(DO:\"obesity\")", namespace:"DO"}}, {_id:131, properties:{name:"Smoking", namespace:"MESH", bel:"path(MESH:\"Smoking\")"}}, {_id:132, properties:{bel:"path(DO:\"diabetes mellitus\")", name:"diabetes mellitus", namespace:"DO"}}, {_id:133, properties:{namespace:"DO", bel:"path(DO:\"diabetes insipidus\")", name:"diabetes insipidus"}}, {_id:134, properties:{name:"atherosclerosis", namespace:"DO", bel:"path(DO:\"atherosclerosis\")"}}, {_id:135, properties:{name:"periodontitis", namespace:"DO", bel:"path(DO:\"periodontitis\")"}}, {_id:136, properties:{name:"influenza", namespace:"DO", bel:"path(DO:\"influenza\")"}}, {_id:137, properties:{name:"Parkinson's disease-like symptoms", bel:"path(FIXME:\"Parkinson's disease-like symptoms\")", namespace:"FIXME"}}, {_id:141, properties:{namespace:"HP", bel:"path(HP:\"Neurodegeneration\")", name:"Neurodegeneration"}}, {_id:152, properties:{name:"Resting tremor", namespace:"HP", bel:"path(HP:\"Resting tremor\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:153, properties:{name:"Bradykinesia", namespace:"HP", bel:"path(HP:\"Bradykinesia\")"}}, {_id:154, properties:{name:"Rigidity", bel:"path(HP:\"Rigidity\")", namespace:"HP"}}, {_id:155, properties:{name:"Gait Disorders, Neurologic", bel:"path(MESH:\"Gait Disorders, Neurologic\")", namespace:"MESH"}}, {_id:168, properties:{namespace:"HP", bel:"path(HP:\"acute inflammation\")", name:"acute inflammation"}}, {_id:171, properties:{name:"Sepsis", bel:"path(MESH:\"Sepsis\")", namespace:"MESH"}}, {_id:207, properties:{name:"Neurotoxicity", namespace:"FIXME", bel:"path(FIXME:\"Neurotoxicity\")"}}, {_id:219, properties:{name:"synucleinopathy", namespace:"DO", bel:"path(DO:\"synucleinopathy\")"}}, {_id:220, properties:{namespace:"DO", bel:"path(DO:\"multiple system atrophy\")", name:"multiple system atrophy"}}, {_id:261, properties:{bel:"path(HP:\"Decreased proportion of CD3-positive T cells\")", name:"Decreased proportion of CD3-positive T cells", namespace:"HP"}}, {_id:264, properties:{namespace:"DO", bel:"path(DO:\"multiple sclerosis\")", name:"multiple sclerosis"}}, {_id:265, properties:{name:"Down syndrome", namespace:"DO", bel:"path(DO:\"Down syndrome\")"}}, {_id:309, properties:{namespace:"DO", bel:"path(DO:\"type 1 diabetes mellitus\")", name:"type 1 diabetes mellitus"}}, {_id:310, properties:{name:"Inflammatory abnormality of the skin", bel:"path(HP:\"Inflammatory abnormality of the skin\")", namespace:"HP"}}, {_id:311, properties:{bel:"path(DO:\"myasthenia gravis\")", name:"myasthenia gravis", namespace:"DO"}}, {_id:312, properties:{namespace:"DO", bel:"path(DO:\"rheumatoid arthritis\")", name:"rheumatoid arthritis"}}, {_id:313, properties:{namespace:"DO", bel:"path(DO:\"systemic lupus erythematosus\")", name:"systemic lupus erythematosus"}}, {_id:314, properties:{namespace:"DO", bel:"path(DO:\"inflammatory bowel disease\")", name:"inflammatory bowel disease"}}, {_id:315, properties:{bel:"path(DO:\"immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome\")", name:"immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome", namespace:"DO"}}, {_id:318, properties:{name:"Gliosis", namespace:"MESH", bel:"path(MESH:\"Gliosis\")"}}, {_id:338, properties:{namespace:"DO", bel:"path(DO:\"mumps\")", name:"mumps"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:339, properties:{name:"scarlet fever", namespace:"DO", bel:"path(DO:\"scarlet fever\")"}}, {_id:340, properties:{name:"pertussis", namespace:"DO", bel:"path(DO:\"pertussis\")"}}, {_id:341, properties:{name:"herpes simplex", namespace:"DO", bel:"path(DO:\"herpes simplex\")"}}, {_id:353, properties:{namespace:"MESH", bel:"path(MESH:\"Motor Disorders\")", name:"Motor Disorders"}}, {_id:358, properties:{name:"toxoplasmosis", namespace:"DO", bel:"path(DO:\"toxoplasmosis\")"}}, {_id:386, properties:{namespace:"DO", bel:"path(DO:\"bullous pemphigoid\")", name:"bullous pemphigoid"}}, {_id:387, properties:{name:"Marinesco-Sjogren syndrome", bel:"path(DO:\"Marinesco-Sjogren syndrome\")", namespace:"DO"}}, {_id:389, properties:{name:"Crohn Disease", namespace:"MESH", bel:"path(MESH:\"Crohn Disease\")"}}, {_id:390, properties:{name:"Parkinson's disease 8", bel:"path(DO:\"Parkinson's disease 8\")", namespace:"DO"}}, {_id:391, properties:{name:"Epstein-Barr Virus Infections", bel:"path(MESH:\"Epstein-Barr Virus Infections\")", namespace:"MESH"}}, {_id:395, properties:{name:"Parkinson Disease, Postencephalitic", bel:"path(MESH:\"Parkinson Disease, Postencephalitic\")", namespace:"MESH"}}, {_id:397, properties:{name:"Hypokinesia", namespace:"MESH", bel:"path(MESH:\"Hypokinesia\")"}}, {_id:409, properties:{name:"Micronuclei, Chromosome-Defective", bel:"path(MESH:\"Micronuclei, Chromosome-Defective\")", namespace:"MESH"}}, {_id:418, properties:{namespace:"MESH", bel:"path(MESH:\"Behavioral Symptoms\")", name:"Behavioral Symptoms"}}, {_id:426, properties:{name:"autoimmune lymphoproliferative syndrome", bel:"path(DO:\"autoimmune lymphoproliferative syndrome\")", namespace:"DO"}}, {_id:454, properties:{name:"Infection", namespace:"MESH", bel:"path(MESH:\"Infection\")"}}, {_id:457, properties:{name:"leprosy", bel:"path(DO:\"leprosy\")", namespace:"DO"}}, {_id:458, properties:{name:"Crohn's disease", namespace:"DO", bel:"path(DO:\"Crohn's disease\")"}}, {_id:460, properties:{name:"colitis", bel:"path(DO:\"colitis\")", namespace:"DO"}}, {_id:465, properties:{name:"Parkinson's disease 2", bel:"path(DO:\"Parkinson's disease 2\")", namespace:"DO"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:471, properties:{name:"Protein Aggregation, Pathological", bel:"path(MESH:\"Protein Aggregation, Pathological\")", namespace:"MESH"}}, {_id:476, properties:{name:"Poor fine motor coordination", bel:"path(HP:\"Poor fine motor coordination\")", namespace:"HP"}}, {_id:497, properties:{namespace:"DO", bel:"path(DO:\"fetal erythroblastosis\")", name:"fetal erythroblastosis"}}, {_id:498, properties:{name:"thrombocytopenia", namespace:"DO", bel:"path(DO:\"thrombocytopenia\")"}}, {_id:499, properties:{namespace:"DO", bel:"path(DO:\"demyelinating polyneuropathy\")", name:"demyelinating polyneuropathy"}}, {_id:500, properties:{name:"Helicobacter pylori infection", bel:"path(HP:\"Helicobacter pylori infection\")", namespace:"HP"}}, {_id:539, properties:{namespace:"DO", bel:"path(DO:\"ulcerative colitis\")", name:"ulcerative colitis"}}, {_id:549, properties:{bel:"path(HP:\"Abnormality of central motor function\")", name:"Abnormality of central motor function", namespace:"HP"}}, {_id:551, properties:{name:"Dysbiosis", namespace:"MESH", bel:"path(MESH:\"Dysbiosis\")"}}, {_id:553, properties:{name:"gastrointestinal system disease", bel:"path(DO:\"gastrointestinal system disease\")", namespace:"DO"}}, {_id:554, properties:{name:"Hyposmia", bel:"path(HP:\"Hyposmia\")", namespace:"HP"}}, {_id:562, properties:{namespace:"HP", bel:"path(HP:\"rapid eye movement sleep\")", name:"rapid eye movement sleep"}}, {_id:576, properties:{namespace:"DO", bel:"path(DO:\"type 2 diabetes mellitus\")", name:"type 2 diabetes mellitus"}}, {_id:579, properties:{bel:"path(HP:\"Decreased activity of mitochondrial complex I\")", name:"Decreased activity of mitochondrial complex I", namespace:"HP"}}, {_id:589, properties:{namespace:"DO", bel:"path(DO:\"viral infectious disease\")", name:"viral infectious disease"}}, {_id:590, properties:{namespace:"DO", bel:"path(DO:\"bacterial infectious disease\")", name:"bacterial infectious disease"}}, {_id:640, properties:{name:"COVID-19", bel:"path(DO:\"COVID-19\")", namespace:"DO"}}, {_id:641, properties:{name:"Dizziness", namespace:"MESH", bel:"path(MESH:\"Dizziness\")"}}, {_id:642, properties:{name:"Headache", namespace:"MESH", bel:"path(MESH:\"Headache\")"}}, {_id:643, properties:{namespace:"MESH", bel:"path(MESH:\"Consciousness Disorders\")", name:"Consciousness Disorders"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:644, properties:{name:"Seizures", namespace:"MESH", bel:"path(MESH:\"Seizures\")"}}, {_id:645, properties:{name:"Agitation", namespace:"HP", bel:"path(HP:\"Agitation\")"}}, {_id:646, properties:{name:"Confusion", namespace:"MESH", bel:"path(MESH:\"Confusion\")"}}, {_id:648, properties:{name:"Clonus", bel:"path(HP:\"Clonus\")", namespace:"HP"}}, {_id:649, properties:{namespace:"DO", bel:"path(DO:\"olfactory nerve disease\")", name:"olfactory nerve disease"}}, {_id:650, properties:{name:"Dysgeusia", namespace:"MESH", bel:"path(MESH:\"Dysgeusia\")"}}, {_id:651, properties:{name:"Anosmia", bel:"path(HP:\"Anosmia\")", namespace:"HP"}}, {_id:652, properties:{name:"disseminated intravascular coagulation", bel:"path(DO:\"disseminated intravascular coagulation\")", namespace:"DO"}}, {_id:653, properties:{namespace:"EFO", bel:"path(EFO:\"endothelial dysfunction\")", name:"endothelial dysfunction"}}, {_id:654, properties:{namespace:"HP", bel:"path(HP:\"Cerebral ischemia\")", name:"Cerebral ischemia"}}, {_id:655, properties:{namespace:"DO", bel:"path(DO:\"Guillain-Barre syndrome\")", name:"Guillain-Barre syndrome"}}, {_id:656, properties:{namespace:"DO", bel:"path(DO:\"Miller Fisher syndrome\")", name:"Miller Fisher syndrome"}}, {_id:657, properties:{name:"Kawasaki disease", namespace:"DO", bel:"path(DO:\"Kawasaki disease\")"}}, {_id:658, properties:{namespace:"HP", bel:"path(HP:\"Functional motor deficit\")", name:"Functional motor deficit"}}, {_id:668, properties:{name:"adult respiratory distress syndrome", bel:"path(DO:\"adult respiratory distress syndrome\")", namespace:"DO"}}, {_id:669, properties:{namespace:"HP", bel:"path(HP:\"Cognitive impairment\")", name:"Cognitive impairment"}}, {_id:670, properties:{namespace:"MESH", bel:"path(MESH:\"Executive Function\")", name:"Executive Function"}}, {_id:675, properties:{name:"Hypercapnia", namespace:"MESH", bel:"path(MESH:\"Hypercapnia\")"}}, {_id:678, properties:{name:"amyloidosis", namespace:"DO", bel:"path(DO:\"amyloidosis\")"}}, {_id:680, properties:{name:"Encephalopathy", namespace:"HP", bel:"path(HP:\"Encephalopathy\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:681, properties:{name:"encephalitis", namespace:"DO", bel:"path(DO:\"encephalitis\")"}}, {_id:685, properties:{name:"Death", bel:"path(MESH:\"Death\")", namespace:"MESH"}}, {_id:686, properties:{namespace:"DO", bel:"path(DO:\"respiratory system disease\")", name:"respiratory system disease"}}, {_id:687, properties:{name:"Abnormality of the nervous system", bel:"path(HP:\"Abnormality of the nervous system\")", namespace:"HP"}}, {_id:688, properties:{name:"severe acute respiratory syndrome", bel:"path(DO:\"severe acute respiratory syndrome\")", namespace:"DO"}}, {_id:689, properties:{namespace:"DO", bel:"path(DO:\"central nervous system disease\")", name:"central nervous system disease"}}, {_id:690, properties:{name:"peripheral nervous system disease", bel:"path(DO:\"peripheral nervous system disease\")", namespace:"DO"}}, {_id:692, properties:{namespace:"DO", bel:"path(DO:\"neuromuscular disease\")", name:"neuromuscular disease"}}, {_id:693, properties:{namespace:"DO", bel:"path(DO:\"motor peripheral neuropathy\")", name:"motor peripheral neuropathy"}}, {_id:694, properties:{name:"myopathy", bel:"path(DO:\"myopathy\")", namespace:"DO"}}, {_id:695, properties:{name:"Middle East respiratory syndrome", bel:"path(DO:\"Middle East respiratory syndrome\")", namespace:"DO"}}, {_id:696, properties:{name:"acute disseminated encephalomyelitis", bel:"path(DO:\"acute disseminated encephalomyelitis\")", namespace:"DO"}}, {_id:697, properties:{name:"Bickerstaff brainstem encephalitis", bel:"path(FIXME:\"Bickerstaff brainstem encephalitis\")", namespace:"FIXME"}}, {_id:698, properties:{name:"neuropathy", namespace:"DO", bel:"path(DO:\"neuropathy\")"}}, {_id:700, properties:{name:"Headache", bel:"path(HP:\"Headache\")", namespace:"HP"}}, {_id:701, properties:{name:"Stiff neck", namespace:"HP", bel:"path(HP:\"Stiff neck\")"}}, {_id:703, properties:{name:"CSF lymphocytic pleiocytosis", bel:"path(HP:\"CSF lymphocytic pleiocytosis\")", namespace:"HP"}}, {_id:704, properties:{name:"Abnormality of brain morphology", bel:"path(HP:\"Abnormality of brain morphology\")", namespace:"HP"}}, {_id:706, properties:{namespace:"HP", bel:"path(HP:\"Infantile encephalopathy\")", name:"Infantile encephalopathy"}}, {_id:707, properties:{namespace:"HP", bel:"path(HP:\"Leukoencephalopathy\")", name:"Leukoencephalopathy"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:708, properties:{name:"Myelopathy", namespace:"HP", bel:"path(HP:\"Myelopathy\")"}}, {_id:709, properties:{namespace:"MESH", bel:"path(MESH:\"Mental Disorders\")", name:"Mental Disorders"}}, {_id:710, properties:{name:"Psychosis", namespace:"HP", bel:"path(HP:\"Psychosis\")"}}, {_id:711, properties:{namespace:"MESH", bel:"path(MESH:\"Neurocognitive Disorders\")", name:"Neurocognitive Disorders"}}, {_id:712, properties:{name:"Affective Disorders, Psychotic", bel:"path(MESH:\"Affective Disorders, Psychotic\")", namespace:"MESH"}}, {_id:713, properties:{namespace:"MESH", bel:"path(MESH:\"Cerebrovascular Disorders\")", name:"Cerebrovascular Disorders"}}, {_id:714, properties:{name:"Ischemic stroke", namespace:"HP", bel:"path(HP:\"Ischemic stroke\")"}}, {_id:715, properties:{namespace:"EFO", bel:"path(EFO:\"intracerebral hemorrhage\")", name:"intracerebral hemorrhage"}}, {_id:716, properties:{name:"central nervous system vasculitis", bel:"path(DO:\"central nervous system vasculitis\")", namespace:"DO"}}, {_id:717, properties:{namespace:"DO", bel:"path(DO:\"Coronavirus infection\")", name:"Coronavirus infection"}}, {_id:718, properties:{name:"Irritability", namespace:"HP", bel:"path(HP:\"Irritability\")"}}, {_id:719, properties:{name:"Reduced consciousness/confusion", bel:"path(HP:\"Reduced consciousness/confusion\")", namespace:"HP"}}, {_id:720, properties:{name:"Ataxia", bel:"path(MESH:\"Ataxia\")", namespace:"MESH"}}, {_id:721, properties:{namespace:"HP", bel:"path(HP:\"Abnormality of vision\")", name:"Abnormality of vision"}}, {_id:722, properties:{name:"Hiccup", bel:"path(MESH:\"Hiccup\")", namespace:"MESH"}}, {_id:723, properties:{name:"Weakness of facial musculature", bel:"path(HP:\"Weakness of facial musculature\")", namespace:"HP"}}, {_id:724, properties:{bel:"path(HP:\"Abnormal morphology of the cerebellar cortex\")", name:"Abnormal morphology of the cerebellar cortex", namespace:"HP"}}, {_id:725, properties:{bel:"path(HP:\"Abnormality of the corticospinal tract\")", name:"Abnormality of the corticospinal tract", namespace:"HP"}}, {_id:726, properties:{name:"Leptomeningeal enhancement", bel:"path(HP:\"Leptomeningeal enhancement\")", namespace:"HP"}}, {_id:731, properties:{name:"Dysphagia", namespace:"HP", bel:"path(HP:\"Dysphagia\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:732, properties:{name:"Dysarthria", namespace:"HP", bel:"path(HP:\"Dysarthria\")"}}, {_id:733, properties:{name:"Myalgia", namespace:"MESH", bel:"path(MESH:\"Myalgia\")"}}, {_id:734, properties:{namespace:"DO", bel:"path(DO:\"respiratory failure\")", name:"respiratory failure"}}, {_id:735, properties:{name:"myelitis", bel:"path(DO:\"myelitis\")", namespace:"DO"}}, {_id:736, properties:{name:"Fatigue", namespace:"MESH", bel:"path(MESH:\"Fatigue\")"}}, {_id:737, properties:{name:"Paraparesis", namespace:"MESH", bel:"path(MESH:\"Paraparesis\")"}}, {_id:738, properties:{name:"Hyporeflexia", namespace:"HP", bel:"path(HP:\"Hyporeflexia\")"}}, {_id:741, properties:{namespace:"HP", bel:"path(HP:\"Limb muscle weakness\")", name:"Limb muscle weakness"}}, {_id:742, properties:{name:"Areflexia", namespace:"HP", bel:"path(HP:\"Areflexia\")"}}, {_id:743, properties:{bel:"path(HP:\"Abnormality of central sensory function\")", name:"Abnormality of central sensory function", namespace:"HP"}}, {_id:744, properties:{name:"lymphopenia", namespace:"DO", bel:"path(DO:\"lymphopenia\")"}}, {_id:745, properties:{name:"diarrhea", bel:"path(DO:\"diarrhea\")", namespace:"DO"}}, {_id:747, properties:{name:"autonomic nervous system disease", bel:"path(DO:\"autonomic nervous system disease\")", namespace:"DO"}}, {_id:748, properties:{name:"hypertension", namespace:"DO", bel:"path(DO:\"hypertension\")"}}, {_id:749, properties:{name:"Sphincter of Oddi Dysfunction", bel:"path(MESH:\"Sphincter of Oddi Dysfunction\")", namespace:"MESH"}}, {_id:750, properties:{bel:"path(DO:\"axonal neuropathy\")", name:"axonal neuropathy", namespace:"DO"}}, {_id:751, properties:{name:"ophthalmoplegia", namespace:"DO", bel:"path(DO:\"ophthalmoplegia\")"}}, {_id:753, properties:{name:"Ageusia", namespace:"MESH", bel:"path(MESH:\"Ageusia\")"}}, {_id:754, properties:{name:"Abducens Palsy", namespace:"MESH", bel:"path(MESH:\"Abducens Palsy\")"}}, {_id:755, properties:{namespace:"FIXME", bel:"path(FIXME:\"acute vestibular syndrome\")", name:"acute vestibular syndrome"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:756, properties:{namespace:"MESH", bel:"path(MESH:\"Nystagmus, Pathologic\")", name:"Nystagmus, Pathologic"}}, {_id:757, properties:{name:"oscillopsia", namespace:"FIXME", bel:"path(FIXME:\"oscillopsia\")"}}, {_id:760, properties:{name:"Muscle injury", namespace:"FIXME", bel:"path(FIXME:\"Muscle injury\")"}}, {_id:761, properties:{name:"Rhabdomyolysis", namespace:"MESH", bel:"path(MESH:\"Rhabdomyolysis\")"}}, {_id:762, properties:{namespace:"MESH", bel:"path(MESH:\"Taste Disorders\")", name:"Taste Disorders"}}, {_id:763, properties:{namespace:"MESH", bel:"path(MESH:\"Cerebral Hemorrhage\")", name:"Cerebral Hemorrhage"}}, {_id:764, properties:{name:"Cerebral venous sinus thrombosis", bel:"path(FIXME:\"Cerebral venous sinus thrombosis\")", namespace:"FIXME"}}, {_id:765, properties:{namespace:"FIXME", bel:"path(FIXME:\"hemorrhagic stroke\")", name:"hemorrhagic stroke"}}, {_id:766, properties:{name:"blood clot", namespace:"HP", bel:"path(HP:\"blood clot\")"}}, {_id:767, properties:{name:"Infarction", namespace:"MESH", bel:"path(MESH:\"Infarction\")"}}, {_id:769, properties:{namespace:"DO", bel:"path(DO:\"pulmonary embolism\")", name:"pulmonary embolism"}}, {_id:772, properties:{namespace:"DO", bel:"path(DO:\"blood coagulation disease\")", name:"blood coagulation disease"}}, {_id:777, properties:{name:"Edema", bel:"path(MESH:\"Edema\")", namespace:"MESH"}}, {_id:778, properties:{name:"Necrosis", namespace:"MESH", bel:"path(MESH:\"Necrosis\")"}}, {_id:779, properties:{name:"Hyperplasia", namespace:"MESH", bel:"path(MESH:\"Hyperplasia\")"}}, {_id:783, properties:{name:"Degeneration of anterior horn cells", bel:"path(HP:\"Degeneration of anterior horn cells\")", namespace:"HP"}}, {_id:786, properties:{name:"chronic obstructive pulmonary disease", bel:"path(DO:\"chronic obstructive pulmonary disease\")", namespace:"DO"}}, {_id:787, properties:{name:"Cough", bel:"path(MESH:\"Cough\")", namespace:"MESH"}}, {_id:788, properties:{name:"Dyspnea", namespace:"MESH", bel:"path(MESH:\"Dyspnea\")"}}, {_id:790, properties:{name:"Chest Pain", namespace:"MESH", bel:"path(MESH:\"Chest Pain\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:791, properties:{namespace:"FIXME", bel:"path(FIXME:\"Diffuse alveolar damage\")", name:"Diffuse alveolar damage"}}, {_id:792, properties:{name:"bronchopneumonia", namespace:"DO", bel:"path(DO:\"bronchopneumonia\")"}}, {_id:794, properties:{name:"bronchiolitis", namespace:"DO", bel:"path(DO:\"bronchiolitis\")"}}, {_id:795, properties:{name:"mucormycosis", namespace:"DO", bel:"path(DO:\"mucormycosis\")"}}, {_id:796, properties:{name:"vasculitis", namespace:"DO", bel:"path(DO:\"vasculitis\")"}}, {_id:797, properties:{name:"thrombosis", namespace:"DO", bel:"path(DO:\"thrombosis\")"}}, {_id:798, properties:{namespace:"DO", bel:"path(DO:\"coronary thrombosis\")", name:"coronary thrombosis"}}, {_id:801, properties:{name:"pericarditis", namespace:"DO", bel:"path(DO:\"pericarditis\")"}}, {_id:802, properties:{name:"Left ventricular hypertrophy", bel:"path(HP:\"Left ventricular hypertrophy\")", namespace:"HP"}}, {_id:803, properties:{namespace:"DO", bel:"path(DO:\"marantic endocarditis\")", name:"marantic endocarditis"}}, {_id:804, properties:{name:"Hemophagocytosis", namespace:"HP", bel:"path(HP:\"Hemophagocytosis\")"}}, {_id:809, properties:{name:"pancreatitis", namespace:"DO", bel:"path(DO:\"pancreatitis\")"}}, {_id:810, properties:{namespace:"DO", bel:"path(DO:\"acute kidney tubular necrosis\")", name:"acute kidney tubular necrosis"}}, {_id:811, properties:{name:"Microaneurysm", namespace:"MESH", bel:"path(MESH:\"Microaneurysm\")"}}, {_id:812, properties:{name:"arteriosclerosis", namespace:"DO", bel:"path(DO:\"arteriosclerosis\")"}}, {_id:813, properties:{namespace:"HP", bel:"path(HP:\"Hepatic steatosis\")", name:"Hepatic steatosis"}}, {_id:814, properties:{name:"liver cirrhosis", namespace:"DO", bel:"path(DO:\"liver cirrhosis\")"}}, {_id:815, properties:{name:"Hepatic fibrosis", namespace:"HP", bel:"path(HP:\"Hepatic fibrosis\")"}}, {_id:816, properties:{namespace:"DO", bel:"path(DO:\"hepatic infarction\")", name:"hepatic infarction"}}, {_id:817, properties:{name:"Hepatomegaly", namespace:"MESH", bel:"path(MESH:\"Hepatomegaly\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:862, properties:{name:"Abnormality of the choroid plexus", bel:"path(HP:\"Abnormality of the choroid plexus\")", namespace:"HP"}}, {_id:864, properties:{name:"viral pneumonia", namespace:"DO", bel:"path(DO:\"viral pneumonia\")"}}, {_id:865, properties:{name:"brain edema", namespace:"DO", bel:"path(DO:\"brain edema\")"}}, {_id:867, properties:{name:"Heterotopia", namespace:"HP", bel:"path(HP:\"Heterotopia\")"}}, {_id:868, properties:{namespace:"MESH", bel:"path(MESH:\"Neoplasm Metastasis\")", name:"Neoplasm Metastasis"}}, {_id:869, properties:{name:"posterior cerebral artery infarction", bel:"path(DO:\"posterior cerebral artery infarction\")", namespace:"DO"}}, {_id:870, properties:{name:"anterior cerebral artery infarction", bel:"path(DO:\"anterior cerebral artery infarction\")", namespace:"DO"}}, {_id:871, properties:{name:"middle cerebral artery infarction", bel:"path(DO:\"middle cerebral artery infarction\")", namespace:"DO"}}, {_id:872, properties:{name:"Astrocytosis", namespace:"HP", bel:"path(HP:\"Astrocytosis\")"}}, {_id:900, properties:{name:"Intraventricular hemorrhage", bel:"path(HP:\"Intraventricular hemorrhage\")", namespace:"HP"}}, {_id:901, properties:{namespace:"HP", bel:"path(HP:\"Behavioral abnormality\")", name:"Behavioral abnormality"}}, {_id:902, properties:{namespace:"MESH", bel:"path(MESH:\"Cardiovascular Diseases\")", name:"Cardiovascular Diseases"}}, {_id:903, properties:{namespace:"MESH", bel:"path(MESH:\"Hyperlipidemias\")", name:"Hyperlipidemias"}}, {_id:904, properties:{namespace:"DO", bel:"path(DO:\"chronic kidney disease\")", name:"chronic kidney disease"}}, {_id:905, properties:{namespace:"MESH", bel:"path(MESH:\"Thromboembolism\")", name:"Thromboembolism"}}, {_id:906, properties:{namespace:"FIXME", bel:"path(FIXME:\"perivascular edema\")", name:"perivascular edema"}}, {_id:923, properties:{name:"Thirst", bel:"path(MESH:\"Thirst\")", namespace:"MESH"}}, {_id:924, properties:{namespace:"MESH", bel:"path(MESH:\"Stress, Psychological\")", name:"Stress, Psychological"}}, {_id:956, properties:{name:"Weight Loss", namespace:"MESH", bel:"path(MESH:\"Weight Loss\")"}}, {_id:957, properties:{name:"Hemorrhage", namespace:"MESH", bel:"path(MESH:\"Hemorrhage\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:997, properties:{name:"Anorexia", namespace:"MESH", bel:"path(MESH:\"Anorexia\")"}}, {_id:998, properties:{name:"Hypoxia", namespace:"MESH", bel:"path(MESH:\"Hypoxia\")"}}, {_id:1002, properties:{name:"Macrophage Activation Syndrome", bel:"path(MESH:\"Macrophage Activation Syndrome\")", namespace:"MESH"}}, {_id:1010, properties:{bel:"path(HP:\"Disseminated intravascular coagulation\")", name:"Disseminated intravascular coagulation", namespace:"HP"}}, {_id:1013, properties:{bel:"path(FIXME:\"cellular damage\")", name:"cellular damage", namespace:"FIXME"}}, {_id:1014, properties:{name:"pulmonary edema", namespace:"DO", bel:"path(DO:\"pulmonary edema\")"}}, {_id:1023, properties:{name:"Blood Coagulation Disorders", bel:"path(MESH:\"Blood Coagulation Disorders\")", namespace:"MESH"}}, {_id:1039, properties:{namespace:"MESH", bel:"path(MESH:\"Acute Lung Injury\")", name:"Acute Lung Injury"}}, {_id:1040, properties:{namespace:"HP", bel:"path(HP:\"Hypercoagulability\")", name:"Hypercoagulability"}}, {_id:1041, properties:{namespace:"MESH", bel:"path(MESH:\"Venous Thromboembolism\")", name:"Venous Thromboembolism"}}, {_id:1057, properties:{name:"Diarrhea", namespace:"MESH", bel:"path(MESH:\"Diarrhea\")"}}, {_id:1058, properties:{name:"Conjunctivitis", namespace:"MESH", bel:"path(MESH:\"Conjunctivitis\")"}}, {_id:1059, properties:{name:"Muscle Cramp", namespace:"MESH", bel:"path(MESH:\"Muscle Cramp\")"}}, {_id:1060, properties:{name:"Laryngitis", namespace:"MESH", bel:"path(MESH:\"Laryngitis\")"}}, {_id:1061, properties:{name:"Rhinorrhea", namespace:"HP", bel:"path(HP:\"Rhinorrhea\")"}}, {_id:1062, properties:{bel:"path(FIXME:\"nasal irritation\")", name:"nasal irritation", namespace:"FIXME"}}, {_id:1063, properties:{name:"Hyperacusis", namespace:"MESH", bel:"path(MESH:\"Hyperacusis\")"}}, {_id:1070, properties:{name:"Paresthesia", namespace:"MESH", bel:"path(MESH:\"Paresthesia\")"}}, {_id:1071, properties:{name:"Vertigo", namespace:"MESH", bel:"path(MESH:\"Vertigo\")"}}, {_id:1072, properties:{namespace:"MESH", bel:"path(MESH:\"Nasal Obstruction\")", name:"Nasal Obstruction"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:1073, properties:{bel:"path(FIXME:\"wriggling nose\")", name:"wriggling nose", namespace:"FIXME"}}, {_id:1074, properties:{namespace:"MESH", bel:"path(MESH:\"Pain\")", name:"Pain"}}, {_id:1075, properties:{name:"Arm Pain", namespace:"NCIT", bel:"path(NCIT:\"Arm Pain\")"}}, {_id:1122, properties:{name:"Viremia", namespace:"MESH", bel:"path(MESH:\"Viremia\")"}}, {_id:1130, properties:{name:"Abnormal mitochondrial morphology", bel:"path(HP:\"Abnormal mitochondrial morphology\")", namespace:"HP"}}, {_id:1131, properties:{namespace:"MESH", bel:"path(MESH:\"Vascular System Injuries\")", name:"Vascular System Injuries"}}, {_id:1146, properties:{name:"pneumonia", namespace:"DO", bel:"path(DO:\"pneumonia\")"}}, {_id:1202, properties:{name:"Cell Survival", namespace:"MESH", bel:"path(MESH:\"Cell Survival\")"}}, {_id:1235, properties:{name:"Cytomegalovirus Infections", bel:"path(MESH:\"Cytomegalovirus Infections\")", namespace:"MESH"}}, {_id:1236, properties:{namespace:"DO", bel:"path(DO:\"acute kidney failure\")", name:"acute kidney failure"}}, {_id:1237, properties:{bel:"path(FIXME:\"refractory shock\")", name:"refractory shock", namespace:"FIXME"}}, {_id:1238, properties:{name:"Petechiae", namespace:"HP", bel:"path(HP:\"Petechiae\")"}}, {_id:1239, properties:{namespace:"MESH", bel:"path(MESH:\"Subarachnoid Hemorrhage\")", name:"Subarachnoid Hemorrhage"}}, {_id:1240, properties:{name:"Abnormal synaptic transmission", bel:"path(HP:\"Abnormal synaptic transmission\")", namespace:"HP"}}, {_id:1241, properties:{bel:"path(HP:\"Abnormality of the cerebral white matter\")", name:"Abnormality of the cerebral white matter", namespace:"HP"}}, {_id:1245, properties:{namespace:"HP", bel:"path(HP:\"Axonal degeneration\")", name:"Axonal degeneration"}}, {_id:1246, properties:{name:"Cerebral Small Vessel Diseases", bel:"path(MESH:\"Cerebral Small Vessel Diseases\")", namespace:"MESH"}}, {_id:1252, properties:{namespace:"FIXME", bel:"path(FIXME:\"diffuse alveolar damage\")", name:"diffuse alveolar damage"}}, {_id:1254, properties:{namespace:"HP", bel:"path(HP:\"Acute tubular necrosis\")", name:"Acute tubular necrosis"}}, {_id:1255, properties:{namespace:"FIXME", bel:"path(FIXME:\"visceral congestion\")", name:"visceral congestion"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:1318, properties:{name:"Tremor", bel:"path(MESH:\"Tremor\")", namespace:"MESH"}}, {_id:1319, properties:{namespace:"HP", bel:"path(HP:\"Postural instability\")", name:"Postural instability"}}, {_id:1345, properties:{name:"Motor Activity", namespace:"MESH", bel:"path(MESH:\"Motor Activity\")"}}, {_id:1353, properties:{namespace:"MESH", bel:"path(MESH:\"Helicobacter Infections\")", name:"Helicobacter Infections"}}, {_id:1354, properties:{name:"Mortality", namespace:"MESH", bel:"path(MESH:\"Mortality\")"}}, {_id:1362, properties:{namespace:"FIXME", bel:"path(FIXME:\"alpha-synuclein aggregation\")", name:"alpha-synuclein aggregation"}}, {_id:1406, properties:{namespace:"FIXME", bel:"path(FIXME:\"adaptive inflammation\")", name:"adaptive inflammation"}}, {_id:1421, properties:{namespace:"FIXME", bel:"path(FIXME:\"intestinal dysfunction\")", name:"intestinal dysfunction"}}, {_id:1448, properties:{namespace:"DO", bel:"path(DO:\"Gaucher's disease\")", name:"Gaucher's disease"}}, {_id:1453, properties:{namespace:"FIXME", bel:"path(FIXME:\"alpha-synuclein fibrillation\")", name:"alpha-synuclein fibrillation"}}, {_id:1525, properties:{name:"Parkinsonism", namespace:"HP", bel:"path(HP:\"Parkinsonism\")"}}, {_id:1544, properties:{name:"Gliosis", bel:"path(HP:\"Gliosis\")", namespace:"HP"}}, {_id:1565, properties:{name:"Fatigue", bel:"path(HP:\"Fatigue\")", namespace:"HP"}}, {_id:1566, properties:{bel:"path(DO:\"mental depression\")", name:"mental depression", namespace:"DO"}}, {_id:1567, properties:{name:"anxiety disorder", namespace:"DO", bel:"path(DO:\"anxiety disorder\")"}}, {_id:1568, properties:{bel:"path(HP:\"Abnormal autonomic nervous system physiology\")", name:"Abnormal autonomic nervous system physiology", namespace:"HP"}}, {_id:1569, properties:{bel:"path(HP:\"Abnormality of the gastrointestinal tract\")", name:"Abnormality of the gastrointestinal tract", namespace:"HP"}}, {_id:1570, properties:{name:"sleep disorder", namespace:"DO", bel:"path(DO:\"sleep disorder\")"}}, {_id:1571, properties:{name:"Chronic fatigue", namespace:"HP", bel:"path(HP:\"Chronic fatigue\")"}}, {_id:1572, properties:{namespace:"DO", bel:"path(DO:\"cognitive disorder\")", name:"cognitive disorder"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:1575, properties:{namespace:"ADO", bel:"path(ADO:\"Neuropsychiatric_symptoms\")", name:"Neuropsychiatric_symptoms"}}, {_id:1702, properties:{namespace:"FIXME", bel:"path(FIXME:\"myocardial infiltrates\")", name:"myocardial infiltrates"}}, {_id:1703, properties:{name:"myocarditis", namespace:"DO", bel:"path(DO:\"myocarditis\")"}}, {_id:1705, properties:{bel:"path(FIXME:\"steatohepatitis\")", name:"steatohepatitis", namespace:"FIXME"}}, {_id:1722, properties:{namespace:"DO", bel:"path(DO:\"viral encephalitis\")", name:"viral encephalitis"}}, {_id:1723, properties:{name:"common wart", namespace:"DO", bel:"path(DO:\"common wart\")"}}, {_id:1724, properties:{bel:"path(DO:\"vascular dementia\")", name:"vascular dementia", namespace:"DO"}}, {_id:1725, properties:{namespace:"DO", bel:"path(DO:\"intestinal infectious disease\")", name:"intestinal infectious disease"}}, {_id:1727, properties:{name:"Bell's palsy", namespace:"DO", bel:"path(DO:\"Bell's palsy\")"}}, {_id:1741, properties:{bel:"path(FIXME:\"Multiple system atrophy parkinsonian variant\")", name:"Multiple system atrophy parkinsonian variant", namespace:"FIXME"}}, {_id:1742, properties:{bel:"path(FIXME:\"Multiple system atrophy cerebellar variant\")", name:"Multiple system atrophy cerebellar variant", namespace:"FIXME"}}, {_id:1743, properties:{bel:"path(FIXME:\"Parkinson’s disease with dementia\")", name:"Parkinson’s disease with dementia", namespace:"FIXME"}}, {_id:1744, properties:{namespace:"HP", bel:"path(HP:\"Poor motor coordination\")", name:"Poor motor coordination"}}, {_id:1746, properties:{namespace:"DO", bel:"path(DO:\"congestive heart failure\")", name:"congestive heart failure"}}, {_id:1750, properties:{namespace:"MESH", bel:"path(MESH:\"Multiple System Atrophy\")", name:"Multiple System Atrophy"}}, {_id:1752, properties:{namespace:"FIXME", bel:"path(FIXME:\"microhemorrhagic foci\")", name:"microhemorrhagic foci"}}, {_id:1755, properties:{namespace:"DO", bel:"path(DO:\"neuroaxonal dystrophy\")", name:"neuroaxonal dystrophy"}}, {_id:1763, properties:{name:"cell damage", namespace:"FIXME", bel:"path(FIXME:\"cell damage\")"}}, {_id:1780, properties:{namespace:"HP", bel:"path(HP:\"Increased body mass index\")", name:"Increased body mass index"}}, {_id:1781, properties:{namespace:"MESH", bel:"path(MESH:\"Body Mass Index\")", name:"Body Mass Index"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:1829, properties:{name:"long COVID", namespace:"FIXME", bel:"path(FIXME:\"long COVID\")"}}, {_id:1830, properties:{name:"Chronic Cough", namespace:"FIXME", bel:"path(FIXME:\"Chronic Cough\")"}}, {_id:1831, properties:{namespace:"MESH", bel:"path(MESH:\"Headache Disorders\")", name:"Headache Disorders"}}, {_id:1832, properties:{namespace:"HP", bel:"path(HP:\"Memory impairment\")", name:"Memory impairment"}}, {_id:1833, properties:{name:"Anxiety", bel:"path(HP:\"Anxiety\")", namespace:"HP"}}, {_id:1834, properties:{bel:"path(HP:\"Abnormality of nervous system physiology\")", name:"Abnormality of nervous system physiology", namespace:"HP"}}, {_id:1839, properties:{namespace:"MESH", bel:"path(MESH:\"Prostatic Hyperplasia\")", name:"Prostatic Hyperplasia"}}, {_id:1840, properties:{name:"fibromyalgia", namespace:"DO", bel:"path(DO:\"fibromyalgia\")"}}, {_id:1841, properties:{name:"Mental Fatigue", namespace:"MESH", bel:"path(MESH:\"Mental Fatigue\")"}}, {_id:1842, properties:{name:"Mood Disorders", namespace:"MESH", bel:"path(MESH:\"Mood Disorders\")"}}, {_id:1845, properties:{namespace:"FIXME", bel:"path(FIXME:\"post-acute infection syndrome\")", name:"post-acute infection syndrome"}}, {_id:1851, properties:{namespace:"DO", bel:"path(DO:\"cardiovascular system disease\")", name:"cardiovascular system disease"}}, {_id:1856, properties:{namespace:"MESH", bel:"path(MESH:\"Proteostasis Deficiencies\")", name:"Proteostasis Deficiencies"}}, {_id:1867, properties:{name:"REM sleep behavior disorder", bel:"path(DO:\"REM sleep behavior disorder\")", namespace:"DO"}}, {_id:1872, properties:{name:"Abnormality of lysosomal metabolism", bel:"path(HP:\"Abnormality of lysosomal metabolism\")", namespace:"HP"}}, {_id:1886, properties:{bel:"path(FIXME:\"familial glucocerebrosidase Parkinson disease\")", name:"familial glucocerebrosidase Parkinson disease", namespace:"FIXME"}}, {_id:1893, properties:{namespace:"MESH", bel:"path(MESH:\"Prodromal Symptoms\")", name:"Prodromal Symptoms"}}, {_id:1910, properties:{namespace:"FIXME", bel:"path(FIXME:\"Less cognitive problems\")", name:"Less cognitive problems"}}, {_id:1911, properties:{name:"Dyskinesias", namespace:"MESH", bel:"path(MESH:\"Dyskinesias\")"}}, {_id:1914, properties:{namespace:"HP", bel:"path(HP:\"Impaired T cell function\")", name:"Impaired T cell function"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:1920, properties:{namespace:"MESH", bel:"path(MESH:\"Colitis, Ulcerative\")", name:"Colitis, Ulcerative"}}, {_id:1924, properties:{namespace:"GO", bel:"path(GO:\"inflammatory response\")", name:"inflammatory response"}}, {_id:1929, properties:{name:"Respiratory Tract Diseases", bel:"path(MESH:\"Respiratory Tract Diseases\")", namespace:"MESH"}}, {_id:1930, properties:{namespace:"MESH", bel:"path(MESH:\"Multiple Organ Failure\")", name:"Multiple Organ Failure"}}, {_id:1931, properties:{namespace:"FIXME", bel:"path(FIXME:\"multiorgan dysfunction\")", name:"multiorgan dysfunction"}}, {_id:1933, properties:{namespace:"FIXME", bel:"path(FIXME:\"perivascular oedema\")", name:"perivascular oedema"}}, {_id:1936, properties:{name:"acute and fibrinous organizing pneumonia", bel:"path(FIXME:\"acute and fibrinous organizing pneumonia\")", namespace:"FIXME"}}, {_id:1940, properties:{namespace:"HP", bel:"path(HP:\"Immune dysregulation\")", name:"Immune dysregulation"}}, {_id:1941, properties:{namespace:"FIXME", bel:"path(FIXME:\"Fibrotic remodeling\")", name:"Fibrotic remodeling"}}, {_id:1942, properties:{namespace:"FIXME", bel:"path(FIXME:\"vascular insufficiency\")", name:"vascular insufficiency"}}, {_id:1943, properties:{bel:"path(FIXME:\"microischaemia\")", name:"microischaemia", namespace:"FIXME"}}, {_id:1944, properties:{name:"secondary pulmonary lobular microischaemia", bel:"path(FIXME:\"secondary pulmonary lobular microischaemia\")", namespace:"FIXME"}}, {_id:1946, properties:{bel:"path(FIXME:\"microangiopathy\")", name:"microangiopathy", namespace:"FIXME"}}, {_id:1949, properties:{namespace:"MESH", bel:"path(MESH:\"Acute Kidney Injury\")", name:"Acute Kidney Injury"}}, {_id:1951, properties:{namespace:"DO", bel:"path(DO:\"interstitial nephritis\")", name:"interstitial nephritis"}}, {_id:1952, properties:{name:"renal fibrosis", namespace:"DO", bel:"path(DO:\"renal fibrosis\")"}}, {_id:1953, properties:{namespace:"HP", bel:"path(HP:\"cell and tissue damage\")", name:"cell and tissue damage"}}, {_id:1954, properties:{name:"brain ischemia", namespace:"DO", bel:"path(DO:\"brain ischemia\")"}}, {_id:1956, properties:{name:"Lassa fever", namespace:"DO", bel:"path(DO:\"Lassa fever\")"}}, {_id:1957, properties:{namespace:"DO", bel:"path(DO:\"Ebola hemorrhagic fever\")", name:"Ebola hemorrhagic fever"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:1958, properties:{namespace:"HP", bel:"path(HP:\"Abnormal renal physiology\")", name:"Abnormal renal physiology"}}, {_id:2169, properties:{name:"Mental Recall", namespace:"MESH", bel:"path(MESH:\"Mental Recall\")"}}, {_id:2170, properties:{name:"Aphasia", bel:"path(HP:\"Aphasia\")", namespace:"HP"}}, {_id:2171, properties:{namespace:"MESH", bel:"path(MESH:\"Cerebrospinal Fluid Leak\")", name:"Cerebrospinal Fluid Leak"}}, {_id:2176, properties:{name:"Cerebral cortical hemiatrophy", bel:"path(HP:\"Cerebral cortical hemiatrophy\")", namespace:"HP"}}, {_id:2236, properties:{name:"Autoimmunity", namespace:"MESH", bel:"path(MESH:\"Autoimmunity\")"}}, {_id:2242, properties:{bel:"path(MESH:\"Encephalomyelitis, Autoimmune, Experimental\")", name:"Encephalomyelitis, Autoimmune, Experimental", namespace:"MESH"}}, {_id:2244, properties:{namespace:"MESH", bel:"path(MESH:\"Autoimmune Diseases\")", name:"Autoimmune Diseases"}}, {_id:2245, properties:{name:"Allergy", bel:"path(HP:\"Allergy\")", namespace:"HP"}}, {_id:2284, properties:{name:"Neurodegenerative Diseases", bel:"path(MESH:\"Neurodegenerative Diseases\")", namespace:"MESH"}}, {_id:2287, properties:{name:"relapsing-remitting multiple sclerosis", bel:"path(DO:\"relapsing-remitting multiple sclerosis\")", namespace:"DO"}}, {_id:2292, properties:{bel:"path(FIXME:\"paralytic experimental autoimmune encephalomyelitis\")", name:"paralytic experimental autoimmune encephalomyelitis", namespace:"FIXME"}}, {_id:2338, properties:{namespace:"HP", bel:"path(HP:\"Pulmonary infiltrates\")", name:"Pulmonary infiltrates"}}, {_id:2361, properties:{name:"swine influenza", namespace:"DO", bel:"path(DO:\"swine influenza\")"}}, {_id:2365, properties:{namespace:"FIXME", bel:"path(FIXME:\"pulmonary vascular congestion\")", name:"pulmonary vascular congestion"}}, {_id:2366, properties:{namespace:"DO", bel:"path(DO:\"acute interstitial pneumonia\")", name:"acute interstitial pneumonia"}}, {_id:2367, properties:{name:"microthrombus", namespace:"FIXME", bel:"path(FIXME:\"microthrombus\")"}}, {_id:2373, properties:{namespace:"DO", bel:"path(DO:\"pulmonary fibrosis\")", name:"pulmonary fibrosis"}}, {_id:2374, properties:{namespace:"MESH", bel:"path(MESH:\"Bacterial Infections\")", name:"Bacterial Infections"}}, {_id:2375, properties:{namespace:"FIXME", bel:"path(FIXME:\"acute glomerular alteration\")", name:"acute glomerular alteration"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:2376, properties:{namespace:"FIXME", bel:"path(FIXME:\"hypoxic myocytic injury\")", name:"hypoxic myocytic injury"}}, {_id:2377, properties:{name:"Brain Edema", namespace:"MESH", bel:"path(MESH:\"Brain Edema\")"}}, {_id:2378, properties:{name:"Spongiosis", namespace:"NCIT", bel:"path(NCIT:\"Spongiosis\")"}}, {_id:2379, properties:{bel:"path(FIXME:\"vascular cuffing\")", name:"vascular cuffing", namespace:"FIXME"}}, {_id:2381, properties:{namespace:"DO", bel:"path(DO:\"pulmonary emphysema\")", name:"pulmonary emphysema"}}, {_id:2382, properties:{name:"dystelectasis", namespace:"FIXME", bel:"path(FIXME:\"dystelectasis\")"}}, {_id:2383, properties:{name:"anthracosis", namespace:"DO", bel:"path(DO:\"anthracosis\")"}}, {_id:2384, properties:{namespace:"DO", bel:"path(DO:\"glomerulosclerosis\")", name:"glomerulosclerosis"}}, {_id:2385, properties:{namespace:"DO", bel:"path(DO:\"arteriolosclerosis\")", name:"arteriolosclerosis"}}, {_id:2386, properties:{name:"Fibrosis", namespace:"MESH", bel:"path(MESH:\"Fibrosis\")"}}, {_id:2388, properties:{name:"Atrophy", namespace:"MESH", bel:"path(MESH:\"Atrophy\")"}}, {_id:2389, properties:{namespace:"HP", bel:"path(HP:\"CNS demyelination\")", name:"CNS demyelination"}}, {_id:2390, properties:{name:"hemosiderosis", namespace:"DO", bel:"path(DO:\"hemosiderosis\")"}}, {_id:2391, properties:{namespace:"FIXME", bel:"path(FIXME:\"cerebral microbleeds\")", name:"cerebral microbleeds"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Pathology;
UNWIND [{_id:107, properties:{bel:"var(\"?\")", hgvs:"?"}}, {_id:342, properties:{bel:"var(\"p.Asn370Ser\")", hgvs:"p.Asn370Ser"}}, {_id:448, properties:{bel:"var(\"p.Arg144Cys\")", hgvs:"p.Arg144Cys"}}, {_id:569, properties:{bel:"var(\"p.Ala53Thr\")", hgvs:"p.Ala53Thr"}}, {_id:584, properties:{bel:"var(\"p.Gly2019Ser\")", hgvs:"p.Gly2019Ser"}}, {_id:634, properties:{bel:"var(\"HSA.pSi4\")", hgvs:"HSA.pSi4"}}, {_id:1080, properties:{bel:"var(\"p.CBD_del\")", hgvs:"p.CBD_del"}}, {_id:1082, properties:{bel:"var(\"p.HSA_del\")", hgvs:"p.HSA_del"}}, {_id:1086, properties:{bel:"var(\"CBD.pSi4\")", hgvs:"CBD.pSi4"}}, {_id:1096, properties:{bel:"var(\"p.His158Cys\")", hgvs:"p.His158Cys"}}, {_id:1097, properties:{bel:"var(\"p.Ser112Cys\")", hgvs:"p.Ser112Cys"}}, {_id:1100, properties:{bel:"var(\"p.His158Arg\")", hgvs:"p.His158Arg"}}, {_id:1103, properties:{bel:"var(\"p.Ser112Arg\")", hgvs:"p.Ser112Arg"}}, {_id:1187, properties:{bel:"var(\"p.Gln231Ala\")", hgvs:"p.Gln231Ala"}}, {_id:1200, properties:{bel:"var(\"p.Cys145Ala\")", hgvs:"p.Cys145Ala"}}, {_id:1256, properties:{bel:"var(\"p.D614G\")", hgvs:"p.D614G"}}, {_id:1257, properties:{bel:"var(\"p.D950N\")", hgvs:"p.D950N"}}, {_id:1258, properties:{bel:"var(\"p.L452R\")", hgvs:"p.L452R"}}, {_id:1259, properties:{bel:"var(\"p.P681R\")", hgvs:"p.P681R"}}, {_id:1260, properties:{bel:"var(\"p.R158G\")", hgvs:"p.R158G"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Variant;
UNWIND [{_id:1261, properties:{bel:"var(\"p.T19R\")", hgvs:"p.T19R"}}, {_id:1262, properties:{bel:"var(\"p.T478K\")", hgvs:"p.T478K"}}, {_id:1263, properties:{bel:"var(\"p.del156EF157\")", hgvs:"p.del156EF157"}}, {_id:1314, properties:{bel:"var(\"p.Pro301Lys\")", hgvs:"p.Pro301Lys"}}, {_id:1367, properties:{bel:"var(\"p.Arg1441Gly\")", hgvs:"p.Arg1441Gly"}}, {_id:1627, properties:{bel:"var(\"p.D405N\")", hgvs:"p.D405N"}}, {_id:1628, properties:{bel:"var(\"p.D796Y\")", hgvs:"p.D796Y"}}, {_id:1629, properties:{bel:"var(\"p.E484A\")", hgvs:"p.E484A"}}, {_id:1630, properties:{bel:"var(\"p.F486V\")", hgvs:"p.F486V"}}, {_id:1631, properties:{bel:"var(\"p.G142D\")", hgvs:"p.G142D"}}, {_id:1632, properties:{bel:"var(\"p.G339D\")", hgvs:"p.G339D"}}, {_id:1633, properties:{bel:"var(\"p.H655Y\")", hgvs:"p.H655Y"}}, {_id:1634, properties:{bel:"var(\"p.K417N\")", hgvs:"p.K417N"}}, {_id:1635, properties:{bel:"var(\"p.L24S\")", hgvs:"p.L24S"}}, {_id:1636, properties:{bel:"var(\"p.N440K\")", hgvs:"p.N440K"}}, {_id:1637, properties:{bel:"var(\"p.N501Y\")", hgvs:"p.N501Y"}}, {_id:1638, properties:{bel:"var(\"p.N679K\")", hgvs:"p.N679K"}}, {_id:1639, properties:{bel:"var(\"p.N764K\")", hgvs:"p.N764K"}}, {_id:1640, properties:{bel:"var(\"p.N969K\")", hgvs:"p.N969K"}}, {_id:1641, properties:{bel:"var(\"p.P681H\")", hgvs:"p.P681H"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Variant;
UNWIND [{_id:1642, properties:{bel:"var(\"p.Q498R\")", hgvs:"p.Q498R"}}, {_id:1643, properties:{bel:"var(\"p.Q954H\")", hgvs:"p.Q954H"}}, {_id:1644, properties:{bel:"var(\"p.R408S\")", hgvs:"p.R408S"}}, {_id:1645, properties:{bel:"var(\"p.S371F\")", hgvs:"p.S371F"}}, {_id:1646, properties:{bel:"var(\"p.S373P\")", hgvs:"p.S373P"}}, {_id:1647, properties:{bel:"var(\"p.S375F\")", hgvs:"p.S375F"}}, {_id:1648, properties:{bel:"var(\"p.S477N\")", hgvs:"p.S477N"}}, {_id:1649, properties:{bel:"var(\"p.T19I\")", hgvs:"p.T19I"}}, {_id:1650, properties:{bel:"var(\"p.T376A\")", hgvs:"p.T376A"}}, {_id:1651, properties:{bel:"var(\"p.V213G\")", hgvs:"p.V213G"}}, {_id:1652, properties:{bel:"var(\"p.Y505H\")", hgvs:"p.Y505H"}}, {_id:1653, properties:{bel:"var(\"p.del25PPA27\")", hgvs:"p.del25PPA27"}}, {_id:1654, properties:{bel:"var(\"p.del69HV70\")", hgvs:"p.del69HV70"}}, {_id:1983, properties:{bel:"var(\"tv2a\")", hgvs:"tv2a"}}, {_id:2032, properties:{bel:"var(\"tva\")", hgvs:"tva"}}, {_id:2034, properties:{bel:"var(\"tvb\")", hgvs:"tvb"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Variant;
UNWIND [{_id:59, properties:{bel:"reactants(a(CHEBI:\"nitric oxide\"),a(CHEBI:\"superoxide\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Reactants;
UNWIND [{_id:100, properties:{namespace:"GO", bel:"loc(GO:\"extracellular region\")", name:"extracellular region"}}, {_id:102, properties:{name:"intracellular", namespace:"GO", bel:"loc(GO:\"intracellular\")"}}, {_id:143, properties:{name:"cytoplasm", bel:"loc(GO:\"cytoplasm\")", namespace:"GO"}}, {_id:150, properties:{name:"Caudate Nucleus", namespace:"MESH", bel:"loc(MESH:\"Caudate Nucleus\")"}}, {_id:436, properties:{name:"CD4-Positive T-Lymphocytes", bel:"loc(MESH:\"CD4-Positive T-Lymphocytes\")", namespace:"MESH"}}, {_id:440, properties:{name:"T-Lymphocytes", namespace:"MESH", bel:"loc(MESH:\"T-Lymphocytes\")"}}, {_id:727, properties:{namespace:"MESH", bel:"loc(MESH:\"Endothelial Cells\")", name:"Endothelial Cells"}}, {_id:880, properties:{name:"Meninges", namespace:"MESH", bel:"loc(MESH:\"Meninges\")"}}, {_id:925, properties:{name:"Brain", bel:"loc(MESH:\"Brain\")", namespace:"MESH"}}, {_id:927, properties:{namespace:"MESH", bel:"loc(MESH:\"Subcutaneous Fat\")", name:"Subcutaneous Fat"}}, {_id:929, properties:{name:"Liver", bel:"loc(MESH:\"Liver\")", namespace:"MESH"}}, {_id:936, properties:{name:"Neurons", bel:"loc(MESH:\"Neurons\")", namespace:"MESH"}}, {_id:938, properties:{namespace:"MESH", bel:"loc(MESH:\"Ependymoglial Cells\")", name:"Ependymoglial Cells"}}, {_id:940, properties:{namespace:"CELL", bel:"loc(CELL:\"neural progenitor cell\")", name:"neural progenitor cell"}}, {_id:1160, properties:{name:"perinuclear region of cytoplasm", bel:"loc(GO:\"perinuclear region of cytoplasm\")", namespace:"GO"}}, {_id:1467, properties:{name:"Serum", bel:"loc(MESH:\"Serum\")", namespace:"MESH"}}, {_id:1471, properties:{name:"Astrocytes", namespace:"MESH", bel:"loc(MESH:\"Astrocytes\")"}}, {_id:1708, properties:{namespace:"UBERON", bel:"loc(UBERON:\"perivascular space\")", name:"perivascular space"}}, {_id:1712, properties:{namespace:"MESH", bel:"loc(MESH:\"Parenchymal Tissue\")", name:"Parenchymal Tissue"}}, {_id:1753, properties:{name:"White Matter", namespace:"MESH", bel:"loc(MESH:\"White Matter\")"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Location;
UNWIND [{_id:2276, properties:{namespace:"MESH", bel:"loc(MESH:\"Tumor Microenvironment\")", name:"Tumor Microenvironment"}}, {_id:2282, properties:{namespace:"MESH", bel:"loc(MESH:\"Intestine, Small\")", name:"Intestine, Small"}}, {_id:2392, properties:{name:"Heart", bel:"loc(MESH:\"Heart\")", namespace:"MESH"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Location;
UNWIND [{_id:164, properties:{bel:"surf(p(GFAM:\"Selectins\"))"}}, {_id:190, properties:{bel:"surf(p(HGNC:\"SELE\"))"}}, {_id:256, properties:{bel:"surf(p(GFAM:\"C1q domain containing\"))"}}, {_id:278, properties:{bel:"surf(p(HGNC:\"IL2RA\"))"}}, {_id:288, properties:{bel:"surf(p(MGI:\"Cd4\"))"}}, {_id:290, properties:{bel:"surf(p(MGI:\"Il2ra\"))"}}, {_id:294, properties:{bel:"surf(p(HGNC:\"CD4\"))"}}, {_id:296, properties:{bel:"surf(p(HGNC:\"ENTPD1\"))"}}, {_id:298, properties:{bel:"surf(p(HGNC:\"ITGA4\"))"}}, {_id:380, properties:{bel:"surf(complex(GO:\"MHC class II protein complex\"))"}}, {_id:406, properties:{bel:"surf(p(HGNC:\"PTPRC\"))"}}, {_id:408, properties:{bel:"surf(p(HGNC:\"FAS\"))"}}, {_id:873, properties:{bel:"surf(p(HGNC:\"CD68\"))"}}, {_id:875, properties:{bel:"surf(p(HGNC:\"TMEM119\"))"}}, {_id:1152, properties:{bel:"surf(p(MGI:\"Nrp1\"))"}}, {_id:1154, properties:{bel:"surf(p(MGI:\"Bsg\"))"}}, {_id:1157, properties:{bel:"surf(p(HGNC:\"NRP1\"))"}}, {_id:1159, properties:{bel:"surf(p(HGNC:\"BSG\"))"}}, {_id:1266, properties:{bel:"surf(a(CHEBI:\"heparan sulfate\"))"}}, {_id:1317, properties:{bel:"surf(p(MGI:\"Sdc3\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:CellSurfaceExpression;
UNWIND [{_id:1528, properties:{bel:"surf(p(HGNC:\"CD46\"))"}}, {_id:1530, properties:{bel:"surf(p(HGNC:\"CD200\"))"}}, {_id:2040, properties:{bel:"surf(r(HGNC:\"ICOS\"))"}}, {_id:2045, properties:{bel:"surf(r(HGNC:\"CXCR3\"))"}}, {_id:2047, properties:{bel:"surf(r(HGNC:\"CCR4\"))"}}, {_id:2239, properties:{bel:"surf(p(HGNC:\"TLR3\"))"}}, {_id:2261, properties:{bel:"surf(p(HGNC:\"CD80\"))"}}, {_id:2262, properties:{bel:"surf(p(HGNC:\"CD86\"))"}}, {_id:2265, properties:{bel:"surf(p(MGI:\"Cd80\"))"}}, {_id:2267, properties:{bel:"surf(p(MGI:\"Cd86\"))"}}, {_id:2311, properties:{bel:"surf(a(MESH:\"Kv1.3 Potassium Channel\"))"}}, {_id:2350, properties:{bel:"surf(p(MGI:\"Cd68\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:CellSurfaceExpression;
UNWIND [{_id:202, properties:{bel:"tloc(complex(GO:\"NF-kappaB complex\"),fromLoc(GO:\"cytoplasm\"),toLoc(GO:\"nucleus\"))"}}, {_id:462, properties:{bel:"tloc(p(GFAM:\"Nuclear factors of activated T-cells\"),fromLoc(GO:\"cytoplasm\"),toLoc(GO:\"nucleus\"))"}}, {_id:606, properties:{bel:"tloc(p(HGNC:\"APP\",frag(\"1_42\")),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:613, properties:{bel:"tloc(p(HGNC:\"TF\"),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:628, properties:{bel:"tloc(p(HGNC:\"SNCA\"),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:629, properties:{bel:"tloc(p(HGNC:\"MAPT\"),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:828, properties:{bel:"tloc(p(HGNC:\"MAPT\"),fromLoc(GO:\"axon\"),toLoc(GO:\"cell body\"))"}}, {_id:831, properties:{bel:"tloc(p(HGNC:\"MAPT\",pmod(Ph,Y,231)),fromLoc(GO:\"axon\"),toLoc(GO:\"cell body\"))"}}, {_id:954, properties:{bel:"tloc(a(TAX:\"Severe acute respiratory syndrome coronavirus 2\"),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1077, properties:{bel:"tloc(p(UNIPROT:\"P0DTC2\"),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1091, properties:{bel:"tloc(p(UNIPROT:\"P0DTC2\",frag(\"14_685\")),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1099, properties:{bel:"tloc(p(HGNC:\"APOE\",var(\"p.His158Cys\"),var(\"p.Ser112Cys\")),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1102, properties:{bel:"tloc(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Cys\")),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1105, properties:{bel:"tloc(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Arg\")),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1126, properties:{bel:"tloc(a(TAX:\"Severe acute respiratory syndrome coronavirus 2\"),fromLoc(MESH:\"Blood\"),toLoc(MESH:\"Brain\"))"}}, {_id:1192, properties:{bel:"tloc(p(HGNC:\"RELA\"),fromLoc(GO:\"cytoplasm\"),toLoc(GO:\"nucleus\"))"}}, {_id:1197, properties:{bel:"tloc(p(MGI:\"Rela\"),fromLoc(GO:\"cytoplasm\"),toLoc(GO:\"nucleus\"))"}}, {_id:1213, properties:{bel:"tloc(complex(GO:\"IgG immunoglobulin complex\"),fromLoc(MESH:\"Blood Vessels\"),toLoc(MESH:\"Brain\"))"}}, {_id:1215, properties:{bel:"tloc(p(MGI:\"Alb\"),fromLoc(MESH:\"Blood Vessels\"),toLoc(MESH:\"Brain\"))"}}, {_id:1225, properties:{bel:"tloc(complex(GO:\"IgG immunoglobulin complex\"),fromLoc(MESH:\"Blood Vessels\"),toLoc(MESH:\"Parenchymal Tissue\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Translocation;
UNWIND [{_id:1226, properties:{bel:"tloc(p(MGI:\"Alb\"),fromLoc(MESH:\"Blood Vessels\"),toLoc(MESH:\"Parenchymal Tissue\"))"}}, {_id:1265, properties:{bel:"tloc(p(UNIPROT:\"P0DTC2\",var(\"p.D614G\"),var(\"p.D950N\"),var(\"p.L452R\"),var(\"p.P681R\"),var(\"p.R158G\"),var(\"p.T19R\"),var(\"p.T478K\"),var(\"p.del156EF157\")),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1331, properties:{bel:"tloc(a(FIXME:\"microbial-derived products\"),fromLoc(MESH:\"Gastrointestinal Tract\"),toLoc(MESH:\"Blood\"))"}}, {_id:1333, properties:{bel:"tloc(a(MESH:\"Inflammation Mediators\"),fromLoc(MESH:\"Gastrointestinal Tract\"),toLoc(MESH:\"Blood\"))"}}, {_id:1395, properties:{bel:"tloc(p(HGNC:\"PRKN\"),fromLoc(GO:\"cytosol\"),toLoc(FIXME:\"damaged mitochondria\"))"}}, {_id:1463, properties:{bel:"tloc(a(GO:\"mitochondrial chromosome\"),fromLoc(FIXME:\"damaged mitochondria\"),toLoc(GO:\"cytosol\"))"}}, {_id:1519, properties:{bel:"tloc(p(UNIPROT:\"P0DTC9\"),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:1772, properties:{bel:"tloc(a(GO:\"mitochondrion\"),fromLoc(CELL:\"neuron\"),toLoc(CELL:\"neuron\"))"}}, {_id:1928, properties:{bel:"tloc(p(UNIPROT:\"P0DTC2\",var(\"p.D405N\"),var(\"p.D614G\"),var(\"p.D796Y\"),var(\"p.E484A\"),var(\"p.F486V\"),var(\"p.G142D\"),var(\"p.G339D\"),var(\"p.H655Y\"),var(\"p.K417N\"),var(\"p.L24S\"),var(\"p.L452R\"),var(\"p.N440K\"),var(\"p.N501Y\"),var(\"p.N679K\"),var(\"p.N764K\"),var(\"p.N969K\"),var(\"p.P681H\"),var(\"p.Q498R\"),var(\"p.Q954H\"),var(\"p.R408S\"),var(\"p.S371F\"),var(\"p.S373P\"),var(\"p.S375F\"),var(\"p.S477N\"),var(\"p.T19I\"),var(\"p.T376A\"),var(\"p.T478K\"),var(\"p.V213G\"),var(\"p.Y505H\"),var(\"p.del25PPA27\"),var(\"p.del69HV70\")),fromLoc(GO:\"extracellular region\"),toLoc(GO:\"intracellular\"))"}}, {_id:2320, properties:{bel:"tloc(a(MESH:\"T-Lymphocytes, Regulatory\"),fromLoc(MESH:\"Blood\"),toLoc(MESH:\"Central Nervous System\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Translocation;
UNWIND [{_id:109, properties:{bel:"composite(a(MESH:\"Endotoxins\"),p(MGI:\"Sod1\",var(\"?\")))"}}, {_id:114, properties:{bel:"composite(p(HGNC:\"APP\"),p(HGNC:\"MAPT\",var(\"?\")),p(HGNC:\"PSEN1\"))"}}, {_id:332, properties:{bel:"composite(a(MESH:\"T-Lymphocytes, Regulatory\"),a(MESH:\"Th17 Cells\"))"}}, {_id:333, properties:{bel:"composite(a(MESH:\"T-Lymphocytes, Regulatory\"),a(MESH:\"Th1 Cells\"))"}}, {_id:366, properties:{bel:"composite(a(CHEBI:\"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\"),a(CHEBI:\"dexamethasone\"))"}}, {_id:368, properties:{bel:"composite(a(CHEBI:\"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\"),a(CHEBI:\"anti-inflammatory drug\"))"}}, {_id:370, properties:{bel:"composite(a(CHEBI:\"anti-inflammatory drug\"),a(CHEBI:\"oxidopamine\"))"}}, {_id:385, properties:{bel:"composite(a(MESH:\"Environmental Exposure\"),complex(GO:\"MHC class II protein complex\"))"}}, {_id:503, properties:{bel:"composite(g(HGNC:\"HLA-DRB1\",var(\"?\")),g(HGNC:\"HLA-DRB5\",var(\"?\")))"}}, {_id:547, properties:{bel:"composite(a(CHEBI:\"EC 1.1.1.205 (IMP dehydrogenase) inhibitor\"),a(CHEBI:\"corticosteroid\"))"}}, {_id:571, properties:{bel:"composite(a(CHEBI:\"pesticide\"),p(HGNC:\"SNCA\",var(\"p.Ala53Thr\")))"}}, {_id:676, properties:{bel:"composite(complex(GO:\"NLRP3 inflammasome complex\"),p(HGNC:\"IL1B\"))"}}, {_id:962, properties:{bel:"composite(a(CHEBI:\"camostat\"),a(FIXME:\"EK1 peptide\"))"}}, {_id:964, properties:{bel:"composite(a(CHEBI:\"camostat\"),a(CHEBI:\"nafamostat\"),a(FIXME:\"EK1 peptide\"))"}}, {_id:1088, properties:{bel:"composite(p(HGNC:\"ACE2\"),p(HGNC:\"SDC1\"))"}}, {_id:1111, properties:{bel:"composite(p(HGNC:\"APOE\"),p(HGNC:\"SDC3\"))"}}, {_id:1112, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Cys\"),var(\"p.Ser112Cys\")),p(HGNC:\"APP\",frag(\"1_42\")))"}}, {_id:1113, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Cys\")),p(HGNC:\"APP\",frag(\"1_42\")))"}}, {_id:1114, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Arg\")),p(HGNC:\"APP\",frag(\"1_42\")))"}}, {_id:1115, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Cys\"),var(\"p.Ser112Cys\")),p(HGNC:\"APP\",frag(\"1_42\")),p(HGNC:\"SDC3\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Composite;
UNWIND [{_id:1116, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Cys\")),p(HGNC:\"APP\",frag(\"1_42\")),p(HGNC:\"SDC3\"))"}}, {_id:1117, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Arg\")),p(HGNC:\"APP\",frag(\"1_42\")),p(HGNC:\"SDC3\"))"}}, {_id:1119, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Arg\")))"}}, {_id:1120, properties:{bel:"composite(p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Arg\")),p(HGNC:\"SDC3\"))"}}, {_id:1121, properties:{bel:"composite(p(HGNC:\"APP\",frag(\"1_42\")),p(HGNC:\"SDC3\"))"}}, {_id:1189, properties:{bel:"composite(p(HGNC:\"IKBKG\",var(\"p.Gln231Ala\")),p(UNIPROT:\"P0DTC1\"))"}}, {_id:1190, properties:{bel:"composite(p(HGNC:\"IL1B\"),p(UNIPROT:\"P0DTC1\"))"}}, {_id:1195, properties:{bel:"composite(p(MGI:\"Il1b\"),p(UNIPROT:\"P0DTC1\"))"}}, {_id:1199, properties:{bel:"composite(p(HGNC:\"TNF\"),p(UNIPROT:\"P0DTC1\"))"}}, {_id:1211, properties:{bel:"composite(p(MGI:\"Fadd\"),p(MGI:\"Ikbkg\"))"}}, {_id:1218, properties:{bel:"composite(a(MESH:\"Tamoxifen\"),p(MGI:\"Fadd\"),p(MGI:\"Ikbkg\"))"}}, {_id:1221, properties:{bel:"composite(a(MESH:\"Tamoxifen\"),p(MGI:\"Ikbkg\"),p(MGI:\"Ripk3\"))"}}, {_id:1222, properties:{bel:"composite(p(MGI:\"Ikbkg\"),p(MGI:\"Ripk3\"))"}}, {_id:1231, properties:{bel:"composite(p(MGI:\"Ripk3\"),p(UNIPROT:\"P0DTC1\"))"}}, {_id:1233, properties:{bel:"composite(a(PUBCHEM:\"134521814\"),p(UNIPROT:\"P0DTC1\"))"}}, {_id:1270, properties:{bel:"composite(a(CHEBI:\"heparan sulfate\"),p(HGNC:\"SDC1\"))"}}, {_id:1271, properties:{bel:"composite(a(CHEBI:\"heparan sulfate\"),p(HGNC:\"SDC4\"))"}}, {_id:1316, properties:{bel:"composite(p(MGI:\"App\",var(\"?\")),p(MGI:\"Mapt\",var(\"p.Pro301Lys\")))"}}, {_id:1369, properties:{bel:"composite(a(CHEBI:\"lipopolysaccharide\"),p(MGI:\"Lrrk2\",var(\"p.Arg1441Gly\")))"}}, {_id:1399, properties:{bel:"composite(p(HGNC:\"PINK1\"),p(HGNC:\"PRKN\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Composite;
UNWIND [{_id:1410, properties:{bel:"composite(p(MGI:\"Pink1\"),p(MGI:\"Prkn\"))"}}, {_id:1699, properties:{bel:"composite(a(CHEBI:\"sofosbuvir\"),a(TAX:\"Severe acute respiratory syndrome coronavirus 2\"))"}}, {_id:1765, properties:{bel:"composite(p(HGNC:\"ACE2\"),p(UNIPROT:\"P0DTC2\"))"}}, {_id:1877, properties:{bel:"composite(a(FIXME:\"senescence markers\"),a(MESH:\"Cytokines\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Composite;
UNWIND [{_id:4, properties:{name:"Cytokines", bel:"a(MESH:\"Cytokines\")", namespace:"MESH", pure:true}}, {_id:6, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"reactive oxygen species\")", name:"reactive oxygen species", pure:true}}, {_id:8, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"anti-inflammatory drug\")", name:"anti-inflammatory drug", pure:true}}, {_id:30, properties:{namespace:"MESH", bel:"a(MESH:\"Acute-Phase Proteins\")", name:"Acute-Phase Proteins", pure:true}}, {_id:31, properties:{name:"Complement System Proteins", bel:"a(MESH:\"Complement System Proteins\")", namespace:"MESH", pure:true}}, {_id:46, properties:{name:"Advanced Oxidation Protein Products", bel:"a(MESH:\"Advanced Oxidation Protein Products\")", namespace:"MESH", pure:true}}, {_id:51, properties:{name:"hydroxyl", bel:"a(CHEBI:\"hydroxyl\")", namespace:"CHEBI", pure:true}}, {_id:52, properties:{name:"arachidonate", namespace:"CHEBI", bel:"a(CHEBI:\"arachidonate\")", pure:true}}, {_id:53, properties:{name:"ceramide", bel:"a(CHEBI:\"ceramide\")", namespace:"CHEBI", pure:true}}, {_id:57, properties:{name:"nitric oxide", namespace:"CHEBI", bel:"a(CHEBI:\"nitric oxide\")", pure:true}}, {_id:58, properties:{name:"superoxide", namespace:"CHEBI", bel:"a(CHEBI:\"superoxide\")", pure:true}}, {_id:60, properties:{name:"peroxynitrite", namespace:"CHEBI", bel:"a(CHEBI:\"peroxynitrite\")", pure:true}}, {_id:64, properties:{name:"nitrotyrosine", namespace:"CHEBI", bel:"a(CHEBI:\"nitrotyrosine\")", pure:true}}, {_id:68, properties:{name:"nitrite", bel:"a(CHEBI:\"nitrite\")", namespace:"CHEBI", pure:true}}, {_id:75, properties:{name:"Macrophages", namespace:"MESH", bel:"a(MESH:\"Macrophages\")", pure:true}}, {_id:78, properties:{name:"neuron projection", namespace:"GO", bel:"a(GO:\"neuron projection\")", pure:true}}, {_id:80, properties:{name:"Alarmins", bel:"a(MESH:\"Alarmins\")", namespace:"MESH", pure:true}}, {_id:85, properties:{name:"lesion size", namespace:"FIXME", bel:"a(FIXME:\"lesion size\")", pure:true}}, {_id:87, properties:{name:"Nerve Fibers", namespace:"MESH", bel:"a(MESH:\"Nerve Fibers\")", pure:true}}, {_id:90, properties:{name:"non-steroidal anti-inflammatory drug", bel:"a(CHEBI:\"non-steroidal anti-inflammatory drug\")", namespace:"CHEBI", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:104, properties:{namespace:"MESH", bel:"a(MESH:\"Nitric Oxide Synthase\")", name:"Nitric Oxide Synthase", pure:true}}, {_id:105, properties:{name:"Endotoxins", namespace:"MESH", bel:"a(MESH:\"Endotoxins\")", pure:true}}, {_id:110, properties:{name:"synapse", bel:"a(GO:\"synapse\")", namespace:"GO", pure:true}}, {_id:115, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"lipopolysaccharide\")", name:"lipopolysaccharide", pure:true}}, {_id:120, properties:{namespace:"FIXME", bel:"a(FIXME:\"proinflammatory microglia\")", name:"proinflammatory microglia", pure:true}}, {_id:123, properties:{name:"Neurons", bel:"a(MESH:\"Neurons\")", namespace:"MESH", pure:true}}, {_id:144, properties:{bel:"a(MESH:\"Lewy Bodies\",loc(GO:\"cytoplasm\"))", name:"Lewy Bodies", namespace:"MESH"}}, {_id:145, properties:{name:"Lewy Bodies", namespace:"MESH", bel:"a(MESH:\"Lewy Bodies\")", pure:true}}, {_id:149, properties:{name:"dopamine", bel:"a(CHEBI:\"dopamine\")", namespace:"CHEBI", pure:true}}, {_id:151, properties:{namespace:"MESH", bel:"a(MESH:\"Dopaminergic Neurons\",loc(MESH:\"Caudate Nucleus\"))", name:"Dopaminergic Neurons"}}, {_id:157, properties:{name:"Neural Cell Adhesion Molecules", bel:"a(MESH:\"Neural Cell Adhesion Molecules\")", namespace:"MESH", pure:true}}, {_id:158, properties:{namespace:"NCIT", bel:"a(NCIT:\"Lymphocytic Infiltrate\")", name:"Lymphocytic Infiltrate", pure:true}}, {_id:172, properties:{name:"Cellular Debris", namespace:"NCIT", bel:"a(NCIT:\"Cellular Debris\")", pure:true}}, {_id:178, properties:{name:"Chemokines", namespace:"MESH", bel:"a(MESH:\"Chemokines\")", pure:true}}, {_id:191, properties:{namespace:"MESH", bel:"a(MESH:\"Cell Adhesion Molecules\")", name:"Cell Adhesion Molecules", pure:true}}, {_id:194, properties:{name:"T-Lymphocytes", namespace:"MESH", bel:"a(MESH:\"T-Lymphocytes\")", pure:true}}, {_id:195, properties:{name:"Microglia", bel:"a(MESH:\"Microglia\")", namespace:"MESH", pure:true}}, {_id:210, properties:{namespace:"MESH", bel:"a(MESH:\"Dopaminergic Neurons\")", name:"Dopaminergic Neurons", pure:true}}, {_id:231, properties:{name:"neuromelanin", namespace:"MESH", bel:"a(MESH:\"neuromelanin\")", pure:true}}, {_id:234, properties:{name:"HLA-DR Antigens", namespace:"MESH", bel:"a(MESH:\"HLA-DR Antigens\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:235, properties:{name:"HLA-DQ Antigens", namespace:"MESH", bel:"a(MESH:\"HLA-DQ Antigens\")", pure:true}}, {_id:237, properties:{namespace:"MESH", bel:"a(MESH:\"Antigen-Presenting Cells\")", name:"Antigen-Presenting Cells", pure:true}}, {_id:242, properties:{name:"neurofilament", namespace:"GO", bel:"a(GO:\"neurofilament\")", pure:true}}, {_id:244, properties:{namespace:"MESH", bel:"a(MESH:\"Myelin Basic Protein\")", name:"Myelin Basic Protein", pure:true}}, {_id:245, properties:{name:"amyloid-beta", namespace:"CHEBI", bel:"a(CHEBI:\"amyloid-beta\")", pure:true}}, {_id:248, properties:{namespace:"CELL", bel:"a(CELL:\"mature microglial cell\")", name:"mature microglial cell", pure:true}}, {_id:257, properties:{name:"CD8-Positive T-Lymphocytes", bel:"a(MESH:\"CD8-Positive T-Lymphocytes\")", namespace:"MESH", pure:true}}, {_id:258, properties:{name:"CD4-Positive T-Lymphocytes", bel:"a(MESH:\"CD4-Positive T-Lymphocytes\")", namespace:"MESH", pure:true}}, {_id:260, properties:{name:"B cell, CD19-positive", bel:"a(CELL:\"B cell, CD19-positive\")", namespace:"CELL", pure:true}}, {_id:262, properties:{name:"CD4 Positive Naive T-Lymphocyte", bel:"a(NCIT:\"CD4 Positive Naive T-Lymphocyte\")", namespace:"NCIT", pure:true}}, {_id:263, properties:{name:"memory T cell", namespace:"CELL", bel:"a(CELL:\"memory T cell\")", pure:true}}, {_id:267, properties:{name:"Th1 Cells", bel:"a(MESH:\"Th1 Cells\")", namespace:"MESH", pure:true}}, {_id:270, properties:{name:"Th2 Cells", bel:"a(MESH:\"Th2 Cells\")", namespace:"MESH", pure:true}}, {_id:273, properties:{bel:"a(CELL:\"CD4-positive, CD25-positive, alpha-beta regulatory T cell\")", name:"CD4-positive, CD25-positive, alpha-beta regulatory T cell", namespace:"CELL", pure:true}}, {_id:276, properties:{namespace:"CELL", bel:"a(CELL:\"gamma-delta T cell\")", name:"gamma-delta T cell", pure:true}}, {_id:277, properties:{name:"alpha-beta T cell", namespace:"CELL", bel:"a(CELL:\"alpha-beta T cell\")", pure:true}}, {_id:283, properties:{namespace:"MESH", bel:"a(MESH:\"T-Lymphocytes, Regulatory\")", name:"T-Lymphocytes, Regulatory", pure:true}}, {_id:284, properties:{name:"effector T cell", namespace:"CELL", bel:"a(CELL:\"effector T cell\")", pure:true}}, {_id:300, properties:{namespace:"EFO", bel:"a(EFO:\"induced T-regulatory cell\")", name:"induced T-regulatory cell", pure:true}}, {_id:302, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"all-trans-retinoic acid\")", name:"all-trans-retinoic acid", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:303, properties:{name:"Histone Deacetylase Inhibitors", bel:"a(MESH:\"Histone Deacetylase Inhibitors\")", namespace:"MESH", pure:true}}, {_id:317, properties:{bel:"a(NCIT:\"CD4+ CD25+ Regulatory T Cells\")", name:"CD4+ CD25+ Regulatory T Cells", namespace:"NCIT", pure:true}}, {_id:319, properties:{name:"Microgliosis", namespace:"NCIT", bel:"a(NCIT:\"Microgliosis\")", pure:true}}, {_id:331, properties:{name:"Th17 Cells", namespace:"MESH", bel:"a(MESH:\"Th17 Cells\")", pure:true}}, {_id:354, properties:{name:"N-methyl-4-phenylpyridinium", bel:"a(CHEBI:\"N-methyl-4-phenylpyridinium\")", namespace:"CHEBI", pure:true}}, {_id:356, properties:{name:"neuronal injury", namespace:"FIXME", bel:"a(FIXME:\"neuronal injury\")", pure:true}}, {_id:364, properties:{bel:"a(CHEBI:\"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\")", name:"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", namespace:"CHEBI", pure:true}}, {_id:365, properties:{name:"dexamethasone", namespace:"CHEBI", bel:"a(CHEBI:\"dexamethasone\")", pure:true}}, {_id:369, properties:{name:"oxidopamine", namespace:"CHEBI", bel:"a(CHEBI:\"oxidopamine\")", pure:true}}, {_id:381, properties:{name:"Duration", bel:"a(NCIT:\"Duration\")", namespace:"NCIT", pure:true}}, {_id:383, properties:{bel:"a(NCIT:\"UHDRS 1999 Version - Total Motor Score\")", name:"UHDRS 1999 Version - Total Motor Score", namespace:"NCIT", pure:true}}, {_id:384, properties:{namespace:"MESH", bel:"a(MESH:\"Environmental Exposure\")", name:"Environmental Exposure", pure:true}}, {_id:392, properties:{name:"H5N1 subtype", namespace:"TAX", bel:"a(TAX:\"H5N1 subtype\")", pure:true}}, {_id:394, properties:{name:"Japanese encephalitis virus", bel:"a(TAX:\"Japanese encephalitis virus\")", namespace:"TAX", pure:true}}, {_id:398, properties:{name:"catecholamine", namespace:"CHEBI", bel:"a(CHEBI:\"catecholamine\")", pure:true}}, {_id:402, properties:{name:"Lymphocytes", namespace:"MESH", bel:"a(MESH:\"Lymphocytes\")", pure:true}}, {_id:403, properties:{name:"Precursor Cells, T-Lymphoid", bel:"a(MESH:\"Precursor Cells, T-Lymphoid\")", namespace:"MESH", pure:true}}, {_id:411, properties:{namespace:"FIXME", bel:"a(FIXME:\"purine nucleotide oxidation\")", name:"purine nucleotide oxidation", pure:true}}, {_id:412, properties:{name:"L-dopa", bel:"a(CHEBI:\"L-dopa\")", namespace:"CHEBI", pure:true}}, {_id:430, properties:{name:"Immunoglobulins", namespace:"MESH", bel:"a(MESH:\"Immunoglobulins\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:433, properties:{name:"Immunoglobulin G", namespace:"MESH", bel:"a(MESH:\"Immunoglobulin G\")", pure:true}}, {_id:447, properties:{name:"Lentivirus", bel:"a(TAX:\"Lentivirus\")", namespace:"TAX", pure:true}}, {_id:459, properties:{name:"dextran sulfate", namespace:"CHEBI", bel:"a(CHEBI:\"dextran sulfate\")", pure:true}}, {_id:478, properties:{namespace:"MESH", bel:"a(MESH:\"Glatiramer Acetate\")", name:"Glatiramer Acetate", pure:true}}, {_id:482, properties:{name:"colchicine", namespace:"CHEBI", bel:"a(CHEBI:\"colchicine\")", pure:true}}, {_id:485, properties:{name:"Abatacept", bel:"a(MESH:\"Abatacept\")", namespace:"MESH", pure:true}}, {_id:491, properties:{name:"Belatacept", namespace:"NCIT", bel:"a(NCIT:\"Belatacept\")", pure:true}}, {_id:492, properties:{name:"Natalizumab", namespace:"MESH", bel:"a(MESH:\"Natalizumab\")", pure:true}}, {_id:494, properties:{name:"rituximab", namespace:"CHEBI", bel:"a(CHEBI:\"rituximab\")", pure:true}}, {_id:495, properties:{name:"B-Lymphocytes", namespace:"MESH", bel:"a(MESH:\"B-Lymphocytes\")", pure:true}}, {_id:496, properties:{name:"Immunoglobulins, Intravenous", bel:"a(MESH:\"Immunoglobulins, Intravenous\")", namespace:"MESH", pure:true}}, {_id:540, properties:{name:"Anti-Tumor Necrosis Factor Therapy", bel:"a(NCIT:\"Anti-Tumor Necrosis Factor Therapy\")", namespace:"NCIT", pure:true}}, {_id:541, properties:{name:"corticosteroid", namespace:"CHEBI", bel:"a(CHEBI:\"corticosteroid\")", pure:true}}, {_id:542, properties:{bel:"a(CHEBI:\"EC 1.1.1.205 (IMP dehydrogenase) inhibitor\")", name:"EC 1.1.1.205 (IMP dehydrogenase) inhibitor", namespace:"CHEBI", pure:true}}, {_id:543, properties:{name:"methotrexate", namespace:"CHEBI", bel:"a(CHEBI:\"methotrexate\")", pure:true}}, {_id:544, properties:{name:"mycophenolate", namespace:"CHEBI", bel:"a(CHEBI:\"mycophenolate\")", pure:true}}, {_id:545, properties:{name:"prednisone", namespace:"CHEBI", bel:"a(CHEBI:\"prednisone\")", pure:true}}, {_id:546, properties:{name:"meprednisone", namespace:"CHEBI", bel:"a(CHEBI:\"meprednisone\")", pure:true}}, {_id:550, properties:{name:"pathogen", bel:"a(EFO:\"pathogen\")", namespace:"EFO", pure:true}}, {_id:552, properties:{namespace:"MESH", bel:"a(MESH:\"Environmental Pollutants\")", name:"Environmental Pollutants", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:555, properties:{name:"Norovirus", bel:"a(TAX:\"Norovirus\")", namespace:"TAX", pure:true}}, {_id:556, properties:{name:"Lactobacillus", namespace:"TAX", bel:"a(TAX:\"Lactobacillus\")", pure:true}}, {_id:557, properties:{name:"Akkermansia", namespace:"TAX", bel:"a(TAX:\"Akkermansia\")", pure:true}}, {_id:558, properties:{name:"Bifidobacterium", namespace:"TAX", bel:"a(TAX:\"Bifidobacterium\")", pure:true}}, {_id:559, properties:{name:"Prevotella", bel:"a(TAX:\"Prevotella\")", namespace:"TAX", pure:true}}, {_id:560, properties:{name:"Blautia", bel:"a(TAX:\"Blautia\")", namespace:"TAX", pure:true}}, {_id:561, properties:{name:"Faecalibacterium", namespace:"TAX", bel:"a(TAX:\"Faecalibacterium\")", pure:true}}, {_id:563, properties:{namespace:"NCIT", bel:"a(NCIT:\"Tryptophan Metabolite\")", name:"Tryptophan Metabolite", pure:true}}, {_id:564, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"short-chain fatty acid\")", name:"short-chain fatty acid", pure:true}}, {_id:565, properties:{name:"pesticide", namespace:"CHEBI", bel:"a(CHEBI:\"pesticide\")", pure:true}}, {_id:574, properties:{name:"Lysosomal Function Inhibition", bel:"a(NCIT:\"Lysosomal Function Inhibition\")", namespace:"NCIT", pure:true}}, {_id:577, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"immunosuppressive agent\")", name:"immunosuppressive agent", pure:true}}, {_id:578, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"anti-inflammatory agent\")", name:"anti-inflammatory agent", pure:true}}, {_id:592, properties:{name:"Mycobacterium tuberculosis", bel:"a(TAX:\"Mycobacterium tuberculosis\")", namespace:"TAX", pure:true}}, {_id:599, properties:{name:"neurotoxin", namespace:"CHEBI", bel:"a(CHEBI:\"neurotoxin\")", pure:true}}, {_id:609, properties:{name:"plasma membrane", namespace:"GO", bel:"a(GO:\"plasma membrane\")", pure:true}}, {_id:618, properties:{name:"sodium chlorate", namespace:"CHEBI", bel:"a(CHEBI:\"sodium chlorate\")", pure:true}}, {_id:626, properties:{name:"heparan sulfate", namespace:"CHEBI", bel:"a(CHEBI:\"heparan sulfate\")", pure:true}}, {_id:647, properties:{namespace:"NCIT", bel:"a(NCIT:\"Deep Tendon Reflex\")", name:"Deep Tendon Reflex", pure:true}}, {_id:671, properties:{name:"Quality of Life", namespace:"MESH", bel:"a(MESH:\"Quality of Life\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:679, properties:{namespace:"GO", bel:"a(GO:\"neurofibrillary tangle\")", name:"neurofibrillary tangle", pure:true}}, {_id:682, properties:{name:"fibrin fragment D", namespace:"MESH", bel:"a(MESH:\"fibrin fragment D\")", pure:true}}, {_id:683, properties:{name:"Ferritin", bel:"a(CHEBI:\"Ferritin\")", namespace:"CHEBI", pure:true}}, {_id:684, properties:{bel:"a(TAX:\"Severe acute respiratory syndrome coronavirus 2\")", name:"Severe acute respiratory syndrome coronavirus 2", namespace:"TAX", pure:true}}, {_id:691, properties:{bel:"a(TAX:\"Severe acute respiratory syndrome coronavirus\")", name:"Severe acute respiratory syndrome coronavirus", namespace:"TAX", pure:true}}, {_id:699, properties:{namespace:"TAX", bel:"a(TAX:\"Human coronavirus OC43\")", name:"Human coronavirus OC43", pure:true}}, {_id:728, properties:{bel:"a(TAX:\"Severe acute respiratory syndrome coronavirus 2\",loc(MESH:\"Endothelial Cells\"))", name:"Severe acute respiratory syndrome coronavirus 2", namespace:"TAX"}}, {_id:729, properties:{name:"Demyelination", namespace:"NCIT", bel:"a(NCIT:\"Demyelination\")", pure:true}}, {_id:730, properties:{name:"Neurological Signs and Symptoms", bel:"a(NCIT:\"Neurological Signs and Symptoms\")", namespace:"NCIT", pure:true}}, {_id:739, properties:{name:"Intravenous Immunoglobulin Therapy", bel:"a(NCIT:\"Intravenous Immunoglobulin Therapy\")", namespace:"NCIT", pure:true}}, {_id:740, properties:{name:"Immunotherapy", namespace:"MESH", bel:"a(MESH:\"Immunotherapy\")", pure:true}}, {_id:746, properties:{namespace:"NCIT", bel:"a(NCIT:\"Facial Nerve Disorder\")", name:"Facial Nerve Disorder", pure:true}}, {_id:752, properties:{name:"ganglioside, GD1b", namespace:"MESH", bel:"a(MESH:\"ganglioside, GD1b\")", pure:true}}, {_id:768, properties:{namespace:"NCIT", bel:"a(NCIT:\"Deep Vein Thrombosis\")", name:"Deep Vein Thrombosis", pure:true}}, {_id:771, properties:{name:"Low Molecular Weight Heparin", bel:"a(NCIT:\"Low Molecular Weight Heparin\")", namespace:"NCIT", pure:true}}, {_id:773, properties:{name:"Olfactory Bulb", namespace:"MESH", bel:"a(MESH:\"Olfactory Bulb\")", pure:true}}, {_id:780, properties:{name:"Monokines", bel:"a(MESH:\"Monokines\")", namespace:"MESH", pure:true}}, {_id:782, properties:{namespace:"NCIT", bel:"a(NCIT:\"Acute Flaccid Myelitis\")", name:"Acute Flaccid Myelitis", pure:true}}, {_id:784, properties:{namespace:"TAX", bel:"a(TAX:\"Human alphaherpesvirus 3\")", name:"Human alphaherpesvirus 3", pure:true}}, {_id:789, properties:{name:"Low Blood Oxygen Saturation", bel:"a(NCIT:\"Low Blood Oxygen Saturation\")", namespace:"NCIT", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:800, properties:{namespace:"NCIT", bel:"a(NCIT:\"Right Atrial Thrombus\")", name:"Right Atrial Thrombus", pure:true}}, {_id:805, properties:{namespace:"NCIT", bel:"a(NCIT:\"Erythrophagocytosis\")", name:"Erythrophagocytosis", pure:true}}, {_id:806, properties:{name:"Plasma Cells", namespace:"MESH", bel:"a(MESH:\"Plasma Cells\")", pure:true}}, {_id:807, properties:{name:"Histiocytes", namespace:"MESH", bel:"a(MESH:\"Histiocytes\")", pure:true}}, {_id:866, properties:{name:"Lesion", bel:"a(NCIT:\"Lesion\")", namespace:"NCIT", pure:true}}, {_id:879, properties:{namespace:"MESH", bel:"a(MESH:\"T-Lymphocytes, Cytotoxic\")", name:"T-Lymphocytes, Cytotoxic", pure:true}}, {_id:881, properties:{namespace:"MESH", bel:"a(MESH:\"T-Lymphocytes, Cytotoxic\",loc(MESH:\"Meninges\"))", name:"T-Lymphocytes, Cytotoxic"}}, {_id:882, properties:{name:"IBA1-positive macrophage", bel:"a(FIXME:\"IBA1-positive macrophage\")", namespace:"FIXME", pure:true}}, {_id:883, properties:{name:"CD68-positive macrophage", bel:"a(FIXME:\"CD68-positive macrophage\")", namespace:"FIXME", pure:true}}, {_id:884, properties:{name:"TMEM119-negative macrophage", bel:"a(FIXME:\"TMEM119-negative macrophage\")", namespace:"FIXME", pure:true}}, {_id:893, properties:{name:"apolipoprotein", namespace:"CHEBI", bel:"a(CHEBI:\"apolipoprotein\")", pure:true}}, {_id:897, properties:{name:"lipid vesicles", namespace:"FIXME", bel:"a(FIXME:\"lipid vesicles\")", pure:true}}, {_id:907, properties:{name:"Endothelial Cells", namespace:"MESH", bel:"a(MESH:\"Endothelial Cells\")", pure:true}}, {_id:911, properties:{name:"microthrombus", namespace:"FIXME", bel:"a(FIXME:\"microthrombus\")", pure:true}}, {_id:926, properties:{bel:"a(MESH:\"Viral Proteins\",loc(MESH:\"Brain\"))", name:"Viral Proteins", namespace:"MESH"}}, {_id:928, properties:{bel:"a(MESH:\"Viral Proteins\",loc(MESH:\"Subcutaneous Fat\"))", name:"Viral Proteins", namespace:"MESH"}}, {_id:930, properties:{bel:"a(MESH:\"Viral Proteins\",loc(MESH:\"Liver\"))", name:"Viral Proteins", namespace:"MESH"}}, {_id:937, properties:{bel:"a(MESH:\"RNA, Viral\",loc(MESH:\"Neurons\"))", name:"RNA, Viral", namespace:"MESH"}}, {_id:939, properties:{bel:"a(MESH:\"RNA, Viral\",loc(MESH:\"Ependymoglial Cells\"))", name:"RNA, Viral", namespace:"MESH"}}, {_id:941, properties:{bel:"a(MESH:\"RNA, Viral\",loc(CELL:\"neural progenitor cell\"))", name:"RNA, Viral", namespace:"MESH"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:942, properties:{name:"RNA, Viral", namespace:"MESH", bel:"a(MESH:\"RNA, Viral\")", pure:true}}, {_id:946, properties:{name:"Zika virus", bel:"a(TAX:\"Zika virus\")", namespace:"TAX", pure:true}}, {_id:958, properties:{name:"Tissue Damage", namespace:"NCIT", bel:"a(NCIT:\"Tissue Damage\")", pure:true}}, {_id:959, properties:{name:"camostat", bel:"a(CHEBI:\"camostat\")", namespace:"CHEBI", pure:true}}, {_id:960, properties:{name:"EK1 peptide", namespace:"FIXME", bel:"a(FIXME:\"EK1 peptide\")", pure:true}}, {_id:963, properties:{name:"nafamostat", namespace:"CHEBI", bel:"a(CHEBI:\"nafamostat\")", pure:true}}, {_id:1003, properties:{name:"Neutrophils", namespace:"MESH", bel:"a(MESH:\"Neutrophils\")", pure:true}}, {_id:1004, properties:{namespace:"CELL", bel:"a(CELL:\"myeloid dendritic cell\")", name:"myeloid dendritic cell", pure:true}}, {_id:1005, properties:{namespace:"CELL", bel:"a(CELL:\"plasmacytoid dendritic cell\")", name:"plasmacytoid dendritic cell", pure:true}}, {_id:1015, properties:{name:"hyaline thrombus", namespace:"FIXME", bel:"a(FIXME:\"hyaline thrombus\")", pure:true}}, {_id:1020, properties:{name:"Mortality", bel:"a(NCIT:\"Mortality\")", namespace:"NCIT", pure:true}}, {_id:1021, properties:{name:"Blood Platelets", namespace:"MESH", bel:"a(MESH:\"Blood Platelets\")", pure:true}}, {_id:1027, properties:{name:"Organ Weight", namespace:"NCIT", bel:"a(NCIT:\"Organ Weight\")", pure:true}}, {_id:1028, properties:{namespace:"NCIT", bel:"a(NCIT:\"Pulmonary Compliance\")", name:"Pulmonary Compliance", pure:true}}, {_id:1029, properties:{namespace:"MESH", bel:"a(MESH:\"Extracellular Traps\")", name:"Extracellular Traps", pure:true}}, {_id:1030, properties:{namespace:"CHEBI", bel:"a(CHEBI:\"deoxyribonucleic acid\")", name:"deoxyribonucleic acid", pure:true}}, {_id:1033, properties:{name:"Antithrombins", namespace:"MESH", bel:"a(MESH:\"Antithrombins\")", pure:true}}, {_id:1036, properties:{name:"dabigatran", namespace:"CHEBI", bel:"a(CHEBI:\"dabigatran\")", pure:true}}, {_id:1037, properties:{name:"phorbol 13-acetate 12-myristate", bel:"a(CHEBI:\"phorbol 13-acetate 12-myristate\")", namespace:"CHEBI", pure:true}}, {_id:1042, properties:{name:"heparin", bel:"a(CHEBI:\"heparin\")", namespace:"CHEBI", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1044, properties:{name:"dipyridamole", namespace:"CHEBI", bel:"a(CHEBI:\"dipyridamole\")", pure:true}}, {_id:1046, properties:{name:"eculizumab", namespace:"MESH", bel:"a(MESH:\"eculizumab\")", pure:true}}, {_id:1051, properties:{name:"Ravulizumab", namespace:"NCIT", bel:"a(NCIT:\"Ravulizumab\")", pure:true}}, {_id:1054, properties:{name:"131634231", namespace:"PUBCHEM", bel:"a(PUBCHEM:\"131634231\")", pure:true}}, {_id:1127, properties:{bel:"a(TAX:\"Severe acute respiratory syndrome coronavirus 2\",loc(MESH:\"Neurons\"))", name:"Severe acute respiratory syndrome coronavirus 2", namespace:"TAX"}}, {_id:1138, properties:{name:"basement membrane", namespace:"GO", bel:"a(GO:\"basement membrane\")", pure:true}}, {_id:1142, properties:{name:"transendothelial electrical resistance", bel:"a(FIXME:\"transendothelial electrical resistance\")", namespace:"FIXME", pure:true}}, {_id:1144, properties:{name:"Collagen Type IV", namespace:"MESH", bel:"a(MESH:\"Collagen Type IV\")", pure:true}}, {_id:1145, properties:{name:"string vessel", namespace:"FIXME", bel:"a(FIXME:\"string vessel\")", pure:true}}, {_id:1147, properties:{namespace:"NCIT", bel:"a(NCIT:\"Mechanical Ventilation\")", name:"Mechanical Ventilation", pure:true}}, {_id:1148, properties:{namespace:"FIXME", bel:"a(FIXME:\"string vessel length\")", name:"string vessel length", pure:true}}, {_id:1203, properties:{namespace:"NCIT", bel:"a(NCIT:\"Blood Vessel Density\")", name:"Blood Vessel Density", pure:true}}, {_id:1207, properties:{name:"Pericytes", bel:"a(MESH:\"Pericytes\")", namespace:"MESH", pure:true}}, {_id:1209, properties:{name:"52936034", namespace:"PUBCHEM", bel:"a(PUBCHEM:\"52936034\")", pure:true}}, {_id:1216, properties:{name:"brain weight", namespace:"CMO", bel:"a(CMO:\"brain weight\")", pure:true}}, {_id:1217, properties:{name:"Tamoxifen", bel:"a(MESH:\"Tamoxifen\")", namespace:"MESH", pure:true}}, {_id:1219, properties:{name:"Survival", bel:"a(MESH:\"Survival\")", namespace:"MESH", pure:true}}, {_id:1229, properties:{namespace:"FIXME", bel:"a(FIXME:\"IgG filled vesicles\")", name:"IgG filled vesicles", pure:true}}, {_id:1232, properties:{name:"134521814", namespace:"PUBCHEM", bel:"a(PUBCHEM:\"134521814\")", pure:true}}, {_id:1242, properties:{name:"Tissue Congestion", namespace:"NCIT", bel:"a(NCIT:\"Tissue Congestion\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1243, properties:{name:"Eosinophils", namespace:"MESH", bel:"a(MESH:\"Eosinophils\")", pure:true}}, {_id:1247, properties:{namespace:"NCIT", bel:"a(NCIT:\"Hemosiderin Deposition\")", name:"Hemosiderin Deposition", pure:true}}, {_id:1248, properties:{name:"Alzheimer Type II Astrocyte", bel:"a(NCIT:\"Alzheimer Type II Astrocyte\")", namespace:"NCIT", pure:true}}, {_id:1249, properties:{name:"Corpora Amylacea", namespace:"NCIT", bel:"a(NCIT:\"Corpora Amylacea\")", pure:true}}, {_id:1251, properties:{name:"Vascular Ectasia", namespace:"NCIT", bel:"a(NCIT:\"Vascular Ectasia\")", pure:true}}, {_id:1253, properties:{name:"Megakaryocytes", namespace:"MESH", bel:"a(MESH:\"Megakaryocytes\")", pure:true}}, {_id:1267, properties:{name:"DX600 peptide", namespace:"MESH", bel:"a(MESH:\"DX600 peptide\")", pure:true}}, {_id:1320, properties:{namespace:"CELL", bel:"a(CELL:\"dopaminergic neuron\")", name:"dopaminergic neuron", pure:true}}, {_id:1321, properties:{bel:"a(MESH:\"Pathogen-Associated Molecular Pattern Molecules\")", name:"Pathogen-Associated Molecular Pattern Molecules", namespace:"MESH", pure:true}}, {_id:1323, properties:{name:"peptidoglycan", namespace:"CHEBI", bel:"a(CHEBI:\"peptidoglycan\")", pure:true}}, {_id:1325, properties:{name:"viral dsRNA", namespace:"FIXME", bel:"a(FIXME:\"viral dsRNA\")", pure:true}}, {_id:1328, properties:{namespace:"FIXME", bel:"a(FIXME:\"microbial-derived products\")", name:"microbial-derived products", pure:true}}, {_id:1332, properties:{namespace:"MESH", bel:"a(MESH:\"Inflammation Mediators\")", name:"Inflammation Mediators", pure:true}}, {_id:1334, properties:{namespace:"MESH", bel:"a(MESH:\"Blood-Brain Barrier\")", name:"Blood-Brain Barrier", pure:true}}, {_id:1338, properties:{name:"butyrate", bel:"a(CHEBI:\"butyrate\")", namespace:"CHEBI", pure:true}}, {_id:1339, properties:{name:"valerate", bel:"a(CHEBI:\"valerate\")", namespace:"CHEBI", pure:true}}, {_id:1340, properties:{name:"acetate", bel:"a(CHEBI:\"acetate\")", namespace:"CHEBI", pure:true}}, {_id:1341, properties:{name:"propionate", namespace:"CHEBI", bel:"a(CHEBI:\"propionate\")", pure:true}}, {_id:1342, properties:{name:"Prevotellaceae", namespace:"TAX", bel:"a(TAX:\"Prevotellaceae\")", pure:true}}, {_id:1343, properties:{name:"Lachnospiraceae", namespace:"TAX", bel:"a(TAX:\"Lachnospiraceae\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1344, properties:{name:"Fecal Microbiota Transplantation", bel:"a(MESH:\"Fecal Microbiota Transplantation\")", namespace:"MESH", pure:true}}, {_id:1346, properties:{name:"Christensenella", namespace:"TAX", bel:"a(TAX:\"Christensenella\")", pure:true}}, {_id:1351, properties:{name:"Enterococcaceae", namespace:"TAX", bel:"a(TAX:\"Enterococcaceae\")", pure:true}}, {_id:1352, properties:{name:"Enterobacteriaceae", namespace:"TAX", bel:"a(TAX:\"Enterobacteriaceae\")", pure:true}}, {_id:1442, properties:{name:"Rikenellaceae", namespace:"TAX", bel:"a(TAX:\"Rikenellaceae\")", pure:true}}, {_id:1443, properties:{name:"Alistipes", bel:"a(TAX:\"Alistipes\")", namespace:"TAX", pure:true}}, {_id:1444, properties:{name:"malonate(2-)", namespace:"CHEBI", bel:"a(CHEBI:\"malonate(2-)\")", pure:true}}, {_id:1452, properties:{namespace:"MESH", bel:"a(MESH:\"Glucosylceramidase\")", name:"Glucosylceramidase", pure:true}}, {_id:1455, properties:{name:"gap junction", namespace:"GO", bel:"a(GO:\"gap junction\")", pure:true}}, {_id:1456, properties:{name:"cytoneme", bel:"a(GO:\"cytoneme\")", namespace:"GO", pure:true}}, {_id:1460, properties:{namespace:"GO", bel:"a(GO:\"mitochondrial chromosome\")", name:"mitochondrial chromosome", pure:true}}, {_id:1468, properties:{namespace:"GO", bel:"a(GO:\"mitochondrial chromosome\",loc(MESH:\"Serum\"))", name:"mitochondrial chromosome"}}, {_id:1473, properties:{namespace:"FIXME", bel:"a(FIXME:\"dsRNA viral genome\")", name:"dsRNA viral genome", pure:true}}, {_id:1477, properties:{bel:"a(TAX:\"Severe acute respiratory syndrome coronavirus 2\",loc(MESH:\"Astrocytes\"))", name:"Severe acute respiratory syndrome coronavirus 2", namespace:"TAX"}}, {_id:1504, properties:{name:"neuron", bel:"a(CELL:\"neuron\")", namespace:"CELL", pure:true}}, {_id:1514, properties:{name:"vildagliptin", namespace:"CHEBI", bel:"a(CHEBI:\"vildagliptin\")", pure:true}}, {_id:1515, properties:{name:"Cellular Stress", namespace:"NCIT", bel:"a(NCIT:\"Cellular Stress\")", pure:true}}, {_id:1521, properties:{namespace:"GO", bel:"a(GO:\"postsynaptic density\")", name:"postsynaptic density", pure:true}}, {_id:1554, properties:{name:"extracellular matrix regulatory enzymes", bel:"a(FIXME:\"extracellular matrix regulatory enzymes\")", namespace:"FIXME", pure:true}}, {_id:1562, properties:{name:"oxygen saturation", namespace:"CMO", bel:"a(CMO:\"oxygen saturation\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1573, properties:{name:"zinc ion", bel:"a(CHEBI:\"zinc ion\")", namespace:"CHEBI", pure:true}}, {_id:1574, properties:{name:"malonaldehyde", namespace:"CHEBI", bel:"a(CHEBI:\"malonaldehyde\")", pure:true}}, {_id:1577, properties:{name:"antioxidant", namespace:"CHEBI", bel:"a(CHEBI:\"antioxidant\")", pure:true}}, {_id:1581, properties:{name:"Pfizer/BioNTech", namespace:"FIXME", bel:"a(FIXME:\"Pfizer/BioNTech\")", pure:true}}, {_id:1582, properties:{bel:"a(FIXME:\"Oxford-AstraZeneca COVID-19 vaccine\")", name:"Oxford-AstraZeneca COVID-19 vaccine", namespace:"FIXME", pure:true}}, {_id:1583, properties:{name:"Astrocytes", namespace:"MESH", bel:"a(MESH:\"Astrocytes\")", pure:true}}, {_id:1592, properties:{name:"133081972", namespace:"PUBCHEM", bel:"a(PUBCHEM:\"133081972\")", pure:true}}, {_id:1593, properties:{name:"45142253", namespace:"PUBCHEM", bel:"a(PUBCHEM:\"45142253\")", pure:true}}, {_id:1594, properties:{name:"Cytotoxicity", namespace:"NCIT", bel:"a(NCIT:\"Cytotoxicity\")", pure:true}}, {_id:1595, properties:{name:"(+)-Tetrandrine", namespace:"CHEBI", bel:"a(CHEBI:\"(+)-Tetrandrine\")", pure:true}}, {_id:1696, properties:{name:"sofosbuvir", namespace:"CHEBI", bel:"a(CHEBI:\"sofosbuvir\")", pure:true}}, {_id:1700, properties:{name:"excitatory synapse", namespace:"GO", bel:"a(GO:\"excitatory synapse\")", pure:true}}, {_id:1701, properties:{name:"Acute Pneumonia", namespace:"NCIT", bel:"a(NCIT:\"Acute Pneumonia\")", pure:true}}, {_id:1704, properties:{namespace:"NCIT", bel:"a(NCIT:\"Diabetic Nephropathy\")", name:"Diabetic Nephropathy", pure:true}}, {_id:1710, properties:{name:"Neuronophagia", namespace:"NCIT", bel:"a(NCIT:\"Neuronophagia\")", pure:true}}, {_id:1711, properties:{name:"CD68+ microglial nodule", bel:"a(FIXME:\"CD68+ microglial nodule\")", namespace:"FIXME", pure:true}}, {_id:1713, properties:{name:"CD4-Positive T-Lymphocytes", bel:"a(MESH:\"CD4-Positive T-Lymphocytes\",loc(MESH:\"Parenchymal Tissue\"))", namespace:"MESH"}}, {_id:1714, properties:{name:"CD4-Positive T-Lymphocytes", bel:"a(MESH:\"CD4-Positive T-Lymphocytes\",loc(UBERON:\"perivascular space\"))", namespace:"MESH"}}, {_id:1715, properties:{name:"CD4-Positive T-Lymphocytes", bel:"a(MESH:\"CD4-Positive T-Lymphocytes\",loc(MESH:\"Meninges\"))", namespace:"MESH"}}, {_id:1716, properties:{name:"CD8-Positive T-Lymphocytes", bel:"a(MESH:\"CD8-Positive T-Lymphocytes\",loc(MESH:\"Parenchymal Tissue\"))", namespace:"MESH"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1717, properties:{name:"CD8-Positive T-Lymphocytes", bel:"a(MESH:\"CD8-Positive T-Lymphocytes\",loc(UBERON:\"perivascular space\"))", namespace:"MESH"}}, {_id:1718, properties:{name:"CD8-Positive T-Lymphocytes", bel:"a(MESH:\"CD8-Positive T-Lymphocytes\",loc(MESH:\"Meninges\"))", namespace:"MESH"}}, {_id:1719, properties:{name:"CD3-positive T-lymphocyte", bel:"a(FIXME:\"CD3-positive T-lymphocyte\",loc(MESH:\"Parenchymal Tissue\"))", namespace:"FIXME"}}, {_id:1720, properties:{name:"CD3-positive T-lymphocyte", bel:"a(FIXME:\"CD3-positive T-lymphocyte\",loc(UBERON:\"perivascular space\"))", namespace:"FIXME"}}, {_id:1721, properties:{name:"CD3-positive T-lymphocyte", bel:"a(FIXME:\"CD3-positive T-lymphocyte\",loc(MESH:\"Meninges\"))", namespace:"FIXME"}}, {_id:1726, properties:{name:"Varicella Zoster Infection", bel:"a(NCIT:\"Varicella Zoster Infection\")", namespace:"NCIT", pure:true}}, {_id:1728, properties:{namespace:"FIXME", bel:"a(FIXME:\"microvascular thrombosis\")", name:"microvascular thrombosis", pure:true}}, {_id:1731, properties:{name:"lysosome", bel:"a(GO:\"lysosome\")", namespace:"GO", pure:true}}, {_id:1734, properties:{name:"Number of Hospitalization Days", bel:"a(NCIT:\"Number of Hospitalization Days\")", namespace:"NCIT", pure:true}}, {_id:1736, properties:{namespace:"CELL", bel:"a(CELL:\"inflammatory macrophage\")", name:"inflammatory macrophage", pure:true}}, {_id:1739, properties:{name:"Cell Density", namespace:"NCIT", bel:"a(NCIT:\"Cell Density\")", pure:true}}, {_id:1740, properties:{namespace:"FIXME", bel:"a(FIXME:\"microglial density\")", name:"microglial density", pure:true}}, {_id:1745, properties:{name:"delayed heart-to-mediastinum ratio", bel:"a(FIXME:\"delayed heart-to-mediastinum ratio\")", namespace:"FIXME", pure:true}}, {_id:1747, properties:{namespace:"FIXME", bel:"a(FIXME:\"fibrous inclusions\")", name:"fibrous inclusions", pure:true}}, {_id:1748, properties:{name:"pale inclusions", namespace:"FIXME", bel:"a(FIXME:\"pale inclusions\")", pure:true}}, {_id:1749, properties:{name:"inclusion body", namespace:"GO", bel:"a(GO:\"inclusion body\")", pure:true}}, {_id:1751, properties:{name:"Oligodendroglia", namespace:"MESH", bel:"a(MESH:\"Oligodendroglia\")", pure:true}}, {_id:1754, properties:{namespace:"FIXME", bel:"a(FIXME:\"CD163 positive macrophage\",loc(MESH:\"White Matter\"))", name:"CD163 positive macrophage"}}, {_id:1756, properties:{name:"Spongiosis", namespace:"NCIT", bel:"a(NCIT:\"Spongiosis\")", pure:true}}, {_id:1759, properties:{name:"siderophage", namespace:"FIXME", bel:"a(FIXME:\"siderophage\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1760, properties:{namespace:"FIXME", bel:"a(FIXME:\"CD163 positive macrophage\")", name:"CD163 positive macrophage", pure:true}}, {_id:1769, properties:{name:"mitochondrion", namespace:"GO", bel:"a(GO:\"mitochondrion\")", pure:true}}, {_id:1773, properties:{name:"Neuroglia", bel:"a(MESH:\"Neuroglia\")", namespace:"MESH", pure:true}}, {_id:1775, properties:{name:"calcium ion", namespace:"CHEBI", bel:"a(CHEBI:\"calcium ion\")", pure:true}}, {_id:1779, properties:{namespace:"NCIT", bel:"a(NCIT:\"Activity Hours per Week\")", name:"Activity Hours per Week", pure:true}}, {_id:1823, properties:{name:"Lectins", bel:"a(MESH:\"Lectins\")", namespace:"MESH", pure:true}}, {_id:1827, properties:{bel:"a(MESH:\"T-Lymphocytes\",loc(MESH:\"Brain\"))", name:"T-Lymphocytes", namespace:"MESH"}}, {_id:1828, properties:{name:"Injury", bel:"a(NCIT:\"Injury\")", namespace:"NCIT", pure:true}}, {_id:1835, properties:{name:"Hypogeusia", namespace:"NCIT", bel:"a(NCIT:\"Hypogeusia\")", pure:true}}, {_id:1836, properties:{namespace:"NCIT", bel:"a(NCIT:\"Age\")", name:"Age", pure:true}}, {_id:1837, properties:{namespace:"NCIT", bel:"a(NCIT:\"Socioeconomic Factors\")", name:"Socioeconomic Factors", pure:true}}, {_id:1838, properties:{name:"Smoking", bel:"a(NCIT:\"Smoking\")", namespace:"NCIT", pure:true}}, {_id:1844, properties:{namespace:"FIXME", bel:"a(FIXME:\"common respiratory viruses\")", name:"common respiratory viruses", pure:true}}, {_id:1846, properties:{name:"Gray Matter", namespace:"MESH", bel:"a(MESH:\"Gray Matter\")", pure:true}}, {_id:1859, properties:{name:"endolysosome", namespace:"GO", bel:"a(GO:\"endolysosome\")", pure:true}}, {_id:1863, properties:{name:"Digestive System Infection", bel:"a(NCIT:\"Digestive System Infection\")", namespace:"NCIT", pure:true}}, {_id:1868, properties:{namespace:"FIXME", bel:"a(FIXME:\"alpha-synuclein oligomer\")", name:"alpha-synuclein oligomer", pure:true}}, {_id:1869, properties:{namespace:"FIXME", bel:"a(FIXME:\"alpha-synuclein fibril\")", name:"alpha-synuclein fibril", pure:true}}, {_id:1873, properties:{name:"enhanced regulatory T cell capacity", bel:"a(FIXME:\"enhanced regulatory T cell capacity\")", namespace:"FIXME", pure:true}}, {_id:1876, properties:{namespace:"FIXME", bel:"a(FIXME:\"senescence markers\")", name:"senescence markers", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1878, properties:{namespace:"CELL", bel:"a(CELL:\"classical monocyte\")", name:"classical monocyte", pure:true}}, {_id:1879, properties:{namespace:"CELL", bel:"a(CELL:\"intermediate monocyte\")", name:"intermediate monocyte", pure:true}}, {_id:1882, properties:{name:"Monocytes", bel:"a(MESH:\"Monocytes\")", namespace:"MESH", pure:true}}, {_id:1885, properties:{name:"neutrophil percentage of leukocytes", bel:"a(EFO:\"neutrophil percentage of leukocytes\")", namespace:"EFO", pure:true}}, {_id:1887, properties:{bel:"a(FIXME:\"familial glucocerebrosidase Parkinson disease\")", name:"familial glucocerebrosidase Parkinson disease", namespace:"FIXME", pure:true}}, {_id:1891, properties:{bel:"a(CELL:\"CD4-positive, alpha-beta memory T cell\")", name:"CD4-positive, alpha-beta memory T cell", namespace:"CELL", pure:true}}, {_id:1892, properties:{namespace:"FIXME", bel:"a(FIXME:\"psychiatric complications\")", name:"psychiatric complications", pure:true}}, {_id:1895, properties:{namespace:"FIXME", bel:"a(FIXME:\"Immunosuppression\")", name:"Immunosuppression", pure:true}}, {_id:1896, properties:{name:"Clonal Expansion", namespace:"NCIT", bel:"a(NCIT:\"Clonal Expansion\")", pure:true}}, {_id:1897, properties:{name:"T cell bias", namespace:"FIXME", bel:"a(FIXME:\"T cell bias\")", pure:true}}, {_id:1899, properties:{name:"B cell", bel:"a(CELL:\"B cell\")", namespace:"CELL", pure:true}}, {_id:1900, properties:{name:"naive B cell", namespace:"CELL", bel:"a(CELL:\"naive B cell\")", pure:true}}, {_id:1901, properties:{namespace:"CELL", bel:"a(CELL:\"unswitched memory B cell\")", name:"unswitched memory B cell", pure:true}}, {_id:1903, properties:{name:"B cell bias", namespace:"FIXME", bel:"a(FIXME:\"B cell bias\")", pure:true}}, {_id:1904, properties:{name:"regulatory B cell", namespace:"CELL", bel:"a(CELL:\"regulatory B cell\")", pure:true}}, {_id:1905, properties:{name:"memory B cell", namespace:"CELL", bel:"a(CELL:\"memory B cell\")", pure:true}}, {_id:1906, properties:{name:"autoantibody level", namespace:"CMO", bel:"a(CMO:\"autoantibody level\")", pure:true}}, {_id:1909, properties:{name:"specific B cell STIP1 epitopes", bel:"a(FIXME:\"specific B cell STIP1 epitopes\")", namespace:"FIXME", pure:true}}, {_id:1915, properties:{namespace:"CELL", bel:"a(CELL:\"natural killer cell\")", name:"natural killer cell", pure:true}}, {_id:1916, properties:{bel:"a(CELL:\"effector memory CD8-positive, alpha-beta T cell\")", name:"effector memory CD8-positive, alpha-beta T cell", namespace:"CELL", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:1917, properties:{namespace:"FIXME", bel:"a(FIXME:\"monocyte cell function\")", name:"monocyte cell function", pure:true}}, {_id:1918, properties:{name:"naive T cell", namespace:"CELL", bel:"a(CELL:\"naive T cell\")", pure:true}}, {_id:1919, properties:{namespace:"FIXME", bel:"a(FIXME:\"resting natural killer cells\")", name:"resting natural killer cells", pure:true}}, {_id:1934, properties:{namespace:"NCIT", bel:"a(NCIT:\"Squamous Metaplasia\")", name:"Squamous Metaplasia", pure:true}}, {_id:1935, properties:{namespace:"CELL", bel:"a(CELL:\"type II pneumocyte\")", name:"type II pneumocyte", pure:true}}, {_id:1937, properties:{name:"type I pneumocyte", namespace:"CELL", bel:"a(CELL:\"type I pneumocyte\")", pure:true}}, {_id:1945, properties:{name:"Lung Injury", namespace:"MESH", bel:"a(MESH:\"Lung Injury\")", pure:true}}, {_id:1948, properties:{name:"microthrombi", namespace:"FIXME", bel:"a(FIXME:\"microthrombi\")", pure:true}}, {_id:1950, properties:{name:"Thrombotic Microangiopathy", bel:"a(NCIT:\"Thrombotic Microangiopathy\")", namespace:"NCIT", pure:true}}, {_id:2038, properties:{bel:"a(FIXME:\"CD8-positive natural killer T cells\")", name:"CD8-positive natural killer T cells", namespace:"FIXME", pure:true}}, {_id:2042, properties:{bel:"a(CELL:\"CD8-positive, CXCR3-positive, alpha-beta regulatory T cell\")", name:"CD8-positive, CXCR3-positive, alpha-beta regulatory T cell", namespace:"CELL", pure:true}}, {_id:2043, properties:{name:"CCR4-positive CD8 T cells", bel:"a(FIXME:\"CCR4-positive CD8 T cells\")", namespace:"FIXME", pure:true}}, {_id:2066, properties:{bel:"a(CELL:\"activated CD8-positive, alpha-beta T cell\")", name:"activated CD8-positive, alpha-beta T cell", namespace:"CELL", pure:true}}, {_id:2144, properties:{name:"Lipofuscin", namespace:"MESH", bel:"a(MESH:\"Lipofuscin\")", pure:true}}, {_id:2150, properties:{namespace:"FIXME", bel:"a(FIXME:\"lysosomal accumulation\")", name:"lysosomal accumulation", pure:true}}, {_id:2152, properties:{name:"Riluzole", bel:"a(CHEBI:\"Riluzole\")", namespace:"CHEBI", pure:true}}, {_id:2153, properties:{name:"metformin", namespace:"CHEBI", bel:"a(CHEBI:\"metformin\")", pure:true}}, {_id:2154, properties:{name:"imatinib", bel:"a(CHEBI:\"imatinib\")", namespace:"CHEBI", pure:true}}, {_id:2166, properties:{name:"Oxygen Therapy", namespace:"NCIT", bel:"a(NCIT:\"Oxygen Therapy\")", pure:true}}, {_id:2172, properties:{namespace:"NIFT", bel:"a(NIFT:\"Whole brain volume\")", name:"Whole brain volume", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:2174, properties:{namespace:"NIFT", bel:"a(NIFT:\"White matter volume\")", name:"White matter volume", pure:true}}, {_id:2234, properties:{name:"accumulation of abnormal proteins", bel:"a(FIXME:\"accumulation of abnormal proteins\")", namespace:"FIXME", pure:true}}, {_id:2235, properties:{name:"Dendritic Cells", namespace:"MESH", bel:"a(MESH:\"Dendritic Cells\")", pure:true}}, {_id:2240, properties:{name:"alternatively activated macrophage", bel:"a(CELL:\"alternatively activated macrophage\")", namespace:"CELL", pure:true}}, {_id:2241, properties:{namespace:"NCIT", bel:"a(NCIT:\"Nervous System Injury\")", name:"Nervous System Injury", pure:true}}, {_id:2255, properties:{name:"Tr1 cell", bel:"a(CELL:\"Tr1 cell\")", namespace:"CELL", pure:true}}, {_id:2271, properties:{bel:"a(HP:\"ATP\",loc(GO:\"extracellular region\"))", name:"ATP", namespace:"HP"}}, {_id:2272, properties:{bel:"a(HP:\"ATP\")", name:"ATP", namespace:"HP", pure:true}}, {_id:2283, properties:{namespace:"MESH", bel:"a(MESH:\"T-Lymphocytes, Regulatory\",loc(MESH:\"Intestine, Small\"))", name:"T-Lymphocytes, Regulatory"}}, {_id:2290, properties:{name:"Angiotensin II", namespace:"MESH", bel:"a(MESH:\"Angiotensin II\")", pure:true}}, {_id:2295, properties:{namespace:"TAX", bel:"a(TAX:\"Bordetella pertussis\")", name:"Bordetella pertussis", pure:true}}, {_id:2296, properties:{namespace:"MESH", bel:"a(MESH:\"Killer Cells, Natural\")", name:"Killer Cells, Natural", pure:true}}, {_id:2300, properties:{name:"17beta-estradiol", namespace:"FIXME", bel:"a(FIXME:\"17beta-estradiol\")", pure:true}}, {_id:2302, properties:{name:"glucocorticoid", namespace:"HP", bel:"a(HP:\"glucocorticoid\")", pure:true}}, {_id:2303, properties:{name:"Erythropoietin", namespace:"MESH", bel:"a(MESH:\"Erythropoietin\")", pure:true}}, {_id:2304, properties:{namespace:"MESH", bel:"a(MESH:\"Peripheral Nervous System\")", name:"Peripheral Nervous System", pure:true}}, {_id:2307, properties:{name:"Vasoactive Intestinal Peptide", bel:"a(MESH:\"Vasoactive Intestinal Peptide\")", namespace:"MESH", pure:true}}, {_id:2310, properties:{name:"Kv1.3 Potassium Channel", bel:"a(MESH:\"Kv1.3 Potassium Channel\")", namespace:"MESH", pure:true}}, {_id:2312, properties:{name:"Phycocyanin", namespace:"MESH", bel:"a(MESH:\"Phycocyanin\")", pure:true}}, {_id:2313, properties:{name:"Nitric Oxide", namespace:"MESH", bel:"a(MESH:\"Nitric Oxide\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:2314, properties:{namespace:"MESH", bel:"a(MESH:\"Soluble Guanylyl Cyclase\")", name:"Soluble Guanylyl Cyclase", pure:true}}, {_id:2315, properties:{name:"Cyclic GMP", namespace:"MESH", bel:"a(MESH:\"Cyclic GMP\")", pure:true}}, {_id:2318, properties:{name:"dopamine", bel:"a(HP:\"dopamine\")", namespace:"HP", pure:true}}, {_id:2326, properties:{name:"Clostridium", namespace:"TAX", bel:"a(TAX:\"Clostridium\")", pure:true}}, {_id:2327, properties:{name:"Polysaccharide A", namespace:"FIXME", bel:"a(FIXME:\"Polysaccharide A\")", pure:true}}, {_id:2328, properties:{namespace:"TAX", bel:"a(TAX:\"Bacteroides fragilis\")", name:"Bacteroides fragilis", pure:true}}, {_id:2337, properties:{name:"Remdesivir", namespace:"NCIT", bel:"a(NCIT:\"Remdesivir\")", pure:true}}, {_id:2359, properties:{namespace:"CELL", bel:"a(CELL:\"oligodendrocyte precursor cell\")", name:"oligodendrocyte precursor cell", pure:true}}, {_id:2360, properties:{namespace:"MESH", bel:"a(MESH:\"Nerve Fibers, Myelinated\")", name:"Nerve Fibers, Myelinated", pure:true}}, {_id:2368, properties:{namespace:"NCIT", bel:"a(NCIT:\"Acute Glomerulonephritis\")", name:"Acute Glomerulonephritis", pure:true}}, {_id:2369, properties:{namespace:"NCIT", bel:"a(NCIT:\"Inflammatory Infiltrate\")", name:"Inflammatory Infiltrate", pure:true}}, {_id:2372, properties:{namespace:"FIXME", bel:"a(FIXME:\"interstitial macrophage foci\")", name:"interstitial macrophage foci", pure:true}}, {_id:2380, properties:{namespace:"NCIT", bel:"a(NCIT:\"Tissue Rarefaction\")", name:"Tissue Rarefaction", pure:true}}, {_id:2387, properties:{name:"fatty infiltrate", namespace:"FIXME", bel:"a(FIXME:\"fatty infiltrate\")", pure:true}}, {_id:2393, properties:{bel:"a(CELL:\"macrophage\",loc(MESH:\"Heart\"))", name:"macrophage", namespace:"CELL"}}, {_id:2412, properties:{bel:"a(MESH:\"Viral Proteins\")", name:"Viral Proteins", namespace:"MESH", pure:true}}, {_id:2415, properties:{name:"CD3-positive T-lymphocyte", bel:"a(FIXME:\"CD3-positive T-lymphocyte\")", namespace:"FIXME", pure:true}}, {_id:2424, properties:{bel:"a(CELL:\"macrophage\")", name:"macrophage", namespace:"CELL", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Abundance;
UNWIND [{_id:9, properties:{name:"IL1R1", bel:"p(HGNC:\"IL1R1\")", namespace:"HGNC", pure:true}}, {_id:10, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL1B\")", name:"IL1B", pure:true}}, {_id:12, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL6R\")", name:"IL6R", pure:true}}, {_id:13, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL6\")", name:"IL6", pure:true}}, {_id:14, properties:{namespace:"HGNC", bel:"p(HGNC:\"TNF\")", name:"TNF", pure:true}}, {_id:20, properties:{namespace:"HGNC", bel:"p(HGNC:\"AGER\")", name:"AGER", pure:true}}, {_id:21, properties:{namespace:"HGNC", bel:"p(HGNC:\"APP\")", name:"APP", pure:true}}, {_id:25, properties:{namespace:"HGNC", bel:"p(HGNC:\"CSF1\")", name:"CSF1", pure:true}}, {_id:26, properties:{name:"S100B", bel:"p(HGNC:\"S100B\")", namespace:"HGNC", pure:true}}, {_id:29, properties:{name:"Histocompatibility complex", bel:"p(GFAM:\"Histocompatibility complex\")", namespace:"GFAM", pure:true}}, {_id:32, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL10\")", name:"IL10", pure:true}}, {_id:33, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD59\")", name:"CD59", pure:true}}, {_id:35, properties:{namespace:"HGNC", bel:"p(HGNC:\"CLU\")", name:"CLU", pure:true}}, {_id:42, properties:{name:"Ptgs2", bel:"p(RGD:\"Ptgs2\")", namespace:"RGD", pure:true}}, {_id:43, properties:{namespace:"RGD", bel:"p(RGD:\"Nos2\")", name:"Nos2", pure:true}}, {_id:44, properties:{namespace:"HGNC", bel:"p(HGNC:\"NOS2\")", name:"NOS2", pure:true}}, {_id:55, properties:{name:"NFKBIA", namespace:"HGNC", bel:"p(HGNC:\"NFKBIA\",pmod(Ph))"}}, {_id:69, properties:{name:"Q9IZE4", namespace:"UNIPROT", bel:"p(UNIPROT:\"Q9IZE4\")", pure:true}}, {_id:72, properties:{name:"Cd200", bel:"p(MGI:\"Cd200\")", namespace:"MGI", pure:true}}, {_id:73, properties:{namespace:"HGNC", bel:"p(HGNC:\"TSPO\")", name:"TSPO", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:91, properties:{name:"PTGS1", bel:"p(HGNC:\"PTGS1\")", namespace:"HGNC", pure:true}}, {_id:93, properties:{name:"PTGS2", bel:"p(HGNC:\"PTGS2\")", namespace:"HGNC", pure:true}}, {_id:95, properties:{namespace:"HGNC", bel:"p(HGNC:\"APCS\")", name:"APCS", pure:true}}, {_id:97, properties:{namespace:"GFAM", bel:"p(GFAM:\"C1q domain containing\")", name:"C1q domain containing", pure:true}}, {_id:101, properties:{bel:"p(FIXME:\"misfolded protein\",loc(GO:\"extracellular region\"))", name:"misfolded protein", namespace:"FIXME"}}, {_id:103, properties:{bel:"p(FIXME:\"misfolded protein\",loc(GO:\"intracellular\"))", name:"misfolded protein", namespace:"FIXME"}}, {_id:108, properties:{name:"Sod1", namespace:"MGI", bel:"p(MGI:\"Sod1\",var(\"?\"))"}}, {_id:112, properties:{name:"MAPT", namespace:"HGNC", bel:"p(HGNC:\"MAPT\",var(\"?\"))"}}, {_id:113, properties:{name:"PSEN1", bel:"p(HGNC:\"PSEN1\")", namespace:"HGNC", pure:true}}, {_id:116, properties:{namespace:"MGI", bel:"p(MGI:\"App\")", name:"App", pure:true}}, {_id:118, properties:{namespace:"MGI", bel:"p(MGI:\"Csf1\")", name:"Csf1", pure:true}}, {_id:146, properties:{namespace:"HGNC", bel:"p(HGNC:\"SNCA\")", name:"SNCA", pure:true}}, {_id:147, properties:{name:"ubiquitin", bel:"p(PFAM:\"ubiquitin\")", namespace:"PFAM", pure:true}}, {_id:159, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL1A\")", name:"IL1A", pure:true}}, {_id:163, properties:{name:"Selectins", bel:"p(GFAM:\"Selectins\")", namespace:"GFAM", pure:true}}, {_id:173, properties:{namespace:"GFAM", bel:"p(GFAM:\"Toll like receptors\")", name:"Toll like receptors", pure:true}}, {_id:182, properties:{namespace:"HGNC", bel:"p(HGNC:\"TANK\")", name:"TANK", pure:true}}, {_id:183, properties:{name:"NFKB1", bel:"p(HGNC:\"NFKB1\")", namespace:"HGNC", pure:true}}, {_id:184, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL15\")", name:"IL15", pure:true}}, {_id:185, properties:{namespace:"HGNC", bel:"p(HGNC:\"CCL5\")", name:"CCL5", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:189, properties:{namespace:"HGNC", bel:"p(HGNC:\"SELE\")", name:"SELE", pure:true}}, {_id:196, properties:{name:"TGFB1", bel:"p(HGNC:\"TGFB1\")", namespace:"HGNC", pure:true}}, {_id:203, properties:{namespace:"HGNC", bel:"p(HGNC:\"NGF\")", name:"NGF", pure:true}}, {_id:204, properties:{namespace:"HGNC", bel:"p(HGNC:\"NT3\")", name:"NT3", pure:true}}, {_id:205, properties:{name:"Neurotrophins", namespace:"GFAM", bel:"p(GFAM:\"Neurotrophins\")", pure:true}}, {_id:212, properties:{name:"SNCA", namespace:"HGNC", bel:"p(HGNC:\"SNCA\",pmod(Ub))"}}, {_id:214, properties:{name:"SNCA", namespace:"HGNC", bel:"p(HGNC:\"SNCA\",pmod(Ph))"}}, {_id:216, properties:{bel:"p(HGNC:\"SNCA\",pmod(GO:\"protein oxidation\"))", name:"SNCA", namespace:"HGNC"}}, {_id:218, properties:{bel:"p(HGNC:\"SNCA\",pmod(FIXME:\"protein nitration\"))", name:"SNCA", namespace:"HGNC"}}, {_id:221, properties:{name:"SNCA", namespace:"HGNC", bel:"p(HGNC:\"SNCA\",var(\"?\"))"}}, {_id:224, properties:{bel:"p(MGI:\"Snca\",pmod(FIXME:\"protein nitration\"))", name:"Snca", namespace:"MGI"}}, {_id:230, properties:{bel:"p(HGNC:\"SNCA\",pmod(FIXME:\"protein misfolding\"))", name:"SNCA", namespace:"HGNC"}}, {_id:241, properties:{namespace:"HGNC", bel:"p(HGNC:\"GFAP\")", name:"GFAP", pure:true}}, {_id:243, properties:{namespace:"HGNC", bel:"p(HGNC:\"MAPT\")", name:"MAPT", pure:true}}, {_id:251, properties:{name:"FCGR1A", bel:"p(HGNC:\"FCGR1A\")", namespace:"HGNC", pure:true}}, {_id:266, properties:{namespace:"HGNC", bel:"p(HGNC:\"FAS\")", name:"FAS", pure:true}}, {_id:268, properties:{namespace:"HGNC", bel:"p(HGNC:\"IFNG\")", name:"IFNG", pure:true}}, {_id:271, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL4\")", name:"IL4", pure:true}}, {_id:274, properties:{name:"IL2RA", bel:"p(HGNC:\"IL2RA\")", namespace:"HGNC", pure:true}}, {_id:275, properties:{name:"TNFRSF1A", bel:"p(HGNC:\"TNFRSF1A\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:280, properties:{namespace:"MGI", bel:"p(MGI:\"Snca\")", name:"Snca", pure:true}}, {_id:287, properties:{namespace:"MGI", bel:"p(MGI:\"Cd4\")", name:"Cd4", pure:true}}, {_id:289, properties:{name:"Il2ra", bel:"p(MGI:\"Il2ra\")", namespace:"MGI", pure:true}}, {_id:291, properties:{name:"Foxp3", bel:"p(MGI:\"Foxp3\")", namespace:"MGI", pure:true}}, {_id:292, properties:{name:"FOXP3", bel:"p(HGNC:\"FOXP3\")", namespace:"HGNC", pure:true}}, {_id:293, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD4\")", name:"CD4", pure:true}}, {_id:295, properties:{name:"ENTPD1", bel:"p(HGNC:\"ENTPD1\")", namespace:"HGNC", pure:true}}, {_id:297, properties:{name:"ITGA4", bel:"p(HGNC:\"ITGA4\")", namespace:"HGNC", pure:true}}, {_id:299, properties:{bel:"p(GFAM:\"Transforming growth factor beta family\")", name:"Transforming growth factor beta family", namespace:"GFAM", pure:true}}, {_id:301, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL2\")", name:"IL2", pure:true}}, {_id:307, properties:{namespace:"HGNC", bel:"p(HGNC:\"BDNF\")", name:"BDNF", pure:true}}, {_id:308, properties:{namespace:"HGNC", bel:"p(HGNC:\"GDNF\")", name:"GDNF", pure:true}}, {_id:320, properties:{namespace:"MGI", bel:"p(MGI:\"Bdnf\")", name:"Bdnf", pure:true}}, {_id:321, properties:{namespace:"MGI", bel:"p(MGI:\"Gdnf\")", name:"Gdnf", pure:true}}, {_id:324, properties:{name:"ISG15", bel:"p(HGNC:\"ISG15\")", namespace:"HGNC", pure:true}}, {_id:325, properties:{name:"CASP3", bel:"p(HGNC:\"CASP3\")", namespace:"HGNC", pure:true}}, {_id:328, properties:{namespace:"HGNC", bel:"p(HGNC:\"ARG1\")", name:"ARG1", pure:true}}, {_id:343, properties:{bel:"p(HGNC:\"GBA\",var(\"p.Asn370Ser\"))", name:"GBA", namespace:"HGNC"}}, {_id:360, properties:{namespace:"HGNC", bel:"p(HGNC:\"TLR4\")", name:"TLR4", pure:true}}, {_id:362, properties:{bel:"p(MGI:\"Th\")", name:"Th", namespace:"MGI", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:363, properties:{name:"IFNA1", bel:"p(HGNC:\"IFNA1\")", namespace:"HGNC", pure:true}}, {_id:372, properties:{namespace:"MGI", bel:"p(MGI:\"Tnf\")", name:"Tnf", pure:true}}, {_id:375, properties:{namespace:"HGNC", bel:"p(HGNC:\"ALB\")", name:"ALB", pure:true}}, {_id:376, properties:{name:"ABCB1", bel:"p(HGNC:\"ABCB1\")", namespace:"HGNC", pure:true}}, {_id:378, properties:{name:"ICAM1", bel:"p(HGNC:\"ICAM1\")", namespace:"HGNC", pure:true}}, {_id:379, properties:{name:"Icam1", bel:"p(MGI:\"Icam1\")", namespace:"MGI", pure:true}}, {_id:382, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD68\")", name:"CD68", pure:true}}, {_id:388, properties:{name:"LRRK2", namespace:"HGNC", bel:"p(HGNC:\"LRRK2\",var(\"?\"))"}}, {_id:393, properties:{name:"Snca", namespace:"MGI", bel:"p(MGI:\"Snca\",pmod(Ph))"}}, {_id:399, properties:{namespace:"HGNC", bel:"p(HGNC:\"B2M\")", name:"B2M", pure:true}}, {_id:405, properties:{namespace:"HGNC", bel:"p(HGNC:\"PTPRC\")", name:"PTPRC", pure:true}}, {_id:413, properties:{namespace:"HGNC", bel:"p(HGNC:\"SOD1\")", name:"SOD1", pure:true}}, {_id:415, properties:{namespace:"HGNC", bel:"p(HGNC:\"ITGAL\")", name:"ITGAL", pure:true}}, {_id:419, properties:{namespace:"MGI", bel:"p(MGI:\"Rag2\")", name:"Rag2", pure:true}}, {_id:421, properties:{name:"Fasl", namespace:"MGI", bel:"p(MGI:\"Fasl\",var(\"?\"))"}}, {_id:422, properties:{namespace:"HGNC", bel:"p(HGNC:\"FASLG\")", name:"FASLG", pure:true}}, {_id:428, properties:{bel:"p(MGI:\"Snca\",frag(\"?_*\"),pmod(FIXME:\"protein nitration\"))", name:"Snca", namespace:"MGI"}}, {_id:429, properties:{namespace:"PFAM", bel:"p(PFAM:\"IL17\")", name:"IL17", pure:true}}, {_id:431, properties:{bel:"p(RGD:\"Th\")", name:"Th", namespace:"RGD", pure:true}}, {_id:437, properties:{bel:"p(HGNC:\"SNCA\",loc(MESH:\"CD4-Positive T-Lymphocytes\"))", name:"SNCA", namespace:"HGNC"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:441, properties:{bel:"p(MGI:\"Snca\",loc(MESH:\"T-Lymphocytes\"))", name:"Snca", namespace:"MGI"}}, {_id:449, properties:{bel:"p(MGI:\"Lrrk2\",var(\"p.Arg144Cys\"))", name:"Lrrk2", namespace:"MGI"}}, {_id:450, properties:{name:"Map1lc3b", bel:"p(MGI:\"Map1lc3b\")", namespace:"MGI", pure:true}}, {_id:453, properties:{name:"LRRK2", bel:"p(HGNC:\"LRRK2\")", namespace:"HGNC", pure:true}}, {_id:461, properties:{name:"Nuclear factors of activated T-cells", bel:"p(GFAM:\"Nuclear factors of activated T-cells\")", namespace:"GFAM", pure:true}}, {_id:466, properties:{namespace:"HGNC", bel:"p(HGNC:\"PRKN\")", name:"PRKN", pure:true}}, {_id:473, properties:{namespace:"HGNC", bel:"p(HGNC:\"TP53\")", name:"TP53", pure:true}}, {_id:477, properties:{namespace:"FLYBASE", bel:"p(FLYBASE:\"park\")", name:"park", pure:true}}, {_id:486, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD28\")", name:"CD28", pure:true}}, {_id:487, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD80\")", name:"CD80", pure:true}}, {_id:489, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD86\")", name:"CD86", pure:true}}, {_id:505, properties:{bel:"p(HGNC:\"SNCA\",frag(\"31_45\"))", name:"SNCA", namespace:"HGNC"}}, {_id:506, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL5\")", name:"IL5", pure:true}}, {_id:509, properties:{bel:"p(HGNC:\"SNCA\",frag(\"32_46\"))", name:"SNCA", namespace:"HGNC"}}, {_id:512, properties:{bel:"p(HGNC:\"SNCA\",frag(\"116_140\"),pmod(Ph,S,129))", name:"SNCA", namespace:"HGNC"}}, {_id:514, properties:{bel:"p(HGNC:\"SNCA\",frag(\"121_135\"),pmod(Ph,S,129))", name:"SNCA", namespace:"HGNC"}}, {_id:516, properties:{bel:"p(HGNC:\"SNCA\",frag(\"126_140\"),pmod(Ph,S,129))", name:"SNCA", namespace:"HGNC"}}, {_id:518, properties:{bel:"p(HGNC:\"SNCA\",frag(\"32_46\"),pmod(Ph,Y,39))", name:"SNCA", namespace:"HGNC"}}, {_id:519, properties:{bel:"p(HGNC:\"SNCA\",frag(\"126_140\"))", name:"SNCA", namespace:"HGNC"}}, {_id:521, properties:{name:"SNCA", namespace:"HGNC", bel:"p(HGNC:\"SNCA\",frag(\"?\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:525, properties:{bel:"p(HGNC:\"SNCA\",frag(\"121_135\"))", name:"SNCA", namespace:"HGNC"}}, {_id:528, properties:{bel:"p(HGNC:\"SNCA\",frag(\"121_135\"),pmod(Ph,Y,39))", name:"SNCA", namespace:"HGNC"}}, {_id:534, properties:{bel:"p(HGNC:\"SNCA\",frag(\"36_45\"))", name:"SNCA", namespace:"HGNC"}}, {_id:536, properties:{bel:"p(HGNC:\"SNCA\",frag(\"37_45\"))", name:"SNCA", namespace:"HGNC"}}, {_id:538, properties:{bel:"p(HGNC:\"SNCA\",frag(\"37_46\"))", name:"SNCA", namespace:"HGNC"}}, {_id:570, properties:{bel:"p(HGNC:\"SNCA\",var(\"p.Ala53Thr\"))", name:"SNCA", namespace:"HGNC"}}, {_id:575, properties:{namespace:"HGNC", bel:"p(HGNC:\"CRP\")", name:"CRP", pure:true}}, {_id:582, properties:{name:"PINK1", bel:"p(HGNC:\"PINK1\")", namespace:"HGNC", pure:true}}, {_id:585, properties:{bel:"p(HGNC:\"LRRK2\",var(\"p.Gly2019Ser\"))", name:"LRRK2", namespace:"HGNC"}}, {_id:586, properties:{namespace:"MESH", bel:"p(MESH:\"Glucosylceramidase\",var(\"?\"))", name:"Glucosylceramidase"}}, {_id:597, properties:{name:"GBA", namespace:"HGNC", bel:"p(HGNC:\"GBA\",var(\"?\"))"}}, {_id:601, properties:{namespace:"HGNC", bel:"p(HGNC:\"SDC3\")", name:"SDC3", pure:true}}, {_id:603, properties:{name:"APP", namespace:"HGNC", bel:"p(HGNC:\"APP\",frag(\"1_42\"))"}}, {_id:607, properties:{namespace:"HGNC", bel:"p(HGNC:\"SDC4\")", name:"SDC4", pure:true}}, {_id:608, properties:{namespace:"HGNC", bel:"p(HGNC:\"SDC2\")", name:"SDC2", pure:true}}, {_id:611, properties:{namespace:"HGNC", bel:"p(HGNC:\"SDC1\")", name:"SDC1", pure:true}}, {_id:612, properties:{namespace:"HGNC", bel:"p(HGNC:\"TF\")", name:"TF", pure:true}}, {_id:614, properties:{name:"external side of plasma membrane", bel:"p(GO:\"external side of plasma membrane\")", namespace:"GO", pure:true}}, {_id:620, properties:{bel:"p(HGNC:\"SDC1\",pmod(GO:\"protein sulfation\"))", name:"SDC1", namespace:"HGNC"}}, {_id:621, properties:{bel:"p(HGNC:\"SDC2\",pmod(GO:\"protein sulfation\"))", name:"SDC2", namespace:"HGNC"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:622, properties:{bel:"p(HGNC:\"SDC3\",pmod(GO:\"protein sulfation\"))", name:"SDC3", namespace:"HGNC"}}, {_id:623, properties:{bel:"p(HGNC:\"SDC4\",pmod(GO:\"protein sulfation\"))", name:"SDC4", namespace:"HGNC"}}, {_id:635, properties:{bel:"p(HGNC:\"SDC4\",var(\"HSA.pSi4\"))", name:"SDC4", namespace:"HGNC"}}, {_id:661, properties:{name:"IL2RB", bel:"p(HGNC:\"IL2RB\")", namespace:"HGNC", pure:true}}, {_id:662, properties:{name:"IL2RG", bel:"p(HGNC:\"IL2RG\")", namespace:"HGNC", pure:true}}, {_id:663, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL18\")", name:"IL18", pure:true}}, {_id:664, properties:{namespace:"HGNC", bel:"p(HGNC:\"CSF3\")", name:"CSF3", pure:true}}, {_id:665, properties:{name:"CXCL10", bel:"p(HGNC:\"CXCL10\")", namespace:"HGNC", pure:true}}, {_id:666, properties:{namespace:"HGNC", bel:"p(HGNC:\"CCL2\")", name:"CCL2", pure:true}}, {_id:667, properties:{namespace:"HGNC", bel:"p(HGNC:\"CCL3\")", name:"CCL3", pure:true}}, {_id:672, properties:{name:"P0DTC3", namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC3\")", pure:true}}, {_id:705, properties:{name:"RANBP2", namespace:"HGNC", bel:"p(HGNC:\"RANBP2\",var(\"?\"))"}}, {_id:775, properties:{namespace:"HGNC", bel:"p(HGNC:\"ACE2\")", name:"ACE2", pure:true}}, {_id:781, properties:{name:"CXCL9", bel:"p(HGNC:\"CXCL9\")", namespace:"HGNC", pure:true}}, {_id:823, properties:{namespace:"HGNC", bel:"p(HGNC:\"MAP2\")", name:"MAP2", pure:true}}, {_id:824, properties:{namespace:"HGNC", bel:"p(HGNC:\"DLG4\")", name:"DLG4", pure:true}}, {_id:825, properties:{namespace:"HGNC", bel:"p(HGNC:\"SYN1\")", name:"SYN1", pure:true}}, {_id:830, properties:{bel:"p(HGNC:\"MAPT\",pmod(Ph,Y,231))", name:"MAPT", namespace:"HGNC"}}, {_id:834, properties:{name:"MAPT", namespace:"HGNC", bel:"p(HGNC:\"MAPT\",pmod(Ph))"}}, {_id:847, properties:{name:"MAPK14", namespace:"HGNC", bel:"p(HGNC:\"MAPK14\",pmod(Ph))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:851, properties:{namespace:"HGNC", bel:"p(HGNC:\"NPPB\")", name:"NPPB", pure:true}}, {_id:853, properties:{namespace:"HGNC", bel:"p(HGNC:\"VCAN\")", name:"VCAN", pure:true}}, {_id:858, properties:{namespace:"HGNC", bel:"p(HGNC:\"AQP1\")", name:"AQP1", pure:true}}, {_id:859, properties:{namespace:"HGNC", bel:"p(HGNC:\"AQP4\")", name:"AQP4", pure:true}}, {_id:860, properties:{name:"SLC22A8", bel:"p(HGNC:\"SLC22A8\")", namespace:"HGNC", pure:true}}, {_id:863, properties:{namespace:"HGNC", bel:"p(HGNC:\"TTR\")", name:"TTR", pure:true}}, {_id:874, properties:{name:"TMEM119", bel:"p(HGNC:\"TMEM119\")", namespace:"HGNC", pure:true}}, {_id:887, properties:{name:"APOA1", bel:"p(HGNC:\"APOA1\")", namespace:"HGNC", pure:true}}, {_id:889, properties:{name:"APOA2", bel:"p(HGNC:\"APOA2\")", namespace:"HGNC", pure:true}}, {_id:891, properties:{name:"TMPRSS2", bel:"p(HGNC:\"TMPRSS2\")", namespace:"HGNC", pure:true}}, {_id:892, properties:{name:"TMPRSS4", bel:"p(HGNC:\"TMPRSS4\")", namespace:"HGNC", pure:true}}, {_id:894, properties:{namespace:"HGNC", bel:"p(HGNC:\"DPP4\")", name:"DPP4", pure:true}}, {_id:895, properties:{namespace:"HGNC", bel:"p(HGNC:\"ANPEP\")", name:"ANPEP", pure:true}}, {_id:896, properties:{name:"P0DTC2", namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\")", pure:true}}, {_id:898, properties:{name:"CLDN5", bel:"p(HGNC:\"CLDN5\")", namespace:"HGNC", pure:true}}, {_id:912, properties:{name:"MFSD2A", bel:"p(HGNC:\"MFSD2A\")", namespace:"HGNC", pure:true}}, {_id:913, properties:{name:"INPP5D", bel:"p(HGNC:\"INPP5D\")", namespace:"HGNC", pure:true}}, {_id:914, properties:{name:"GRIN2A", bel:"p(HGNC:\"GRIN2A\")", namespace:"HGNC", pure:true}}, {_id:915, properties:{name:"GRIN2B", bel:"p(HGNC:\"GRIN2B\")", namespace:"HGNC", pure:true}}, {_id:916, properties:{name:"GRIN2C", bel:"p(HGNC:\"GRIN2C\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:917, properties:{name:"GRIN2D", bel:"p(HGNC:\"GRIN2D\")", namespace:"HGNC", pure:true}}, {_id:918, properties:{namespace:"HGNC", bel:"p(HGNC:\"NOS1\")", name:"NOS1", pure:true}}, {_id:920, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",frag(\"319_541\"))", name:"P0DTC2"}}, {_id:922, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",frag(\"16_685\"))", name:"P0DTC2"}}, {_id:931, properties:{namespace:"MGI", bel:"p(MGI:\"Ace2\")", name:"Ace2", pure:true}}, {_id:932, properties:{name:"Casp3", bel:"p(MGI:\"Casp3\")", namespace:"MGI", pure:true}}, {_id:933, properties:{namespace:"MGI", bel:"p(MGI:\"Il6\")", name:"Il6", pure:true}}, {_id:934, properties:{name:"Mfsd2a", bel:"p(MGI:\"Mfsd2a\")", namespace:"MGI", pure:true}}, {_id:935, properties:{namespace:"MGI", bel:"p(MGI:\"Nos1\")", name:"Nos1", pure:true}}, {_id:999, properties:{namespace:"HGNC", bel:"p(HGNC:\"CSF2\")", name:"CSF2", pure:true}}, {_id:1006, properties:{name:"CXCL8", bel:"p(HGNC:\"CXCL8\")", namespace:"HGNC", pure:true}}, {_id:1007, properties:{namespace:"HGNC", bel:"p(HGNC:\"CCL7\")", name:"CCL7", pure:true}}, {_id:1009, properties:{namespace:"HGNC", bel:"p(HGNC:\"VWF\")", name:"VWF", pure:true}}, {_id:1012, properties:{name:"SERPINE1", bel:"p(HGNC:\"SERPINE1\")", namespace:"HGNC", pure:true}}, {_id:1016, properties:{name:"ADAMTS13", bel:"p(HGNC:\"ADAMTS13\")", namespace:"HGNC", pure:true}}, {_id:1018, properties:{namespace:"HGNC", bel:"p(HGNC:\"SELP\")", name:"SELP", pure:true}}, {_id:1019, properties:{namespace:"HGNC", bel:"p(HGNC:\"THBD\")", name:"THBD", pure:true}}, {_id:1022, properties:{name:"VCAM1", bel:"p(HGNC:\"VCAM1\")", namespace:"HGNC", pure:true}}, {_id:1031, properties:{namespace:"HGNC", bel:"p(HGNC:\"MPO\")", name:"MPO", pure:true}}, {_id:1034, properties:{namespace:"HGNC", bel:"p(HGNC:\"F2\")", name:"F2", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1043, properties:{namespace:"HGNC", bel:"p(HGNC:\"PLAT\")", name:"PLAT", pure:true}}, {_id:1047, properties:{namespace:"HGNC", bel:"p(HGNC:\"C5\")", name:"C5", pure:true}}, {_id:1050, properties:{bel:"p(HGNC:\"C5\",frag(\"678_751\"))", name:"C5", namespace:"HGNC"}}, {_id:1055, properties:{namespace:"HGNC", bel:"p(HGNC:\"C3\")", name:"C3", pure:true}}, {_id:1069, properties:{name:"CASP3", namespace:"HGNC", bel:"p(HGNC:\"CASP3\",frag(\"?\"))"}}, {_id:1076, properties:{namespace:"HGNC", bel:"p(HGNC:\"AIF1\")", name:"AIF1", pure:true}}, {_id:1081, properties:{bel:"p(HGNC:\"SDC4\",var(\"p.CBD_del\"))", name:"SDC4", namespace:"HGNC"}}, {_id:1083, properties:{bel:"p(HGNC:\"SDC4\",var(\"p.HSA_del\"))", name:"SDC4", namespace:"HGNC"}}, {_id:1085, properties:{name:"SDC4", namespace:"HGNC", bel:"p(HGNC:\"SDC4\",var(\"?\"))"}}, {_id:1087, properties:{bel:"p(HGNC:\"SDC4\",var(\"CBD.pSi4\"))", name:"SDC4", namespace:"HGNC"}}, {_id:1090, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",frag(\"14_685\"))", name:"P0DTC2"}}, {_id:1092, properties:{bel:"p(HGNC:\"SDC4\",var(\"p.CBD_del\"),var(\"p.HSA_del\"))", name:"SDC4", namespace:"HGNC"}}, {_id:1095, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",frag(\"680_685\"))", name:"P0DTC2"}}, {_id:1098, properties:{bel:"p(HGNC:\"APOE\",var(\"p.His158Cys\"),var(\"p.Ser112Cys\"))", name:"APOE", namespace:"HGNC"}}, {_id:1101, properties:{bel:"p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Cys\"))", name:"APOE", namespace:"HGNC"}}, {_id:1104, properties:{bel:"p(HGNC:\"APOE\",var(\"p.His158Arg\"),var(\"p.Ser112Arg\"))", name:"APOE", namespace:"HGNC"}}, {_id:1109, properties:{namespace:"HGNC", bel:"p(HGNC:\"APOE\")", name:"APOE", pure:true}}, {_id:1128, properties:{name:"A0A1U7QTA1", namespace:"UNIPROT", bel:"p(UNIPROT:\"A0A1U7QTA1\")", pure:true}}, {_id:1132, properties:{namespace:"MGI", bel:"p(MGI:\"Aif1\")", name:"Aif1", pure:true}}, {_id:1141, properties:{namespace:"MGI", bel:"p(MGI:\"Mmp9\")", name:"Mmp9", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1151, properties:{namespace:"MGI", bel:"p(MGI:\"Nrp1\")", name:"Nrp1", pure:true}}, {_id:1153, properties:{namespace:"MGI", bel:"p(MGI:\"Bsg\")", name:"Bsg", pure:true}}, {_id:1156, properties:{namespace:"HGNC", bel:"p(HGNC:\"NRP1\")", name:"NRP1", pure:true}}, {_id:1158, properties:{namespace:"HGNC", bel:"p(HGNC:\"BSG\")", name:"BSG", pure:true}}, {_id:1161, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",loc(GO:\"perinuclear region of cytoplasm\"))", name:"P0DTC2"}}, {_id:1162, properties:{namespace:"HGNC", bel:"p(HGNC:\"IKBKG\")", name:"IKBKG", pure:true}}, {_id:1164, properties:{name:"IKBKG", namespace:"HGNC", bel:"p(HGNC:\"IKBKG\",frag(\"?\"))"}}, {_id:1165, properties:{name:"P0DTC1", namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC1\")", pure:true}}, {_id:1168, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"1_83\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1170, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"84_419\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1172, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"1_205\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1174, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"206_419\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1176, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"1_231\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1178, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"232_419\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1180, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"1_304\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1182, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"305_419\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1184, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"1_313\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1186, properties:{bel:"p(HGNC:\"IKBKG\",frag(\"314_419\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1188, properties:{bel:"p(HGNC:\"IKBKG\",var(\"p.Gln231Ala\"))", name:"IKBKG", namespace:"HGNC"}}, {_id:1191, properties:{namespace:"HGNC", bel:"p(HGNC:\"RELA\")", name:"RELA", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1194, properties:{namespace:"MGI", bel:"p(MGI:\"Il1b\")", name:"Il1b", pure:true}}, {_id:1196, properties:{namespace:"MGI", bel:"p(MGI:\"Rela\")", name:"Rela", pure:true}}, {_id:1201, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC1\",var(\"p.Cys145Ala\"))", name:"P0DTC1"}}, {_id:1204, properties:{name:"Ikbkg", bel:"p(MGI:\"Ikbkg\")", namespace:"MGI", pure:true}}, {_id:1208, properties:{namespace:"MGI", bel:"p(MGI:\"Gfap\")", name:"Gfap", pure:true}}, {_id:1210, properties:{namespace:"MGI", bel:"p(MGI:\"Fadd\")", name:"Fadd", pure:true}}, {_id:1214, properties:{namespace:"MGI", bel:"p(MGI:\"Alb\")", name:"Alb", pure:true}}, {_id:1220, properties:{name:"Ripk3", bel:"p(MGI:\"Ripk3\")", namespace:"MGI", pure:true}}, {_id:1227, properties:{namespace:"MGI", bel:"p(MGI:\"Ocln\")", name:"Ocln", pure:true}}, {_id:1234, properties:{namespace:"HGNC", bel:"p(HGNC:\"NEFL\")", name:"NEFL", pure:true}}, {_id:1264, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",var(\"p.D614G\"),var(\"p.D950N\"),var(\"p.L452R\"),var(\"p.P681R\"),var(\"p.R158G\"),var(\"p.T19R\"),var(\"p.T478K\"),var(\"p.del156EF157\"))", name:"P0DTC2"}}, {_id:1291, properties:{name:"IFITM2", bel:"p(HGNC:\"IFITM2\")", namespace:"HGNC", pure:true}}, {_id:1292, properties:{namespace:"HGNC", bel:"p(HGNC:\"TJP1\")", name:"TJP1", pure:true}}, {_id:1312, properties:{namespace:"MGI", bel:"p(MGI:\"Sdc3\")", name:"Sdc3", pure:true}}, {_id:1313, properties:{name:"App", namespace:"MGI", bel:"p(MGI:\"App\",var(\"?\"))"}}, {_id:1315, properties:{bel:"p(MGI:\"Mapt\",var(\"p.Pro301Lys\"))", name:"Mapt", namespace:"MGI"}}, {_id:1358, properties:{name:"PINK1", namespace:"HGNC", bel:"p(HGNC:\"PINK1\",var(\"?\"))"}}, {_id:1359, properties:{name:"PRKN", namespace:"HGNC", bel:"p(HGNC:\"PRKN\",var(\"?\"))"}}, {_id:1360, properties:{name:"PARK7", namespace:"HGNC", bel:"p(HGNC:\"PARK7\",var(\"?\"))"}}, {_id:1364, properties:{bel:"p(HGNC:\"SNCA\",pmod(GO:\"post-translational protein modification\"))", name:"SNCA", namespace:"HGNC"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1366, properties:{namespace:"MGI", bel:"p(MGI:\"Il1a\")", name:"Il1a", pure:true}}, {_id:1368, properties:{bel:"p(MGI:\"Lrrk2\",var(\"p.Arg1441Gly\"))", name:"Lrrk2", namespace:"MGI"}}, {_id:1373, properties:{namespace:"MGI", bel:"p(MGI:\"Il10\")", name:"Il10", pure:true}}, {_id:1380, properties:{name:"Il12b", bel:"p(MGI:\"Il12b\")", namespace:"MGI", pure:true}}, {_id:1381, properties:{namespace:"MGI", bel:"p(MGI:\"Ccl4\")", name:"Ccl4", pure:true}}, {_id:1382, properties:{name:"Cxcl1", bel:"p(MGI:\"Cxcl1\")", namespace:"MGI", pure:true}}, {_id:1383, properties:{namespace:"MGI", bel:"p(MGI:\"Ccl3\")", name:"Ccl3", pure:true}}, {_id:1384, properties:{name:"Lrrk2", bel:"p(MGI:\"Lrrk2\")", namespace:"MGI", pure:true}}, {_id:1386, properties:{name:"Traf6", bel:"p(MGI:\"Traf6\")", namespace:"MGI", pure:true}}, {_id:1388, properties:{name:"Nfkbib", namespace:"MGI", bel:"p(MGI:\"Nfkbib\",pmod(Ph))"}}, {_id:1389, properties:{name:"Mitogen-activated protein kinases", bel:"p(GFAM:\"Mitogen-activated protein kinases\",pmod(Ph))", namespace:"GFAM"}}, {_id:1391, properties:{bel:"p(PFAM:\"ubiquitin\",pmod(Ph))", name:"ubiquitin", namespace:"PFAM"}}, {_id:1400, properties:{name:"Pink1", bel:"p(MGI:\"Pink1\")", namespace:"MGI", pure:true}}, {_id:1401, properties:{name:"TRAF2", bel:"p(HGNC:\"TRAF2\")", namespace:"HGNC", pure:true}}, {_id:1403, properties:{name:"TRAF6", bel:"p(HGNC:\"TRAF6\")", namespace:"HGNC", pure:true}}, {_id:1409, properties:{namespace:"MGI", bel:"p(MGI:\"Prkn\")", name:"Prkn", pure:true}}, {_id:1411, properties:{name:"Ifnb1", bel:"p(MGI:\"Ifnb1\")", namespace:"MGI", pure:true}}, {_id:1414, properties:{namespace:"MGI", bel:"p(MGI:\"Il13\")", name:"Il13", pure:true}}, {_id:1417, properties:{namespace:"MGI", bel:"p(MGI:\"Ccl2\")", name:"Ccl2", pure:true}}, {_id:1422, properties:{name:"Pink1", namespace:"MGI", bel:"p(MGI:\"Pink1\",var(\"?\"))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1423, properties:{name:"PARK7", bel:"p(HGNC:\"PARK7\")", namespace:"HGNC", pure:true}}, {_id:1424, properties:{name:"park7", bel:"p(ZFIN:\"park7\")", namespace:"ZFIN", pure:true}}, {_id:1425, properties:{name:"hmgb1a", bel:"p(ZFIN:\"hmgb1a\")", namespace:"ZFIN", pure:true}}, {_id:1426, properties:{name:"hmgb1b", bel:"p(ZFIN:\"hmgb1b\")", namespace:"ZFIN", pure:true}}, {_id:1427, properties:{namespace:"ZFIN", bel:"p(ZFIN:\"ppiaa\")", name:"ppiaa", pure:true}}, {_id:1428, properties:{name:"c3a.1", bel:"p(ZFIN:\"c3a.1\")", namespace:"ZFIN", pure:true}}, {_id:1429, properties:{name:"c3a.2", bel:"p(ZFIN:\"c3a.2\")", namespace:"ZFIN", pure:true}}, {_id:1430, properties:{name:"c3a.3", bel:"p(ZFIN:\"c3a.3\")", namespace:"ZFIN", pure:true}}, {_id:1431, properties:{name:"c3a.4", bel:"p(ZFIN:\"c3a.4\")", namespace:"ZFIN", pure:true}}, {_id:1432, properties:{name:"c3a.5", bel:"p(ZFIN:\"c3a.5\")", namespace:"ZFIN", pure:true}}, {_id:1433, properties:{name:"c3a.6", bel:"p(ZFIN:\"c3a.6\")", namespace:"ZFIN", pure:true}}, {_id:1434, properties:{name:"c3b.1", bel:"p(ZFIN:\"c3b.1\")", namespace:"ZFIN", pure:true}}, {_id:1435, properties:{name:"c3b.2", bel:"p(ZFIN:\"c3b.2\")", namespace:"ZFIN", pure:true}}, {_id:1436, properties:{name:"Park7", bel:"p(MGI:\"Park7\")", namespace:"MGI", pure:true}}, {_id:1445, properties:{name:"S100A8", bel:"p(HGNC:\"S100A8\")", namespace:"HGNC", pure:true}}, {_id:1446, properties:{name:"S100A9", bel:"p(HGNC:\"S100A9\")", namespace:"HGNC", pure:true}}, {_id:1449, properties:{namespace:"HGNC", bel:"p(HGNC:\"GBA\")", name:"GBA", pure:true}}, {_id:1457, properties:{bel:"p(MGI:\"Lrrk2\",var(\"p.Gly2019Ser\"))", name:"Lrrk2", namespace:"MGI"}}, {_id:1464, properties:{name:"NLRP3", bel:"p(HGNC:\"NLRP3\")", namespace:"HGNC", pure:true}}, {_id:1466, properties:{name:"CCL18", bel:"p(HGNC:\"CCL18\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1469, properties:{namespace:"PFAM", bel:"p(PFAM:\"PDGF\")", name:"PDGF", pure:true}}, {_id:1470, properties:{namespace:"HGNC", bel:"p(HGNC:\"VEGFA\")", name:"VEGFA", pure:true}}, {_id:1472, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC9\",loc(MESH:\"Astrocytes\"))", name:"P0DTC9"}}, {_id:1474, properties:{namespace:"HGNC", bel:"p(HGNC:\"HOPX\")", name:"HOPX", pure:true}}, {_id:1475, properties:{namespace:"HGNC", bel:"p(HGNC:\"PAX6\")", name:"PAX6", pure:true}}, {_id:1476, properties:{name:"SLC1A3", bel:"p(HGNC:\"SLC1A3\")", namespace:"HGNC", pure:true}}, {_id:1494, properties:{name:"TREM2", bel:"p(HGNC:\"TREM2\")", namespace:"HGNC", pure:true}}, {_id:1495, properties:{namespace:"HGNC", bel:"p(HGNC:\"SPP1\")", name:"SPP1", pure:true}}, {_id:1496, properties:{namespace:"HGNC", bel:"p(HGNC:\"ITGAX\")", name:"ITGAX", pure:true}}, {_id:1497, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD14\")", name:"CD14", pure:true}}, {_id:1498, properties:{name:"IFITM3", bel:"p(HGNC:\"IFITM3\")", namespace:"HGNC", pure:true}}, {_id:1501, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC4\",loc(MESH:\"Astrocytes\"))", name:"P0DTC4"}}, {_id:1502, properties:{name:"P0DTC4", namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC4\")", pure:true}}, {_id:1503, properties:{name:"P0DTC9", namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC9\")", pure:true}}, {_id:1505, properties:{namespace:"HGNC", bel:"p(HGNC:\"SYNM\")", name:"SYNM", pure:true}}, {_id:1506, properties:{namespace:"HGNC", bel:"p(HGNC:\"VIM\")", name:"VIM", pure:true}}, {_id:1507, properties:{namespace:"HGNC", bel:"p(HGNC:\"EGFR\")", name:"EGFR", pure:true}}, {_id:1508, properties:{name:"ARCN1", bel:"p(HGNC:\"ARCN1\")", namespace:"HGNC", pure:true}}, {_id:1511, properties:{namespace:"HGNC", bel:"p(HGNC:\"FURIN\")", name:"FURIN", pure:true}}, {_id:1512, properties:{namespace:"HGNC", bel:"p(HGNC:\"CTSB\")", name:"CTSB", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1516, properties:{namespace:"MGI", bel:"p(MGI:\"Sdc1\")", name:"Sdc1", pure:true}}, {_id:1517, properties:{namespace:"MGI", bel:"p(MGI:\"Sdc2\")", name:"Sdc2", pure:true}}, {_id:1518, properties:{namespace:"MGI", bel:"p(MGI:\"Sdc4\")", name:"Sdc4", pure:true}}, {_id:1527, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD46\")", name:"CD46", pure:true}}, {_id:1529, properties:{name:"CD200", bel:"p(HGNC:\"CD200\")", namespace:"HGNC", pure:true}}, {_id:1539, properties:{name:"C3AR1", bel:"p(HGNC:\"C3AR1\")", namespace:"HGNC", pure:true}}, {_id:1540, properties:{name:"FCGR3A", bel:"p(HGNC:\"FCGR3A\")", namespace:"HGNC", pure:true}}, {_id:1543, properties:{name:"STAT3", bel:"p(HGNC:\"STAT3\")", namespace:"HGNC", pure:true}}, {_id:1545, properties:{name:"MEGF8", bel:"p(HGNC:\"MEGF8\")", namespace:"HGNC", pure:true}}, {_id:1546, properties:{name:"ABCA1", bel:"p(HGNC:\"ABCA1\")", namespace:"HGNC", pure:true}}, {_id:1550, properties:{name:"Metallothioneins", namespace:"GFAM", bel:"p(GFAM:\"Metallothioneins\")", pure:true}}, {_id:1553, properties:{name:"M10 matrix metallopeptidases", bel:"p(GFAM:\"M10 matrix metallopeptidases\")", namespace:"GFAM", pure:true}}, {_id:1555, properties:{name:"SLC2A1", bel:"p(HGNC:\"SLC2A1\")", namespace:"HGNC", pure:true}}, {_id:1556, properties:{name:"MMP14", bel:"p(HGNC:\"MMP14\")", namespace:"HGNC", pure:true}}, {_id:1563, properties:{name:"GSHPx", bel:"p(PFAM:\"GSHPx\")", namespace:"PFAM", pure:true}}, {_id:1588, properties:{name:"TPCN2", bel:"p(HGNC:\"TPCN2\")", namespace:"HGNC", pure:true}}, {_id:1589, properties:{namespace:"HGNC", bel:"p(HGNC:\"CTSL\")", name:"CTSL", pure:true}}, {_id:1590, properties:{name:"Q14UF1", namespace:"UNIPROT", bel:"p(UNIPROT:\"Q14UF1\")", pure:true}}, {_id:1607, properties:{name:"Mitogen-activated protein kinases", bel:"p(GFAM:\"Mitogen-activated protein kinases\")", namespace:"GFAM", pure:true}}, {_id:1655, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",var(\"p.D405N\"),var(\"p.D614G\"),var(\"p.D796Y\"),var(\"p.E484A\"),var(\"p.F486V\"),var(\"p.G142D\"),var(\"p.G339D\"),var(\"p.H655Y\"),var(\"p.K417N\"),var(\"p.L24S\"),var(\"p.L452R\"),var(\"p.N440K\"),var(\"p.N501Y\"),var(\"p.N679K\"),var(\"p.N764K\"),var(\"p.N969K\"),var(\"p.P681H\"),var(\"p.Q498R\"),var(\"p.Q954H\"),var(\"p.R408S\"),var(\"p.S371F\"),var(\"p.S373P\"),var(\"p.S375F\"),var(\"p.S477N\"),var(\"p.T19I\"),var(\"p.T376A\"),var(\"p.T478K\"),var(\"p.V213G\"),var(\"p.Y505H\"),var(\"p.del25PPA27\"),var(\"p.del69HV70\"))", name:"P0DTC2"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1672, properties:{name:"IFIH1", bel:"p(HGNC:\"IFIH1\")", namespace:"HGNC", pure:true}}, {_id:1674, properties:{name:"DDX58", bel:"p(HGNC:\"DDX58\")", namespace:"HGNC", pure:true}}, {_id:1698, properties:{name:"SLC17A7", bel:"p(HGNC:\"SLC17A7\")", namespace:"HGNC", pure:true}}, {_id:1706, properties:{name:"PECAM1", bel:"p(HGNC:\"PECAM1\")", namespace:"HGNC", pure:true}}, {_id:1709, properties:{bel:"p(HGNC:\"CD68\",loc(UBERON:\"perivascular space\"))", name:"CD68", namespace:"HGNC"}}, {_id:1761, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",loc(MESH:\"Endothelial Cells\"))", name:"P0DTC2"}}, {_id:1762, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC9\",loc(MESH:\"Endothelial Cells\"))", name:"P0DTC9"}}, {_id:1764, properties:{name:"Q918V6", namespace:"UNIPROT", bel:"p(UNIPROT:\"Q918V6\")", pure:true}}, {_id:1782, properties:{namespace:"HGNC", bel:"p(HGNC:\"LEP\")", name:"LEP", pure:true}}, {_id:1783, properties:{name:"FABP4", bel:"p(HGNC:\"FABP4\")", namespace:"HGNC", pure:true}}, {_id:1785, properties:{name:"IL18BP", bel:"p(HGNC:\"IL18BP\")", namespace:"HGNC", pure:true}}, {_id:1786, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL27\")", name:"IL27", pure:true}}, {_id:1787, properties:{name:"DNAJA3", bel:"p(HGNC:\"DNAJA3\")", namespace:"HGNC", pure:true}}, {_id:1789, properties:{name:"CXCL11", bel:"p(HGNC:\"CXCL11\")", namespace:"HGNC", pure:true}}, {_id:1790, properties:{name:"IL12B", bel:"p(HGNC:\"IL12B\")", namespace:"HGNC", pure:true}}, {_id:1791, properties:{name:"IL12A", bel:"p(HGNC:\"IL12A\")", namespace:"HGNC", pure:true}}, {_id:1794, properties:{name:"TNFRSF18", bel:"p(HGNC:\"TNFRSF18\")", namespace:"HGNC", pure:true}}, {_id:1795, properties:{name:"TNFRSF4", bel:"p(HGNC:\"TNFRSF4\")", namespace:"HGNC", pure:true}}, {_id:1796, properties:{name:"TNFRSF8", bel:"p(HGNC:\"TNFRSF8\")", namespace:"HGNC", pure:true}}, {_id:1797, properties:{name:"CCL20", bel:"p(HGNC:\"CCL20\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1798, properties:{name:"TNFRSF13B", bel:"p(HGNC:\"TNFRSF13B\")", namespace:"HGNC", pure:true}}, {_id:1799, properties:{name:"SAMD9L", bel:"p(HGNC:\"SAMD9L\")", namespace:"HGNC", pure:true}}, {_id:1800, properties:{namespace:"HGNC", bel:"p(HGNC:\"MNDA\")", name:"MNDA", pure:true}}, {_id:1801, properties:{name:"LAMP3", bel:"p(HGNC:\"LAMP3\")", namespace:"HGNC", pure:true}}, {_id:1803, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD74\")", name:"CD74", pure:true}}, {_id:1804, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD5\")", name:"CD5", pure:true}}, {_id:1805, properties:{name:"HAVCR2", bel:"p(HGNC:\"HAVCR2\")", namespace:"HGNC", pure:true}}, {_id:1806, properties:{name:"PDCD1", bel:"p(HGNC:\"PDCD1\")", namespace:"HGNC", pure:true}}, {_id:1807, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD83\")", name:"CD83", pure:true}}, {_id:1808, properties:{name:"ANXA1", bel:"p(HGNC:\"ANXA1\")", namespace:"HGNC", pure:true}}, {_id:1809, properties:{name:"ANXA3", bel:"p(HGNC:\"ANXA3\")", namespace:"HGNC", pure:true}}, {_id:1810, properties:{namespace:"HGNC", bel:"p(HGNC:\"MMP8\")", name:"MMP8", pure:true}}, {_id:1811, properties:{name:"SNAP23", bel:"p(HGNC:\"SNAP23\")", namespace:"HGNC", pure:true}}, {_id:1812, properties:{namespace:"HGNC", bel:"p(HGNC:\"STX8\")", name:"STX8", pure:true}}, {_id:1813, properties:{name:"SNAP29", bel:"p(HGNC:\"SNAP29\")", namespace:"HGNC", pure:true}}, {_id:1822, properties:{namespace:"UNIPROT", bel:"p(UNIPROT:\"P0DTC2\",frag(\"?\"))", name:"P0DTC2"}}, {_id:1824, properties:{name:"HAVCR1", bel:"p(HGNC:\"HAVCR1\")", namespace:"HGNC", pure:true}}, {_id:1825, properties:{name:"TIMELESS", bel:"p(HGNC:\"TIMELESS\")", namespace:"HGNC", pure:true}}, {_id:1826, properties:{namespace:"HGNC", bel:"p(HGNC:\"AXL\")", name:"AXL", pure:true}}, {_id:1843, properties:{name:"CCL11", bel:"p(HGNC:\"CCL11\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:1849, properties:{name:"APOE", namespace:"HGNC", bel:"p(HGNC:\"APOE\",var(\"?\"))"}}, {_id:1858, properties:{name:"RAB like GTPases", namespace:"GFAM", bel:"p(GFAM:\"RAB like GTPases\")", pure:true}}, {_id:1870, properties:{namespace:"HGNC", bel:"p(HGNC:\"TLR2\")", name:"TLR2", pure:true}}, {_id:1874, properties:{name:"P48094", namespace:"UNIPROT", bel:"p(UNIPROT:\"P48094\")", pure:true}}, {_id:1875, properties:{name:"P63310", namespace:"UNIPROT", bel:"p(UNIPROT:\"P63310\")", pure:true}}, {_id:1880, properties:{namespace:"HGNC", bel:"p(HGNC:\"CCR2\")", name:"CCR2", pure:true}}, {_id:1881, properties:{namespace:"HGNC", bel:"p(HGNC:\"ITGAM\")", name:"ITGAM", pure:true}}, {_id:1907, properties:{name:"STIP1", bel:"p(HGNC:\"STIP1\")", namespace:"HGNC", pure:true}}, {_id:1912, properties:{name:"Nfkb1", bel:"p(MGI:\"Nfkb1\")", namespace:"MGI", pure:true}}, {_id:1922, properties:{name:"Nr4a2", bel:"p(MGI:\"Nr4a2\")", namespace:"MGI", pure:true}}, {_id:1925, properties:{name:"AGTR2", bel:"p(HGNC:\"AGTR2\")", namespace:"HGNC", pure:true}}, {_id:1926, properties:{name:"Agtr2", bel:"p(MGI:\"Agtr2\")", namespace:"MGI", pure:true}}, {_id:1927, properties:{name:"HSPG2", bel:"p(HGNC:\"HSPG2\")", namespace:"HGNC", pure:true}}, {_id:2030, properties:{namespace:"HGNC", bel:"p(HGNC:\"LRP1\")", name:"LRP1", pure:true}}, {_id:2031, properties:{namespace:"HGNC", bel:"p(HGNC:\"LRP8\")", name:"LRP8", pure:true}}, {_id:2036, properties:{name:"ABCC4", bel:"p(HGNC:\"ABCC4\")", namespace:"HGNC", pure:true}}, {_id:2051, properties:{name:"RPS6", namespace:"HGNC", bel:"p(HGNC:\"RPS6\",pmod(Ph))"}}, {_id:2100, properties:{name:"RUNX3", bel:"p(HGNC:\"RUNX3\")", namespace:"HGNC", pure:true}}, {_id:2101, properties:{name:"RUNX1", bel:"p(HGNC:\"RUNX1\")", namespace:"HGNC", pure:true}}, {_id:2102, properties:{name:"RUNX2", bel:"p(HGNC:\"RUNX2\")", namespace:"HGNC", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:2106, properties:{namespace:"HGNC", bel:"p(HGNC:\"LMO3\")", name:"LMO3", pure:true}}, {_id:2142, properties:{namespace:"HGNC", bel:"p(HGNC:\"GLB1\")", name:"GLB1", pure:true}}, {_id:2148, properties:{name:"CDKN1A", bel:"p(HGNC:\"CDKN1A\")", namespace:"HGNC", pure:true}}, {_id:2149, properties:{name:"LMNB1", bel:"p(HGNC:\"LMNB1\")", namespace:"HGNC", pure:true}}, {_id:2155, properties:{name:"IGFBP7", bel:"p(HGNC:\"IGFBP7\")", namespace:"HGNC", pure:true}}, {_id:2159, properties:{namespace:"HGNC", bel:"p(HGNC:\"TH\")", name:"TH", pure:true}}, {_id:2161, properties:{name:"IL1RN", bel:"p(HGNC:\"IL1RN\")", namespace:"HGNC", pure:true}}, {_id:2162, properties:{namespace:"PFAM", bel:"p(PFAM:\"IL8\")", name:"IL8", pure:true}}, {_id:2163, properties:{namespace:"HGNC", bel:"p(HGNC:\"PROC\")", name:"PROC", pure:true}}, {_id:2164, properties:{name:"PROS1", bel:"p(HGNC:\"PROS1\")", namespace:"HGNC", pure:true}}, {_id:2165, properties:{namespace:"HGNC", bel:"p(HGNC:\"F9\")", name:"F9", pure:true}}, {_id:2167, properties:{namespace:"HGNC", bel:"p(HGNC:\"FGF2\")", name:"FGF2", pure:true}}, {_id:2168, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL13\")", name:"IL13", pure:true}}, {_id:2181, properties:{namespace:"HGNC", bel:"p(HGNC:\"IL9\")", name:"IL9", pure:true}}, {_id:2184, properties:{name:"F13A1", bel:"p(HGNC:\"F13A1\")", namespace:"HGNC", pure:true}}, {_id:2185, properties:{namespace:"HGNC", bel:"p(HGNC:\"F2R\")", name:"F2R", pure:true}}, {_id:2186, properties:{namespace:"HGNC", bel:"p(HGNC:\"PF4\")", name:"PF4", pure:true}}, {_id:2187, properties:{name:"PF4V1", bel:"p(HGNC:\"PF4V1\")", namespace:"HGNC", pure:true}}, {_id:2189, properties:{namespace:"HGNC", bel:"p(HGNC:\"VCL\")", name:"VCL", pure:true}}, {_id:2238, properties:{namespace:"HGNC", bel:"p(HGNC:\"TLR3\")", name:"TLR3", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:2243, properties:{name:"FOXP3", namespace:"HGNC", bel:"p(HGNC:\"FOXP3\",var(\"?\"))"}}, {_id:2246, properties:{name:"LRRC32", bel:"p(HGNC:\"LRRC32\")", namespace:"HGNC", pure:true}}, {_id:2250, properties:{name:"GATA3", bel:"p(HGNC:\"GATA3\")", namespace:"HGNC", pure:true}}, {_id:2251, properties:{name:"S1pr1", bel:"p(MGI:\"S1pr1\")", namespace:"MGI", pure:true}}, {_id:2258, properties:{namespace:"HGNC", bel:"p(HGNC:\"GZMB\")", name:"GZMB", pure:true}}, {_id:2260, properties:{name:"CTLA4", bel:"p(HGNC:\"CTLA4\")", namespace:"HGNC", pure:true}}, {_id:2263, properties:{name:"Ctla4", bel:"p(MGI:\"Ctla4\")", namespace:"MGI", pure:true}}, {_id:2264, properties:{namespace:"MGI", bel:"p(MGI:\"Cd80\")", name:"Cd80", pure:true}}, {_id:2266, properties:{namespace:"MGI", bel:"p(MGI:\"Cd86\")", name:"Cd86", pure:true}}, {_id:2268, properties:{namespace:"HGNC", bel:"p(HGNC:\"LAG3\")", name:"LAG3", pure:true}}, {_id:2273, properties:{namespace:"GFAM", bel:"p(GFAM:\"Purinergic receptors P2X\")", name:"Purinergic receptors P2X", pure:true}}, {_id:2275, properties:{name:"CCL17", bel:"p(HGNC:\"CCL17\")", namespace:"HGNC", pure:true}}, {_id:2277, properties:{bel:"p(HGNC:\"FOXP3\",loc(MESH:\"Tumor Microenvironment\"))", name:"FOXP3", namespace:"HGNC"}}, {_id:2278, properties:{name:"CCL22", bel:"p(HGNC:\"CCL22\")", namespace:"HGNC", pure:true}}, {_id:2279, properties:{name:"Ccl25", bel:"p(MGI:\"Ccl25\")", namespace:"MGI", pure:true}}, {_id:2280, properties:{namespace:"MGI", bel:"p(MGI:\"Ccr9\")", name:"Ccr9", pure:true}}, {_id:2285, properties:{namespace:"HGNC", bel:"p(HGNC:\"CCR6\")", name:"CCR6", pure:true}}, {_id:2286, properties:{namespace:"HGNC", bel:"p(HGNC:\"MOG\")", name:"MOG", pure:true}}, {_id:2288, properties:{name:"CD58", namespace:"HGNC", bel:"p(HGNC:\"CD58\",var(\"?\"))"}}, {_id:2289, properties:{name:"Itgal", bel:"p(MGI:\"Itgal\")", namespace:"MGI", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:2293, properties:{name:"SERPINA1", bel:"p(HGNC:\"SERPINA1\")", namespace:"HGNC", pure:true}}, {_id:2294, properties:{namespace:"MGI", bel:"p(MGI:\"Mog\")", name:"Mog", pure:true}}, {_id:2298, properties:{name:"Pla2g2d", bel:"p(MGI:\"Pla2g2d\")", namespace:"MGI", pure:true}}, {_id:2301, properties:{namespace:"MGI", bel:"p(MGI:\"Esr1\")", name:"Esr1", pure:true}}, {_id:2308, properties:{namespace:"HGNC", bel:"p(HGNC:\"MDK\")", name:"MDK", pure:true}}, {_id:2309, properties:{name:"STAT5A", namespace:"HGNC", bel:"p(HGNC:\"STAT5A\",pmod(Ph))"}}, {_id:2321, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD3D\")", name:"CD3D", pure:true}}, {_id:2322, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD3E\")", name:"CD3E", pure:true}}, {_id:2323, properties:{namespace:"HGNC", bel:"p(HGNC:\"CD3G\")", name:"CD3G", pure:true}}, {_id:2333, properties:{name:"ATP6AP2", bel:"p(HGNC:\"ATP6AP2\")", namespace:"HGNC", pure:true}}, {_id:2339, properties:{namespace:"MGI", bel:"p(MGI:\"Ccl5\")", name:"Ccl5", pure:true}}, {_id:2340, properties:{namespace:"MGI", bel:"p(MGI:\"Il4\")", name:"Il4", pure:true}}, {_id:2341, properties:{name:"Cxcl10", bel:"p(MGI:\"Cxcl10\")", namespace:"MGI", pure:true}}, {_id:2342, properties:{namespace:"MGI", bel:"p(MGI:\"Ifng\")", name:"Ifng", pure:true}}, {_id:2343, properties:{name:"Ccl11", bel:"p(MGI:\"Ccl11\")", namespace:"MGI", pure:true}}, {_id:2344, properties:{name:"Cxcl5", bel:"p(MGI:\"Cxcl5\")", namespace:"MGI", pure:true}}, {_id:2345, properties:{namespace:"MGI", bel:"p(MGI:\"Ccl7\")", name:"Ccl7", pure:true}}, {_id:2346, properties:{name:"Tnfsf13b", bel:"p(MGI:\"Tnfsf13b\")", namespace:"MGI", pure:true}}, {_id:2347, properties:{name:"Cxcl2", bel:"p(MGI:\"Cxcl2\")", namespace:"MGI", pure:true}}, {_id:2348, properties:{namespace:"MGI", bel:"p(MGI:\"Csf2\")", name:"Csf2", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:2349, properties:{namespace:"MGI", bel:"p(MGI:\"Cd68\")", name:"Cd68", pure:true}}, {_id:2362, properties:{namespace:"MGI", bel:"p(MGI:\"Il5\")", name:"Il5", pure:true}}, {_id:2363, properties:{namespace:"MGI", bel:"p(MGI:\"Il18\")", name:"Il18", pure:true}}, {_id:2364, properties:{namespace:"MGI", bel:"p(MGI:\"Il2\")", name:"Il2", pure:true}}, {_id:2394, properties:{name:"NFKBIA", namespace:"HGNC", bel:"p(HGNC:\"NFKBIA\")", pure:true}}, {_id:2395, properties:{namespace:"FIXME", bel:"p(FIXME:\"misfolded protein\")", name:"misfolded protein", pure:true}}, {_id:2396, properties:{name:"Sod1", namespace:"MGI", bel:"p(MGI:\"Sod1\")", pure:true}}, {_id:2398, properties:{name:"Fasl", namespace:"MGI", bel:"p(MGI:\"Fasl\")", pure:true}}, {_id:2409, properties:{name:"Glucosylceramidase", bel:"p(MESH:\"Glucosylceramidase\")", namespace:"MESH", pure:true}}, {_id:2410, properties:{name:"RANBP2", namespace:"HGNC", bel:"p(HGNC:\"RANBP2\")", pure:true}}, {_id:2411, properties:{name:"MAPK14", namespace:"HGNC", bel:"p(HGNC:\"MAPK14\")", pure:true}}, {_id:2413, properties:{name:"Mapt", namespace:"MGI", bel:"p(MGI:\"Mapt\")", pure:true}}, {_id:2414, properties:{name:"Nfkbib", namespace:"MGI", bel:"p(MGI:\"Nfkbib\")", pure:true}}, {_id:2421, properties:{name:"RPS6", namespace:"HGNC", bel:"p(HGNC:\"RPS6\")", pure:true}}, {_id:2422, properties:{name:"CD58", namespace:"HGNC", bel:"p(HGNC:\"CD58\")", pure:true}}, {_id:2423, properties:{name:"STAT5A", namespace:"HGNC", bel:"p(HGNC:\"STAT5A\")", pure:true}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Protein;
UNWIND [{_id:62, properties:{bel:"rxn(reactants(a(CHEBI:\"nitric oxide\"),a(CHEBI:\"superoxide\")),products(a(CHEBI:\"peroxynitrite\")))"}}] AS row
CREATE (n:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row._id}) SET n += row.properties SET n:Reaction;
:commit
:begin
UNWIND [{start: {_id:1209}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"However, ablating microglia by administering the CSF-1R antagonist PLX5622 did neither prevent the formation of string vessels nor prevent the activation of astrocytes (Supplementary Fig. 6).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with microglia ablation"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:170}, end: {_id:186}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:438}, end: {_id:198}, properties:{annotationPublicationtype:["Review"], evidence:"Authophagy plays a critical role in maintenance, activation, and proliferation of T cells [140]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:438}, end: {_id:424}, properties:{annotationPublicationtype:["Review"], evidence:"Authophagy plays a critical role in maintenance, activation, and proliferation of T cells [140]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:438}, end: {_id:439}, properties:{annotationPublicationtype:["Review"], evidence:"Authophagy plays a critical role in maintenance, activation, and proliferation of T cells [140]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1336}, end: {_id:1335}, properties:{annotationPublicationtype:["Review"], evidence:"Other products of microbial metabolism, such as short-chain fatty acids (SCFAs), tryptophan metabolites and the amyloid curli, can have an impact of neuronal activity and modulate neuroinflammation [36–38].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1356}, end: {_id:1357}, properties:{annotationPublicationtype:["Review"], evidence:"While at rest, they are involved in synaptic pruning and remodeling thereby regulating brain connectivity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1029}, end: {_id:187}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, NETs participate in acute lung injury by inducing macrophage release of IL-1β, which in turn can increase NET formation95,96.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:2255}, end: {_id:638}, properties:{annotationPublicationtype:["Review"], evidence:"Another important cytokine in the context of Tregs is IL10, which is strongly secreted by a special subset of T cells with regulatory activity, the so-called Tr1 cells.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2255}, end: {_id:638}, properties:{annotationPublicationtype:["Review"], evidence:"Tr1 cells, which are often present within the intestinal mucosa, do not express Foxp3, and their surface markers are not yet defined. However, they produce high levels of IL10 and TGF-β.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2255}, end: {_id:2256}, properties:{annotationPublicationtype:["Review"], evidence:"Tr1 cells, which are often present within the intestinal mucosa, do not express Foxp3, and their surface markers are not yet defined. However, they produce high levels of IL10 and TGF-β.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:2299}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of a secreted phospholipase A2- IID-Fc fusion protein, which is selectively produced by Tregs, inhibits disease development in murine models of colitis and MS via promoting the differentiation of Tregs and mediating Treg function", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:141}, end: {_id:2320}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore,significantly reduced CD25 high Tregs in sporadic ALS patients have been observed at a less severe stage but not at a more severe stage of the disease suggesting their early recruitment into the CNS area affected by primary neurodegeneration.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Amyotrophic Lateral Sclerosis"], annotationDiseaseSeverity:["less severe"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:5}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:16}, end: {_id:21}, properties:{annotationPublicationtype:["Review"], evidence:"IL-1b activates astrocytes to form much higher levels of not only b-amyloid precursor protein but also S100b peptide mediator which then promotes neurite growth leading to dystrophic neurites [19].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:16}, end: {_id:26}, properties:{annotationPublicationtype:["Review"], evidence:"IL-1b activates astrocytes to form much higher levels of not only b-amyloid precursor protein but also S100b peptide mediator which then promotes neurite growth leading to dystrophic neurites [19].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"It has been demonstrated that proinflammatory cytokines activate cultured primary brain cells (mostly microglia and astrocytes) to induce genes [83–85] including inducible nitric oxide synthase (iNOS), which mediates the synthesis of high levels of nitric oxide (NO), shown to be toxic to neurons [83,86].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCustomCellline:["primary brain cell culture"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:16}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"It has been demonstrated that proinflammatory cytokines activate cultured primary brain cells (mostly microglia and astrocytes) to induce genes [83–85] including inducible nitric oxide synthase (iNOS), which mediates the synthesis of high levels of nitric oxide (NO), shown to be toxic to neurons [83,86].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCustomCellline:["primary brain cell culture"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, it is considered that proinflammatory cytokines activate glia and microglia, very much as is known to occur in the case of iNOS upregulation in macrophages [87,88].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCell:["macrophage"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:16}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, it is considered that proinflammatory cytokines activate glia and microglia, very much as is known to occur in the case of iNOS upregulation in macrophages [87,88].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCell:["macrophage"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:73}, properties:{annotationPublicationtype:["Review"], evidence:"The demonstration that the peripheral benzodiazepine receptor is upregulated in activated microglia led to the development of a ligand, 11C-RPK11195, which binds to this receptor", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:70}, end: {_id:196}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:159}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:203}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:204}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"Aggregated α-syn activates microglia (Zhang et al. 2005), which have been shown to produce nitric oxide and superoxide in mice and inducible nitric oxide synthase (iNOS) in humans, which increases nitration of α-syn and perpetuates the proinflammatory innate immune response in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:198}, end: {_id:274}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence of increased mutual coexpression of CD4 and CD8 by CD45R0+ T cells, increased expression of CD25 (α chain of the high-affinity IL-2 receptor) and TNF-α receptors, and diminished expression of IFN-γ receptors suggest that these T-cell subsets from PD patients are indeed activated.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:198}, end: {_id:275}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence of increased mutual coexpression of CD4 and CD8 by CD45R0+ T cells, increased expression of CD25 (α chain of the high-affinity IL-2 receptor) and TNF-α receptors, and diminished expression of IFN-γ receptors suggest that these T-cell subsets from PD patients are indeed activated.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:522}, end: {_id:271}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:522}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:17}, end: {_id:230}, properties:{annotationPublicationtype:["Review"], evidence:"At the molecular level, inflammatory mediators are known to promote α-synuclein misfolding and aggregation [34]. Importantly, there are also emerging, compelling links between inflammation and the spread of α-synuclein pathology, which could explain how systemic inflammation facilitates the propagation of α-synuclein pathology from peripheral tissues to central nervous system.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:39}, end: {_id:230}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, numerous studies demonstrate that mitochondrial dysfunction results in the chronic production of reactive oxygen species, leading to oxidative stress, and promoting both misfolding of α-synuclein and directly causing neurodegeneration.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:637}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"The α-syn-specific response was further characterized by ICS assays in samples collected between 1998 and 2015, which revealed that the response was mediated by CD4+ T cells for both IFNγ and IL-4 (Fig. 1b, c).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", annotationTechnique:["Intracellular cytokine staining"], citationRef:"32313102"}}, {start: {_id:637}, end: {_id:271}, properties:{annotationPublicationtype:["Research"], evidence:"The α-syn-specific response was further characterized by ICS assays in samples collected between 1998 and 2015, which revealed that the response was mediated by CD4+ T cells for both IFNγ and IL-4 (Fig. 1b, c).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", annotationTechnique:["Intracellular cytokine staining"], citationRef:"32313102"}}, {start: {_id:236}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"The expression of LRRK2 is increased in monocytes activated by IFNγ, suggesting that it could play a role in monocyte maturation", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal dominant"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:17}, end: {_id:775}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, an increase in soluble ACE2 levels has been detected in patients with cardiovascular and inflammatory conditions, in those with COVID-19 and in the aging population, indicating convergence to the ACE2–renin–angiotensin system (Batlle et al., 2022; Verdecchia et al., 2020). ", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:2257}, end: {_id:2258}, properties:{annotationPublicationtype:["Review"], evidence:"Expression of granzyme B in Tregs has been found in a tumor microenvironment, and these Tregs can kill NK cells in a granzyme-Bdependent manner.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:518}, end: {_id:523}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:518}, end: {_id:524}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:525}, end: {_id:527}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:528}, end: {_id:527}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:534}, end: {_id:532}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:536}, end: {_id:532}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:538}, end: {_id:532}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:601}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"Attachment of Aβ1–42 was highest in SDC3 transfectants and peaked at 6h of incubation.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationTimeline:["6 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:615}, properties:{annotationPublicationtype:["Research"], evidence:"Extracellular attachment of Aβ1–42 in SDC4 transfectants was also higher compared to WT K562 cells, while both SDC1 and SDC2 exhibited similar extracellularly attached Aβ1–42 levels as WT K562 cells.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, extracellular attachment of Aβ1–42 was also increased on SDC3 and 4 transfectants (p<0.05 and p<0.01, respectively), while in case of Trf, extracellular attachment to SDC3 transfectants was significantly (p<0.01) reduced (Fig. 3c,d).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, extracellular attachment of Aβ1–42 was also increased on SDC3 and 4 transfectants (p<0.05 and p<0.01, respectively), while in case of Trf, extracellular attachment to SDC3 transfectants was significantly (p<0.01) reduced (Fig. 3c,d).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:620}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:621}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:622}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:623}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:620}, end: {_id:632}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:621}, end: {_id:632}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:622}, end: {_id:632}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:623}, end: {_id:632}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:620}, end: {_id:633}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:621}, end: {_id:633}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:622}, end: {_id:633}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:623}, end: {_id:633}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:1093}, properties:{annotationPublicationtype:["Research"], evidence:"Colocalization studies revealed that spikeS1 colocalizes with SDC4 during increased spikeS1 entry (as shown by the high BDS, MOC and PCC scores obtained with imaging flow cytometry and confocal microscopy (see details in Figure 8F,G), while co-immunoprecipitation showed increased binding of spikeS1 to SDC4 due to SDC4 overexpression (Figure 8H) (incubating the cells with the fluorescently labeled anti-His tag antibodies without spikeS1 pretreatment did not induce any difference in fluorescence among the applied A549 cell line and SDC4 transfectants, showing that no unspecific binding influenced the detected fluorescence intensities in spikeS1-treated cells (Supplementary Figure S15)).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["confocal microscopy", "western blot", "flow cytometry", "immunoprecipitation", "transfection method", "fluorescence method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["A549 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:611}, end: {_id:1106}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1107}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1108}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1106}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1107}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1108}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1106}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1107}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1108}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:775}, end: {_id:1269}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, heparin's effect on reducing the cellular uptake of WT spike into 293T-ACE2 cells was smaller than on 293T, showing that increased ACE2 expression leads to increased ACE2-dependent interactions with WT spike.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["293T cell"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1083}, end: {_id:1272}, properties:{annotationPublicationtype:["Research"], evidence:"The significantly decreased Delta spike uptake into CBD and HSA mutants also shows that both the CBD and the polyanionic HS chains are involved in the attachment of Delta spike protein.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["K-562 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1081}, end: {_id:1272}, properties:{annotationPublicationtype:["Research"], evidence:"The significantly decreased Delta spike uptake into CBD and HSA mutants also shows that both the CBD and the polyanionic HS chains are involved in the attachment of Delta spike protein.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["K-562 cell"], citationType:"PubMed", citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:324}, end: {_id:323}, properties:{annotationPublicationtype:["Review"], evidence:"Up-regulation of the antiviral ubiquitin-like protein, interferon-stimulated gene 15 (ISG15) was concordant with the decrease in viral release from MP , and implicating caspase-3 and granzyme/perforin pathways in MP killing. Finally, it was shown that Treg induce the phenotypic switch of MP from the neurotoxic MI phenotype to the more neurotrophic M2 phenotype with the down-regulation of iNOS and up-regulation of arginase 1.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:26}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Stratification of patients according to the presence or absence of brain fog revealed a general increase in most markers in the brain fog cohort (Fig. ​(Fig.1f),1f), with significantly increased serum levels of protein S100β (Fig. ​(Fig.1g),1g), a marker indirectly associated with BBB dysfunction.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:196}, end: {_id:2182}, properties:{annotationPublicationtype:["Research"], evidence:"Levels of TGFβ and D-dimer were significantly associated with the percentage of voxels with abnormal leakage but only TGFβ was significant after correcting for multiple comparisons (Fig. ​(Fig.5e).5e). The levels of TGFβ were significantly associated with GBV, CSF volume, brainstem volume and amygdala volume.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:196}, end: {_id:2183}, properties:{annotationPublicationtype:["Research"], evidence:"Levels of TGFβ and D-dimer were significantly associated with the percentage of voxels with abnormal leakage but only TGFβ was significant after correcting for multiple comparisons (Fig. ​(Fig.5e).5e). The levels of TGFβ were significantly associated with GBV, CSF volume, brainstem volume and amygdala volume.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:120}, end: {_id:121}, properties:{annotationPublicationtype:["Review"], evidence:"This switch in microglial phenotype was associated with exaggerated symptoms of sickness behavior such as fever and reduced mobility, increased neuronal loss, and an increase in disease progression", annotationDiseaseCondition:["chronic"], annotationPublicationstatus:["Published"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationSection:["Full Text"], annotationMeshdisease:["Prion Diseases"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:120}, end: {_id:124}, properties:{annotationPublicationtype:["Review"], evidence:"This switch in microglial phenotype was associated with exaggerated symptoms of sickness behavior such as fever and reduced mobility, increased neuronal loss, and an increase in disease progression", annotationDiseaseCondition:["chronic"], annotationPublicationstatus:["Published"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationSection:["Full Text"], annotationMeshdisease:["Prion Diseases"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:144}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Pathologically, the disease is characterized by the cytoplasmic accumulation of proteinaceous aggregates called Lewy bodies (LBs), which are mainly comprised of α-synuclein (α-syn) and ubiquitin.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:284}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Thus, Treg have the capacity to keep the disorder in check during the asymptomatic phase, whereas Teff can accelerate disease progression.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:331}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, the adoptive transfer of Treg leads to >90% protection of dopaminergic neurons within the nigrostriatal system, whereas adoptive transfer of Th1 or Th17 Teff exacerbate neuronal degeneration and cotransfer of Treg with Th1 or Th17 increases the protective effect.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], citationRef:"22315722"}}, {start: {_id:267}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, the adoptive transfer of Treg leads to >90% protection of dopaminergic neurons within the nigrostriatal system, whereas adoptive transfer of Th1 or Th17 Teff exacerbate neuronal degeneration and cotransfer of Treg with Th1 or Th17 increases the protective effect.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], citationRef:"22315722"}}, {start: {_id:284}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, the adoptive transfer of Treg leads to >90% protection of dopaminergic neurons within the nigrostriatal system, whereas adoptive transfer of Th1 or Th17 Teff exacerbate neuronal degeneration and cotransfer of Treg with Th1 or Th17 increases the protective effect.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], citationRef:"22315722"}}, {start: {_id:356}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, inflammation is a key pathogenic process in models of PD that often precedes detectable neuronal injury and degeneration.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:394}, end: {_id:395}, properties:{annotationPublicationtype:["Review"], evidence:"Japanese Encephalitis Virus (JEV) has also induced a post-encephalitic parkinsonism with similar neuropathologic features and locomotor dysfunction as that seen in people with sporadic PD [95]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:394}, end: {_id:397}, properties:{annotationPublicationtype:["Review"], evidence:"JEV infection in rats results in hypokinesia attributable to depletion of catecholamines in the CNS [96].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:418}, properties:{annotationPublicationtype:["Review"], evidence:"DA neuron loss and behavioral deficits caused by both chronic and acute MPTP administration are attenuated in RAG2 knockout mice that lack both T and B cells [55, 112].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:194}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Transfer of T cells from immunized mice into MPTP-treated mice enhanced neuroinflammation to a slight but significant degree [115].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:459}, end: {_id:460}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2-/- mice are more susceptible to dextran sodium sulfate-induced colitis.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMouseType:["LRRK2 -/- mice"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:476}, properties:{annotationPublicationtype:["Review"], evidence:"Chronic peripheral low dose LPS intraperitoneal administration in Parkin-/- mice triggers fine-motor deficits and loss of DA neurons in the SN [173].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], annotationMouseType:["PRKN -/- mice"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:550}, end: {_id:551}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:550}, end: {_id:48}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:552}, end: {_id:551}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:552}, end: {_id:48}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:565}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Epidemiological studies have linked pesticide exposure with increased PD risk.  Recent meta-analysis reported exposure to several common pesticides is associated with ≥ 50% increased risk for developing PD.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:574}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"For example, pathogen-induced (trigger) inflammation in the gut resulting in localized α-synuclein accumulation and aggregation in enteric nerves [11] may not promote PD until years later, after an age-related decline in cellular energy homeostasis and lysosomal function (facilitators) has set in, which in turn could enable the propagation of α-synuclein aggregates to the brainstem.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"As of May 19, 2020, the COVID-19 pandemic, caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 4·8 million confirmed cases worldwide and more than 300000 deaths.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:691}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Both CNS and PNS disease were reported following SARS (appendix pp 2–3). SARS-CoV was detected in CSF by RT-PCR in two of three cases of encephalopathy with seizures,6, 7 and was cultured from brain tissue at autopsy in the third.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:691}, end: {_id:644}, properties:{annotationPublicationtype:["Review"], evidence:"Both CNS and PNS disease were reported following SARS (appendix pp 2–3). SARS-CoV was detected in CSF by RT-PCR in two of three cases of encephalopathy with seizures,6, 7 and was cultured from brain tissue at autopsy in the third.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:699}, end: {_id:681}, properties:{annotationPublicationtype:["Review"], evidence:"Human coronavirus OC43, a seasonal coronavirus, has caused encephalitis in an infant with severe combined immunodeficiency,14 and acute disseminated encephalomyelitis in an older immunocompetent child.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["severe combined immunodeficiency"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:699}, end: {_id:696}, properties:{annotationPublicationtype:["Review"], evidence:"Human coronavirus OC43, a seasonal coronavirus, has caused encephalitis in an infant with severe combined immunodeficiency,14 and acute disseminated encephalomyelitis in an older immunocompetent child.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:699}, end: {_id:700}, properties:{annotationPublicationtype:["Review"], evidence:"Headache, neck stiffness, and seizures were described among 22 children (median age 36 months; range 0·8–72 months) with suspected CNS infection and coronavirus IgM antibodies in their serum, CSF, or both.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:699}, end: {_id:701}, properties:{annotationPublicationtype:["Review"], evidence:"Headache, neck stiffness, and seizures were described among 22 children (median age 36 months; range 0·8–72 months) with suspected CNS infection and coronavirus IgM antibodies in their serum, CSF, or both.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:699}, end: {_id:644}, properties:{annotationPublicationtype:["Review"], evidence:"Headache, neck stiffness, and seizures were described among 22 children (median age 36 months; range 0·8–72 months) with suspected CNS infection and coronavirus IgM antibodies in their serum, CSF, or both.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:699}, end: {_id:703}, properties:{annotationPublicationtype:["Review"], evidence:"Ten of these children had pleiocytosis and eight had brain imaging abnormalities. All 22 made a full recovery.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:699}, end: {_id:704}, properties:{annotationPublicationtype:["Review"], evidence:"Ten of these children had pleiocytosis and eight had brain imaging abnormalities. All 22 made a full recovery.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:684}, end: {_id:862}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of downregulated genes revealed a decrease in the expression of many transporters and ion channels, such as AQP1, AQP4, and SLC22A8, which are important for normal CSF secretory function (Figure 4D; Brown et al., 2004; Hladky and Barrand, 2016), suggesting functional deficits of choroid plexus cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:956}, properties:{annotationPublicationtype:["Research"], evidence:"However, intraventricular administration of SARS-CoV-2 resulted in weight loss and death, even at the challenge virus dose 100-fold lower than that used for intranasal infection (Fig. 7, I and J).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["10090"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:685}, properties:{annotationPublicationtype:["Research"], evidence:"However, intraventricular administration of SARS-CoV-2 resulted in weight loss and death, even at the challenge virus dose 100-fold lower than that used for intranasal infection (Fig. 7, I and J).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["10090"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:2}, properties:{annotationPublicationtype:["Research"], evidence:"Upon histological examination, we found multiple microscopic ischemic infarcts in the subcortical white matter, ranging from acute to subacute, and with focal hemorrhagic conversion (Fig. 8 C and Fig. S5 A).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["White Matter"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Upon histological examination, we found multiple microscopic ischemic infarcts in the subcortical white matter, ranging from acute to subacute, and with focal hemorrhagic conversion (Fig. 8 C and Fig. S5 A).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["White Matter"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:1122}, properties:{annotationPublicationtype:["Research"], evidence:"Viral RNA was also detected in the serum of 67% (4/6) of the challenged K18-hACE2 mice, which suggests viremia exists in these model mice.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSpecies:["10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1130}, properties:{annotationPublicationtype:["Research"], evidence:"Meanwhile, pyknotic cells, abnormal mitochondrial ultrastructure, vascular injury, and cell apoptosis were detected (Fig. 1m–t).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1131}, properties:{annotationPublicationtype:["Research"], evidence:"Meanwhile, pyknotic cells, abnormal mitochondrial ultrastructure, vascular injury, and cell apoptosis were detected (Fig. 1m–t).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:1344}, end: {_id:1345}, properties:{annotationPublicationtype:["Review"], evidence:"In support of these observations, transplantation of fecal microbiota from healthy donors as well as butyrate supplementation improved dopamine deficiency and motor impairment in different animal models of PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1338}, end: {_id:1345}, properties:{annotationPublicationtype:["Review"], evidence:"In support of these observations, transplantation of fecal microbiota from healthy donors as well as butyrate supplementation improved dopamine deficiency and motor impairment in different animal models of PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:872}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Notably, proliferative reactive astrocytes (AS-3 and AS-4) appeared mainly at 24hpi but were largely replaced with non-proliferative reactive astrocytes at 72hpi, then in line with the microglial signature suggesting an early switch to a more chronic reactivity state.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:57}, end: {_id:207}, properties:{annotationPublicationtype:["Research"], evidence:"Nonetheless, our study demonstrates that a persistent imbalance between oxidative stress toxicity and reduced ANTIOX is a key component of Long COVID and that increased aldehyde, neutrophil-associated MPO, protein carbonyl, and NO production are the major neurotoxic pathways, which, when combined with decreased ANTIOX, may have a variety of detrimental effects as reviewed before.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1574}, end: {_id:207}, properties:{annotationPublicationtype:["Research"], evidence:"Nonetheless, our study demonstrates that a persistent imbalance between oxidative stress toxicity and reduced ANTIOX is a key component of Long COVID and that increased aldehyde, neutrophil-associated MPO, protein carbonyl, and NO production are the major neurotoxic pathways, which, when combined with decreased ANTIOX, may have a variety of detrimental effects as reviewed before.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1574}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:57}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:789}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1581}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, it is also important to note that vaccinations with AstraZeneca (viral vector, genetically modified virus vaccine) and Pfizer (mRNA vaccine), but not Sinopharm (inactivated virus vaccine), may aggravate the neuropsychiatric symptoms and, in particular, the somatic symptoms of HAMA and HAMD.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1581}, end: {_id:1566}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, it is also important to note that vaccinations with AstraZeneca (viral vector, genetically modified virus vaccine) and Pfizer (mRNA vaccine), but not Sinopharm (inactivated virus vaccine), may aggravate the neuropsychiatric symptoms and, in particular, the somatic symptoms of HAMA and HAMD.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1581}, end: {_id:1567}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, it is also important to note that vaccinations with AstraZeneca (viral vector, genetically modified virus vaccine) and Pfizer (mRNA vaccine), but not Sinopharm (inactivated virus vaccine), may aggravate the neuropsychiatric symptoms and, in particular, the somatic symptoms of HAMA and HAMD.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1582}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, it is also important to note that vaccinations with AstraZeneca (viral vector, genetically modified virus vaccine) and Pfizer (mRNA vaccine), but not Sinopharm (inactivated virus vaccine), may aggravate the neuropsychiatric symptoms and, in particular, the somatic symptoms of HAMA and HAMD.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1582}, end: {_id:1566}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, it is also important to note that vaccinations with AstraZeneca (viral vector, genetically modified virus vaccine) and Pfizer (mRNA vaccine), but not Sinopharm (inactivated virus vaccine), may aggravate the neuropsychiatric symptoms and, in particular, the somatic symptoms of HAMA and HAMD.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1582}, end: {_id:1567}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, it is also important to note that vaccinations with AstraZeneca (viral vector, genetically modified virus vaccine) and Pfizer (mRNA vaccine), but not Sinopharm (inactivated virus vaccine), may aggravate the neuropsychiatric symptoms and, in particular, the somatic symptoms of HAMA and HAMD.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:684}, end: {_id:1763}, properties:{annotationPublicationtype:["Research"], evidence:"In agreement with previous findings (2), we found that high doses of neuronal SARS-CoV-2 infection resulted in cell damage, a phenotype that was not apparent at the lowest doses used within 72 hpi (fig. S1, E and F).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:1823}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in cells with low ACE2 expression, viral infection can be enhanced by additional host factors, such as the extracellular protease BSG (also known as CD147), the transmembrane receptor NRP1 (Cantuti-Castelvetri et al., 2020), lectins (Lempp et al., 2021), or HAVCR1 phosphatidylserine receptors such TIM-1 (also known as TIMELESS) and AXL (Bohan et al., 2021; Wang et al., 2021b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1844}, end: {_id:1845}, properties:{annotationPublicationtype:["Review"], evidence:"Beyond nLong COVID itself, there is concern about an increased risk of dementia as a longer-term consequence of COVID-19. A number of viruses, including common respiratory viruses, cause post-acute infection syndromes (Choutka et al., 2022), with a significant number of patients developing long-term neurological sequelae, including neurodegenerative multiple sclerosis (Bjornevik et al., 2022; Cermelli and Jacobson, 2000).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1844}, end: {_id:264}, properties:{annotationPublicationtype:["Review"], evidence:"Beyond nLong COVID itself, there is concern about an increased risk of dementia as a longer-term consequence of COVID-19. A number of viruses, including common respiratory viruses, cause post-acute infection syndromes (Choutka et al., 2022), with a significant number of patients developing long-term neurological sequelae, including neurodegenerative multiple sclerosis (Bjornevik et al., 2022; Cermelli and Jacobson, 2000).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:364}, end: {_id:1924}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"Males were affected earlier motorically by Nurr1 deficiency [151] and male MPTP-intoxicated monkeys showed higher inflammation markers [43].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9544"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:684}, end: {_id:1953}, properties:{annotationPublicationtype:["Review"], evidence:"The latter are associated with SARS-CoV-2-dependent coagulation activation extending to the myocardium, or ACE2-mediated damage caused by low to moderate viral RNA loads in the heart.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:684}, end: {_id:66}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, SARS-CoV-2 infected DA neurons showed additional senescence-associated phenotypes, including increased accumulation of lysosomes as indicated by LysoTracker staining  (Figure 3K), mitochondrial dysfunction as indicated by EM and MitoTracker staining (Figures 3L and 3M), and increased protein oxidation as indicated by ROS staining (Figure 3N).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["MitoTracker staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["electron microscopy"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:331}, end: {_id:89}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, CD4+CD25+CD127lowFOXP3+CD39+ Tregs play an important role in constraining pathogenic Th17 cells and are impaired in MS patients; this in turn leads to an inability to control Th17-mediated neurodegenerative diseases.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:331}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Reynolds et al. have shown Th17-mediated nigrostriatal dopaminergic neurodegeneration with Treg dysfunction in an animal model of PD immunized by nitrated α-synuclein.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22899644", annotationAnatomy:["nigrostriatal tract"], citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1264}, end: {_id:1541}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Delta"], citationRef:"36314791"}}, {start: {_id:1264}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Delta"], citationRef:"36314791"}}, {start: {_id:1655}, end: {_id:1541}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Omicron"], citationRef:"36314791"}}, {start: {_id:1655}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Omicron"], citationRef:"36314791"}}, {start: {_id:1090}, end: {_id:974}, properties:{annotationPublicationtype:["Research"], evidence:"Exposure of human brain endothelial cells to S1 protein led to a dose-dependent increase in TNF, TGFβ, ICAM1 and VCAM1 mRNA (Extended Data Fig. ​Fig.8e)8e) after 72-h treatment with 0–400 nM S1 spike protein.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationTimeline:["72 hours"], annotationMeshanatomy:["Blood Vessels", "Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1090}, end: {_id:2118}, properties:{annotationPublicationtype:["Research"], evidence:"Exposure of human brain endothelial cells to S1 protein led to a dose-dependent increase in TNF, TGFβ, ICAM1 and VCAM1 mRNA (Extended Data Fig. ​Fig.8e)8e) after 72-h treatment with 0–400 nM S1 spike protein.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationTimeline:["72 hours"], annotationMeshanatomy:["Blood Vessels", "Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1090}, end: {_id:2231}, properties:{annotationPublicationtype:["Research"], evidence:"Exposure of human brain endothelial cells to S1 protein led to a dose-dependent increase in TNF, TGFβ, ICAM1 and VCAM1 mRNA (Extended Data Fig. ​Fig.8e)8e) after 72-h treatment with 0–400 nM S1 spike protein.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationTimeline:["72 hours"], annotationMeshanatomy:["Blood Vessels", "Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1090}, end: {_id:2232}, properties:{annotationPublicationtype:["Research"], evidence:"Exposure of human brain endothelial cells to S1 protein led to a dose-dependent increase in TNF, TGFβ, ICAM1 and VCAM1 mRNA (Extended Data Fig. ​Fig.8e)8e) after 72-h treatment with 0–400 nM S1 spike protein.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationTimeline:["72 hours"], annotationMeshanatomy:["Blood Vessels", "Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:22}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"For example, it has been shown that b-amyloid peptide binds to the neuronal receptor for advanced glycation end products (AGE), which in turn then induces macrophage colony-stimulating factor by an oxidant sensitive nuclear factor-kB (NF-kB) dependent pathway that, therefore, sets in motion microglia supported inflammatory pathways [18], which have been shown to be present and operational in the Alzheimer's brain [18].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:2248}, end: {_id:2249}, properties:{annotationPublicationtype:["Review"], evidence:"GARP is a receptor for latent TGF-β on the surface of activated human Tregs and may be necessary for the ability of Tregs to activate TGF-β upon T cell receptor (TCR) stimulation.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:170}, end: {_id:171}, properties:{annotationPublicationtype:["Review"], evidence:"Innate immunity consists of the immune mechanisms that are encoded in the germline and are possessed at birth, and work in a 'nonspecific' manner, for immediate defense against microbial infection, notably sepsis.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:425}, end: {_id:426}, properties:{annotationPublicationtype:["Review"], evidence:"Impaired FasL-Fas interactions result in unchecked T cell activation and proliferation. An extreme example manifests itself in autoimmune lymphoproliferative syndrome caused by unchecked T cell proliferation [113].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:548}, end: {_id:549}, properties:{annotationPublicationtype:["Review"], evidence:"In idiopathic PD, the triggers are thought to act decades before the loss of nigrostriatal dopaminergic signaling has reached levels necessary for the onset of clinical motor symptoms", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:573}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"For example, pathogen-induced (trigger) inflammation in the gut resulting in localized α-synuclein accumulation and aggregation in enteric nerves [11] may not promote PD until years later, after an age-related decline in cellular energy homeostasis and lysosomal function (facilitators) has set in, which in turn could enable the propagation of α-synuclein aggregates to the brainstem.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:1564}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:17}, end: {_id:1345}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, a proinflammatory environment in the blood of persons with de novo PD was associated with faster motor and cognitive decline in a longitudinal study [71], and a panel combining cytokines and senescence markers in full blood cells was a good predictor of dementia [72], suggesting that inflammatory changes in the periphery denote a more aggressive form of PD", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:264}, end: {_id:1726}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"The HR for varicella-zoster is higher after MS diagnosis, although the confidence intervals do overlap", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:67}, end: {_id:1836}, properties:{annotationPublicationtype:["Review"], evidence:"However, to date, ~80% of PD cases are considered idiopathic (iPD), with age constituting one of the biggest risk factors [4].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1886}, end: {_id:1885}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, the relevance of the increased NLR is true in iPD and genetic GBA-PD, but not in those with genetic LRRK2-PD, supporting a differential immune response in these PD subtypes [90]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:9}, end: {_id:11}, properties:{annotationPublicationtype:["Review"], evidence:"Illustrating these points, McCann's group have shown that the activity of the proinflammatory cytokine IL-1b is inhibited by inhibitory cytokines, one of the most potent of which is IL-1ra, that increases rapidly in the circulatory system to 100-fold higher than the IL-1b levels [13].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cardiovascular System"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:388}, end: {_id:588}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 variants are the leading heritable form of PD [47]. Mutations in LRRK2 associated with PD elevate LRRK2 kinase activity and decrease GTPase activity.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:13}, end: {_id:1017}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, a relative deficiency in ADAMTS13 activity was previously described in inflammatory conditions with high levels of IL-6, as found in patients with SARS-CoV-2 infection64. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1165}, end: {_id:1166}, properties:{annotationPublicationtype:["Research"], evidence:"When coexpressed with NEMO-2A-GFP that self-processes to NEMO-2A and green fluorescent protein (GFP), HA-tagged Mpro completely neutralized NEMO-2A in human hCMEC/D3 cells.", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["western blot"], annotationCustomCellline:["hCMEC/D3 cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:466}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin also suppresses inflammation by degrading TRAF2/6 and preventing the activation of NFkB and JNK signaling pathways", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:608}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"SDC4 transfectants surpassed WT K562 cells in uptake of Aβ1–42 after 6h of incubation, while SDC2 bested K562 cells in uptake and attachment of Aβ1–42 only at 18h.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:611}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to K562 cells, cellular uptake of Aβ1–42 into SDC1 transfectants were lower until 18h of incubation.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:611}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"In case of Trf, attachment of all cells were quite similar, except for SDC1 that seemed to bind less Trf.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"Among SDC transfectants, the neuron specific SDC3 internalized Aβ1–42 the most and Trf the least (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method", "flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:611}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:611}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:611}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, SDC transfectants – except for SDC4 – internalized less Trf at both time points, referring to affected clathrin-mediated endocytosis. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, SDC transfectants – except for SDC4 – internalized less Trf at both time points, referring to affected clathrin-mediated endocytosis. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, SDC transfectants – except for SDC4 – internalized less Trf at both time points, referring to affected clathrin-mediated endocytosis. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpressing SDC3 in SH-SY5Y cells, either differentiated or undifferentiated, induced lower uptake of α-syn or tau monomers at 1h (Fig. 8a,c), but significantly (p<0.05) higher at 18h of incubation, when fibrils are already formed, as revealed by both ThT fluorescence and electron microscopic studies (Fig. 8a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpressing SDC3 in SH-SY5Y cells, either differentiated or undifferentiated, induced lower uptake of α-syn or tau monomers at 1h (Fig. 8a,c), but significantly (p<0.05) higher at 18h of incubation, when fibrils are already formed, as revealed by both ThT fluorescence and electron microscopic studies (Fig. 8a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:1085}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, deleting both the CBD and the HSA with HS chains reduced cellular uptake of SARS-CoV-2, as shown by the markedly reduced intracellular fluorescence detected in Si4 mutants (Figure 3B–D).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"34069441"}}, {start: {_id:1092}, end: {_id:1091}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, deleting both the CBD and the HSA (with HS chains) significantly reduced cellular uptake of spikeS1, as shown by the markedly reduced intracellular fluorescence detected on Si4 mutants (Figure 7A–D).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "confocal microscopy", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:1095}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"As shown in Figure 9A–C, uptake studies demonstrated that while all of the applied inhibitors efficiently reduced SARS-CoV-2 uptake, SPRRAR, a peptide derived from the spikeS1 of SARS-CoV-2 emerged as the most potent one, demonstrating that molecularly detailed understanding of the SARS-CoV-2 internalization could indeed lead to the rational development of potent SARS-CoV-2 therapeutic leads (preincubating the cells with the inhibitors did not influence cell viability, demonstrating that the reduced SARS-CoV-2 uptake due to inhibitor treatment did not arise from disturbed cellular viability (Supplementary Figure S16)).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["A549 cell"], citationType:"PubMed", citationRef:"34069441"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1092}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT SDC4, all structural mutants exhibited significantly decreased Delta spike internalization (Figure 6A–C). Among them, Si4 demonstrated the highest decrease in Delta spike uptake, suggesting that simultaneous removal of SDC4's CBD and HS chains induces the most significant reduction in Delta spike entry.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["K-562 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1083}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT SDC4, all structural mutants exhibited significantly decreased Delta spike internalization (Figure 6A–C). Among them, Si4 demonstrated the highest decrease in Delta spike uptake, suggesting that simultaneous removal of SDC4's CBD and HS chains induces the most significant reduction in Delta spike entry.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["K-562 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1081}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT SDC4, all structural mutants exhibited significantly decreased Delta spike internalization (Figure 6A–C). Among them, Si4 demonstrated the highest decrease in Delta spike uptake, suggesting that simultaneous removal of SDC4's CBD and HS chains induces the most significant reduction in Delta spike entry.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["K-562 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:775}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"A ~6-fold increase in the ACE2 expression with a ~30% reduced HS expression in the ACE2-293T cells (Figure 1B,E) resulted in a modestly (yet significantly, i.e., p < 0.01) increased WT SCV2 cellular uptake, an unchanged Delta cellular uptake, and a significantly reduced Omicron cellular uptake, highlightingthe increased importance of HS in the variants, especially for Omicron's cellular entry(Figure 2A–E).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationSection:["Results"], annotationCustomCellline:["ACE2-293T cell"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", citationType:"PubMed", citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:912}, properties:{annotationPublicationtype:["Research"], evidence:"In comparison, the percentage of neurons with detectable MFSD2A decreased significantly (p < 0.001) in the COVID-19 brains (Table 1) (Fig. 2).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:1563}, properties:{annotationPublicationtype:["Research"], evidence:"The LC group was differentiated from controls by increased body temperature and CRP and lowered SpO2, Gpx and ANTIOX values.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["ELISA"], annotationDisease:["COVID-19"], citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1563}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1563}, properties:{annotationPublicationtype:["Research"], evidence:"Given that the Long COVID group as a whole showed Gpx deficiency, while only a subset of patients demonstrated oxidative damage, we may infer that Gpx deficiency is the main cause of the consequent lipid and protein damage.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1750}, end: {_id:393}, properties:{annotationPublicationtype:["Research"], evidence:"Intriguingly, a reduction in the density of phosphorylated α-synuclein deposits was observed 1 year after MSA seed injection.", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Corpus Striatum", "Brain"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMeshdisease:["Multiple System Atrophy"], annotationCellline:["HEK293"], annotationDurationAfterInjection:["12 months"], citationRef:"37248302"}}, {start: {_id:67}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 is highly expressed in neutrophils, monocytes, and B cells and has a lower expression in microglia [15,16].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:405}, properties:{annotationPublicationtype:["Research"], evidence:"The levels of both CD45RO and pS6 were decreased among CD4 Treg in iPD (Fig. 3e).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2051}, properties:{annotationPublicationtype:["Research"], evidence:"The levels of both CD45RO and pS6 were decreased among CD4 Treg in iPD (Fig. 3e).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:2040}, properties:{annotationPublicationtype:["Research"], evidence:"The activation marker ICOS was significantly decreased in CD8 T cells (Supplementary Fig. 3M).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2045}, properties:{annotationPublicationtype:["Research"], evidence:"In the blood of iPD, we observed a lower frequency of CXCR3+ and CCR4+ cells and their corresponding expression levels (geometric mean, MFI) among total CD8 T cells, whereas CCR6 showed no difference (Supplementary Fig. 4A, B).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], annotationSpecimen:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2047}, properties:{annotationPublicationtype:["Research"], evidence:"In the blood of iPD, we observed a lower frequency of CXCR3+ and CCR4+ cells and their corresponding expression levels (geometric mean, MFI) among total CD8 T cells, whereas CCR6 showed no difference (Supplementary Fig. 4A, B).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], annotationSpecimen:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1209}, end: {_id:16}, properties:{annotationPublicationtype:["Research"], evidence:"However, ablating microglia by administering the CSF-1R antagonist PLX5622 did neither prevent the formation of string vessels nor prevent the activation of astrocytes (Supplementary Fig. 6).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with microglia ablation"], citationRef:"34675436"}}, {start: {_id:684}, end: {_id:416}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, adhesion points anchored within the actin filament network were detected, indicating the integrity of cell-cell contacts (Figure 2K). As reference, TEM images of uninfected hiPS-BCECs are shown in Figure S2D. The overall integrity of the hiPS-BCECs was further demonstrated by intact localization and unaltered expression of TJP1/ZO-1, a TJ marker, after infection.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1110}, properties:{annotationPublicationtype:["Research"], evidence:"The cell viability studies showed that neither of the virus strains affected the cell viability at 1 MOI (Supplementary Figure S10).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"37762442", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["cell proliferation assay"], annotationSarsCov2Variant:["Omicron", "Delta", "wild type"], annotationConcentration:["1 MOI"], annotationCellline:["Calu-3 cell"], citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:283}, end: {_id:291}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:1906}, end: {_id:146}, properties:{annotationPublicationtype:["Review"], evidence:"Increased α-syn autoantibodies in the CSF of people with PD have been reported [124], although it is suggested that those α-syn autoantibodies with high affinity are decreased in the blood [125] and CSF [126] as the disease progresses.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1326}, end: {_id:1370}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:781}, end: {_id:780}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:IS_A]->(end) SET r += row.properties;
UNWIND [{start: {_id:420}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"DA neuron loss and behavioral deficits caused by both chronic and acute MPTP administration are attenuated in RAG2 knockout mice that lack both T and B cells [55, 112].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMouseType:["RAG2 -/- mice"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:24}, end: {_id:23}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:567}, end: {_id:566}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:674}, end: {_id:673}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:759}, end: {_id:758}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1939}, end: {_id:1938}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2325}, end: {_id:2324}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__COMPLEX]->(end) SET r += row.properties;
UNWIND [{start: {_id:233}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Increased susceptibility to PD owing to MHC II molecules could reflect increased neuroinflammation associated with up-regulation of those molecules or alternatively, could represent immune responses to self- or weak nonself-antigens.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:233}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Global loss of MHC-II in a mouse model is protective against neurodegeneration, microglial activation, and T cell infiltration when human alpha-synuclein is virally overexpressed in the SN", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1269}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 infection occurs when the virus spike (S) protein binds to the zinc metalloproteinase angiotensin-converting enzyme 2 (ACE2) at the host cell membrane (Hoffmann et al., 2020a; Lan et al., 2020; Shang et al., 2020a; Wan et al., 2020) (Fig. 2).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cell Membrane"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:71}, end: {_id:380}, properties:{annotationPublicationtype:["Review"], evidence:"Microglial expression of MHC-II molecules has been reported in states of chronic neuroinflammation, including neurodegenerative diseases.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Neurodegenerative Diseases"], annotationMeshanatomy:["Neurons", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:380}, properties:{annotationPublicationtype:["Review"], evidence:"The up-regulation of MHC-II mRNA(HLA-DRA, HLA-DPA1, HLA-DQA1) and increased expression of HLA-DR on monocytes in cerebrospinal fluid (CSF) has been reported [88, 89].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid", "Monocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:380}, properties:{annotationPublicationtype:["Review"], evidence:"In conjunction with HLA-DR expression on microglia, T cell infiltration has been shown in post-mortem brain sections from PD patients.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:640}, end: {_id:873}, properties:{annotationPublicationtype:["Research"], evidence:"Parenchymal and perivascular microglia expressed the lysosomal marker  CD68 while retaining the microglia core marker TMEM119 on their  surfaces (figures 1, 2; appendix p 5).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationAnatomy:["perivascular space"], citationRef:"33031735"}}, {start: {_id:640}, end: {_id:875}, properties:{annotationPublicationtype:["Research"], evidence:"Parenchymal and perivascular microglia expressed the lysosomal marker  CD68 while retaining the microglia core marker TMEM119 on their  surfaces (figures 1, 2; appendix p 5).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationAnatomy:["perivascular space"], citationRef:"33031735"}}, {start: {_id:640}, end: {_id:380}, properties:{annotationPublicationtype:["Research"], evidence:"In the CNS, we found strong upregulation of human leukocyte antigen (HLA)-DR on microglia/macrophages, which were often arranged in so- called microglial nodules, in 13 of 25 individuals analyzed (Supplementary Table 2 and Supplementary Fig. 4b–f).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia", "Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:1152}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, we observed high levels of Nrp1 and Bsg expression in mouse endothelial cells by scRNA-seq and immunostaining (Fig. 2a,b) but no Cd209a, Cd209b, Cd209c, Cd209d or Tmprss2 (Extended Data Fig. 3c–e).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1154}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, we observed high levels of Nrp1 and Bsg expression in mouse endothelial cells by scRNA-seq and immunostaining (Fig. 2a,b) but no Cd209a, Cd209b, Cd209c, Cd209d or Tmprss2 (Extended Data Fig. 3c–e).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1157}, properties:{annotationPublicationtype:["Research"], evidence:"Immunofluorescence staining confirmed the presence of BSG and NRP1 in brain endothelial cells, while only a few cells were positive for ACE2 (Fig. 2d). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1159}, properties:{annotationPublicationtype:["Research"], evidence:"Immunofluorescence staining confirmed the presence of BSG and NRP1 in brain endothelial cells, while only a few cells were positive for ACE2 (Fig. 2d). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:456}, end: {_id:462}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly for adaptive immunity, LRRK2 inhibits the nuclear translocation of NFAT, a master regulator of transcriptional activation in T cells [164].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:627}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"As Fig. 1b,c show, SDCs - especially the neuron predominant SDC3 - increased the cellular uptake of fibrils, while internalization of Trf, the marker of clathrin-mediated endocytosis was reduced by SDC1-3 (and left unaffected by SDC4) suggesting that SDC mediated uptake of the fibrils occur through clathrin-independent routes.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:630}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"As Fig. 1b,c show, SDCs - especially the neuron predominant SDC3 - increased the cellular uptake of fibrils, while internalization of Trf, the marker of clathrin-mediated endocytosis was reduced by SDC1-3 (and left unaffected by SDC4) suggesting that SDC mediated uptake of the fibrils occur through clathrin-independent routes.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:631}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"As Fig. 1b,c show, SDCs - especially the neuron predominant SDC3 - increased the cellular uptake of fibrils, while internalization of Trf, the marker of clathrin-mediated endocytosis was reduced by SDC1-3 (and left unaffected by SDC4) suggesting that SDC mediated uptake of the fibrils occur through clathrin-independent routes.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:630}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:631}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:627}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:280}, end: {_id:428}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:505}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:509}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:512}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:514}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:516}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:518}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:519}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:521}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:525}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:528}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:534}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:536}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:538}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:21}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:920}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:922}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1047}, end: {_id:1050}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:325}, end: {_id:1069}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:1090}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_FRAGMENTED_PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:896}, end: {_id:1095}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1164}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1168}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1170}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1172}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1174}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1176}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1178}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1180}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1182}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1184}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1186}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:1822}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_FRAGMENTED_PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:428}, end: {_id:427}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:505}, end: {_id:504}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:509}, end: {_id:508}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:512}, end: {_id:510}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:514}, end: {_id:513}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:516}, end: {_id:515}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:518}, end: {_id:508}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:519}, end: {_id:515}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:521}, end: {_id:520}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:525}, end: {_id:513}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:528}, end: {_id:513}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:534}, end: {_id:533}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:536}, end: {_id:535}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:538}, end: {_id:537}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:603}, end: {_id:602}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:920}, end: {_id:919}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:922}, end: {_id:921}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1050}, end: {_id:1049}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1069}, end: {_id:520}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1090}, end: {_id:1089}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__FRAGMENT]->(end) SET r += row.properties;
UNWIND [{start: {_id:1095}, end: {_id:1094}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1164}, end: {_id:520}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1168}, end: {_id:1167}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1170}, end: {_id:1169}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1172}, end: {_id:1171}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1174}, end: {_id:1173}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1176}, end: {_id:1175}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1178}, end: {_id:1177}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1180}, end: {_id:1179}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1182}, end: {_id:1181}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1184}, end: {_id:1183}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1186}, end: {_id:1185}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1822}, end: {_id:520}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__FRAGMENT]->(end) SET r += row.properties;
UNWIND [{start: {_id:775}, end: {_id:1266}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to 293T, increased ACE2 expression of 293T-ACE2 cells (i.e., ACE2 expression was about six times that of 293T cells) was associated with significantly lower (~80%) cell surface HS expression (Figure 2A,B,D,E).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationSection:["Results"], annotationCustomCellline:["293T cell overexpressing ACE2"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:2260}, end: {_id:2261}, properties:{annotationPublicationtype:["Review"], evidence:"For example, CTLA4 on Tregs can downregulate the costimulatory molecules CD80 and CD86 on both human and murine DCsin vitro194–197 (Figure 1), although in some studies, the engagement of CTLA4 in the suppressive function of Tregs against CD8+ T cells has not been observed.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes, Regulatory", "Dendritic Cells"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2260}, end: {_id:2262}, properties:{annotationPublicationtype:["Review"], evidence:"For example, CTLA4 on Tregs can downregulate the costimulatory molecules CD80 and CD86 on both human and murine DCsin vitro194–197 (Figure 1), although in some studies, the engagement of CTLA4 in the suppressive function of Tregs against CD8+ T cells has not been observed.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes, Regulatory", "Dendritic Cells"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2263}, end: {_id:2265}, properties:{annotationPublicationtype:["Review"], evidence:"For example, CTLA4 on Tregs can downregulate the costimulatory molecules CD80 and CD86 on both human and murine DCsin vitro194–197 (Figure 1), although in some studies, the engagement of CTLA4 in the suppressive function of Tregs against CD8+ T cells has not been observed.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes, Regulatory", "Dendritic Cells"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2263}, end: {_id:2267}, properties:{annotationPublicationtype:["Review"], evidence:"For example, CTLA4 on Tregs can downregulate the costimulatory molecules CD80 and CD86 on both human and murine DCsin vitro194–197 (Figure 1), although in some studies, the engagement of CTLA4 in the suppressive function of Tregs against CD8+ T cells has not been observed.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes, Regulatory", "Dendritic Cells"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2396}, end: {_id:108}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:243}, end: {_id:112}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:221}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1449}, end: {_id:343}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:453}, end: {_id:388}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2398}, end: {_id:421}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1384}, end: {_id:449}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:570}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:453}, end: {_id:585}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2409}, end: {_id:586}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1449}, end: {_id:597}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:607}, end: {_id:635}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2410}, end: {_id:705}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:607}, end: {_id:1081}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:607}, end: {_id:1083}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:607}, end: {_id:1085}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:607}, end: {_id:1087}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:607}, end: {_id:1092}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1109}, end: {_id:1098}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1109}, end: {_id:1101}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_VARIANT_PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:1109}, end: {_id:1104}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1162}, end: {_id:1188}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1165}, end: {_id:1201}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:1264}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:116}, end: {_id:1313}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2413}, end: {_id:1315}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:582}, end: {_id:1358}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:466}, end: {_id:1359}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1423}, end: {_id:1360}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1384}, end: {_id:1368}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1400}, end: {_id:1422}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1384}, end: {_id:1457}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:1655}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1109}, end: {_id:1849}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:292}, end: {_id:2243}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2422}, end: {_id:2288}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_VARIANT_PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:2361}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"By 7 weeks, microglial reactivity had normalized in the subcortical white matter (Figure 7J).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"By 7 weeks, microglial reactivity had normalized in the subcortical white matter (Figure 7J).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:111}, end: {_id:18}, properties:{annotationPublicationtype:["Review"], evidence:"Synaptic loss correlates positively with dementia progression,and is probably an early component of the neuronal degeneration", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:10}, end: {_id:51}, properties:{annotationPublicationtype:["Review"], evidence:"For example, it has been shown using spin-trapping methods that IL-1b mediates formation of hydroxyl free radicals in fibroblasts [73], as well as in brain cell primary cultures [74].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["fibroblast"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:44}, end: {_id:57}, properties:{annotationPublicationtype:["Review"], evidence:"It has been demonstrated that proinflammatory cytokines activate cultured primary brain cells (mostly microglia and astrocytes) to induce genes [83–85] including inducible nitric oxide synthase (iNOS), which mediates the synthesis of high levels of nitric oxide (NO), shown to be toxic to neurons [83,86].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCustomCellline:["primary brain cell culture"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:44}, end: {_id:57}, properties:{annotationPublicationtype:["Review"], evidence:"iNOS, because it does not require Ca21 for activity, produces much higher levels of NO for longer periods (hours) than does the endothelial or neuronal forms of nitric oxide synthase, which does require Ca21 for activity", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:69}, end: {_id:68}, properties:{annotationPublicationtype:["Review"], annotationAgeGroup:["neonate"], evidence:"Additionally, in an animal model of AIDs dementia, direct measurement of enhanced levels of NO was demonstrated in rat neonates treated with gp120 [103], the AIDs viral envelope protein known to upregulate iNOS in brain glia [104].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationCell:["glial cell"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Acquired Immunodeficiency Syndrome"], citationRef:"10381209"}}, {start: {_id:299}, end: {_id:300}, properties:{annotationPublicationtype:["Review"], evidence:"For example, TGF-β, IL-2, IL-10, and all-trans retinoic acid are known to polarize T cells to iTreg (Zheng et al. 2007, 2008; Khattar et al. 2009; Lee et al. 2009b), whereas histone deacetylase inhibitors are known to increase proliferation and suppressor activity of Treg.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:301}, end: {_id:300}, properties:{annotationPublicationtype:["Review"], evidence:"For example, TGF-β, IL-2, IL-10, and all-trans retinoic acid are known to polarize T cells to iTreg (Zheng et al. 2007, 2008; Khattar et al. 2009; Lee et al. 2009b), whereas histone deacetylase inhibitors are known to increase proliferation and suppressor activity of Treg.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:32}, end: {_id:300}, properties:{annotationPublicationtype:["Review"], evidence:"For example, TGF-β, IL-2, IL-10, and all-trans retinoic acid are known to polarize T cells to iTreg (Zheng et al. 2007, 2008; Khattar et al. 2009; Lee et al. 2009b), whereas histone deacetylase inhibitors are known to increase proliferation and suppressor activity of Treg.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:280}, end: {_id:319}, properties:{annotationPublicationtype:["Review"], evidence:"Other various models of transgenic mutant and wild type alpha-synuclein overexpression also display chronic microgliosis [47–50].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:146}, end: {_id:433}, properties:{annotationPublicationtype:["Review"], evidence:"The AAV-alpha-synuclein model also leads to significant IgG deposition, suggesting that humoral immunity and/or breakdown of the BBB is playing a role [45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:601}, end: {_id:626}, properties:{annotationPublicationtype:["Research"], evidence:"In SH-SY5Y cells, SDC3 overexpression resulted in increased HS expression, along with increased cellular uptake and fibrillation of Aβ1–42 (Fig. 8a–e).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy", "flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:626}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 overexpression – either in differentiated or undifferentiated SH-SY5Y cells - induced increased HS expression, along with increased internalization of both fibrils (Fig. 4a,b).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:10}, end: {_id:679}, properties:{annotationPublicationtype:["Review"], evidence:"The recent finding showing that NLRP3-driven and interleukin-1β-mediated modulation of phosphokinases and phosphatases largely accounts for the pathological formation of neurofibrillary tangles in murine models of tauopathy raises the concern that COVID-19 patients are likely to experience an induction or strong aggravation of neurodegenerative processes.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Tauopathies"], source:"wp4-cbm-comorbidity", pmid:"32498691", citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:922}, end: {_id:926}, properties:{annotationPublicationtype:["Research"], evidence:"The mice treated with the full length S1 subunit showed the viral protein primarily in the brain, subcutaneous fat of the skin, and liver. Over 90% of S1 spike positive cells were endothelia in microvessels (Fig. 4).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], citationRef:"33360731"}}, {start: {_id:922}, end: {_id:928}, properties:{annotationPublicationtype:["Research"], evidence:"The mice treated with the full length S1 subunit showed the viral protein primarily in the brain, subcutaneous fat of the skin, and liver. Over 90% of S1 spike positive cells were endothelia in microvessels (Fig. 4).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], citationRef:"33360731"}}, {start: {_id:922}, end: {_id:930}, properties:{annotationPublicationtype:["Research"], evidence:"The mice treated with the full length S1 subunit showed the viral protein primarily in the brain, subcutaneous fat of the skin, and liver. Over 90% of S1 spike positive cells were endothelia in microvessels (Fig. 4).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], citationRef:"33360731"}}, {start: {_id:920}, end: {_id:926}, properties:{annotationPublicationtype:["Research"], evidence:"The mice treated with the truncated S1 subunit showed scattered cells positive for this spike protein but not in the endothelia. Rather, the viral protein was seen in cells in the brain and liver that had the morphology of macrophages and microglia, respectively.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:920}, end: {_id:930}, properties:{annotationPublicationtype:["Research"], evidence:"The mice treated with the truncated S1 subunit showed scattered cells positive for this spike protein but not in the endothelia. Rather, the viral protein was seen in cells in the brain and liver that had the morphology of macrophages and microglia, respectively.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:1019}, end: {_id:1020}, properties:{annotationPublicationtype:["Review"], evidence:"Higher levels of soluble P-selectin (a marker of endothelial and platelet activation) were observed in patients admitted to the ICU than in patients not in the ICU, whereas increased levels of thrombomodulin (a specific marker of endothelial activation generally released during endothelial cell injury) were associated with increased mortality risk35", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["patients admitted to the ICU"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1165}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"When mice received AAV-BR1-Mpro 2 weeks before, we observed an increased number of string vessels and a decreased vascular density in their brains (Fig. 4j–l).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["western blot"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:146}, end: {_id:1455}, properties:{annotationPublicationtype:["Review"], evidence:"The authors also demonstrated that, upon α-syn exposure, the number of intercellular microglial connections (i.e. tunneling nanotubes and gap junctions) dramatically increased, and this was accompanied by efficient transfer of α-syn aggregates from donor to acceptor cells [125•].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:146}, end: {_id:1456}, properties:{annotationPublicationtype:["Review"], evidence:"The authors also demonstrated that, upon α-syn exposure, the number of intercellular microglial connections (i.e. tunneling nanotubes and gap junctions) dramatically increased, and this was accompanied by efficient transfer of α-syn aggregates from donor to acceptor cells [125•].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:683}, properties:{annotationPublicationtype:["Review"], evidence:"Plasma levels of ferritin, CCL18 and MIP1a were increased in PD patients with biallelic GBA mutations.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:146}, end: {_id:145}, properties:{annotationPublicationtype:["Research"], evidence:"All amplified fibrils derived from patients with RBD with positive IP/RT-QuIC results had the LB diseases-type structure (Supplementary Fig. 2).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["REM Sleep Behavior Disorder"], annotationBioassay:["transmission electron microscopy"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", citationRef:"37248302"}}, {start: {_id:570}, end: {_id:1747}, properties:{annotationPublicationtype:["Research"], evidence:"Intriguingly, a super-resolution microscopy analysis revealed that intracellular inclusions created by the PD seeds, MSA seeds or DLB seeds tend to exhibit different morphological features, such as fibrous inclusions, dense-core inclusions in MSA and pale-core inclusions in DLB/PDD (Fig. 3a). PD seeds formed significantly more fibrous inclusions (P<0.0001), and DLB/PDD seeds formed significantly more pale inclusions (P<0.0001) (Fig. 3b,c).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["Super resolution structured illumination microscopy"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCellline:["HEK293"], citationRef:"37248302"}}, {start: {_id:570}, end: {_id:1748}, properties:{annotationPublicationtype:["Research"], evidence:"Intriguingly, a super-resolution microscopy analysis revealed that intracellular inclusions created by the PD seeds, MSA seeds or DLB seeds tend to exhibit different morphological features, such as fibrous inclusions, dense-core inclusions in MSA and pale-core inclusions in DLB/PDD (Fig. 3a). PD seeds formed significantly more fibrous inclusions (P<0.0001), and DLB/PDD seeds formed significantly more pale inclusions (P<0.0001) (Fig. 3b,c).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["Super resolution structured illumination microscopy"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["HEK293"], annotationDisease:["Lewy body dementia"], annotationCustomDisease:["Parkinson’s disease with dementia"], citationRef:"37248302"}}, {start: {_id:570}, end: {_id:1749}, properties:{annotationPublicationtype:["Research"], evidence:"This analysis confirmed that the fluorescence density of PD inclusions was significantly lower than that of DLB and MSA inclusions (Fig. 3d).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["Super resolution structured illumination microscopy"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Multiple System Atrophy"], annotationCellline:["HEK293"], annotationDisease:["Lewy body dementia"], citationRef:"37248302"}}, {start: {_id:1843}, end: {_id:729}, properties:{annotationPublicationtype:["Review"], evidence:"A recent study showed that the cytokine CCL11 (eotaxin-1) remains elevated in long COVID patients suffering from brain fog, and high levels of CCL11 have been associated with demyelination of oligodendrocytes and activation of hippocampal microglia (Fernández-Castañeda et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationCell:["oligodendrocyte"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationCustomDisease:["Long COVID"], citationRef:"37458167"}}, {start: {_id:1870}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"TLR-2 and 4 have been highlighted as α-syn targets and shown to be upregulated in the brains and blood monocytes of people with PD (reviewed in [47]). This can induce the production of proinflammatory cytokines and reactive oxygen species, and, ultimately, neuronal death.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes", "Brain", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:360}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"TLR-2 and 4 have been highlighted as α-syn targets and shown to be upregulated in the brains and blood monocytes of people with PD (reviewed in [47]). This can induce the production of proinflammatory cytokines and reactive oxygen species, and, ultimately, neuronal death.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes", "Brain", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:274}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Depletion of Tregs by treatment with antiCD25 antibodies following the induction of EAE has been found to cause significant enhancement of disease severity and mortality", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Encephalomyelitis, Autoimmune, Experimental"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2289}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"EAE has been reported to be exacerbated in the absence of LFA-1, and this is correlated with a decrease in the steady-state numbers of Tregs in the LFA-1−/− mice.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMouseType:["Itgal -/-"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:1527}, end: {_id:2255}, properties:{annotationPublicationtype:["Review"], evidence:"CD46-costimulated human conventional CD4+ T cells can induce a Tr1 phenotype with considerable amounts of IL10 production.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2293}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"The primary circulating serine protease inhibitor α-1-antitrypsin can prevent signs of EAE in mice by increasing the population of Tregs and reducing the secretion of MOG-induced pro-inflammatory cytokines.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:1411}, end: {_id:2296}, properties:{annotationPublicationtype:["Review"], evidence:"Intramuscular treatment of IFN-β − 1α in RRMS subjects significantly increased both the percentage of NK cells and FOXP3 mRNA expression compared with untreated RR-MS and healthy controls.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Multiple Sclerosis, Relapsing-Remitting"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:896}, end: {_id:110}, properties:{annotationPublicationtype:["Research"], evidence:"By 72 hpi, the spike+ neurons showed significantly decreased Syn1-positive puncta density in both ApoE3 and ApoE4 neurons (Figures 2G–2J).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", annotationCellline:["AG14048 cell", "AG06869 cell"], pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:115}, end: {_id:117}, properties:{annotationPublicationtype:["Review"], evidence:"Delivery of a large dose of a potent proinflammatory agent such as lipopolysaccharide directly into the brain, for example, will enhance phagocytosis of amyloid by microglia", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Microglia", "Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:684}, end: {_id:899}, properties:{annotationPublicationtype:["Research"], evidence:"We next examined the impact of SARS-CoV-2 infection on the function of the ChP epithelium, specifically its role as an integral part of the blood-CNS barrier. We observed a striking effect on tight junctions, labeled by claudin-5, as early as 2 days post-infection (Figure 4F), with increasing disruption by 4 days post-infection suggesting a potential breakdown of barrier integrity.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationDayspostinfection:["4 days"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:1139}, properties:{annotationPublicationtype:["Research"], evidence:"To further determine whether the BMs of brain vessels suffered damage, Masson staining was carried out. As shown in Fig. ​Fig.2d,2d, blue-stained collagen in BM was destroyed in the brains of infected K18-hACE2 mice and hamsters.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationTechnique:["Masson staining"], annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1163}, properties:{annotationPublicationtype:["Research"], evidence:"Indeed, NEMO was degraded in infected Vero E6 and hCMEC/D3 cells before the cells died (Extended Data Fig. 5a,b).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["western blot"], annotationCustomCellline:["hCMEC/D3 cell"], annotationCellline:["VERO 76 cell"], citationRef:"34675436"}}, {start: {_id:684}, end: {_id:469}, properties:{annotationPublicationtype:["Research"], evidence:"In exposed organoids, we detected an upregulation of pathways related to UPRs, ER stress, proteasomal degradation, and autophagy, among cell types such as microglia, astrocytes, choroid plexus, and perivascular cells.", annotationCustomCell:["perivascular cell"], citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Microglia", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:79}, properties:{annotationPublicationtype:["Research"], evidence:"These results demonstrate that SARS-CoV-2 infection could result in neurite degeneration in both ApoE3 and ApoE4 neurons, with a moredramatic deteriorative effect on ApoE4 neurons than ApoE3 neurons.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", annotationCellline:["AG14048 cell", "AG06869 cell"], pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:263}, properties:{annotationPublicationtype:["Review"], evidence:"A greater loss of naive helper CD4+ T cells (CD45RA+) and either unchanged or increased levels of effector/memory helper T-cell subset (CD29+ or CD45R0+) have also been observed.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:640}, end: {_id:195}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While microglial/macrophage reactivity was evident in white matter by increased expression of the marker CD68, overall numbers of microglia were largely unchanged (Figure S2 ).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["BALB/c", "CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:1751}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Concordant with this pattern of microglial/macrophage reactivity, oligodendrocytes were decreased in the subcortical white matter at 7 days (Figure 7L) but recovered as microglial reactivity resolved by 7 weeks (Figure 7M).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["White Matter", "Corpus Callosum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:47}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"The enhanced oxidative damage to brain noted with increasing age [62], and especially so in neurodegenerative diseases, is most likely due to several factors, including altered mitochondrial production of ROS [54,55, 65]; but it is likely that the increased oxidative damage is also due in part to the increased prevalence of inflammatory conditions where microglia and other brain cells are 'activated' to produce increased ROS. ", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Neurodegenerative Diseases"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:15}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, colon biopsies from PD patients exhibit increased mRNA levels for pro-inflammatory cytokines and glial markers, indicative of enteric inflammation.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:47}, end: {_id:639}, properties:{annotationPublicationtype:["Research"], evidence:"We found a positive correlation between age and T cell reactivity to α-syn, with patients older than 70 years having more frequent responses (p = 0.0177 Fisher's exact test, Fig. 6a). ", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:1776}, end: {_id:1454}, properties:{annotationPublicationtype:["Research"], evidence:"The expression scores of these modules across all samples were significantly correlated with each other, indicating, participants with higher IFN-γ signaling have higher IL-27, IL-18, and NF-κB signaling, and participants with higher TNF signaling have higher IL-1, NF-κB, and IFN-α signaling, suggesting a coordinated activation of immune cascades that drive inflammation (Supplemental Fig. S6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1777}, end: {_id:1524}, properties:{annotationPublicationtype:["Research"], evidence:"The expression scores of these modules across all samples were significantly correlated with each other, indicating, participants with higher IFN-γ signaling have higher IL-27, IL-18, and NF-κB signaling, and participants with higher TNF signaling have higher IL-1, NF-κB, and IFN-α signaling, suggesting a coordinated activation of immune cascades that drive inflammation (Supplemental Fig. S6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:5}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"As has recently been shown, the adoptive transfer of CD3-activated Tregs attenuates astrogliosis and microglial inflammation with concomitant neuroprotection in a murine model of HIV-1-associated neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:90}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Positive associations of PD with influenza, toxoplasmosis, and autoimmunity have been reported while non-steroidal anti-inflammatory drugs decrease risk for PD [16–24]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:257}, end: {_id:1893}, properties:{annotationPublicationtype:["Review"], evidence:"Another study confirmed the decrease in naïve CD8 T cells and the increase in late-differentiated CD4 T cells during PD [108]. Naïve CD8 T cells in blood were positively correlated with the severity of autonomic dysfunction and psychiatric complications, and negatively with the severity of RBD [108].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:283}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Reynolds et al. have shown Th17-mediated nigrostriatal dopaminergic neurodegeneration with Treg dysfunction in an animal model of PD immunized by nitrated α-synuclein.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22899644", annotationAnatomy:["nigrostriatal tract"], citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:616}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"This conclusion is based on not only epidemiological evidence but also on experiments that showed that systemic, NLRP3 inflammasome-mediated inflammation adversely affects beneficial immune functions in the brain and thereby causes the pathological accumulation of neurodegeneration-associated peptides such as fibrillar amyloid-β.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:39}, end: {_id:1566}, properties:{annotationPublicationtype:["Research"], evidence:"OSTOX was associated with depression HAMD, NO with somatic HAMD HAMA and FF, MDA predicted somatic FF and OSTOX/ANTIOX predicted the neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:39}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"OSTOX was associated with depression HAMD, NO with somatic HAMD HAMA and FF, MDA predicted somatic FF and OSTOX/ANTIOX predicted the neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1564}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"OSTOX was associated with depression HAMD, NO with somatic HAMD HAMA and FF, MDA predicted somatic FF and OSTOX/ANTIOX predicted the neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:47}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, carrying the Alzheimer’s disease risk allele APOE ɛ4 (Kuo et al., 2020; Wang et al., 2021c) or being of an advanced age (González-García et al., 2021) increase the risk of severe COVID-19.", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["severe"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:47}, end: {_id:1914}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"The common genomic signature of aging in human PBMCs includes decreases in T cell functions and -> in cytotoxic effector cells (NK and memory CD8) and monocyte cell functions, which appear to be more pronounced in males [145].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:156}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Studies in animal models strongly support the active role of the peripheral immune system in PD.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationSection:["Full Text"], annotationMeshanatomy:["Peripheral Nervous System"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:40}, end: {_id:6}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:177}, end: {_id:4}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:179}, end: {_id:178}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:444}, end: {_id:149}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:600}, end: {_id:599}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:69}, end: {_id:43}, properties:{annotationPublicationtype:["Review"], annotationAgeGroup:["neonate"], evidence:"Additionally, in an animal model of AIDs dementia, direct measurement of enhanced levels of NO was demonstrated in rat neonates treated with gp120 [103], the AIDs viral envelope protein known to upregulate iNOS in brain glia [104].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationCell:["glial cell"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Acquired Immunodeficiency Syndrome"], citationRef:"10381209"}}, {start: {_id:196}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"However, TGF-β released from the damaged brain microvasculature contributes to inflammation by increasing expression of endothelial IL-1β and TNF-α.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:196}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"However, TGF-β released from the damaged brain microvasculature contributes to inflammation by increasing expression of endothelial IL-1β and TNF-α.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:218}, end: {_id:230}, properties:{annotationPublicationtype:["Review"], evidence:"Aberrant posttranslational modifications of α-syn, such as nitration (N-α-syn), can be found in LB inclusions of PD brains (Giasson et al. 2000) and cause the protein to aggregate more readily.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:44}, end: {_id:218}, properties:{annotationPublicationtype:["Review"], evidence:"Aggregated α-syn activates microglia (Zhang et al. 2005), which have been shown to produce nitric oxide and superoxide in mice and inducible nitric oxide synthase (iNOS) in humans, which increases nitration of α-syn and perpetuates the proinflammatory innate immune response in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:224}, end: {_id:429}, properties:{annotationPublicationtype:["Review"], evidence:"T cells from mice immunized with nitrated alpha-synuclein produced mostly IL-17 and TNFalpha after ex vivo restimulation.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:224}, end: {_id:372}, properties:{annotationPublicationtype:["Review"], evidence:"T cells from mice immunized with nitrated alpha-synuclein produced mostly IL-17 and TNFalpha after ex vivo restimulation.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:512}, end: {_id:506}, properties:{annotationPublicationtype:["Research"], evidence:"The second antigenic region was near the C terminus (aa116–140) (referred to as the S129 region) (Fig 1a), and required phosphorylation of amino acid residue S129. The three phosphorylated aaS129 epitopes (aa116MPVDPDNEAYEMPSEaa130, aa121DNEAYEMPSEEGYQDaa135, aa126EMPSEEGYQDYEPEAaa140) produced markedly higher IL-5 responses in PD than HC (p=0.02, Fisher's exact test, 300 SFC threshold) (Fig 1e–g).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:514}, end: {_id:506}, properties:{annotationPublicationtype:["Research"], evidence:"The second antigenic region was near the C terminus (aa116–140) (referred to as the S129 region) (Fig 1a), and required phosphorylation of amino acid residue S129. The three phosphorylated aaS129 epitopes (aa116MPVDPDNEAYEMPSEaa130, aa121DNEAYEMPSEEGYQDaa135, aa126EMPSEEGYQDYEPEAaa140) produced markedly higher IL-5 responses in PD than HC (p=0.02, Fisher's exact test, 300 SFC threshold) (Fig 1e–g).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:516}, end: {_id:506}, properties:{annotationPublicationtype:["Research"], evidence:"The second antigenic region was near the C terminus (aa116–140) (referred to as the S129 region) (Fig 1a), and required phosphorylation of amino acid residue S129. The three phosphorylated aaS129 epitopes (aa116MPVDPDNEAYEMPSEaa130, aa121DNEAYEMPSEEGYQDaa135, aa126EMPSEEGYQDYEPEAaa140) produced markedly higher IL-5 responses in PD than HC (p=0.02, Fisher's exact test, 300 SFC threshold) (Fig 1e–g).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:146}, end: {_id:271}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:146}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:611}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["10 minutes"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["10 minutes"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["10 minutes"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["10 minutes"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"The extent of fibril formation due to SDC overexpression, especially in the case of SDC2-4 is very spectacular:18h after addition of α-syn and tau monomers to SDC transfectants, scanning electron microscopy revealed widespread appearance of mature fibrils (i.e. larger than 2µm) expanding transcellularly. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"The extent of fibril formation due to SDC overexpression, especially in the case of SDC2-4 is very spectacular:18h after addition of α-syn and tau monomers to SDC transfectants, scanning electron microscopy revealed widespread appearance of mature fibrils (i.e. larger than 2µm) expanding transcellularly. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"The extent of fibril formation due to SDC overexpression, especially in the case of SDC2-4 is very spectacular:18h after addition of α-syn and tau monomers to SDC transfectants, scanning electron microscopy revealed widespread appearance of mature fibrils (i.e. larger than 2µm) expanding transcellularly. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:243}, properties:{annotationPublicationtype:["Research"], evidence:"The extent of fibril formation due to SDC overexpression, especially in the case of SDC2-4 is very spectacular:18h after addition of α-syn and tau monomers to SDC transfectants, scanning electron microscopy revealed widespread appearance of mature fibrils (i.e. larger than 2µm) expanding transcellularly. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:601}, end: {_id:243}, properties:{annotationPublicationtype:["Research"], evidence:"The extent of fibril formation due to SDC overexpression, especially in the case of SDC2-4 is very spectacular:18h after addition of α-syn and tau monomers to SDC transfectants, scanning electron microscopy revealed widespread appearance of mature fibrils (i.e. larger than 2µm) expanding transcellularly. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:243}, properties:{annotationPublicationtype:["Research"], evidence:"The extent of fibril formation due to SDC overexpression, especially in the case of SDC2-4 is very spectacular:18h after addition of α-syn and tau monomers to SDC transfectants, scanning electron microscopy revealed widespread appearance of mature fibrils (i.e. larger than 2µm) expanding transcellularly. ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:146}, end: {_id:32}, properties:{annotationPublicationtype:["Research"], evidence:"Comparison of IFNγ, IL-5, and IL-10 production between the two cohorts on a per donor basis revealed no differences when IL-5 and IFNγ were considered separately (Fig. 2a, b), and a significant difference when the IL-10 responses were considered (p = 0.04, Fig. 2c).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:146}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"Comparison of IFNγ, IL-5, and IL-10 production between the two cohorts on a per donor basis revealed no differences when IL-5 and IFNγ were considered separately (Fig. 2a, b), and a significant difference when the IL-10 responses were considered (p = 0.04, Fig. 2c).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:146}, end: {_id:506}, properties:{annotationPublicationtype:["Research"], evidence:"Comparison of IFNγ, IL-5, and IL-10 production between the two cohorts on a per donor basis revealed no differences when IL-5 and IFNγ were considered separately (Fig. 2a, b), and a significant difference when the IL-10 responses were considered (p = 0.04, Fig. 2c).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:268}, end: {_id:781}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:920}, end: {_id:325}, properties:{annotationPublicationtype:["Research"], evidence:"Increasing the concentration of S1 spike protein from 70 to 350 ng/ ml resulted in increased HUVEC cell degeneration and adhesion, as well as a significant increase in the % of cells with the spike subunit and caspase-3 (Table 2 and Fig. 3).", annotationPublicationstatus:["Published"], citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationSection:["Results"], annotationCustomCellline:["HUVEC cell line"], annotationConcentration:["350 ng/ ml"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:896}, end: {_id:931}, properties:{annotationPublicationtype:["Research"], evidence:"ACE2 analyses by immunohistochemistry showed that the three organs with the strongest expression in the microvessels were the skin/subcutaneous fat, brain, and liver.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Skin", "Brain", "Microvessels", "Liver"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:920}, end: {_id:932}, properties:{annotationPublicationtype:["Research"], evidence:"Endothelial cell damage, with increased caspase-3, as well as TNFα, IL6, and C5b-9 expression, was seen in the microvessels of the skin and brain in the mouse model with co-localization with the S1 spike protein (Fig. 4).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Skin", "Brain", "Microvessels"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:920}, end: {_id:933}, properties:{annotationPublicationtype:["Research"], evidence:"Endothelial cell damage, with increased caspase-3, as well as TNFα, IL6, and C5b-9 expression, was seen in the microvessels of the skin and brain in the mouse model with co-localization with the S1 spike protein (Fig. 4).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Skin", "Brain", "Microvessels"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:920}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], evidence:"Endothelial cell damage, with increased caspase-3, as well as TNFα, IL6, and C5b-9 expression, was seen in the microvessels of the skin and brain in the mouse model with co-localization with the S1 spike protein (Fig. 4).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Skin", "Brain", "Microvessels"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:922}, end: {_id:932}, properties:{annotationPublicationtype:["Research"], evidence:"Only the mice treated with the full length S1 subunit showed a significant increase in caspase-3, IL6, C5b-9, and TNFα in the brain.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:922}, end: {_id:933}, properties:{annotationPublicationtype:["Research"], evidence:"Only the mice treated with the full length S1 subunit showed a significant increase in caspase-3, IL6, C5b-9, and TNFα in the brain.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:922}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], evidence:"Only the mice treated with the full length S1 subunit showed a significant increase in caspase-3, IL6, C5b-9, and TNFα in the brain.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:922}, end: {_id:935}, properties:{annotationPublicationtype:["Research"], evidence:"Note the significant decrease in MFSD2a and increase in nNOS in the mice brains exposed to the full length S1 subunit, but not in the other mice (Table 1 and Fig. 4) (p < 0.001).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:1165}, end: {_id:1164}, properties:{annotationPublicationtype:["Research"], evidence:"Purified Mpro cleaved recombinant human NEMO as well as human and mouse NEMO in extracts of brain endothelial or HEK293T cells in a dose-dependent and time-dependent manner (Fig. 3a,b and Extended Data Figs. 6 and 7a,b).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["western blot"], annotationConcentration:["0 µM", "10 µM", "5 µM", "25 µM"], citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1164}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, Mpro cleaved NEMO also in intact brain endothelial cells (Fig 3c and Extended Data Fig. 7c)", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["western blot"], annotationCustomCellline:["hCMEC/D3 cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1164}, properties:{annotationPublicationtype:["Research"], evidence:"In vitro, Mpro produced several NEMO fragments (Fig. 3a and Extended Data Fig. 6). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["western blot"], annotationConcentration:["0 µM", "10 µM", "5 µM", "25 µM"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1168}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1170}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1165}, end: {_id:1172}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1174}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1176}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1178}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1180}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1182}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1184}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1186}, properties:{annotationPublicationtype:["Research"], evidence:"Tryptic digestion of Mpro-treated NEMO followed by mass spectrometry of the generated peptides showed that cleavage occurred at Q83, Q205, Q231, Q304 and Q313 (Fig. 3d,e and Supplementary Fig. 2a–j).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1176}, properties:{annotationPublicationtype:["Research"], evidence:"We verified the cleavage at Q231 by using synthetic peptides as substrates corresponding to both the human and mouse NEMO sequence (Fig. 3f and Supplementary Fig. 3a–c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:372}, end: {_id:1312}, properties:{annotationPublicationtype:["Research"], evidence:"Both cell lines have endogenous SDC3 expression (Supplementary Figure S1), and incubating them with TNF-α for seven days increased their SDC3 expression.", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["hCMEC/d3 cell"], annotationCellline:["SH-SY5Y cell"], citationRef:"35328830"}}, {start: {_id:372}, end: {_id:1312}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 overexpression due to TNF-α was significantly increased in the two cell lines. The effect was most profound in SH-SY5Y cells and slightly less, still significant in HCMEC/D3 cells (Figure 1A–C).", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["hCMEC/d3 cell"], annotationCellline:["SH-SY5Y cell"], citationRef:"35328830"}}, {start: {_id:280}, end: {_id:372}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, the levels of neuroinflammatory markers, TNF, ICAM, IL-6 and IL-1α, are increased in the SN of mouse brain overexpressing α-syn", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:280}, end: {_id:379}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, the levels of neuroinflammatory markers, TNF, ICAM, IL-6 and IL-1α, are increased in the SN of mouse brain overexpressing α-syn", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:280}, end: {_id:933}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, the levels of neuroinflammatory markers, TNF, ICAM, IL-6 and IL-1α, are increased in the SN of mouse brain overexpressing α-syn", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:280}, end: {_id:1366}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, the levels of neuroinflammatory markers, TNF, ICAM, IL-6 and IL-1α, are increased in the SN of mouse brain overexpressing α-syn", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:582}, end: {_id:1391}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 phosphorylates ubiquitin, regulates mitochondrial quality control and plays a key role in mitophagy (the removal of damaged mitochondria from cells). ", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1425}, properties:{annotationPublicationtype:["Review"], evidence:"In Zebrafish, overexpression of DJ-1 in astrocytes was found to upregulate HMGB1 and Cyclophilin-A [107], which have both anti-inflammatory and pro-inflammatory functions.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1426}, properties:{annotationPublicationtype:["Review"], evidence:"In Zebrafish, overexpression of DJ-1 in astrocytes was found to upregulate HMGB1 and Cyclophilin-A [107], which have both anti-inflammatory and pro-inflammatory functions.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1427}, properties:{annotationPublicationtype:["Review"], evidence:"In Zebrafish, overexpression of DJ-1 in astrocytes was found to upregulate HMGB1 and Cyclophilin-A [107], which have both anti-inflammatory and pro-inflammatory functions.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1428}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1424}, end: {_id:1429}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1430}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1431}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1432}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1433}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1434}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1424}, end: {_id:1435}, properties:{annotationPublicationtype:["Review"], evidence:"Proteomic analysis in the brain of DJ-1 knockout (KO) fish revealed downregulation of some inflammatory regulators, including the complement proteins c3a and c3b", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationZebrafishType:["park7-/-"], annotationSection:["Full Text"], annotationSpecies:["7955"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:1006}, properties:{annotationPublicationtype:["Review"], evidence:"Increased plasma levels of IL-8, MCP-1, MIP-1-a, IL-1β and TNFα were shown to be associated with GBA-PD compared to sporadic PD [146, 147].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:666}, properties:{annotationPublicationtype:["Review"], evidence:"Increased plasma levels of IL-8, MCP-1, MIP-1-a, IL-1β and TNFα were shown to be associated with GBA-PD compared to sporadic PD [146, 147].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:667}, properties:{annotationPublicationtype:["Review"], evidence:"Increased plasma levels of IL-8, MCP-1, MIP-1-a, IL-1β and TNFα were shown to be associated with GBA-PD compared to sporadic PD [146, 147].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Increased plasma levels of IL-8, MCP-1, MIP-1-a, IL-1β and TNFα were shown to be associated with GBA-PD compared to sporadic PD [146, 147].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Increased plasma levels of IL-8, MCP-1, MIP-1-a, IL-1β and TNFα were shown to be associated with GBA-PD compared to sporadic PD [146, 147].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:1466}, properties:{annotationPublicationtype:["Review"], evidence:"Plasma levels of ferritin, CCL18 and MIP1a were increased in PD patients with biallelic GBA mutations.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:667}, properties:{annotationPublicationtype:["Review"], evidence:"Plasma levels of ferritin, CCL18 and MIP1a were increased in PD patients with biallelic GBA mutations.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1358}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Serum of PD patients with biallelic PINK1 and Parkin mutations have high levels of IL-6 [24•, 96].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1359}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Serum of PD patients with biallelic PINK1 and Parkin mutations have high levels of IL-6 [24•, 96].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:388}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Studies in the serum and cerebral spinal fluid (CSF) of asymptomatic LRRK2 mutation carriers, showing increased levels of IL-1β, PDGF, VEGF and IL-8 compared to healthy controls, have suggested these molecules as pre-clinical markers of PD onset and development [150].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Cerebrospinal Fluid", "Serum"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:388}, end: {_id:1469}, properties:{annotationPublicationtype:["Review"], evidence:"Studies in the serum and cerebral spinal fluid (CSF) of asymptomatic LRRK2 mutation carriers, showing increased levels of IL-1β, PDGF, VEGF and IL-8 compared to healthy controls, have suggested these molecules as pre-clinical markers of PD onset and development [150].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Cerebrospinal Fluid", "Serum"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:388}, end: {_id:1470}, properties:{annotationPublicationtype:["Review"], evidence:"Studies in the serum and cerebral spinal fluid (CSF) of asymptomatic LRRK2 mutation carriers, showing increased levels of IL-1β, PDGF, VEGF and IL-8 compared to healthy controls, have suggested these molecules as pre-clinical markers of PD onset and development [150].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Cerebrospinal Fluid", "Serum"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:388}, end: {_id:1006}, properties:{annotationPublicationtype:["Review"], evidence:"Studies in the serum and cerebral spinal fluid (CSF) of asymptomatic LRRK2 mutation carriers, showing increased levels of IL-1β, PDGF, VEGF and IL-8 compared to healthy controls, have suggested these molecules as pre-clinical markers of PD onset and development [150].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Cerebrospinal Fluid", "Serum"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:891}, end: {_id:1822}, properties:{annotationPublicationtype:["Review"], evidence:"Alternatively, in the non-endosomal pathway, the primary activation is based on the cleavage of S protein by the cellular transmembrane serine protease 2 (TMPRSS2) (Koch et al., 2021) and subsequent spike cleavage by the endonuclease furin (Bestle et al., 2020; Shang et al., 2020b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1511}, end: {_id:1822}, properties:{annotationPublicationtype:["Review"], evidence:"Alternatively, in the non-endosomal pathway, the primary activation is based on the cleavage of S protein by the cellular transmembrane serine protease 2 (TMPRSS2) (Koch et al., 2021) and subsequent spike cleavage by the endonuclease furin (Bestle et al., 2020; Shang et al., 2020b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:2250}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, GATA3, a previously recognized Th2 (T cell subset 2) master regulator, has also been found to play an essential role in the suppressive function of Tregs by controlling Foxp3 expression.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:196}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"TGF-β has been reported to induce FOXP3 expression in human or murine CD4+CD25− conventional T cells.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2275}, end: {_id:2277}, properties:{annotationPublicationtype:["Review"], evidence:"Later reports have confirmed that CCL17 and CCL22 chemokines are related to the accumulation of Foxp3+ Tregs within the tumor microenvironment of early gastric cancer.2", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", annotationDisease:["microinvasive gastric cancer"], citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2278}, end: {_id:2277}, properties:{annotationPublicationtype:["Review"], evidence:"Later reports have confirmed that CCL17 and CCL22 chemokines are related to the accumulation of Foxp3+ Tregs within the tumor microenvironment of early gastric cancer.2", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", annotationDisease:["microinvasive gastric cancer"], citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2301}, end: {_id:291}, properties:{annotationPublicationtype:["Review"], evidence:"17β-Estradiol (also known as E2) can exert a protective effect against EAE by upregulating the expression of Foxp3 in Tregs via the α-receptor Esr1.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:954}, end: {_id:684}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1126}, end: {_id:684}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1331}, end: {_id:1328}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1333}, end: {_id:1332}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1463}, end: {_id:1460}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1772}, end: {_id:1769}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2320}, end: {_id:283}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:162}, end: {_id:165}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:162}, end: {_id:166}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:162}, end: {_id:167}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:165}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, abnormalities in the BBB have been shown where T-cell infiltration occurs in neuroAIDS (Petito and Cash 1992; Petito et al. 2003), AD (Rogers et al. 1988; Togo et al. 2002; Desai et al. 2007), and PD (Farkas et al. 2000).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease", "Parkinson Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:334}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In an attempt to clear and digest cellular debris, microglia and blood-borne macrophages infiltrate sites of neuronal injury and death and convert to a proinflammatory activated state.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:335}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In an attempt to clear and digest cellular debris, microglia and blood-borne macrophages infiltrate sites of neuronal injury and death and convert to a proinflammatory activated state.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:352}, end: {_id:357}, properties:{annotationPublicationtype:["Review"], evidence:"MPP+ inhibits cellular respiration by direct inhibition of the mitochondrial transport chain leading to neuronal injury and death [12].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:162}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Thus, gut dysbiosis and/or small intestinal bacterial overgrowth, along with increased intestinal permeability, can cause systemic inflammation, which could spread to the CNS through systemic circulation and several neural pathways.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:222}, end: {_id:573}, properties:{annotationPublicationtype:["Review"], evidence:"For example, pathogen-induced (trigger) inflammation in the gut resulting in localized α-synuclein accumulation and aggregation in enteric nerves [11] may not promote PD until years later, after an age-related decline in cellular energy homeostasis and lysosomal function (facilitators) has set in, which in turn could enable the propagation of α-synuclein aggregates to the brainstem.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:598}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"Failure of the lysosomal-autophagy pathway may aggravate progression of neuropathology by elevating levels of extracellular α-synuclein aggregates, and promoting cell-to-cell spread of α-synuclein pathology.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:677}, end: {_id:169}, properties:{annotationPublicationtype:["Review"], evidence:"Given the above cytokine findings in COVID-19 patients and in particular the rise of interleukin-1β and interleukin-18, it seems highly likely that COVID-19 patients suffer from NLRP3 inflammasome activation. This activation and the subsequent increased activity of proinflammatory immune pathways are likely to exert a negative impact on cerebral homeostasis and function.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Cerebrum"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:17}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"This conclusion is based on not only epidemiological evidence but also on experiments that showed that systemic, NLRP3 inflammasome-mediated inflammation adversely affects beneficial immune functions in the brain and thereby causes the pathological accumulation of neurodegeneration-associated peptides such as fibrillar amyloid-β.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:1557}, end: {_id:162}, properties:{annotationHourspostinfection:["24 hours"], annotationPublicationtype:["Research"], evidence:"Further, astrocytes, pericytes and choroid plexus-related cells were observed to downregulate VEGF signaling, a potent inducer of BBB permeability, at 24hpi but then at 72hpi instead display an upregulation, coinciding with increased signaling for leukocyte chemotaxis and activation in astrocytes, as well as antigen processing and presentation in choroid plexus.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Pericytes", "Choroid Plexus", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1560}, end: {_id:39}, properties:{annotationPublicationtype:["Research"], evidence:"Further, a partial translational inhibition could be observed in microglia (module B), as well as most of the other cell types. We also observed downregulation of the ROS metabolism across cell types, which can lead to dysregulation of the antioxidant cellular systems and result in oxidative stress.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:17}, end: {_id:74}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, a proinflammatory environment in the blood of persons with de novo PD was associated with faster motor and cognitive decline in a longitudinal study [71], and a panel combining cytokines and senescence markers in full blood cells was a good predictor of dementia [72], suggesting that inflammatory changes in the periphery denote a more aggressive form of PD", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:17}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"As inflammation can induce a change of BBB integrity, compromised integrity of the BBB might indeed contribute to the initiation and/or progression of AD, PD, epilepsy, or cerebral palsy.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshdisease:["Alzheimer Disease", "Cerebral Palsy", "Parkinson Disease", "Epilepsy"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:5}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs have been found to mediate neuroprotection through the suppression of microglial stimulation,including that by aggregated nitrated α-synuclein in an animal model of PD.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:828}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to control organoids where Tau normally localizes in axons, SARS-CoV-2-positive neurons exhibited an altered Tau localization pattern, although it was challenging to visualize mislocalization of Tau in 3D tissues. Nevertheless, using selected confocal sections, we could image an altered Tau localization in SARS-CoV-2-positive neurons. In particular, we identified an enhanced level of Tau into the somas of the SARS-CoV-2-positive neurons.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunofluorescent labeling", "confocal microscopy"], source:"wp4-cbm-comorbidity", annotationCustomAnatomy:["induced pluripotent stem cells derived neurons"], pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:684}, end: {_id:831}, properties:{annotationPublicationtype:["Research"], evidence:"More precisely, we found that compared to control organoids, early Tau phosphorylation marker AT180 recognizes pT231Tau localized at the soma of the SARS-CoV-2-positive neurons (Fig 2D–F).", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunofluorescent labeling", "confocal microscopy"], source:"wp4-cbm-comorbidity", annotationCustomAnatomy:["induced pluripotent stem cells derived neurons"], pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:626}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"SDC overexpression further increased the internalization efficacy of the Delta spike, especially SDC4, which increased the difference between the cellular uptake of the WT spike and Delta the most (Figure 4C,D).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:611}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Also, as noted in our previous report, SDC overexpression did not alter WT K562's ACE2 expression (Supplementary Figure S5) [28,37].", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:608}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Also, as noted in our previous report, SDC overexpression did not alter WT K562's ACE2 expression (Supplementary Figure S5) [28,37].", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:601}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Also, as noted in our previous report, SDC overexpression did not alter WT K562's ACE2 expression (Supplementary Figure S5) [28,37].", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:607}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Also, as noted in our previous report, SDC overexpression did not alter WT K562's ACE2 expression (Supplementary Figure S5) [28,37].", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"Testing the ACE-2 expression at the mRNA level via a qRT–PCR revealed that both iPSCs-derived brain organoids and neurons exhibited ~12.5- and 50-fold lesser than human respiratory epithelial cells (hREC), which served as a positive control.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], source:"wp4-cbm-comorbidity", annotationCustomAnatomy:["induced pluripotent stem cells derived brain organoids", "induced pluripotent stem cells derived neurons"], pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"RNA-seq analysis showed expression of ACE2 and TMPRSS2 in CPOs at levels similar to the adult human choroid plexus tissue, which were much higher than in hippocampal organoids.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"RNA-seq analysis showed expression of ACE2 and TMPRSS2 in CPOs at levels similar to the adult human choroid plexus tissue, which were much higher than in hippocampal organoids.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"qPCR analysis also showed higher levels of ACE2 and TMPRSS2 expression in CPOs at 50 DIV and 100 DIV than in hippocampal organoids.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"qPCR analysis also showed higher levels of ACE2 and TMPRSS2 expression in CPOs at 50 DIV and 100 DIV than in hippocampal organoids.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"We also confirmed the expression of SARS-CoV-2 receptors ACE2, TMPRSS2, and NRP1 in CPOs at all time points (Figure 4B).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"We also confirmed the expression of SARS-CoV-2 receptors ACE2, TMPRSS2, and NRP1 in CPOs at all time points (Figure 4B).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:837}, properties:{annotationPublicationtype:["Research"], evidence:"We also confirmed the expression of SARS-CoV-2 receptors ACE2, TMPRSS2, and NRP1 in CPOs at all time points (Figure 4B).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:842}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of upregulated genes revealed an increase in inflammatory cytokines CCL7, interleukin-32 (IL-32), CCL2 (MCP1), IL-18, and IL-8 (Figure 4D).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:843}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of upregulated genes revealed an increase in inflammatory cytokines CCL7, interleukin-32 (IL-32), CCL2 (MCP1), IL-18, and IL-8 (Figure 4D).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:844}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of upregulated genes revealed an increase in inflammatory cytokines CCL7, interleukin-32 (IL-32), CCL2 (MCP1), IL-18, and IL-8 (Figure 4D).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:845}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of upregulated genes revealed an increase in inflammatory cytokines CCL7, interleukin-32 (IL-32), CCL2 (MCP1), IL-18, and IL-8 (Figure 4D).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:846}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of upregulated genes revealed an increase in inflammatory cytokines CCL7, interleukin-32 (IL-32), CCL2 (MCP1), IL-18, and IL-8 (Figure 4D).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:849}, properties:{annotationPublicationtype:["Research"], evidence:"Upregulation of many vascular remodeling genes (Figure 4D), such as NPPB and VCAN, suggests that infected choroid plexus cells could signal the vasculature to promote leukocyte invasion (Shechter et al., 2013).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:850}, properties:{annotationPublicationtype:["Research"], evidence:"Upregulation of many vascular remodeling genes (Figure 4D), such as NPPB and VCAN, suggests that infected choroid plexus cells could signal the vasculature to promote leukocyte invasion (Shechter et al., 2013).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of ACE2 and TMPRSS2 was detected predominantly in ChP clusters, but not in the neural progenitor or neuron clusters.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Telencephalon", "Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["single cell RNA sequencing"], citationRef:"33113348"}}, {start: {_id:684}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of ACE2 and TMPRSS2 was detected predominantly in ChP clusters, but not in the neural progenitor or neuron clusters.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Telencephalon", "Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["single cell RNA sequencing"], citationRef:"33113348"}}, {start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"To examine whether these results were in agreement with the expression in vivo, we analyzed data from the Allen Brain Atlas (Hawrylycz et al., 2012; Miller et al., 2017) reporting expression levels of ACE2 in different human brain regions (Figure 1B). Among all the different brain regions compared, we found highest levels of ACE2 in the ChP (Figure 1B), validating our findings in vitro.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:885}, properties:{annotationPublicationtype:["Research"], evidence:"To better characterize the distribution of SARS-CoV-2 entry factors in the different ChP populations, we performed subclustering of all the ChP cell populations, and we identified four prominent clusters of immature ChP, maturing ChP, hem and ChP stroma, as well as two smaller clusters: one that appeared to be neural crest cells and one that was enriched in expression of lipoprotein genes, such as APOA1 and APOA2 (Besler et al., 2012; Wang et al., 2019), suggesting a function in lipid production and transfer.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:886}, properties:{annotationPublicationtype:["Research"], evidence:"To better characterize the distribution of SARS-CoV-2 entry factors in the different ChP populations, we performed subclustering of all the ChP cell populations, and we identified four prominent clusters of immature ChP, maturing ChP, hem and ChP stroma, as well as two smaller clusters: one that appeared to be neural crest cells and one that was enriched in expression of lipoprotein genes, such as APOA1 and APOA2 (Besler et al., 2012; Wang et al., 2019), suggesting a function in lipid production and transfer.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"We then looked at the main SARS-CoV-2 entry genes in these cell populations and found the highest expression of ACE2 in lipoprotein-expressing ChP cells although some cells of other ChP clusters expressed ACE2 to a lower extent.", annotationCellType:["lipoprotein-expressing cells"], citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:1133}, properties:{annotationPublicationtype:["Research"], evidence:"In the present study, we also detected increased levels of IL-6, TNF-ɑ, and MCP1 in the brain of infected K18-hACE2 mice and hamsters by RT-PCR.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1134}, properties:{annotationPublicationtype:["Research"], evidence:"In the present study, we also detected increased levels of IL-6, TNF-ɑ, and MCP1 in the brain of infected K18-hACE2 mice and hamsters by RT-PCR.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1135}, properties:{annotationPublicationtype:["Research"], evidence:"In the present study, we also detected increased levels of IL-6, TNF-ɑ, and MCP1 in the brain of infected K18-hACE2 mice and hamsters by RT-PCR.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1136}, properties:{annotationPublicationtype:["Research"], evidence:"In the present study, we also detected increased levels of IL-6, TNF-ɑ, and MCP1 in the brain of infected K18-hACE2 mice and hamsters by RT-PCR.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1137}, properties:{annotationPublicationtype:["Research"], evidence:"In the present study, we also detected increased levels of IL-6, TNF-ɑ, and MCP1 in the brain of infected K18-hACE2 mice and hamsters by RT-PCR.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1143}, properties:{annotationHourspostinfection:["48 hours"], annotationPublicationtype:["Research"], evidence:"Moreover, both the mRNA and protein levels of MMP9 were increased in the BMEC BBB models at 48 hpi compared with the mock group (Fig. 5k–m).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1133}, properties:{annotationPublicationtype:["Research"], evidence:"Identical to the results in vivo, the relative mRNA levels of the inflammatory factors, IL-6, TNF-ɑ, and MCP1 were much higher in the infected group than the mock control in both in vitro models of K18-hACE2 mice and hamsters (Fig. ​(Fig.5n).5n).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1134}, properties:{annotationPublicationtype:["Research"], evidence:"Identical to the results in vivo, the relative mRNA levels of the inflammatory factors, IL-6, TNF-ɑ, and MCP1 were much higher in the infected group than the mock control in both in vitro models of K18-hACE2 mice and hamsters (Fig. ​(Fig.5n).5n).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1135}, properties:{annotationPublicationtype:["Research"], evidence:"Identical to the results in vivo, the relative mRNA levels of the inflammatory factors, IL-6, TNF-ɑ, and MCP1 were much higher in the infected group than the mock control in both in vitro models of K18-hACE2 mice and hamsters (Fig. ​(Fig.5n).5n).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1136}, properties:{annotationPublicationtype:["Research"], evidence:"Identical to the results in vivo, the relative mRNA levels of the inflammatory factors, IL-6, TNF-ɑ, and MCP1 were much higher in the infected group than the mock control in both in vitro models of K18-hACE2 mice and hamsters (Fig. ​(Fig.5n).5n).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1137}, properties:{annotationPublicationtype:["Research"], evidence:"Identical to the results in vivo, the relative mRNA levels of the inflammatory factors, IL-6, TNF-ɑ, and MCP1 were much higher in the infected group than the mock control in both in vitro models of K18-hACE2 mice and hamsters (Fig. ​(Fig.5n).5n).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1284}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:965}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1285}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1286}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1287}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1288}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1289}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1290}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:1278}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1281}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1279}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1276}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1277}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1280}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"The SARS-CoV-2 entry receptor ACE2 and co-factor/alternative receptor TMPRSS2 and NRP1 are all expressed in hiPS-BCECs as detected by qRT-PCR, with NRP1 being the most abundant (Figure 2F), similar to the situation in human brain tissue.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"The SARS-CoV-2 entry receptor ACE2 and co-factor/alternative receptor TMPRSS2 and NRP1 are all expressed in hiPS-BCECs as detected by qRT-PCR, with NRP1 being the most abundant (Figure 2F), similar to the situation in human brain tissue.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:837}, properties:{annotationPublicationtype:["Research"], evidence:"The SARS-CoV-2 entry receptor ACE2 and co-factor/alternative receptor TMPRSS2 and NRP1 are all expressed in hiPS-BCECs as detected by qRT-PCR, with NRP1 being the most abundant (Figure 2F), similar to the situation in human brain tissue.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1274}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the increase of IFITM1 and IFITM2 expression observed in tissue infected with SARS-CoV-2 could be recapitulated in our model by both mRNA sequencing (p = 0.031 for IFITM1, p = 0.403 for IFITM2) and qRT-PCR.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR", "RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1275}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the increase of IFITM1 and IFITM2 expression observed in tissue infected with SARS-CoV-2 could be recapitulated in our model by both mRNA sequencing (p = 0.031 for IFITM1, p = 0.403 for IFITM2) and qRT-PCR.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR", "RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1302}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1303}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1304}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1305}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1306}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1307}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1308}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1309}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:982}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:837}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"NRP1 is a potential candidate entry factor for infection, as it has been demonstrated to be a SARS-CoV-2 host factor (34). We observed NRP1 RNA expression in primary tissue, specifically in cortical neurons—a population, however, where we observed minimal infection (SI Appendix, Fig. 8A). When we evaluated NRP1 protein abundance, we similarly observed membrane-bound staining in neurons in the cortical plate in primary tissue, but none in dsRNA+-infected cells.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:835}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:" Additionally, SARS-CoV proteases TMPRSS2, FURIN, and CTSB express modest RNA levels across cortical tissue samples, but infected astrocytes have abundant protein of all three proteases.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1509}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:" Additionally, SARS-CoV proteases TMPRSS2, FURIN, and CTSB express modest RNA levels across cortical tissue samples, but infected astrocytes have abundant protein of all three proteases.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1510}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:" Additionally, SARS-CoV proteases TMPRSS2, FURIN, and CTSB express modest RNA levels across cortical tissue samples, but infected astrocytes have abundant protein of all three proteases.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1513}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 restriction factors are also present. LY6E is expressed in a variety of cortical cell types across development, while IFITM1 RNA expression is most robust in adult cortex (SI Appendix, Fig. 8D).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", annotationLifecycleStage:["developing stage"], citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1274}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 restriction factors are also present. LY6E is expressed in a variety of cortical cell types across development, while IFITM1 RNA expression is most robust in adult cortex (SI Appendix, Fig. 8D).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", annotationLifecycleStage:["adult stage"], citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1520}, properties:{annotationPublicationtype:["Research"], evidence:"According to the Human Protein Atlas, SDC4 expression is highest in the liver, the lung, and the brain, while the heart muscle shows medium and the spleen exhibits modest SDC4 expression (Supplementary Table S1).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Brain", "Liver", "Heart"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationCondition:["Heat-inactivated"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["rna-seq method"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:1522}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with our previous microglial characterization (IHC), qRT-PCR on cell lysates suggested the capture of more immature microglia (Supplementary Fig. 2e) and included viral N gene copies.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1531}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1483}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1532}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1533}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1534}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1535}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:985}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1536}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1537}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1541}, properties:{annotationPublicationtype:["Research"], evidence:"AS-0 cells expressed relatively higher levels of anti-viral ISGs, while AS-3 and AS-4 cells had a proliferative profile and exhibited lower expression levels of GFAP.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:2109}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:844}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:968}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2110}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2111}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:1597}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:1670}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2112}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2113}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2114}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2115}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2116}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2117}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2118}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2119}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2120}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2121}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2122}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2123}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2124}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2125}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2126}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:2127}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2128}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2129}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2130}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2131}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2132}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2133}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2134}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:844}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2111}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2135}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:1817}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2136}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2137}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2138}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2139}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2140}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2141}, properties:{annotationPublicationtype:["Research"], evidence:"There was an upregulation of SASP associated genes, including CCL2, CCL20, CSF1, CXCL11, GDF15, IGF2R, IL1B, IL6ST, IQGAP1, and TNFRSF11B upon SARS-CoV-2 infection in DA neurons (Figure 3C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2133}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed the upregulation of IGFBP7 and downregulation of LMNB1, genes reported to be associated with senescence in DA neurons8,19 (Figure 3G).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2133}, properties:{annotationPublicationtype:["Research"], evidence:"scRNA-seq analysis confirmed the upregulation of IGFBP7 and CDKN1A (encoding protein P21) and downregulation of LMNB1 (Figures 3H and 3I).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["single cell RNA-Seq analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:2147}, properties:{annotationPublicationtype:["Research"], evidence:"scRNA-seq analysis confirmed the upregulation of IGFBP7 and CDKN1A (encoding protein P21) and downregulation of LMNB1 (Figures 3H and 3I).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["single cell RNA-Seq analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:2146}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed a decrease in the senescence-pathway associated gene IGFBP7 and an upregulation of LMNB1 for each of the three drugs (Figure 4J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:2146}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed a decrease in the senescence-pathway associated gene IGFBP7 and an upregulation of LMNB1 for each of the three drugs (Figure 4J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:2146}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed a decrease in the senescence-pathway associated gene IGFBP7 and an upregulation of LMNB1 for each of the three drugs (Figure 4J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2330}, properties:{annotationPublicationtype:["Research"], evidence:"Among the host genes examined, ACTR2 (endosomal entry), ATP6AP2 (spike protein cleavage, endosomal acidification and processing), ERMP1 (ER), and CHST14 (Golgi) showed higher expression levels in ApoE4 astrocytes than that in ApoE3 astrocytes (Figures 3E and 3F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["gene expression assay", "real-time PCR "], annotationCellline:["AG14048 cell"], citationRef:"33450186"}}, {start: {_id:684}, end: {_id:2332}, properties:{annotationPublicationtype:["Research"], evidence:"Among the host genes examined, ACTR2 (endosomal entry), ATP6AP2 (spike protein cleavage, endosomal acidification and processing), ERMP1 (ER), and CHST14 (Golgi) showed higher expression levels in ApoE4 astrocytes than that in ApoE3 astrocytes (Figures 3E and 3F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["gene expression assay", "real-time PCR "], annotationCellline:["AG14048 cell"], citationRef:"33450186"}}, {start: {_id:684}, end: {_id:2335}, properties:{annotationPublicationtype:["Research"], evidence:"Among the host genes examined, ACTR2 (endosomal entry), ATP6AP2 (spike protein cleavage, endosomal acidification and processing), ERMP1 (ER), and CHST14 (Golgi) showed higher expression levels in ApoE4 astrocytes than that in ApoE3 astrocytes (Figures 3E and 3F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["gene expression assay", "real-time PCR "], annotationCellline:["AG14048 cell"], citationRef:"33450186"}}, {start: {_id:684}, end: {_id:2336}, properties:{annotationPublicationtype:["Research"], evidence:"Among the host genes examined, ACTR2 (endosomal entry), ATP6AP2 (spike protein cleavage, endosomal acidification and processing), ERMP1 (ER), and CHST14 (Golgi) showed higher expression levels in ApoE4 astrocytes than that in ApoE3 astrocytes (Figures 3E and 3F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["gene expression assay", "real-time PCR "], annotationCellline:["AG14048 cell"], citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1390}, end: {_id:1387}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1561}, end: {_id:1573}, properties:{annotationPublicationtype:["Research"], evidence:"The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict OSTOX, increased NO production, and decreased Gpx and ANTIOX, whereas increased PBT levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID’s increased OSTOX/ANTIOX ratio.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1561}, end: {_id:1577}, properties:{annotationPublicationtype:["Research"], evidence:"The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict OSTOX, increased NO production, and decreased Gpx and ANTIOX, whereas increased PBT levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID’s increased OSTOX/ANTIOX ratio.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:0}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"Other studies have also linked head injuries to the development of neurodegenerative conditions [26–28].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:48}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Whereas acute neuroinflammation is beneficial to regaining homeostasis and normal function of the CNS after injury or infection, chronic neuroinflammation is damaging to the CNS and may initiate or amplify neurodegeneration associated with HIV-1 encephalitis, AD, or PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Alzheimer Disease", "Parkinson Disease"], annotationDisease:["viral encephalitis"], citationRef:"22315722"}}, {start: {_id:207}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"However, during chronic inflammation, the neurotoxic effects of microglia are proposed to eventually out-compete the neurotrophic effects, thus increasing neurodegeneration.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:261}, properties:{annotationPublicationtype:["Review"], evidence:"Peripheral immune aberrations, particularly in lymphocyte subsets, are abundant in PD patients. Total numbers of lymphocytes have been shown to be diminished by 17%, whereas CD19+ B cells are diminished as much as 35% and CD3+ T cells are diminished by 22%. Among CD3+ T cells, numbers of CD4+ T cells have been shown to be diminished by 31%, whereas numbers of CD8+ T cells are not significantly changed.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"PD pathology is characterized by chronic neuroinflammation, Lewy body inclusions, and loss of dopamine-producing (DA) neurons in the substantia nigra parts compacta (SNpc) of the midbrain [4, 6]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:66}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Many mechanisms of neuronal dysfunction have been implicated in PD pathogenesis, including proteasome-mediated protein degradation, mitochondrial dysfunction, and oxidative stress [28].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:409}, properties:{annotationPublicationtype:["Review"], evidence:"Lymphocytes from PD patients display an increased incidence of micronuclei, single strand DNA breaks, and oxidized purine bases [109]. Interestingly,levodopa treatment seems to reduce this DNA damage in peripheral blood lymphocytes [110].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:71}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"The drug, natalizumab has been successful in the treatment of multiple sclerosis [190].  As an antibody against the alpha 4 integrin, this antibody blocks the recruitment of T cells to sites of inflammation. By blocking activation and recruitment of T cells in PD, neuroinflammation could be dampened to prevent subsequent neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:77}, end: {_id:551}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:77}, end: {_id:48}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:551}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:48}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:562}, end: {_id:551}, properties:{annotationPublicationtype:["Review"], evidence:"However, unmedicated patients with rapid eye movement (REM) sleep behavior disorder, who exhibit a high conversion rate to PD, display similar changes in the gut microbiota.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:314}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, patients with inflammatory bowel disease have a higher incidence of PD [37–40], which is substantially reduced by early exposure to anti-inflammatory anti-tumor necrosis factor therapy.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:576}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Systemic inflammation in PD is reflected by elevated serum IL-6, TNF-α and C-reactive protein, which are associated with severity or faster decline of motor symptoms [41]. In addition, there is an increased risk for PD among people who develop type 2 diabetes, especially at younger ages.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:66}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Strong evidence from preclinical and clinical studies supports a role for mitochondrial dysfunction in PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:589}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Macrophages, monocytes, and neutrophils express high levels of LRRK2, implying that it contributes to defense against pathogens [51]. Therefore, people with LRRK2 variants might be more susceptible to viral or bacterial infections, including ones that have been postulated to trigger PD.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:590}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Macrophages, monocytes, and neutrophils express high levels of LRRK2, implying that it contributes to defense against pathogens [51]. Therefore, people with LRRK2 variants might be more susceptible to viral or bacterial infections, including ones that have been postulated to trigger PD.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:71}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Neuroinflammation has been closely linked with neurodegenerative diseases and is often characterized by the activation of glial cells and the overexpression of pro-inflammatory mediators.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:48}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"However, in PD, activated microglia are believed to have a deleterious effect on neurons and emit harmful levels of cytokines. This induces a vicious, self-propagating chronic neuroinflammatory state that contributes to the neurodegenerative process.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:71}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The role of neuroinflammation in PD is supported by the presence of activated microglia in the substantia nigra of PD patients [68] as well as several pre-clinical studies in PD animal models.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:640}, end: {_id:641}, properties:{annotationPublicationtype:["Review"], evidence:"The main symptoms include but are not restricted to dizziness, headache, impaired consciousness, and seizure [1].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:642}, properties:{annotationPublicationtype:["Review"], evidence:"The main symptoms include but are not restricted to dizziness, headache, impaired consciousness, and seizure [1].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:643}, properties:{annotationPublicationtype:["Review"], evidence:"The main symptoms include but are not restricted to dizziness, headache, impaired consciousness, and seizure [1].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:644}, properties:{annotationPublicationtype:["Review"], evidence:"The main symptoms include but are not restricted to dizziness, headache, impaired consciousness, and seizure [1].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:645}, properties:{annotationPublicationtype:["Review"], evidence:"While on intensive care units, patients showed agitation, confusion, and corticospinal tract signs such as enhanced tendon reflexes and clonus.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:646}, properties:{annotationPublicationtype:["Review"], evidence:"While on intensive care units, patients showed agitation, confusion, and corticospinal tract signs such as enhanced tendon reflexes and clonus.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:648}, properties:{annotationPublicationtype:["Review"], evidence:"While on intensive care units, patients showed agitation, confusion, and corticospinal tract signs such as enhanced tendon reflexes and clonus.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:649}, properties:{annotationPublicationtype:["Review"], evidence:"In mild to moderate disease cases, patients reported olfactory (85.6%) and gustatory (88.0%) dysfunctions.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:650}, properties:{annotationPublicationtype:["Review"], evidence:"In mild to moderate disease cases, patients reported olfactory (85.6%) and gustatory (88.0%) dysfunctions.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Review"], evidence:"Importantly, in about 11% of patients, anosmia occurred prior to any other clinical symptoms.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:652}, properties:{annotationPublicationtype:["Review"], evidence:"COVID-19 can further lead to changes of coagulation and, in particular, to inflammation-induced disseminated intravascular coagulation (DIC).", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:652}, end: {_id:653}, properties:{annotationPublicationtype:["Review"], evidence:"Together with endothelial dysfunction, DIC can cause cerebrovascular ischemia even in young patients, many of whom suffer from large vessel ischemic stroke [4, 5].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:652}, end: {_id:654}, properties:{annotationPublicationtype:["Review"], evidence:"Together with endothelial dysfunction, DIC can cause cerebrovascular ischemia even in young patients, many of whom suffer from large vessel ischemic stroke [4, 5].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:655}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, as sub-acute signs that occurred 3–10 days after the development of Covid-19 symptoms, Guillain-Barré syndrome [8] and Miller-Fisher syndrome [9] cases have been reported. Also, clinically striking are cases of Kawaski-like multisystem inflammatory syndromes now being recognized in children and teenagers.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:656}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, as sub-acute signs that occurred 3–10 days after the development of Covid-19 symptoms, Guillain-Barré syndrome [8] and Miller-Fisher syndrome [9] cases have been reported. Also, clinically striking are cases of Kawaski-like multisystem inflammatory syndromes now being recognized in children and teenagers.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:657}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, as sub-acute signs that occurred 3–10 days after the development of Covid-19 symptoms, Guillain-Barré syndrome [8] and Miller-Fisher syndrome [9] cases have been reported. Also, clinically striking are cases of Kawaski-like multisystem inflammatory syndromes now being recognized in children and teenagers.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:129}, properties:{annotationPublicationtype:["Review"], evidence:"This concern is supported by findings that show that one third of patients at the time of discharge have evidence of cognitive impairment and motor deficits [2].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:658}, properties:{annotationPublicationtype:["Review"], evidence:"This concern is supported by findings that show that one third of patients at the time of discharge have evidence of cognitive impairment and motor deficits [2].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:668}, properties:{annotationPublicationtype:["Review"], evidence:"In keeping with this, the most frequent clinical presentation of COVID-19 is the development of acute respiratory distress syndrome (ARDS) [16], the latter being, along with chronic ventilation, highly associated with subsequent cognitive decline, executive dysfunction, and reduced quality of life, often persisting months and years after hospital discharge [17] reviewed in [18]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:141}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Thus, both peripheral and central induction of the NLRP3 inflammasome can directly induce or aggravate neurodegenerative processes that lead to functional impairment in AD [25] or strongly contribute to the spreading of pathology and thus the progression of the disease.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Encephalopathy has been reported for 93 patients in total, including 16 (7%) of 214 hospitalised patients with COVID-19 in Wuhan, China, and 40 (69%) of 58 patients in intensive care with COVID-19 in France.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:681}, properties:{annotationPublicationtype:["Review"], evidence:"Encephalitis has been described in eight patients to date, and Guillain-Barré syndrome in 19 patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:655}, properties:{annotationPublicationtype:["Review"], evidence:"Encephalitis has been described in eight patients to date, and Guillain-Barré syndrome in 19 patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:41}, properties:{annotationPublicationtype:["Review"], evidence:"Unexpectedly, acute cerebrovascular disease is also emerging as an important complication, with cohort studies reporting stroke in 2–6% of patients hospitalised with COVID-19. So far, 96 patients with stroke have been described, who frequently had vascular events in the context of a pro-inflammatory hypercoagulable state with elevated C-reactive protein, D-dimer, and ferritin.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:685}, properties:{annotationPublicationtype:["Review"], evidence:"As of May 19, 2020, the COVID-19 pandemic, caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 4·8 million confirmed cases worldwide and more than 300000 deaths.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:686}, properties:{annotationPublicationtype:["Review"], evidence:"Although the most common and important presentation is with respiratory disease, reports of neurological features are increasing.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:687}, properties:{annotationPublicationtype:["Review"], evidence:"Although the most common and important presentation is with respiratory disease, reports of neurological features are increasing.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:688}, end: {_id:689}, properties:{annotationPublicationtype:["Review"], evidence:"Both CNS and PNS disease were reported following SARS (appendix pp 2–3). SARS-CoV was detected in CSF by RT-PCR in two of three cases of encephalopathy with seizures,6, 7 and was cultured from brain tissue at autopsy in the third.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:688}, end: {_id:690}, properties:{annotationPublicationtype:["Review"], evidence:"Both CNS and PNS disease were reported following SARS (appendix pp 2–3). SARS-CoV was detected in CSF by RT-PCR in two of three cases of encephalopathy with seizures,6, 7 and was cultured from brain tissue at autopsy in the third.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:688}, end: {_id:692}, properties:{annotationPublicationtype:["Review"], evidence:"Four patients with severe SARS developed neuromuscular disease, predominantly motor neuropathy, myopathy, or both,9 which might have been SARS-specific or secondary to critical illness.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:688}, end: {_id:693}, properties:{annotationPublicationtype:["Review"], evidence:"Four patients with severe SARS developed neuromuscular disease, predominantly motor neuropathy, myopathy, or both,9 which might have been SARS-specific or secondary to critical illness.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:688}, end: {_id:694}, properties:{annotationPublicationtype:["Review"], evidence:"Four patients with severe SARS developed neuromuscular disease, predominantly motor neuropathy, myopathy, or both,9 which might have been SARS-specific or secondary to critical illness.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:695}, end: {_id:689}, properties:{annotationPublicationtype:["Review"], evidence:"CNS involvement was described for five adults with MERS; two had acute disseminated encephalomyelitis, two had cerebrovascular disease, and one had Bickerstaff's brainstem encephalitis. Neuropathy was described in three patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:695}, end: {_id:696}, properties:{annotationPublicationtype:["Review"], evidence:"CNS involvement was described for five adults with MERS; two had acute disseminated encephalomyelitis, two had cerebrovascular disease, and one had Bickerstaff's brainstem encephalitis. Neuropathy was described in three patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:695}, end: {_id:41}, properties:{annotationPublicationtype:["Review"], evidence:"CNS involvement was described for five adults with MERS; two had acute disseminated encephalomyelitis, two had cerebrovascular disease, and one had Bickerstaff's brainstem encephalitis. Neuropathy was described in three patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:695}, end: {_id:697}, properties:{annotationPublicationtype:["Review"], evidence:"CNS involvement was described for five adults with MERS; two had acute disseminated encephalomyelitis, two had cerebrovascular disease, and one had Bickerstaff's brainstem encephalitis. Neuropathy was described in three patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:695}, end: {_id:698}, properties:{annotationPublicationtype:["Review"], evidence:"CNS involvement was described for five adults with MERS; two had acute disseminated encephalomyelitis, two had cerebrovascular disease, and one had Bickerstaff's brainstem encephalitis. Neuropathy was described in three patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:136}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological complications have also been described for other respiratory viruses, particularly seasonal and pandemic influenza.3 These complications include acute necrotising encephalopathy (associated with mutations in the RANBP2 gene), acute infantile encephalopathy, and acute haemorrhagic leukoencephalopathy and myelopathy in adults.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:136}, end: {_id:706}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological complications have also been described for other respiratory viruses, particularly seasonal and pandemic influenza.3 These complications include acute necrotising encephalopathy (associated with mutations in the RANBP2 gene), acute infantile encephalopathy, and acute haemorrhagic leukoencephalopathy and myelopathy in adults.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:136}, end: {_id:707}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological complications have also been described for other respiratory viruses, particularly seasonal and pandemic influenza.3 These complications include acute necrotising encephalopathy (associated with mutations in the RANBP2 gene), acute infantile encephalopathy, and acute haemorrhagic leukoencephalopathy and myelopathy in adults.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:136}, end: {_id:708}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological complications have also been described for other respiratory viruses, particularly seasonal and pandemic influenza.3 These complications include acute necrotising encephalopathy (associated with mutations in the RANBP2 gene), acute infantile encephalopathy, and acute haemorrhagic leukoencephalopathy and myelopathy in adults.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:709}, properties:{annotationPublicationtype:["Review"], evidence:"In one national registry of 125 patients with COVID-19 and neurological or psychiatric disease reported over a 3-week period,25 39 (31%) patients had altered mental status, which included 16 (13%) with encephalopathy (of whom seven [6%] had encephalitis), and 23 (18%) with a neuropsychiatric diagnosis, including ten (8%) with psychosis, six (5%) with neurocognitive (dementia-like) syndrome, and four (3%) with an affective disorder.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationTimeline:["3 week"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"In one national registry of 125 patients with COVID-19 and neurological or psychiatric disease reported over a 3-week period,25 39 (31%) patients had altered mental status, which included 16 (13%) with encephalopathy (of whom seven [6%] had encephalitis), and 23 (18%) with a neuropsychiatric diagnosis, including ten (8%) with psychosis, six (5%) with neurocognitive (dementia-like) syndrome, and four (3%) with an affective disorder.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationTimeline:["3 week"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:681}, properties:{annotationPublicationtype:["Review"], evidence:"In one national registry of 125 patients with COVID-19 and neurological or psychiatric disease reported over a 3-week period,25 39 (31%) patients had altered mental status, which included 16 (13%) with encephalopathy (of whom seven [6%] had encephalitis), and 23 (18%) with a neuropsychiatric diagnosis, including ten (8%) with psychosis, six (5%) with neurocognitive (dementia-like) syndrome, and four (3%) with an affective disorder.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationTimeline:["3 week"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:710}, properties:{annotationPublicationtype:["Review"], evidence:"In one national registry of 125 patients with COVID-19 and neurological or psychiatric disease reported over a 3-week period,25 39 (31%) patients had altered mental status, which included 16 (13%) with encephalopathy (of whom seven [6%] had encephalitis), and 23 (18%) with a neuropsychiatric diagnosis, including ten (8%) with psychosis, six (5%) with neurocognitive (dementia-like) syndrome, and four (3%) with an affective disorder.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationTimeline:["3 week"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:711}, properties:{annotationPublicationtype:["Review"], evidence:"In one national registry of 125 patients with COVID-19 and neurological or psychiatric disease reported over a 3-week period,25 39 (31%) patients had altered mental status, which included 16 (13%) with encephalopathy (of whom seven [6%] had encephalitis), and 23 (18%) with a neuropsychiatric diagnosis, including ten (8%) with psychosis, six (5%) with neurocognitive (dementia-like) syndrome, and four (3%) with an affective disorder.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationTimeline:["3 week"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:712}, properties:{annotationPublicationtype:["Review"], evidence:"In one national registry of 125 patients with COVID-19 and neurological or psychiatric disease reported over a 3-week period,25 39 (31%) patients had altered mental status, which included 16 (13%) with encephalopathy (of whom seven [6%] had encephalitis), and 23 (18%) with a neuropsychiatric diagnosis, including ten (8%) with psychosis, six (5%) with neurocognitive (dementia-like) syndrome, and four (3%) with an affective disorder.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationTimeline:["3 week"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:713}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, 77 (62%) patients had a cerebrovascular event: 57 (46%) ischaemic strokes, nine (7%) intracerebral haemorrhages, one (<1%) CNS vasculitis, and ten (8%) other cerebrovascular events.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:714}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, 77 (62%) patients had a cerebrovascular event: 57 (46%) ischaemic strokes, nine (7%) intracerebral haemorrhages, one (<1%) CNS vasculitis, and ten (8%) other cerebrovascular events.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:715}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, 77 (62%) patients had a cerebrovascular event: 57 (46%) ischaemic strokes, nine (7%) intracerebral haemorrhages, one (<1%) CNS vasculitis, and ten (8%) other cerebrovascular events.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:716}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, 77 (62%) patients had a cerebrovascular event: 57 (46%) ischaemic strokes, nine (7%) intracerebral haemorrhages, one (<1%) CNS vasculitis, and ten (8%) other cerebrovascular events.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:681}, properties:{annotationPublicationtype:["Review"], annotationAgeGroup:["24–78 years"], evidence:"As of May 19, 2020, eight adults aged 24–78 years (median 62 [IQR 40–70]), including four women, have been described with encephalitis associated with COVID-19,mostly diagnosed through a nasal or nasopharyngeal swab.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:121}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:681}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:718}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:646}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:719}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:644}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:701}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:710}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had fever only, with no respiratory features.The neurological manifestations were typical for encephalitis, with irritability, confusion, and reduced consciousness, sometimes associated with seizures; three patients also had neck stiffness31, 58, 59 and another had psychotic symptoms.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:720}, properties:{annotationPublicationtype:["Review"], evidence:"A man aged 40 years developed ataxia, oscillopsia, hiccups, and bilateral facial weakness.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], annotationAge:["40 years"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:721}, properties:{annotationPublicationtype:["Review"], evidence:"A man aged 40 years developed ataxia, oscillopsia, hiccups, and bilateral facial weakness.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], annotationAge:["40 years"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:722}, properties:{annotationPublicationtype:["Review"], evidence:"A man aged 40 years developed ataxia, oscillopsia, hiccups, and bilateral facial weakness.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], annotationAge:["40 years"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:723}, properties:{annotationPublicationtype:["Review"], evidence:"A man aged 40 years developed ataxia, oscillopsia, hiccups, and bilateral facial weakness.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], annotationAge:["40 years"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:703}, properties:{annotationPublicationtype:["Review"], evidence:"CSF analysis was reported for six patients; it showed a pleiocytosis in five, mostly lymphocytic, and was normal in one patient.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], annotationSpecimen:["cerebrospinal fluid specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:704}, properties:{annotationPublicationtype:["Review"], evidence:"Brain imaging was normal or had no acute changes for six patients, and showed high signal intensity in two, including temporal lobe changes in one (figure 2A, B );31 the patient with ataxia had a cerebellar lesion that extended into the spinal cord.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:724}, properties:{annotationPublicationtype:["Review"], evidence:"Brain imaging was normal or had no acute changes for six patients, and showed high signal intensity in two, including temporal lobe changes in one (figure 2A, B );31 the patient with ataxia had a cerebellar lesion that extended into the spinal cord.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Ataxia"], annotationBioassay:["imaging method"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:641}, properties:{annotationPublicationtype:["Review"], evidence:"The largest study to date,36 from Wuhan, China, retrospectively described 214 patients with COVID-19, of whom 53 (25%) had CNS symptoms, including dizziness (36 [17%] patients), headache (28 [13%]), and impaired consciousness (16 [7%]).", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:700}, properties:{annotationPublicationtype:["Review"], evidence:"The largest study to date,36 from Wuhan, China, retrospectively described 214 patients with COVID-19, of whom 53 (25%) had CNS symptoms, including dizziness (36 [17%] patients), headache (28 [13%]), and impaired consciousness (16 [7%]).", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:719}, properties:{annotationPublicationtype:["Review"], evidence:"The largest study to date,36 from Wuhan, China, retrospectively described 214 patients with COVID-19, of whom 53 (25%) had CNS symptoms, including dizziness (36 [17%] patients), headache (28 [13%]), and impaired consciousness (16 [7%]).", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:686}, properties:{annotationPublicationtype:["Review"], evidence:"27 (51%) of the patients with CNS symptoms had severe respiratory disease, but there was little further detail.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["central nervous system disease", "COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"In a French series of 58 intensive care patients with COVID-19,35 49 (84%) had neurological complications, including 40 (69%) with encephalopathy and 39 (67%) with corticospinal tract signs.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:725}, properties:{annotationPublicationtype:["Review"], evidence:"In a French series of 58 intensive care patients with COVID-19,35 49 (84%) had neurological complications, including 40 (69%) with encephalopathy and 39 (67%) with corticospinal tract signs.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:726}, properties:{annotationPublicationtype:["Review"], evidence:"MRI in 13 patients showed leptomeningeal enhancement for eight and acute ischaemic change for two; CSF examination for seven patients showed no pleiocytosis.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:2}, properties:{annotationPublicationtype:["Review"], evidence:"MRI in 13 patients showed leptomeningeal enhancement for eight and acute ischaemic change for two; CSF examination for seven patients showed no pleiocytosis.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, some case reports have appeared, including a woman with encephalopathy with imaging changes consistent with acute necrotising encephalopathy (figure 2C, D)37 and a fatal case in which viral particles were found in endothelial cells and neural tissue, although there was no indication of whether this was associated with inflammation.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:644}, properties:{annotationPublicationtype:["Review"], evidence:"Several reports have described seizures in children with SARS-CoV-2 infection.", annotationAgeGroup:["children"], citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:696}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis is a syndrome of multifocal demyelination, typically occurring weeks after an infection, which generally presents with focal neurological symptoms, often with encephalopathy.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:696}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis is a syndrome of multifocal demyelination, typically occurring weeks after an infection, which generally presents with focal neurological symptoms, often with encephalopathy.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:696}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:731}, properties:{annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationTimeline:["9 days"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:732}, properties:{annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationTimeline:["9 days"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationTimeline:["9 days"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:700}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:733}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:719}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:644}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:734}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Two case reports, describe middle-aged women with acute disseminated encephalomyelitis and SARS-CoV-2 detected on respiratory swabs. One developed dysphagia, dysarthria, and encephalopathy 9 days after the onset of headache and myalgia (figure 1).41 The other presented with seizures and reduced consciousness, and required intubation for respiratory failure.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:696}, end: {_id:704}, properties:{annotationPublicationtype:["Review"], evidence:"Both patients had normal CSF and high signal intensities on MRI, typical of acute disseminated encephalomyelitis.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:735}, properties:{annotationPublicationtype:["Review"], evidence:"To date, a single report exists of myelitis (inflammation of the spinal cord; appendix p 8) associated with COVID-19. A man aged 66 years in Wuhan, China, developed fever, fatigue, and then acute flaccid paraparesis with incontinence.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:121}, properties:{annotationPublicationtype:["Review"], evidence:"To date, a single report exists of myelitis (inflammation of the spinal cord; appendix p 8) associated with COVID-19. A man aged 66 years in Wuhan, China, developed fever, fatigue, and then acute flaccid paraparesis with incontinence.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:736}, properties:{annotationPublicationtype:["Review"], evidence:"To date, a single report exists of myelitis (inflammation of the spinal cord; appendix p 8) associated with COVID-19. A man aged 66 years in Wuhan, China, developed fever, fatigue, and then acute flaccid paraparesis with incontinence.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:737}, properties:{annotationPublicationtype:["Review"], evidence:"To date, a single report exists of myelitis (inflammation of the spinal cord; appendix p 8) associated with COVID-19. A man aged 66 years in Wuhan, China, developed fever, fatigue, and then acute flaccid paraparesis with incontinence.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:738}, properties:{annotationPublicationtype:["Review"], evidence:"Examination showed hyporeflexia and a sensory level at T10. He was treated with dexamethasone and intravenous immunoglobulin, and was discharged for rehabilitation.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:696}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis and myelitis, usually considered post-infectious diseases, are treated typically with corticosteroids or other immunotherapies.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:735}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis and myelitis, usually considered post-infectious diseases, are treated typically with corticosteroids or other immunotherapies.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:655}, end: {_id:741}, properties:{annotationPublicationtype:["Review"], evidence:"Guillain-Barré syndrome is an acute polyradiculopathy characterised by rapidly progressive, symmetrical limb weakness, areflexia on examination, sensory symptoms, and, in some patients, facial weakness, although several variants exist (appendix p 9).", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:655}, end: {_id:742}, properties:{annotationPublicationtype:["Review"], evidence:"Guillain-Barré syndrome is an acute polyradiculopathy characterised by rapidly progressive, symmetrical limb weakness, areflexia on examination, sensory symptoms, and, in some patients, facial weakness, although several variants exist (appendix p 9).", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:655}, end: {_id:743}, properties:{annotationPublicationtype:["Review"], evidence:"Guillain-Barré syndrome is an acute polyradiculopathy characterised by rapidly progressive, symmetrical limb weakness, areflexia on examination, sensory symptoms, and, in some patients, facial weakness, although several variants exist (appendix p 9).", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:655}, end: {_id:723}, properties:{annotationPublicationtype:["Review"], evidence:"Guillain-Barré syndrome is an acute polyradiculopathy characterised by rapidly progressive, symmetrical limb weakness, areflexia on examination, sensory symptoms, and, in some patients, facial weakness, although several variants exist (appendix p 9).", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:655}, end: {_id:121}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological symptoms started at a median of 7 days (range −7 to 24) after respiratory or systemic features (figure 1), although two patients developed febrile illness 7 days after the onset of Guillain-Barré syndrome;45, 68 on hospital admission, one had a positive swab for SARS-CoV-2 and the other had lymphocytopenia and thrombocytopenia, which are characteristic for SARS-CoV-2 infection.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:744}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological symptoms started at a median of 7 days (range −7 to 24) after respiratory or systemic features (figure 1), although two patients developed febrile illness 7 days after the onset of Guillain-Barré syndrome;45, 68 on hospital admission, one had a positive swab for SARS-CoV-2 and the other had lymphocytopenia and thrombocytopenia, which are characteristic for SARS-CoV-2 infection.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:498}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological symptoms started at a median of 7 days (range −7 to 24) after respiratory or systemic features (figure 1), although two patients developed febrile illness 7 days after the onset of Guillain-Barré syndrome;45, 68 on hospital admission, one had a positive swab for SARS-CoV-2 and the other had lymphocytopenia and thrombocytopenia, which are characteristic for SARS-CoV-2 infection.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:745}, properties:{annotationPublicationtype:["Review"], evidence:"Three patients had diarrhoea before the onset of neurological disease.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:655}, properties:{annotationPublicationtype:["Review"], evidence:"11 patients had Guillain-Barré syndrome with weakness of all four limbs with or without sensory loss,43, 44, 45, 69, 70, 71, 72, 73, 74 three had a paraparetic variant with leg weakness only,44, 68, 75 and one had lower limb paraesthesia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:655}, end: {_id:741}, properties:{annotationPublicationtype:["Review"], evidence:"11 patients had Guillain-Barré syndrome with weakness of all four limbs with or without sensory loss,43, 44, 45, 69, 70, 71, 72, 73, 74 three had a paraparetic variant with leg weakness only,44, 68, 75 and one had lower limb paraesthesia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:655}, end: {_id:743}, properties:{annotationPublicationtype:["Review"], evidence:"11 patients had Guillain-Barré syndrome with weakness of all four limbs with or without sensory loss,43, 44, 45, 69, 70, 71, 72, 73, 74 three had a paraparetic variant with leg weakness only,44, 68, 75 and one had lower limb paraesthesia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:731}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:734}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:747}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:748}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:749}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:750}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:655}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:751}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:720}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:742}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:753}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:754}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:755}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:756}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:757}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:761}, properties:{annotationPublicationtype:["Review"], evidence:"Muscle injury associated with raised creatine kinase affected 23 (11%) of 214 patients in the Wuhan series. Rhabdomyolysis due to COVID-19 has also been reported.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Review"], evidence:"Loss of smell (anosmia) and taste (ageusia) have emerged as common symptoms of COVID-19, either with other features or in isolation, suggesting that they might be useful diagnostic markers.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:753}, properties:{annotationPublicationtype:["Review"], evidence:"Loss of smell (anosmia) and taste (ageusia) have emerged as common symptoms of COVID-19, either with other features or in isolation, suggesting that they might be useful diagnostic markers.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:649}, properties:{annotationPublicationtype:["Review"], evidence:"In a European study,50 olfactory dysfunction was reported for 357 (86%) of 417 COVID-19 patients; 342 (82%) reported gustatory disorders.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:762}, properties:{annotationPublicationtype:["Review"], evidence:"In a European study,50 olfactory dysfunction was reported for 357 (86%) of 417 COVID-19 patients; 342 (82%) reported gustatory disorders.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:714}, properties:{annotationPublicationtype:["Review"], evidence:"Cerebrovascular manifestations were reported for 13 (6%) of 221 COVID-19 patients in an early retrospective case series from Wuhan:53 11 (5%) patients developed ischaemic stroke, one (<1%) had intracerebral haemorrhage, and one (<1%) had cerebral venous sinus thrombosis.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:763}, properties:{annotationPublicationtype:["Review"], evidence:"Cerebrovascular manifestations were reported for 13 (6%) of 221 COVID-19 patients in an early retrospective case series from Wuhan:53 11 (5%) patients developed ischaemic stroke, one (<1%) had intracerebral haemorrhage, and one (<1%) had cerebral venous sinus thrombosis.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:764}, properties:{annotationPublicationtype:["Review"], evidence:"Cerebrovascular manifestations were reported for 13 (6%) of 221 COVID-19 patients in an early retrospective case series from Wuhan:53 11 (5%) patients developed ischaemic stroke, one (<1%) had intracerebral haemorrhage, and one (<1%) had cerebral venous sinus thrombosis.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:714}, properties:{annotationPublicationtype:["Review"], evidence:"In total, 88 patients with ischaemic stroke and eight with haemorrhagic stroke53, 54, 56, 77, 93 have been reported, 18 (19%) of whom died.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:765}, properties:{annotationPublicationtype:["Review"], evidence:"In total, 88 patients with ischaemic stroke and eight with haemorrhagic stroke53, 54, 56, 77, 93 have been reported, 18 (19%) of whom died.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:714}, properties:{annotationPublicationtype:["Review"], evidence:"In two patients, ischaemic stroke has been associated with thrombus in the aorta,95, 96 and indeed multiple infarcts have been reported in these and other patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:714}, end: {_id:766}, properties:{annotationPublicationtype:["Review"], evidence:"In two patients, ischaemic stroke has been associated with thrombus in the aorta,95, 96 and indeed multiple infarcts have been reported in these and other patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Aorta"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:767}, properties:{annotationPublicationtype:["Review"], evidence:"In two patients, ischaemic stroke has been associated with thrombus in the aorta,95, 96 and indeed multiple infarcts have been reported in these and other patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:81}, end: {_id:769}, properties:{annotationPublicationtype:["Review"], evidence:"Concurrent deep vein thrombosis and pulmonary embolism have been found in other stroke patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Review"], evidence:"Viral entry to the brain through the olfactory bulb—the only part of the CNS not protected by dura—is one plausible route for SARS-CoV-2, especially given the anosmia in COVID-19.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Autopsy material from a patient who developed encephalopathy weeks after presenting with SARS showed oedema, neuronal necrosis, and broad gliocyte hyperplasia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:680}, end: {_id:777}, properties:{annotationPublicationtype:["Review"], evidence:"Autopsy material from a patient who developed encephalopathy weeks after presenting with SARS showed oedema, neuronal necrosis, and broad gliocyte hyperplasia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:680}, end: {_id:778}, properties:{annotationPublicationtype:["Review"], evidence:"Autopsy material from a patient who developed encephalopathy weeks after presenting with SARS showed oedema, neuronal necrosis, and broad gliocyte hyperplasia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:680}, end: {_id:779}, properties:{annotationPublicationtype:["Review"], evidence:"Autopsy material from a patient who developed encephalopathy weeks after presenting with SARS showed oedema, neuronal necrosis, and broad gliocyte hyperplasia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationCell:["glial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:81}, end: {_id:498}, properties:{annotationPublicationtype:["Review"], evidence:"Thrombocytopenia with elevated D-dimer and C-reactive protein in severe COVID-19 and stroke are consistent with a virus-associated microangiopathic process.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:498}, properties:{annotationPublicationtype:["Review"], evidence:"Thrombocytopenia with elevated D-dimer and C-reactive protein in severe COVID-19 and stroke are consistent with a virus-associated microangiopathic process.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:653}, end: {_id:38}, properties:{annotationPublicationtype:["Review"], evidence:"Endothelial dysfunction can potentially lead to microvascular and macrovascular complications in the brain, as described systemically.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:748}, end: {_id:685}, properties:{annotationPublicationtype:["Research"], evidence:"Hypertension (four [40%] patients) and chronic obstructive pulmonary disease (three [30%]) were the most common contributing factors to death according to MCCD", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"32844161", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32844161"}}, {start: {_id:786}, end: {_id:685}, properties:{annotationPublicationtype:["Research"], evidence:"Hypertension (four [40%] patients) and chronic obstructive pulmonary disease (three [30%]) were the most common contributing factors to death according to MCCD", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"32844161", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32844161"}}, {start: {_id:640}, end: {_id:121}, properties:{annotationPublicationtype:["Research"], evidence:"All ten patients developed fever and had at least two respiratory symptoms or signs (cough, shortness of breath, reduced oxygen saturations, or pleuritic chest pain) during their early presentation.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"32844161", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32844161"}}, {start: {_id:640}, end: {_id:787}, properties:{annotationPublicationtype:["Research"], evidence:"All ten patients developed fever and had at least two respiratory symptoms or signs (cough, shortness of breath, reduced oxygen saturations, or pleuritic chest pain) during their early presentation.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"32844161", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32844161"}}, {start: {_id:640}, end: {_id:788}, properties:{annotationPublicationtype:["Research"], evidence:"All ten patients developed fever and had at least two respiratory symptoms or signs (cough, shortness of breath, reduced oxygen saturations, or pleuritic chest pain) during their early presentation.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"32844161", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32844161"}}, {start: {_id:640}, end: {_id:790}, properties:{annotationPublicationtype:["Research"], evidence:"All ten patients developed fever and had at least two respiratory symptoms or signs (cough, shortness of breath, reduced oxygen saturations, or pleuritic chest pain) during their early presentation.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"32844161", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32844161"}}, {start: {_id:640}, end: {_id:1}, properties:{annotationPublicationtype:["Research"], evidence:"Of eight patients assessed for inflammatory markers, all (100%) had elevated inflammatory markers.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:685}, properties:{annotationPublicationtype:["Research"], evidence:"Most patients died within 3 weeks of symptom onset (seven [70%] patients) and were not intubated or ventilated (six [60%] patients).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:791}, properties:{annotationPublicationtype:["Research"], evidence:"All patients had DAD: six showed purely exudative phase DAD and four showed a mixture of exudative and organising DAD (appendix p 22, figure 1 ). Three of four patients with organising-phase DAD had spent a substantial period on a ventilator (6 days, 12 days, and >20 days).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:1}, properties:{annotationPublicationtype:["Research"], evidence:"Florid acute bronchopneumonia and ventilator-associated pneumonia were not noted in this series, although mild interstitial neutrophilic inflammation (three [30%] of ten patients) and patchy acute bronchopneumonia (three [30%] patients) were observed. Interstitial macrophages were prominent.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:792}, properties:{annotationPublicationtype:["Research"], evidence:"Florid acute bronchopneumonia and ventilator-associated pneumonia were not noted in this series, although mild interstitial neutrophilic inflammation (three [30%] of ten patients) and patchy acute bronchopneumonia (three [30%] patients) were observed. Interstitial macrophages were prominent.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:1}, properties:{annotationPublicationtype:["Research"], evidence:"Mild or moderate lymphocyte inflammation was present in all ten patients, although focal lymphocyte cuffing of small vessels was noted in six patients (60%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lymphocytes"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:794}, properties:{annotationPublicationtype:["Research"], evidence:"Chronic bronchiolitis was seen in most patients (nine [90%] of ten). No granulomas or viral inclusion were seen. Invasive mucormycosis was noted in one patient (PM5, figure 1) and confirmed with Mucorales-specific PCR. The mucormycosis was vasculocentric and disseminated, involving the hilar lymph nodes, heart, brain, and kidney in the same patient.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:795}, properties:{annotationPublicationtype:["Research"], evidence:"Chronic bronchiolitis was seen in most patients (nine [90%] of ten). No granulomas or viral inclusion were seen. Invasive mucormycosis was noted in one patient (PM5, figure 1) and confirmed with Mucorales-specific PCR. The mucormycosis was vasculocentric and disseminated, involving the hilar lymph nodes, heart, brain, and kidney in the same patient.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lymph Nodes", "Brain", "Kidney", "Heart"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["polymerase chain reaction"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:769}, properties:{annotationPublicationtype:["Research"], evidence:"Macroscopic (two [23%] of nine patients) and microscopic (eight [89%] of nine) pulmonary thromboemboli were frequent observations", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:796}, properties:{annotationPublicationtype:["Research"], evidence:"Very focal lymphocytic vasculitis was identified in one patient.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Research"], evidence:"Thrombotic features were universal in this cohort and all nine patients who underwent a full autopsy had at least one micro-thrombosis or macro-thrombosis in a major organ.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:798}, properties:{annotationPublicationtype:["Research"], evidence:" One (11%) of nine patients had a macroscopic acute coronary thrombosis in the right coronary artery, whereas five patients (56%) had thrombi in the microcirculation of the heart on histological analysis. ", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSpecies:["9606"], annotationSection:["Results"], annotationDiseaseSeverity:["Severe"], annotationAnatomy:["right coronary artery"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Research"], evidence:" One (11%) of nine patients had a macroscopic acute coronary thrombosis in the right coronary artery, whereas five patients (56%) had thrombi in the microcirculation of the heart on histological analysis. ", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:801}, properties:{annotationPublicationtype:["Research"], evidence:" A single patient (11%) had a right atrial thrombus. Pericarditis was identified in two patients (22%); one patient showed florid fibrinous pericarditis containing fungal hyphae (PM5), while the other showed only microscopic acute pericarditis (appendix p 22, figure 3 ).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:802}, properties:{annotationPublicationtype:["Research"], evidence:"The median heart weight was high (450 g) and four (44%) of nine patients had left ventricular hypertrophy.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:803}, properties:{annotationPublicationtype:["Research"], evidence:"Non-bacterial thrombotic (marantic) endocarditis was noted in one patient (PM5) with no known history or autopsy findings consistent with malignancy or chronic disorder associated with non-bacterial thrombotic (marantic) endocarditis (appendix p 22, figure 2).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:795}, properties:{annotationPublicationtype:["Research"], evidence:"PM5 had disseminated mucormycosis and numerous other thrombotic features (appendix p 3). Cardiac amyloidosis and right atrial thrombosis were identified in one (10%) of ten patients (PM8; appendix p 28).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:678}, properties:{annotationPublicationtype:["Research"], evidence:"PM5 had disseminated mucormycosis and numerous other thrombotic features (appendix p 3). Cardiac amyloidosis and right atrial thrombosis were identified in one (10%) of ten patients (PM8; appendix p 28).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Research"], evidence:"PM5 had disseminated mucormycosis and numerous other thrombotic features (appendix p 3). Cardiac amyloidosis and right atrial thrombosis were identified in one (10%) of ten patients (PM8; appendix p 28).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSpecies:["9606"], annotationSection:["Results"], annotationDiseaseSeverity:["Severe"], annotationAnatomy:["cavity of right atrium"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:804}, properties:{annotationPublicationtype:["Research"], evidence:"Bone marrow haemophagocytosis was prominent in two patients (PM4 and PM8) and focal in two patients (PM7 and PM9).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Bone Marrow"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:779}, properties:{annotationPublicationtype:["Research"], evidence:"Bone marrow samples showed reactive changes with trilineage hyperplasia, and prominence of plasma cells and histiocytes were a common finding.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Bone Marrow"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:809}, properties:{annotationPublicationtype:["Research"], evidence:"Pancreatitis was noted in two (25%) of eight patients. PM5 was a 22-year-old man with frank necrotic-haemorrhagic pancreatitis and secondary mucormycosis (figure 3).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:795}, properties:{annotationPublicationtype:["Research"], evidence:"Pancreatitis was noted in two (25%) of eight patients. PM5 was a 22-year-old man with frank necrotic-haemorrhagic pancreatitis and secondary mucormycosis (figure 3).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:778}, properties:{annotationPublicationtype:["Research"], evidence:"A third of patients (three [33%] of nine) showed patchy areas of infarct-type adrenocortical necrosis, with one patient showing organising microthrombi in adrenal vessels (figure 3).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Adrenal Cortex"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:766}, properties:{annotationPublicationtype:["Research"], evidence:"A third of patients (three [33%] of nine) showed patchy areas of infarct-type adrenocortical necrosis, with one patient showing organising microthrombi in adrenal vessels (figure 3).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:810}, properties:{annotationPublicationtype:["Research"], evidence:"Salient renal pathology findings were acute tubular injury in all nine patients, underlying moderate cortical scarring of uncertain cause in one patient (11%), glomerular microaneurysm and thrombi in one patient (11%; figure 2), and rare thrombi in interlobular arteries in four patients (44%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:766}, properties:{annotationPublicationtype:["Research"], evidence:"Salient renal pathology findings were acute tubular injury in all nine patients, underlying moderate cortical scarring of uncertain cause in one patient (11%), glomerular microaneurysm and thrombi in one patient (11%; figure 2), and rare thrombi in interlobular arteries in four patients (44%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:811}, properties:{annotationPublicationtype:["Research"], evidence:"Salient renal pathology findings were acute tubular injury in all nine patients, underlying moderate cortical scarring of uncertain cause in one patient (11%), glomerular microaneurysm and thrombi in one patient (11%; figure 2), and rare thrombi in interlobular arteries in four patients (44%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney Glomerulus"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:812}, properties:{annotationPublicationtype:["Research"], evidence:"PM6 (24-year-old man) had a higher degree of arterial intimal thickening than expected for that age.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:813}, properties:{annotationPublicationtype:["Research"], evidence:"Large droplet fatty change was seen in most patients (seven [88%] of eight). Cirrhosis or bridging hepatic fibrosis were noted in three patients (38%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:814}, properties:{annotationPublicationtype:["Research"], evidence:"Large droplet fatty change was seen in most patients (seven [88%] of eight). Cirrhosis or bridging hepatic fibrosis were noted in three patients (38%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:815}, properties:{annotationPublicationtype:["Research"], evidence:"Large droplet fatty change was seen in most patients (seven [88%] of eight). Cirrhosis or bridging hepatic fibrosis were noted in three patients (38%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:816}, properties:{annotationPublicationtype:["Research"], evidence:"No liver thrombosis was identified histologically, but one patient showed macroscopic liver infarction (figure 2).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:817}, properties:{annotationPublicationtype:["Research"], evidence:"The median liver weight was 1432 g (IQR 1012–2466) and three (33%) of nine patients showed hepatomegaly (liver weighing >2000 g). ", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:763}, properties:{annotationPublicationtype:["Research"], evidence:"However, no necrosis of brain tissue or extensive infiltration of inflammatory cells in brain parenchyma or meninges was observed on histological examination, although one (11%) of nine patients showed macroscopic haemorrhagic transformation in a large recent cerebral infarction in the distribution of the middle cerebral artery.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:864}, end: {_id:685}, properties:{annotationPublicationtype:["Research"], evidence:"Cause of death was mainly attributed to the respiratory system, with  viral pneumonia as the underlying condition in most cases(table).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"33031735", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:865}, properties:{annotationPublicationtype:["Research"], evidence:"The mean weight of the unfixed brains was 1302 g(SD 171; median 1270 g  [1195–1438]; range 950–1665; table) with 23 patients (53%) showing  signs of mild to moderate brain oedema, commonly seen as unspecific  agonal changes.", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationDiseaseSeverity:["mild to moderate"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:812}, properties:{annotationPublicationtype:["Research"], evidence:"Arteriosclerosis of the basal vessels was mild in 12 (28%) patients,  moderate in 22 (51%), and severe in nine (21%; table).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationDiseaseSeverity:["moderate", "mild", "severe"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:2}, properties:{annotationPublicationtype:["Research"], evidence:"13 brains (30%) showed gross macroscopic abnormalities (fresh  territorial ischaemic lesions in six patients, older territorial  ischaemic lesions in five patients, grey matter heterotopia in one  patient with trisomy 21, and cerebellar metastasis of a non-small cell  lung carcinoma in one patient; table).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:867}, properties:{annotationPublicationtype:["Research"], evidence:"13 brains (30%) showed gross macroscopic abnormalities (fresh  territorial ischaemic lesions in six patients, older territorial  ischaemic lesions in five patients, grey matter heterotopia in one  patient with trisomy 21, and cerebellar metastasis of a non-small cell  lung carcinoma in one patient; table).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Down Syndrome"], annotationMeshanatomy:["Brain", "Gray Matter"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:868}, properties:{annotationPublicationtype:["Research"], evidence:"13 brains (30%) showed gross macroscopic abnormalities (fresh  territorial ischaemic lesions in six patients, older territorial  ischaemic lesions in five patients, grey matter heterotopia in one  patient with trisomy 21, and cerebellar metastasis of a non-small cell  lung carcinoma in one patient; table).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Carcinoma, Non-Small-Cell Lung"], annotationMeshanatomy:["Brain", "Cerebellum"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:869}, properties:{annotationPublicationtype:["Research"], evidence:"Six (14%) patients had fresh ischaemic infarctions: three in the  territory of the posterior cerebral artery, two in the territory of  the anterior cerebral artery, and one in the territory of the middle  cerebral artery, which were most likely due to thromboembolic events.", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:870}, properties:{annotationPublicationtype:["Research"], evidence:"Six (14%) patients had fresh ischaemic infarctions: three in the  territory of the posterior cerebral artery, two in the territory of  the anterior cerebral artery, and one in the territory of the middle  cerebral artery, which were most likely due to thromboembolic events.", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:871}, properties:{annotationPublicationtype:["Research"], evidence:"Six (14%) patients had fresh ischaemic infarctions: three in the  territory of the posterior cerebral artery, two in the territory of  the anterior cerebral artery, and one in the territory of the middle  cerebral artery, which were most likely due to thromboembolic events.", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:872}, properties:{annotationPublicationtype:["Research"], evidence:"A highly variable degree of astrogliosis was seen in all patients,  with 37 patients (86%) showing astrogliosis in all assessed regions.", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:872}, properties:{annotationPublicationtype:["Research"], evidence:"The olfactory bulb showed a high degree of astrogliosis and  microgliosis, but only minor infiltration by cytotoxic T  lymphocytes(figures 1, 4).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Olfactory Bulb"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:1}, properties:{annotationPublicationtype:["Research"], evidence:"Cases 2, 16, 21, and 41 showed more brainstem inflammation(in terms of  infiltration by cytotoxic CD8-positive T cells or activation of  microglia) than all others (figure 4).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain Stem"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:905}, properties:{annotationPublicationtype:["Research"], evidence:"In line with recent clinical data demonstrating thromboembolic CNS events in a few individuals with COVID-19 (ref. 31), we found in 18% of the 33 individuals investigated (n=6 of 33) a histopathological correlate of microthrombosis and subsequent acute territorial brain infarcts (Fig. 6a–c and Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunofluorescent labeling"], source:"wp4-cbm-comorbidity", pmid:"33257876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33257876"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:36}, properties:{annotationPublicationtype:["Research"], evidence:"In line with recent clinical data demonstrating thromboembolic CNS events in a few individuals with COVID-19 (ref. 31), we found in 18% of the 33 individuals investigated (n=6 of 33) a histopathological correlate of microthrombosis and subsequent acute territorial brain infarcts (Fig. 6a–c and Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunofluorescent labeling"], source:"wp4-cbm-comorbidity", pmid:"33257876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:905}, properties:{annotationPublicationtype:["Research"], evidence:"As shown for the CNS, microthromboembolic events were also detectable in the olfactory mucosa in one individual.", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Olfactory Mucosa"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:906}, properties:{annotationPublicationtype:["Research"], evidence:"The hematoxylin and eosin findings revealed two differences: 1) Microvessels of the brain of COVID-19 patients showed perivascular edema as defined by a zone of edema at least 50 μm in size around a capillary. 2) Less commonly, microvessels in the COVID-19 cases had endothelial cells that were degenerated, mummified, and detached, showed focal basement membrane duplication, and/or microthrombi.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationTechnique:["Hematoxylin and eosin staining"], citationRef:"33360731"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Review"], evidence:"It is now apparent that SARS-CoV-2 infection induces a prothrombotic state manifesting especially with microthrombosis3,4, as observed in patients with COVID-19 and in post-mortem samples from individuals who died after SARS-CoV-2 infection5–9.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:121}, properties:{annotationPublicationtype:["Review"], evidence:"After approximately 7–10days of symptoms(including fever, cough, fatigue, anorexia and myalgias), a subgroup of patients progresses to severe disease and develops hypoxaemia (low oxygen levels in the blood) and dyspnoea (shortness of breath), potentially evolving towards ARDS.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:787}, properties:{annotationPublicationtype:["Review"], evidence:"After approximately 7–10days of symptoms(including fever, cough, fatigue, anorexia and myalgias), a subgroup of patients progresses to severe disease and develops hypoxaemia (low oxygen levels in the blood) and dyspnoea (shortness of breath), potentially evolving towards ARDS.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:736}, properties:{annotationPublicationtype:["Review"], evidence:"After approximately 7–10days of symptoms(including fever, cough, fatigue, anorexia and myalgias), a subgroup of patients progresses to severe disease and develops hypoxaemia (low oxygen levels in the blood) and dyspnoea (shortness of breath), potentially evolving towards ARDS.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:997}, properties:{annotationPublicationtype:["Review"], evidence:"After approximately 7–10days of symptoms(including fever, cough, fatigue, anorexia and myalgias), a subgroup of patients progresses to severe disease and develops hypoxaemia (low oxygen levels in the blood) and dyspnoea (shortness of breath), potentially evolving towards ARDS.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:733}, properties:{annotationPublicationtype:["Review"], evidence:"After approximately 7–10days of symptoms(including fever, cough, fatigue, anorexia and myalgias), a subgroup of patients progresses to severe disease and develops hypoxaemia (low oxygen levels in the blood) and dyspnoea (shortness of breath), potentially evolving towards ARDS.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:998}, properties:{annotationPublicationtype:["Review"], evidence:"After approximately 7–10days of symptoms(including fever, cough, fatigue, anorexia and myalgias), a subgroup of patients progresses to severe disease and develops hypoxaemia (low oxygen levels in the blood) and dyspnoea (shortness of breath), potentially evolving towards ARDS.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:788}, properties:{annotationPublicationtype:["Review"], evidence:"After approximately 7–10days of symptoms(including fever, cough, fatigue, anorexia and myalgias), a subgroup of patients progresses to severe disease and develops hypoxaemia (low oxygen levels in the blood) and dyspnoea (shortness of breath), potentially evolving towards ARDS.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1010}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, DIC has been reported in a few patients, usually in the advanced stages of the disease", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["Advanced"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1013}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 directly infects vascular endothelial cells and leads to cellular damage and apoptosis, thus decreasing the antithrombotic activity of the normal endothelium7,55.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 directly infects vascular endothelial cells and leads to cellular damage and apoptosis, thus decreasing the antithrombotic activity of the normal endothelium7,55.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1014}, properties:{annotationPublicationtype:["Review"], evidence:"Alveolar damage, vessel wall oedema, hyaline thrombi, microhaemorrhage and diffuse thrombosis of peripheral small vessels have emerged as key features of COVID-19 contributing to respiratory failure6,8,46 (Fig. 2).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood Vessels", "Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Review"], evidence:"Alveolar damage, vessel wall oedema, hyaline thrombi, microhaemorrhage and diffuse thrombosis of peripheral small vessels have emerged as key features of COVID-19 contributing to respiratory failure6,8,46 (Fig. 2).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Review"], evidence:"Alveolar damage, vessel wall oedema, hyaline thrombi, microhaemorrhage and diffuse thrombosis of peripheral small vessels have emerged as key features of COVID-19 contributing to respiratory failure6,8,46 (Fig. 2).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:734}, properties:{annotationPublicationtype:["Review"], evidence:"Alveolar damage, vessel wall oedema, hyaline thrombi, microhaemorrhage and diffuse thrombosis of peripheral small vessels have emerged as key features of COVID-19 contributing to respiratory failure6,8,46 (Fig. 2).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1023}, properties:{annotationPublicationtype:["Review"], evidence:"Considering the important role of the endothelium in regulating haemostasis, fibrinolysis and vessel wall permeability, endothelial dysfunction in pulmonary microvessels acts as a trigger for immunothrombosis, resulting in the coagulopathy observed in patients with COVID-19 (refs27,47,67,68).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:653}, end: {_id:2}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, endothelial dysfunction is recognized as a risk factor of microvascular dysfunction through a shift towards vasoconstriction, by promoting ischaemia, inflammation and a procoagulant state69", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1023}, end: {_id:653}, properties:{annotationPublicationtype:["Review"], evidence:"All of these elements support the hypothesis that endothelial dysfunction, or endotheliopathy35,75, and platelet activation are key features of COVID-19-associated coagulopathy and may mediate the damage leading to severe disease.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"33824483", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1040}, properties:{annotationPublicationtype:["Review"], evidence:"In support of this, there is increasing evidence that COVID-19 is a disease of the endothelium35 that results in elevated levels of PAI1 and VWF, increased platelet activation and a state of hypercoagulability, with consequent venous, arterial and microvascular thrombosis.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1041}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, a study reported that 40% of patients hospitalized with COVID-19 are at high risk of VTE104 and data from a large retrospective cohort of patients in the United States suggested that anticoagulation may reduce mortality, especially among those with severe disease requiring invasive mechanical ventilation105.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationDiseaseType:["patients hospitalized"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1146}, properties:{annotationPublicationtype:["Research"], evidence:"Because of pneumonia, more SARS-CoV-2-infected patients were ventilated than controls (Supplementary Table 2). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34675436", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:36}, properties:{annotationPublicationtype:["Research"], evidence:"One patient had cortical–subcortical probably chronic infarcts with petechial hemorrhages (two large infarcts—right frontal and left parietal, and two smaller infarct—left cerebellar and right frontal) (Fig. 2).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Cerebellum"], annotationCell:["right frontal lobe", "left parietal lobe"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1238}, properties:{annotationPublicationtype:["Research"], evidence:"One patient had cortical–subcortical probably chronic infarcts with petechial hemorrhages (two large infarcts—right frontal and left parietal, and two smaller infarct—left cerebellar and right frontal) (Fig. 2).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Cerebellum"], annotationCell:["right frontal lobe", "left parietal lobe"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"One patient had bilateral frontal and parietal subarachnoid hemorrhage, and signal abnormalities in both corticospinal tracts, bilateral basal ganglia, hippocampi and cortical/subcortical parietal bilaterally, and in the right frontal lobe (Fig. 3). ", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", annotationAnatomy:["frontal sulcus", "sulcus of parietal lobe"], citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1239}, properties:{annotationPublicationtype:["Research"], evidence:"One patient had bilateral frontal and parietal subarachnoid hemorrhage, and signal abnormalities in both corticospinal tracts, bilateral basal ganglia, hippocampi and cortical/subcortical parietal bilaterally, and in the right frontal lobe (Fig. 3). ", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1240}, properties:{annotationPublicationtype:["Research"], evidence:"One patient had bilateral frontal and parietal subarachnoid hemorrhage, and signal abnormalities in both corticospinal tracts, bilateral basal ganglia, hippocampi and cortical/subcortical parietal bilaterally, and in the right frontal lobe (Fig. 3). ", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", annotationAnatomy:["corticospinal tract", "hippocampal field", "right frontal lobe", "collection of basal ganglia"], citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Increased T2 and FLAIR signal associated with punctate hemorrhagic foci was identifed in the splenium of corpus callosum in patient 4 (Fig. 4c, d).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", annotationAnatomy:["splenium of the corpus callosum"], citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1241}, properties:{annotationPublicationtype:["Research"], evidence:"Patient 5 had some nonspecific multifocal white matter abnormalities with increased T2 and FLAIR signal, and some punctate hemorrhagic foci in the right frontal white matter (Fig.  5a, b).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationCell:["white matter of frontal lobe"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", annotationTechnique:["computed tomography scan"], annotationSpecies:["9606"], annotationSection:["Results"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Periventricular punctate hemorrhagic foci were noted in patient 7 (Fig. 5c, d).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:865}, properties:{annotationPublicationtype:["Research"], evidence:"One subject had difuse edema and patchy white matter focal abnormalities. This patient did not undergo cerebral sampling (family did not consent) (Fig. 4a, b).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1241}, properties:{annotationPublicationtype:["Research"], evidence:"One subject had difuse edema and patchy white matter focal abnormalities. This patient did not undergo cerebral sampling (family did not consent) (Fig. 4a, b).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"35032223"}}, {start: {_id:640}, end: {_id:318}, properties:{annotationPublicationtype:["Research"], evidence:"Histological brain analysis showed reactive gliosis, congestion and cortical neuron eosinophilic degeneration, and axonal disruption in all six cases (Fig. 6)", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1245}, properties:{annotationPublicationtype:["Research"], evidence:"Histological brain analysis showed reactive gliosis, congestion and cortical neuron eosinophilic degeneration, and axonal disruption in all six cases (Fig. 6)", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:865}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1246}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:2}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:681}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1146}, properties:{annotationPublicationtype:["Research"], evidence:"Other autopsy findings included typical COVID-19 pneumonia (diffuse alveolar damage, pneumocyte cytopathic changes, fibrin thrombi and increased megakaryocytes in septal vessels), acute tubular necrosis and visceral congestion.", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1252}, properties:{annotationPublicationtype:["Research"], evidence:"Other autopsy findings included typical COVID-19 pneumonia (diffuse alveolar damage, pneumocyte cytopathic changes, fibrin thrombi and increased megakaryocytes in septal vessels), acute tubular necrosis and visceral congestion.", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1254}, properties:{annotationPublicationtype:["Research"], evidence:"Other autopsy findings included typical COVID-19 pneumonia (diffuse alveolar damage, pneumocyte cytopathic changes, fibrin thrombi and increased megakaryocytes in septal vessels), acute tubular necrosis and visceral congestion.", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1255}, properties:{annotationPublicationtype:["Research"], evidence:"Other autopsy findings included typical COVID-19 pneumonia (diffuse alveolar damage, pneumocyte cytopathic changes, fibrin thrombi and increased megakaryocytes in septal vessels), acute tubular necrosis and visceral congestion.", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:67}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"Parkinson’s disease (PD) is characterized by the cardinal signs of the movement disorder such as tremor and postural instability, as well as the histopathological hallmarks of alpha-synuclein (α-syn) accumulation and loss of dopaminergic neurons in the substantia nigra (SN).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1318}, properties:{annotationPublicationtype:["Review"], evidence:"Parkinson’s disease (PD) is characterized by the cardinal signs of the movement disorder such as tremor and postural instability, as well as the histopathological hallmarks of alpha-synuclein (α-syn) accumulation and loss of dopaminergic neurons in the substantia nigra (SN).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1319}, properties:{annotationPublicationtype:["Review"], evidence:"Parkinson’s disease (PD) is characterized by the cardinal signs of the movement disorder such as tremor and postural instability, as well as the histopathological hallmarks of alpha-synuclein (α-syn) accumulation and loss of dopaminergic neurons in the substantia nigra (SN).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1353}, end: {_id:1354}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, H. pylori-positive PD patients displayed higher mortality rate and motor dysfunction compared to healthy controls, a clinical phenotype significantly improved following Helicobacter eradication", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1362}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast, insoluble aggregates of α-syn, which are also a feature of sporadic PD, can trigger neuroinflammation [60]. ", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["familial"], annotationMeshanatomy:["Central Nervous System"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationProteinType:["insoluble"], citationRef:"35674870"}}, {start: {_id:1362}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Recent studies suggested that α-syn aggregation at nerve terminals as well as its capability to leave the cell into exosomes can trigger neuroinflammation and could be used as a potential biomarker for early PD diagnosis and a prognostic tool for disease progression", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Central Nervous System", "Nerve Endings"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:640}, end: {_id:18}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, both these disorders are characterized by a microglia-mediated early synapse loss [34], and epidemiological register studies have indicated an increased risk of dementia and parkinsonism after COVID-19 infection.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:640}, end: {_id:1525}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, both these disorders are characterized by a microglia-mediated early synapse loss [34], and epidemiological register studies have indicated an increased risk of dementia and parkinsonism after COVID-19 infection.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:640}, end: {_id:1565}, properties:{annotationPublicationtype:["Research"], evidence:"We found that the total FF, HAMD and HAMA, somatic FF, HAMD and HAMA scores, depression HAMD and anxiety HAMA, as well as the autonomic and GIS symptoms, were significantly different between the three classes and increased from controls→LC→LC+O&NS.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1566}, properties:{annotationPublicationtype:["Research"], evidence:"We found that the total FF, HAMD and HAMA, somatic FF, HAMD and HAMA scores, depression HAMD and anxiety HAMA, as well as the autonomic and GIS symptoms, were significantly different between the three classes and increased from controls→LC→LC+O&NS.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1567}, properties:{annotationPublicationtype:["Research"], evidence:"We found that the total FF, HAMD and HAMA, somatic FF, HAMD and HAMA scores, depression HAMD and anxiety HAMA, as well as the autonomic and GIS symptoms, were significantly different between the three classes and increased from controls→LC→LC+O&NS.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1568}, properties:{annotationPublicationtype:["Research"], evidence:"We found that the total FF, HAMD and HAMA, somatic FF, HAMD and HAMA scores, depression HAMD and anxiety HAMA, as well as the autonomic and GIS symptoms, were significantly different between the three classes and increased from controls→LC→LC+O&NS.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1569}, properties:{annotationPublicationtype:["Research"], evidence:"We found that the total FF, HAMD and HAMA, somatic FF, HAMD and HAMA scores, depression HAMD and anxiety HAMA, as well as the autonomic and GIS symptoms, were significantly different between the three classes and increased from controls→LC→LC+O&NS.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1570}, properties:{annotationPublicationtype:["Research"], evidence:"Sleep disorders, chronic fatigue and cognitive disorders were significantly higher in Long COVID than in controls.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1571}, properties:{annotationPublicationtype:["Research"], evidence:"Sleep disorders, chronic fatigue and cognitive disorders were significantly higher in Long COVID than in controls.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1572}, properties:{annotationPublicationtype:["Research"], evidence:"Sleep disorders, chronic fatigue and cognitive disorders were significantly higher in Long COVID than in controls.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Together, these data suggest that high levels of SARS-CoV-2 infection remain in astrocytes, although lower levels of infection in neurons and neural progenitor cells also occur.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1252}, properties:{annotationPublicationtype:["Research"], evidence:"Of 44 cases, 38 were determined to have died from COVID-19, and of these, 35 (92.1%) had either acute pneumonia or diffuse alveolar damage at the time of death (Supplementary Data 2).", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36517603"}}, {start: {_id:640}, end: {_id:769}, properties:{annotationPublicationtype:["Research"], evidence:"Pulmonary thromboembolic complications were noted in 10 (23%) cases and myocardial infiltrates were observed in four cases, including one case of substantial myocarditis17 (P3). In the lymph nodes and spleen, we observed both lymphodepletion and follicular and paracortical hyperplasia.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36517603"}}, {start: {_id:640}, end: {_id:1702}, properties:{annotationPublicationtype:["Research"], evidence:"Pulmonary thromboembolic complications were noted in 10 (23%) cases and myocardial infiltrates were observed in four cases, including one case of substantial myocarditis17 (P3). In the lymph nodes and spleen, we observed both lymphodepletion and follicular and paracortical hyperplasia.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36517603"}}, {start: {_id:640}, end: {_id:1703}, properties:{annotationPublicationtype:["Research"], evidence:"Pulmonary thromboembolic complications were noted in 10 (23%) cases and myocardial infiltrates were observed in four cases, including one case of substantial myocarditis17 (P3). In the lymph nodes and spleen, we observed both lymphodepletion and follicular and paracortical hyperplasia.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36517603"}}, {start: {_id:640}, end: {_id:779}, properties:{annotationPublicationtype:["Research"], evidence:"Pulmonary thromboembolic complications were noted in 10 (23%) cases and myocardial infiltrates were observed in four cases, including one case of substantial myocarditis17 (P3). In the lymph nodes and spleen, we observed both lymphodepletion and follicular and paracortical hyperplasia.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Spleen", "Lymph Nodes"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:1252}, end: {_id:685}, properties:{annotationPublicationtype:["Research"], evidence:"The main cause of death in COVID-19 subjects was diffuse alveolar damage", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36781876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36781876"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Research"], evidence:"In three out of nine cases, microthromboses were identified only within the CNS, while in the remaining six subjects, pulmonary thromboses were also detected.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Lung", "Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"36781876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36781876"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Research"], evidence:"Some of these subjects (#7, #9, #11, #17, #18) also displayed endothelial cell immunoreactivity in small vessels of the cerebral cortex (subject #11), deep cerebellar nuclei (#17–18) hippocampus (#7)(Fig. 4) and midbrain (#9) (Fig. 2j); small vessel thromboses,perivascular extravasation and hemorrhagic injury were found within affected regions of these cases.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "Cerebellar Nuclei", "Cerebral Cortex", "Microvessels"], annotationCell:["midbrain"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Some of these subjects (#7, #9, #11, #17, #18) also displayed endothelial cell immunoreactivity in small vessels of the cerebral cortex (subject #11), deep cerebellar nuclei (#17–18) hippocampus (#7)(Fig. 4) and midbrain (#9) (Fig. 2j); small vessel thromboses,perivascular extravasation and hemorrhagic injury were found within affected regions of these cases.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "Cerebellar Nuclei", "Cerebral Cortex", "Microvessels"], annotationCell:["midbrain"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Research"], evidence:"Similarly, the deep cerebellar white matter and dentate nuclei in cases #17–18 presented small vessel thromboses and extensive hemorrhagic injury (case #17).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["White Matter", "Microvessels", "Cerebellum"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["dentate nucleus"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Similarly, the deep cerebellar white matter and dentate nuclei in cases #17–18 presented small vessel thromboses and extensive hemorrhagic injury (case #17).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["White Matter", "Microvessels", "Cerebellum"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["dentate nucleus"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1246}, properties:{annotationPublicationtype:["Research"], evidence:"As mentioned previously, radiological findings shared common features in the cases for whom MRI was available (Fig. 1, a-p). The same was true for neuropathology.", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["magnetic resonance imaging"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1752}, properties:{annotationPublicationtype:["Research"], evidence:"As mentioned previously, radiological findings shared common features in the cases for whom MRI was available (Fig. 1, a-p). The same was true for neuropathology.", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["magnetic resonance imaging"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1755}, properties:{annotationPublicationtype:["Research"], evidence:"In the foci, numerous and large axonal swellings were seen and white matter was vacuolized (Fig. 1. x). ", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Axons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["magnetic resonance imaging"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Some recent blood extravasation (Fig. 1. r) and a few siderophages were observed.", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["hematoxylin staining"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Macroscopic examination of the three autopsied brains was characterized by multiple hemorrhages scattered in the deep and subcortical white matter. In case # 4 these were predominant in the supramarginal gyrus, first and second temporal gyri, where they were particularly numerous, and also in the pons and cerebellum. There was a 4 mm hemorrhage in the left occipital pole.", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["White Matter", "Brain", "Cerebellum", "Pons"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCustomAnatomy:["first temporal gyrus", "second temporal gyrus"], annotationAnatomy:["supramarginal gyrus"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"In cases # 5 and # 6 the hemorrhages were predominant in the frontal lobe with additional bleeds in the striatum (case # 5) and in the pons (case # 6).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Frontal Lobe", "Pons"], source:"wp4-cbm-comorbidity", pmid:"37283933", annotationAnatomy:["striatum"], citationType:"PubMed", citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1755}, properties:{annotationPublicationtype:["Research"], evidence:"The most conspicuous lesions were small foci rich in CD163 positive macrophages centered by a small caliber arteriole (Fig. 2. a, b, c) associated with swollen axons and vacuolization of the surrounding white matter (Fig. 2. d, e).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Axons"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["hematoxylin-eosin staining"], citationRef:"37283933"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to biopsy cases, perivascular bleeding was more frequent and of different age (Fig. 2. f, g).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37283933", annotationAnatomy:["perivascular space"], citationType:"PubMed", annotationTechnique:["hematoxylin-eosin staining"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1246}, properties:{annotationPublicationtype:["Research"], evidence:"Aβ IHC was negative indicating absence of amyloid angiopathy. In summary, the lesions of the white matter can be described as CCM.", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", citationRef:"37283933"}}, {start: {_id:1829}, end: {_id:736}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:788}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1830}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:790}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1831}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1832}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:669}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:733}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:651}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:753}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1566}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1833}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the difficulties in adequate diagnosis, long COVID includes a combination of multifactorial symptoms such as fatigue, dyspnea, persistent cough, chest pain, persistent headache, memory and cognitive impairment, muscle aches, loss of smell or taste, depression and/or anxiety (Davis et al., 2023; de Erausquin et al., 2021; Lechien et al., 2020; Vos et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:788}, properties:{annotationPublicationtype:["Review"], evidence:"Some long COVID patients report persistent symptoms 6 months after acute infection, most commonly dyspnea and a diverse array of neurological problems (Box 1, Fig. 1).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["6 months after acute infection"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1834}, properties:{annotationPublicationtype:["Review"], evidence:"Some long COVID patients report persistent symptoms 6 months after acute infection, most commonly dyspnea and a diverse array of neurological problems (Box 1, Fig. 1).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["6 months after acute infection"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:642}, properties:{annotationPublicationtype:["Review"], evidence:"For example, a meta-analysis of ~10,000 COVID-19 studies revealed the persistence of headache in between 8% and 15% of patients in the first 6 months after SARS-CoV-2 infection (Fernández-de-las-Peñas et al., 2021), and two independent patient cohort studies reported partial taste and smell disorders in 40% of patients (Lechien et al., 2020; Leedman et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["6 months after acute infection"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:651}, properties:{annotationPublicationtype:["Review"], evidence:"For example, a meta-analysis of ~10,000 COVID-19 studies revealed the persistence of headache in between 8% and 15% of patients in the first 6 months after SARS-CoV-2 infection (Fernández-de-las-Peñas et al., 2021), and two independent patient cohort studies reported partial taste and smell disorders in 40% of patients (Lechien et al., 2020; Leedman et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["6 months after acute infection"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:642}, properties:{annotationPublicationtype:["Review"], evidence:"The most frequently reported manifestations of long COVID are neurological symptoms (hereafter, nLong COVID), which include headache, confusion and ‘brain fog’, mood disorders and dementia(Fig. 3).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:646}, properties:{annotationPublicationtype:["Review"], evidence:"The most frequently reported manifestations of long COVID are neurological symptoms (hereafter, nLong COVID), which include headache, confusion and ‘brain fog’, mood disorders and dementia(Fig. 3).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1829}, end: {_id:1841}, properties:{annotationPublicationtype:["Review"], evidence:"The most frequently reported manifestations of long COVID are neurological symptoms (hereafter, nLong COVID), which include headache, confusion and ‘brain fog’, mood disorders and dementia(Fig. 3).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1842}, properties:{annotationPublicationtype:["Review"], evidence:"The most frequently reported manifestations of long COVID are neurological symptoms (hereafter, nLong COVID), which include headache, confusion and ‘brain fog’, mood disorders and dementia(Fig. 3).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:18}, properties:{annotationPublicationtype:["Review"], evidence:"The most frequently reported manifestations of long COVID are neurological symptoms (hereafter, nLong COVID), which include headache, confusion and ‘brain fog’, mood disorders and dementia(Fig. 3).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:640}, end: {_id:18}, properties:{annotationPublicationtype:["Review"], evidence:"Beyond nLong COVID itself, there is concern about an increased risk of dementia as a longer-term consequence of COVID-19. A number of viruses, including common respiratory viruses, cause post-acute infection syndromes (Choutka et al., 2022), with a significant number of patients developing long-term neurological sequelae, including neurodegenerative multiple sclerosis (Bjornevik et al., 2022; Cermelli and Jacobson, 2000).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:640}, end: {_id:18}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, the risk of being diagnosed with dementia is increased in the 6 months after acute COVID. In the general population, the risk is 0.7% higher, and it rises to 2.7% in patients older than 65 years and to 4.7% in those who have developed encephalopathy during acute infection (Taquet et al., 2021).", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["6 months after acute COVID"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:640}, end: {_id:685}, properties:{annotationPublicationtype:["Review"], evidence:"First, the most severely hit population by COVID-19 is the age group of 65 years and above (WHO World Health Statistics, 2023), with an increased risk of poor outcome for those with dementia (Numbers et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationAge:["older than 65 years"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Dementia"], citationRef:"37458167"}}, {start: {_id:640}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 infection triggers cellular changes in the brain compatible with the progression of neurodegeneration (Heneka et al., 2020; Yang et al., 2021), which was recapitulated in brain organoid models of acute infection.", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:67}, end: {_id:66}, properties:{annotationPublicationtype:["Review"], evidence:"The causes of iPD remain elusive, although several pathological processes are associated with its progression. Mitochondrial dysfunction, impaired proteostasis, calcium dysregulation, and chronic inflammation have been extensively shown in PD animal models and people with PD (reviewed in [5])", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1856}, properties:{annotationPublicationtype:["Review"], evidence:"The causes of iPD remain elusive, although several pathological processes are associated with its progression. Mitochondrial dysfunction, impaired proteostasis, calcium dysregulation, and chronic inflammation have been extensively shown in PD animal models and people with PD (reviewed in [5])", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:48}, properties:{annotationPublicationtype:["Review"], evidence:"The causes of iPD remain elusive, although several pathological processes are associated with its progression. Mitochondrial dysfunction, impaired proteostasis, calcium dysregulation, and chronic inflammation have been extensively shown in PD animal models and people with PD (reviewed in [5])", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:66}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, transcriptomic analysis of monocytes from people with PD showed mitochondrial and lysosomal alterations, although differential transcriptomic profiles were observed between people with familial (glucocerebrosidase) GBA-PD versus iPD [59].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1872}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, transcriptomic analysis of monocytes from people with PD showed mitochondrial and lysosomal alterations, although differential transcriptomic profiles were observed between people with familial (glucocerebrosidase) GBA-PD versus iPD [59].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:66}, properties:{annotationPublicationtype:["Review"], evidence:"By contrast, CD4 T cells from people with PD showed decreased migratory capacity in vitro associated with mitochondrial dysfunction [112]. Interestingly, transcriptomic analysis of CD4 T cells upon in vitro activation suggests that mitochondrial dysfunction and defective DNA repair mechanisms contribute to T cell-related PD pathogenesis [106].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1911}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Females typically show slower progression and develop fewer cognitive problems, but more dyskinesias [135].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:66}, properties:{annotationPublicationtype:["Review"], evidence:"The second study found a common over-representation of genes associated with mitochondrial dysfunction, oxidative stress, and inflammation in PD, but with the genes involved differing between sexes [142].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1920}, end: {_id:37}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"In an ulcerative colitis mouse model, males exhibited more pronounced immune changes and neurodegeneration [150].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:640}, end: {_id:1929}, properties:{annotationPublicationtype:["Review"], evidence:"Studies employing Syrian hamsters exhibit often mild to moderate disease courses with a pulmonary pathology resembling COVID-19, that is, respiratory tract and lung pathology, alveolar and perivascular oedema and endotheliitis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10036"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:777}, properties:{annotationPublicationtype:["Review"], evidence:"Studies employing Syrian hamsters exhibit often mild to moderate disease courses with a pulmonary pathology resembling COVID-19, that is, respiratory tract and lung pathology, alveolar and perivascular oedema and endotheliitis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10036"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1041}, properties:{annotationPublicationtype:["Review"], evidence:"As early as May 2020, venous thromboembolism was identified as a major complication of COVID-19 (ref. 11), prompting international randomized controlled trials on the coagulation management of patients with COVID-19 (ref. 12).", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:734}, properties:{annotationPublicationtype:["Review"], evidence:"Extensive autopsy studies have revealed the leading causes of death in patients undergoing severe and critical COVID-19: respiratory failure (53%) and multiorgan dysfunction.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1930}, properties:{annotationPublicationtype:["Review"], evidence:"Extensive autopsy studies have revealed the leading causes of death in patients undergoing severe and critical COVID-19: respiratory failure (53%) and multiorgan dysfunction.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:734}, end: {_id:685}, properties:{annotationPublicationtype:["Review"], evidence:"Extensive autopsy studies have revealed the leading causes of death in patients undergoing severe and critical COVID-19: respiratory failure (53%) and multiorgan dysfunction.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1931}, end: {_id:685}, properties:{annotationPublicationtype:["Review"], evidence:"Extensive autopsy studies have revealed the leading causes of death in patients undergoing severe and critical COVID-19: respiratory failure (53%) and multiorgan dysfunction.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:668}, properties:{annotationPublicationtype:["Review"], evidence:"For example, acute respiratory distress syndrome (ARDS) was described as the leading cause of death in COVID-19 based on microscopic examination of the lungs of deceased patients. Changes were observed resembling those of diffuse alveolar damage (DAD), the hallmark of ARDS.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:668}, end: {_id:685}, properties:{annotationPublicationtype:["Review"], evidence:"For example, acute respiratory distress syndrome (ARDS) was described as the leading cause of death in COVID-19 based on microscopic examination of the lungs of deceased patients. Changes were observed resembling those of diffuse alveolar damage (DAD), the hallmark of ARDS.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:668}, end: {_id:1252}, properties:{annotationPublicationtype:["Review"], evidence:"For example, acute respiratory distress syndrome (ARDS) was described as the leading cause of death in COVID-19 based on microscopic examination of the lungs of deceased patients. Changes were observed resembling those of diffuse alveolar damage (DAD), the hallmark of ARDS.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1252}, properties:{annotationPublicationtype:["Review"], evidence:"In detail, DAD is a multi-stage process with three major phases: exudative, proliferative and fibrotic. These stages can be observed in the lungs of COVID-19 autopsies.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1252}, end: {_id:1933}, properties:{annotationPublicationtype:["Review"], evidence:"The initial exudative phase is characterized by hyaline membrane formation (deposits along the alveolar walls composed of fibrin, mucopolysaccharides and cell debris), cell death, pulmonary oedema and inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1936}, properties:{annotationPublicationtype:["Review"], evidence:"Besides DAD, acute and fibrinous organizing pneumonia (AFOP)  has been reported as a rare condition in patients with COVID-19 and is  associated with poor prognosis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1252}, properties:{annotationPublicationtype:["Review"], evidence:"Besides DAD, acute and fibrinous organizing pneumonia (AFOP)  has been reported as a rare condition in patients with COVID-19 and is  associated with poor prognosis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1936}, end: {_id:1040}, properties:{annotationPublicationtype:["Review"], evidence:" AFOP may represent a form of lung injury distinct from typical ARDS. It may be related to microvascular injury and inflammation, and it is associated with a hypercoagulable state and microvascular thrombosis in the  lungs.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:797}, properties:{annotationPublicationtype:["Review"], evidence:" AFOP may represent a form of lung injury distinct from typical ARDS. It may be related to microvascular injury and inflammation, and it is associated with a hypercoagulable state and microvascular thrombosis in the  lungs.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1940}, properties:{annotationPublicationtype:["Review"], evidence:"Others have shown opposing monocyte and macrophage immune profiles, further aggravating immune dysregulation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], annotationCell:["monocyte"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1941}, properties:{annotationPublicationtype:["Review"], evidence:"Fibrotic remodelling in the lungs occurs at late disease stages and in a prolonged disease course.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], annotationCell:["monocyte"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1942}, properties:{annotationPublicationtype:["Review"], evidence:"Recent investigations in human autopsy lung tissue showed that vascular insufficiency (compromised pulmonary and bronchial circulation) and secondary pulmonary lobular microischaemia (vascular insufficiency causing microischaemia of secondary lung lobules) precede the fibrotic changes.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["monocyte"], annotationMeshanatomy:["Lung"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1943}, properties:{annotationPublicationtype:["Review"], evidence:"Recent investigations in human autopsy lung tissue showed that vascular insufficiency (compromised pulmonary and bronchial circulation) and secondary pulmonary lobular microischaemia (vascular insufficiency causing microischaemia of secondary lung lobules) precede the fibrotic changes.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["monocyte"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:1942}, end: {_id:1941}, properties:{annotationPublicationtype:["Review"], evidence:"Recent investigations in human autopsy lung tissue showed that vascular insufficiency (compromised pulmonary and bronchial circulation) and secondary pulmonary lobular microischaemia (vascular insufficiency causing microischaemia of secondary lung lobules) precede the fibrotic changes.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["monocyte"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:1944}, end: {_id:1941}, properties:{annotationPublicationtype:["Review"], evidence:"Recent investigations in human autopsy lung tissue showed that vascular insufficiency (compromised pulmonary and bronchial circulation) and secondary pulmonary lobular microischaemia (vascular insufficiency causing microischaemia of secondary lung lobules) precede the fibrotic changes.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["monocyte"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:1941}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Fibrotic remodelling and the associated impairment of lung function could also contribute to long COVID.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationCell:["monocyte"], source:"wp4-cbm-comorbidity", pmid:"37798476", annotationAnatomy:["secondary pulmonary lobule"], citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:905}, properties:{annotationPublicationtype:["Review"], evidence:"Autopsy studies reported high frequencies of thromboembolisms in COVID-19 deceased early in the pandemic. In line with this, vascular damage within and outside the lungs is now a recognized hallmark of severe COVID-19.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationCell:["monocyte"], source:"wp4-cbm-comorbidity", pmid:"37798476", annotationAnatomy:["secondary pulmonary lobule"], citationType:"PubMed", citationRef:"37798476"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1131}, properties:{annotationPublicationtype:["Review"], evidence:"Autopsy studies reported high frequencies of thromboembolisms in COVID-19 deceased early in the pandemic. In line with this, vascular damage within and outside the lungs is now a recognized hallmark of severe COVID-19.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationCell:["monocyte"], source:"wp4-cbm-comorbidity", pmid:"37798476", annotationAnatomy:["secondary pulmonary lobule"], citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1946}, properties:{annotationPublicationtype:["Review"], evidence:"COVID-19 autopsy lungs revealed endothelial injury, microangiopathy (injury of capillaries with thickening and weakening of the vessel walls) and intussusceptive angiogenesis (an aberrant blood vessel neoformation), and perivascular inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1949}, properties:{annotationPublicationtype:["Review"], evidence:"Autopsy studies also identified the kidney as another site of COVID-19-related complications, with ~30–50% of hospitalized and critically ill COVID-19 patients developing acute kidney injury.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1254}, properties:{annotationPublicationtype:["Review"], evidence:"In autopsy specimens, renal histomorphological alterations include acute tubular necrosis, thrombotic microangiopathy, interstitial inflammation and fibrosis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1951}, properties:{annotationPublicationtype:["Review"], evidence:"In autopsy specimens, renal histomorphological alterations include acute tubular necrosis, thrombotic microangiopathy, interstitial inflammation and fibrosis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1952}, properties:{annotationPublicationtype:["Review"], evidence:"In autopsy specimens, renal histomorphological alterations include acute tubular necrosis, thrombotic microangiopathy, interstitial inflammation and fibrosis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:709}, properties:{annotationPublicationtype:["Review"], evidence:"About 30% of patients with COVID-19, including those with mild  disease, display neurological symptoms such as an altered mental  status, dizziness and headache, and, in rare cases, brain ischaemia.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:641}, properties:{annotationPublicationtype:["Review"], evidence:"About 30% of patients with COVID-19, including those with mild  disease, display neurological symptoms such as an altered mental  status, dizziness and headache, and, in rare cases, brain ischaemia.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:642}, properties:{annotationPublicationtype:["Review"], evidence:"About 30% of patients with COVID-19, including those with mild  disease, display neurological symptoms such as an altered mental  status, dizziness and headache, and, in rare cases, brain ischaemia.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1954}, properties:{annotationPublicationtype:["Review"], evidence:"About 30% of patients with COVID-19, including those with mild  disease, display neurological symptoms such as an altered mental  status, dizziness and headache, and, in rare cases, brain ischaemia.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:1956}, end: {_id:1949}, properties:{annotationPublicationtype:["Review"], evidence:"The most recent autopsy related to Lassa virus infection was published 40 years ago62, although 100,000 to 300,000 infections are estimated to occur annually, with case fatality rates ranging from 15% to 70% (ref. 63). Clinical manifestations of this fatal disease can include acute kidney injury, neurological complications and haemorrhage.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1956}, end: {_id:957}, properties:{annotationPublicationtype:["Review"], evidence:"The most recent autopsy related to Lassa virus infection was published 40 years ago62, although 100,000 to 300,000 infections are estimated to occur annually, with case fatality rates ranging from 15% to 70% (ref. 63). Clinical manifestations of this fatal disease can include acute kidney injury, neurological complications and haemorrhage.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1957}, end: {_id:685}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, and in analogy to long COVID, it has been noted that survivors of acute Ebola virus infection suffer from a range of long-term sequelae, including an increased risk of intermediate-term death and increased prevalence  of renal dysfunction.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1957}, end: {_id:1958}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, and in analogy to long COVID, it has been noted that survivors of acute Ebola virus infection suffer from a range of long-term sequelae, including an increased risk of intermediate-term death and increased prevalence  of renal dysfunction.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:788}, properties:{annotationPublicationtype:["Research"], evidence:"The most frequent presenting symptoms included dyspnea (47), loss of smell and taste (46), cough (45), fatigue (40) and fever (36).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Research"], evidence:"The most frequent presenting symptoms included dyspnea (47), loss of smell and taste (46), cough (45), fatigue (40) and fever (36).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:753}, properties:{annotationPublicationtype:["Research"], evidence:"The most frequent presenting symptoms included dyspnea (47), loss of smell and taste (46), cough (45), fatigue (40) and fever (36).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:787}, properties:{annotationPublicationtype:["Research"], evidence:"The most frequent presenting symptoms included dyspnea (47), loss of smell and taste (46), cough (45), fatigue (40) and fever (36).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:736}, properties:{annotationPublicationtype:["Research"], evidence:"The most frequent presenting symptoms included dyspnea (47), loss of smell and taste (46), cough (45), fatigue (40) and fever (36).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:121}, properties:{annotationPublicationtype:["Research"], evidence:"The most frequent presenting symptoms included dyspnea (47), loss of smell and taste (46), cough (45), fatigue (40) and fever (36).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Research"], evidence:"Sixteen (50%) participants reported anosmia, which was confirmed using Q-SIT testing (average score 1 out of 3; 159±88 days duration) at the time of scanning.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2170}, properties:{annotationPublicationtype:["Research"], evidence:"Six participants with brain fog showed mild-to-moderate cognitive impairment on the Montreal Cognitive Assessment (MOCA) test (score 18–25) along with deficits in recall, executive functioning and word finding.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2171}, properties:{annotationPublicationtype:["Research"], evidence:"While standard diagnostic MRI scans showed no clinically relevant pathological findings in any participant, DCE-MRI imaging revealed significantly increased whole-brain leakage in patients with long COVID with brain fog (Fig. 2d–f), with an increased percentage of brain volume with leaky blood vessels in the cohort with brain fog compared to the cohort without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:957}, properties:{annotationPublicationtype:["Research"], evidence:"While standard diagnostic MRI scans showed no clinically relevant pathological findings in any participant, DCE-MRI imaging revealed significantly increased whole-brain leakage in patients with long COVID with brain fog (Fig. 2d–f), with an increased percentage of brain volume with leaky blood vessels in the cohort with brain fog compared to the cohort without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2176}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Cortical thinning was also evident predominantly in the TLs and frontal lobes (FLs) when analyzing all patients with previous SARS-CoV-2 infection compared to unaffected controls.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2176}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Cortical thinning was also evident predominantly in the TLs and frontal lobes (FLs) when analyzing all patients with previous SARS-CoV-2 infection compared to unaffected controls.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1829}, end: {_id:1841}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:315}, end: {_id:2244}, properties:{annotationPublicationtype:["Review"], evidence:"IPEX patients suffer from a severe autoimmune disease and allergy, similar to phenotypes in rodents following the depletion of CD4+CD25+ Tregs. CD25 deficiency also causes IPEX-like syndrome.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:315}, end: {_id:2245}, properties:{annotationPublicationtype:["Review"], evidence:"IPEX patients suffer from a severe autoimmune disease and allergy, similar to phenotypes in rodents following the depletion of CD4+CD25+ Tregs. CD25 deficiency also causes IPEX-like syndrome.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:640}, end: {_id:2338}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"As expected, SARS-CoV-2 was present in the lungs of infected mice, and lung histopathology demonstrated minimal interstitial infiltrates without evidence of alveolar damage (Figures S1B and S1C).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1252}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["24-73"], evidence:"Lung examination of these cases revealed infection-associated lung injury that ranged from none to moderate (diffuse alveolar damage), without evidence of the necrotizing pneumonia that characterizes severe pulmonary COVID (Figures S3B–S3E; Table S2).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:956}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:28}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2365}, properties:{annotationPublicationtype:["Research"], evidence:"In the lung, H&E revealed severe congestion, diffuse alveolar damage, and interstitial pneumonia presenting as septal infiltrate shown in the middle of the image (A); SARS-CoV-2 positivity is evident in alveolar pneumocytes showing cytopathic features (B) and in the bronchiolar ciliated epithelium (B); diffuse interstitial macrophages detected by CD68 antibody (C, arrowheads); T-lymphocyte (D) and B-lymphocyte (E) infiltrates are revealed by CD3 and CD20 reactions, respectively; CD42b marks several microthrombi in capillary and interstitial vessels characterized by a rosary crown feature (F).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:1252}, properties:{annotationPublicationtype:["Research"], evidence:"In the lung, H&E revealed severe congestion, diffuse alveolar damage, and interstitial pneumonia presenting as septal infiltrate shown in the middle of the image (A); SARS-CoV-2 positivity is evident in alveolar pneumocytes showing cytopathic features (B) and in the bronchiolar ciliated epithelium (B); diffuse interstitial macrophages detected by CD68 antibody (C, arrowheads); T-lymphocyte (D) and B-lymphocyte (E) infiltrates are revealed by CD3 and CD20 reactions, respectively; CD42b marks several microthrombi in capillary and interstitial vessels characterized by a rosary crown feature (F).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2366}, properties:{annotationPublicationtype:["Research"], evidence:"In the lung, H&E revealed severe congestion, diffuse alveolar damage, and interstitial pneumonia presenting as septal infiltrate shown in the middle of the image (A); SARS-CoV-2 positivity is evident in alveolar pneumocytes showing cytopathic features (B) and in the bronchiolar ciliated epithelium (B); diffuse interstitial macrophages detected by CD68 antibody (C, arrowheads); T-lymphocyte (D) and B-lymphocyte (E) infiltrates are revealed by CD3 and CD20 reactions, respectively; CD42b marks several microthrombi in capillary and interstitial vessels characterized by a rosary crown feature (F).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"In the lung, H&E revealed severe congestion, diffuse alveolar damage, and interstitial pneumonia presenting as septal infiltrate shown in the middle of the image (A); SARS-CoV-2 positivity is evident in alveolar pneumocytes showing cytopathic features (B) and in the bronchiolar ciliated epithelium (B); diffuse interstitial macrophages detected by CD68 antibody (C, arrowheads); T-lymphocyte (D) and B-lymphocyte (E) infiltrates are revealed by CD3 and CD20 reactions, respectively; CD42b marks several microthrombi in capillary and interstitial vessels characterized by a rosary crown feature (F).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"In the kidney, H&E labeled acute glomerular alterations in the lower part of the image and inflammatory infiltrates at the top (G); SARS-CoV-2 immunoreactivity detectable in some vascular endothelial cells (H, arrows); occasional foci of macrophages detected by the CD68 antibody (I, arrowheads); as in the lung, T-lymphocyte (J) and B-lymphocyte (K) infiltrates are revealed by CD3 and CD20 reactions, respectively; occasional microthrombi in the glomerular capillary are marked by CD42b antibody (L).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"In the heart, H&E stained parenchymal dissociation and myocyte vacuolization in the upper part of the image (M); rare SARS-CoV-2 traces observed in the endocardium (N, arrows); occasional foci of interstitial macrophages labeled by the CD68 antibody (O, arrowheads), rare subepicardial T-lymphocyte (P, arrows) and B-lymphocyte (Q, arrowheads) infiltrates revealed by CD3 and CD20 reactions in the upper and lower parts of the images, respectively; CD42b antibody marks focal and sporadic capillary microthrombi (R).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:865}, properties:{annotationPublicationtype:["Research"], evidence:"In the brain, H&E revealed diffuse neuronal loss and cortical edema characterized by spongiosis (S); very rare SARS-CoV-2-positive cells detected in the pons (T); amoeboid microglial cells and several microglial nodules identified by the CD68 antibody, mainly in the brainstem (U); rare T and B lymphocytes are observed in the perivascular spaces (V) and in some nodules (W); frequent capillary microthrombi are observed in the brainstem (X).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"In the brain, H&E revealed diffuse neuronal loss and cortical edema characterized by spongiosis (S); very rare SARS-CoV-2-positive cells detected in the pons (T); amoeboid microglial cells and several microglial nodules identified by the CD68 antibody, mainly in the brainstem (U); rare T and B lymphocytes are observed in the perivascular spaces (V) and in some nodules (W); frequent capillary microthrombi are observed in the brainstem (X).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain Stem"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:1014}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationCell:["type II pneumocyte"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2365}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pulmonary capillary"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:1252}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pulmonary capillary"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2366}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pulmonary capillary"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2373}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pulmonary capillary"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2374}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pulmonary capillary"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pulmonary capillary"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2365}, properties:{annotationPublicationtype:["Research"], evidence:"Findings from the kidneys included: (1) congestion and acute glomerular alterations in three cases; (2) SARS-CoV-2 positivity in the tubular epithelium and the capillary endothelium in three cases, and moderate to severe inflammatory infiltrates (T-lymphocytes and B-lymphocytes in the majority of cases, while macrophages were quite rare in all but one case); and (3) microthrombi and clots in two cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2375}, properties:{annotationPublicationtype:["Research"], evidence:"Findings from the kidneys included: (1) congestion and acute glomerular alterations in three cases; (2) SARS-CoV-2 positivity in the tubular epithelium and the capillary endothelium in three cases, and moderate to severe inflammatory infiltrates (T-lymphocytes and B-lymphocytes in the majority of cases, while macrophages were quite rare in all but one case); and (3) microthrombi and clots in two cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"Findings from the kidneys included: (1) congestion and acute glomerular alterations in three cases; (2) SARS-CoV-2 positivity in the tubular epithelium and the capillary endothelium in three cases, and moderate to severe inflammatory infiltrates (T-lymphocytes and B-lymphocytes in the majority of cases, while macrophages were quite rare in all but one case); and (3) microthrombi and clots in two cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2376}, properties:{annotationPublicationtype:["Research"], evidence:"The heart samples revealed: (1) hypoxic myocytic injuries; (2) sporadic SARS-CoV-2 traces in the endothelial and endocardial cells of one case, perivascular–parenchymal inflammatory infiltrates (prominent only in two cases) characterized by predominant macrophages with no evidence of T-lymphocytes and rare B-lymphocytes; and (3) relevant microthrombi in only one case.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"The heart samples revealed: (1) hypoxic myocytic injuries; (2) sporadic SARS-CoV-2 traces in the endothelial and endocardial cells of one case, perivascular–parenchymal inflammatory infiltrates (prominent only in two cases) characterized by predominant macrophages with no evidence of T-lymphocytes and rare B-lymphocytes; and (3) relevant microthrombi in only one case.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2377}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:998}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2378}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2379}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36231087", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["H&E staining"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels", "Frontal Lobe", "Pons"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2381}, properties:{annotationPublicationtype:["Research"], evidence:"The lungs frequently showed emphysema, dystelectasis, and anthracosis", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2382}, properties:{annotationPublicationtype:["Research"], evidence:"The lungs frequently showed emphysema, dystelectasis, and anthracosis", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:2383}, properties:{annotationPublicationtype:["Research"], evidence:"The lungs frequently showed emphysema, dystelectasis, and anthracosis", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2384}, properties:{annotationPublicationtype:["Research"], evidence:"The kidneys showed glomerulosclerosis and arteriolosclerosis.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2385}, properties:{annotationPublicationtype:["Research"], evidence:"The kidneys showed glomerulosclerosis and arteriolosclerosis.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2386}, properties:{annotationPublicationtype:["Research"], evidence:"The heart samples presented with myocardiosclerosis, lipofuscin deposits, and fatty infiltrates.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["myocardium"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2388}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:126}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:318}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2385}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2390}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2391}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2367}, properties:{annotationPublicationtype:["Research"], evidence:"Microthrombosis assumed a clinico-pathological relevance only in the lungs, with a significant prevalence of pulmonary microthrombi in COVID-19 cases (Figure 5; p = 0.023) in comparison with non-COVID pneumonia", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36231087", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["H&E staining"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:10}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"Well-studied molecules that promote neuronal degeneration include interleukin 1β and tumor necrosis factor(TNF).These cytokines in turn induce the synthesis of chemokines, leading to the recruitment of neutrophils and monocytes from the blood ", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:14}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"Well-studied molecules that promote neuronal degeneration include interleukin 1β and tumor necrosis factor(TNF).These cytokines in turn induce the synthesis of chemokines, leading to the recruitment of neutrophils and monocytes from the blood ", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:108}, end: {_id:65}, properties:{annotationPublicationtype:["Review"], evidence:"When the mouse lines are manipulated to reduce the expression of mutant SOD1 in microglia, including those adjacent to the diseased motor neurons, the rate of disease progression is slowed and lifespan extended", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationCell:["microglial cell"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Amyotrophic Lateral Sclerosis"], citationRef:"20234358"}}, {start: {_id:14}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, 13 089 patients with IBD were exposed to anti-TNF therapy on or after the IBD index date. We observed a markedly lower PD incidence rate (0.08 per 1000 patient-years)among patients with IBD who were exposed to anti-TNF therapy compared with patients with IBD who were not exposed to anti-TNF therapy (0.76 per 1000 patient-years)(Table 3)", citationTitle:"JAMA Neurol. 2018 Aug 1;75(8):939-946. doi:10.1001/jamaneurol.2018.0605.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Inflammatory Bowel Diseases"], source:"wp4-cbm-comorbidity", pmid:"29710331", citationType:"PubMed", citationRef:"29710331"}}, {start: {_id:775}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"These findings support the hypothesis that, also in the brain, susceptibility to infection by SARS-CoV-2 is governed by expression of ACE2, which is only present on ChP epithelial cells of the organoids.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:597}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Biallelic homozygous and compound heterozygous mutations in the GBA gene are known to cause Gaucher Disease, whereas individuals with heterozygous GBA mutations have a risk to develop PD which is 5 to 20 times higher compared to non-carriers", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:214}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Immunostaining showed accumulation of p-a-Syn (cohort 1, Figure 7F) in COVID-19 samples compared with the expression in non-COVID-19 samples, which indicates a potential link of PD phenotypes within the substantia nigra of COVID-19 patients despite the lack of acute clinical symptoms specific to midbrain dysfunction.34", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2243}, end: {_id:315}, properties:{annotationPublicationtype:["Review"], evidence:"FOXP3 was further considered as a specific intracellular marker of human Tregs(Figure 1), because mutations in FOXP3 were shown to cause human immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX)-like syndrome genetically.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:371}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"In mice expressing human wild type alpha-synuclein under the Thy1 promoter, frequencies of CD4 and CD8 T cells are increased in the peripheral blood [46].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:371}, end: {_id:257}, properties:{annotationPublicationtype:["Review"], evidence:"In mice expressing human wild type alpha-synuclein under the Thy1 promoter, frequencies of CD4 and CD8 T cells are increased in the peripheral blood [46].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1205}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, small-diameter vessels were predominantly lost and mice developed patchy hypoxia in the brain (Fig. 5g,h) but not in peripheral organs (Supplementary Fig. 5a,b).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1205}, end: {_id:1203}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, Nemo deletion led to a significant vessel rarefaction in the brain (Fig. 6a) and to a BBB disruption (Fig. 6c,f and Supplementary Fig. 5c)", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1205}, end: {_id:1207}, properties:{annotationPublicationtype:["Research"], evidence:"While the overall coverage of vessels by pericytes was slightly lowered (Fig. 5i), the number of microglia increased and they exhibited an activated morphology (Fig. 5j). The astrogliosis marker glial fibrillary acidic protein (GFAP) was strongly upregulated, indicating an inflammatory response (Fig. 5k).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:2325}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"As has recently been shown, the adoptive transfer of CD3-activated Tregs attenuates astrogliosis and microglial inflammation with concomitant neuroprotection in a murine model of HIV-1-associated neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:467}, end: {_id:469}, properties:{annotationPublicationtype:["Review"], evidence:"The Parkin gene encodes a multidomain protein that contains E3 ubiquitin ligase activity that plays a role in the regulation of numerous cellular activities including proteasomal degradation and ubiquitin-mediated signaling.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1190}, end: {_id:1193}, properties:{annotationPublicationtype:["Research"], evidence:"When expressed in human brain endothelial hCMEC/D3 cells, Mpro prevented the nuclear translocation of the NF-κB subunit p65, reflecting its activation in response to IL-1β (Fig. 4a). Mpro also abolished the stimulation of NF-κB-mediated gene transcription by IL-1β, which we investigated in hCMEC/D3 cells and mouse brain endothelial bEnd.3 cells using luciferase reporter gene assays (Fig. 4b, c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationConcentration:["0.25 µg/ml"], annotationCustomCellline:["hCMEC/D3 cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1195}, end: {_id:1198}, properties:{annotationPublicationtype:["Research"], evidence:"When expressed in human brain endothelial hCMEC/D3 cells, Mpro prevented the nuclear translocation of the NF-κB subunit p65, reflecting its activation in response to IL-1β (Fig. 4a). Mpro also abolished the stimulation of NF-κB-mediated gene transcription by IL-1β, which we investigated in hCMEC/D3 cells and mouse brain endothelial bEnd.3 cells using luciferase reporter gene assays (Fig. 4b, c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationConcentration:["0.25 µg/ml"], source:"wp4-cbm-comorbidity", annotationCellline:["bEnd.3 cell"], pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:420}, end: {_id:418}, properties:{annotationPublicationtype:["Review"], evidence:"DA neuron loss and behavioral deficits caused by both chronic and acute MPTP administration are attenuated in RAG2 knockout mice that lack both T and B cells [55, 112].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMouseType:["RAG2 -/- mice"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1205}, end: {_id:998}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, small-diameter vessels were predominantly lost and mice developed patchy hypoxia in the brain (Fig. 5g,h) but not in peripheral organs (Supplementary Fig. 5a,b).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1205}, end: {_id:872}, properties:{annotationPublicationtype:["Research"], evidence:"While the overall coverage of vessels by pericytes was slightly lowered (Fig. 5i), the number of microglia increased and they exhibited an activated morphology (Fig. 5j). The astrogliosis marker glial fibrillary acidic protein (GFAP) was strongly upregulated, indicating an inflammatory response (Fig. 5k).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:481}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, also α-syn silencing may cause neuroinflammation, suggesting that not only excessive α-syn concentrations but also perturbation of physiological α-syn levels could support PD pathogenesis", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1699}, end: {_id:1698}, properties:{annotationPublicationtype:["Research"], evidence:"The pre-synaptic proteins vGLUT1 and Synapsin 1 were decreased by 70% in MAP2+ cells (60% in overall cells) and by 60%, respectively, upon infection with SARS-CoV-2 compared to mock conditions, which were rescued upon treatment with SOF post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:1699}, end: {_id:825}, properties:{annotationPublicationtype:["Research"], evidence:"The pre-synaptic proteins vGLUT1 and Synapsin 1 were decreased by 70% in MAP2+ cells (60% in overall cells) and by 60%, respectively, upon infection with SARS-CoV-2 compared to mock conditions, which were rescued upon treatment with SOF post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:1699}, end: {_id:825}, properties:{annotationPublicationtype:["Research"], evidence:"Co-localized pre- and post-synaptic markers (Synapsin 1 and PSD95) also showed a significant reduction in infected BCO, which was also rescued with SOF treatment post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:1699}, end: {_id:824}, properties:{annotationPublicationtype:["Research"], evidence:"Co-localized pre- and post-synaptic markers (Synapsin 1 and PSD95) also showed a significant reduction in infected BCO, which was also rescued with SOF treatment post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:109}, end: {_id:108}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:114}, end: {_id:21}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:114}, end: {_id:112}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:114}, end: {_id:113}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:571}, end: {_id:570}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:676}, end: {_id:10}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1088}, end: {_id:775}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1088}, end: {_id:611}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1111}, end: {_id:1109}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1111}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1112}, end: {_id:1098}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1112}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1113}, end: {_id:1101}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1113}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1114}, end: {_id:1104}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1114}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1115}, end: {_id:1098}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1115}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1115}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1116}, end: {_id:1101}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:1116}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1116}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1117}, end: {_id:1104}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1117}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1117}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1119}, end: {_id:1104}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1120}, end: {_id:1104}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1120}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1121}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1121}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1189}, end: {_id:1188}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1189}, end: {_id:1165}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1190}, end: {_id:10}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1190}, end: {_id:1165}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1195}, end: {_id:1194}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1195}, end: {_id:1165}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1199}, end: {_id:14}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1199}, end: {_id:1165}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1211}, end: {_id:1210}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1211}, end: {_id:1204}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:1218}, end: {_id:1210}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1218}, end: {_id:1204}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1221}, end: {_id:1204}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1221}, end: {_id:1220}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1222}, end: {_id:1204}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1222}, end: {_id:1220}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1231}, end: {_id:1220}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1231}, end: {_id:1165}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1233}, end: {_id:1165}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1270}, end: {_id:611}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1271}, end: {_id:607}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1316}, end: {_id:1313}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1316}, end: {_id:1315}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1369}, end: {_id:1368}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1399}, end: {_id:582}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1399}, end: {_id:466}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1410}, end: {_id:1400}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1410}, end: {_id:1409}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1765}, end: {_id:775}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1765}, end: {_id:896}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:177}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia and monocytes in PD brains and CFS secrete proinflammatory and neurotoxic cytokines and chemokines that disrupt the BBB and attract lymphocytes to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid", "Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:179}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia and monocytes in PD brains and CFS secrete proinflammatory and neurotoxic cytokines and chemokines that disrupt the BBB and attract lymphocytes to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid", "Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:676}, end: {_id:669}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, ventilation-induced hypercapnia has been experimentally shown to lead to cognitive impairment in a NLRP3 inflammasome-interleukin-1β-dependent manner [23].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:1877}, end: {_id:18}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, a proinflammatory environment in the blood of persons with de novo PD was associated with faster motor and cognitive decline in a longitudinal study [71], and a panel combining cytokines and senescence markers in full blood cells was a good predictor of dementia [72], suggesting that inflammatory changes in the periphery denote a more aggressive form of PD", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:385}, end: {_id:233}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:676}, end: {_id:673}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__COMPLEX]->(end) SET r += row.properties;
UNWIND [{start: {_id:405}, end: {_id:122}, properties:{annotationPublicationtype:["Review"], evidence:"CD45RO+ expression also positively correlates with UPDRS motor score", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:437}, end: {_id:438}, properties:{annotationPublicationtype:["Review"], evidence:"CD4 T cells from people with the autoimmune disorder systemic lupus erythematosus have a 5-fold increase in alpha-synuclein expression that correlates with higher basal levels of autophagy [139].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Lupus Erythematosus, Systemic"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:13}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Systemic inflammation in PD is reflected by elevated serum IL-6, TNF-α and C-reactive protein, which are associated with severity or faster decline of motor symptoms [41]. In addition, there is an increased risk for PD among people who develop type 2 diabetes, especially at younger ages.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:14}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Systemic inflammation in PD is reflected by elevated serum IL-6, TNF-α and C-reactive protein, which are associated with severity or faster decline of motor symptoms [41]. In addition, there is an increased risk for PD among people who develop type 2 diabetes, especially at younger ages.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:575}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Systemic inflammation in PD is reflected by elevated serum IL-6, TNF-α and C-reactive protein, which are associated with severity or faster decline of motor symptoms [41]. In addition, there is an increased risk for PD among people who develop type 2 diabetes, especially at younger ages.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:582}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The consensus is that the wild type PD proteins PINK1 and Parkin contribute to an overall inflammatory defense.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:466}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The consensus is that the wild type PD proteins PINK1 and Parkin contribute to an overall inflammatory defense.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:575}, end: {_id:1561}, properties:{annotationPublicationtype:["Research"], evidence:"Figure 3 shows the partial regression of serum CRP on PBT during the acute phase of COVID-19 (performed in Long COVID and control participants combined).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationTimeline:["3-4 months post infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"36280755", citationType:"PubMed", annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36280755"}}, {start: {_id:1503}, end: {_id:1697}, properties:{annotationPublicationtype:["Research"], evidence:"The increase in viral N protein presence in BCO was accompanied by increased cell death.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:781}, end: {_id:47}, properties:{annotationPublicationtype:["Research"], evidence:"Specifically, CXCL9, CXCL10, and IL18BP in addition to the type II interferon signaling module that have been associated with the process described as 'inflammaging' 25, were positively correlated with higher age in cluster 4 in our cohort (Fig. 1H,I).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:665}, end: {_id:47}, properties:{annotationPublicationtype:["Research"], evidence:"Specifically, CXCL9, CXCL10, and IL18BP in addition to the type II interferon signaling module that have been associated with the process described as 'inflammaging' 25, were positively correlated with higher age in cluster 4 in our cohort (Fig. 1H,I).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1785}, end: {_id:47}, properties:{annotationPublicationtype:["Research"], evidence:"Specifically, CXCL9, CXCL10, and IL18BP in addition to the type II interferon signaling module that have been associated with the process described as 'inflammaging' 25, were positively correlated with higher age in cluster 4 in our cohort (Fig. 1H,I).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:26}, end: {_id:47}, properties:{annotationPublicationtype:["Research"], evidence:"We also found a significant association between serum S100β and age.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:196}, end: {_id:2175}, properties:{annotationPublicationtype:["Research"], evidence:"Levels of TGFβ and D-dimer were significantly associated with the percentage of voxels with abnormal leakage but only TGFβ was significant after correcting for multiple comparisons (Fig. ​(Fig.5e).5e). The levels of TGFβ were significantly associated with GBV, CSF volume, brainstem volume and amygdala volume.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:9}, properties:{annotationPublicationtype:["Review"], evidence:"Illustrating these points, McCann's group have shown that the activity of the proinflammatory cytokine IL-1b is inhibited by inhibitory cytokines, one of the most potent of which is IL-1ra, that increases rapidly in the circulatory system to 100-fold higher than the IL-1b levels [13].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cardiovascular System"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:12}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast to the circulatory system they find very little increase in IL-1ra in the brain, and if then, only much later once IL-1b levels have risen significantly [13].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast to the circulatory system they find very little increase in IL-1ra in the brain, and if then, only much later once IL-1b levels have risen significantly [13].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Another amplification system invoking cytokine-mediated processes shown to occur in Alzheimer's disease involves increased IL-1b production in neuritic plaques [19].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Plaque, Amyloid"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:29}, properties:{annotationPublicationtype:["Review"], evidence:"They cite many studies that have shown that several markers of inflammation (major histocompatibility complex, acute phase reactants, complement proteins, cytokines, etc.) have been shown to be significantly increased in the Alzheimer's brain but importantly in most cases the complimentary anti-inflammatory component is also increasingly present [14].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Other anti-inflammatory mediators that have been shown to increase when the corresponding inflammatory agent is increased include: (1) IL-10, which is thought to counteract IL-6 [20]; (2) CD59, the membrane inhibitor of reactive lysis [21]; and (3) SP-40,40 which has clusterin activity [22].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:33}, properties:{annotationPublicationtype:["Review"], evidence:"Other anti-inflammatory mediators that have been shown to increase when the corresponding inflammatory agent is increased include: (1) IL-10, which is thought to counteract IL-6 [20]; (2) CD59, the membrane inhibitor of reactive lysis [21]; and (3) SP-40,40 which has clusterin activity [22].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:35}, properties:{annotationPublicationtype:["Review"], evidence:"Other anti-inflammatory mediators that have been shown to increase when the corresponding inflammatory agent is increased include: (1) IL-10, which is thought to counteract IL-6 [20]; (2) CD59, the membrane inhibitor of reactive lysis [21]; and (3) SP-40,40 which has clusterin activity [22].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:41}, end: {_id:42}, properties:{annotationPublicationtype:["Review"], evidence:"Experimental stroke in a rat model has been shown to cause the upregulation of cycloxygenase II (COX II) genes in neurons [32], and the induction of inducible nitric oxide synthase (iNOS) in the microvasculature [33].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:41}, end: {_id:43}, properties:{annotationPublicationtype:["Review"], evidence:"Experimental stroke in a rat model has been shown to cause the upregulation of cycloxygenase II (COX II) genes in neurons [32], and the induction of inducible nitric oxide synthase (iNOS) in the microvasculature [33].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshanatomy:["Microvessels"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:67}, end: {_id:93}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, COX-2 is present as increased levels of TRAF family member-associated NFκB activator (TANK) and NFKB1 in the SN, and IL-15, RANTES, and IL-10 levels are significantly elevated in brains and peripheral circulation in PD patients .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:182}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, COX-2 is present as increased levels of TRAF family member-associated NFκB activator (TANK) and NFKB1 in the SN, and IL-15, RANTES, and IL-10 levels are significantly elevated in brains and peripheral circulation in PD patients .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:183}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, COX-2 is present as increased levels of TRAF family member-associated NFκB activator (TANK) and NFKB1 in the SN, and IL-15, RANTES, and IL-10 levels are significantly elevated in brains and peripheral circulation in PD patients .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:184}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, COX-2 is present as increased levels of TRAF family member-associated NFκB activator (TANK) and NFKB1 in the SN, and IL-15, RANTES, and IL-10 levels are significantly elevated in brains and peripheral circulation in PD patients .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:185}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, COX-2 is present as increased levels of TRAF family member-associated NFκB activator (TANK) and NFKB1 in the SN, and IL-15, RANTES, and IL-10 levels are significantly elevated in brains and peripheral circulation in PD patients .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, COX-2 is present as increased levels of TRAF family member-associated NFκB activator (TANK) and NFKB1 in the SN, and IL-15, RANTES, and IL-10 levels are significantly elevated in brains and peripheral circulation in PD patients .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:214}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, aberrant species of disease-specific proteins, including phosphorylated α-syn, are present in tissues outside the CNS in PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, levels of IL-1β, IL-6, and TNF-α are elevated in the CFS of PD patients (Blum-Degen et al. 1995; Gonzalez-Scarano and Baltuch 1999), and intercellular adhesion molecule-1 (ICAM-1)-positive glia are also increased in the SN of PD brains.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, levels of IL-1β, IL-6, and TNF-α are elevated in the CFS of PD patients (Blum-Degen et al. 1995; Gonzalez-Scarano and Baltuch 1999), and intercellular adhesion molecule-1 (ICAM-1)-positive glia are also increased in the SN of PD brains.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, levels of IL-1β, IL-6, and TNF-α are elevated in the CFS of PD patients (Blum-Degen et al. 1995; Gonzalez-Scarano and Baltuch 1999), and intercellular adhesion molecule-1 (ICAM-1)-positive glia are also increased in the SN of PD brains.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:26}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:241}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:203}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:243}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:146}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:146}, properties:{annotationPublicationtype:["Review"], evidence:"In PD patients, approximately 4% of the pigmented neurons contained Lewy bodies and all pigmented, Lewy body-containing neurons showed detectable IgG and α-syn within inclusions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:146}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, levels of antibodies to α-syn and catecholamine-derived melanin (neuromelanin) are increased in PD patients with antineuromelanin immunoglobulin binding shown to be more active in early disease.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:184}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:185}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Increased levels of cytokines (including IL-1B, TGF-B, IFN, and IL-6) as measured post-mortem were found in the CSF and nigrostriatal regions of individuals with PD relative to age-matched healthy controls [31, 37–39].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["nigrostriatal tract", "cerebrospinal fluid"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:196}, properties:{annotationPublicationtype:["Review"], evidence:"Increased levels of cytokines (including IL-1B, TGF-B, IFN, and IL-6) as measured post-mortem were found in the CSF and nigrostriatal regions of individuals with PD relative to age-matched healthy controls [31, 37–39].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["nigrostriatal tract", "cerebrospinal fluid"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:363}, properties:{annotationPublicationtype:["Review"], evidence:"Increased levels of cytokines (including IL-1B, TGF-B, IFN, and IL-6) as measured post-mortem were found in the CSF and nigrostriatal regions of individuals with PD relative to age-matched healthy controls [31, 37–39].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["nigrostriatal tract", "cerebrospinal fluid"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Increased levels of cytokines (including IL-1B, TGF-B, IFN, and IL-6) as measured post-mortem were found in the CSF and nigrostriatal regions of individuals with PD relative to age-matched healthy controls [31, 37–39].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["nigrostriatal tract", "cerebrospinal fluid"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Serum levels of TNFalpha are elevated in PD patients and the serum levels of IL-6 correlate with Hoehn and Yahr staging [41].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Serum levels of TNFalpha are elevated in PD patients and the serum levels of IL-6 correlate with Hoehn and Yahr staging [41].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:378}, properties:{annotationPublicationtype:["Review"], evidence:"Upregulation of ICAM-1, an important adhesion molecule for immune cell diapedesis, has been reported on blood vessels near the SN in postmortem brain tissue from PD patients.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:399}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, levels of B2 microglobulin, a protein required for stability of MHC-I molecules, are increased in the striatum of PD patients [38].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["striatum"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:325}, properties:{annotationPublicationtype:["Review"], evidence:"Markers of apoptosis, caspase-3, and Cu/Zn superoxide dismutase activity are increased in lymphocytes from people with PD [111].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCell:["lymphocyte"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:441}, properties:{annotationPublicationtype:["Review"], evidence:"Alpha-synuclein is also over-expressed in the T cells of these mice, thus the role of this protein in immune cells versus neurons will need to be evaluated in greater depth.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:458}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"In fact, increased LRRK2 expression is found in the epithelium of  Crohn's disease patients in many cell types including macrophages, dendritic cells, and B lymphocytes[160].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Crohn Disease"], annotationMeshanatomy:["B-Lymphocytes", "Macrophages", "Dendritic Cells", "Epithelium"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:301}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:274}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:661}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:662}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:271}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:663}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:268}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:575}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:664}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:665}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:666}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:667}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Cytokines and related inflammatory mediators found to be elevated include interleukin-1β, interleukin-2, interleukin-2 receptor, interleukin-4, interleukin-10, interleukin-18, interferon-γ, C-reactive protein, granulocyte colony-stimulating factor, interferon-γ, CXCL10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α [10, 12]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Given the above cytokine findings in COVID-19 patients and in particular the rise of interleukin-1β and interleukin-18, it seems highly likely that COVID-19 patients suffer from NLRP3 inflammasome activation. This activation and the subsequent increased activity of proinflammatory immune pathways are likely to exert a negative impact on cerebral homeostasis and function.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:663}, properties:{annotationPublicationtype:["Review"], evidence:"Given the above cytokine findings in COVID-19 patients and in particular the rise of interleukin-1β and interleukin-18, it seems highly likely that COVID-19 patients suffer from NLRP3 inflammasome activation. This activation and the subsequent increased activity of proinflammatory immune pathways are likely to exert a negative impact on cerebral homeostasis and function.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"A correlate of this HLA-DR-positive, presumably myeloid-driven inflammatory response was found in the CSF, where levels of inflammatory mediators such as interleukin (IL)-6, IL-18, CC-chemokine ligand 2 (CCL2) and soluble intercellular adhesion molecule-1 (sICAM-1) were found to be increased (Supplementary Fig. 4a)30.", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:663}, properties:{annotationPublicationtype:["Research"], evidence:"A correlate of this HLA-DR-positive, presumably myeloid-driven inflammatory response was found in the CSF, where levels of inflammatory mediators such as interleukin (IL)-6, IL-18, CC-chemokine ligand 2 (CCL2) and soluble intercellular adhesion molecule-1 (sICAM-1) were found to be increased (Supplementary Fig. 4a)30.", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:666}, properties:{annotationPublicationtype:["Research"], evidence:"A correlate of this HLA-DR-positive, presumably myeloid-driven inflammatory response was found in the CSF, where levels of inflammatory mediators such as interleukin (IL)-6, IL-18, CC-chemokine ligand 2 (CCL2) and soluble intercellular adhesion molecule-1 (sICAM-1) were found to be increased (Supplementary Fig. 4a)30.", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:378}, properties:{annotationPublicationtype:["Research"], evidence:"A correlate of this HLA-DR-positive, presumably myeloid-driven inflammatory response was found in the CSF, where levels of inflammatory mediators such as interleukin (IL)-6, IL-18, CC-chemokine ligand 2 (CCL2) and soluble intercellular adhesion molecule-1 (sICAM-1) were found to be increased (Supplementary Fig. 4a)30.", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"The data presented in Table 1 highlights the significant association between each cytokine and SARS CoV-2 protein detection in the microvessels (each p < 0.001).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Microvessels"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:14}, properties:{annotationPublicationtype:["Research"], evidence:"The data presented in Table 1 highlights the significant association between each cytokine and SARS CoV-2 protein detection in the microvessels (each p < 0.001).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Microvessels"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:914}, properties:{annotationPublicationtype:["Research"], evidence:"NMDAR2 was not detected in the normal brain tissues. It was expressed in the COVID-19 brains where it was evident in neurons adjacent to SARS-CoV-2 positive microvessels (Table 1 and Fig. 2).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:915}, properties:{annotationPublicationtype:["Research"], evidence:"NMDAR2 was not detected in the normal brain tissues. It was expressed in the COVID-19 brains where it was evident in neurons adjacent to SARS-CoV-2 positive microvessels (Table 1 and Fig. 2).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:916}, properties:{annotationPublicationtype:["Research"], evidence:"NMDAR2 was not detected in the normal brain tissues. It was expressed in the COVID-19 brains where it was evident in neurons adjacent to SARS-CoV-2 positive microvessels (Table 1 and Fig. 2).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:917}, properties:{annotationPublicationtype:["Research"], evidence:"NMDAR2 was not detected in the normal brain tissues. It was expressed in the COVID-19 brains where it was evident in neurons adjacent to SARS-CoV-2 positive microvessels (Table 1 and Fig. 2).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:918}, properties:{annotationPublicationtype:["Research"], evidence:"Similarly, the percentage of neurons with nNOS was significantly greater (p < 0.001) in the COVID-19 brain tissues compared to the controls (Table 1 and Fig. 2).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:640}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that infection was more efficient in neurons than in NPCs (Figures 3F and 3G), an observation that correlates with the levels of ACE2 and TMPRSS2 expression in neurons and NPCs (Figures 3B and 3C).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunofluorescent labeling"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:891}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that infection was more efficient in neurons than in NPCs (Figures 3F and 3G), an observation that correlates with the levels of ACE2 and TMPRSS2 expression in neurons and NPCs (Figures 3B and 3C).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunofluorescent labeling"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"This stage of the disease is characterized by high levels of pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL-1β, IL-18 and  granulocyte–macrophage colony-stimulating factor (GM–CSF)", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"This stage of the disease is characterized by high levels of pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL-1β, IL-18 and  granulocyte–macrophage colony-stimulating factor (GM–CSF)", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:663}, properties:{annotationPublicationtype:["Review"], evidence:"This stage of the disease is characterized by high levels of pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL-1β, IL-18 and  granulocyte–macrophage colony-stimulating factor (GM–CSF)", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:999}, properties:{annotationPublicationtype:["Review"], evidence:"This stage of the disease is characterized by high levels of pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL-1β, IL-18 and  granulocyte–macrophage colony-stimulating factor (GM–CSF)", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, NLRP3 inflammasome products, such as IL-1β and IL-18, are increased in patients with severe COVID-19 and positively correlated with adverse clinical outcomes", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:663}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, NLRP3 inflammasome products, such as IL-1β and IL-18, are increased in patients with severe COVID-19 and positively correlated with adverse clinical outcomes", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"They also had higher levels of pro-inflammatory cytokines (such as IL-6, IL-8 and IL-1β) and chemokines (such as CCL2, CCL3, CCL4 and CCL7) in the bronchoalveolar fluid", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1006}, properties:{annotationPublicationtype:["Review"], evidence:"They also had higher levels of pro-inflammatory cytokines (such as IL-6, IL-8 and IL-1β) and chemokines (such as CCL2, CCL3, CCL4 and CCL7) in the bronchoalveolar fluid", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"They also had higher levels of pro-inflammatory cytokines (such as IL-6, IL-8 and IL-1β) and chemokines (such as CCL2, CCL3, CCL4 and CCL7) in the bronchoalveolar fluid", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:666}, properties:{annotationPublicationtype:["Review"], evidence:"They also had higher levels of pro-inflammatory cytokines (such as IL-6, IL-8 and IL-1β) and chemokines (such as CCL2, CCL3, CCL4 and CCL7) in the bronchoalveolar fluid", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:667}, properties:{annotationPublicationtype:["Review"], evidence:"They also had higher levels of pro-inflammatory cytokines (such as IL-6, IL-8 and IL-1β) and chemokines (such as CCL2, CCL3, CCL4 and CCL7) in the bronchoalveolar fluid", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1007}, properties:{annotationPublicationtype:["Review"], evidence:"They also had higher levels of pro-inflammatory cytokines (such as IL-6, IL-8 and IL-1β) and chemokines (such as CCL2, CCL3, CCL4 and CCL7) in the bronchoalveolar fluid", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1012}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, high levels of plasminogen activator inhibitor 1 (PAI1) were described in patients with SARS-CoV", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:159}, properties:{annotationPublicationtype:["Review"], evidence:"Endothelial cells of lung blood vessels can be activated by the high levels of pro-inflammatory cytokines (IL-1, IL-6 and TNF) and ferritin in severe COVID-19 (ref.60).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Endothelial cells of lung blood vessels can be activated by the high levels of pro-inflammatory cytokines (IL-1, IL-6 and TNF) and ferritin in severe COVID-19 (ref.60).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Endothelial cells of lung blood vessels can be activated by the high levels of pro-inflammatory cytokines (IL-1, IL-6 and TNF) and ferritin in severe COVID-19 (ref.60).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1018}, properties:{annotationPublicationtype:["Review"], evidence:"Higher levels of soluble P-selectin (a marker of endothelial and platelet activation) were observed in patients admitted to the ICU than in patients not in the ICU, whereas increased levels of thrombomodulin (a specific marker of endothelial activation generally released during endothelial cell injury) were associated with increased mortality risk35", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["patients admitted to the ICU"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1019}, properties:{annotationPublicationtype:["Review"], evidence:"Higher levels of soluble P-selectin (a marker of endothelial and platelet activation) were observed in patients admitted to the ICU than in patients not in the ICU, whereas increased levels of thrombomodulin (a specific marker of endothelial activation generally released during endothelial cell injury) were associated with increased mortality risk35", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["patients admitted to the ICU"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1022}, properties:{annotationPublicationtype:["Review"], evidence:"Higher numbers of circulating endothelial cells were described in patients with COVID-19, especially among those admitted to the ICU, and the presence of circulating endothelial cells positively correlated with platelet and lymphocyte counts and with the classical endothelial marker soluble vascular cell adhesion molecule 1 (sVCAM1)65.", annotationCellType:["Circulating"], citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["patients admitted to the ICU"], annotationProteinType:["Soluble"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:378}, properties:{annotationPublicationtype:["Review"], evidence:"This was recently confirmed by another report from Italy,showing that patients with COVID-19 had increased circulating endothelial cells and higher plasma levels of soluble intercellular adhesion molecule 1 (sICAM1) and sVCAM1, further supporting the concept of endothelial dysfunction in COVID-19 (ref.66).", annotationCellType:["Circulating"], citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationProteinType:["Soluble"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1022}, properties:{annotationPublicationtype:["Review"], evidence:"This was recently confirmed by another report from Italy,showing that patients with COVID-19 had increased circulating endothelial cells and higher plasma levels of soluble intercellular adhesion molecule 1 (sICAM1) and sVCAM1, further supporting the concept of endothelial dysfunction in COVID-19 (ref.66).", annotationCellType:["Circulating"], citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationProteinType:["Soluble"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1069}, properties:{annotationPublicationtype:["Research"], evidence:"A strong cleaved caspase-3 signal was detected both in infected and non-infected cells in patients with COVID-19, whereas no signal was detected in samples from control individuals (Fig. 1, E and F, Fig. 2C, Tables S1 and S2).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Olfaction Disorders"], annotationBioassay:["immunofluorescent labeling"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:391}, end: {_id:1234}, properties:{annotationPublicationtype:["Research"], evidence:"Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion.", citationTitle:"Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Abstract"], annotationMeshdisease:["Multiple Sclerosis"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35025605", citationType:"PubMed", citationRef:"35025605"}}, {start: {_id:391}, end: {_id:1234}, properties:{annotationPublicationtype:["Research"], evidence:"sNfL levels in individuals who were EBV-negative at baseline and went on to develop MS were similar to those of non-MS controls before and around the time of EBV infection but increased after EBV infection (Fig. 3, A to C, and fig. S4).", citationTitle:"Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Multiple Sclerosis"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35025605", citationType:"PubMed", citationRef:"35025605"}}, {start: {_id:640}, end: {_id:1291}, properties:{annotationPublicationtype:["Research"], evidence:"To validate our findings, we performed immunohistochemical staining of IFITM2 in COVID-19 and control brains. Here, we could show that IFITM2 expression is restricted to the neurovascular unit and upregulated in COVID-19 patients.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunolabeling method"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1156}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast to these highly specific transcriptional changes, the brain endothelial marker CD31 revealed no significant differences between COVID-19 and control brains (Figures S1A and S1B). Assessment of the abundance of the SARS-CoV-2 entry factors ACE2 and NRP1 in human cortex brain vessels revealed that NRP1 was more abundant than ACE2.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:67}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Early findings mainly looked at cytokines and other inflammatory markers in the cerebral spinal fluid (CSF) of PD patients, revealing increased levels of IL-1β and IL-6 [135, 136]", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:67}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Early findings mainly looked at cytokines and other inflammatory markers in the cerebral spinal fluid (CSF) of PD patients, revealing increased levels of IL-1β and IL-6 [135, 136]", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:67}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, LRRK2 expression was upregulated in B cells, T cells and CD16 monocytes from sporadic PD patients compared to healthy controls [152], highlighting cell type specificity as an important factor in biomarker studies.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["B-Lymphocytes", "T-Lymphocytes", "Monocytes"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1472}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Strikingly, we observed abundant infection in astrocytes, as indicated by the presence of viral N protein, S RNA, and dsRNA, with 90% of infected cells expressing glial fibrillary acidic protein (GFAP) or Aquaporin 4 (AQP4) throughout the outer subventricular zone (SVZ) of primary cortical tissue (Fig. 1B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:241}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Strikingly, we observed abundant infection in astrocytes, as indicated by the presence of viral N protein, S RNA, and dsRNA, with 90% of infected cells expressing glial fibrillary acidic protein (GFAP) or Aquaporin 4 (AQP4) throughout the outer subventricular zone (SVZ) of primary cortical tissue (Fig. 1B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:859}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Strikingly, we observed abundant infection in astrocytes, as indicated by the presence of viral N protein, S RNA, and dsRNA, with 90% of infected cells expressing glial fibrillary acidic protein (GFAP) or Aquaporin 4 (AQP4) throughout the outer subventricular zone (SVZ) of primary cortical tissue (Fig. 1B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1474}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Immature astrocytes expressing HOPX and PAX6, as well as maturing astrocytes expressing S100B and GLAST, demonstrated high infectivity.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["immature astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1475}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Immature astrocytes expressing HOPX and PAX6, as well as maturing astrocytes expressing S100B and GLAST, demonstrated high infectivity.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["immature astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:26}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Immature astrocytes expressing HOPX and PAX6, as well as maturing astrocytes expressing S100B and GLAST, demonstrated high infectivity.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["mature astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1476}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Immature astrocytes expressing HOPX and PAX6, as well as maturing astrocytes expressing S100B and GLAST, demonstrated high infectivity.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["mature astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:775}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Additionally, vascular units, many of which were surrounded by GFAP+ astrocytes forming the blood brain barrier, express a SARS-CoV-2 entry factor, ACE2.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1494}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:293}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1495}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1496}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1497}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"In addition to an increase in inflammatory and reactivity gene expression in microglia, there was an increased abundance of CD14, IFITM3, and TREM2 protein in infected astrocytes.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1498}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"In addition to an increase in inflammatory and reactivity gene expression in microglia, there was an increased abundance of CD14, IFITM3, and TREM2 protein in infected astrocytes.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1494}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"In addition to an increase in inflammatory and reactivity gene expression in microglia, there was an increased abundance of CD14, IFITM3, and TREM2 protein in infected astrocytes.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1501}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Although there was enrichment for microglial and astrocyte activation in the gene set upregulated in infection, genes associated with high SARS-CoV-2 E and N were overwhelmingly enriched in two reactive astrocyte states that appear to be downstream of Nuclear factor kappa B (NF-κB) signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1472}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Although there was enrichment for microglial and astrocyte activation in the gene set upregulated in infection, genes associated with high SARS-CoV-2 E and N were overwhelmingly enriched in two reactive astrocyte states that appear to be downstream of Nuclear factor kappa B (NF-κB) signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1158}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Three days after SARS-CoV-2 exposure, astrocytes treated with the control scramble-red fluorescent protein (RFP) lentivirus displayed robust infection by SARS-CoV-2 (Fig. 5D). When slices were pretreated with a potent shRNA against CD147, there was a significant reduction in SARS-CoV-2 infection.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1158}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We exposed the CD147- or DPP4-expressing organoids to SARS-CoV-2 for 2 h. We observed a significant increase in SARS-CoV-2 N+ cells with DPP4 overexpression and an increase in dsRNA+ cells in both DPP4- and CD147-overexpressing conditions (SI Appendix, Fig. 13C). Taken together with the loss of function and inhibition studies, these findings indicate that DPP4 and CD147 are sufficient to mediate SARS-CoV-2 infection and suggest that DPP4 may promote viral entry, while CD147 may promote viral replication.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:894}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We exposed the CD147- or DPP4-expressing organoids to SARS-CoV-2 for 2 h. We observed a significant increase in SARS-CoV-2 N+ cells with DPP4 overexpression and an increase in dsRNA+ cells in both DPP4- and CD147-overexpressing conditions (SI Appendix, Fig. 13C). Taken together with the loss of function and inhibition studies, these findings indicate that DPP4 and CD147 are sufficient to mediate SARS-CoV-2 infection and suggest that DPP4 may promote viral entry, while CD147 may promote viral replication.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1158}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We found that GFAP+ adult cortical astrocytes, similar to developing astrocytes, express both CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:894}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We found that GFAP+ adult cortical astrocytes, similar to developing astrocytes, express both CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1158}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Moreover, infected SARS-CoV-2 S+ VIM+ astrocytes expressed DPP4 and CD147 but not ACE2 (Fig. 6C). The high abundance of VIM in infected cells suggests both specific astrocyte tropism as well as reactivity in adult tissue. Together with our observations in infected organoids and developing tissue, these data suggest tropism of SARS-CoV-2 for astrocytes in both developing and adult human cortex. Furthermore, the capacity for viral propagation can occur independent of ACE2 and is mediated, in part, by CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:894}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Moreover, infected SARS-CoV-2 S+ VIM+ astrocytes expressed DPP4 and CD147 but not ACE2 (Fig. 6C). The high abundance of VIM in infected cells suggests both specific astrocyte tropism as well as reactivity in adult tissue. Together with our observations in infected organoids and developing tissue, these data suggest tropism of SARS-CoV-2 for astrocytes in both developing and adult human cortex. Furthermore, the capacity for viral propagation can occur independent of ACE2 and is mediated, in part, by CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1506}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Moreover, infected SARS-CoV-2 S+ VIM+ astrocytes expressed DPP4 and CD147 but not ACE2 (Fig. 6C). The high abundance of VIM in infected cells suggests both specific astrocyte tropism as well as reactivity in adult tissue. Together with our observations in infected organoids and developing tissue, these data suggest tropism of SARS-CoV-2 for astrocytes in both developing and adult human cortex. Furthermore, the capacity for viral propagation can occur independent of ACE2 and is mediated, in part, by CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1566}, end: {_id:575}, properties:{annotationPublicationtype:["Research"], evidence:"We found that 23.0% of the variance in the somatic HAMD score (regression #2) was explained by the cumulative effects of lowered Gpx and zinc, increased NO and CRP and vaccination with AstraZeneca or Pfizer.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1706}, properties:{annotationPublicationtype:["Case Report"], evidence:"The perivascular region from the patient showed immune cell infiltrates, fibrinogen leakage, increased PECAM-1 expression, and CD68 infiltrates (Figure 1A).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:1781}, end: {_id:1782}, properties:{annotationPublicationtype:["Research"], evidence:"We noted that well-described BMI associated proteins like (Leptin (LEP) and Fatty Acid Binding Protein(FABP4)) and the Leptin signaling module were significantly increased in participants with high BMI (clusters 4 and 5) in our cohort (Fig. 1E,F)22–24", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1781}, end: {_id:1783}, properties:{annotationPublicationtype:["Research"], evidence:"We noted that well-described BMI associated proteins like (Leptin (LEP) and Fatty Acid Binding Protein(FABP4)) and the Leptin signaling module were significantly increased in participants with high BMI (clusters 4 and 5) in our cohort (Fig. 1E,F)22–24", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1781}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"We also noted that interleukin-6 (IL-6), identified as part of the inflammatory signature associated with PASC, was positively correlated with BMI (Fig. 1E)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1781}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"These data suggest that BMI may be a risk factor for exhibiting an inflammatory PASC phenotype but does not account fully for the increased IL-6 observed in inflammatory PASC because a small subset of participants whose BMI was within the 'healthy' range also had increased IL-6 as part of their inflammatory proteomic signature.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1786}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1787}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ was the cytokine that most significantly defines cluster 4 (Fig. 3A, B, Supplemental Fig. S8, Supplemental Data S8). In addition to IFN-γ, increased expression of chemokines and cytokines known to be regulated by IFN-γ including CXCL9, CXCL10, CXCL11 and IL-27 in cluster 4 suggests that it is functionally active", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:781}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ was the cytokine that most significantly defines cluster 4 (Fig. 3A, B, Supplemental Fig. S8, Supplemental Data S8). In addition to IFN-γ, increased expression of chemokines and cytokines known to be regulated by IFN-γ including CXCL9, CXCL10, CXCL11 and IL-27 in cluster 4 suggests that it is functionally active", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:665}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ was the cytokine that most significantly defines cluster 4 (Fig. 3A, B, Supplemental Fig. S8, Supplemental Data S8). In addition to IFN-γ, increased expression of chemokines and cytokines known to be regulated by IFN-γ including CXCL9, CXCL10, CXCL11 and IL-27 in cluster 4 suggests that it is functionally active", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1789}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ was the cytokine that most significantly defines cluster 4 (Fig. 3A, B, Supplemental Fig. S8, Supplemental Data S8). In addition to IFN-γ, increased expression of chemokines and cytokines known to be regulated by IFN-γ including CXCL9, CXCL10, CXCL11 and IL-27 in cluster 4 suggests that it is functionally active", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1786}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ was the cytokine that most significantly defines cluster 4 (Fig. 3A, B, Supplemental Fig. S8, Supplemental Data S8). In addition to IFN-γ, increased expression of chemokines and cytokines known to be regulated by IFN-γ including CXCL9, CXCL10, CXCL11 and IL-27 in cluster 4 suggests that it is functionally active", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1790}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed increased expression of IL-12 p40(IL12B) and the IL-12 p40/p70 heterodimer (IL12A_IL12B) in cluster 4,which may drive expression of IFN-γ and an overall Th1 signature(Fig. 3A, B). While not as strongly differentially expressed in cluster 5,IFN-γ and IFN-γ induced chemokines are enriched compared to those that recovered from COVID or were uninfected (Fig. 3B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed increased expression of IL-12 p40(IL12B) and the IL-12 p40/p70 heterodimer (IL12A_IL12B) in cluster 4,which may drive expression of IFN-γ and an overall Th1 signature(Fig. 3A, B). While not as strongly differentially expressed in cluster 5,IFN-γ and IFN-γ induced chemokines are enriched compared to those that recovered from COVID or were uninfected (Fig. 3B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:781}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed increased expression of IL-12 p40(IL12B) and the IL-12 p40/p70 heterodimer (IL12A_IL12B) in cluster 4,which may drive expression of IFN-γ and an overall Th1 signature(Fig. 3A, B). While not as strongly differentially expressed in cluster 5,IFN-γ and IFN-γ induced chemokines are enriched compared to those that recovered from COVID or were uninfected (Fig. 3B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:665}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed increased expression of IL-12 p40(IL12B) and the IL-12 p40/p70 heterodimer (IL12A_IL12B) in cluster 4,which may drive expression of IFN-γ and an overall Th1 signature(Fig. 3A, B). While not as strongly differentially expressed in cluster 5,IFN-γ and IFN-γ induced chemokines are enriched compared to those that recovered from COVID or were uninfected (Fig. 3B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1789}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed increased expression of IL-12 p40(IL12B) and the IL-12 p40/p70 heterodimer (IL12A_IL12B) in cluster 4,which may drive expression of IFN-γ and an overall Th1 signature(Fig. 3A, B). While not as strongly differentially expressed in cluster 5,IFN-γ and IFN-γ induced chemokines are enriched compared to those that recovered from COVID or were uninfected (Fig. 3B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1786}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed increased expression of IL-12 p40(IL12B) and the IL-12 p40/p70 heterodimer (IL12A_IL12B) in cluster 4,which may drive expression of IFN-γ and an overall Th1 signature(Fig. 3A, B). While not as strongly differentially expressed in cluster 5,IFN-γ and IFN-γ induced chemokines are enriched compared to those that recovered from COVID or were uninfected (Fig. 3B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ, IL-12 p40, and IFN-γ-driven chemokines were consistently elevated in inflammatory PASC relative to the other 2 groups (Fig. 3C and supplemental Fig. S9).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1790}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ, IL-12 p40, and IFN-γ-driven chemokines were consistently elevated in inflammatory PASC relative to the other 2 groups (Fig. 3C and supplemental Fig. S9).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:781}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ, IL-12 p40, and IFN-γ-driven chemokines were consistently elevated in inflammatory PASC relative to the other 2 groups (Fig. 3C and supplemental Fig. S9).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:665}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ, IL-12 p40, and IFN-γ-driven chemokines were consistently elevated in inflammatory PASC relative to the other 2 groups (Fig. 3C and supplemental Fig. S9).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1789}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ, IL-12 p40, and IFN-γ-driven chemokines were consistently elevated in inflammatory PASC relative to the other 2 groups (Fig. 3C and supplemental Fig. S9).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1786}, properties:{annotationPublicationtype:["Research"], evidence:"IFN-γ, IL-12 p40, and IFN-γ-driven chemokines were consistently elevated in inflammatory PASC relative to the other 2 groups (Fig. 3C and supplemental Fig. S9).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:14}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1007}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1794}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1795}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:781}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1796}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1785}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:665}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1797}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1798}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to the IFN-γ related signature noted above, we also observed that TNF, TNF-driven cytokines and chemokines (including IL-6 and CCL7 (MCP3)), and several TNF receptor superfamily members were also increased in both inflammatory PASC clusters but most extensively in cluster 4 (Fig. 3A, E).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1841}, end: {_id:1843}, properties:{annotationPublicationtype:["Review"], evidence:"A recent study showed that the cytokine CCL11 (eotaxin-1) remains elevated in long COVID patients suffering from brain fog, and high levels of CCL11 have been associated with demyelination of oligodendrocytes and activation of hippocampal microglia (Fernández-Castañeda et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationCustomDisease:["Long COVID"], citationRef:"37458167"}}, {start: {_id:67}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 appears to be involved in monocyte maturation and stimulation [16], and, interestingly, LRRK2 is upregulated in blood immune cells during iPD [22,23].", annotationCustomCell:["Blood immune cells"], citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:382}, properties:{annotationPublicationtype:["Review"], evidence:"The concept of neuroinflammation in PD was initially proposed based on the presence of responsive microglia in PD postmortem brains, as revealed by upregulated human leukocyte antigen (HLA)- DR (major histocompatibility complex; MHC-II) and CD68 [29,30]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1870}, properties:{annotationPublicationtype:["Review"], evidence:"TLR-2 and 4 have been highlighted as α-syn targets and shown to be upregulated in the brains and blood monocytes of people with PD (reviewed in [47]). This can induce the production of proinflammatory cytokines and reactive oxygen species, and, ultimately, neuronal death.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes", "Brain", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:360}, properties:{annotationPublicationtype:["Review"], evidence:"TLR-2 and 4 have been highlighted as α-syn targets and shown to be upregulated in the brains and blood monocytes of people with PD (reviewed in [47]). This can induce the production of proinflammatory cytokines and reactive oxygen species, and, ultimately, neuronal death.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes", "Brain", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:196}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, increased TGFβ1, IL1β, and IL6 are consistently observed in the cerebrospinal fluid(CSF) of people with PD [48].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, increased TGFβ1, IL1β, and IL6 are consistently observed in the cerebrospinal fluid(CSF) of people with PD [48].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, increased TGFβ1, IL1β, and IL6 are consistently observed in the cerebrospinal fluid(CSF) of people with PD [48].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:10}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:301}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:575}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:185}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1874}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9544"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1875}, properties:{annotationPublicationtype:["Review"], evidence:"Further confirming an ongoing peripheral immune process in PD, -> in IL6, TNF, IL1β, IL2, IL10, C-reactive protein, and RANTES are seen in blood from people with PD (meta-analysis [67]). The monkey MPTP model shows long-term increased TNF and IFNγ in serum [68].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9544"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:582}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, Parkin and LRRK2 were downregulated in CD4 and upregulated in CD8 memory T cells in the responder group. However, other enriched pathways were shared across both memory T cell types, such as OXPHOS and TNF signaling, which are well-known PD-associated neurotoxic mechanisms [118].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["CD8-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, Parkin and LRRK2 were downregulated in CD4 and upregulated in CD8 memory T cells in the responder group. However, other enriched pathways were shared across both memory T cell types, such as OXPHOS and TNF signaling, which are well-known PD-associated neurotoxic mechanisms [118].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["CD8-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1912}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"By contrast, male mice microglia showed higher expression of NF-κB and its inflammatory target genes, higher MHC expression, and ATP responsiveness [138,139].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:640}, end: {_id:1009}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2161}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2162}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:665}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:664}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2163}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:999}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Moderate", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:1012}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:378}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:1022}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2164}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2165}, properties:{annotationPublicationtype:["Research"], evidence:"Of the 50 markers investigated, 4, 11 and 25 serum and plasma analytes were significantly different from controls in mild, moderate and severe groups, respectively after false discovery rate (FDR) correction and included several well-defined pro-inflammatory cytokines, including interferon-γ (IFNγ), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-1RA (IL-1RA), interleukin-8 (IL-8) and 10 kDa interferon gamma-induced protein (IP-10); growth factors, including granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF); and markers of thrombosis and endothelial cell activation including plasminogen activator inhibitor-1 (PAI-1), protein C, protein S, Von Willebrand factor (vWF), factor IX, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 (VCAM-1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDiseaseSeverity:["Mild", "Severe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:26}, properties:{annotationPublicationtype:["Research"], evidence:"Stratification of patients according to the presence or absence of brain fog revealed a general increase in most markers in the brain fog cohort (Fig. ​(Fig.1f),1f), with significantly increased serum levels of protein S100β (Fig. ​(Fig.1g),1g), a marker indirectly associated with BBB dysfunction.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2167}, properties:{annotationPublicationtype:["Research"], evidence:"There were also increased levels of basic fibroblast growth factor (bFGF), interleukin-13 (IL-13) and monocyte chemoattractant protein-1 (MCP-1) in patients with brain fog (Fig. 1h–j).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2168}, properties:{annotationPublicationtype:["Research"], evidence:"There were also increased levels of basic fibroblast growth factor (bFGF), interleukin-13 (IL-13) and monocyte chemoattractant protein-1 (MCP-1) in patients with brain fog (Fig. 1h–j).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1841}, end: {_id:666}, properties:{annotationPublicationtype:["Research"], evidence:"There were also increased levels of basic fibroblast growth factor (bFGF), interleukin-13 (IL-13) and monocyte chemoattractant protein-1 (MCP-1) in patients with brain fog (Fig. 1h–j).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:14}, properties:{annotationPublicationtype:["Research"], evidence:"Therefore, partial correlations were performed with age, sex and all comorbidities as covariates, which revealed positive associations between serum concentrations of tumor necrosis factor (TNF), interleukin-6 (IL-6), IL-1β and IP-10 with COVID severity and an inverse association with plasma protein S.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"Therefore, partial correlations were performed with age, sex and all comorbidities as covariates, which revealed positive associations between serum concentrations of tumor necrosis factor (TNF), interleukin-6 (IL-6), IL-1β and IP-10 with COVID severity and an inverse association with plasma protein S.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationPublicationtype:["Research"], evidence:"Therefore, partial correlations were performed with age, sex and all comorbidities as covariates, which revealed positive associations between serum concentrations of tumor necrosis factor (TNF), interleukin-6 (IL-6), IL-1β and IP-10 with COVID severity and an inverse association with plasma protein S.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:665}, properties:{annotationPublicationtype:["Research"], evidence:"Therefore, partial correlations were performed with age, sex and all comorbidities as covariates, which revealed positive associations between serum concentrations of tumor necrosis factor (TNF), interleukin-6 (IL-6), IL-1β and IP-10 with COVID severity and an inverse association with plasma protein S.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2168}, properties:{annotationPublicationtype:["Research"], evidence:"There was a significant decrease in serum concentrations of coagulation factors including PAI-1 and the cell adhesion molecules VCAM-1 and ICAM-1, while there was an increase in IL-13 and IL-8 between T1 and T2.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2162}, properties:{annotationPublicationtype:["Research"], evidence:"There was a significant decrease in serum concentrations of coagulation factors including PAI-1 and the cell adhesion molecules VCAM-1 and ICAM-1, while there was an increase in IL-13 and IL-8 between T1 and T2.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:26}, properties:{annotationPublicationtype:["Research"], evidence:"Given the significantly increased serum concentrations of S100β, our data indicated that active and acute SARS-CoV-2 infection is associated with potential BBB dysfunction in individuals with neurological impairment.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2161}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we analyzed blood-based biomarkers of neuroinflammation and BBB dysfunction in the recovered and long COVID cohort using multiplex Luminex panels as done for the acute cohort (Extended Data Fig. ​Fig.6a).6a). We examined 50 markers of BBB integrity and inflammation. Several markers were increased across all groups compared to controls including IL-1RA, IL-1β, bFGF and IL-13, while IL-9 was the only cytokine decreased in all groups (Fig. 5a–c and Extended Data Fig. ​Fig.6).6).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:10}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we analyzed blood-based biomarkers of neuroinflammation and BBB dysfunction in the recovered and long COVID cohort using multiplex Luminex panels as done for the acute cohort (Extended Data Fig. ​Fig.6a).6a). We examined 50 markers of BBB integrity and inflammation. Several markers were increased across all groups compared to controls including IL-1RA, IL-1β, bFGF and IL-13, while IL-9 was the only cytokine decreased in all groups (Fig. 5a–c and Extended Data Fig. ​Fig.6).6).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2167}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we analyzed blood-based biomarkers of neuroinflammation and BBB dysfunction in the recovered and long COVID cohort using multiplex Luminex panels as done for the acute cohort (Extended Data Fig. ​Fig.6a).6a). We examined 50 markers of BBB integrity and inflammation. Several markers were increased across all groups compared to controls including IL-1RA, IL-1β, bFGF and IL-13, while IL-9 was the only cytokine decreased in all groups (Fig. 5a–c and Extended Data Fig. ​Fig.6).6).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2168}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we analyzed blood-based biomarkers of neuroinflammation and BBB dysfunction in the recovered and long COVID cohort using multiplex Luminex panels as done for the acute cohort (Extended Data Fig. ​Fig.6a).6a). We examined 50 markers of BBB integrity and inflammation. Several markers were increased across all groups compared to controls including IL-1RA, IL-1β, bFGF and IL-13, while IL-9 was the only cytokine decreased in all groups (Fig. 5a–c and Extended Data Fig. ​Fig.6).6).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:241}, properties:{annotationPublicationtype:["Research"], evidence:"Glial fibrillary acidic protein (GFAP) was increased in the cohort with brain fog compared to recovered individuals while only transforming growth factor-β (TGFβ) was selectively increased in the cohort with brain fog compared to the cohort with long COVID without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:196}, properties:{annotationPublicationtype:["Research"], evidence:"Glial fibrillary acidic protein (GFAP) was increased in the cohort with brain fog compared to recovered individuals while only transforming growth factor-β (TGFβ) was selectively increased in the cohort with brain fog compared to the cohort with long COVID without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:241}, properties:{annotationPublicationtype:["Research"], evidence:"Glial fibrillary acidic protein (GFAP) was increased in the cohort with brain fog compared to recovered individuals while only transforming growth factor-β (TGFβ) was selectively increased in the cohort with brain fog compared to the cohort with long COVID without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:196}, properties:{annotationPublicationtype:["Research"], evidence:"Glial fibrillary acidic protein (GFAP) was increased in the cohort with brain fog compared to recovered individuals while only transforming growth factor-β (TGFβ) was selectively increased in the cohort with brain fog compared to the cohort with long COVID without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2164}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"There were also changes in plasma levels of coagulation markers with significantly increased levels of proteins C and S in the recovered cohort and the cohort with brain fog (Extended Data Fig. ​Fig.6g).6g).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2163}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"There were also changes in plasma levels of coagulation markers with significantly increased levels of proteins C and S in the recovered cohort and the cohort with brain fog (Extended Data Fig. ​Fig.6g).6g).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2164}, properties:{annotationPublicationtype:["Research"], evidence:"There were also changes in plasma levels of coagulation markers with significantly increased levels of proteins C and S in the recovered cohort and the cohort with brain fog (Extended Data Fig. ​Fig.6g).6g).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:14}, properties:{annotationPublicationtype:["Research"], evidence:"We next examined immunovascular interactions in PBMCs isolated from patients with COVID-19 and found increased adhesion of PBMCs to human brain endothelial cells in the cohort with long COVID compared to unaffected individuals, which was heightened in the presence of TNF and only modestly affected by blocking antibodies against ICAM-1 and VCAM-1.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell", "peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2284}, end: {_id:2285}, properties:{annotationPublicationtype:["Review"], evidence:"More interestingly, enhanced expression of CCR6 has been observed in the spinal cord. CCR6 has recently been shown to be involved in the migration of Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:640}, end: {_id:2339}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2340}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2341}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2342}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1417}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2344}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:933}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2345}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2346}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2347}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Despite the lack of evident symptoms/signs of illness in this respiratory infection model, we found prominently elevated cytokine profiles in serum and in cerebrospinal fluid (CSF) at 7-day and 7-week time points following respiratory infection (Figures 1D–1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2342}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:933}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2341}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2345}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1417}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2348}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2346}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"At 7 days post-infection, elevated CSF cytokines and chemokines include IFN-γ, IL6, TNF-α, CXCL10, CCL7, CCL2, CCL11, GMCSF, and BAFF, among others (Figures 1F and 1H; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2341}, properties:{annotationPublicationtype:["Research"], evidence:"Of these, CXCL10, CCL7, CCL2, CCL11, and GMCSF remain elevated, and IL10 and CCL5 become elevated in CSF by 7 weeks post-infection (Figures 1G and 1I; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2345}, properties:{annotationPublicationtype:["Research"], evidence:"Of these, CXCL10, CCL7, CCL2, CCL11, and GMCSF remain elevated, and IL10 and CCL5 become elevated in CSF by 7 weeks post-infection (Figures 1G and 1I; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1417}, properties:{annotationPublicationtype:["Research"], evidence:"Of these, CXCL10, CCL7, CCL2, CCL11, and GMCSF remain elevated, and IL10 and CCL5 become elevated in CSF by 7 weeks post-infection (Figures 1G and 1I; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2348}, properties:{annotationPublicationtype:["Research"], evidence:"Of these, CXCL10, CCL7, CCL2, CCL11, and GMCSF remain elevated, and IL10 and CCL5 become elevated in CSF by 7 weeks post-infection (Figures 1G and 1I; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1373}, properties:{annotationPublicationtype:["Research"], evidence:"Of these, CXCL10, CCL7, CCL2, CCL11, and GMCSF remain elevated, and IL10 and CCL5 become elevated in CSF by 7 weeks post-infection (Figures 1G and 1I; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2339}, properties:{annotationPublicationtype:["Research"], evidence:"Of these, CXCL10, CCL7, CCL2, CCL11, and GMCSF remain elevated, and IL10 and CCL5 become elevated in CSF by 7 weeks post-infection (Figures 1G and 1I; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Of these, CXCL10, CCL7, CCL2, CCL11, and GMCSF remain elevated, and IL10 and CCL5 become elevated in CSF by 7 weeks post-infection (Figures 1G and 1I; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Notably, CSF levels of CCL11, a chemokine associated with cognitive impairment in aging (Villeda et al., 2011), were further increased at 7 weeks compared with 7 days post-infection (Figures 1J and 1K; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"In the same mice, serum CCL11 levels were elevated at 7 days post-infection and—in contrast to persistent elevation in CSF—normalized in serum by 7 weeks post-infection (Figures 1D, 1E, ​1E,S6C,S6C, and S6D; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:933}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"The CSF cytokine profiles following mild respiratory SARS-CoV-2 infection described above highlight elevated IL6 in CSF at 7 days and persistently elevated CCL11 in CSF at 7 weeks (Figures 1F and 1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"The CSF cytokine profiles following mild respiratory SARS-CoV-2 infection described above highlight elevated IL6 in CSF at 7 days and persistently elevated CCL11 in CSF at 7 weeks (Figures 1F and 1G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:1841}, end: {_id:1843}, properties:{annotationPublicationtype:["Research"], evidence:"We found elevated CCL11 levels in the plasma of people with long COVID exhibiting cognitive deficits, or 'brain fog' (n = 48 subjects, 16 male/32 female, mean age 46.1 ± 14.6 years) compared with those with long COVID lacking cognitive symptoms (n = 15 subjects, 4 male/11 female, mean age 46.7 ± 14.1 years; Figure 5 A).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationMeshanatomy:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:1841}, end: {_id:1843}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent comparisons revealed that those with a history of autoimmune disease had higher CCL11 levels than those patients who did not (Figure 5B) and that—despite a higher incidence of cognitive symptoms and long COVID reported in female patients overall (Seeßle et al., 2022; Sudre et al., 2021; Tabacof et al., 2022)—male patients had significantly higher levels of CCL11 than female patients in this cohort (Figure S6B). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID with autoimmune disease history"], annotationMeshanatomy:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationGender:["Male"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2344}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:933}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2342}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2345}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1417}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1373}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:2362}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2363}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We examined a mouse model of respiratory H1N1 influenza, which causes only minimal sickness behavior with mild (<10%) weight loss (Figures 7A and 7B) and elevation in serum cytokines/chemokines (Figures 7C and 7D; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2342}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Examination of CSF cytokines at 7 days revealed elevation in several cytokines/chemokines similar to mice with mild respiratory COVID, including IFN-γ, CCL11, CCL2, and GMCSF, as well as distinct elevations in IL4 and CCL5 (Figure 7G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Examination of CSF cytokines at 7 days revealed elevation in several cytokines/chemokines similar to mice with mild respiratory COVID, including IFN-γ, CCL11, CCL2, and GMCSF, as well as distinct elevations in IL4 and CCL5 (Figure 7G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:1417}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Examination of CSF cytokines at 7 days revealed elevation in several cytokines/chemokines similar to mice with mild respiratory COVID, including IFN-γ, CCL11, CCL2, and GMCSF, as well as distinct elevations in IL4 and CCL5 (Figure 7G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2348}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Examination of CSF cytokines at 7 days revealed elevation in several cytokines/chemokines similar to mice with mild respiratory COVID, including IFN-γ, CCL11, CCL2, and GMCSF, as well as distinct elevations in IL4 and CCL5 (Figure 7G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2340}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Examination of CSF cytokines at 7 days revealed elevation in several cytokines/chemokines similar to mice with mild respiratory COVID, including IFN-γ, CCL11, CCL2, and GMCSF, as well as distinct elevations in IL4 and CCL5 (Figure 7G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2339}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Examination of CSF cytokines at 7 days revealed elevation in several cytokines/chemokines similar to mice with mild respiratory COVID, including IFN-γ, CCL11, CCL2, and GMCSF, as well as distinct elevations in IL4 and CCL5 (Figure 7G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"By 7 weeks after influenza infection, the only chemokine that remained elevated—and in fact increased from the 7 day time point—is CCL11 (Figures 7E–7G). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:" However, a number of additional cytokines/chemokines were elevated at 7 weeks after influenza that were not elevated at 7 days, including TNF-α, IL6, IL2, CXCL5, and IL18, among others (Figures 7E–7G; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:933}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:" However, a number of additional cytokines/chemokines were elevated at 7 weeks after influenza that were not elevated at 7 days, including TNF-α, IL6, IL2, CXCL5, and IL18, among others (Figures 7E–7G; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2364}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:" However, a number of additional cytokines/chemokines were elevated at 7 weeks after influenza that were not elevated at 7 days, including TNF-α, IL6, IL2, CXCL5, and IL18, among others (Figures 7E–7G; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2344}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:" However, a number of additional cytokines/chemokines were elevated at 7 weeks after influenza that were not elevated at 7 days, including TNF-α, IL6, IL2, CXCL5, and IL18, among others (Figures 7E–7G; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2363}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:" However, a number of additional cytokines/chemokines were elevated at 7 weeks after influenza that were not elevated at 7 days, including TNF-α, IL6, IL2, CXCL5, and IL18, among others (Figures 7E–7G; Table S4).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"In contrast, microglial/macrophage reactivity persisted at 7 weeks in hippocampal white matter (Figure 7K), a finding that is consistent with the persistently elevated CSF CCL11 levels (Figure 7F), which we demonstrate above specifically increases reactivity of hippocampal microglia/macrophages (Figures 5F and 5G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1316}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], evidence:"TNF-α blood concentrations of APPSWE-Tau were also significantly higher than WT controls (Figure 3B).", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Blood"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["ELISA"], citationRef:"35328830"}}, {start: {_id:1316}, end: {_id:1312}, properties:{annotationPublicationtype:["Research"], evidence:"ELISA measurements also revealed increased SDC3 concentrations in the brain (Figure 4A) and the periphery, namely the liver (Figure 4B).", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Liver"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["ELISA"], citationRef:"35328830"}}, {start: {_id:1316}, end: {_id:1312}, properties:{annotationPublicationtype:["Research"], evidence:"As Figure 5A–C shows that the SDC3 expression of PBECs isolated from APPSWE-Tau was significantly increased compared with those isolated from WT mice.", annotationCustomCell:["Primary brain endothelial cell"], citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationSection:["Results"], annotationSpecies:["10090"], citationRef:"35328830"}}, {start: {_id:1316}, end: {_id:1312}, properties:{annotationPublicationtype:["Research"], evidence:"Monocytes isolated from APPSWE-Tau mice exhibited increased SDC3 expression than those from WT mice (Figure 6A–C).", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationCell:["monocyte"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["flow cytometry"], citationRef:"35328830"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:172}, end: {_id:174}, properties:{annotationPublicationtype:["Review"], evidence:"Cell debris and foreign matter within the CNS engage toll-like receptors (TLRs), which are expressed by microglia, astrocytes, oligodendrocytes, as well as by neurons (Lv et al. 2011; Zurolo et al. 2011). Engagement of TLRs activates signaling cascades that result in proinflammatory cytokine and chemokine production and in effects on the brain directly or indirectly through glial or BBB function.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Microglia", "Astrocytes"], annotationCell:["oligodendrocyte"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:115}, end: {_id:361}, properties:{annotationPublicationtype:["Review"], evidence:"The bacterial endotoxin, lipopolysaccharide (LPS),directly activates TLR4 receptors on microglia (and other innate immune cells) to initiate an inflammatory response", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:369}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:"Other studies have shown an activation of NLRP3 inflammasome in distinct α-syn PD models, including primary monocytes and primary microglia exposed to fibrillar α-syn, mouse striatum subjected to 6-OHDA treatment, α-syn pre-formed fibrils (PFF)-injected mice, post-mortem SN sections from PD brains and also blood and CSF samples from PD patients [68, 69, 70•].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["Cerebrospinal Fluid", "Blood"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:115}, end: {_id:1385}, properties:{annotationPublicationtype:["Review"], evidence:"The expression and kinase activity of LRRK2 were increased in LPS-treated lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:684}, end: {_id:1939}, properties:{annotationPublicationtype:["Review"], evidence:"Independent studies have shown that SARS-CoV-2 can infect blood monocytes through an antibody-opsonized virus, which in turn may lead to inflammasome  activation and systemic inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], annotationCell:["monocyte"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:684}, end: {_id:2143}, properties:{annotationPublicationtype:["Research"], evidence:"Acidic lysosomal senescence-associated β-galactosidase (SA-β-gal) activity, a biomarker of cellular senescence,8 was also upregulated in SARS-CoV-2 infected hPSC-derived DA neurons (Figure 3D).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["β-Gal Staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2143}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with the data of H9 hESC-derived DA neurons, MEL-1 hESC-derived DA neurons also showed increased β-gal staining and lysosomal accumulation upon SARS-CoV-2 infection (Figures S3M and S3N).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["β-Gal Staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2143}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 infection increased both the percentage of β-gal+ cells (Figure S4D) and lysosomal accumulation (Figure S4E) in all iPSC-derived DA neurons.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2143}, properties:{annotationPublicationtype:["Research"], evidence:"However, the percentage of β-gal+ cells (Figure S4D) and lysosomal accumulation (Figure S4E) increased progressively along with the copy number of SNCA both in mock condition and upon SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2272}, end: {_id:2274}, properties:{annotationPublicationtype:["Review"], evidence:"Schenk et al. have recently shown that ATP inhibits the generation and suppressive function of murine Tregs through the activation of purinergic P2X receptors", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1048}, end: {_id:1050}, properties:{annotationPublicationtype:["Review"], evidence:"Currently, two FDA-approved complement inhibitors are available, eculizumab and ravulizumab, both of which bind to C5 and sterically block the cleavage of C5 to C5a, and thus membrane attack complex formation. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1052}, end: {_id:1050}, properties:{annotationPublicationtype:["Review"], evidence:"Currently, two FDA-approved complement inhibitors are available, eculizumab and ravulizumab, both of which bind to C5 and sterically block the cleavage of C5 to C5a, and thus membrane attack complex formation. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:775}, end: {_id:1953}, properties:{annotationPublicationtype:["Review"], evidence:"The latter are associated with SARS-CoV-2-dependent coagulation activation extending to the myocardium, or ACE2-mediated damage caused by low to moderate viral RNA loads in the heart.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:775}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"ACE2 and cellular proteases, such as TMPRSS2, have been identified as receptors and priming factors for SARS-CoV-2.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:891}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"ACE2 and cellular proteases, such as TMPRSS2, have been identified as receptors and priming factors for SARS-CoV-2.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:2036}, end: {_id:7}, properties:{annotationPublicationtype:["Research"], evidence:"Five significantly regulated transcripts were shared by all three (co-cultures with PCs, MGCs, and NSCs) LOAD NVU models compared to CON NVU models, including modulation of ABCC4 and down-regulation of CLDN7, TJP1, LSR, and SLC7A5 (Fig. 3C, D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1410}, end: {_id:1420}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:47}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"To explore this timing further, and to examine whether protein levels displayed a similar pattern, we performed immunoblotting for both ACE2 and APOJ, an abundant CSF lipoprotein present in various-sized lipoprotein particles (Wang and Eckel, 2014). We could detect both APOJ and ACE2 in ChP organoid lysates with increasing abundance over time.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoblot"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:47}, end: {_id:35}, properties:{annotationPublicationtype:["Research"], evidence:"To explore this timing further, and to examine whether protein levels displayed a similar pattern, we performed immunoblotting for both ACE2 and APOJ, an abundant CSF lipoprotein present in various-sized lipoprotein particles (Wang and Eckel, 2014). We could detect both APOJ and ACE2 in ChP organoid lysates with increasing abundance over time.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoblot"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:1561}, end: {_id:575}, properties:{annotationPublicationtype:["Research"], evidence:"The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict OSTOX, increased NO production, and decreased Gpx and ANTIOX, whereas increased PBT levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID’s increased OSTOX/ANTIOX ratio.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1776}, end: {_id:1786}, properties:{annotationPublicationtype:["Research"], evidence:"The expression scores of these modules across all samples were significantly correlated with each other, indicating, participants with higher IFN-γ signaling have higher IL-27, IL-18, and NF-κB signaling, and participants with higher TNF signaling have higher IL-1, NF-κB, and IFN-α signaling, suggesting a coordinated activation of immune cascades that drive inflammation (Supplemental Fig. S6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1776}, end: {_id:663}, properties:{annotationPublicationtype:["Research"], evidence:"The expression scores of these modules across all samples were significantly correlated with each other, indicating, participants with higher IFN-γ signaling have higher IL-27, IL-18, and NF-κB signaling, and participants with higher TNF signaling have higher IL-1, NF-κB, and IFN-α signaling, suggesting a coordinated activation of immune cascades that drive inflammation (Supplemental Fig. S6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1777}, end: {_id:159}, properties:{annotationPublicationtype:["Research"], evidence:"The expression scores of these modules across all samples were significantly correlated with each other, indicating, participants with higher IFN-γ signaling have higher IL-27, IL-18, and NF-κB signaling, and participants with higher TNF signaling have higher IL-1, NF-κB, and IFN-α signaling, suggesting a coordinated activation of immune cascades that drive inflammation (Supplemental Fig. S6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:1777}, end: {_id:183}, properties:{annotationPublicationtype:["Research"], evidence:"The expression scores of these modules across all samples were significantly correlated with each other, indicating, participants with higher IFN-γ signaling have higher IL-27, IL-18, and NF-κB signaling, and participants with higher TNF signaling have higher IL-1, NF-κB, and IFN-α signaling, suggesting a coordinated activation of immune cascades that drive inflammation (Supplemental Fig. S6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:256}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, compared with controls, PD patients show increased areas of C1q-opsonized extracellular depositions of neuromelanin within the parenchyma, and C1q-expressing phagocytic microglia surround those areas, as well as cells around the luminal surfaces of the vasculature that express neuromelanin and C1q, suggesting a role for antiself antibodies and C1q-mediated clearing pathways in PD.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationCell:["mature microglial cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2192}, end: {_id:2193}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:198}, end: {_id:2193}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2192}, end: {_id:974}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:198}, end: {_id:974}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2194}, end: {_id:2195}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2194}, end: {_id:2196}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2194}, end: {_id:2197}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2198}, end: {_id:2199}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2198}, end: {_id:2200}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2198}, end: {_id:2201}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2192}, end: {_id:2099}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:198}, end: {_id:2099}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2192}, end: {_id:973}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:198}, end: {_id:973}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2192}, end: {_id:2210}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:198}, end: {_id:2210}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2211}, end: {_id:2212}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2211}, end: {_id:2213}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2211}, end: {_id:2214}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2215}, end: {_id:2216}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2215}, end: {_id:2217}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2215}, end: {_id:2218}, properties:{annotationPublicationtype:["Research"], evidence:"We also compared the transcriptome profile of individuals with and without brain fog in our cohort with long COVID. Upregulated genes were enriched in pathways related to T cell differentiation and activation (for example, RUNX3, IFNG, TNFSF9), negative regulation of the immune response (for example, WASL, ID2, TNFAIP3) and circadian regulation of gene expression (for example, RORA, PER1, NRIP1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1336}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"Other products of microbial metabolism, such as short-chain fatty acids (SCFAs), tryptophan metabolites and the amyloid curli, can have an impact of neuronal activity and modulate neuroinflammation [36–38].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:332}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, the adoptive transfer of Treg leads to >90% protection of dopaminergic neurons within the nigrostriatal system, whereas adoptive transfer of Th1 or Th17 Teff exacerbate neuronal degeneration and cotransfer of Treg with Th1 or Th17 increases the protective effect.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], citationRef:"22315722"}}, {start: {_id:333}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, the adoptive transfer of Treg leads to >90% protection of dopaminergic neurons within the nigrostriatal system, whereas adoptive transfer of Th1 or Th17 Teff exacerbate neuronal degeneration and cotransfer of Treg with Th1 or Th17 increases the protective effect.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], citationRef:"22315722"}}, {start: {_id:1112}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thioflavin T (ThT) fluorescence studies revealed the slight fibrillation of Aβ1–42 at 3 h and a more intense one at 18 h, based on Figure 5A,B.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1113}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thioflavin T (ThT) fluorescence studies revealed the slight fibrillation of Aβ1–42 at 3 h and a more intense one at 18 h, based on Figure 5A,B.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1114}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thioflavin T (ThT) fluorescence studies revealed the slight fibrillation of Aβ1–42 at 3 h and a more intense one at 18 h, based on Figure 5A,B.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1115}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thioflavin T (ThT) fluorescence studies revealed the slight fibrillation of Aβ1–42 at 3 h and a more intense one at 18 h, based on Figure 5A,B.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1116}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thioflavin T (ThT) fluorescence studies revealed the slight fibrillation of Aβ1–42 at 3 h and a more intense one at 18 h, based on Figure 5A,B.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thioflavin T (ThT) fluorescence studies revealed the slight fibrillation of Aβ1–42 at 3 h and a more intense one at 18 h, based on Figure 5A,B.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1115}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 overexpression increased the fibrillation of Aβ1–42 at 18 h, while its effect at 3 h of incubation was insignificant (Figure 5A).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1116}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 overexpression increased the fibrillation of Aβ1–42 at 18 h, while its effect at 3 h of incubation was insignificant (Figure 5A).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 overexpression increased the fibrillation of Aβ1–42 at 18 h, while its effect at 3 h of incubation was insignificant (Figure 5A).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["electron microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted differential effects on Aβ1–42 aggregation: ApoE2 decreased Aβ1–42 aggregation, even in SDC3-overexpressing transfectants at 18 h, while ApoE4 markedly increased it, both in the case of the WT SH-SY5Y cells and the SDC3 transfectants.", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1114}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted differential effects on Aβ1–42 aggregation: ApoE2 decreased Aβ1–42 aggregation, even in SDC3-overexpressing transfectants at 18 h, while ApoE4 markedly increased it, both in the case of the WT SH-SY5Y cells and the SDC3 transfectants.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"Scanning electron microscopy further confirmed the effect of ApoEs on Aβ1–42 aggregation: the representative images of Figure 5B clearly show that ApoE2 reduced, and ApoE4 increased, Aβ1–42 aggregation.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1114}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"Scanning electron microscopy further confirmed the effect of ApoEs on Aβ1–42 aggregation: the representative images of Figure 5B clearly show that ApoE2 reduced, and ApoE4 increased, Aβ1–42 aggregation.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"These effects of ApoE2 and 4 were rather striking on SDC3-overexpressing SH-SY5Y cells, where ApoE2 reduced the number of aggregates, while ApoE4 further increased them.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1119}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"ThT fluorescence studies on ApoE-treated SH-SY5Y cells and SDC3 transfectants revealed the fibrillation of ApoE4 at both 3 and 18 h of incubation (along with the fibrillation of ApoE3 at 3 h, Figure 5C).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationTimeline:["18 hours", "3 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1120}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"ThT fluorescence studies on ApoE-treated SH-SY5Y cells and SDC3 transfectants revealed the fibrillation of ApoE4 at both 3 and 18 h of incubation (along with the fibrillation of ApoE3 at 3 h, Figure 5C).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationTimeline:["18 hours", "3 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1120}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Electron microscopic studies also show the formation of fibrillar-like aggregates on the surfaces of ApoE4-treated cells, especially at 18 h of incubation. The presence of such small fibrils on ApoE3-treated cells was less evident, while electron microscopy did not reveal ApoE2 fibrils on ApoE2-treated SH-SY5Y cells and SDC3 transfectants (Figure 5D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1199}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Mpro-expressing cells were more often positive for the cell death marker TUNEL, especially when exposed to TNF (Fig. 4d,e), demonstrating that Mpro promotes endothelial cell death. ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationConcentration:["100 ng/ml"], annotationCustomCellline:["hCMEC/D3 cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1211}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated FADD"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1223}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, Ripk3 deletion abrogated endothelial proliferation (Fig. 6a). Ripk3 deletion also normalized survival, brain weight and body weight of mice with a NEMO deficiency in brain endothelial cells and reduced the extravasation of IgG and albumin into the parenchyma, showing that disruption of the BBB was mitigated (Fig. 6b,c and Extended Data Fig. 9c–f). Consequentially, Nemo deletion did not activate microglia or astrocytes in the absence of RIPK3 (Fig. 6d).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, Ripk3 deletion abrogated endothelial proliferation (Fig. 6a). Ripk3 deletion also normalized survival, brain weight and body weight of mice with a NEMO deficiency in brain endothelial cells and reduced the extravasation of IgG and albumin into the parenchyma, showing that disruption of the BBB was mitigated (Fig. 6b,c and Extended Data Fig. 9c–f). Consequentially, Nemo deletion did not activate microglia or astrocytes in the absence of RIPK3 (Fig. 6d).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:16}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, Ripk3 deletion abrogated endothelial proliferation (Fig. 6a). Ripk3 deletion also normalized survival, brain weight and body weight of mice with a NEMO deficiency in brain endothelial cells and reduced the extravasation of IgG and albumin into the parenchyma, showing that disruption of the BBB was mitigated (Fig. 6b,c and Extended Data Fig. 9c–f). Consequentially, Nemo deletion did not activate microglia or astrocytes in the absence of RIPK3 (Fig. 6d).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1230}, properties:{annotationPublicationtype:["Research"], evidence:"RIPK3 deficiency did not counteract the effect of NEMO ablation on IgG transcytosis (Fig. 6f). Therefore, we conclude that RIPK3 deficiency improves the BBB tightness of NemobeKO mice mainly by preventing endothelial cell death and rescuing tight junctions.", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1765}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"The expression of the fusogen spike S and its receptor hACE2 in adjacent cells resulted in the fusion of these neurons and the mixing of the fluorescent proteins.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationTechnique:["fluorescence fusion assay"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"37285437"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:55}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:212}, end: {_id:211}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:214}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:216}, end: {_id:215}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:218}, end: {_id:217}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:224}, end: {_id:217}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:230}, end: {_id:229}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:393}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:428}, end: {_id:217}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:512}, end: {_id:511}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:514}, end: {_id:511}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:516}, end: {_id:511}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:518}, end: {_id:517}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:528}, end: {_id:517}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:620}, end: {_id:619}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:621}, end: {_id:619}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:622}, end: {_id:619}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:623}, end: {_id:619}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:830}, end: {_id:829}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:834}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PMOD]->(end) SET r += row.properties;
UNWIND [{start: {_id:847}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1364}, end: {_id:1363}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1388}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1389}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1391}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2051}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2309}, end: {_id:54}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PMOD]->(end) SET r += row.properties;
UNWIND [{start: {_id:2397}, end: {_id:316}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2399}, end: {_id:434}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2400}, end: {_id:442}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2401}, end: {_id:443}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2402}, end: {_id:464}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2403}, end: {_id:501}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2404}, end: {_id:502}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2405}, end: {_id:526}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2406}, end: {_id:529}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2407}, end: {_id:531}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2408}, end: {_id:580}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_VARIANT_GENE]->(end) SET r += row.properties;
UNWIND [{start: {_id:954}, end: {_id:774}, properties:{annotationPublicationtype:["Research"], evidence:"Our findings reveal that SDC4 KD markedly diminished the cellular entry of all viruses (Figure 4A–G).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron", "Delta", "wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:45}, properties:{annotationPublicationtype:["Review"], evidence:"Of direct pertinence are the demonstrations that brain microvessels isolated from Alzheimer's disease brains showed significantly elevated nitric oxide synthase activity [34], as well as enhanced levels of protein oxidation products [35].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microvessels"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:67}, end: {_id:414}, properties:{annotationPublicationtype:["Review"], evidence:"Markers of apoptosis, caspase-3, and Cu/Zn superoxide dismutase activity are increased in lymphocytes from people with PD [111].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCell:["lymphocyte"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:640}, end: {_id:1673}, properties:{annotationPublicationtype:["Research"], evidence:"Gene ontology (GO) and WikiPathways analyses of the upregulated genes in infected cells revealed the enrichment of genes induced by type I, II, and III interferons and genes involved in Toll-like receptor (TLR), MDA5, and RIG-I sensing of double-stranded RNA.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1675}, properties:{annotationPublicationtype:["Research"], evidence:"Gene ontology (GO) and WikiPathways analyses of the upregulated genes in infected cells revealed the enrichment of genes induced by type I, II, and III interferons and genes involved in Toll-like receptor (TLR), MDA5, and RIG-I sensing of double-stranded RNA.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1781}, end: {_id:1784}, properties:{annotationPublicationtype:["Research"], evidence:"We noted that well-described BMI associated proteins like (Leptin (LEP) and Fatty Acid Binding Protein(FABP4)) and the Leptin signaling module were significantly increased in participants with high BMI (clusters 4 and 5) in our cohort (Fig. 1E,F)22–24", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:67}, end: {_id:1908}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, autoantibodies against the neuroprotective compound stress-inducible phosphoprotein-1 (STIP1) and specific B cell STIP1 epitopes have been reported in PD [129].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:832}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Analyzing the nuclei of SARS-CoV-2-positive cells (Fig 3A), we realized that they are highly condensed or fragmented exhibiting a strong reaction to 4′,6-diamidino-2-phenylindole (DAPI) that labels nuclei, a feature quite frequently observed in dead cells.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:1623}, end: {_id:1624}, properties:{annotationPublicationtype:["Research"], evidence:"In this regard, DNA methylation profiling of SARS-CoV-2-infected brain organoids also revealed the hypermethylation of numerous genes involved in neurogenesis, axonogenesis, and synaptic transmission (Fig. 4F and Fig. S3 and S4)", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1623}, end: {_id:1625}, properties:{annotationPublicationtype:["Research"], evidence:"In this regard, DNA methylation profiling of SARS-CoV-2-infected brain organoids also revealed the hypermethylation of numerous genes involved in neurogenesis, axonogenesis, and synaptic transmission (Fig. 4F and Fig. S3 and S4)", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1623}, end: {_id:1361}, properties:{annotationPublicationtype:["Research"], evidence:"In this regard, DNA methylation profiling of SARS-CoV-2-infected brain organoids also revealed the hypermethylation of numerous genes involved in neurogenesis, axonogenesis, and synaptic transmission (Fig. 4F and Fig. S3 and S4)", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:56}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"It should be noted that gene activation via NF-kB transcription factor is complex and can be accomplished perhaps by several routes including increased proteolytic degradation of hyperphosphorylated IkB-a [82], but signal transduction events that cause enhanced protein phosphorylation appear to also involve ROS intermediates.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:1292}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, adhesion points anchored within the actin filament network were detected, indicating the integrity of cell-cell contacts (Figure 2K). As reference, TEM images of uninfected hiPS-BCECs are shown in Figure S2D. The overall integrity of the hiPS-BCECs was further demonstrated by intact localization and unaltered expression of TJP1/ZO-1, a TJ marker, after infection.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:95}, end: {_id:96}, properties:{annotationPublicationtype:["Review"], evidence:"In AD, amyloid in both plaques and blood vessel walls in the brain is associated with SAP and, as in peripheral tissues, SAP might prevent the efficient phagocytosis of the amyloid deposits", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCustomAnatomy:["Peripheral tissue"], pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:95}, end: {_id:96}, properties:{annotationPublicationtype:["Review"], evidence:"Studies on the degradation of amyloid-β (aβ) peptides—the main constituent of amyloid plaques in AD—have shown that SAP inhibits proteolysis of Aβ in vitro", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:1204}, end: {_id:1228}, properties:{annotationPublicationtype:["Research"], evidence:"NEMO deficiency led to interruptions and the disintegration of occludin-positive tight junctions, which was prevented by RIPK3 deficiency (Fig. 6e).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2040}, end: {_id:2039}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2045}, end: {_id:2044}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2047}, end: {_id:2046}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__RNA]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:1528}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with this upregulation in microglia, and the extensive initiation of neuronal apoptosis and decreased postsynaptic density in infected organoids, neurons at 72hpi downregulated the expression of ‘don’t-eat-me’ signals such as CD46 and CD200.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1530}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with this upregulation in microglia, and the extensive initiation of neuronal apoptosis and decreased postsynaptic density in infected organoids, neurons at 72hpi downregulated the expression of ‘don’t-eat-me’ signals such as CD46 and CD200.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:128}, end: {_id:129}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, a study published in 2009 demonstrated that both acute and chronic systemic inflammation are associated with raised levels of serum tnF, which in turn is associated with accelerated, delirium-independent cognitive decline in patients with AD", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:67}, end: {_id:338}, properties:{annotationPublicationtype:["Research"], evidence:"As can be observed from Table 1, cases reported mumps, scarlet fever, influenza, whooping cough and herpes simplex infections significantly more frequently than their controls.", citationTitle:"Int J Neurosci. 2013 May;123(5):329-32. doi: 10.3109/00207454.2012.760560. Epub 2013 Feb 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"23270425", citationType:"PubMed", citationRef:"23270425"}}, {start: {_id:67}, end: {_id:339}, properties:{annotationPublicationtype:["Research"], evidence:"As can be observed from Table 1, cases reported mumps, scarlet fever, influenza, whooping cough and herpes simplex infections significantly more frequently than their controls.", citationTitle:"Int J Neurosci. 2013 May;123(5):329-32. doi: 10.3109/00207454.2012.760560. Epub 2013 Feb 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"23270425", citationType:"PubMed", citationRef:"23270425"}}, {start: {_id:67}, end: {_id:136}, properties:{annotationPublicationtype:["Research"], evidence:"As can be observed from Table 1, cases reported mumps, scarlet fever, influenza, whooping cough and herpes simplex infections significantly more frequently than their controls.", citationTitle:"Int J Neurosci. 2013 May;123(5):329-32. doi: 10.3109/00207454.2012.760560. Epub 2013 Feb 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"23270425", citationType:"PubMed", citationRef:"23270425"}}, {start: {_id:67}, end: {_id:340}, properties:{annotationPublicationtype:["Research"], evidence:"As can be observed from Table 1, cases reported mumps, scarlet fever, influenza, whooping cough and herpes simplex infections significantly more frequently than their controls.", citationTitle:"Int J Neurosci. 2013 May;123(5):329-32. doi: 10.3109/00207454.2012.760560. Epub 2013 Feb 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"23270425", citationType:"PubMed", citationRef:"23270425"}}, {start: {_id:67}, end: {_id:341}, properties:{annotationPublicationtype:["Research"], evidence:"As can be observed from Table 1, cases reported mumps, scarlet fever, influenza, whooping cough and herpes simplex infections significantly more frequently than their controls.", citationTitle:"Int J Neurosci. 2013 May;123(5):329-32. doi: 10.3109/00207454.2012.760560. Epub 2013 Feb 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"23270425", citationType:"PubMed", citationRef:"23270425"}}, {start: {_id:67}, end: {_id:386}, properties:{annotationPublicationtype:["Review"], evidence:"This idea is supported by the association between PD and autoimmune diseases, such as bullous pemphigoid, systemic lupus erythematosus, and Sjogren's syndrome [16, 17, 20, 22]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:313}, properties:{annotationPublicationtype:["Review"], evidence:"This idea is supported by the association between PD and autoimmune diseases, such as bullous pemphigoid, systemic lupus erythematosus, and Sjogren's syndrome [16, 17, 20, 22]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:387}, properties:{annotationPublicationtype:["Review"], evidence:"This idea is supported by the association between PD and autoimmune diseases, such as bullous pemphigoid, systemic lupus erythematosus, and Sjogren's syndrome [16, 17, 20, 22]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:668}, end: {_id:669}, properties:{annotationPublicationtype:["Review"], evidence:"In keeping with this, the most frequent clinical presentation of COVID-19 is the development of acute respiratory distress syndrome (ARDS) [16], the latter being, along with chronic ventilation, highly associated with subsequent cognitive decline, executive dysfunction, and reduced quality of life, often persisting months and years after hospital discharge [17] reviewed in [18]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:132}, properties:{annotationPublicationtype:["Research"], evidence:"Coexisting conditions included diabetes mellitus (n=4), hypertension (n=21), cardiovascular disease (n=9), hyperlipidemia (n=2), chronic kidney diseasechronic kidney disease (n=2), prior stroke (n=6) and dementia (n=5) (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:748}, properties:{annotationPublicationtype:["Research"], evidence:"Coexisting conditions included diabetes mellitus (n=4), hypertension (n=21), cardiovascular disease (n=9), hyperlipidemia (n=2), chronic kidney diseasechronic kidney disease (n=2), prior stroke (n=6) and dementia (n=5) (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:902}, properties:{annotationPublicationtype:["Research"], evidence:"Coexisting conditions included diabetes mellitus (n=4), hypertension (n=21), cardiovascular disease (n=9), hyperlipidemia (n=2), chronic kidney diseasechronic kidney disease (n=2), prior stroke (n=6) and dementia (n=5) (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:903}, properties:{annotationPublicationtype:["Research"], evidence:"Coexisting conditions included diabetes mellitus (n=4), hypertension (n=21), cardiovascular disease (n=9), hyperlipidemia (n=2), chronic kidney diseasechronic kidney disease (n=2), prior stroke (n=6) and dementia (n=5) (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:904}, properties:{annotationPublicationtype:["Research"], evidence:"Coexisting conditions included diabetes mellitus (n=4), hypertension (n=21), cardiovascular disease (n=9), hyperlipidemia (n=2), chronic kidney diseasechronic kidney disease (n=2), prior stroke (n=6) and dementia (n=5) (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:81}, properties:{annotationPublicationtype:["Research"], evidence:"Coexisting conditions included diabetes mellitus (n=4), hypertension (n=21), cardiovascular disease (n=9), hyperlipidemia (n=2), chronic kidney diseasechronic kidney disease (n=2), prior stroke (n=6) and dementia (n=5) (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:18}, properties:{annotationPublicationtype:["Research"], evidence:"Coexisting conditions included diabetes mellitus (n=4), hypertension (n=21), cardiovascular disease (n=9), hyperlipidemia (n=2), chronic kidney diseasechronic kidney disease (n=2), prior stroke (n=6) and dementia (n=5) (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:391}, end: {_id:264}, properties:{annotationPublicationtype:["Research"], evidence:"Using a Z score of >3.5 as an enrichment cutoff for identifying the presence of a peptide-specific antibody (22), the number of antibody-recognized EBV peptides with a nominally significant difference between MS cases and controls clearly stood out, both in the pre-onset (Fig. 4, E and G, and table S1) and post-onset (Fig. 4, F and H, and table S2) samples, which supports the specificity of the association between EBV and MS and argues against a second hit from another virus playing a major role in MS etiology.", citationTitle:"Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Multiple Sclerosis"], source:"wp4-cbm-comorbidity", pmid:"35025605", citationType:"PubMed", citationRef:"35025605"}}, {start: {_id:1236}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"All patients were very critically ill, with acute respiratory distress syndrome and mechanical ventilation, associated with acute kidney failure and refractory shock", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:1237}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"All patients were very critically ill, with acute respiratory distress syndrome and mechanical ventilation, associated with acute kidney failure and refractory shock", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:18}, end: {_id:1722}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Dementia had the most replicated associations after multiple test correction, with six viral groupings showing significant results: viral encephalitis, other viral diseases, viral warts, all influenza, influenza and pneumonia, and viral pneumonia.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", citationRef:"36669485"}}, {start: {_id:18}, end: {_id:1723}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Dementia had the most replicated associations after multiple test correction, with six viral groupings showing significant results: viral encephalitis, other viral diseases, viral warts, all influenza, influenza and pneumonia, and viral pneumonia.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", citationRef:"36669485"}}, {start: {_id:18}, end: {_id:136}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Dementia had the most replicated associations after multiple test correction, with six viral groupings showing significant results: viral encephalitis, other viral diseases, viral warts, all influenza, influenza and pneumonia, and viral pneumonia.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", citationRef:"36669485"}}, {start: {_id:18}, end: {_id:1146}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Dementia had the most replicated associations after multiple test correction, with six viral groupings showing significant results: viral encephalitis, other viral diseases, viral warts, all influenza, influenza and pneumonia, and viral pneumonia.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", citationRef:"36669485"}}, {start: {_id:18}, end: {_id:864}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Dementia had the most replicated associations after multiple test correction, with six viral groupings showing significant results: viral encephalitis, other viral diseases, viral warts, all influenza, influenza and pneumonia, and viral pneumonia.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", citationRef:"36669485"}}, {start: {_id:136}, end: {_id:7}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:136}, end: {_id:65}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:136}, end: {_id:18}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:136}, end: {_id:67}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:136}, end: {_id:1724}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1146}, end: {_id:7}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1146}, end: {_id:65}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1146}, end: {_id:18}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1146}, end: {_id:67}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1146}, end: {_id:1724}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Influenza and pneumonia were significantly associated with five of the six NDDs (AD, ALS, dementia, PD, and VAS) in FinnGen; all five were replicated using the cross-sectional data from UKB.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1722}, end: {_id:65}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Viral encephalitis and viral and other specified intestinal infections were significant and replicated for both AD and dementia; the varicella-zoster virus was significant and replicated for both MS and VAS (as a note, varicella-zoster virus is referred to as Zoster [herpes zoster] in the FinnGen and UKB coding system).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1722}, end: {_id:18}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Viral encephalitis and viral and other specified intestinal infections were significant and replicated for both AD and dementia; the varicella-zoster virus was significant and replicated for both MS and VAS (as a note, varicella-zoster virus is referred to as Zoster [herpes zoster] in the FinnGen and UKB coding system).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1725}, end: {_id:65}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Viral encephalitis and viral and other specified intestinal infections were significant and replicated for both AD and dementia; the varicella-zoster virus was significant and replicated for both MS and VAS (as a note, varicella-zoster virus is referred to as Zoster [herpes zoster] in the FinnGen and UKB coding system).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Intestines"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1725}, end: {_id:18}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Viral encephalitis and viral and other specified intestinal infections were significant and replicated for both AD and dementia; the varicella-zoster virus was significant and replicated for both MS and VAS (as a note, varicella-zoster virus is referred to as Zoster [herpes zoster] in the FinnGen and UKB coding system).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Intestines"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:391}, end: {_id:264}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"As a positive control, we replicated the previously published findings showing an association between a preceding EBV exposure and increased risk of MS in FinnGen (HR 26.5; CI 3.7–191.6; p = 0.001).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:391}, end: {_id:89}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"For 100% of these pairings, the hazard ratio for developing an NDD after a viral exposure was higher than the hazard ratio for being infected with a virus after the diagnosis of an NDD.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:2}, end: {_id:777}, properties:{annotationPublicationtype:["Research"], evidence:"In case #7, ischemic injury of the right rostral hippocampal formation due to posterior cerebral artery (PCA) occlusion was associated with perivascular extravasation, edema, fibrinogen leakage and viral protein immunoreactivity within small vessel endothelium, further confirmed by RT-PCR.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell", "hippocampal formation"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1780}, properties:{annotationPublicationtype:["Research"], evidence:"BMI was significantly higher in the inflammatory PASC groups(clusters 4 and 5) compared to participants in the other non-inflammatory clusters (Fig. 1D)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:67}, end: {_id:124}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Females typically show slower progression and develop fewer cognitive problems, but more dyskinesias [135].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1910}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"Females typically show slower progression and develop fewer cognitive problems, but more dyskinesias [135].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:640}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Immunostaining showed accumulation of p-a-Syn (cohort 1, Figure 7F) in COVID-19 samples compared with the expression in non-COVID-19 samples, which indicates a potential link of PD phenotypes within the substantia nigra of COVID-19 patients despite the lack of acute clinical symptoms specific to midbrain dysfunction.34", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:551}, end: {_id:314}, properties:{annotationPublicationtype:["Review"], evidence:"Substantial changes in the composition of the microbiota are associated with IBDs, and changes in the individual species of microbial flora can shape the induction of T cell subsets, including Th17 and Tregs in the intestine.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:529}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:33}, end: {_id:34}, properties:{annotationPublicationtype:["Review"], evidence:"Other anti-inflammatory mediators that have been shown to increase when the corresponding inflammatory agent is increased include: (1) IL-10, which is thought to counteract IL-6 [20]; (2) CD59, the membrane inhibitor of reactive lysis [21]; and (3) SP-40,40 which has clusterin activity [22].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:159}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:14}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:10}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:14}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:196}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:196}, end: {_id:198}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:421}, end: {_id:223}, properties:{annotationPublicationtype:["Review"], evidence:"Reconstitution of Rag1-/- mice with FasL-mutant splenocytes attenuated DA neuron cell death while reconstitution with IFN-/- splenocytes did not.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationCell:["splenocyte"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMouseType:["RAG1 -/- mice"], citationRef:"24275605"}}, {start: {_id:146}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"The AAV-alpha-synuclein model also leads to significant IgG deposition, suggesting that humoral immunity and/or breakdown of the BBB is playing a role [45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:466}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, genetic loss of Parkin in mice and Drosophila models has been shown to increase susceptibility to infection. This effect on immune function was shown to be related to Parkin's role in autophagy [177].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:477}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, genetic loss of Parkin in mice and Drosophila models has been shown to increase susceptibility to infection. This effect on immune function was shown to be related to Parkin's role in autophagy [177].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["7227"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:466}, end: {_id:581}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, mutations in genes known to cause familial PD have been directly or indirectly implicated in causing mitochondrial dysfunction. For example, PINK1 and Parkin actively inhibit mitochondrial-derived vesicle formation and mitochondrial antigen presentation; thus mutation of these genes in autosomal recessive Parkinson’s disease may result in excessive antigen presentation that provokes an autoimmune response.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:582}, end: {_id:583}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, mutations in genes known to cause familial PD have been directly or indirectly implicated in causing mitochondrial dysfunction. For example, PINK1 and Parkin actively inhibit mitochondrial-derived vesicle formation and mitochondrial antigen presentation; thus mutation of these genes in autosomal recessive Parkinson’s disease may result in excessive antigen presentation that provokes an autoimmune response.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:1141}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Here, the level of MMP9 expression was remarkably increased in the cerebral vessels compared to mock-treated animals (Fig. 3e, g). These results provide a clue that SARS-CoV-2 infection could damage BBB via MMP9-mediated BMs disruption.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Arteries"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:1165}, end: {_id:1110}, properties:{annotationPublicationtype:["Research"], evidence:"The inactive p.Cys145Ala-Mpro had no effect on string vessels or vascular density. In line with a detrimental effect of Mpro on endothelial cell survival, there were less HA-positive vessels after expression of Mpro-HA in comparison to p.Cys145Ala-Mpro-HA (Supplementary Fig. 4c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["western blot"], citationRef:"34675436"}}, {start: {_id:466}, end: {_id:1405}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin also suppresses inflammation by degrading TRAF2/6 and preventing the activation of NFkB and JNK signaling pathways", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:582}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have suggested that wild type PINK1 inhibits peripheral inflammation [92], and both PINK1 and Parkin repress mitochondrial antigen presentation thereby preventing adaptive inflammation", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1457}, end: {_id:1458}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 mutation impairs this 'double-rescue' strategy, as demonstrated by less efficient redistribution of α-syn between microglial cells from LRRK2 G2019S mice, thereby amplifying neuroinflammation [125•].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1563}, end: {_id:1578}, properties:{annotationPublicationtype:["Research"], evidence:"Given that the Long COVID group as a whole showed Gpx deficiency, while only a subset of patients demonstrated oxidative damage, we may infer that Gpx deficiency is the main cause of the consequent lipid and protein damage.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1563}, end: {_id:1579}, properties:{annotationPublicationtype:["Research"], evidence:"Given that the Long COVID group as a whole showed Gpx deficiency, while only a subset of patients demonstrated oxidative damage, we may infer that Gpx deficiency is the main cause of the consequent lipid and protein damage.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1764}, end: {_id:1766}, properties:{annotationPublicationtype:["Research"], evidence:"During our analysis of p15 expressed in mechanosensory neurons, we observed additional phenotypes that included defects in axonal guidance and axonal maintenance (visible as axonal breakages), as well as loss of mechanosensory neurons (fig. S6, D and E).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["6239"], annotationSection:["Results"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:1764}, end: {_id:1767}, properties:{annotationPublicationtype:["Research"], evidence:"During our analysis of p15 expressed in mechanosensory neurons, we observed additional phenotypes that included defects in axonal guidance and axonal maintenance (visible as axonal breakages), as well as loss of mechanosensory neurons (fig. S6, D and E).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["6239"], annotationSection:["Results"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:1764}, end: {_id:1768}, properties:{annotationPublicationtype:["Research"], evidence:"During our analysis of p15 expressed in mechanosensory neurons, we observed additional phenotypes that included defects in axonal guidance and axonal maintenance (visible as axonal breakages), as well as loss of mechanosensory neurons (fig. S6, D and E).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["6239"], annotationSection:["Results"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:2251}, end: {_id:2252}, properties:{annotationPublicationtype:["Review"], evidence:"Except for genes positive to the suppressive function of Tregs, the S1p receptor 1 (S1pr1) blocks the differentiation of murine thymic Treg precursors and inhibits the function of mature Tregs", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Thymus Gland"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2251}, end: {_id:2253}, properties:{annotationPublicationtype:["Review"], evidence:"Except for genes positive to the suppressive function of Tregs, the S1p receptor 1 (S1pr1) blocks the differentiation of murine thymic Treg precursors and inhibits the function of mature Tregs", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Thymus Gland"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2293}, end: {_id:455}, properties:{annotationPublicationtype:["Review"], evidence:"The primary circulating serine protease inhibitor α-1-antitrypsin can prevent signs of EAE in mice by increasing the population of Tregs and reducing the secretion of MOG-induced pro-inflammatory cytokines.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:896}, end: {_id:822}, properties:{annotationPublicationtype:["Research"], evidence:"However, by 72 hpi, the neurite length of the spike+ neurons decreased significantly in both ApoE3 and ApoE4 neurons (Figures 2D and 2E), compared to mock-treated neurons and spike– neurons.The decrease of neurite length in the ApoE4 spike+ neurons compared to the ApoE4 spike– neurons is more dramatic (p < 0.001) than the decrease in the ApoE3 spike+ neurons compared to the ApoE3 spike– neurons (p < 0.05).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["AG14048 cell", "AG06869 cell"], pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:485}, end: {_id:488}, properties:{annotationPublicationtype:["Review"], evidence:"Abatacept and belatacept block the interaction between CD28 on T cells with CD80/CD86 molecules on antigen presenting cells [188, 189]. These drugs have been used in transplant rejection and rheumatoid arthritis with great success.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationCell:["professional antigen presenting cell", "T cell"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:485}, end: {_id:490}, properties:{annotationPublicationtype:["Review"], evidence:"Abatacept and belatacept block the interaction between CD28 on T cells with CD80/CD86 molecules on antigen presenting cells [188, 189]. These drugs have been used in transplant rejection and rheumatoid arthritis with great success.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationCell:["professional antigen presenting cell", "T cell"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:491}, end: {_id:488}, properties:{annotationPublicationtype:["Review"], evidence:"Abatacept and belatacept block the interaction between CD28 on T cells with CD80/CD86 molecules on antigen presenting cells [188, 189]. These drugs have been used in transplant rejection and rheumatoid arthritis with great success.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationCell:["professional antigen presenting cell", "T cell"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:491}, end: {_id:490}, properties:{annotationPublicationtype:["Review"], evidence:"Abatacept and belatacept block the interaction between CD28 on T cells with CD80/CD86 molecules on antigen presenting cells [188, 189]. These drugs have been used in transplant rejection and rheumatoid arthritis with great success.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationCell:["professional antigen presenting cell", "T cell"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:684}, end: {_id:1140}, properties:{annotationPublicationtype:["Research"], evidence:"The expression of collagen IV, a major component of BMs, was measured by IHC and found to be significantly decreased in the cerebral vessels of infected animals, compared to the mock group.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Arteries"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1140}, properties:{annotationHourspostinfection:["48 hours"], annotationPublicationtype:["Research"], evidence:"To further assess the BBB impairment due to SARS-CoV-2 infection in vitro, we examined the expression of collagen IV. In line with the above in vivo results, collagen IV was decreased in the BBB models using BMECs from both K18-hACE2 mice and hamsters at 48 hpi.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:5}, end: {_id:65}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence that activated microglia contribute to disease progression in ALS comes from elegant studies in transgenic mice that express mutated superoxide dismutase 1 (SOD1) as a model of familial ALS", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationCell:["microglial cell"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Amyotrophic Lateral Sclerosis"], citationRef:"20234358"}}, {start: {_id:222}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Two anatomical sites have been suggested to be of particular relevance as places of origin for PD pathology. In 2003, Braak and colleagues first proposed that the olfactory epithelium and intestines [9] might be where PD begins. This was based on the histological observation of α-synuclein aggregates in these sites in very early stage PD, and even in cases presumed to be prodromal PD.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:222}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Gastrointestinal dysfunction and hyposmia are core features of PD, often occurring years to decades before the emergence of motor symptoms [10]. Their involvement in the early symptoms of PD, together with the findings of α-synuclein aggregates in these tissues [9], indicate that the gastrointestinal tract and olfactory system might be trigger sites in PD pathogenesis.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:222}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Aggregated α-synuclein is present in the enteric nervous system in PD patients [12], but it has also more recently been shown to occur in healthy people, indicating that α-synuclein aggregates in the gut are not specific to PD .", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:17}, end: {_id:549}, properties:{annotationPublicationtype:["Review"], evidence:"Systemic inflammation in PD is reflected by elevated serum IL-6, TNF-α and C-reactive protein, which are associated with severity or faster decline of motor symptoms [41]. In addition, there is an increased risk for PD among people who develop type 2 diabetes, especially at younger ages.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:17}, end: {_id:576}, properties:{annotationPublicationtype:["Review"], evidence:"Since type 2 diabetes is coupled to systemic inflammation, this might suggest a facilitating role for inflammatory changes in those who happen to be exposed to disease triggers.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:5}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"The role of neuroinflammation in PD is supported by the presence of activated microglia in the substantia nigra of PD patients [68] as well as several pre-clinical studies in PD animal models.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:5}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, both these disorders are characterized by a microglia-mediated early synapse loss [34], and epidemiological register studies have indicated an increased risk of dementia and parkinsonism after COVID-19 infection.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:222}, end: {_id:1744}, properties:{annotationPublicationtype:["Research"], evidence:"The forming rates correlated with Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) (P=0.028) and disease duration (P=0.0051) in PD", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", citationRef:"37248302"}}, {start: {_id:222}, end: {_id:1746}, properties:{annotationPublicationtype:["Research"], evidence:"The results of Pearson’s chi-square tests showed a significant positive correlation between the results of the IP/RT-QuIC and delayed heart-to-mediastinum (H/M) ratio with 123I-metaiodobenzylguanidine (MIBG) cardiac scintigraphy in patients with PD (Supplementary Table 8a) but not in patients with MSA (Supplementary Table 8b).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["cardiac scintigraphy"], citationRef:"37248302"}}, {start: {_id:47}, end: {_id:1841}, properties:{annotationPublicationtype:["Research"], evidence:"Patients with brain fog had a higher mean age (53.7 versus 42.7) and were more likely to be hospitalized and require oxygen therapy; therefore, age, sex, comorbidities and severity of infection were included in the statistical model to identify differences between groups (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1463}, end: {_id:673}, properties:{annotationPublicationtype:["Review"], evidence:"Cytoplasmic release of damaged mitochondria DNA (mtDNA) is an important DAMP that initiates multiple inflammatory pathways, including STING, NLRP3 inflammasome and NFKB signaling [133].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:451}, end: {_id:452}, properties:{annotationPublicationtype:["Review"], evidence:"IFN-gamma stimulation of immune cells results in upregulation of LRRK2 expression, which was shown to activate the NF-κB pathway, to be important for production of microbicidal reactive oxygen species during phagocytosis, and to colocalize near pathogens during intracellular infection [160]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1587}, end: {_id:1522}, properties:{annotationPublicationtype:["Research"], evidence:"The siRNAs specific for NRP1, but not AXL, strongly inhibited the infection of astrocytes by SARS-CoV-2, as assessed by the reduced expression of viral nucleocapsid (N) mRNA (Fig. 2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:225}, end: {_id:194}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:247}, end: {_id:210}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:254}, end: {_id:195}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:255}, end: {_id:231}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:610}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:617}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:624}, end: {_id:618}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:625}, end: {_id:618}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:632}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:633}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:776}, end: {_id:684}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1032}, end: {_id:1030}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1035}, end: {_id:1033}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1048}, end: {_id:1046}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1052}, end: {_id:1051}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1079}, end: {_id:684}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1106}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1107}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1108}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1268}, end: {_id:626}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:1272}, end: {_id:609}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1774}, end: {_id:1773}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1774}, end: {_id:123}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:913}, properties:{annotationPublicationtype:["Research"], evidence:"As seen in Table 1, there was a significant decreased expression of SHIP1 in the COVID-19 brain tissues (p value <0.001) (Fig. 2)", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:1566}, end: {_id:1563}, properties:{annotationPublicationtype:["Research"], evidence:"We found that 23.0% of the variance in the somatic HAMD score (regression #2) was explained by the cumulative effects of lowered Gpx and zinc, increased NO and CRP and vaccination with AstraZeneca or Pfizer.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:67}, end: {_id:582}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, Parkin and LRRK2 were downregulated in CD4 and upregulated in CD8 memory T cells in the responder group. However, other enriched pathways were shared across both memory T cell types, such as OXPHOS and TNF signaling, which are well-known PD-associated neurotoxic mechanisms [118].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, Parkin and LRRK2 were downregulated in CD4 and upregulated in CD8 memory T cells in the responder group. However, other enriched pathways were shared across both memory T cell types, such as OXPHOS and TNF signaling, which are well-known PD-associated neurotoxic mechanisms [118].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:640}, end: {_id:2164}, properties:{annotationPublicationtype:["Research"], evidence:"Therefore, partial correlations were performed with age, sex and all comorbidities as covariates, which revealed positive associations between serum concentrations of tumor necrosis factor (TNF), interleukin-6 (IL-6), IL-1β and IP-10 with COVID severity and an inverse association with plasma protein S.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:1012}, properties:{annotationPublicationtype:["Research"], evidence:"There was a significant decrease in serum concentrations of coagulation factors including PAI-1 and the cell adhesion molecules VCAM-1 and ICAM-1, while there was an increase in IL-13 and IL-8 between T1 and T2.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:378}, properties:{annotationPublicationtype:["Research"], evidence:"There was a significant decrease in serum concentrations of coagulation factors including PAI-1 and the cell adhesion molecules VCAM-1 and ICAM-1, while there was an increase in IL-13 and IL-8 between T1 and T2.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:1022}, properties:{annotationPublicationtype:["Research"], evidence:"There was a significant decrease in serum concentrations of coagulation factors including PAI-1 and the cell adhesion molecules VCAM-1 and ICAM-1, while there was an increase in IL-13 and IL-8 between T1 and T2.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2181}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we analyzed blood-based biomarkers of neuroinflammation and BBB dysfunction in the recovered and long COVID cohort using multiplex Luminex panels as done for the acute cohort (Extended Data Fig. ​Fig.6a).6a). We examined 50 markers of BBB integrity and inflammation. Several markers were increased across all groups compared to controls including IL-1RA, IL-1β, bFGF and IL-13, while IL-9 was the only cytokine decreased in all groups (Fig. 5a–c and Extended Data Fig. ​Fig.6).6).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["multiplexed readout"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2287}, end: {_id:1706}, properties:{annotationPublicationtype:["Review"], evidence:"Subsequent studies have shown that the frequency of CD31 and CD45RA expression in newly thymic emigrating Tregs (the so-called naive Tregs) is decreased in the peripheral blood of RR-MS patients.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["naive regulatory T cell"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2287}, end: {_id:405}, properties:{annotationPublicationtype:["Review"], evidence:"Subsequent studies have shown that the frequency of CD31 and CD45RA expression in newly thymic emigrating Tregs (the so-called naive Tregs) is decreased in the peripheral blood of RR-MS patients.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["naive regulatory T cell"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:264}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"Absolute numbers of FOXP3 and CD4+ cells were low in the MS brain lesions, and Tregs were not detectable in 30% of the MS biopsies, despite the presence of CD4+ infiltrates.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:264}, end: {_id:293}, properties:{annotationPublicationtype:["Review"], evidence:"Absolute numbers of FOXP3 and CD4+ cells were low in the MS brain lesions, and Tregs were not detectable in 30% of the MS biopsies, despite the presence of CD4+ infiltrates.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2242}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"The earlier development of EAE is associated with a defect of Tregs and the downregulation of Foxp3.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2202}, end: {_id:2203}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2202}, end: {_id:2204}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2202}, end: {_id:2205}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2206}, end: {_id:2207}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2206}, end: {_id:2208}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2206}, end: {_id:2209}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the recovered cases, there was a strong enrichment in upregulated terms for pathways related to T cell differentiation and activation (for example, PRDM1, TNF), TGFβ signaling (for example, SMAD3, SNAI1, SMURF1) and regulation of angiogenesis (for example, HES1, DLL1, HIF1A), while there was downregulation in genes involved in platelet activation, signaling and aggregation (for example, PF4V1, PF4, TREML1) and hemostasis (for example, F13A1, GP1BA, GP1BB) (Fig. ​(Fig.6e6e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:770}, end: {_id:2203}, properties:{annotationPublicationtype:["Research"], evidence:"In agreement with previous studies, several factors involved in the coagulation pathway were downregulated specifically in the cohort with brain fog, including PF4, PF4V1 and SELP.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:770}, end: {_id:2204}, properties:{annotationPublicationtype:["Research"], evidence:"In agreement with previous studies, several factors involved in the coagulation pathway were downregulated specifically in the cohort with brain fog, including PF4, PF4V1 and SELP.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:770}, end: {_id:2227}, properties:{annotationPublicationtype:["Research"], evidence:"In agreement with previous studies, several factors involved in the coagulation pathway were downregulated specifically in the cohort with brain fog, including PF4, PF4V1 and SELP.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:198}, end: {_id:279}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, a large proportion of the TCRγδ+ T cells also express CD25, suggesting these CSF-obtained T cells are preferentially activated in PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:17}, end: {_id:233}, properties:{annotationPublicationtype:["Review"], evidence:"In PD brains, HLA-DR immunostain-positive microglia are found throughout the nigrostriatal tract and other parts of the CNS, including the hippocampus, entorhinal cortex, and cingulated cortex [72–74].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Hippocampus", "Entorhinal Cortex", "Microglia", "Gyrus Cinguli"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["nigrostriatal tract"], citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:148}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:148}, end: {_id:147}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:366}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, activation of microglia, increased endothelial expression of adhesion molecules, and infiltration of T lymphocytes can be dampened by dexamethasone treatment", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:366}, end: {_id:227}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, activation of microglia, increased endothelial expression of adhesion molecules, and infiltration of T lymphocytes can be dampened by dexamethasone treatment", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:366}, end: {_id:367}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, activation of microglia, increased endothelial expression of adhesion molecules, and infiltration of T lymphocytes can be dampened by dexamethasone treatment", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:571}, end: {_id:572}, properties:{annotationPublicationtype:["Review"], evidence:"Human dopaminergic neurons carrying the SNCA-A53T mutation develop impaired anterograde mitochondrial transport when exposed to regulated and approved pesticides.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:964}, end: {_id:322}, properties:{annotationPublicationtype:["Research"], evidence:"Next, we compared these results with a lung epithelial cell line, Calu-3, and obtained similar results whereby EK1 peptide or TMPRSS2 inhibitors, camostat and nafamostat, repressed viral infection, which was further reduced when both classes of inhibitors were combined (Figure S1I).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], source:"wp4-cbm-comorbidity", pmid:"33631122", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:1115}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted differential effects on Aβ1–42 aggregation: ApoE2 decreased Aβ1–42 aggregation, even in SDC3-overexpressing transfectants at 18 h, while ApoE4 markedly increased it, both in the case of the WT SH-SY5Y cells and the SDC3 transfectants.", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1112}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted differential effects on Aβ1–42 aggregation: ApoE2 decreased Aβ1–42 aggregation, even in SDC3-overexpressing transfectants at 18 h, while ApoE4 markedly increased it, both in the case of the WT SH-SY5Y cells and the SDC3 transfectants.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1115}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"Scanning electron microscopy further confirmed the effect of ApoEs on Aβ1–42 aggregation: the representative images of Figure 5B clearly show that ApoE2 reduced, and ApoE4 increased, Aβ1–42 aggregation.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1112}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"Scanning electron microscopy further confirmed the effect of ApoEs on Aβ1–42 aggregation: the representative images of Figure 5B clearly show that ApoE2 reduced, and ApoE4 increased, Aβ1–42 aggregation.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1115}, end: {_id:1118}, properties:{annotationPublicationtype:["Research"], evidence:"These effects of ApoE2 and 4 were rather striking on SDC3-overexpressing SH-SY5Y cells, where ApoE2 reduced the number of aggregates, while ApoE4 further increased them.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1222}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, Ripk3 deletion abrogated endothelial proliferation (Fig. 6a). Ripk3 deletion also normalized survival, brain weight and body weight of mice with a NEMO deficiency in brain endothelial cells and reduced the extravasation of IgG and albumin into the parenchyma, showing that disruption of the BBB was mitigated (Fig. 6b,c and Extended Data Fig. 9c–f). Consequentially, Nemo deletion did not activate microglia or astrocytes in the absence of RIPK3 (Fig. 6d).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"RIPK3 deficiency did not counteract the effect of NEMO ablation on IgG transcytosis (Fig. 6f). Therefore, we conclude that RIPK3 deficiency improves the BBB tightness of NemobeKO mice mainly by preventing endothelial cell death and rescuing tight junctions.", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1399}, end: {_id:209}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have suggested that wild type PINK1 inhibits peripheral inflammation [92], and both PINK1 and Parkin repress mitochondrial antigen presentation thereby preventing adaptive inflammation", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:942}, end: {_id:684}, properties:{annotationPublicationtype:["Research"], evidence:"With an added SARS-CoV-2 annotation, SARS-CoV-2 transcript reads were localized to a variety of cell clusters (Fig. 3 A), demonstrating the widespread infectivity of SARS-CoV-2 in neurons, radial glia, and neuronal progenitor cells.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Organoids"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["rna-seq method"], annotationCustomCellline:["induced human neural progenitor cell"], citationRef:"33433624"}}, {start: {_id:684}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Strikingly, we observed abundant infection in astrocytes, as indicated by the presence of viral N protein, S RNA, and dsRNA, with 90% of infected cells expressing glial fibrillary acidic protein (GFAP) or Aquaporin 4 (AQP4) throughout the outer subventricular zone (SVZ) of primary cortical tissue (Fig. 1B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We investigated the impact of SARS-CoV-2 on cellular stress by evaluating the abundance of endoplasmic reticulum stress and the unfolded protein response gene ARCN1. ARCN1 is lowly expressed in developing human cortex tissue, but after infection by SARS-CoV-2, we found a 15% increase in expression, exclusively in infected cells coexpressing dsRNA.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"To probe the functional role of DPP4 in infectivity, organotypic slice cultures were treated with the DPP4 inhibitor Vildagliptin for 24 h prior to and throughout the duration of infection. As before, there was robust infection in GFAP+ astrocytes in virally exposed samples after 72 h. However, in tissue samples treated with the DPP4 inhibitor, there was a 35% reduction in the number of SARS-CoV-2 N+ cells and a 60% reduction in dsRNA+ cells (SI Appendix, Fig. 12E). Additionally, there was a 70% reduction in the number of cells expressing ARCN1 after DPP4 inhibition, indicating decreased activation of cellular stress.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We exposed the CD147- or DPP4-expressing organoids to SARS-CoV-2 for 2 h. We observed a significant increase in SARS-CoV-2 N+ cells with DPP4 overexpression and an increase in dsRNA+ cells in both DPP4- and CD147-overexpressing conditions (SI Appendix, Fig. 13C). Taken together with the loss of function and inhibition studies, these findings indicate that DPP4 and CD147 are sufficient to mediate SARS-CoV-2 infection and suggest that DPP4 may promote viral entry, while CD147 may promote viral replication.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1906}, end: {_id:231}, properties:{annotationPublicationtype:["Review"], evidence:"Similarly, neuromelanin autoantibodies are found in people with PD and decrease as the disease progresses [131].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:2327}, end: {_id:2328}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, oral administration with purified zwitterionic capsular polysaccharide A of Bacteroides fragilis protects mice against EAE prophylactically and therapeutically by inducing the conversion of naive CD4+ T cells into IL10-producing Foxp3+ Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:775}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to Delta-treated 293T cells, Delta uptake into 293T-ACE cells remained almost unchanged, suggesting that Delta's cellular entry is less dependent on ACE2 than WT spike's", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationConcentration:["50 nM"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["293T cell overexpressing ACE2"], citationRef:"35054983"}}, {start: {_id:775}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"A ~6-fold increase in the ACE2 expression with a ~30% reduced HS expression in the ACE2-293T cells (Figure 1B,E) resulted in a modestly (yet significantly, i.e., p < 0.01) increased WT SCV2 cellular uptake, an unchanged Delta cellular uptake, and a significantly reduced Omicron cellular uptake, highlightingthe increased importance of HS in the variants, especially for Omicron's cellular entry(Figure 2A–E).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationSection:["Results"], annotationCustomCellline:["ACE2-293T cell"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", citationType:"PubMed", citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:118}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"These approaches would, however, be of little clinical relevance in an elderly, frail population with AD, since BMT carries substantial risks, and CsF-1 is a proinflammatory factor that exacerbates inflammatory disease", annotationDiseaseCondition:["chronic"], annotationPublicationstatus:["Published"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:1208}, end: {_id:318}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast, specific inhibition of GCase in mice resulted in α-syn neuropathology and inflammation, as revealed by elevated GFAP levels that are indicative of astrogliosis", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:274}, end: {_id:315}, properties:{annotationPublicationtype:["Review"], evidence:"IPEX patients suffer from a severe autoimmune disease and allergy, similar to phenotypes in rodents following the depletion of CD4+CD25+ Tregs. CD25 deficiency also causes IPEX-like syndrome.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:415}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"EAE has been reported to be exacerbated in the absence of LFA-1, and this is correlated with a decrease in the steady-state numbers of Tregs in the LFA-1−/− mice.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1045}, end: {_id:684}, properties:{annotationPublicationtype:["Review"], evidence:"Liu et al. demonstrated that dipyridamole can suppress SARS-CoV-2 replication in vitro and improve lung pathology in an animal model of viral pneumonia through a type I interferon response125. This drug was tested in 14 patients and led to an improvement in clinical status compared with controls125.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:322}, end: {_id:684}, properties:{annotationPublicationtype:["Research"], evidence:"These results support the conclusion that astrocytes can support SARS-CoV-2 replication.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:249}, end: {_id:250}, properties:{annotationPublicationtype:["Review"], evidence:"This pattern of antibody reactivity was consistent with activated microglia and destruction of dopaminergic neurons in PD.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:464}, end: {_id:209}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, mutations in genes known to cause familial PD have been directly or indirectly implicated in causing mitochondrial dysfunction. For example, PINK1 and Parkin actively inhibit mitochondrial-derived vesicle formation and mitochondrial antigen presentation; thus mutation of these genes in autosomal recessive Parkinson’s disease may result in excessive antigen presentation that provokes an autoimmune response.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:580}, end: {_id:209}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, mutations in genes known to cause familial PD have been directly or indirectly implicated in causing mitochondrial dysfunction. For example, PINK1 and Parkin actively inhibit mitochondrial-derived vesicle formation and mitochondrial antigen presentation; thus mutation of these genes in autosomal recessive Parkinson’s disease may result in excessive antigen presentation that provokes an autoimmune response.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1327}, end: {_id:1331}, properties:{annotationPublicationtype:["Review"], evidence:"In turn, this results in a leakage of microbial-derived products and inflammatory mediators into the bloodstream, through which they can cross the blood-brain barrier (BBB) and finally reach the brain [34] (Fig. 1).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1327}, end: {_id:1333}, properties:{annotationPublicationtype:["Review"], evidence:"In turn, this results in a leakage of microbial-derived products and inflammatory mediators into the bloodstream, through which they can cross the blood-brain barrier (BBB) and finally reach the brain [34] (Fig. 1).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2}, end: {_id:319}, properties:{annotationPublicationtype:["Research"], evidence:"Hence, while microgliosis is strongly characteristic of COVID-19 subjects and differs from controls, brainstem hypoxia/ischemia plays a major role in mediating medullary microgliosis, as seen in our cohort and in accordance to previous literature.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["brainstem"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:998}, end: {_id:319}, properties:{annotationPublicationtype:["Research"], evidence:"Hence, while microgliosis is strongly characteristic of COVID-19 subjects and differs from controls, brainstem hypoxia/ischemia plays a major role in mediating medullary microgliosis, as seen in our cohort and in accordance to previous literature.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["brainstem"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1149}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, we observed high levels of Nrp1 and Bsg expression in mouse endothelial cells by scRNA-seq and immunostaining (Fig. 2a,b) but no Cd209a, Cd209b, Cd209c, Cd209d or Tmprss2 (Extended Data Fig. 3c–e).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["rna-seq method"], citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1150}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, we observed high levels of Nrp1 and Bsg expression in mouse endothelial cells by scRNA-seq and immunostaining (Fig. 2a,b) but no Cd209a, Cd209b, Cd209c, Cd209d or Tmprss2 (Extended Data Fig. 3c–e).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["rna-seq method"], citationRef:"34675436"}}, {start: {_id:640}, end: {_id:837}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the mouse data, BSG and NRP1 were highly expressed in endothelial cells (Fig. 2c). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1155}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the mouse data, BSG and NRP1 were highly expressed in endothelial cells (Fig. 2c). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1584}, properties:{annotationPublicationtype:["Research"], evidence:"As expected, the ACE2 protein was highly expressed in Vero-E6 cells but only weakly detected in astrocytes, suggesting the potential involvement of an alternative receptor in astrocytes. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationCustomCellline:["VERO-E6 cell"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:837}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, NRP1, a recently identified receptor for SARS-CoV-2(34, 35), was highly expressed in astrocytes and neurons but only minimally expressed in Vero-E6 cells.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Neurons", "Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1585}, properties:{annotationPublicationtype:["Research"], evidence:"AXL, a second potential receptor for SARS-CoV-2, was highly expressed in Vero-E6 cells and astrocytes but not neurons (36).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", annotationCellline:["VERO 76 cell"], citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1586}, properties:{annotationPublicationtype:["Research"], evidence:"AXL, a second potential receptor for SARS-CoV-2, was highly expressed in Vero-E6 cells and astrocytes but not neurons (36).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:837}, properties:{annotationPublicationtype:["Research"], evidence:"The levels of NRP1 and AXL mRNAs were 3,000-fold and 150-fold higher, respectively, than the levels of ACE2 mRNA in neurons(Fig. S1B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1586}, properties:{annotationPublicationtype:["Research"], evidence:"The levels of NRP1 and AXL mRNAs were 3,000-fold and 150-fold higher, respectively, than the levels of ACE2 mRNA in neurons(Fig. S1B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:974}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1816}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1817}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:973}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:842}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1818}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1819}, properties:{annotationPublicationtype:["Research"], evidence:"Despite the different matrices(serum vs. plasma) and different quantification methods (NGS vs.qPCR) used for the two cohorts, results were robust with cluster E demonstrating elevation of cytokines and chemokines observed in our inflammatory PASC cluster 4 (IFN-γ, IL12, CXCL10, CXCL11, TNF, CCL7, etc.) (Fig. 5C) combined with those elevated in our inflammatory PASC cluster 5 (DDX58, LAMP3, etc.) (Supplemental Fig. S12 & Data S9)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:567}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:567}, properties:{annotationPublicationtype:["Review"], evidence:"PD patients have reduced mitochondrial complex I activity in the substantia nigra, skeletal muscles, and platelets.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:4}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Among earlier observations that stand out as pointing toward the need to consider inflammatory processes as important include: (1) Colton's demonstrations that cytokine-activated microglia produce ROS [3,4]; (2) that, in contrast to normal brain, proinflammatory cytokines are prevalent in Alzheimer's brains [5–7]; (3) the early indications that anti-inflammatory therapeutics may delay on-set of Alzheimer's disease [8]; and (4) the early demonstrations that complement and classic markers of immune-mediated damage are expressed in neurodegenerative brains [9,10].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:4}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"It has been demonstrated that proinflammatory cytokines activate cultured primary brain cells (mostly microglia and astrocytes) to induce genes [83–85] including inducible nitric oxide synthase (iNOS), which mediates the synthesis of high levels of nitric oxide (NO), shown to be toxic to neurons [83,86].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCustomCellline:["primary brain cell culture"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:4}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"It has been demonstrated that proinflammatory cytokines activate cultured primary brain cells (mostly microglia and astrocytes) to induce genes [83–85] including inducible nitric oxide synthase (iNOS), which mediates the synthesis of high levels of nitric oxide (NO), shown to be toxic to neurons [83,86].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCustomCellline:["primary brain cell culture"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:4}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, it is considered that proinflammatory cytokines activate glia and microglia, very much as is known to occur in the case of iNOS upregulation in macrophages [87,88].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:4}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, it is considered that proinflammatory cytokines activate glia and microglia, very much as is known to occur in the case of iNOS upregulation in macrophages [87,88].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:75}, end: {_id:76}, properties:{annotationPublicationtype:["Review"], evidence:"A key role of tissue macrophages is the rapid response to tissue injury", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:105}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"A study in which injection of endotoxin—a potent activator of microglia—into the substantia nigra led to microglial activation and death of dopaminergic cells, however, supports the hypothesis that activated microglia and inflammation might be contributory factors to PD pathogenesis", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:105}, end: {_id:106}, properties:{annotationPublicationtype:["Review"], evidence:"A study in which injection of endotoxin—a potent activator of microglia—into the substantia nigra led to microglial activation and death of dopaminergic cells, however, supports the hypothesis that activated microglia and inflammation might be contributory factors to PD pathogenesis", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationCell:["dopaminergic neuron"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["9606"], citationRef:"20234358"}}, {start: {_id:80}, end: {_id:125}, properties:{annotationPublicationtype:["Review"], evidence:"The loss of neurons and their ligands that bind itim receptors on microglia, as well as the presence of DamPs, leads to microglial ‘priming’ as neurodegeneration progresses.", annotationDiseaseCondition:["chronic"], annotationPublicationstatus:["Published"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:191}, end: {_id:192}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:191}, end: {_id:186}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:191}, end: {_id:193}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:194}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:75}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:195}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:6}, end: {_id:223}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, reactive oxygen species produced by activated microglia increases nitration of α-syn and neuronal cell death (Shavali et al. 2006); and in turn, immune T cells that recognize nitrated α-syn (N-α-syn) enhance the neurotoxic activities of microglia in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of nigrostriatal degeneration . Activated T cells and B cells are then able to enter the CNS more readily and migrate to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", annotationDisease:["Parkinson's disease 1"], citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:303}, end: {_id:304}, properties:{annotationPublicationtype:["Review"], evidence:"For example, TGF-β, IL-2, IL-10, and all-trans retinoic acid are known to polarize T cells to iTreg (Zheng et al. 2007, 2008; Khattar et al. 2009; Lee et al. 2009b), whereas histone deacetylase inhibitors are known to increase proliferation and suppressor activity of Treg.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:" In the brain, Treg promote neurotrophic support by inducing astrocytes to increase expression of brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) (Benner et al. 2004; Reynolds et al. 2007), and may promote glutamate clearance.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:273}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Adoptive transfer of activated CD4+CD25+ Treg to HIV-1 encephalitic mice is neuroprotective.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:283}, end: {_id:106}, properties:{annotationPublicationtype:["Review"], evidence:"Treg inhibit release of viral particles from HIV-1-infected human mononuclear phagocytes (MP), kill infected cells, and induce phenotypic changes in MP.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:283}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, the adoptive transfer of Treg leads to >90% protection of dopaminergic neurons within the nigrostriatal system, whereas adoptive transfer of Th1 or Th17 Teff exacerbate neuronal degeneration and cotransfer of Treg with Th1 or Th17 increases the protective effect.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], citationRef:"22315722"}}, {start: {_id:356}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"MPP+ inhibits cellular respiration by direct inhibition of the mitochondrial transport chain leading to neuronal injury and death [12].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:356}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, inflammation can induce neuronal death through the production of neurotoxic cytokines or direct neuronal injury", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Chronic infusion of a low dose of LPS into the rat SN leads to peak microglial activation in two weeks followed by delayed and selective loss of DA neurons.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationTimeline:["2 weeks"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, activation of microglia, increased endothelial expression of adhesion molecules, and infiltration of T lymphocytes can be dampened by dexamethasone treatment", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:227}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, activation of microglia, increased endothelial expression of adhesion molecules, and infiltration of T lymphocytes can be dampened by dexamethasone treatment", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:367}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, activation of microglia, increased endothelial expression of adhesion molecules, and infiltration of T lymphocytes can be dampened by dexamethasone treatment", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:6}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Neuronal death can occur in response to cytokines such as TNFalpha, to ligation of death receptors such as Fas, and to toxicity of reactive oxygen species, as well as phagocytosis [59, 66].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Chronic microglial activation is also seen years after initial MPTP administration in primate models of PD irrespective of acute or chronic dosing [76–78].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:392}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Infection of mice with the A/VN/1203/04 strain of the H5N1 influenza virus demonstrated viral replication in the CNS, microglial activation and increased proinflammatory cytokine and chemokine expression lasting 90 days after viral clearance", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationTimeline:["90 days after viral clearance"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:392}, end: {_id:99}, properties:{annotationPublicationtype:["Review"], evidence:"Infection of mice with the A/VN/1203/04 strain of the H5N1 influenza virus demonstrated viral replication in the CNS, microglial activation and increased proinflammatory cytokine and chemokine expression lasting 90 days after viral clearance", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationTimeline:["90 days after viral clearance"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:392}, end: {_id:175}, properties:{annotationPublicationtype:["Review"], evidence:"Infection of mice with the A/VN/1203/04 strain of the H5N1 influenza virus demonstrated viral replication in the CNS, microglial activation and increased proinflammatory cytokine and chemokine expression lasting 90 days after viral clearance", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationTimeline:["90 days after viral clearance"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:392}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"A transient decrease in tyrosine hydroxylase(TH) expression in the SN was also observed [93]. This virus can also induce alpha-synuclein phosphorylation and aggregation [94].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:445}, properties:{annotationPublicationtype:["Review"], evidence:"Mouse bone marrow-derived macrophages (BMDMs) significantly upregulate LRRK2 mRNA expression after stimulation with LPS and lentiviral particles.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:447}, end: {_id:445}, properties:{annotationPublicationtype:["Review"], evidence:"Mouse bone marrow-derived macrophages (BMDMs) significantly upregulate LRRK2 mRNA expression after stimulation with LPS and lentiviral particles.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, LRRK2 inhibition and knockdown in microglia attenuated LPS-induced inflammatory signaling as measured by cytokine secretion, microglial chemotaxis, and morphologic remodeling [161].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:455}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, LRRK2 inhibition and knockdown in microglia attenuated LPS-induced inflammatory signaling as measured by cytokine secretion, microglial chemotaxis, and morphologic remodeling [161].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:335}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, LRRK2 inhibition and knockdown in microglia attenuated LPS-induced inflammatory signaling as measured by cytokine secretion, microglial chemotaxis, and morphologic remodeling [161].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:565}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:565}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:565}, end: {_id:568}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:364}, end: {_id:223}, properties:{annotationPublicationtype:["Review"], evidence:"Intravenous injection of the neurotoxin MPTP (e.g., through use of the synthetic analgesic drug MPPP when accidentally contaminated with MPTP) causes rapid death of nigral dopamine neurons and, consequently, PD symptoms.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:550}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"For example, pathogen-induced (trigger) inflammation in the gut resulting in localized α-synuclein accumulation and aggregation in enteric nerves [11] may not promote PD until years later, after an age-related decline in cellular energy homeostasis and lysosomal function (facilitators) has set in, which in turn could enable the propagation of α-synuclein aggregates to the brainstem.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:6}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, numerous studies demonstrate that mitochondrial dysfunction results in the chronic production of reactive oxygen species, leading to oxidative stress, and promoting both misfolding of α-synuclein and directly causing neurodegeneration.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:773}, end: {_id:774}, properties:{annotationPublicationtype:["Review"], evidence:"Viral entry to the brain through the olfactory bulb—the only part of the CNS not protected by dura—is one plausible route for SARS-CoV-2, especially given the anosmia in COVID-19.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:691}, end: {_id:99}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:691}, end: {_id:142}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:784}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"A vasculitis process similar to that for varicella zoster virus, in which viral replication in the cerebral arterial wall triggers local inflammation,is also plausible; endothelial infection by SARS-CoV-2 with inflammation and apoptosis of endothelial cells has been shown in kidney, heart, bowel, and lung at autopsy,but cerebral vessels have not yet been investigated.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["cerebral artery"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:684}, end: {_id:819}, properties:{annotationPublicationtype:["Research"], evidence:"We confirmed the infection of new Vero cells by the emergence of virus-induced cytopathic effects (CPEs) and an increase in SARS-CoV-2 RNA over 4-dpi.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], annotationCustomCellline:["Vero CCL-81"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:684}, end: {_id:820}, properties:{annotationPublicationtype:["Research"], evidence:"These findings indicate that SARS-CoV-2 has a preferred tropism to neurons, as reported recently.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:684}, end: {_id:822}, properties:{annotationPublicationtype:["Research"], evidence:"These cultures exhibit neuronal outgrowths as long-range axonal fibers expressing mature neuronal markers of MAP2, Tau, synapsin-1, and PSD95.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:684}, end: {_id:832}, properties:{annotationPublicationtype:["Research"], evidence:"Analyzing the nuclei of SARS-CoV-2-positive cells (Fig 3A), we realized that they are highly condensed or fragmented exhibiting a strong reaction to 4′,6-diamidino-2-phenylindole (DAPI) that labels nuclei, a feature quite frequently observed in dead cells.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:684}, end: {_id:223}, properties:{annotationPublicationtype:["Research"], evidence:"To test neuronal cell death as a consequence of SARS-CoV-2 infection, we stained the SARS-CoV-2-exposed samples with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) that detects fragmented DNA in dead cells (Darzynkiewicz et al, 2008). Compared to un-exposed control organoids, we identified an overall increase in TUNEL-positive cells in SARS-CoV-2-exposed organoids suggesting that virus exposure has caused cell death within 2-dpi.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationDayspostinfection:["2 days"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["Terminal deoxynucleotidyl transferase dUTP nick end labeling"], citationRef:"32876341"}}, {start: {_id:684}, end: {_id:833}, properties:{annotationPublicationtype:["Research"], evidence:"Staining for SARS-CoV-2-positive cells revealed that most of the virus-positive cells were TUNEL-positive. Besides, we also noticed that some SARS-CoV-2-positive cells were also positive for caspase-3, a protease that specifies programmed cell death.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["Terminal deoxynucleotidyl transferase dUTP nick end labeling"], citationRef:"32876341"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"We observed the presence of syncytia in SARS-CoV-2-infected cells, which significantly increased from an average of 4.6% at 24 hpi to 10.5% by 72 hpi (Figures 3D and 3E).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, in addition to syncytia, we observed a significant increase in cell death in both infected and uninfected TTR+ choroid plexus cells in CPOs exposed to SARS-CoV-2 as measured by TUNEL immunolabeling.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunolabeling method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Together, using CPOs as a 3D human cellular model, our findings reveal SARS-CoV-2 tropism for choroid plexus epithelial cells that results in productive infection, increased cell syncytia that may promote viral spread through cell-cell fusion, and increased cell death among both infected and uninfected adjacent cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Together, using CPOs as a 3D human cellular model, our findings reveal SARS-CoV-2 tropism for choroid plexus epithelial cells that results in productive infection, increased cell syncytia that may promote viral spread through cell-cell fusion, and increased cell death among both infected and uninfected adjacent cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:838}, properties:{annotationPublicationtype:["Research"], evidence:"More detailed gene ontology (GO) analysis of upregulated genes at 72 hpi showed enrichment for genes related to viral responses, RNA processing, response to cytokine, cytoskeletal rearrangement, and cell death (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:839}, properties:{annotationPublicationtype:["Research"], evidence:"More detailed gene ontology (GO) analysis of upregulated genes at 72 hpi showed enrichment for genes related to viral responses, RNA processing, response to cytokine, cytoskeletal rearrangement, and cell death (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:840}, properties:{annotationPublicationtype:["Research"], evidence:"More detailed gene ontology (GO) analysis of upregulated genes at 72 hpi showed enrichment for genes related to viral responses, RNA processing, response to cytokine, cytoskeletal rearrangement, and cell death (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"More detailed gene ontology (GO) analysis of upregulated genes at 72 hpi showed enrichment for genes related to viral responses, RNA processing, response to cytokine, cytoskeletal rearrangement, and cell death (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:841}, properties:{annotationPublicationtype:["Research"], evidence:"More detailed gene ontology (GO) analysis of upregulated genes at 72 hpi showed enrichment for genes related to viral responses, RNA processing, response to cytokine, cytoskeletal rearrangement, and cell death (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:373}, properties:{annotationPublicationtype:["Research"], evidence:"Upregulation of many vascular remodeling genes (Figure 4D), such as NPPB and VCAN, suggests that infected choroid plexus cells could signal the vasculature to promote leukocyte invasion (Shechter et al., 2013).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:854}, properties:{annotationPublicationtype:["Research"], evidence:"GO analysis of downregulated genes at 72 hpi, on the other hand, showed enrichment for genes related to ion transport, transmembrane transport, cilium, and cell junction (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:855}, properties:{annotationPublicationtype:["Research"], evidence:"GO analysis of downregulated genes at 72 hpi, on the other hand, showed enrichment for genes related to ion transport, transmembrane transport, cilium, and cell junction (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:856}, properties:{annotationPublicationtype:["Research"], evidence:"GO analysis of downregulated genes at 72 hpi, on the other hand, showed enrichment for genes related to ion transport, transmembrane transport, cilium, and cell junction (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:857}, properties:{annotationPublicationtype:["Research"], evidence:"GO analysis of downregulated genes at 72 hpi, on the other hand, showed enrichment for genes related to ion transport, transmembrane transport, cilium, and cell junction (Figure 4C; Table S3).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"Together, these transcriptome analyses suggest that SARS-CoV-2 infection of choroid plexus cells leads to viral RNA production and inflammatory cellular responses with a concomitant compromise of normal barrier and secretory functions as well as increased cell death.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Together, these transcriptome analyses suggest that SARS-CoV-2 infection of choroid plexus cells leads to viral RNA production and inflammatory cellular responses with a concomitant compromise of normal barrier and secretory functions as well as increased cell death.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Together, these transcriptome analyses suggest that SARS-CoV-2 infection of choroid plexus cells leads to viral RNA production and inflammatory cellular responses with a concomitant compromise of normal barrier and secretory functions as well as increased cell death.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:416}, properties:{annotationPublicationtype:["Research"], evidence:"Macroscopic changes included increased adhesion and degeneration of the HUVEC cells and degeneration in the MN1 cell lines.", annotationPublicationstatus:["Published"], citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationSection:["Results"], annotationCustomCellline:["HUVEC cell line"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:684}, end: {_id:819}, properties:{annotationPublicationtype:["Research"], evidence:"Macroscopic changes included increased adhesion and degeneration of the HUVEC cells and degeneration in the MN1 cell lines.", annotationPublicationstatus:["Published"], citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationSection:["Results"], annotationCustomCellline:["HUVEC cell line"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, Tdt-mediated dUTP-biotin nick end labeling (TUNEL) staining indicated increased cell death (Fig. S1 A).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationTechnique:["TUNEL staining"], citationRef:"33433624"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Organoid infection resulted in extensive neuronal cell death; strikingly, however, the majority of TUNEL-positive cells were SARS- CoV-2 negative (Fig. 2, F and G; and Fig. S1 F), and only ~15% of the cells infected with SARS-CoV-2 were TUNEL positive (Fig. 2 H). Increased cell death was correlated with a higher density of SARS- CoV-2–positive cells (Fig. 2 I), which, however, were not overtly dying (Fig. 2, G and H).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Organoids"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationTechnique:["TUNEL staining"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCustomCellline:["induced human neural progenitor cell"], citationRef:"33433624"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"This is consistent with findings from TUNEL staining (Fig. 2, E–G), which demonstrated minimal overlap between SARS-CoV-2–infected cells and those undergoing cell death.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Organoids"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationTechnique:["TUNEL staining"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCustomCellline:["induced human neural progenitor cell"], citationRef:"33433624"}}, {start: {_id:684}, end: {_id:943}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–infected brain organoid up-regulated pathways related to cell division, organelle fission, and metabolic processes, while ZIKV showed enrichment in type I IFN pathways (Fig. 5 D).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:944}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–infected brain organoid up-regulated pathways related to cell division, organelle fission, and metabolic processes, while ZIKV showed enrichment in type I IFN pathways (Fig. 5 D).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:945}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–infected brain organoid up-regulated pathways related to cell division, organelle fission, and metabolic processes, while ZIKV showed enrichment in type I IFN pathways (Fig. 5 D).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:946}, end: {_id:947}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–infected brain organoid up-regulated pathways related to cell division, organelle fission, and metabolic processes, while ZIKV showed enrichment in type I IFN pathways (Fig. 5 D).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:948}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–positive cells showed enrichment of genes corresponding to viral transcription, along with enrichment for metabolic processes including electron transport–coupled proton transport, cytochrome c to oxygen, and NADH to ubiquinone (Fig. 5 E, top panel).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:949}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–positive cells showed enrichment of genes corresponding to viral transcription, along with enrichment for metabolic processes including electron transport–coupled proton transport, cytochrome c to oxygen, and NADH to ubiquinone (Fig. 5 E, top panel).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:950}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–positive cells showed enrichment of genes corresponding to viral transcription, along with enrichment for metabolic processes including electron transport–coupled proton transport, cytochrome c to oxygen, and NADH to ubiquinone (Fig. 5 E, top panel).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:951}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2–positive cells showed enrichment of genes corresponding to viral transcription, along with enrichment for metabolic processes including electron transport–coupled proton transport, cytochrome c to oxygen, and NADH to ubiquinone (Fig. 5 E, top panel).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:952}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, we confirmed that infection by SARS-CoV-2 induced a locally hypoxic environment in neuronal regions by staining for HIF1α (Fig. 5, F and G) in mock-infected and SARS-CoV-2–infected organoids.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Organoids"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunofluorescent labeling"], annotationCustomCellline:["induced human neural progenitor cell"], citationRef:"33433624"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Most infarcts showed signs of tissue damage and localized cell death, and positive viral staining was present predominantly around the edges of the infarct and to a lesser degree within the center.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["White Matter"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:684}, end: {_id:1038}, properties:{annotationPublicationtype:["Review"], evidence:"The virus itself is also reported to directly activate neutrophils towards NETosis, promoting epithelial cell death89.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neutrophils"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1046}, end: {_id:1053}, properties:{annotationPublicationtype:["Review"], evidence:"Among 35 patients admitted to the ICU with COVID-19, eculizumab treatment improved 15-day survival and hypoxia compared with patients treated with standard care alone148. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["patients admitted to the ICU"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:684}, end: {_id:1123}, properties:{annotationPublicationtype:["Research"], evidence:"These data indicate that SARS-CoV-2 may infect brain endothelial cells, leading to increased vascular permeability, which supports the probability that SARS-CoV-2 crosses the BBB.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34489403", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34489403"}}, {start: {_id:684}, end: {_id:186}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, we observed perivascular inflammatory cell infiltration in the brain of infected K18-hACE2 mice (Fig. ​(Fig.1f).1f).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSpecies:["10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:1127}, end: {_id:223}, properties:{annotationPublicationtype:["Research"], evidence:"On the whole, we found that the vast majority of viruses co-localized with NeuN (a marker for neurons), but not GFAP (a marker for astrocytes) by FISH examination (Fig. 1g, h), leading to neuronal death as shown in Fig. 1i, j, k.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["fluorescent DNA hybridization probe method"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"To further verify the central nervous system effects of SARS-CoV-2, transmission electron microscopy (TEM) was performed. Indeed, virus-like particles appeared in the cortex of K18-hACE2 mice (Fig. ​(Fig.1l).1l).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1129}, properties:{annotationPublicationtype:["Research"], evidence:"Meanwhile, pyknotic cells, abnormal mitochondrial ultrastructure, vascular injury, and cell apoptosis were detected (Fig. 1m–t).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:785}, properties:{annotationPublicationtype:["Research"], evidence:"Meanwhile, pyknotic cells, abnormal mitochondrial ultrastructure, vascular injury, and cell apoptosis were detected (Fig. 1m–t).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"The expression of Iba1, a marker for microglia, was evidence of microglial cell activation and proliferation in K18-hACE2 mice infected with SARS-CoV-2 (Fig. 2a, b).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"There was no significant increase in the number of microglia in infected hamsters, but microglial activation (M1 and M2) was noticeable by morphological observation.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["transmission electron microscopy"], source:"wp4-cbm-comorbidity", pmid:"34489403", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34489403"}}, {start: {_id:684}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"We also tested for CD68, a marker of activated microglia (M1), and found that the number of Iba1-positive cells co-staining for CD68 was increased in infected K18-hACE2 mice and hamsters (Fig. 2c, d). With respect to astrocytes, there was distinct activation in the cortex and hippocampus of infected K18-hACE2 mice compared to the mock-treated group, but little activation or proliferation in infected hamsters.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:16}, properties:{annotationPublicationtype:["Research"], evidence:"We also tested for CD68, a marker of activated microglia (M1), and found that the number of Iba1-positive cells co-staining for CD68 was increased in infected K18-hACE2 mice and hamsters (Fig. 2c, d). With respect to astrocytes, there was distinct activation in the cortex and hippocampus of infected K18-hACE2 mice compared to the mock-treated group, but little activation or proliferation in infected hamsters.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"If SARS-CoV-2 particles could pass through barrier cells, they would exist in the basal chamber. The results showed clearly that the SARS-CoV-2 viral RNA could be detected in the basal chamber in both hamsters and K18-hACE2 mice in vitro models (Fig. ​4f).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationMeshanatomy:["Basal Ganglia"], source:"wp4-cbm-comorbidity", pmid:"34489403", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34489403"}}, {start: {_id:684}, end: {_id:799}, properties:{annotationHourspostinfection:["48 hours"], annotationPublicationtype:["Research"], evidence:"As exhibited in Fig. ​Fig.4g,4g, SARS-CoV-2 infected and replicated in the BMECs and the viral RNA load in compartment supernatants peaked at 48 hpi and maintained a steady level up to 96h. Using FISH, we detected SARS-CoV-2-S in Vero E6 and BMECs at 48 hpi.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"34489403"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:1282}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent gene set enrichment analysis (GSEA) revealed an upregulation of mRNAs related to antigen processing and major histocompatibility complex (MHC) class I-dependent antigen presentation supporting the notion that SARS-CoV-2 directly affects brain endothelial cells.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:170}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:947}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1311}, properties:{annotationPublicationtype:["Research"], evidence:"Intriguingly, SARS-CoV-2 infection of endothelial cells consistently resulted in downregulation of metabolic pathways and upregulation of a cellular interferon response.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"We thus show that brain endothelial cells show intrinsic inflammatory profiles upon contact with SARS-CoV-2, independent of immune cells.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:1321}, end: {_id:1322}, properties:{annotationPublicationtype:["Review"], evidence:"Among these, pathogen-associated molecular patterns (PAMPs), including, e.g. bacterial lipopolysaccharides (LPS), peptidoglycans, CpG oligonucleotides and viral double-stranded RNAs (dsRNAs), can trigger the innate immune system by acting as ligands for the corresponding pattern recognition receptors (PRRs) on the surface of host cells", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:115}, end: {_id:1322}, properties:{annotationPublicationtype:["Review"], evidence:"Among these, pathogen-associated molecular patterns (PAMPs), including, e.g. bacterial lipopolysaccharides (LPS), peptidoglycans, CpG oligonucleotides and viral double-stranded RNAs (dsRNAs), can trigger the innate immune system by acting as ligands for the corresponding pattern recognition receptors (PRRs) on the surface of host cells", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1323}, end: {_id:1322}, properties:{annotationPublicationtype:["Review"], evidence:"Among these, pathogen-associated molecular patterns (PAMPs), including, e.g. bacterial lipopolysaccharides (LPS), peptidoglycans, CpG oligonucleotides and viral double-stranded RNAs (dsRNAs), can trigger the innate immune system by acting as ligands for the corresponding pattern recognition receptors (PRRs) on the surface of host cells", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1325}, end: {_id:1322}, properties:{annotationPublicationtype:["Review"], evidence:"Among these, pathogen-associated molecular patterns (PAMPs), including, e.g. bacterial lipopolysaccharides (LPS), peptidoglycans, CpG oligonucleotides and viral double-stranded RNAs (dsRNAs), can trigger the innate immune system by acting as ligands for the corresponding pattern recognition receptors (PRRs) on the surface of host cells", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1338}, end: {_id:1327}, properties:{annotationPublicationtype:["Review"], evidence:"Most SCFAs have anti-inflammatory properties (e.g. butyrate, valerate) and contribute to maintain the integrity of intestinal barrier; as a consequence, a low abundance of SCFA-producing bacteria may cause leakiness of the gut epithelium thus promoting the passage of intestinal pathogens into the bloodstream and systemic inflammation [39, 40].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1339}, end: {_id:1327}, properties:{annotationPublicationtype:["Review"], evidence:"Most SCFAs have anti-inflammatory properties (e.g. butyrate, valerate) and contribute to maintain the integrity of intestinal barrier; as a consequence, a low abundance of SCFA-producing bacteria may cause leakiness of the gut epithelium thus promoting the passage of intestinal pathogens into the bloodstream and systemic inflammation [39, 40].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:115}, end: {_id:1326}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:80}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Damaged or dysfunctional mitochondria are the main source of damage-associated molecular patterns (DAMPs), which play additional functions outside the organelle and are recognized by the immune system in a similar way to PAMPs (see above).They often stimulate an inflammatory response and any necessary regeneration.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:80}, end: {_id:1459}, properties:{annotationPublicationtype:["Review"], evidence:"Mitochondrial DAMPs induce cytotoxicity, and cells have been shown to use the secretion of harmful molecules via EVs for cell homeostasis.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:684}, end: {_id:1478}, properties:{annotationCellCulture:["human stem cell derived cortical organoid cultures"], annotationPublicationtype:["Research"], evidence:"However, by week 22 of differentiation—a stage when significant gliogenesis has occurred in our organoids—GFAP+AQP4+ astrocytes were robustly infected, consistent with our results in primary tissue samples.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:785}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"However, there was an increase in the overall number of TUNEL+ apoptotic cells in cultures exposed to SARS-CoV-2 (Fig. 3D). Although we observed no change in astrocyte cell death, there was an overall decrease in the number of neurons .", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"To exclude those microglia that only stained positive for viral RNA (dsRNA, N gene), and/or CASP3, due to engulfment of infected cells within the organoid, we derived induced human microglia-like cells (iMGs) in 2D-culture [20] from one donor and exposed these cells to live SARS-CoV-2 virus (using a lower MOI of 0.01 given monoculture). The proportion of IBA1+ cells positive for dsRNA and CASP3 then increased with time.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], annotationCustomCellline:["induced human microglia-like cells"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"To exclude those microglia that only stained positive for viral RNA (dsRNA, N gene), and/or CASP3, due to engulfment of infected cells within the organoid, we derived induced human microglia-like cells (iMGs) in 2D-culture [20] from one donor and exposed these cells to live SARS-CoV-2 virus (using a lower MOI of 0.01 given monoculture). The proportion of IBA1+ cells positive for dsRNA and CASP3 then increased with time.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], annotationCustomCellline:["induced human microglia-like cells"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"In infected organoids (MOI 0.3, 72hpi), the total numbers of Iba1+ cells were slightly increased but did not reach significance (Supplementary Fig. 3a) while we observed a clear increase in CD68+ cells (Supplementary Fig. 3b) and a threefold increase in uptake of synaptic structures in microglia (Fig. 4d, e).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:5}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"While module B was largely comprised of genes encoding for cytosolic ribosomal proteins (Supplementary Fig. 7a, b), we detected several interferon-stimulated genes (ISGs) in module A (Fig. 6b, Supplementary Table 3). Accordingly, IHC validation of ISG15 protein showed a general increase in interferon response in organoids at 72hpi as well as a specific upregulation in IBA1+ cells, compared to control mock organoids.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:70}, properties:{annotationHourspostinfection:["24 hours"], annotationPublicationtype:["Research"], evidence:"At 24hpi, we detected upregulation of pathways (Supplementary Table 4) that can serve as activating stimuli for primed inflammasome components, and are required for the production and maturation of pro-inflammatory cytokines.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1524}, properties:{annotationHourspostinfection:["24 hours"], annotationPublicationtype:["Research"], evidence:"Taken together, this suggests that SARS-CoV-2 activates interferon signaling in microglia although the expression of pro-inflammatory cytokines are at normal levels already at 24hpi.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1526}, properties:{annotationPublicationtype:["Research"], evidence:"Actin-cytoskeletal remodeling pathways, essential for promoting migration and phagocytosis [39], were also upregulated in microglia exposed to SARS-CoV-2.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:352}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with this upregulation in microglia, and the extensive initiation of neuronal apoptosis and decreased postsynaptic density in infected organoids, neurons at 72hpi downregulated the expression of ‘don’t-eat-me’ signals such as CD46 and CD200.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1538}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1547}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"We also observed upregulation of metal ion (zinc, copper, iron) homeostasis pathways involving metallothioneins in AS-2 astrocytes at 72hpi (Fig. 7c).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1548}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"We also observed upregulation of metal ion (zinc, copper, iron) homeostasis pathways involving metallothioneins in AS-2 astrocytes at 72hpi (Fig. 7c).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1549}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"We also observed upregulation of metal ion (zinc, copper, iron) homeostasis pathways involving metallothioneins in AS-2 astrocytes at 72hpi (Fig. 7c).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1490}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"At 24hpi, we observed an enrichment of metallothioneins, similar to what we observed in astrocytes at 72hpi, whereas genes involved in viral defense response, regulation of reactive oxygen species, and ECM organization, were enriched at 72hpi.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1551}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"At 24hpi, we observed an enrichment of metallothioneins, similar to what we observed in astrocytes at 72hpi, whereas genes involved in viral defense response, regulation of reactive oxygen species, and ECM organization, were enriched at 72hpi.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1552}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"At 24hpi, we observed an enrichment of metallothioneins, similar to what we observed in astrocytes at 72hpi, whereas genes involved in viral defense response, regulation of reactive oxygen species, and ECM organization, were enriched at 72hpi.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:373}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Further, astrocytes, pericytes and choroid plexus-related cells were observed to downregulate VEGF signaling, a potent inducer of BBB permeability, at 24hpi but then at 72hpi instead display an upregulation, coinciding with increased signaling for leukocyte chemotaxis and activation in astrocytes, as well as antigen processing and presentation in choroid plexus.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:16}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Further, astrocytes, pericytes and choroid plexus-related cells were observed to downregulate VEGF signaling, a potent inducer of BBB permeability, at 24hpi but then at 72hpi instead display an upregulation, coinciding with increased signaling for leukocyte chemotaxis and activation in astrocytes, as well as antigen processing and presentation in choroid plexus.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:209}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Further, astrocytes, pericytes and choroid plexus-related cells were observed to downregulate VEGF signaling, a potent inducer of BBB permeability, at 24hpi but then at 72hpi instead display an upregulation, coinciding with increased signaling for leukocyte chemotaxis and activation in astrocytes, as well as antigen processing and presentation in choroid plexus.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1558}, properties:{annotationPublicationtype:["Research"], evidence:"In exposed organoids, we detected an upregulation of pathways related to UPRs, ER stress, proteasomal degradation, and autophagy, among cell types such as microglia, astrocytes, choroid plexus, and perivascular cells.", annotationCustomCell:["perivascular cell"], citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Microglia", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1559}, properties:{annotationPublicationtype:["Research"], evidence:"In exposed organoids, we detected an upregulation of pathways related to UPRs, ER stress, proteasomal degradation, and autophagy, among cell types such as microglia, astrocytes, choroid plexus, and perivascular cells.", annotationCustomCell:["perivascular cell"], citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Microglia", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:438}, properties:{annotationPublicationtype:["Research"], evidence:"In exposed organoids, we detected an upregulation of pathways related to UPRs, ER stress, proteasomal degradation, and autophagy, among cell types such as microglia, astrocytes, choroid plexus, and perivascular cells.", annotationCustomCell:["perivascular cell"], citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Microglia", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1583}, end: {_id:322}, properties:{annotationPublicationtype:["Research"], evidence:"These results support the conclusion that astrocytes can support SARS-CoV-2 replication.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1595}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Tetrandrine, a calcium channel blocker and inhibitor of the TPCN2 gene product, also produced dose-dependent inhibition of SARS-CoV-2 infection (Fig. S1D). Fifty percent cell death was observed at the highest drug concentration (20 mM), but at lower, nontoxic doses, viral infection was inhibited in a dose-related manner (Fig. S1E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], annotationConcentration:["20 mM"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:684}, end: {_id:1697}, properties:{annotationPublicationtype:["Research"], evidence:"We detected similar proportions of increase in cell death both in NPCs (identified both with Nestin and SOX2 antibodies) and neurons (Figs 2A–2F and S3A–S3C), while GFAP+ astrocyte did not show any statistically significant differences compared to mock conditions.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], annotationCell:["neuron", "neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"36327326", citationType:"PubMed", annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationDisease:["COVID-19"], citationRef:"36327326"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:836}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Seventy-two hours post-infection (hpi), the cultures were fixed and examined by confocal fluorescence microscopy, revealing the presence of fused neurons [positive for the neuronal marker microtubule- associated protein 2 (MAP2)], as characterized by the presence of both the GFP and mCherry fluorescent proteins for all the SARS-CoV-2 titers used.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["fluorescence microscopy"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Antibody staining revealed that fused neurons were positive for the fusogenic spike S protein , which was distributed across the surface of infected neurons.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Upon SARS-CoV-2 infection, glial cells expressing hACE2 were also positive for the spike S protein (fig. S1, C and D), and we observed additional fusion phenotypes, including neuron-glia (fig. S2, A to C) and glia-glia fusion (fig. S2, D to F).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["glial cell", "neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Similar to what was observed after infection of 2D neuronal cultures, we found that SARS-CoV-2–infected brain organoids exhibited neuronal syncytia formed by GFP-interconnected neurons.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"We found that, upon SARS-CoV-2 infection, neuronal fusion occurred between the somas, as well as between the neurites far from the somas (Fig. 1D and fig. S9, A and B).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:1751}, end: {_id:1852}, properties:{annotationPublicationtype:["Review"], evidence:"The reduction in myelinating oligodendrocytes causes loss of myelin and, ultimately, alters cognitive function and neural circuit dynamics (Steadman et al., 2020).", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1863}, end: {_id:285}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in PINK1-knockout mice, gut infection resulted in dopaminergic degeneration mediated by cytotoxic CD8+ T cells (Tc), which was induced by an autoimmune mechanism [28].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMouseType:["PINK1 -/-"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1868}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Oligomeric and fibrillar α-syn released by neurons can act as damage-associated molecular patterns (DAMPs) initiating an inflammatory response in microglia/macrophages (reviewed in [46];Box 2).", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Macrophages", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1869}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Oligomeric and fibrillar α-syn released by neurons can act as damage-associated molecular patterns (DAMPs) initiating an inflammatory response in microglia/macrophages (reviewed in [46];Box 2).", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Macrophages", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1873}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, pharmacological strategies to modify monocytes [60], decrease T cells, or enhance Treg capacity [61–63] are neuroprotective in animal/PD models, with the latter already examined in an early small safety clinical trial [64].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:684}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The exact mechanism underlying the induction of ARDS by SARS-CoV-2 remains unclear, but it has been proposed to be a consequence of hyperinflammatory conditions in the lungs associated with the presence of viral RNA.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Review"], evidence:"Although the exact link between viral infections and ARDS is not fully understood, certain alterations can be attributed to direct viral cytopathic effects, in particular, syncytial multinucleated giant cells and reactive AT2 hyperplasia.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:684}, end: {_id:770}, properties:{annotationPublicationtype:["Review"], evidence:"The latter are associated with SARS-CoV-2-dependent coagulation activation extending to the myocardium, or ACE2-mediated damage caused by low to moderate viral RNA loads in the heart.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:684}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2145}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, SARS-CoV-2 infected DA neurons also showed increased nuclear size (Figure 3F).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["transmission electron microscopy"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2151}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, SARS-CoV-2 infected DA neurons showed additional senescence-associated phenotypes, including increased accumulation of lysosomes as indicated by LysoTracker staining  (Figure 3K), mitochondrial dysfunction as indicated by EM and MitoTracker staining (Figures 3L and 3M), and increased protein oxidation as indicated by ROS staining (Figure 3N).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["ROS staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:2158}, properties:{annotationPublicationtype:["Research"], evidence:"GSEA also identified the upregulation of the adenosine monophosphate-activated protein kinase (AMPK) pathway upon metformin treatment (Figures 6D and 6E).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:1828}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"However, under injury and pathological conditions including specific pathogen invasion and abnormal protein accumulation, microglia become ‘activated’ and promote adaptive immune responses for various neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshdisease:["Neurodegenerative Diseases"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2234}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"However, under injury and pathological conditions including specific pathogen invasion and abnormal protein accumulation, microglia become ‘activated’ and promote adaptive immune responses for various neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshdisease:["Neurodegenerative Diseases"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2271}, end: {_id:2270}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs can inhibit the costimulatory capability of DCs by CD39-mediated inactivation of extracellular ATP, which is an inducer of DC activation.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:283}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"As has recently been shown, the adoptive transfer of CD3-activated Tregs attenuates astrogliosis and microglial inflammation with concomitant neuroprotection in a murine model of HIV-1-associated neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we observed syncytia formation, a typical cytopathic effect in cultured cells infected with SARS-CoV-2, in both ApoE3 and ApoE4 neurons (Figures S3B and S3C), with a higher percentage of syncytia nucleus in E4 neurons than that in E3 neurons (Figure S3C), suggesting that SARS-CoV-2 may also spread in neurons through syncytia formation.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["neuron", "astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["co-culture"], annotationCellline:["AG14048 cell", "AG06869 cell"], citationRef:"33450186"}}, {start: {_id:684}, end: {_id:1757}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that ApoE4 astrocytes showed more fragmented nuclei after viral infection compared to ApoE3 astrocytes (Figures 3D and S4D), indicating that SARS-CoV-2 infection may cause a more severe cytopathogenic effect in ApoE4 astrocytes than in ApoE3 astrocytes.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", annotationCellline:["AG14048 cell"], pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}, {start: {_id:684}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Similar with our observation in neurons, we observed syncytia formation in astrocytes, suggesting that one way SARS-CoV-2 spreads in astrocytes may be through syncytia formation (Figure 3A).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}, {start: {_id:2337}, end: {_id:822}, properties:{annotationPublicationtype:["Research"], evidence:"Significantly increased neurite length was detected in remdesivir-treated neurons compared to SARS-CoV-2-infected neurons without remdesivir treatment (Figure 4C).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"33450186", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2}, end: {_id:40}, properties:{annotationPublicationtype:["Review"], evidence:"Isolated brain microvasculature can be activated by ischemia/reoxygenation insults to cause them to produce increased levels of ROS [31].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microvessels"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:445}, end: {_id:446}, properties:{annotationPublicationtype:["Review"], evidence:"Mouse bone marrow-derived macrophages (BMDMs) significantly upregulate LRRK2 mRNA expression after stimulation with LPS and lentiviral particles.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:17}, end: {_id:85}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence from animal models of acute injury indicates that the innate inflammatory response exacerbates lesion size and is detrimental to neurological outcome", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:336}, end: {_id:172}, properties:{annotationPublicationtype:["Review"], evidence:"Misfolded and modified α-synuclein species draining from these sites also have the capability to activate antigen-presenting cells in peripheral lymphoid tissues inducing effector neurotoxic T-cell responses. This normally serves to facilitate debris clearance and repair functions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphoid Tissue"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"Chronic infusion of a low dose of LPS into the rat SN leads to peak microglial activation in two weeks followed by delayed and selective loss of DA neurons.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:5}, end: {_id:110}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, both these disorders are characterized by a microglia-mediated early synapse loss [34], and epidemiological register studies have indicated an increased risk of dementia and parkinsonism after COVID-19 infection.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:474}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin knockout animals do not have loss of DA neurons in the SN and do not have increased vulnerability to MPTP, yet they do show non-motor behavioral changes related to changes in the nigrostriatal pathway [171, 172].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1205}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"Similar to the Mpro-mediated cleavage of NEMO, its genetic ablation led to numerous string vessels in the brain (Fig. 5a,b).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1205}, end: {_id:195}, properties:{annotationPublicationtype:["Research"], evidence:"While the overall coverage of vessels by pericytes was slightly lowered (Fig. 5i), the number of microglia increased and they exhibited an activated morphology (Fig. 5j). The astrogliosis marker glial fibrillary acidic protein (GFAP) was strongly upregulated, indicating an inflammatory response (Fig. 5k).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:2274}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Schenk et al. have recently shown that ATP inhibits the generation and suppressive function of murine Tregs through the activation of purinergic P2X receptors", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:95}, end: {_id:21}, properties:{annotationPublicationtype:["Review"], evidence:"In AD, amyloid in both plaques and blood vessel walls in the brain is associated with SAP and, as in peripheral tissues, SAP might prevent the efficient phagocytosis of the amyloid deposits", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Plaque, Amyloid"], citationRef:"20234358"}}, {start: {_id:2333}, end: {_id:1822}, properties:{annotationPublicationtype:["Research"], evidence:"Among the host genes examined, ACTR2 (endosomal entry), ATP6AP2 (spike protein cleavage, endosomal acidification and processing), ERMP1 (ER), and CHST14 (Golgi) showed higher expression levels in ApoE4 astrocytes than that in ApoE3 astrocytes (Figures 3E and 3F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["gene expression assay", "real-time PCR "], annotationCellline:["AG14048 cell"], citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:177}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:179}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1205}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"While the overall coverage of vessels by pericytes was slightly lowered (Fig. 5i), the number of microglia increased and they exhibited an activated morphology (Fig. 5j). The astrogliosis marker glial fibrillary acidic protein (GFAP) was strongly upregulated, indicating an inflammatory response (Fig. 5k).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:10}, end: {_id:15}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:13}, end: {_id:15}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:14}, end: {_id:15}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:10}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:13}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:14}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:10}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"IL-1b activates astrocytes to form much higher levels of not only b-amyloid precursor protein but also S100b peptide mediator which then promotes neurite growth leading to dystrophic neurites [19].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:10}, end: {_id:83}, properties:{annotationPublicationtype:["Review"], evidence:"Well-studied molecules that promote neuronal degeneration include interleukin 1β and tumor necrosis factor(TNF).These cytokines in turn induce the synthesis of chemokines, leading to the recruitment of neutrophils and monocytes from the blood ", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:14}, end: {_id:84}, properties:{annotationPublicationtype:["Review"], evidence:"Well-studied molecules that promote neuronal degeneration include interleukin 1β and tumor necrosis factor(TNF).These cytokines in turn induce the synthesis of chemokines, leading to the recruitment of neutrophils and monocytes from the blood ", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:101}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In some neurodegenerative diseases, such as AD and prion disease, most misfolded protein accumulates extracellularly and activates the microglia in the local microenvironment", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease", "Prion Diseases"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:103}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"By contrast, the misfolded proteins present in other disorders such as PD, ALS and Huntington disease (HD) accumulate intracellularly, but are nevertheless still associated with microglial activation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Huntington Disease", "Amyotrophic Lateral Sclerosis", "Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:108}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence that activated microglia contribute to disease progression in ALS comes from elegant studies in transgenic mice that express mutated superoxide dismutase 1 (SOD1) as a model of familial ALS", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationCell:["microglial cell"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Amyotrophic Lateral Sclerosis"], citationRef:"20234358"}}, {start: {_id:118}, end: {_id:119}, properties:{annotationPublicationtype:["Review"], evidence:"Other manipulations of the innate immune system that lead to enhanced phagocytosis include whole-body irradiation followed by bone marrow transplantation (Bmt),in which the bone marrow-derived cells have been observed to phagocytose the amyloid, and systemic injection of macrophage colony stimulating factor 1 (CsF-1)", annotationDiseaseCondition:["chronic"], annotationPublicationstatus:["Published"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:196}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:212}, end: {_id:213}, properties:{annotationPublicationtype:["Review"], evidence:"These α-syn species are created by ubiquitination (Shimura et al. 2001), phosphorylation (Fujiwara et al. 2002), or oxidation and nitration (Giasson et al. 2000), and are found in LB inclusions, extraneuronally in PD brains (Lee 2008), and in the periphery of PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:214}, end: {_id:213}, properties:{annotationPublicationtype:["Review"], evidence:"These α-syn species are created by ubiquitination (Shimura et al. 2001), phosphorylation (Fujiwara et al. 2002), or oxidation and nitration (Giasson et al. 2000), and are found in LB inclusions, extraneuronally in PD brains (Lee 2008), and in the periphery of PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:216}, end: {_id:213}, properties:{annotationPublicationtype:["Review"], evidence:"These α-syn species are created by ubiquitination (Shimura et al. 2001), phosphorylation (Fujiwara et al. 2002), or oxidation and nitration (Giasson et al. 2000), and are found in LB inclusions, extraneuronally in PD brains (Lee 2008), and in the periphery of PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:218}, end: {_id:213}, properties:{annotationPublicationtype:["Review"], evidence:"These α-syn species are created by ubiquitination (Shimura et al. 2001), phosphorylation (Fujiwara et al. 2002), or oxidation and nitration (Giasson et al. 2000), and are found in LB inclusions, extraneuronally in PD brains (Lee 2008), and in the periphery of PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:221}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"Although most cases of PD have no family history of disease, point mutations in the gene encoding α-syn (SNCA; OMIM 163890) are linked to autosomal-dominant parkinsonism (PARK1, OMIM 168601) (Polymeropoulos et al. 1996, 1997; Kruger et al. 1998; Zarranz et al. 2004), as are duplications and triplications of the SNCA gene (PARK4, OMIM 605543) (Singleton et al. 2003; Chartier-Harlin et al. 2004), all of which present increased aggregation of α-syn.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", annotationDisease:["Parkinson's disease 1"], citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:230}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"The occurrence of these aberrant forms of α-syn in the periphery, such as the gastrointestinal tract and draining cervical lymph nodes, presents a possible means for exposure to the protein and subsequent activation of the adaptive immune system.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["cervical lymph node"], citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:218}, end: {_id:213}, properties:{annotationPublicationtype:["Review"], evidence:"Aberrant posttranslational modifications of α-syn, such as nitration (N-α-syn), can be found in LB inclusions of PD brains (Giasson et al. 2000) and cause the protein to aggregate more readily.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:218}, end: {_id:170}, properties:{annotationPublicationtype:["Review"], evidence:"Aggregated α-syn activates microglia (Zhang et al. 2005), which have been shown to produce nitric oxide and superoxide in mice and inducible nitric oxide synthase (iNOS) in humans, which increases nitration of α-syn and perpetuates the proinflammatory innate immune response in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:218}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Nitrated α-syn in turn amplifies activation of microglia and antigen-presenting cells that correspondingly up-regulate both humoral and cell-mediated responses to nitrated α-syn in the MPTP model.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:251}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Of interest, deletion of the FcγR by genetic ablation inhibits microglial activation and dopaminergic cell death in animal models of PD.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:251}, end: {_id:106}, properties:{annotationPublicationtype:["Review"], evidence:"Of interest, deletion of the FcγR by genetic ablation inhibits microglial activation and dopaminergic cell death in animal models of PD.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:280}, end: {_id:198}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, in MPTP-intoxicated mice, α-syn drains to cervical lymph nodes where it activates antigen-presenting cells and T cells.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["cervical lymph node"], citationRef:"22315722"}}, {start: {_id:280}, end: {_id:209}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, in MPTP-intoxicated mice, α-syn drains to cervical lymph nodes where it activates antigen-presenting cells and T cells.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["cervical lymph node"], citationRef:"22315722"}}, {start: {_id:230}, end: {_id:209}, properties:{annotationPublicationtype:["Review"], evidence:"Misfolded and modified α-synuclein species draining from these sites also have the capability to activate antigen-presenting cells in peripheral lymphoid tissues inducing effector neurotoxic T-cell responses. This normally serves to facilitate debris clearance and repair functions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphoid Tissue"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:230}, end: {_id:337}, properties:{annotationPublicationtype:["Review"], evidence:"Once modified protein species enters the peripheral lymphoid tissues, activate antigen-presenting cells, and are presented as neoepitopes, adaptive immune responses are induced.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:280}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Viral overexpression of human alpha-synuclein in the mouse SN induces inflammation and microglial activation that is followed months later by progressive death of TH+ neurons[45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:280}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Viral overexpression of human alpha-synuclein in the mouse SN induces inflammation and microglial activation that is followed months later by progressive death of TH+ neurons[45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:280}, end: {_id:223}, properties:{annotationPublicationtype:["Review"], evidence:"Viral overexpression of human alpha-synuclein in the mouse SN induces inflammation and microglial activation that is followed months later by progressive death of TH+ neurons[45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:280}, end: {_id:170}, properties:{annotationPublicationtype:["Review"], evidence:"Innate immune activation is also observed in various transgenic mouse models of alpha-synuclein overexpression", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:14}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Neuronal death can occur in response to cytokines such as TNFalpha, to ligation of death receptors such as Fas, and to toxicity of reactive oxygen species, as well as phagocytosis [59, 66].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:266}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Neuronal death can occur in response to cytokines such as TNFalpha, to ligation of death receptors such as Fas, and to toxicity of reactive oxygen species, as well as phagocytosis [59, 66].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:415}, end: {_id:416}, properties:{annotationPublicationtype:["Review"], evidence:"In this model, these lymphocytes have increased expression of LFA-1, an integrin that binds endothelial adhesion molecules, to allow for diapedesis across the BBB [42].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:415}, end: {_id:417}, properties:{annotationPublicationtype:["Review"], evidence:"In this model, these lymphocytes have increased expression of LFA-1, an integrin that binds endothelial adhesion molecules, to allow for diapedesis across the BBB [42].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:280}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In the intranigral AAV-human-alpha-synuclein overexpression mouse model, B and T lymphocyte infiltration in the SN persists after peak of microglial activation suggesting that adaptive immune cells propagate inflammation in this model as well [45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], annotationMouseType:["AAV-human-alpha-synuclein overexpression mouse"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:428}, end: {_id:198}, properties:{annotationPublicationtype:["Review"], evidence:"Robust T cell responses were initiated when mice were immunized with the C-terminus of the nitrated alpha-synuclein.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:146}, end: {_id:239}, properties:{annotationPublicationtype:["Review"], evidence:"The AAV-alpha-synuclein model also leads to significant IgG deposition, suggesting that humoral immunity and/or breakdown of the BBB is playing a role [45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:146}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Signs of synergy between inflammation and alpha-synuclein-induced degeneration have been observed in numerous cell culture and animal model studies as discussed previously.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:466}, end: {_id:472}, properties:{annotationPublicationtype:["Review"], evidence:"Potential roles for this protein are in preventing protein aggregation and/or promoting mitophagy [167–169]. Parkin has also been suggested to function as a transcription factor, regulating p53 expression [170] independent of its ligase activity", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:453}, end: {_id:596}, properties:{annotationPublicationtype:["Review"], evidence:"The targets of the LRRK2 kinase, and cell model experiments, suggest that mutations can also alter vesicular trafficking, mitochondrial function, protein synthesis, cytoskeletal dynamics [57], and autophagy–functions that, when impaired, may facilitate PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:601}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"ThT fluorescence studies quantitatively showed that SDCs, especially SDC3 and SDC4 significantly (p<0.05) facilitate the fibrillation of Aβ1–42 (Fig. 2a).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"ThT fluorescence studies quantitatively showed that SDCs, especially SDC3 and SDC4 significantly (p<0.05) facilitate the fibrillation of Aβ1–42 (Fig. 2a).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells with relatively low surface HS expression, SDC3 and SDC4 induce the fibrillation of Aβ1–42 even after 1h of incubation, as shown by increased ThT fluorescence of Aβ1–42-treated SDC3 and 4 transfectants.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:607}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells with relatively low surface HS expression, SDC3 and SDC4 induce the fibrillation of Aβ1–42 even after 1h of incubation, as shown by increased ThT fluorescence of Aβ1–42-treated SDC3 and 4 transfectants.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:601}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Simultaneous scanning electron microscopy studies also confirmed the fibrillation triggering effect of SDCs - especially SDC3 and SDC4 - on surface attached Aβ1–42 (Fig. 2b).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours", "6 hours", "1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:607}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Simultaneous scanning electron microscopy studies also confirmed the fibrillation triggering effect of SDCs - especially SDC3 and SDC4 - on surface attached Aβ1–42 (Fig. 2b).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours", "6 hours", "1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:601}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy also showed increased number of fibrillar Aβ1–42 assemblies on SDC3 and SDC4 overexpressing cells, even after 1h incubation.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy", "fluorescent labeling method"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:607}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy also showed increased number of fibrillar Aβ1–42 assemblies on SDC3 and SDC4 overexpressing cells, even after 1h incubation.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy", "fluorescent labeling method"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:601}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy studies then revealed ThT labeled fibrillar structures inside of Aβ1–42 treated cells, especially in SDC3 and SDC4 transfectants, suggesting while triggering Aβ1–42 fibrillation, SDCs also mediate the intracellular translocation of Aβ1–42 oligomers (Fig. 2c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method", "confocal microscopy"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy studies then revealed ThT labeled fibrillar structures inside of Aβ1–42 treated cells, especially in SDC3 and SDC4 transfectants, suggesting while triggering Aβ1–42 fibrillation, SDCs also mediate the intracellular translocation of Aβ1–42 oligomers (Fig. 2c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method", "confocal microscopy"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"In SH-SY5Y cells, SDC3 overexpression resulted in increased HS expression, along with increased cellular uptake and fibrillation of Aβ1–42 (Fig. 8a–e).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy", "flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:522}, properties:{annotationPublicationtype:["Research"], evidence:"Thus SDC3 and to a lesser extent, SDC4 and triggered fibrillation of α-syn and tau over time (Fig. 5a,b).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:601}, end: {_id:636}, properties:{annotationPublicationtype:["Research"], evidence:"Thus SDC3 and to a lesser extent, SDC4 and triggered fibrillation of α-syn and tau over time (Fig. 5a,b).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:607}, end: {_id:522}, properties:{annotationPublicationtype:["Research"], evidence:"Thus SDC3 and to a lesser extent, SDC4 and triggered fibrillation of α-syn and tau over time (Fig. 5a,b).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:607}, end: {_id:636}, properties:{annotationPublicationtype:["Research"], evidence:"Thus SDC3 and to a lesser extent, SDC4 and triggered fibrillation of α-syn and tau over time (Fig. 5a,b).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:601}, end: {_id:522}, properties:{annotationPublicationtype:["Research"], evidence:"Thus 18h after addition of α-syn or tau monomers, overexpressed SDC3 - either in undifferentiated or differentiated SH-SY5Y cells - triggered the fibrillation of both proteins", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:636}, properties:{annotationPublicationtype:["Research"], evidence:"Thus 18h after addition of α-syn or tau monomers, overexpressed SDC3 - either in undifferentiated or differentiated SH-SY5Y cells - triggered the fibrillation of both proteins", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:601}, end: {_id:522}, properties:{annotationPublicationtype:["Research"], evidence:"Electron microscopy also revealed widespread presence of mature fibrils on SDC3 overexpressing SH-SY5Y cells at 18h (Fig. 8c–e), while confocal microscopic studies showed higher number of ThT-labeled aggregates in SDC3 transfectants at the same time point (Fig. 8f), suggesting that while inducing fibrillation, SDC3 also facilitate the uptake of fibrillar α-syn or tau.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:636}, properties:{annotationPublicationtype:["Research"], evidence:"Electron microscopy also revealed widespread presence of mature fibrils on SDC3 overexpressing SH-SY5Y cells at 18h (Fig. 8c–e), while confocal microscopic studies showed higher number of ThT-labeled aggregates in SDC3 transfectants at the same time point (Fig. 8f), suggesting that while inducing fibrillation, SDC3 also facilitate the uptake of fibrillar α-syn or tau.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:146}, end: {_id:637}, properties:{annotationPublicationtype:["Research"], evidence:"The α-syn-specific response was further characterized by ICS assays in samples collected between 1998 and 2015, which revealed that the response was mediated by CD4+ T cells for both IFNγ and IL-4 (Fig. 1b, c).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", annotationTechnique:["Intracellular cytokine staining"], citationRef:"32313102"}}, {start: {_id:834}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, TUNEL-positive cells in un-exposed control organoids (which could be after programmed cell death) did not contain pT231Tau suggesting that this different Tau phosphorylation pattern is associated with SARS-CoV-2 entry (Fig 3Ciii). Thus, it appears that Tau is aberrantly phosphorylated in response to the viral-induced stress, which may elicit further cell death programs that remains to be elucidated.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["Terminal deoxynucleotidyl transferase dUTP nick end labeling"], citationRef:"32876341"}}, {start: {_id:847}, end: {_id:848}, properties:{annotationPublicationtype:["Research"], evidence:"We validated the upregulation of p38 signaling by immunostaining of the phosphorylated form of p38 in infected cells (Figures S4C and S4D). Interestingly, quantification showed elevated levels of phospho-p38 in nearby uninfected cells, although to a lesser degree than in infected cells, suggesting a substantial non-cell-autonomous effect .", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:858}, end: {_id:861}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of downregulated genes revealed a decrease in the expression of many transporters and ion channels, such as AQP1, AQP4, and SLC22A8, which are important for normal CSF secretory function (Figure 4D; Brown et al., 2004; Hladky and Barrand, 2016), suggesting functional deficits of choroid plexus cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:859}, end: {_id:861}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of downregulated genes revealed a decrease in the expression of many transporters and ion channels, such as AQP1, AQP4, and SLC22A8, which are important for normal CSF secretory function (Figure 4D; Brown et al., 2004; Hladky and Barrand, 2016), suggesting functional deficits of choroid plexus cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:860}, end: {_id:861}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of downregulated genes revealed a decrease in the expression of many transporters and ion channels, such as AQP1, AQP4, and SLC22A8, which are important for normal CSF secretory function (Figure 4D; Brown et al., 2004; Hladky and Barrand, 2016), suggesting functional deficits of choroid plexus cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:887}, end: {_id:888}, properties:{annotationPublicationtype:["Research"], evidence:"To better characterize the distribution of SARS-CoV-2 entry factors in the different ChP populations, we performed subclustering of all the ChP cell populations, and we identified four prominent clusters of immature ChP, maturing ChP, hem and ChP stroma, as well as two smaller clusters: one that appeared to be neural crest cells and one that was enriched in expression of lipoprotein genes, such as APOA1 and APOA2 (Besler et al., 2012; Wang et al., 2019), suggesting a function in lipid production and transfer.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:889}, end: {_id:888}, properties:{annotationPublicationtype:["Research"], evidence:"To better characterize the distribution of SARS-CoV-2 entry factors in the different ChP populations, we performed subclustering of all the ChP cell populations, and we identified four prominent clusters of immature ChP, maturing ChP, hem and ChP stroma, as well as two smaller clusters: one that appeared to be neural crest cells and one that was enriched in expression of lipoprotein genes, such as APOA1 and APOA2 (Besler et al., 2012; Wang et al., 2019), suggesting a function in lipid production and transfer.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:887}, end: {_id:890}, properties:{annotationPublicationtype:["Research"], evidence:"To better characterize the distribution of SARS-CoV-2 entry factors in the different ChP populations, we performed subclustering of all the ChP cell populations, and we identified four prominent clusters of immature ChP, maturing ChP, hem and ChP stroma, as well as two smaller clusters: one that appeared to be neural crest cells and one that was enriched in expression of lipoprotein genes, such as APOA1 and APOA2 (Besler et al., 2012; Wang et al., 2019), suggesting a function in lipid production and transfer.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:889}, end: {_id:890}, properties:{annotationPublicationtype:["Research"], evidence:"To better characterize the distribution of SARS-CoV-2 entry factors in the different ChP populations, we performed subclustering of all the ChP cell populations, and we identified four prominent clusters of immature ChP, maturing ChP, hem and ChP stroma, as well as two smaller clusters: one that appeared to be neural crest cells and one that was enriched in expression of lipoprotein genes, such as APOA1 and APOA2 (Besler et al., 2012; Wang et al., 2019), suggesting a function in lipid production and transfer.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:896}, end: {_id:820}, properties:{annotationPublicationtype:["Research"], evidence:"We performed three independent infections with SARS-CoV-2 Spike pseudovirions of organoids aged more than 55 days to ensure a mature identity, which revealed viral tropism for ChP epithelial tissue, as indicated by the GFP antibody-positive signal.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:920}, end: {_id:819}, properties:{annotationPublicationtype:["Research"], evidence:"Increasing the concentration of S1 spike protein from 70 to 350 ng/ ml resulted in increased HUVEC cell degeneration and adhesion, as well as a significant increase in the % of cells with the spike subunit and caspase-3 (Table 2 and Fig. 3).", annotationPublicationstatus:["Published"], citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationSection:["Results"], annotationCustomCellline:["HUVEC cell line"], annotationConcentration:["350 ng/ ml"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:920}, end: {_id:416}, properties:{annotationPublicationtype:["Research"], evidence:"Increasing the concentration of S1 spike protein from 70 to 350 ng/ ml resulted in increased HUVEC cell degeneration and adhesion, as well as a significant increase in the % of cells with the spike subunit and caspase-3 (Table 2 and Fig. 3).", annotationPublicationstatus:["Published"], citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationSection:["Results"], annotationCustomCellline:["HUVEC cell line"], annotationConcentration:["350 ng/ ml"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:607}, end: {_id:1078}, properties:{annotationPublicationtype:["Research"], evidence:"PSV studies thus showed that besides facilitating SARS-CoV-2 uptake, SDC4-mediated cellular entry also maintains the biological activity (i.e., the gene transduction ability) of the virus.", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["reporter gene assay", "flow cytometry", "confocal microscopy", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:1104}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Electron microscopic studies also show the formation of fibrillar-like aggregates on the surfaces of ApoE4-treated cells, especially at 18 h of incubation. The presence of such small fibrils on ApoE3-treated cells was less evident, while electron microscopy did not reveal ApoE2 fibrils on ApoE2-treated SH-SY5Y cells and SDC3 transfectants (Figure 5D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:146}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Not only aggregation, but also the overexpression and post-translational modifications (e.g. nitration) of α-syn are linked to sustained microglial activation [61–66], an effect likely mediated by the NFkB and MAPK signaling pathways", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1364}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Not only aggregation, but also the overexpression and post-translational modifications (e.g. nitration) of α-syn are linked to sustained microglial activation [61–66], an effect likely mediated by the NFkB and MAPK signaling pathways", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:146}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, also α-syn silencing may cause neuroinflammation, suggesting that not only excessive α-syn concentrations but also perturbation of physiological α-syn levels could support PD pathogenesis", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:268}, end: {_id:236}, properties:{annotationPublicationtype:["Review"], evidence:"The expression of LRRK2 is increased in monocytes activated by IFNγ, suggesting that it could play a role in monocyte maturation", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal dominant"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:466}, end: {_id:1396}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is an E3-ubiquitin ligase that is responsible for the ubiquitylation and degradation of mitochondrial proteins and the recruitment of autophagy receptors that facilitate the removal of damaged mitochondria during mitophagy", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:466}, end: {_id:1397}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is an E3-ubiquitin ligase that is responsible for the ubiquitylation and degradation of mitochondrial proteins and the recruitment of autophagy receptors that facilitate the removal of damaged mitochondria during mitophagy", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:466}, end: {_id:472}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is an E3-ubiquitin ligase that is responsible for the ubiquitylation and degradation of mitochondrial proteins and the recruitment of autophagy receptors that facilitate the removal of damaged mitochondria during mitophagy", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:582}, end: {_id:1407}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, PINK1 deficiency triggers an innate immune response mediated by mitochondrial dysfunction and a dysregulation in anti-microbial defense mechanisms ", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:582}, end: {_id:1408}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, PINK1 deficiency triggers an innate immune response mediated by mitochondrial dysfunction and a dysregulation in anti-microbial defense mechanisms ", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1457}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 mutation impairs this 'double-rescue' strategy, as demonstrated by less efficient redistribution of α-syn between microglial cells from LRRK2 G2019S mice, thereby amplifying neuroinflammation [125•].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:597}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In a separate study, GBA mutation carriers without PD were found to have increased microglial activation compared to age matched healthy controls, suggesting that inflammation could be an early event.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:1494}, end: {_id:5}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:293}, end: {_id:5}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1495}, end: {_id:5}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1496}, end: {_id:5}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1502}, end: {_id:16}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Although there was enrichment for microglial and astrocyte activation in the gene set upregulated in infection, genes associated with high SARS-CoV-2 E and N were overwhelmingly enriched in two reactive astrocyte states that appear to be downstream of Nuclear factor kappa B (NF-κB) signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1503}, end: {_id:16}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Although there was enrichment for microglial and astrocyte activation in the gene set upregulated in infection, genes associated with high SARS-CoV-2 E and N were overwhelmingly enriched in two reactive astrocyte states that appear to be downstream of Nuclear factor kappa B (NF-κB) signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1156}, end: {_id:774}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"NRP1 is a potential candidate entry factor for infection, as it has been demonstrated to be a SARS-CoV-2 host factor (34). We observed NRP1 RNA expression in primary tissue, specifically in cortical neurons—a population, however, where we observed minimal infection (SI Appendix, Fig. 8A). When we evaluated NRP1 protein abundance, we similarly observed membrane-bound staining in neurons in the cortical plate in primary tissue, but none in dsRNA+-infected cells.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:894}, end: {_id:774}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We exposed the CD147- or DPP4-expressing organoids to SARS-CoV-2 for 2 h. We observed a significant increase in SARS-CoV-2 N+ cells with DPP4 overexpression and an increase in dsRNA+ cells in both DPP4- and CD147-overexpressing conditions (SI Appendix, Fig. 13C). Taken together with the loss of function and inhibition studies, these findings indicate that DPP4 and CD147 are sufficient to mediate SARS-CoV-2 infection and suggest that DPP4 may promote viral entry, while CD147 may promote viral replication.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1158}, end: {_id:322}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We exposed the CD147- or DPP4-expressing organoids to SARS-CoV-2 for 2 h. We observed a significant increase in SARS-CoV-2 N+ cells with DPP4 overexpression and an increase in dsRNA+ cells in both DPP4- and CD147-overexpressing conditions (SI Appendix, Fig. 13C). Taken together with the loss of function and inhibition studies, these findings indicate that DPP4 and CD147 are sufficient to mediate SARS-CoV-2 infection and suggest that DPP4 may promote viral entry, while CD147 may promote viral replication.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1158}, end: {_id:322}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Moreover, infected SARS-CoV-2 S+ VIM+ astrocytes expressed DPP4 and CD147 but not ACE2 (Fig. 6C). The high abundance of VIM in infected cells suggests both specific astrocyte tropism as well as reactivity in adult tissue. Together with our observations in infected organoids and developing tissue, these data suggest tropism of SARS-CoV-2 for astrocytes in both developing and adult human cortex. Furthermore, the capacity for viral propagation can occur independent of ACE2 and is mediated, in part, by CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:894}, end: {_id:322}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Moreover, infected SARS-CoV-2 S+ VIM+ astrocytes expressed DPP4 and CD147 but not ACE2 (Fig. 6C). The high abundance of VIM in infected cells suggests both specific astrocyte tropism as well as reactivity in adult tissue. Together with our observations in infected organoids and developing tissue, these data suggest tropism of SARS-CoV-2 for astrocytes in both developing and adult human cortex. Furthermore, the capacity for viral propagation can occur independent of ACE2 and is mediated, in part, by CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:575}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Nevertheless, in the present study, we detected that the patient group with Long COVID showed increased CRP levels compared with control levels, indicating a mild inflammatory response.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1069}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, the immunostaining revealed a significant increase in cell death measured by both cleaved caspase 3 (CC3) by 20% and TUNEL immunostainings by 30%, accompanied by a 15% increase in the amount of SARS-CoV-2+ cells in virus-infected BCO when compared to non-infected controls (Fig 1J, ​,1K,1K, and ​and1M).1M). Treatment with SOF significantly decreased both SARS-CoV-2 viral protein levels and viral-induced cell death.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", citationType:"PubMed", annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationBioassay:["immunolabeling method"], annotationDisease:["COVID-19"], citationRef:"36327326"}}, {start: {_id:896}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Antibody staining revealed that fused neurons were positive for the fusogenic spike S protein , which was distributed across the surface of infected neurons.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:1764}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Our results revealed that the expression of p15 was sufficient to induce neuronal fusion, as detected by the presence of neurons containing both the GFP and mCherry fluorescent proteins a phenotype that was never observed when the control vector was cotransfected in the absence of p15.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationTechnique:["fluorescence fusion assay"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:1764}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"With both p15 and spike S, we observed not only neuron-neuron fusion but also neuron-glia and glia-glia fusion when the fusogens were expressed in these cell types (fig. S4), a result that mimics our observation with SARS-CoV-2 infection.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["glial cell", "neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationTechnique:["fluorescence fusion assay"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:896}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"With both p15 and spike S, we observed not only neuron-neuron fusion but also neuron-glia and glia-glia fusion when the fusogens were expressed in these cell types (fig. S4), a result that mimics our observation with SARS-CoV-2 infection.", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["glial cell", "neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationTechnique:["fluorescence fusion assay"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:1764}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Similar to what we observed in neuronal cultures and in C. elegans mechanosensory neurons, p15 expression resulted in neuronal fusion presenting as clusters of interconnected GFP-positive cells (fig. S7, A to E, and movie S2). Neuronal fusion was observed both in the hippocampus and in the cortex (fig. S7, F to I), representing up to 15% of transduced hippocampal neurons at 14 days after AAV infection (fig. S7H).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], annotationMeshanatomy:["Hippocampus", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"37285437", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"37285437"}}, {start: {_id:1764}, end: {_id:836}, properties:{annotationPublicationtype:["Research"], evidence:"Three days after the expression of the fusogens, the neuronal cultures were inspected, revealing the formation of neuronal clusters of interconnected GFP-positive cells that resembled the neuronal syncytium observed after p15 expression in murine neurons (fig. S8, A to C).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:1158}, end: {_id:774}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, the extracellular proteases BSG and DPP4 have also been identified as additional entry receptors for SARS-CoV-2 on astrocytes, providing new detail on the neuropathogenesis of COVID-19 (Andrews et al., 2022; Wang et al., 2020) (Fig. 2).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:894}, end: {_id:774}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, the extracellular proteases BSG and DPP4 have also been identified as additional entry receptors for SARS-CoV-2 on astrocytes, providing new detail on the neuropathogenesis of COVID-19 (Andrews et al., 2022; Wang et al., 2020) (Fig. 2).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1843}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"A recent study showed that the cytokine CCL11 (eotaxin-1) remains elevated in long COVID patients suffering from brain fog, and high levels of CCL11 have been associated with demyelination of oligodendrocytes and activation of hippocampal microglia (Fernández-Castañeda et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Hippocampus"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationCustomDisease:["Long COVID"], citationRef:"37458167"}}, {start: {_id:1843}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Second, the increased levels of cytokines and chemokines, such as CCL11, upon acute COVID infection are sufficient to induce long-lasting reactivity of white matter microglia in the subcortical and hippocampal regions, compatible with the pathophysiology of cognitive impairment (Etter et al., 2022; Fernández-Castañeda et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationCustomAnatomy:["Subcortical region"], annotationDisease:["COVID-19"], citationRef:"37458167"}}, {start: {_id:582}, end: {_id:583}, properties:{annotationPublicationtype:["Review"], evidence:"PTEN-induced serine/threonine kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin, mutations of which are associated with recessive familial PD, are both involved in mitochondrial antigen presentation, and their dysfunction may lead to an inflammatory response [24].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:466}, end: {_id:583}, properties:{annotationPublicationtype:["Review"], evidence:"PTEN-induced serine/threonine kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin, mutations of which are associated with recessive familial PD, are both involved in mitochondrial antigen presentation, and their dysfunction may lead to an inflammatory response [24].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1870}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"TLR-2 and 4 have been highlighted as α-syn targets and shown to be upregulated in the brains and blood monocytes of people with PD (reviewed in [47]). This can induce the production of proinflammatory cytokines and reactive oxygen species, and, ultimately, neuronal death.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes", "Brain", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:360}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"TLR-2 and 4 have been highlighted as α-syn targets and shown to be upregulated in the brains and blood monocytes of people with PD (reviewed in [47]). This can induce the production of proinflammatory cytokines and reactive oxygen species, and, ultimately, neuronal death.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes", "Brain", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1423}, end: {_id:1888}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, the lack of DJ-1 [an oxidative stress sensor related to familial PD (PARK7) [98]] prevents the immunosenescence of T cells, suggesting a differential role for the aging mechanism with regard to these cells in PD [99].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:14}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Astrocytes express high levels of Tolllike receptor-3 (TLR3) but low levels of other TLRs, leading to pro-inflammatory responses by producing tumor necrosis factor (TNF), interleukin 6 (IL6), and other cytokines.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:13}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Astrocytes express high levels of Tolllike receptor-3 (TLR3) but low levels of other TLRs, leading to pro-inflammatory responses by producing tumor necrosis factor (TNF), interleukin 6 (IL6), and other cytokines.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2246}, end: {_id:2247}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, we and others have shown that glycoprotein A repetitions predominant [GARP, also known as leucine-rich repeat protein 32 (LRRC32)] is important for the suppressor function and the regulation of FOXP3 expression in human Tregs.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:292}, end: {_id:2247}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, GATA3, a previously recognized Th2 (T cell subset 2) master regulator, has also been found to play an essential role in the suppressive function of Tregs by controlling Foxp3 expression.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1527}, end: {_id:637}, properties:{annotationPublicationtype:["Review"], evidence:"More interestingly, the loss of IL10 is only associated with costimulation by CD46, but not by CD28.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2294}, end: {_id:455}, properties:{annotationPublicationtype:["Review"], evidence:"The primary circulating serine protease inhibitor α-1-antitrypsin can prevent signs of EAE in mice by increasing the population of Tregs and reducing the secretion of MOG-induced pro-inflammatory cytokines.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:224}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs have been found to mediate neuroprotection through the suppression of microglial stimulation,including that by aggregated nitrated α-synuclein in an animal model of PD.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:896}, end: {_id:2329}, properties:{annotationPublicationtype:["Research"], evidence:"We found that the spike+ ApoE4 astrocytes exhibited increased cell size (soma size and process length) compared to the spike+ ApoE3 astrocytes (Figures 3A, 3C, S4A, and S4C), suggesting that ApoE4 astrocytes react differently from ApoE3 astrocytes upon SARS-CoV-2 viral infection.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", annotationCellline:["AG14048 cell"], pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}, {start: {_id:1843}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"Systemic CCL11 induced microglial/macrophage reactivity specifically in hippocampal white matter (Figures 5F and 5G), and not in the cortex or subcortical white matter (Figures 5D and 5E).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["11 days post-CCL11 injection"], annotationMeshanatomy:["Hippocampus", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:1843}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], evidence:"Systemic CCL11 induced microglial/macrophage reactivity specifically in hippocampal white matter (Figures 5F and 5G), and not in the cortex or subcortical white matter (Figures 5D and 5E).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["11 days post-CCL11 injection"], annotationMeshanatomy:["Hippocampus", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:1843}, end: {_id:1624}, properties:{annotationPublicationtype:["Research"], evidence:"As expected (Villeda et al., 2011), we also found decreased hippocampal neurogenesis following systemic CCL11 administration (Figures 5H and 5I).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["11 days post-CCL11 injection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:5}, end: {_id:232}, properties:{annotationPublicationtype:["Review"], evidence:"Since 1988, when McGeer and colleagues found HLA-DR-positive (activated) microglia phagocytosing-free neuromelanin in post mortem PD SN (McGeer et al. 1988a), activated microglial consistently have been observed in PD patients, whereas others have shown higher expression levels of polymorphic major histocompatibility complex (MHC) class II (MHC II) molecules, HLA-DR and HLA-DQ, expressed by monocytes in the CSF and peripheral blood of PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:1864}, end: {_id:250}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in PINK1-knockout mice, gut infection resulted in dopaminergic degeneration mediated by cytotoxic CD8+ T cells (Tc), which was induced by an autoimmune mechanism [28].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMouseType:["PINK1 -/-"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2299}, end: {_id:2252}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of a secreted phospholipase A2- IID-Fc fusion protein, which is selectively produced by Tregs, inhibits disease development in murine models of colitis and MS via promoting the differentiation of Tregs and mediating Treg function", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:21}, end: {_id:126}, properties:{annotationPublicationtype:["Review"], evidence:"In keeping with the studies in animal models, the immunization of patients who have AD has indeed led to clearance of amyloid plaques, which was associated with amyloid phagocytosis by macrophages and microglia (Figure 2).", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:466}, end: {_id:471}, properties:{annotationPublicationtype:["Review"], evidence:"Potential roles for this protein are in preventing protein aggregation and/or promoting mitophagy [167–169]. Parkin has also been suggested to function as a transcription factor, regulating p53 expression [170] independent of its ligase activity", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1043}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, tissue-type plasminogen activator infusion showed benefit in three patients with severe COVID-19 (ref.119), and a phase IIa trial in patients with COVID-19-related ARDS is currently ongoing (NCT04357730).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1373}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1400}, end: {_id:1421}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, it was shown that intestinal infection/dysfunction in PINK1-KO mice and PINK1-mutant flies also leads to neuroinflammation and neurotoxicity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Pink1-/-"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1400}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, it was shown that intestinal infection/dysfunction in PINK1-KO mice and PINK1-mutant flies also leads to neuroinflammation and neurotoxicity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Pink1-/-"], citationRef:"35674870"}}, {start: {_id:1400}, end: {_id:63}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, it was shown that intestinal infection/dysfunction in PINK1-KO mice and PINK1-mutant flies also leads to neuroinflammation and neurotoxicity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Pink1-/-"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1563}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:274}, end: {_id:1354}, properties:{annotationPublicationtype:["Review"], evidence:"Depletion of Tregs by treatment with antiCD25 antibodies following the induction of EAE has been found to cause significant enhancement of disease severity and mortality", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Encephalomyelitis, Autoimmune, Experimental"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2293}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"The primary circulating serine protease inhibitor α-1-antitrypsin can prevent signs of EAE in mice by increasing the population of Tregs and reducing the secretion of MOG-induced pro-inflammatory cytokines.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:1806}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"E2 can also suppress EAE by the upregulation of programmed death 1 (PD1) expression in Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:246}, properties:{annotationPublicationtype:["Review"], evidence:"In PD patients, approximately 4% of the pigmented neurons contained Lewy bodies and all pigmented, Lewy body-containing neurons showed detectable IgG and α-syn within inclusions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:255}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, compared with controls, PD patients show increased areas of C1q-opsonized extracellular depositions of neuromelanin within the parenchyma, and C1q-expressing phagocytic microglia surround those areas, as well as cells around the luminal surfaces of the vasculature that express neuromelanin and C1q, suggesting a role for antiself antibodies and C1q-mediated clearing pathways in PD.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:640}, end: {_id:1032}, properties:{annotationPublicationtype:["Review"], evidence:"MPO–DNA complexes and thrombin–antithrombin complexes were positively correlated in patients with COVID-19, and the anticoagulant dabigatran or complement targeting inhibited NETosis86, further suggesting a central role for NETs in the immunothrombotic milieu.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1035}, properties:{annotationPublicationtype:["Review"], evidence:"MPO–DNA complexes and thrombin–antithrombin complexes were positively correlated in patients with COVID-19, and the anticoagulant dabigatran or complement targeting inhibited NETosis86, further suggesting a central role for NETs in the immunothrombotic milieu.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1792}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed increased expression of IL-12 p40(IL12B) and the IL-12 p40/p70 heterodimer (IL12A_IL12B) in cluster 4,which may drive expression of IFN-γ and an overall Th1 signature(Fig. 3A, B). While not as strongly differentially expressed in cluster 5,IFN-γ and IFN-γ induced chemokines are enriched compared to those that recovered from COVID or were uninfected (Fig. 3B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:67}, end: {_id:233}, properties:{annotationPublicationtype:["Review"], evidence:"The concept of neuroinflammation in PD was initially proposed based on the presence of responsive microglia in PD postmortem brains, as revealed by upregulated human leukocyte antigen (HLA)- DR (major histocompatibility complex; MHC-II) and CD68 [29,30]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:400}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"By contrast, male mice microglia showed higher expression of NF-κB and its inflammatory target genes, higher MHC expression, and ATP responsiveness [138,139].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:233}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"By contrast, male mice microglia showed higher expression of NF-κB and its inflammatory target genes, higher MHC expression, and ATP responsiveness [138,139].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:523}, end: {_id:501}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:524}, end: {_id:502}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:527}, end: {_id:526}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:530}, end: {_id:529}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:532}, end: {_id:531}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__GENE]->(end) SET r += row.properties;
UNWIND [{start: {_id:194}, end: {_id:479}, properties:{annotationPublicationtype:["Review"], evidence:"The adoptively transferred T cells accumulate in the SN, suppress microglial activation, and are correlated with an increase in neurotrophic factors [180]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:682}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Blood D-dimer concentration was raised in many patients with COVID-19, consistent with a pro-inflammatory, coagulopathic state in the setting of critical illness.51, 52, 53, 54, 55, 77, 92, 95, 96 Positive lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein-1 antibodies have also been reported in COVID-19-associated stroke,52, 77 although these can be raised in other critical illnesses, including infections.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:789}, end: {_id:39}, properties:{annotationPublicationtype:["Research"], evidence:"The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict OSTOX, increased NO production, and decreased Gpx and ANTIOX, whereas increased PBT levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID’s increased OSTOX/ANTIOX ratio.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:684}, end: {_id:2107}, properties:{annotationPublicationtype:["Research"], evidence:"Ingenuity pathway analysis of genes differentially expressed between mock and SARS-CoV-2 infected hPSC-derived DA neurons highlighted the cell cycle, DNA replication, and senescence pathways as the top upregulated pathways in SARS-CoV-2 infected DA neurons.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["pathway analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2108}, properties:{annotationPublicationtype:["Research"], evidence:"Ingenuity pathway analysis of genes differentially expressed between mock and SARS-CoV-2 infected hPSC-derived DA neurons highlighted the cell cycle, DNA replication, and senescence pathways as the top upregulated pathways in SARS-CoV-2 infected DA neurons.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["pathway analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Ingenuity pathway analysis of genes differentially expressed between mock and SARS-CoV-2 infected hPSC-derived DA neurons highlighted the cell cycle, DNA replication, and senescence pathways as the top upregulated pathways in SARS-CoV-2 infected DA neurons.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["pathway analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Gene set enrichment analysis (GSEA) further confirmed the enrichment of senescence pathway in SARS-CoV-2 versus mock-infected purified hPSC-derived DA neurons (Figure 3B).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Senescence-associated genes are also significantly upregulated in SARS-CoV-2 infected DA neurons (Figure S3K).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:283}, end: {_id:47}, properties:{annotationPublicationtype:["Review"], evidence:"The relative frequency of Tregs increases with age in both AD and PD patients and in non-affected individuals.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:24}, end: {_id:119}, properties:{annotationPublicationtype:["Review"], evidence:"IFN-gamma stimulation of immune cells results in upregulation of LRRK2 expression, which was shown to activate the NF-κB pathway, to be important for production of microbicidal reactive oxygen species during phagocytosis, and to colocalize near pathogens during intracellular infection [160]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:467}, end: {_id:470}, properties:{annotationPublicationtype:["Review"], evidence:"The Parkin gene encodes a multidomain protein that contains E3 ubiquitin ligase activity that plays a role in the regulation of numerous cellular activities including proteasomal degradation and ubiquitin-mediated signaling.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:456}, end: {_id:591}, properties:{annotationPublicationtype:["Review"], evidence:"A recent study, for instance, demonstrated that LRRK2 activity regulates Mycobacterium tuberculosis replication by affecting phagosome maturation in macrophages [52], and LRRK2 mutations may trigger PD pathogenesis via a dysregulation of responses to such bacteria.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:24}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is known to regulate oxidative stress and maintain mitochondrial function within the cell and, together with PINK1, was originally shown to provide neuroprotection by activating the NFkB transcription factor that regulates immune response among others", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1861}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"PTEN-induced serine/threonine kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin, mutations of which are associated with recessive familial PD, are both involved in mitochondrial antigen presentation, and their dysfunction may lead to an inflammatory response [24].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:474}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"PTEN-induced serine/threonine kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin, mutations of which are associated with recessive familial PD, are both involved in mitochondrial antigen presentation, and their dysfunction may lead to an inflammatory response [24].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:2249}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"GARP is a receptor for latent TGF-β on the surface of activated human Tregs and may be necessary for the ability of Tregs to activate TGF-β upon T cell receptor (TCR) stimulation.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1065}, properties:{annotationPublicationtype:["Research"], evidence:"Taste changes were characterized in the 6 patients by dysgeusia where they had a reduced acuity for sweet taste, had a bad taste in the mouth, reduced or increased acuity for bitter, reduced acuity for salt or sour were reported in 4 out of the 6 patients with dysgeusia.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1065}, properties:{annotationPublicationtype:["Research"], evidence:"Two patients complained of bad taste (Table S2). Reduced or increased acuity for bitter, reduced acuity for salt or sour were reported by the two patients with dysgeusia", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:551}, end: {_id:1326}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, modifications in the composition of microorganisms that populate the gut, also known as dysbiosis, may lead to dysregulated TLR signaling, persistent production of proinflammatory cytokines and disruption of the gut epithelial barrier.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1920}, end: {_id:1921}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"In an ulcerative colitis mouse model, males exhibited more pronounced immune changes and neurodegeneration [150].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:90}, end: {_id:92}, properties:{annotationPublicationtype:["Review"], evidence:"Possible reasons for these negative findings have been discussed in detail elsewhere; however, the fact that inhibition of cyclooxygenase activity by NSAIDs only inhibits the release of a limited number of inflammatory mediators secreted by microglia could be one explanation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:90}, end: {_id:94}, properties:{annotationPublicationtype:["Review"], evidence:"Possible reasons for these negative findings have been discussed in detail elsewhere; however, the fact that inhibition of cyclooxygenase activity by NSAIDs only inhibits the release of a limited number of inflammatory mediators secreted by microglia could be one explanation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:283}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, Treg control microglia function by suppressing reactive oxygen species production and NFκB activation via mechanisms that modulate redox enzymes, cell migration, and phagocytosis .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:492}, end: {_id:493}, properties:{annotationPublicationtype:["Review"], evidence:"The drug, natalizumab has been successful in the treatment of multiple sclerosis [190].  As an antibody against the alpha 4 integrin, this antibody blocks the recruitment of T cells to sites of inflammation. By blocking activation and recruitment of T cells in PD, neuroinflammation could be dampened to prevent subsequent neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:565}, end: {_id:567}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:960}, end: {_id:961}, properties:{annotationPublicationtype:["Research"], evidence:"We showed that camostat or EK1 peptide inhibited viral infection, confirming that pseudovirus entry is mediated by the spike protein and is dependent on TMPRSS2 function (Figure 2C). ", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:1054}, end: {_id:1056}, properties:{annotationPublicationtype:["Review"], evidence:"In a report from Italy, a patient with severe COVID-19-related ARDS was safely and successfully treated with the compstatin-based complement C3 inhibitor AMY-101 (ref.149). ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:2152}, end: {_id:2143}, properties:{annotationPublicationtype:["Research"], evidence:"Three drugs, riluzole (Figures 4B and 4E), metformin (Figures 4C and 4F), and imatinib (EC50 = 3.25 μM, CC50 = 17.14 μM, Figures 4D and 4G), reduced β-gal activity in a dose-dependent manner without inducing cytotoxicity.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:2143}, properties:{annotationPublicationtype:["Research"], evidence:"Three drugs, riluzole (Figures 4B and 4E), metformin (Figures 4C and 4F), and imatinib (EC50 = 3.25 μM, CC50 = 17.14 μM, Figures 4D and 4G), reduced β-gal activity in a dose-dependent manner without inducing cytotoxicity.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:2143}, properties:{annotationPublicationtype:["Research"], evidence:"Three drugs, riluzole (Figures 4B and 4E), metformin (Figures 4C and 4F), and imatinib (EC50 = 3.25 μM, CC50 = 17.14 μM, Figures 4D and 4G), reduced β-gal activity in a dose-dependent manner without inducing cytotoxicity.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2337}, end: {_id:961}, properties:{annotationPublicationtype:["Research"], evidence:"These results together indicate that remdesivir could effectively inhibit SARS-CoV-2 infection and rescue disease phenotypes in neurons and astrocytes and therefore can be used to manage neurological infection by SARS-CoV-2.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["neuron", "astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["AG14048 cell"], annotationDisease:["COVID-19"], citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:14}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"The source of TNF-a induced production of ROS probably arises from mitochondria activated in some manner by this cytokine [77-79].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:14}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Mitochondria are induced to produce more ROS by TNF-a via a second messenger component(s), perhaps a membrane component, such as arachidonate [80] or ceramide [81].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:1358}, end: {_id:1460}, properties:{annotationPublicationtype:["Review"], evidence:"Increased circulating cell free levels of mtDNA (discussed as an inflammation trigger) were also observed in PD patients with PINK1 mutations.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:388}, end: {_id:90}, properties:{annotationPublicationtype:["Review"], evidence:"Here, it was shown that the penetrance of PD-linked LRRK2 mutations was reduced based on NSAID treatment [155]. ", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:824}, end: {_id:1521}, properties:{annotationPublicationtype:["Research"], evidence:"Infected organoids then displayed a significant decrease in postsynaptic density (PSD-95) as compared to the mock-treated organoids.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:824}, end: {_id:1521}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings in 2D models [20], this revealed a baseline uptake of postsynaptic structures (indicated by PSD-95) in microglia residing in brain organoids", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:24}, end: {_id:25}, properties:{annotationPublicationtype:["Review"], evidence:"For example, it has been shown that b-amyloid peptide binds to the neuronal receptor for advanced glycation end products (AGE), which in turn then induces macrophage colony-stimulating factor by an oxidant sensitive nuclear factor-kB (NF-kB) dependent pathway that, therefore, sets in motion microglia supported inflammatory pathways [18], which have been shown to be present and operational in the Alzheimer's brain [18].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:371}, end: {_id:372}, properties:{annotationPublicationtype:["Review"], evidence:"In a mouse model, expression of wild-type alpha-synuclein under the direction of the Thy1 promoter resulted in microglial activation and TNFalpha expression in the striatum at 1 month of age and progression to the SN at 5-6 months of age [46].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationAge:["1 month"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["10090"], annotationAnatomy:["striatum"], citationRef:"24275605"}}, {start: {_id:953}, end: {_id:1161}, properties:{annotationPublicationtype:["Research"], evidence:"In ACE2-positive cells, but not ACE2-negative cells, the spike protein was found in a perinuclear localization as reported for pulmonary endothelial cells (Fig. 2e)32. ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationTimeline:["24 hours post infection"], annotationMeshanatomy:["Lung"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCustomCellline:["hCMEC/D3 cell"], citationRef:"34675436"}}, {start: {_id:1390}, end: {_id:1388}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1390}, end: {_id:1389}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:86}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Wallerian degeneration in the CNS is accompanied by the activation of microglia along the degenerating fiber tracts and, over time, foam cells, which are responsible for the removal of degenerating axons and myelin, become evident.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:126}, end: {_id:119}, properties:{annotationPublicationtype:["Review"], evidence:"In keeping with the studies in animal models, the immunization of patients who have AD has indeed led to clearance of amyloid plaques, which was associated with amyloid phagocytosis by macrophages and microglia (Figure 2).", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:418}, end: {_id:475}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin knockout animals do not have loss of DA neurons in the SN and do not have increased vulnerability to MPTP, yet they do show non-motor behavioral changes related to changes in the nigrostriatal pathway [171, 172].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"These data suggest that SARS-CoV-2 infection is associated with inflammation of the olfactory mucosa in patients with olfactory impairment, we thus measured the profile of local cytokine and inflammatory mediators.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], annotationMeshanatomy:["Olfactory Mucosa"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:1571}, end: {_id:39}, properties:{annotationPublicationtype:["Research"], evidence:"Most importantly, the results of our study show that chronic fatigue, depression and anxiety symptoms in Long COVID are all manifestations of the same core, which is strongly associated with OSTOX/ANTIOX and inflammatory signs.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1566}, end: {_id:39}, properties:{annotationPublicationtype:["Research"], evidence:"Most importantly, the results of our study show that chronic fatigue, depression and anxiety symptoms in Long COVID are all manifestations of the same core, which is strongly associated with OSTOX/ANTIOX and inflammatory signs.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1567}, end: {_id:39}, properties:{annotationPublicationtype:["Research"], evidence:"Most importantly, the results of our study show that chronic fatigue, depression and anxiety symptoms in Long COVID are all manifestations of the same core, which is strongly associated with OSTOX/ANTIOX and inflammatory signs.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1571}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Most importantly, the results of our study show that chronic fatigue, depression and anxiety symptoms in Long COVID are all manifestations of the same core, which is strongly associated with OSTOX/ANTIOX and inflammatory signs.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1566}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Most importantly, the results of our study show that chronic fatigue, depression and anxiety symptoms in Long COVID are all manifestations of the same core, which is strongly associated with OSTOX/ANTIOX and inflammatory signs.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1567}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Most importantly, the results of our study show that chronic fatigue, depression and anxiety symptoms in Long COVID are all manifestations of the same core, which is strongly associated with OSTOX/ANTIOX and inflammatory signs.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:2}, end: {_id:1729}, properties:{annotationPublicationtype:["Research"], evidence:"In case #7, ischemic injury of the right rostral hippocampal formation due to posterior cerebral artery (PCA) occlusion was associated with perivascular extravasation, edema, fibrinogen leakage and viral protein immunoreactivity within small vessel endothelium, further confirmed by RT-PCR.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell", "hippocampal formation"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:2}, end: {_id:1707}, properties:{annotationPublicationtype:["Research"], evidence:"In case #7, ischemic injury of the right rostral hippocampal formation due to posterior cerebral artery (PCA) occlusion was associated with perivascular extravasation, edema, fibrinogen leakage and viral protein immunoreactivity within small vessel endothelium, further confirmed by RT-PCR.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell", "hippocampal formation"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:957}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Acute hemorrhagic injury in the territory of the right middle cerebral artery (MCA) in #11 (Fig. 1b) was associated with endothelitis within perilesional tissue, displaying both viral protein immunoreactive endothelium and positive RT-PCR.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Middle Cerebral Artery"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:1829}, end: {_id:47}, properties:{annotationPublicationtype:["Review"], evidence:"A similar meta-analysis also revealed that patients of 70 years and above are at higher risk of long COVID, although it is not exclusive to adults (Sudre et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationAge:["70 years and above"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:11}, end: {_id:10}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:45}, end: {_id:44}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:92}, end: {_id:91}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:94}, end: {_id:93}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:174}, end: {_id:173}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:326}, end: {_id:325}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:361}, end: {_id:360}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:371}, end: {_id:280}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:414}, end: {_id:413}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:420}, end: {_id:419}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:451}, end: {_id:268}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:456}, end: {_id:453}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:467}, end: {_id:466}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:474}, end: {_id:466}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:480}, end: {_id:372}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:481}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:493}, end: {_id:297}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:587}, end: {_id:453}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:588}, end: {_id:453}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:627}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:630}, end: {_id:611}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:631}, end: {_id:608}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:953}, end: {_id:775}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:961}, end: {_id:896}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1017}, end: {_id:1016}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1056}, end: {_id:1055}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1166}, end: {_id:1162}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1193}, end: {_id:1191}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1198}, end: {_id:1196}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1205}, end: {_id:1204}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1206}, end: {_id:932}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1273}, end: {_id:607}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1385}, end: {_id:1384}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1390}, end: {_id:1384}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1450}, end: {_id:1449}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1451}, end: {_id:1449}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1587}, end: {_id:1156}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1591}, end: {_id:1590}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1608}, end: {_id:1607}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1673}, end: {_id:1672}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:1675}, end: {_id:1674}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1733}, end: {_id:382}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1737}, end: {_id:13}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1738}, end: {_id:14}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1784}, end: {_id:1782}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1861}, end: {_id:582}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1908}, end: {_id:1907}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2143}, end: {_id:2142}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2160}, end: {_id:2159}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2228}, end: {_id:378}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2229}, end: {_id:1022}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2249}, end: {_id:196}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2274}, end: {_id:2273}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:247}, end: {_id:246}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2269}, end: {_id:233}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__COMPLEX]->(end) SET r += row.properties;
UNWIND [{start: {_id:1213}, end: {_id:1229}, properties:{annotationPublicationtype:["Research"], evidence:"The increased IgG extravasation in NemobeKO mice was associated with a lower number of IgG-filled vesicles in brain endothelial cells", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1860}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 variant rs76904798, associated with increased PD risk, affects LRRK2 expression in monocytes but not in cells isolated from the cortex, further highlighting the relevance of the peripheral immune system in PD [12].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2416}, end: {_id:1984}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2417}, end: {_id:1990}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1993}, end: {_id:1997}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2418}, end: {_id:1999}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2419}, end: {_id:2013}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2420}, end: {_id:2019}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1993}, end: {_id:2033}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1993}, end: {_id:2035}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_VARIANT_RNA]->(end) SET r += row.properties;
UNWIND [{start: {_id:283}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"Up-regulation of the antiviral ubiquitin-like protein, interferon-stimulated gene 15 (ISG15) was concordant with the decrease in viral release from MP , and implicating caspase-3 and granzyme/perforin pathways in MP killing. Finally, it was shown that Treg induce the phenotypic switch of MP from the neurotoxic MI phenotype to the more neurotrophic M2 phenotype with the down-regulation of iNOS and up-regulation of arginase 1.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:328}, properties:{annotationPublicationtype:["Review"], evidence:"Up-regulation of the antiviral ubiquitin-like protein, interferon-stimulated gene 15 (ISG15) was concordant with the decrease in viral release from MP , and implicating caspase-3 and granzyme/perforin pathways in MP killing. Finally, it was shown that Treg induce the phenotypic switch of MP from the neurotoxic MI phenotype to the more neurotrophic M2 phenotype with the down-regulation of iNOS and up-regulation of arginase 1.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:115}, end: {_id:362}, properties:{annotationPublicationtype:["Review"], evidence:"Within a week after direct LPS injection into the SN of mice, significant decreases in dopamine and dopamine metabolite levels (>60%) in the striatum and in tyrosine hydroxylase immunostain-positive(TH+) neuron number in the SN are detectable. These changes are detectable even a year after the injection[34, 35].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationTimeline:["1 year after injection"], annotationMeshanatomy:["Neurons", "Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:392}, end: {_id:362}, properties:{annotationPublicationtype:["Review"], evidence:"A transient decrease in tyrosine hydroxylase(TH) expression in the SN was also observed [93]. This virus can also induce alpha-synuclein phosphorylation and aggregation [94].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:430}, end: {_id:431}, properties:{annotationPublicationtype:["Review"], evidence:"A pathogenic role for anti-neuronal antibodies in PD is further supported by a study using immunoglobulins from PD patients in a rat model. These immunoglobulins were injected into the SN of rats resulting in a loss of TH+ neurons while acetylcholinesterase-positive neurons in the medial septal region were spared [126].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Parkinson Disease"], citationRef:"24275605"}}, {start: {_id:430}, end: {_id:431}, properties:{annotationPublicationtype:["Review"], evidence:"These immunoglobulins induced perivascular inflammation,microgliosis, and loss of TH+ neurons in the SN that was dependent on expression of the Fc receptor [127].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Parkinson Disease"], citationRef:"24275605"}}, {start: {_id:115}, end: {_id:466}, properties:{annotationPublicationtype:["Review"], evidence:"In microglia, neurons, and peripheral macrophages, LPS or TNFalpha stimulation transiently reduces Parkin expression in a dose-dependent manner.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationCell:["macrophage", "microglial cell", "neuron"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:618}, end: {_id:620}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:618}, end: {_id:621}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:618}, end: {_id:622}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:618}, end: {_id:623}, properties:{annotationPublicationtype:["Research"], evidence:"Promoting undersulfation of SDCs with NaClO3 exerted an evident and significant (p<0.05) inhibition of Aβ1–42 attachment in all cells lines, however the inhibitory effect on uptake was only significant (p<0.05) in case of SDC3 and 4 transfectants (especially SDC3 and 4) than in WT K562 cells (Fig. 6c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:618}, end: {_id:620}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:618}, end: {_id:621}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:618}, end: {_id:622}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:618}, end: {_id:623}, properties:{annotationPublicationtype:["Research"], evidence:"Inducing undersulfation of SDCs’ HS chains with sodium chlorate (NaClO3), an inhibitor of protein sulfation, significantly (p<0.01) reduced on α-syn and tau fibril uptake in all cells lines, highlighting the importance of polyanionic HS chains in interaction with the proteins (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell", "SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:684}, end: {_id:858}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of downregulated genes revealed a decrease in the expression of many transporters and ion channels, such as AQP1, AQP4, and SLC22A8, which are important for normal CSF secretory function (Figure 4D; Brown et al., 2004; Hladky and Barrand, 2016), suggesting functional deficits of choroid plexus cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:859}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of downregulated genes revealed a decrease in the expression of many transporters and ion channels, such as AQP1, AQP4, and SLC22A8, which are important for normal CSF secretory function (Figure 4D; Brown et al., 2004; Hladky and Barrand, 2016), suggesting functional deficits of choroid plexus cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:860}, properties:{annotationPublicationtype:["Research"], evidence:"Closer examination of downregulated genes revealed a decrease in the expression of many transporters and ion channels, such as AQP1, AQP4, and SLC22A8, which are important for normal CSF secretory function (Figure 4D; Brown et al., 2004; Hladky and Barrand, 2016), suggesting functional deficits of choroid plexus cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:863}, properties:{annotationPublicationtype:["Research"], evidence:"We validated downregulation of TTR levels in infected cells by immunostaining (Figures S4C and S4D). We also observed downregulation of TTR levels in uninfected cells at 72 hpi, although to a lesser degree than in infected cells, again suggesting a non-cell-autonomous effect (Figure S4D).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:1046}, end: {_id:575}, properties:{annotationPublicationtype:["Review"], evidence:"Four patients with COVID-19 receiving eculizumab intravenously showed a prompt reduction in C-reactive protein levels and an improvement of the lesions observed through chest computed tomography scan147.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"33824483"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1452}, end: {_id:1208}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast, specific inhibition of GCase in mice resulted in α-syn neuropathology and inflammation, as revealed by elevated GFAP levels that are indicative of astrogliosis", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1514}, end: {_id:1503}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"To probe the functional role of DPP4 in infectivity, organotypic slice cultures were treated with the DPP4 inhibitor Vildagliptin for 24 h prior to and throughout the duration of infection. As before, there was robust infection in GFAP+ astrocytes in virally exposed samples after 72 h. However, in tissue samples treated with the DPP4 inhibitor, there was a 35% reduction in the number of SARS-CoV-2 N+ cells and a 60% reduction in dsRNA+ cells (SI Appendix, Fig. 12E). Additionally, there was a 70% reduction in the number of cells expressing ARCN1 after DPP4 inhibition, indicating decreased activation of cellular stress.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1312}, properties:{annotationPublicationtype:["Research"], evidence:"Compared with K562, L929 and RAW cells exhibited slightly increased SDC1 yet significantly decreased SDC3 expression (Figure 3A–C)", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCellline:["L929 cell", "RAW 264.7 cell"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:824}, properties:{annotationPublicationtype:["Research"], evidence:"Infected organoids then displayed a significant decrease in postsynaptic density (PSD-95) as compared to the mock-treated organoids.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1555}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"In addition to choroid plexus, a differential expression analysis showed significant increase in expression of matrix metalloproteases and ECM-regulatory enzymes at 72hpi in microglia, astrocytes and perivascular cells, whereas endothelial cells reduced expression levels of solute carrier SLC2A1 (Fig. 7g), all in agreement with signaling that promotes compromised CNS barriers.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1696}, end: {_id:1503}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent immunoblotting and immunostaining experiments on SARS-CoV-2-infected BCOs 7 days post-infection revealed that SOF treatment also reduced SARS-CoV-2 nucleoprotein (N) protein levels (Fig 1D–1J).", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", citationType:"PubMed", annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationBioassay:["immunoblot", "immunolabeling method"], annotationDisease:["COVID-19"], citationRef:"36327326"}}, {start: {_id:1696}, end: {_id:1503}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, the immunostaining revealed a significant increase in cell death measured by both cleaved caspase 3 (CC3) by 20% and TUNEL immunostainings by 30%, accompanied by a 15% increase in the amount of SARS-CoV-2+ cells in virus-infected BCO when compared to non-infected controls (Fig 1J, ​,1K,1K, and ​and1M).1M). Treatment with SOF significantly decreased both SARS-CoV-2 viral protein levels and viral-induced cell death.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", citationType:"PubMed", annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationBioassay:["immunolabeling method"], annotationDisease:["COVID-19"], citationRef:"36327326"}}, {start: {_id:684}, end: {_id:1698}, properties:{annotationPublicationtype:["Research"], evidence:"The pre-synaptic proteins vGLUT1 and Synapsin 1 were decreased by 70% in MAP2+ cells (60% in overall cells) and by 60%, respectively, upon infection with SARS-CoV-2 compared to mock conditions, which were rescued upon treatment with SOF post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:684}, end: {_id:825}, properties:{annotationPublicationtype:["Research"], evidence:"The pre-synaptic proteins vGLUT1 and Synapsin 1 were decreased by 70% in MAP2+ cells (60% in overall cells) and by 60%, respectively, upon infection with SARS-CoV-2 compared to mock conditions, which were rescued upon treatment with SOF post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:684}, end: {_id:825}, properties:{annotationPublicationtype:["Research"], evidence:"Co-localized pre- and post-synaptic markers (Synapsin 1 and PSD95) also showed a significant reduction in infected BCO, which was also rescued with SOF treatment post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:684}, end: {_id:824}, properties:{annotationPublicationtype:["Research"], evidence:"Co-localized pre- and post-synaptic markers (Synapsin 1 and PSD95) also showed a significant reduction in infected BCO, which was also rescued with SOF treatment post-infection.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:684}, end: {_id:2106}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, quantitative RNA in situ hybridization further confirmed the decrease of A9 marker LMO3, but not A10 marker CALB1 expression following SARS-CoV-2 infection, indicating the loss of cell identity of A9-type DA neurons upon SARS-CoV-2 infection (Figure 2I).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["nucleic acid hybridization-based method"], source:"wp4-cbm-comorbidity", pmid:"38237586", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2149}, properties:{annotationPublicationtype:["Research"], evidence:"Western blotting further validated the upregulation of P21 and downregulation of LMNB1 at the protein level .", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["western blot"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:1503}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with pre-treatment, the candidate drugs significantly decreased both replicating viral RNA (Figure 5D) and the percentage of SARS-N+ cells (Figures 5E and 5F) when applied at the post-infection time point.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:1503}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with pre-treatment, the candidate drugs significantly decreased both replicating viral RNA (Figure 5D) and the percentage of SARS-N+ cells (Figures 5E and 5F) when applied at the post-infection time point.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:1503}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with pre-treatment, the candidate drugs significantly decreased both replicating viral RNA (Figure 5D) and the percentage of SARS-N+ cells (Figures 5E and 5F) when applied at the post-infection time point.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:283}, end: {_id:295}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs can inhibit the costimulatory capability of DCs by CD39-mediated inactivation of extracellular ATP, which is an inducer of DC activation.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2313}, end: {_id:291}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, inhibition of Foxp3 expression by nitric oxide has been observed in MBP-primed murine T cells via soluble guanylyl-cyclase-mediated production of cGMP.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2337}, end: {_id:896}, properties:{annotationPublicationtype:["Research"], evidence:"Remdesivir treatment reduced detectable spike+ neurons (Figure 4 A) and astrocytes (Figures 4E, 4G, and S4E) substantially.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["neuron", "astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:346}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"In particular, people homozygous for a risk-conferring SNP, r3129882, in the first intron of HLA-DRA have a 1.7 fold higher risk for PD than individuals homozygous for the non-risk conferring allele [81, 82].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:501}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:502}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:109}, end: {_id:58}, properties:{annotationPublicationtype:["Review"], evidence:"Microglia expressing the mutated soD1 protein generate more superoxide and nitric oxide when challenged with endotoxin than do wild-type microglia", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationCell:["microglial cell"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Amyotrophic Lateral Sclerosis"], citationRef:"20234358"}}, {start: {_id:109}, end: {_id:57}, properties:{annotationPublicationtype:["Review"], evidence:"Microglia expressing the mutated soD1 protein generate more superoxide and nitric oxide when challenged with endotoxin than do wild-type microglia", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationCell:["microglial cell"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Amyotrophic Lateral Sclerosis"], citationRef:"20234358"}}, {start: {_id:368}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"People with PD have significant BBB dysfunction, which is discussed below. The use of anti-inflammatory drugs in neurotoxin animal models such as MPTP and 6-hydroxydopamine (6-OHDA) also attenuates DA neuron loss [44].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:370}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"People with PD have significant BBB dysfunction, which is discussed below. The use of anti-inflammatory drugs in neurotoxin animal models such as MPTP and 6-hydroxydopamine (6-OHDA) also attenuates DA neuron loss [44].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1211}, end: {_id:1148}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated FADD"], citationRef:"34675436"}}, {start: {_id:1218}, end: {_id:1219}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated FADD"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, RIPK3 deficiency, which by itself did not affect the cerebral microvasculature, prevented the formation of string vessels and the rarefaction of cerebral vessels due to Nemo deletion (Fig. 6a).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1203}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, RIPK3 deficiency, which by itself did not affect the cerebral microvasculature, prevented the formation of string vessels and the rarefaction of cerebral vessels due to Nemo deletion (Fig. 6a).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1229}, properties:{annotationPublicationtype:["Research"], evidence:"RIPK3 deficiency did not counteract the effect of NEMO ablation on IgG transcytosis (Fig. 6f). Therefore, we conclude that RIPK3 deficiency improves the BBB tightness of NemobeKO mice mainly by preventing endothelial cell death and rescuing tight junctions.", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1231}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the Mpro-induced string vessel formation also depended on the presence of RIPK3 (Fig. 7a,b), suggesting that inhibitors of RIPK signaling may protect against the microvascular pathology induced by Mpro", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["Mouse with inactivated Ripk3"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:202}, end: {_id:200}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:462}, end: {_id:200}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:606}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:613}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:628}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:629}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:828}, end: {_id:826}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:831}, end: {_id:826}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:954}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1077}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1091}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1099}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1102}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1105}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1126}, end: {_id:1124}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1192}, end: {_id:200}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1197}, end: {_id:200}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1213}, end: {_id:1212}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1215}, end: {_id:1212}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1225}, end: {_id:1212}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__FROM_LOCATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1226}, end: {_id:1212}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1265}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1331}, end: {_id:1329}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1333}, end: {_id:1329}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1395}, end: {_id:1393}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1463}, end: {_id:1461}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1519}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1772}, end: {_id:1770}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1928}, end: {_id:604}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2320}, end: {_id:1124}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__FROM_LOCATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1400}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"However, both increased and reduced activation of NFkB signaling have been observed in PINK1 KO mice and mouse macrophage cultures subjected to PINK1 knockdown", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationCell:["macrophage"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Pink1-/-"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:635}, end: {_id:1079}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that both the HSA and CBD of SDC4 has a significant role in interacting with SARS-CoV-2 (Figure 3B–D).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"34069441"}}, {start: {_id:1087}, end: {_id:1079}, properties:{annotationPublicationtype:["Research"], evidence:"However, the insignificant reduction in the cellular fluorescence of SARS-CoV-2-treated CBD mutants showed that the CBD plays an important role in interacting with the virus.", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"34069441"}}, {start: {_id:1083}, end: {_id:1079}, properties:{annotationPublicationtype:["Research"], evidence:"Overall, our studies with SDC4 deletion mutants revealed that besides the polyanionic HS chains, SARS-CoV-2 also interacts with the CBD of SDC4, highlighting the importance of the HS-independent parts of the SDC4 core protein (incubating the cells with the AF 633-labeled secondary antibodies did not induce any difference in fluorescence among the applied SDC4 transfectants and SDC4 mutants, showing that no unspecific binding influenced the difference in the detected fluorescence intensities in SARS-CoV-2-treated cells (Supplementary Figure S8)).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"34069441"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2394}, end: {_id:55}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:212}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:214}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:216}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:218}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:280}, end: {_id:224}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:230}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:280}, end: {_id:393}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:280}, end: {_id:428}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:512}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:514}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:516}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:518}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:528}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:611}, end: {_id:620}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:608}, end: {_id:621}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:601}, end: {_id:622}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:607}, end: {_id:623}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:243}, end: {_id:830}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:243}, end: {_id:834}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_MODIFIED_PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:2411}, end: {_id:847}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:1364}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2414}, end: {_id:1388}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1607}, end: {_id:1389}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:147}, end: {_id:1391}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2421}, end: {_id:2051}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2423}, end: {_id:2309}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_MODIFIED_PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:2316}, end: {_id:2194}, properties:{annotationPublicationtype:["Review"], evidence:"MiR-106b and miR-25 were previously shown to modulate TGF-β signaling through their action on CDKN1A/P21 and BCL2L11/Bim", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2317}, end: {_id:2194}, properties:{annotationPublicationtype:["Review"], evidence:"MiR-106b and miR-25 were previously shown to modulate TGF-β signaling through their action on CDKN1A/P21 and BCL2L11/Bim", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:469}, end: {_id:468}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__COMPLEX]->(end) SET r += row.properties;
UNWIND [{start: {_id:202}, end: {_id:23}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1213}, end: {_id:246}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1225}, end: {_id:246}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__COMPLEX]->(end) SET r += row.properties;
UNWIND [{start: {_id:626}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Unlike DX600, which left the cellular uptake of the spike proteins unaffected, heparin reduced the WT and Delta spike uptake in 293T and 293T-ACE2 cells, as shown by data obtained with imaging flow cytometry (Figure 3A–H).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationConcentration:["50 nM"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["293T cell", "293T cell overexpressing ACE2"], citationRef:"35054983"}}, {start: {_id:626}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Unlike DX600, which left the cellular uptake of the spike proteins unaffected, heparin reduced the WT and Delta spike uptake in 293T and 293T-ACE2 cells, as shown by data obtained with imaging flow cytometry (Figure 3A–H).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationConcentration:["50 nM"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["293T cell", "293T cell overexpressing ACE2"], citationRef:"35054983"}}, {start: {_id:626}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, heparin's effect on reducing the cellular uptake of WT spike into 293T-ACE2 cells was smaller than on 293T, showing that increased ACE2 expression leads to increased ACE2-dependent interactions with WT spike.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["293T cell"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1042}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"The cellular uptake of the Delta spike could be significantly reduced with either SDC4 knockdown(KD) or heparin co-incubation(Figure 9A-C)", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1042}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Thus, a fold change of 0.6 in SDC4 expression exerted an uptake inhibition of about 34%, while heparin inhibited the Delta spike uptake with about 55% efficacy (Figure 9B).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1042}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"SDCK4 KD or heparin co-incubation also decreased the gene transduction efficacy of the Delta PSV. Namely, heparin inhibited the Delta PSV- mediated gene delivery with ~68% efficacy, compared to the ~44% inhibition efficacy of SDC4 KD (Figure 9C).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1042}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Compared with the WT Calu-3 cells, heparin inhibited the cellular entry of all the examined viruses, with the strongest effect observed for Omicron (Figure 4D,E,G).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron", "Delta", "wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:2154}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Luciferase activity assay following infection of SARS-CoV-2-entry virus to DA neurons showed decreased luciferase activity in imatinib treated condition compared to mock, indicating that imatinib can block SARS-CoV-2 viral entry in DA neurons (Figure 6A).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["luciferase enzyme activity assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:156}, end: {_id:451}, properties:{annotationPublicationtype:["Review"], evidence:"IFN-gamma stimulation of immune cells results in upregulation of LRRK2 expression, which was shown to activate the NF-κB pathway, to be important for production of microbicidal reactive oxygen species during phagocytosis, and to colocalize near pathogens during intracellular infection [160]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:141}, end: {_id:149}, properties:{annotationPublicationtype:["Review"], evidence:"Progressive degeneration of dopaminergic neurons in the substantia nigra (SN) pars compacta and their projections into the caudate nucleus leads to substantial decreases in dopamine levels, which manifest as resting tremor, bradykinesia, rigidity, and gait dysfunction.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", annotationAnatomy:["substantia nigra pars compacta"], citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:260}, properties:{annotationPublicationtype:["Review"], evidence:"Peripheral immune aberrations, particularly in lymphocyte subsets, are abundant in PD patients. Total numbers of lymphocytes have been shown to be diminished by 17%, whereas CD19+ B cells are diminished as much as 35% and CD3+ T cells are diminished by 22%. Among CD3+ T cells, numbers of CD4+ T cells have been shown to be diminished by 31%, whereas numbers of CD8+ T cells are not significantly changed.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"Peripheral immune aberrations, particularly in lymphocyte subsets, are abundant in PD patients. Total numbers of lymphocytes have been shown to be diminished by 17%, whereas CD19+ B cells are diminished as much as 35% and CD3+ T cells are diminished by 22%. Among CD3+ T cells, numbers of CD4+ T cells have been shown to be diminished by 31%, whereas numbers of CD8+ T cells are not significantly changed.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:264}, end: {_id:262}, properties:{annotationPublicationtype:["Review"], evidence:"Selective loss of CD4+CD45RA+ cells are also detected in other neuoropathological-associated disorders such as MS and Down's syndrome, suggesting a common immunological abnormality in neurological disorders.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Down Syndrome", "Multiple Sclerosis"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:265}, end: {_id:262}, properties:{annotationPublicationtype:["Review"], evidence:"Selective loss of CD4+CD45RA+ cells are also detected in other neuoropathological-associated disorders such as MS and Down's syndrome, suggesting a common immunological abnormality in neurological disorders.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Down Syndrome", "Multiple Sclerosis"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:273}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:264}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:309}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:310}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:311}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:312}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:313}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:314}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:315}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"PD pathology is characterized by chronic neuroinflammation, Lewy body inclusions, and loss of dopamine-producing (DA) neurons in the substantia nigra parts compacta (SNpc) of the midbrain [4, 6]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["midbrain"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:397}, end: {_id:398}, properties:{annotationPublicationtype:["Review"], evidence:"JEV infection in rats results in hypokinesia attributable to depletion of catecholamines in the CNS [96].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:402}, properties:{annotationPublicationtype:["Review"], evidence:"PD patients are reported to have decreased overall numbers of lymphocytes without a change in frequency [101, 102].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:403}, properties:{annotationPublicationtype:["Review"], evidence:"Compared to people with other neurologic diseases, individuals with PD have increased memory T cells but decreased naive T cells [88].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:559}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have reported changes in gut microbiota in PD, including increases in Lactobacillus, Akkermansia, and Bifidobacterium, and decreases in Prevotella, Blautia and Faecalibacterium.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:560}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have reported changes in gut microbiota in PD, including increases in Lactobacillus, Akkermansia, and Bifidobacterium, and decreases in Prevotella, Blautia and Faecalibacterium.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:561}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have reported changes in gut microbiota in PD, including increases in Lactobacillus, Akkermansia, and Bifidobacterium, and decreases in Prevotella, Blautia and Faecalibacterium.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:640}, end: {_id:194}, properties:{annotationPublicationtype:["Review"], evidence:"Concomitantly, most patients show signs of T cell exhaustion with lower lymphocyte counts.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:402}, properties:{annotationPublicationtype:["Review"], evidence:"Concomitantly, most patients show signs of T cell exhaustion with lower lymphocyte counts.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:668}, end: {_id:671}, properties:{annotationPublicationtype:["Review"], evidence:"In keeping with this, the most frequent clinical presentation of COVID-19 is the development of acute respiratory distress syndrome (ARDS) [16], the latter being, along with chronic ventilation, highly associated with subsequent cognitive decline, executive dysfunction, and reduced quality of life, often persisting months and years after hospital discharge [17] reviewed in [18]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:402}, properties:{annotationPublicationtype:["Research"], evidence:"Lymphocyte depletion involving specific compartments and increased phagocytosis were prominent findings (appendix p 24, figure 4 ).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:1004}, properties:{annotationPublicationtype:["Review"], evidence:"Analysis of the bronchoalveolar fluid of patients with severe or critical COVID-19 showed a higher percentage of macrophages and neutrophils and a lower proportion of myeloid dendritic cells, plasmacytoid dendritic cells and T cells than that of patients with moderate disease", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1005}, properties:{annotationPublicationtype:["Review"], evidence:"Analysis of the bronchoalveolar fluid of patients with severe or critical COVID-19 showed a higher percentage of macrophages and neutrophils and a lower proportion of myeloid dendritic cells, plasmacytoid dendritic cells and T cells than that of patients with moderate disease", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:194}, properties:{annotationPublicationtype:["Review"], evidence:"Analysis of the bronchoalveolar fluid of patients with severe or critical COVID-19 showed a higher percentage of macrophages and neutrophils and a lower proportion of myeloid dendritic cells, plasmacytoid dendritic cells and T cells than that of patients with moderate disease", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1253}, properties:{annotationPublicationtype:["Research"], evidence:"Other autopsy findings included typical COVID-19 pneumonia (diffuse alveolar damage, pneumocyte cytopathic changes, fibrin thrombi and increased megakaryocytes in septal vessels), acute tubular necrosis and visceral congestion.", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCustomAnatomy:["septal vessel"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:67}, end: {_id:1320}, properties:{annotationPublicationtype:["Review"], evidence:"Parkinson’s disease (PD) is characterized by the cardinal signs of the movement disorder such as tremor and postural instability, as well as the histopathological hallmarks of alpha-synuclein (α-syn) accumulation and loss of dopaminergic neurons in the substantia nigra (SN).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:71}, end: {_id:1334}, properties:{annotationPublicationtype:["Review"], evidence:"Of note, in PD as well as in other brain diseases, neuroinflammation also dampens BBB integrity, making it more porous to substances, including toxins and bacterial metabolites, which may otherwise not be permitted through", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Brain Diseases", "Parkinson Disease"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:48}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"Based on growing evidence including the pioneering studies showing reactive microglia in the SN of PD patients [48], it has now been accepted that chronic inflammation in the basal ganglia of PD brains can contribute to the progressive loss of dopaminergic neurons.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Basal Ganglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:640}, end: {_id:1562}, properties:{annotationPublicationtype:["Research"], evidence:"The LC group was differentiated from controls by increased body temperature and CRP and lowered SpO2, Gpx and ANTIOX values.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1562}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1573}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1577}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:402}, properties:{annotationPublicationtype:["Research"], evidence:"Pulmonary thromboembolic complications were noted in 10 (23%) cases and myocardial infiltrates were observed in four cases, including one case of substantial myocarditis17 (P3). In the lymph nodes and spleen, we observed both lymphodepletion and follicular and paracortical hyperplasia.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Spleen", "Lymph Nodes"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:640}, end: {_id:1779}, properties:{annotationPublicationtype:["Research"], evidence:"Inflammatory PASC participants in clusters 4 & 5 had a significantly higher pre-PASC clinical activity score or higher impact on ADLs (two-sided Wilcoxon test p = 0.002) compared to non-inflammatory PASC participants in clusters 2 & 3 (Fig. 1C)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1846}, properties:{annotationPublicationtype:["Review"], evidence:"Researchers have observed a significant and progressive reduction in COVID-19 patients’ gray matter in the parahippocampal gyrus, the entorhinal cortex and the hippocampus after SARS-CoV-2 infection (Di Stadio et al., 2022; Douaud et al., 2022; Griffanti et al., 2021). These regions relate to olfaction and memory function.", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Hippocampus", "Entorhinal Cortex", "Parahippocampal Gyrus"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:67}, end: {_id:402}, properties:{annotationPublicationtype:["Review"], evidence:"Analyses of blood from people with PD showed increased neutrophils and decreased lymphocytes many years before diagnosis, thus associating a higher NLR with PD risk [56,5", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["many years before diagnosis"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1572}, end: {_id:1885}, properties:{annotationPublicationtype:["Review"], evidence:"Another study, in which people with PD were divided according to cognitive performance, showed that those with mild cognitive impairment had a higher level of lymphocytes (i.e., lower NLR) compared with those with normal cognition [92].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:194}, properties:{annotationPublicationtype:["Review"], evidence:"However, more research has been done on T cells, the decrease of which in the blood is suggested to be due to their infiltration into the brain seen in both people with PD and PD models.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:194}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the decrease in total T cells, the percentage of activated (HLA-DR+) T cells (CD8 and CD4) are increased in the blood and CSF in PD [105].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:257}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:257}, properties:{annotationPublicationtype:["Review"], evidence:"Another study confirmed the decrease in naïve CD8 T cells and the increase in late-differentiated CD4 T cells during PD [108]. Naïve CD8 T cells in blood were positively correlated with the severity of autonomic dysfunction and psychiatric complications, and negatively with the severity of RBD [108].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1895}, properties:{annotationPublicationtype:["Review"], evidence:"Supporting the idea that chronic inflammation is important in PD, studies showed that people with PD have a reduced immunoregulatory compartment and Tregs of less regulatory-suppressive capacity, which was associated with an increase in proinflammatory effector T cells [81,109].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1899}, properties:{annotationPublicationtype:["Review"], evidence:"Besides T cells, people with PD also have a reduced number of B cells [119,120]. Additionally, the B cell compartment during PD shows decreased naïve B cells and increased unswitched memory B cells [107,121].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1900}, properties:{annotationPublicationtype:["Review"], evidence:"Besides T cells, people with PD also have a reduced number of B cells [119,120]. Additionally, the B cell compartment during PD shows decreased naïve B cells and increased unswitched memory B cells [107,121].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1904}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1905}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1900}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1906}, properties:{annotationPublicationtype:["Review"], evidence:"Increased α-syn autoantibodies in the CSF of people with PD have been reported [124], although it is suggested that those α-syn autoantibodies with high affinity are decreased in the blood [125] and CSF [126] as the disease progresses.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["With disease progression"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1906}, properties:{annotationPublicationtype:["Review"], evidence:"Similarly, neuromelanin autoantibodies are found in people with PD and decrease as the disease progresses [131].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["With disease progression"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:640}, end: {_id:1937}, properties:{annotationPublicationtype:["Review"], evidence:"These data revealed the loss of alveolar type I (AT1) and AT2 cells and the aberrant activation of monocyte-derived macrophages and alveolar macrophages in the lungs with a specific cytokine profile.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1935}, properties:{annotationPublicationtype:["Review"], evidence:"These data revealed the loss of alveolar type I (AT1) and AT2 cells and the aberrant activation of monocyte-derived macrophages and alveolar macrophages in the lungs with a specific cytokine profile.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:67}, end: {_id:277}, properties:{annotationPublicationtype:["Research"], evidence:"Total classical αβ T cells were modestly reduced in PD (Supplementary Fig. 2A), reflected by a decrease of total CD4 T cells(Supplementary Fig. 2B), whereas the γδ T cells were unchanged among total living CD45+ cells (Supplementary Fig. 2C).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:258}, properties:{annotationPublicationtype:["Research"], evidence:"Total classical αβ T cells were modestly reduced in PD (Supplementary Fig. 2A), reflected by a decrease of total CD4 T cells(Supplementary Fig. 2B), whereas the γδ T cells were unchanged among total living CD45+ cells (Supplementary Fig. 2C).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:640}, end: {_id:231}, properties:{annotationPublicationtype:["Research"], evidence:"The density of NM-containing and TH-immunoreactive neurons was decreased in COVID-19 and PD(D) brain donors compared with age-matched controls (NM+: −58%, p = 0.008% and −71%, p < 0.001, respectively; TH+: −44%, p = 0.035; −64%, p < 0.002). The percentage area of TH-immunoreactivity threads was also decreased in COVID-19 and PD(D) donors (TH+ −55%, p = 0.006; 60%, p = 0.006, respectively) (cohort 2, Figures 7G and 7H).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:67}, end: {_id:231}, properties:{annotationPublicationtype:["Research"], evidence:"The density of NM-containing and TH-immunoreactive neurons was decreased in COVID-19 and PD(D) brain donors compared with age-matched controls (NM+: −58%, p = 0.008% and −71%, p < 0.001, respectively; TH+: −44%, p = 0.035; −64%, p < 0.002). The percentage area of TH-immunoreactivity threads was also decreased in COVID-19 and PD(D) donors (TH+ −55%, p = 0.006; 60%, p = 0.006, respectively) (cohort 2, Figures 7G and 7H).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1841}, end: {_id:2172}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Comparing all individuals with previous COVID infection to unaffected controls revealed volumetric deficits predominantly in the FLs and TLs and increases in the lateral ventricles and occipital lobes (OLs), while group-wise comparisons of macrostructures revealed decreased GBV in patients with brain fog along with significantly reduced cerebral WM volume in both hemispheres in the recovered and brain fog cohorts along with reduced cerebellar WM volume in the recovered, long COVID and brain fog cohorts.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2174}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Comparing all individuals with previous COVID infection to unaffected controls revealed volumetric deficits predominantly in the FLs and TLs and increases in the lateral ventricles and occipital lobes (OLs), while group-wise comparisons of macrostructures revealed decreased GBV in patients with brain fog along with significantly reduced cerebral WM volume in both hemispheres in the recovered and brain fog cohorts along with reduced cerebellar WM volume in the recovered, long COVID and brain fog cohorts.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebrum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2174}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Comparing all individuals with previous COVID infection to unaffected controls revealed volumetric deficits predominantly in the FLs and TLs and increases in the lateral ventricles and occipital lobes (OLs), while group-wise comparisons of macrostructures revealed decreased GBV in patients with brain fog along with significantly reduced cerebral WM volume in both hemispheres in the recovered and brain fog cohorts along with reduced cerebellar WM volume in the recovered, long COVID and brain fog cohorts.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebrum"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2242}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"The earlier development of EAE is associated with a defect of Tregs and the downregulation of Foxp3.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:640}, end: {_id:2359}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"However, by 7 weeks following infection, a mild decrease (10%) in the number of oligodendrocyte precursor cells was evident (Figures 6B and 6C).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Corpus Callosum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1751}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Mature oligodendrocytes, assessed by ASPA and CC1 immunoreactivity, exhibited a greater magnitude of depletion (Figures 6D–6F, S7A, and S7B), with loss of approximately one third of oligodendrocytes occurring by 7 days post-infection (Figure 6D). This depletion in mature oligodendrocytes persisted until at least 7 weeks post-infection (Figure 6E).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Corpus Callosum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2360}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We found a decrease in myelinated axon density in subcortical white matter (cingulum of the corpus callosum) evident by 7 days post-infection (Figures 6G–6I). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Corpus Callosum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2360}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"This loss of myelin persisted until at least 7 weeks following mild respiratory SARS-CoV-2 infection and was similar in magnitude to the loss of myelinated axons seen 4 weeks (Figures 6J, ​J,S7J,S7J, and S7K) and 6 months (Figures 6K, ​K,S7J,S7J, and S7K) after methotrexate chemotherapy exposure.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Corpus Callosum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:1751}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Concordant with this pattern of microglial/macrophage reactivity, oligodendrocytes were decreased in the subcortical white matter at 7 days (Figure 7L) but recovered as microglial reactivity resolved by 7 weeks (Figure 7M).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["White Matter", "Corpus Callosum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:123}, properties:{annotationPublicationtype:["Research"], evidence:"In the brain, H&E revealed diffuse neuronal loss and cortical edema characterized by spongiosis (S); very rare SARS-CoV-2-positive cells detected in the pons (T); amoeboid microglial cells and several microglial nodules identified by the CD68 antibody, mainly in the brainstem (U); rare T and B lymphocytes are observed in the perivascular spaces (V) and in some nodules (W); frequent capillary microthrombi are observed in the brainstem (X).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2395}, end: {_id:101}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2395}, end: {_id:103}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:146}, end: {_id:437}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:280}, end: {_id:441}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:1161}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1503}, end: {_id:1472}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1502}, end: {_id:1501}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:382}, end: {_id:1709}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:896}, end: {_id:1761}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1503}, end: {_id:1762}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:292}, end: {_id:2277}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_LOCATED_PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:"Given the above cytokine findings in COVID-19 patients and in particular the rise of interleukin-1β and interleukin-18, it seems highly likely that COVID-19 patients suffer from NLRP3 inflammasome activation. This activation and the subsequent increased activity of proinflammatory immune pathways are likely to exert a negative impact on cerebral homeostasis and function.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:759}, properties:{annotationPublicationtype:["Review"], evidence:"Muscle injury associated with raised creatine kinase affected 23 (11%) of 214 patients in the Wuhan series. Rhabdomyolysis due to COVID-19 has also been reported.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:"Through the analysis of lungs of patients who died from COVID-19-related ARDS, SARS-CoV-2 was found to activate the NLRP3 inflammasome", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:"In vitro studies also showed NLRP3 inflammasome activation by SARS-CoV-2 infection of primary human monocytes.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:326}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the notion that string vessels are formed when endothelial cells die, we observed cells that stained for the apoptosis marker active caspase-3 in brain microvessels. These cells were rare in brain sections of the frontal cortex but significantly more frequent in SARS-CoV-2-infected patients than in controls (Fig. 1d).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:24}, properties:{annotationPublicationtype:["Research"], evidence:"NOD2, a member of the Nod-like receptor (NLR) family of intracellular sensors of pathogen/microbe-associated molecular patterns,was upregulated, promoting NF-kB and mitogen-activated protein kinase (MAPK) activation, which in turn stimulated the production of proinflammatory cytokines and chemokines(Fig. 4D). ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1608}, properties:{annotationPublicationtype:["Research"], evidence:"NOD2, a member of the Nod-like receptor (NLR) family of intracellular sensors of pathogen/microbe-associated molecular patterns,was upregulated, promoting NF-kB and mitogen-activated protein kinase (MAPK) activation, which in turn stimulated the production of proinflammatory cytokines and chemokines(Fig. 4D). ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1732}, properties:{annotationPublicationtype:["Research"], evidence:"In 23 COVID-19 subjects parenchymal microglia displayed an activated phenotype with characteristic thorny ramifications or amoeboid morphology (Fig. 5a, b).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1733}, properties:{annotationPublicationtype:["Research"], evidence:"While microglial cells expressed homeostatic marker TMEM119 as well as lysosomal-activity marker CD68 in both COVID-19 and control subjects (5A–D), COVID-19 subjects displayed a more widespread CD68+ immunoreactivity (5A–B), with statistically significant differences in CD68 immunoreactive area (expressed as percentage, A%) at the level of the medulla and midbrain, but not the pons, when compared to controls (Fig. 5e, Welch ANOVA W = 42.68; medulla p < 0.0001; pons p = 0.733; midbrain p < 0.0001).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Medulla Oblongata"], annotationCell:["midbrain"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:11}, properties:{annotationPublicationtype:["Research"], evidence:"While the expression of M1/M2 cell surface markers was not detected, TMEM119+ microglial cells displayed immunoreactivity for Interleukin-1β, Interleukin-6, TNF-α but not Interleukin-4, indicating a pro-inflammatory phenotype (Fig. 7k–r).", annotationCustomCell:["TMEM119+ microglial cell"], citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1737}, properties:{annotationPublicationtype:["Research"], evidence:"While the expression of M1/M2 cell surface markers was not detected, TMEM119+ microglial cells displayed immunoreactivity for Interleukin-1β, Interleukin-6, TNF-α but not Interleukin-4, indicating a pro-inflammatory phenotype (Fig. 7k–r).", annotationCustomCell:["TMEM119+ microglial cell"], citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1738}, properties:{annotationPublicationtype:["Research"], evidence:"While the expression of M1/M2 cell surface markers was not detected, TMEM119+ microglial cells displayed immunoreactivity for Interleukin-1β, Interleukin-6, TNF-α but not Interleukin-4, indicating a pro-inflammatory phenotype (Fig. 7k–r).", annotationCustomCell:["TMEM119+ microglial cell"], citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:56}, end: {_id:55}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:96}, end: {_id:21}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:117}, end: {_id:116}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:899}, end: {_id:898}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1163}, end: {_id:1162}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1228}, end: {_id:1227}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1402}, end: {_id:1401}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1404}, end: {_id:1403}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"qRT-PCR results showed that ACE2 and TMPRSS2 are expressed in CORGs and in all three cell types analyzed including NPCs, neurons, and astrocytes (Figures 3B and 3C).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Astrocytes"], annotationCell:["neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"qRT-PCR results showed that ACE2 and TMPRSS2 are expressed in CORGs and in all three cell types analyzed including NPCs, neurons, and astrocytes (Figures 3B and 3C).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:995}, properties:{annotationPublicationtype:["Research"], evidence:"Apoptotic gene caspase-3 was upregulated while the anti-apoptotic genes, BCL2 and BAX, were downregulated in infected neurons (Figure 3N).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:996}, properties:{annotationPublicationtype:["Research"], evidence:"Apoptotic gene caspase-3 was upregulated while the anti-apoptotic genes, BCL2 and BAX, were downregulated in infected neurons (Figure 3N).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:1485}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1486}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1487}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1488}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1489}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1614}, properties:{annotationPublicationtype:["Research"], evidence:"SLC-mediated transporters for thyroid hormone, ions, amino acids, choline, and energetic substrates (47) (e.g., SLC16A2, SLC41A3, SLC16A10, SLC44A1, and SLC35C2) were downregulated following viral infection (Fig. S2C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1615}, properties:{annotationPublicationtype:["Research"], evidence:"SLC-mediated transporters for thyroid hormone, ions, amino acids, choline, and energetic substrates (47) (e.g., SLC16A2, SLC41A3, SLC16A10, SLC44A1, and SLC35C2) were downregulated following viral infection (Fig. S2C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1616}, properties:{annotationPublicationtype:["Research"], evidence:"SLC-mediated transporters for thyroid hormone, ions, amino acids, choline, and energetic substrates (47) (e.g., SLC16A2, SLC41A3, SLC16A10, SLC44A1, and SLC35C2) were downregulated following viral infection (Fig. S2C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1617}, properties:{annotationPublicationtype:["Research"], evidence:"SLC-mediated transporters for thyroid hormone, ions, amino acids, choline, and energetic substrates (47) (e.g., SLC16A2, SLC41A3, SLC16A10, SLC44A1, and SLC35C2) were downregulated following viral infection (Fig. S2C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1618}, properties:{annotationPublicationtype:["Research"], evidence:"SLC-mediated transporters for thyroid hormone, ions, amino acids, choline, and energetic substrates (47) (e.g., SLC16A2, SLC41A3, SLC16A10, SLC44A1, and SLC35C2) were downregulated following viral infection (Fig. S2C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1619}, properties:{annotationPublicationtype:["Research"], evidence:"Lower expression levels of genes associated with synapse function, including CAMK2D, ERBB2, C1QL, and SYPL1, were also observed (Fig. S2C), suggesting that SARS-CoV-2 infection can negatively impact neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1620}, properties:{annotationPublicationtype:["Research"], evidence:"Lower expression levels of genes associated with synapse function, including CAMK2D, ERBB2, C1QL, and SYPL1, were also observed (Fig. S2C), suggesting that SARS-CoV-2 infection can negatively impact neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1621}, properties:{annotationPublicationtype:["Research"], evidence:"Lower expression levels of genes associated with synapse function, including CAMK2D, ERBB2, C1QL, and SYPL1, were also observed (Fig. S2C), suggesting that SARS-CoV-2 infection can negatively impact neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1622}, properties:{annotationPublicationtype:["Research"], evidence:"Lower expression levels of genes associated with synapse function, including CAMK2D, ERBB2, C1QL, and SYPL1, were also observed (Fig. S2C), suggesting that SARS-CoV-2 infection can negatively impact neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1621}, properties:{annotationPublicationtype:["Research"], evidence:"The proinflammatory chemokines CCL3, CXCL3, and CXCL10 were also upregulated following infection, while synapse-related genes, including C1QL1 and SYPL1, were downregulated (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1622}, properties:{annotationPublicationtype:["Research"], evidence:"The proinflammatory chemokines CCL3, CXCL3, and CXCL10 were also upregulated following infection, while synapse-related genes, including C1QL1 and SYPL1, were downregulated (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1626}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the expression of the major water channel in astrocytes, aquaporin-4 (AQP4), was strikingly inhibited following viral infection.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1626}, properties:{annotationPublicationtype:["Research"], evidence:"GO analyses of downregulated genes in infected astrocytes again revealed the enrichment of genes involved in water transport, synaptic transmission, ion and lipid transport, the formation of cell junctions, and calcium binding (Fig. 5D). These included AQP4, the predominant water channel found within the foot processes of astrocytes, and a number of SLC-mediated transporters, including SLC1A2, SLC7A10, SLC18A3, SLC6A1, SLC4A10, and SLCO1C1. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1687}, properties:{annotationPublicationtype:["Research"], evidence:"GO analyses of downregulated genes in infected astrocytes again revealed the enrichment of genes involved in water transport, synaptic transmission, ion and lipid transport, the formation of cell junctions, and calcium binding (Fig. 5D). These included AQP4, the predominant water channel found within the foot processes of astrocytes, and a number of SLC-mediated transporters, including SLC1A2, SLC7A10, SLC18A3, SLC6A1, SLC4A10, and SLCO1C1. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1688}, properties:{annotationPublicationtype:["Research"], evidence:"GO analyses of downregulated genes in infected astrocytes again revealed the enrichment of genes involved in water transport, synaptic transmission, ion and lipid transport, the formation of cell junctions, and calcium binding (Fig. 5D). These included AQP4, the predominant water channel found within the foot processes of astrocytes, and a number of SLC-mediated transporters, including SLC1A2, SLC7A10, SLC18A3, SLC6A1, SLC4A10, and SLCO1C1. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1689}, properties:{annotationPublicationtype:["Research"], evidence:"GO analyses of downregulated genes in infected astrocytes again revealed the enrichment of genes involved in water transport, synaptic transmission, ion and lipid transport, the formation of cell junctions, and calcium binding (Fig. 5D). These included AQP4, the predominant water channel found within the foot processes of astrocytes, and a number of SLC-mediated transporters, including SLC1A2, SLC7A10, SLC18A3, SLC6A1, SLC4A10, and SLCO1C1. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1690}, properties:{annotationPublicationtype:["Research"], evidence:"GO analyses of downregulated genes in infected astrocytes again revealed the enrichment of genes involved in water transport, synaptic transmission, ion and lipid transport, the formation of cell junctions, and calcium binding (Fig. 5D). These included AQP4, the predominant water channel found within the foot processes of astrocytes, and a number of SLC-mediated transporters, including SLC1A2, SLC7A10, SLC18A3, SLC6A1, SLC4A10, and SLCO1C1. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1691}, properties:{annotationPublicationtype:["Research"], evidence:"GO analyses of downregulated genes in infected astrocytes again revealed the enrichment of genes involved in water transport, synaptic transmission, ion and lipid transport, the formation of cell junctions, and calcium binding (Fig. 5D). These included AQP4, the predominant water channel found within the foot processes of astrocytes, and a number of SLC-mediated transporters, including SLC1A2, SLC7A10, SLC18A3, SLC6A1, SLC4A10, and SLCO1C1. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1692}, properties:{annotationPublicationtype:["Research"], evidence:"GO analyses of downregulated genes in infected astrocytes again revealed the enrichment of genes involved in water transport, synaptic transmission, ion and lipid transport, the formation of cell junctions, and calcium binding (Fig. 5D). These included AQP4, the predominant water channel found within the foot processes of astrocytes, and a number of SLC-mediated transporters, including SLC1A2, SLC7A10, SLC18A3, SLC6A1, SLC4A10, and SLCO1C1. ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1693}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the marked decrease in the expression of genes involved in synapse maintenance, including SYNPR, SYT, C1QL1, and TUBB4A (Fig. S5G), within astrocytes further highlights an indirect mechanism through which SARS-CoV-2 can adversely affect synaptic transmission and overall neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1694}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the marked decrease in the expression of genes involved in synapse maintenance, including SYNPR, SYT, C1QL1, and TUBB4A (Fig. S5G), within astrocytes further highlights an indirect mechanism through which SARS-CoV-2 can adversely affect synaptic transmission and overall neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1621}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the marked decrease in the expression of genes involved in synapse maintenance, including SYNPR, SYT, C1QL1, and TUBB4A (Fig. S5G), within astrocytes further highlights an indirect mechanism through which SARS-CoV-2 can adversely affect synaptic transmission and overall neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1695}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the marked decrease in the expression of genes involved in synapse maintenance, including SYNPR, SYT, C1QL1, and TUBB4A (Fig. S5G), within astrocytes further highlights an indirect mechanism through which SARS-CoV-2 can adversely affect synaptic transmission and overall neuronal function.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:7}, end: {_id:1960}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1961}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1962}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1963}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1964}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1965}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1966}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1967}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:1968}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1969}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1970}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1971}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1974}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1975}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1976}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1977}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1978}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1979}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1980}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1988}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1989}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1990}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1991}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1963}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1960}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1962}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1992}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1979}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:1993}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1994}, properties:{annotationPublicationtype:["Research"], evidence:"For example, PCs down-regulated claudins (CLDN5, -7, -10 tvb), TJ transcripts (TJP1, OCLN), transporters and receptors (ABCC4, LRP8, LSR, SLC7A5), and mucins (MUC1 tva, MUC18) in LOAD BCECs (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1995}, properties:{annotationPublicationtype:["Research"], evidence:"ACs decreased the transcription of claudins (CLDN17, -23) in LOAD BCECs compared to CON BCECs. Mucins were altered with transcript variant a (tva) of MUC1 being reduced and tvb being increased (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1987}, properties:{annotationPublicationtype:["Research"], evidence:"ACs decreased the transcription of claudins (CLDN17, -23) in LOAD BCECs compared to CON BCECs. Mucins were altered with transcript variant a (tva) of MUC1 being reduced and tvb being increased (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1996}, properties:{annotationPublicationtype:["Research"], evidence:"ACs decreased the transcription of claudins (CLDN17, -23) in LOAD BCECs compared to CON BCECs. Mucins were altered with transcript variant a (tva) of MUC1 being reduced and tvb being increased (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1997}, properties:{annotationPublicationtype:["Research"], evidence:"ACs decreased the transcription of claudins (CLDN17, -23) in LOAD BCECs compared to CON BCECs. Mucins were altered with transcript variant a (tva) of MUC1 being reduced and tvb being increased (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1998}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1999}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1978}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1991}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2000}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2001}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2002}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1992}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2003}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2004}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1979}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1614}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2005}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2006}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:2007}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1997}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1980}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1965}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2010}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1989}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2011}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1990}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2012}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2013}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1995}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1985}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1967}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1966}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1978}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1974}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1977}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1991}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2014}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1963}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:2008}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1960}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2017}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2001}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2002}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1962}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1992}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2003}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2004}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1976}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1979}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1961}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1614}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1975}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1996}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2007}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1997}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2026}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2027}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1980}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:2033}, properties:{annotationPublicationtype:["Research"], evidence:"The gene encoding the aging marker advanced glycosylation end-product specific receptor (AGER; receptor for advanced glycosylation end-product, RAGE) was increased. Finally, mucins were also altered including two MUC1 transcripts (tva was reduced and tvb increased) (Fig. 3C).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2033}, properties:{annotationPublicationtype:["Research"], evidence:"Indeed, down-regulation of tva of MUC1 was observed independent of the respective brain cell type and the only significantly, differentially regulated transcript shared by all LOAD NVU models (PCs, p = 0.014; ACs, p = 0.0004; MGCs, p = 0.00004; NSCs, p = 0.00002) (Fig. 3D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell", "astrocyte"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1989}, properties:{annotationPublicationtype:["Research"], evidence:"Five significantly regulated transcripts were shared by all three (co-cultures with PCs, MGCs, and NSCs) LOAD NVU models compared to CON NVU models, including modulation of ABCC4 and down-regulation of CLDN7, TJP1, LSR, and SLC7A5 (Fig. 3C, D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1991}, properties:{annotationPublicationtype:["Research"], evidence:"Five significantly regulated transcripts were shared by all three (co-cultures with PCs, MGCs, and NSCs) LOAD NVU models compared to CON NVU models, including modulation of ABCC4 and down-regulation of CLDN7, TJP1, LSR, and SLC7A5 (Fig. 3C, D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1992}, properties:{annotationPublicationtype:["Research"], evidence:"Five significantly regulated transcripts were shared by all three (co-cultures with PCs, MGCs, and NSCs) LOAD NVU models compared to CON NVU models, including modulation of ABCC4 and down-regulation of CLDN7, TJP1, LSR, and SLC7A5 (Fig. 3C, D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1979}, properties:{annotationPublicationtype:["Research"], evidence:"Five significantly regulated transcripts were shared by all three (co-cultures with PCs, MGCs, and NSCs) LOAD NVU models compared to CON NVU models, including modulation of ABCC4 and down-regulation of CLDN7, TJP1, LSR, and SLC7A5 (Fig. 3C, D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["pericyte cell"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:67}, end: {_id:2041}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed a decreased expression of the amino acid transporter CD98 (Supplementary Fig. 3O), nevertheless being independent of CD45RO expression levels (Supplementary Fig. 3P).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2049}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our observation of reduced CD8 Treg, the expression of other markers relevant to CD8 Treg, such as CD25 (IL2RA) and CD122 (IL2RB)50, was also reduced in CD8 T cells of iPD vs HC (Fig. 3b).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2050}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our observation of reduced CD8 Treg, the expression of other markers relevant to CD8 Treg, such as CD25 (IL2RA) and CD122 (IL2RB)50, was also reduced in CD8 T cells of iPD vs HC (Fig. 3b).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2061}, properties:{annotationPublicationtype:["Research"], evidence:"Concurrently, several genes, critically involving in the mRNA deadenylation-dependent degradation (enrichment P = 7.63E-8 among downregulated genes, Fisher’s exact test, GO process), such as CNOT6L, ZFP36 and ZFP36L2, were substantially downregulated in CD8 TEMRA of iPD vs HC (Fig. 6J, Supplementary Fig. 6E). ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2062}, properties:{annotationPublicationtype:["Research"], evidence:"Concurrently, several genes, critically involving in the mRNA deadenylation-dependent degradation (enrichment P = 7.63E-8 among downregulated genes, Fisher’s exact test, GO process), such as CNOT6L, ZFP36 and ZFP36L2, were substantially downregulated in CD8 TEMRA of iPD vs HC (Fig. 6J, Supplementary Fig. 6E). ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2063}, properties:{annotationPublicationtype:["Research"], evidence:"Concurrently, several genes, critically involving in the mRNA deadenylation-dependent degradation (enrichment P = 7.63E-8 among downregulated genes, Fisher’s exact test, GO process), such as CNOT6L, ZFP36 and ZFP36L2, were substantially downregulated in CD8 TEMRA of iPD vs HC (Fig. 6J, Supplementary Fig. 6E). ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2081}, properties:{annotationPublicationtype:["Research"], evidence:"TGFB1 and its downstream signaling molecules, such as SMAD7, SKI and SKIL, which inhibit the expression of CD8 key effector molecules68, were all substantially downregulated in all the clusters of CD8 TEM (Supplementary Fig. 6M).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2082}, properties:{annotationPublicationtype:["Research"], evidence:"TGFB1 and its downstream signaling molecules, such as SMAD7, SKI and SKIL, which inhibit the expression of CD8 key effector molecules68, were all substantially downregulated in all the clusters of CD8 TEM (Supplementary Fig. 6M).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2083}, properties:{annotationPublicationtype:["Research"], evidence:"TGFB1 and its downstream signaling molecules, such as SMAD7, SKI and SKIL, which inhibit the expression of CD8 key effector molecules68, were all substantially downregulated in all the clusters of CD8 TEM (Supplementary Fig. 6M).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2084}, properties:{annotationPublicationtype:["Research"], evidence:"Concomitantly, prosurvival or anti-apoptotic genes such as LMNA, GADD45B and BCL2 were downregulated, indicative of more short-lived CD8 TEM in iPD(Supplementary Fig. 6M). ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2085}, properties:{annotationPublicationtype:["Research"], evidence:"Concomitantly, prosurvival or anti-apoptotic genes such as LMNA, GADD45B and BCL2 were downregulated, indicative of more short-lived CD8 TEM in iPD(Supplementary Fig. 6M). ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:995}, properties:{annotationPublicationtype:["Research"], evidence:"Concomitantly, prosurvival or anti-apoptotic genes such as LMNA, GADD45B and BCL2 were downregulated, indicative of more short-lived CD8 TEM in iPD(Supplementary Fig. 6M). ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2099}, properties:{annotationPublicationtype:["Research"], evidence:"Concurrently, RUNX3, known to suppress the expression of both RUNX1 and RUNX2 genes and terminal differentiation79, was slightly reduced in CD8 Tn (Supplementary Fig. 7F).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2061}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, similar to the scenario in other CD8 subsets, several members of the linker histone H1 family genes showed a substantial increase in both clusters of CD8 Tn, while CNOT6L was still among the most downregulated genes (Supplementary Fig. 7H).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1", "C0"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1841}, end: {_id:2220}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2221}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2222}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2223}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2224}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2225}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2226}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:57}, end: {_id:66}, properties:{annotationPublicationtype:["Review"], evidence:"Nitric oxide (most likely peroxynitrite) has been implicated in mitochondrial dysfunction in neurodegenerative diseases [98].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Neurodegenerative Diseases"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:234}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Since 1988, when McGeer and colleagues found HLA-DR-positive (activated) microglia phagocytosing-free neuromelanin in post mortem PD SN (McGeer et al. 1988a), activated microglial consistently have been observed in PD patients, whereas others have shown higher expression levels of polymorphic major histocompatibility complex (MHC) class II (MHC II) molecules, HLA-DR and HLA-DQ, expressed by monocytes in the CSF and peripheral blood of PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebrospinal Fluid", "Blood"], annotationCell:["T cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"22315722"}}, {start: {_id:235}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Since 1988, when McGeer and colleagues found HLA-DR-positive (activated) microglia phagocytosing-free neuromelanin in post mortem PD SN (McGeer et al. 1988a), activated microglial consistently have been observed in PD patients, whereas others have shown higher expression levels of polymorphic major histocompatibility complex (MHC) class II (MHC II) molecules, HLA-DR and HLA-DQ, expressed by monocytes in the CSF and peripheral blood of PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebrospinal Fluid", "Blood"], annotationCell:["T cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"22315722"}}, {start: {_id:234}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, genome-wide association studies (GWASs) of PD patients (Hamza et al. 2010; Saiki et al. 2010; Nalls et al. 2011; Puschmann et al. 2011; Simon-Sanchez et al. 2011), including a meta-analysis of the GWASs (Nalls et al. 2011), verified an increased relative risk for PD and expression of HLA-DR or HLA-DQ MHC II molecules, leading to the designation of HLA-DRA as PARK18.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:235}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, genome-wide association studies (GWASs) of PD patients (Hamza et al. 2010; Saiki et al. 2010; Nalls et al. 2011; Puschmann et al. 2011; Simon-Sanchez et al. 2011), including a meta-analysis of the GWASs (Nalls et al. 2011), verified an increased relative risk for PD and expression of HLA-DR or HLA-DQ MHC II molecules, leading to the designation of HLA-DRA as PARK18.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:195}, end: {_id:2}, properties:{annotationPublicationtype:["Research"], evidence:"Conversely, microglial density in the medulla also correlates with hypoxic/ischemic damage of the brainstem, evaluated along a four-tiered semi-quantitative scale (r = 0.59; p = 0.004), as also seen in Thakur et al.19.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["brainstem"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:195}, end: {_id:998}, properties:{annotationPublicationtype:["Research"], evidence:"Conversely, microglial density in the medulla also correlates with hypoxic/ischemic damage of the brainstem, evaluated along a four-tiered semi-quantitative scale (r = 0.59; p = 0.004), as also seen in Thakur et al.19.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["brainstem"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:1836}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1837}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1838}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1879}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Increased intermediate blood monocytes were associated with higher disease severity in people with PD [81].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1885}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Analyses of blood from people with PD showed increased neutrophils and decreased lymphocytes many years before diagnosis, thus associating a higher NLR with PD risk [56,5", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["many years before diagnosis"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:257}, end: {_id:1568}, properties:{annotationPublicationtype:["Review"], evidence:"Another study confirmed the decrease in naïve CD8 T cells and the increase in late-differentiated CD4 T cells during PD [108]. Naïve CD8 T cells in blood were positively correlated with the severity of autonomic dysfunction and psychiatric complications, and negatively with the severity of RBD [108].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:547}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"For those taking both a corticosteroid and an IMDH inhibitor, risk of PD was 0.53 (95% CI 0.40–0.70) in the unlagged model and 0.60 (95% CI 0.42–0.84) in the 12-month lagged model.", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:962}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"As expected, combination of camostat and EK1 peptide robustly inhibited viral infection in LORGs (Figure 2C).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:316}, end: {_id:315}, properties:{annotationPublicationtype:["Review"], evidence:"Dysfunctional and reduced frequencies of Treg are associated with several autoimmune diseases (Costantino et al. 2008), including multiple MS (Venken et al. 2008; Fletcher et al. 2009; Royal et al. 2009; Koen 2010), type 1 diabetes (Glisic et al. 2009), inflammatory skin disorders (Fujimura et al. 2008), autoimmune myasthenia gravis (Mu et al. 2009), and rheumatoid arthritis (Cao et al. 2003) as well as chronic inflammatory diseases such as systemic lupus erythematosus (Horwitz 2008; Venigalla et al. 2008; Barreto et al. 2009), asthma (Xue et al. 2007), inflammatory bowel disease (Bourreau et al. 2009), and immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, which is caused by a genetic mutation in the transcription factor FOXP3.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:344}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:345}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:346}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:347}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:348}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:349}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:350}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:351}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:434}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The first identified mutation to cause PD was in the SNCA gene, which encodes alpha-synuclein.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:442}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Mutations in LRRK2 (PARK8), a gene encoding a MAPK-kinase-kinase, GTPase, and ankyrin domain-containing protein, cause an autosomal dominant form of PD with a clinical presentation and age of onset similar to sporadic PD [141].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:442}, end: {_id:207}, properties:{annotationPublicationtype:["Review"], evidence:"In vitro and targeted in vivo overexpression of mutant LRRK2 induces neurotoxicity in a kinase- and GTPase-dependent manner [149–153]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:442}, end: {_id:457}, properties:{annotationPublicationtype:["Review"], evidence:"Polymorphisms in LRRK2 are also associated with leprosy and Crohn's disease [162, 163].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:442}, end: {_id:458}, properties:{annotationPublicationtype:["Review"], evidence:"Polymorphisms in LRRK2 are also associated with leprosy and Crohn's disease [162, 163].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:464}, end: {_id:465}, properties:{annotationPublicationtype:["Review"], evidence:"Loss of function mutations and deletions in the Parkin (PARK2) gene cause autosomal recessive forms of juvenile PD [165].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:442}, end: {_id:458}, properties:{annotationPublicationtype:["Review"], evidence:"This may be particularly relevant in the gastrointestinal tract, as there is growing evidence for a critical role of intestinal inflammation in PD pathogenesis [54]. Additionally, LRRK2 has been identified as a major susceptibility gene for Crohn’s disease, which is associated with deep transmural inflammation.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:1860}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 variant rs76904798, associated with increased PD risk, affects LRRK2 expression in monocytes but not in cells isolated from the cortex, further highlighting the relevance of the peripheral immune system in PD [12].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:1293}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1294}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1295}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1296}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1297}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1298}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1299}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1300}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1301}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:1542}, properties:{annotationPublicationtype:["Research"], evidence:"AS-0 cells expressed relatively higher levels of anti-viral ISGs, while AS-3 and AS-4 cells had a proliferative profile and exhibited lower expression levels of GFAP.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:2146}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed the upregulation of IGFBP7 and downregulation of LMNB1, genes reported to be associated with senescence in DA neurons8,19 (Figure 3G).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2146}, properties:{annotationPublicationtype:["Research"], evidence:"scRNA-seq analysis confirmed the upregulation of IGFBP7 and CDKN1A (encoding protein P21) and downregulation of LMNB1 (Figures 3H and 3I).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["single cell RNA-Seq analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:2133}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed a decrease in the senescence-pathway associated gene IGFBP7 and an upregulation of LMNB1 for each of the three drugs (Figure 4J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:2133}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed a decrease in the senescence-pathway associated gene IGFBP7 and an upregulation of LMNB1 for each of the three drugs (Figure 4J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:2133}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed a decrease in the senescence-pathway associated gene IGFBP7 and an upregulation of LMNB1 for each of the three drugs (Figure 4J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:316}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:434}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:442}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:443}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:464}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:501}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:502}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:526}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:529}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:531}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:580}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__VARIANT]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:247}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining of tissues from idiopathic and familial PD patients show dopaminergic neurons within the SN bind IgG, but not IgM, whereas tissues from age-matched controls and nonnigral control tissues show no detectable bound immunoglobulins .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:640}, end: {_id:233}, properties:{annotationPublicationtype:["Research"], evidence:"A correlate of this HLA-DR-positive, presumably myeloid-driven inflammatory response was found in the CSF, where levels of inflammatory mediators such as interleukin (IL)-6, IL-18, CC-chemokine ligand 2 (CCL2) and soluble intercellular adhesion molecule-1 (sICAM-1) were found to be increased (Supplementary Fig. 4a)30.", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:1008}, properties:{annotationPublicationtype:["Review"], evidence:"The occurrence of a COVID-19-specific coagulopathy is suggested by elevated levels of fibrinogen, von Willebrand factor (VWF) and the fibrin degradation product D-dimer in the blood, whereas patients generally show minor or no changes in prothrombin time (a measure of time to clot), activated partial thromboplastin time (coagulation time), antithrombin levels, activated protein C levels and platelet count", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1032}, properties:{annotationPublicationtype:["Review"], evidence:"NETs are markers of disease severity in patients with SARS-CoV-2 infection80,85. Compared with controls, patients with COVID-19 have higher levels of serum85 or plasma80myeloperoxidase (MPO)–DNA complexes, which are biomarkers of circulating NET fragments, and further increases were found in those patients requiring invasive mechanical ventilation", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationDiseaseType:["patients requiring invasive mechanical ventilation"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:67}, end: {_id:233}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:462}, end: {_id:461}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:606}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:613}, end: {_id:612}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:628}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:629}, end: {_id:243}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:828}, end: {_id:243}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:831}, end: {_id:830}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1077}, end: {_id:896}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1091}, end: {_id:1090}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1099}, end: {_id:1098}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1102}, end: {_id:1101}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1105}, end: {_id:1104}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1192}, end: {_id:1191}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1197}, end: {_id:1196}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1215}, end: {_id:1214}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1226}, end: {_id:1214}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1265}, end: {_id:1264}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1395}, end: {_id:466}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1519}, end: {_id:1503}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1928}, end: {_id:1655}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:908}, properties:{annotationPublicationtype:["Research"], evidence:"The hematoxylin and eosin findings revealed two differences: 1) Microvessels of the brain of COVID-19 patients showed perivascular edema as defined by a zone of edema at least 50 μm in size around a capillary. 2) Less commonly, microvessels in the COVID-19 cases had endothelial cells that were degenerated, mummified, and detached, showed focal basement membrane duplication, and/or microthrombi.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationTechnique:["Hematoxylin and eosin staining"], annotationSpecies:["9606"], annotationSection:["Results"], citationRef:"33360731"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Evoking the concept of neuroinflammatory processes can also explain the observed increased presence of proinflammatory cytokines in Alzheimer's brains [5–7,107,108].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:49}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"As a consequence of brain injury or disease, resident microglia change phenotype from their downregulated state to an ‘activated’ phenotype, which is characterized by shortened and extensively branched processes and hypertrophy of the cell body", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:77}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:81}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:67}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Since 1988, when McGeer and colleagues found HLA-DR-positive (activated) microglia phagocytosing-free neuromelanin in post mortem PD SN (McGeer et al. 1988a), activated microglial consistently have been observed in PD patients, whereas others have shown higher expression levels of polymorphic major histocompatibility complex (MHC) class II (MHC II) molecules, HLA-DR and HLA-DQ, expressed by monocytes in the CSF and peripheral blood of PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, levels of IL-1β, IL-6, and TNF-α are elevated in the CFS of PD patients (Blum-Degen et al. 1995; Gonzalez-Scarano and Baltuch 1999), and intercellular adhesion molecule-1 (ICAM-1)-positive glia are also increased in the SN of PD brains.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationCell:["glial cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"22315722"}}, {start: {_id:67}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"During disease, dopaminergic neurons accumulate α-synuclein together with other misfolded proteins seen as intracellular Lewy body inclusions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Nonetheless, as disease becomes more robust, activated microglia are seen in abundant numbers removed from proximate areas of neuronal death.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:285}, properties:{annotationPublicationtype:["Review"], evidence:"Positive associations of PD with influenza, toxoplasmosis, and autoimmunity have been reported while non-steroidal anti-inflammatory drugs decrease risk for PD [16–24]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:253}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, proteins of the complement system, a serum-mediated mechanism designed to clear antibody and various immune targets, are found in extraneuronal Lewy bodies postmortem.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lewy Bodies"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Inflammation in PD is present both in the periphery (systemic inflammation) and in the central nervous system.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"This may be particularly relevant in the gastrointestinal tract, as there is growing evidence for a critical role of intestinal inflammation in PD pathogenesis [54]. Additionally, LRRK2 has been identified as a major susceptibility gene for Crohn’s disease, which is associated with deep transmural inflammation.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:458}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"This may be particularly relevant in the gastrointestinal tract, as there is growing evidence for a critical role of intestinal inflammation in PD pathogenesis [54]. Additionally, LRRK2 has been identified as a major susceptibility gene for Crohn’s disease, which is associated with deep transmural inflammation.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:640}, end: {_id:770}, properties:{annotationPublicationtype:["Review"], evidence:"Blood D-dimer concentration was raised in many patients with COVID-19, consistent with a pro-inflammatory, coagulopathic state in the setting of critical illness.51, 52, 53, 54, 55, 77, 92, 95, 96 Positive lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein-1 antibodies have also been reported in COVID-19-associated stroke,52, 77 although these can be raised in other critical illnesses, including infections.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Together, this first set of data indicates that SARS-CoV-2 exhibits an unambiguous tropism for the olfactory neuroepithelium, and this infection is associated with increased local inflammation.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], annotationMeshanatomy:["Olfactory Mucosa"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1283}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, we found that interferon-γ signaling was enhanced in COVID-19 (Figure 1F).", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:67}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Another study observed a defective meningeal lymphatic drainage in sporadic PD patients [144], known to impair clearance of toxic CSF waste from the brain leading to an aggravated inflammatory response [145].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Although there was enrichment for microglial and astrocyte activation in the gene set upregulated in infection, genes associated with high SARS-CoV-2 E and N were overwhelmingly enriched in two reactive astrocyte states that appear to be downstream of Nuclear factor kappa B (NF-κB) signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:16}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Although there was enrichment for microglial and astrocyte activation in the gene set upregulated in infection, genes associated with high SARS-CoV-2 E and N were overwhelmingly enriched in two reactive astrocyte states that appear to be downstream of Nuclear factor kappa B (NF-κB) signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:947}, properties:{annotationPublicationtype:["Research"], evidence:"The upregulation of various IFN-induced oligoadenylate synthetase (OAS) antiviral genes, including OAS1, OAS2, OAS3, and OASL, was also detected in the infected astrocytes (Fig. S5E), further confirming the activation of type I IFN signaling in astrocytes", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:947}, properties:{annotationPublicationtype:["Research"], evidence:"Gene ontology (GO) and WikiPathways analyses of the upregulated genes in infected cells revealed the enrichment of genes induced by type I, II, and III interferons and genes involved in Toll-like receptor (TLR), MDA5, and RIG-I sensing of double-stranded RNA.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1283}, properties:{annotationPublicationtype:["Research"], evidence:"Gene ontology (GO) and WikiPathways analyses of the upregulated genes in infected cells revealed the enrichment of genes induced by type I, II, and III interferons and genes involved in Toll-like receptor (TLR), MDA5, and RIG-I sensing of double-stranded RNA.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1671}, properties:{annotationPublicationtype:["Research"], evidence:"Gene ontology (GO) and WikiPathways analyses of the upregulated genes in infected cells revealed the enrichment of genes induced by type I, II, and III interferons and genes involved in Toll-like receptor (TLR), MDA5, and RIG-I sensing of double-stranded RNA.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1326}, properties:{annotationPublicationtype:["Research"], evidence:"Gene ontology (GO) and WikiPathways analyses of the upregulated genes in infected cells revealed the enrichment of genes induced by type I, II, and III interferons and genes involved in Toll-like receptor (TLR), MDA5, and RIG-I sensing of double-stranded RNA.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1676}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the levels of genes involved in DNA demethylation, proinflammatory responses, apoptosis, p38 MAPK signaling, and neurodegenerative signaling like that found in Parkinson's disease and amyotrophic lateral sclerosis were also increased (Fig. 5C and Fig. S5F).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the levels of genes involved in DNA demethylation, proinflammatory responses, apoptosis, p38 MAPK signaling, and neurodegenerative signaling like that found in Parkinson's disease and amyotrophic lateral sclerosis were also increased (Fig. 5C and Fig. S5F).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:785}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the levels of genes involved in DNA demethylation, proinflammatory responses, apoptosis, p38 MAPK signaling, and neurodegenerative signaling like that found in Parkinson's disease and amyotrophic lateral sclerosis were also increased (Fig. 5C and Fig. S5F).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1677}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the levels of genes involved in DNA demethylation, proinflammatory responses, apoptosis, p38 MAPK signaling, and neurodegenerative signaling like that found in Parkinson's disease and amyotrophic lateral sclerosis were also increased (Fig. 5C and Fig. S5F).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:67}, end: {_id:1913}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"By contrast, male mice microglia showed higher expression of NF-κB and its inflammatory target genes, higher MHC expression, and ATP responsiveness [138,139].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1122}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In the literature, viraemia is not only predictive of patient survival but is also associated with worse respiratory disease severity, increased markers of inflammation, and increased pulmonary viral RNA load.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:67}, end: {_id:2096}, properties:{annotationPublicationtype:["Research"], evidence:"The pathway enrichment analysis revealed that RUNX1-regulated transcription related to myeloid differentiation was ranked top (odd ratio of 84.68, P-value = 4.71E-4) (Supplementary Fig. 7D).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2103}, properties:{annotationPublicationtype:["Research"], evidence:"TCR signaling was also among the top-ranked pathways enriched for upregulated genes in CD8 Tn of iPD vs HC (Supplementary Fig. 7D).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:640}, end: {_id:2190}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:253}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2191}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1399}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is known to regulate oxidative stress and maintain mitochondrial function within the cell and, together with PINK1, was originally shown to provide neuroprotection by activating the NFkB transcription factor that regulates immune response among others", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1453}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Based on recent studies, the cell-to-cell spreading of α-syn aggregates, and in particular the fibrillar forms of α-syn, can trigger an inflammatory response that contributes to PD progression [68, 119].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationProteinType:["fibril"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:266}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:196}, end: {_id:2172}, properties:{annotationPublicationtype:["Research"], evidence:"Levels of TGFβ and D-dimer were significantly associated with the percentage of voxels with abnormal leakage but only TGFβ was significant after correcting for multiple comparisons (Fig. ​(Fig.5e).5e). The levels of TGFβ were significantly associated with GBV, CSF volume, brainstem volume and amygdala volume.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:896}, end: {_id:684}, properties:{annotationPublicationtype:["Research"], evidence:"However, by 72 hpi, the neurite length of the spike+ neurons decreased significantly in both ApoE3 and ApoE4 neurons (Figures 2D and 2E), compared to mock-treated neurons and spike– neurons.The decrease of neurite length in the ApoE4 spike+ neurons compared to the ApoE4 spike– neurons is more dramatic (p < 0.001) than the decrease in the ApoE3 spike+ neurons compared to the ApoE3 spike– neurons (p < 0.05).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["AG14048 cell", "AG06869 cell"], pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:627}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"As Fig. 1b,c show, SDCs - especially the neuron predominant SDC3 - increased the cellular uptake of fibrils, while internalization of Trf, the marker of clathrin-mediated endocytosis was reduced by SDC1-3 (and left unaffected by SDC4) suggesting that SDC mediated uptake of the fibrils occur through clathrin-independent routes.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:627}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"As Fig. 1b,c show, SDCs - especially the neuron predominant SDC3 - increased the cellular uptake of fibrils, while internalization of Trf, the marker of clathrin-mediated endocytosis was reduced by SDC1-3 (and left unaffected by SDC4) suggesting that SDC mediated uptake of the fibrils occur through clathrin-independent routes.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:630}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:630}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:631}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:631}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:627}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:627}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Microscopic studies revealed similar pattern as flow cytometry:namely that compared to WT K562 cells, fibril-treated SDC transfectants exhibited higher intracellular fluorescent signals (Fig. 1d).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["laser scanning confocal microscope"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:953}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"We detected significant inhibition of SARS-CoV-2 infection upon pretreatment with ACE2 antibody compared with isotype control, indicating the requirement of ACE2 for infection of brain organoids (Fig. 6, B and F; and Fig. S2 C).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:1273}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"The cellular uptake of the Delta spike could be significantly reduced with either SDC4 knockdown(KD) or heparin co-incubation(Figure 9A-C)", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1273}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Thus, a fold change of 0.6 in SDC4 expression exerted an uptake inhibition of about 34%, while heparin inhibited the Delta spike uptake with about 55% efficacy (Figure 9B).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1273}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"SDCK4 KD or heparin co-incubation also decreased the gene transduction efficacy of the Delta PSV. Namely, heparin inhibited the Delta PSV- mediated gene delivery with ~68% efficacy, compared to the ~44% inhibition efficacy of SDC4 KD (Figure 9C).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"35054983", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1273}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Our findings reveal that SDC4 KD markedly diminished the cellular entry of all viruses (Figure 4A–G).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron", "Delta", "wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:1273}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, the uptake of the Omicron variant was significantly lower compared to WT SCV2 in the SDC4 KD cells (Figure 4D–F).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:1273}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"The gene delivery studies with red fluorescent proteins (RFPs) encoding PSVs bearing the spike proteins of the respective strains (WT SCV2, Delta, or Omicron) showed that SDC4 KD decreased the cellular entry and gene delivery of all PSVs (Figure 6).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:1273}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"The gene delivery studies with red fluorescent proteins (RFPs) encoding PSVs bearing the spike proteins of the respective strains (WT SCV2, Delta, or Omicron) showed that SDC4 KD decreased the cellular entry and gene delivery of all PSVs (Figure 6).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:1273}, end: {_id:1928}, properties:{annotationPublicationtype:["Research"], evidence:"The gene delivery studies with red fluorescent proteins (RFPs) encoding PSVs bearing the spike proteins of the respective strains (WT SCV2, Delta, or Omicron) showed that SDC4 KD decreased the cellular entry and gene delivery of all PSVs (Figure 6).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:1273}, end: {_id:1928}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to the WT SCV2 spike-bearing PSVs, the Omicron spike-bearing PSVs exhibited significantly decreased gene delivery (p < 0.05; Figure 6C).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:380}, end: {_id:233}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__COMPLEX]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of ACE2 was highest in oligodendrocytes, while TMPRSS2 and  TMPRSS4 were highest in neurons, CTSL was highest in microglia, and  TPCN2 was highest in astrocytes (figure 3).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Oligodendroglia"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of ACE2 was highest in oligodendrocytes, while TMPRSS2 and  TMPRSS4 were highest in neurons, CTSL was highest in microglia, and  TPCN2 was highest in astrocytes (figure 3).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:876}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of ACE2 was highest in oligodendrocytes, while TMPRSS2 and  TMPRSS4 were highest in neurons, CTSL was highest in microglia, and  TPCN2 was highest in astrocytes (figure 3).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:877}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of ACE2 was highest in oligodendrocytes, while TMPRSS2 and  TMPRSS4 were highest in neurons, CTSL was highest in microglia, and  TPCN2 was highest in astrocytes (figure 3).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:878}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of ACE2 was highest in oligodendrocytes, while TMPRSS2 and  TMPRSS4 were highest in neurons, CTSL was highest in microglia, and  TPCN2 was highest in astrocytes (figure 3).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:965}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:966}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:967}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:968}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:970}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:971}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:972}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:973}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:974}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:975}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:846}, properties:{annotationPublicationtype:["Research"], evidence:"To investigate physiological effects of virus infection, we examined the host response genes and we found that expression of a number of immuneregulatory genes including STAT1, STAT2, interferons (IFNs), and chemokines were upregulated in LORGs (Figure 2F).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationTimeline:["72 h post infection"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:968}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that CCL5, CXCL10, IFN-b, interleukin-6 (IL-6), and IL-8 were all upregulated >10-fold, and these findings are consistent with the data obtained from SARS-CoV-2 infection of lung epithelial cells (Blanco-Melo et al., 2020) and COVID-19 patients relative to healthy donors (Daamen et al., 2020). ", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that CCL5, CXCL10, IFN-b, interleukin-6 (IL-6), and IL-8 were all upregulated >10-fold, and these findings are consistent with the data obtained from SARS-CoV-2 infection of lung epithelial cells (Blanco-Melo et al., 2020) and COVID-19 patients relative to healthy donors (Daamen et al., 2020). ", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:972}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that CCL5, CXCL10, IFN-b, interleukin-6 (IL-6), and IL-8 were all upregulated >10-fold, and these findings are consistent with the data obtained from SARS-CoV-2 infection of lung epithelial cells (Blanco-Melo et al., 2020) and COVID-19 patients relative to healthy donors (Daamen et al., 2020). ", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:846}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that CCL5, CXCL10, IFN-b, interleukin-6 (IL-6), and IL-8 were all upregulated >10-fold, and these findings are consistent with the data obtained from SARS-CoV-2 infection of lung epithelial cells (Blanco-Melo et al., 2020) and COVID-19 patients relative to healthy donors (Daamen et al., 2020). ", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:976}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, our results also indicate that SARS-CoV-2 infection activates the inflammasome pathway because the key genes of this pathway including NLRP3, ASC, IL-18, and caspase-1 were upregulated (Figure 2G).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:977}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, our results also indicate that SARS-CoV-2 infection activates the inflammasome pathway because the key genes of this pathway including NLRP3, ASC, IL-18, and caspase-1 were upregulated (Figure 2G).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:978}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, our results also indicate that SARS-CoV-2 infection activates the inflammasome pathway because the key genes of this pathway including NLRP3, ASC, IL-18, and caspase-1 were upregulated (Figure 2G).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:979}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, our results also indicate that SARS-CoV-2 infection activates the inflammasome pathway because the key genes of this pathway including NLRP3, ASC, IL-18, and caspase-1 were upregulated (Figure 2G).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:845}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, our results also indicate that SARS-CoV-2 infection activates the inflammasome pathway because the key genes of this pathway including NLRP3, ASC, IL-18, and caspase-1 were upregulated (Figure 2G).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:980}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, our results also indicate that SARS-CoV-2 infection activates the inflammasome pathway because the key genes of this pathway including NLRP3, ASC, IL-18, and caspase-1 were upregulated (Figure 2G).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:821}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that infection was more efficient in neurons than in NPCs (Figures 3F and 3G), an observation that correlates with the levels of ACE2 and TMPRSS2 expression in neurons and NPCs (Figures 3B and 3C).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:835}, properties:{annotationPublicationtype:["Research"], evidence:"Our results showed that infection was more efficient in neurons than in NPCs (Figures 3F and 3G), an observation that correlates with the levels of ACE2 and TMPRSS2 expression in neurons and NPCs (Figures 3B and 3C).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:640}, end: {_id:975}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:981}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:982}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:983}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:984}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:985}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:986}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:987}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:988}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:989}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:990}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:991}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:992}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:993}, properties:{annotationPublicationtype:["Research"], evidence:"Our analyses showed that SARS-COV-2 infection upregulated genes involved in innate immunity including IL6, IFIT3, OAS2, TLR3, and TLR7, complement system, calpain pathways, CDK5, apoptosis, and RIPK1/3-regulated necroptosis pathways (Figures 3K, 3L, 3M, and S2J).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:994}, properties:{annotationPublicationtype:["Research"], evidence:"Apoptotic gene caspase-3 was upregulated while the anti-apoptotic genes, BCL2 and BAX, were downregulated in infected neurons (Figure 3N).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["real-time PCR "], annotationDisease:["COVID-19"], citationRef:"33631122"}}, {start: {_id:640}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of gene transcript of Cxcl10 was elevated in the olfactory mucosa in most patients with detectable SARS-CoV-2 antigens  as compared to control patients, and in contrast, an interindividual variability, both in SARS-CoV-2-infected and control individuals, was observed in Il-6, Ccl5, Isg20 and Mx1 gene transcript expression (Fig. 2D, Tables S1 and S2).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Olfactory Mucosa"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Olfaction Disorders"], annotationBioassay:["real-time PCR "], citationRef:"33941622"}}, {start: {_id:640}, end: {_id:975}, properties:{annotationPublicationtype:["Research"], evidence:"Quantification of IL-6 gene expression revealed an up-regulation of this proinflammatory cytokine in the olfactory mucosa of the three patients with high viral load, but not in the case #6, which nevertheless presented SARS-CoV-2 antigens in the neuroepithelium (Table S4).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Olfactory Mucosa"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Olfaction Disorders"], annotationBioassay:["real-time PCR "], citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1274}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, IFITM1 and IFITM2, which are necessary for SARS-CoV-2 infection in human lung cells (Shi et al., 2021), were significantly upregulated (p = 0.03 for IFITM1, p = 0.01 for IFITM2) in COVID-19 patients.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1275}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, IFITM1 and IFITM2, which are necessary for SARS-CoV-2 infection in human lung cells (Shi et al., 2021), were significantly upregulated (p = 0.03 for IFITM1, p = 0.01 for IFITM2) in COVID-19 patients.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1276}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent gene set enrichment analysis (GSEA) revealed an upregulation of mRNAs related to antigen processing and major histocompatibility complex (MHC) class I-dependent antigen presentation supporting the notion that SARS-CoV-2 directly affects brain endothelial cells.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1277}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent gene set enrichment analysis (GSEA) revealed an upregulation of mRNAs related to antigen processing and major histocompatibility complex (MHC) class I-dependent antigen presentation supporting the notion that SARS-CoV-2 directly affects brain endothelial cells.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1278}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent gene set enrichment analysis (GSEA) revealed an upregulation of mRNAs related to antigen processing and major histocompatibility complex (MHC) class I-dependent antigen presentation supporting the notion that SARS-CoV-2 directly affects brain endothelial cells.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1279}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent gene set enrichment analysis (GSEA) revealed an upregulation of mRNAs related to antigen processing and major histocompatibility complex (MHC) class I-dependent antigen presentation supporting the notion that SARS-CoV-2 directly affects brain endothelial cells.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1280}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent gene set enrichment analysis (GSEA) revealed an upregulation of mRNAs related to antigen processing and major histocompatibility complex (MHC) class I-dependent antigen presentation supporting the notion that SARS-CoV-2 directly affects brain endothelial cells.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1281}, properties:{annotationPublicationtype:["Research"], evidence:"Subsequent gene set enrichment analysis (GSEA) revealed an upregulation of mRNAs related to antigen processing and major histocompatibility complex (MHC) class I-dependent antigen presentation supporting the notion that SARS-CoV-2 directly affects brain endothelial cells.", citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:640}, end: {_id:1479}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1480}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1481}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1482}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1483}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1484}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:837}, properties:{annotationPublicationtype:["Research"], evidence:"At the RNA level, the levels of NRP1 and AXL mRNAs were 140,000-fold and 200,000-fold higher, respectively, than the levels of ACE2 mRNA in astrocytes (Fig. S1A).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1586}, properties:{annotationPublicationtype:["Research"], evidence:"At the RNA level, the levels of NRP1 and AXL mRNAs were 140,000-fold and 200,000-fold higher, respectively, than the levels of ACE2 mRNA in astrocytes (Fig. S1A).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1596}, properties:{annotationPublicationtype:["Research"], evidence:"Hierarchical clustering revealed that SARS-CoV-2 induced increased transcription of inflammatory chemokines, including CCL3 and CXCL3 (Fig. S2A and B), indicating the activation of an intrinsic inflammatory response.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1597}, properties:{annotationPublicationtype:["Research"], evidence:"Hierarchical clustering revealed that SARS-CoV-2 induced increased transcription of inflammatory chemokines, including CCL3 and CXCL3 (Fig. S2A and B), indicating the activation of an intrinsic inflammatory response.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1598}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:981}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:965}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1599}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1541}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:970}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1305}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1600}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1274}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1601}, properties:{annotationPublicationtype:["Research"], evidence:"Type I interferon (IFN-I)-related genes, including IFIT1, IFIT3, STAT1, EGR1, ISG15, MX1, IFI6, IFI27, IFITM1, and BST2, were also strongly induced following SARS-CoV-2 infection (Fig. 4C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1602}, properties:{annotationPublicationtype:["Research"], evidence:"Pathway analysis revealed the activation of genes involved in chromatin modification (CHD1, H2BC5, H2AC12, and INO80) as well as genes mediating cell activation and apoptosis (Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1603}, properties:{annotationPublicationtype:["Research"], evidence:"Pathway analysis revealed the activation of genes involved in chromatin modification (CHD1, H2BC5, H2AC12, and INO80) as well as genes mediating cell activation and apoptosis (Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1604}, properties:{annotationPublicationtype:["Research"], evidence:"Pathway analysis revealed the activation of genes involved in chromatin modification (CHD1, H2BC5, H2AC12, and INO80) as well as genes mediating cell activation and apoptosis (Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1605}, properties:{annotationPublicationtype:["Research"], evidence:"Pathway analysis revealed the activation of genes involved in chromatin modification (CHD1, H2BC5, H2AC12, and INO80) as well as genes mediating cell activation and apoptosis (Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:970}, properties:{annotationPublicationtype:["Research"], evidence:"RT-qPCR was used to validate the activation of several genes in the type I interferon pathway, including MX1, IFI6, and ISG15 (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1305}, properties:{annotationPublicationtype:["Research"], evidence:"RT-qPCR was used to validate the activation of several genes in the type I interferon pathway, including MX1, IFI6, and ISG15 (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1541}, properties:{annotationPublicationtype:["Research"], evidence:"RT-qPCR was used to validate the activation of several genes in the type I interferon pathway, including MX1, IFI6, and ISG15 (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1596}, properties:{annotationPublicationtype:["Research"], evidence:"The proinflammatory chemokines CCL3, CXCL3, and CXCL10 were also upregulated following infection, while synapse-related genes, including C1QL1 and SYPL1, were downregulated (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1597}, properties:{annotationPublicationtype:["Research"], evidence:"The proinflammatory chemokines CCL3, CXCL3, and CXCL10 were also upregulated following infection, while synapse-related genes, including C1QL1 and SYPL1, were downregulated (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"The proinflammatory chemokines CCL3, CXCL3, and CXCL10 were also upregulated following infection, while synapse-related genes, including C1QL1 and SYPL1, were downregulated (Fig. S2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1656}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1600}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1657}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1305}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1658}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1659}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1513}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:970}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1660}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1598}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1661}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:981}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1662}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1663}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1541}, properties:{annotationPublicationtype:["Research"], evidence:"A marked upregulation of type I IFN-stimulated genes (ISGs), including IFI144, IFI27, IFI35, IFI6, IFI30, IFI44L, LY6E, MX1, MX2, IFIT1, IFIT2, IFIT3, IFIT5, ISG20, and ISG15, was observed in infected cells (Fig. 5A and B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1303}, properties:{annotationPublicationtype:["Research"], evidence:"The upregulation of various IFN-induced oligoadenylate synthetase (OAS) antiviral genes, including OAS1, OAS2, OAS3, and OASL, was also detected in the infected astrocytes (Fig. S5E), further confirming the activation of type I IFN signaling in astrocytes", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:982}, properties:{annotationPublicationtype:["Research"], evidence:"The upregulation of various IFN-induced oligoadenylate synthetase (OAS) antiviral genes, including OAS1, OAS2, OAS3, and OASL, was also detected in the infected astrocytes (Fig. S5E), further confirming the activation of type I IFN signaling in astrocytes", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1664}, properties:{annotationPublicationtype:["Research"], evidence:"The upregulation of various IFN-induced oligoadenylate synthetase (OAS) antiviral genes, including OAS1, OAS2, OAS3, and OASL, was also detected in the infected astrocytes (Fig. S5E), further confirming the activation of type I IFN signaling in astrocytes", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1665}, properties:{annotationPublicationtype:["Research"], evidence:"The upregulation of various IFN-induced oligoadenylate synthetase (OAS) antiviral genes, including OAS1, OAS2, OAS3, and OASL, was also detected in the infected astrocytes (Fig. S5E), further confirming the activation of type I IFN signaling in astrocytes", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1541}, properties:{annotationPublicationtype:["Research"], evidence:"The upregulation of various IFN-induced oligoadenylate synthetase (OAS) antiviral genes, including OAS1, OAS2, OAS3, and OASL, was also detected in the infected astrocytes (Fig. S5E), further confirming the activation of type I IFN signaling in astrocytes", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:969}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2-infected astrocytes also exhibited increased transcription levels of many inflammatory chemokines/cytokines, including CXCL10, CXCL16, CXCL1, CXCL2, interleukin-15 (IL-15), and IL-7 (Fig. 5B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1666}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2-infected astrocytes also exhibited increased transcription levels of many inflammatory chemokines/cytokines, including CXCL10, CXCL16, CXCL1, CXCL2, interleukin-15 (IL-15), and IL-7 (Fig. 5B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1667}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2-infected astrocytes also exhibited increased transcription levels of many inflammatory chemokines/cytokines, including CXCL10, CXCL16, CXCL1, CXCL2, interleukin-15 (IL-15), and IL-7 (Fig. 5B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1668}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2-infected astrocytes also exhibited increased transcription levels of many inflammatory chemokines/cytokines, including CXCL10, CXCL16, CXCL1, CXCL2, interleukin-15 (IL-15), and IL-7 (Fig. 5B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1669}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2-infected astrocytes also exhibited increased transcription levels of many inflammatory chemokines/cytokines, including CXCL10, CXCL16, CXCL1, CXCL2, interleukin-15 (IL-15), and IL-7 (Fig. 5B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1670}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2-infected astrocytes also exhibited increased transcription levels of many inflammatory chemokines/cytokines, including CXCL10, CXCL16, CXCL1, CXCL2, interleukin-15 (IL-15), and IL-7 (Fig. 5B).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1678}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 infection of astrocytes upregulates the expression of APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3G, and APOBEC3F.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1679}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 infection of astrocytes upregulates the expression of APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3G, and APOBEC3F.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1680}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 infection of astrocytes upregulates the expression of APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3G, and APOBEC3F.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1681}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 infection of astrocytes upregulates the expression of APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3G, and APOBEC3F.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1682}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 infection of astrocytes upregulates the expression of APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3G, and APOBEC3F.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:842}, properties:{annotationPublicationtype:["Research"], evidence:"We identified a three protein panel (CCL7, CD40LG and S100A12) that performed well to distinguish inflammatory versus non-inflammatory PASC in this model(See Methods & Supplemental Data S10). These proteins were up regulated in the inflammatory clusters at ≥60 days PSO and persisted over time in the inflammatory PASC group compared to the non-inflammatory PASC group, with the exception of CD40LG that was significantly higher only around the 60 days PSO time point, specifically in the inflammatory cluster 5 participants (Fig. 6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", annotationPostSymptomOnsetDays:["Greater than or equal to 60 days"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1820}, properties:{annotationPublicationtype:["Research"], evidence:"We identified a three protein panel (CCL7, CD40LG and S100A12) that performed well to distinguish inflammatory versus non-inflammatory PASC in this model(See Methods & Supplemental Data S10). These proteins were up regulated in the inflammatory clusters at ≥60 days PSO and persisted over time in the inflammatory PASC group compared to the non-inflammatory PASC group, with the exception of CD40LG that was significantly higher only around the 60 days PSO time point, specifically in the inflammatory cluster 5 participants (Fig. 6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", annotationPostSymptomOnsetDays:["Greater than or equal to 60 days"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1821}, properties:{annotationPublicationtype:["Research"], evidence:"We identified a three protein panel (CCL7, CD40LG and S100A12) that performed well to distinguish inflammatory versus non-inflammatory PASC in this model(See Methods & Supplemental Data S10). These proteins were up regulated in the inflammatory clusters at ≥60 days PSO and persisted over time in the inflammatory PASC group compared to the non-inflammatory PASC group, with the exception of CD40LG that was significantly higher only around the 60 days PSO time point, specifically in the inflammatory cluster 5 participants (Fig. 6).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", annotationPostSymptomOnsetDays:["Greater than or equal to 60 days"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"37296110"}}, {start: {_id:67}, end: {_id:1889}, properties:{annotationPublicationtype:["Review"], evidence:"Transcriptomic analyses of T cells from people with PD upon in vitro activation showed upregulation of pathways such as IL17, IL10, STAT, and G-proteins, which supports the idea of autoimmunity (IL17) and anti-inflammatory (IL-10) processes occurring in parallel [106]", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1890}, properties:{annotationPublicationtype:["Review"], evidence:"Transcriptomic analyses of T cells from people with PD upon in vitro activation showed upregulation of pathways such as IL17, IL10, STAT, and G-proteins, which supports the idea of autoimmunity (IL17) and anti-inflammatory (IL-10) processes occurring in parallel [106]", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:965}, properties:{annotationPublicationtype:["Review"], evidence:"Transcriptomic analyses of T cells from people with PD upon in vitro activation showed upregulation of pathways such as IL17, IL10, STAT, and G-proteins, which supports the idea of autoimmunity (IL17) and anti-inflammatory (IL-10) processes occurring in parallel [106]", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:7}, end: {_id:1972}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1973}, properties:{annotationPublicationtype:["Research"], evidence:"In LOAD BCECs, we found a predominance of down-regulated transcripts in all co-cultures (Fig. 2D).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1981}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we studied differences between the CON and LOAD NVU model to investigate the influence of LOAD on the mRNA expression of BBB markers in the related isogenic BCECs (Fig. 3). Our analysis revealed transcriptional changes in LOAD BCECs compared with CON BCECs. The heat map of Log2FC values shows 90 BBB markers in LOAD BCECs compared to CON BCECs.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1982}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we studied differences between the CON and LOAD NVU model to investigate the influence of LOAD on the mRNA expression of BBB markers in the related isogenic BCECs (Fig. 3). Our analysis revealed transcriptional changes in LOAD BCECs compared with CON BCECs. The heat map of Log2FC values shows 90 BBB markers in LOAD BCECs compared to CON BCECs.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1985}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we studied differences between the CON and LOAD NVU model to investigate the influence of LOAD on the mRNA expression of BBB markers in the related isogenic BCECs (Fig. 3). Our analysis revealed transcriptional changes in LOAD BCECs compared with CON BCECs. The heat map of Log2FC values shows 90 BBB markers in LOAD BCECs compared to CON BCECs.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1986}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we studied differences between the CON and LOAD NVU model to investigate the influence of LOAD on the mRNA expression of BBB markers in the related isogenic BCECs (Fig. 3). Our analysis revealed transcriptional changes in LOAD BCECs compared with CON BCECs. The heat map of Log2FC values shows 90 BBB markers in LOAD BCECs compared to CON BCECs.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1967}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we studied differences between the CON and LOAD NVU model to investigate the influence of LOAD on the mRNA expression of BBB markers in the related isogenic BCECs (Fig. 3). Our analysis revealed transcriptional changes in LOAD BCECs compared with CON BCECs. The heat map of Log2FC values shows 90 BBB markers in LOAD BCECs compared to CON BCECs.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1987}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we studied differences between the CON and LOAD NVU model to investigate the influence of LOAD on the mRNA expression of BBB markers in the related isogenic BCECs (Fig. 3). Our analysis revealed transcriptional changes in LOAD BCECs compared with CON BCECs. The heat map of Log2FC values shows 90 BBB markers in LOAD BCECs compared to CON BCECs.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1966}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we studied differences between the CON and LOAD NVU model to investigate the influence of LOAD on the mRNA expression of BBB markers in the related isogenic BCECs (Fig. 3). Our analysis revealed transcriptional changes in LOAD BCECs compared with CON BCECs. The heat map of Log2FC values shows 90 BBB markers in LOAD BCECs compared to CON BCECs.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1997}, properties:{annotationPublicationtype:["Research"], evidence:"ACs decreased the transcription of claudins (CLDN17, -23) in LOAD BCECs compared to CON BCECs. Mucins were altered with transcript variant a (tva) of MUC1 being reduced and tvb being increased (Fig. 3C).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2008}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1960}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2009}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1977}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1976}, properties:{annotationPublicationtype:["Research"], evidence:"MGCs altered the transcription of claudins (CLDN7, -25 tv1-4) and other TJ (F11R, JAM3, TJP1, TJP2) and adherens junction makers (AJs; CDH1), transporters and receptors (ABCB1, ABCC4, INSR, LRP1, LSR, MFSD2A, SLC2A1, SLC7A1, SLC7A3, SLC7A5, SLC16A2), and other factors (KRT18, FN1, MUC1 tva, WWC2) in LOAD BCECs (Fig. 3C).", annotationCustomCell:["microglia-like cell"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1971}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2015}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2016}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2018}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:2009}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2019}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2020}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2021}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2022}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2023}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1969}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2024}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2025}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1997}, properties:{annotationPublicationtype:["Research"], evidence:"NSCs had the strongest effect on transcriptional changes in LOAD BCECs (Fig. 3C) including increased, but mainly decreased expression of numerous claudins (CLDN3, -4, -7, -8, -10, -11, -12 tv2, -17, -19, -21, -22, -24) and TJ proteins (F11R, JAM2, JAM3, TJP1, TJP3, OCLN, MARVELD2).", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["co-culture", "quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2003}, properties:{annotationPublicationtype:["Research"], evidence:"We also found increased transcription of the six SLC transporters SLC2A1/GLUT1, SLC7A1 (cationic amino acid transporter 1, CAT1), SLC7A3 (CAT3), SLC7A5 (large neutral amino acid transporter 1, LAT1), SLC16A1 (monocarboxylate transporter 1, MCT1, and SLC16A2 (MCT8).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1614}, properties:{annotationPublicationtype:["Research"], evidence:"We also found increased transcription of the six SLC transporters SLC2A1/GLUT1, SLC7A1 (cationic amino acid transporter 1, CAT1), SLC7A3 (CAT3), SLC7A5 (large neutral amino acid transporter 1, LAT1), SLC16A1 (monocarboxylate transporter 1, MCT1, and SLC16A2 (MCT8).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1976}, properties:{annotationPublicationtype:["Research"], evidence:"We also found increased transcription of the six SLC transporters SLC2A1/GLUT1, SLC7A1 (cationic amino acid transporter 1, CAT1), SLC7A3 (CAT3), SLC7A5 (large neutral amino acid transporter 1, LAT1), SLC16A1 (monocarboxylate transporter 1, MCT1, and SLC16A2 (MCT8).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1979}, properties:{annotationPublicationtype:["Research"], evidence:"We also found increased transcription of the six SLC transporters SLC2A1/GLUT1, SLC7A1 (cationic amino acid transporter 1, CAT1), SLC7A3 (CAT3), SLC7A5 (large neutral amino acid transporter 1, LAT1), SLC16A1 (monocarboxylate transporter 1, MCT1, and SLC16A2 (MCT8).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1961}, properties:{annotationPublicationtype:["Research"], evidence:"We also found increased transcription of the six SLC transporters SLC2A1/GLUT1, SLC7A1 (cationic amino acid transporter 1, CAT1), SLC7A3 (CAT3), SLC7A5 (large neutral amino acid transporter 1, LAT1), SLC16A1 (monocarboxylate transporter 1, MCT1, and SLC16A2 (MCT8).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2028}, properties:{annotationPublicationtype:["Research"], evidence:"We also found increased transcription of the six SLC transporters SLC2A1/GLUT1, SLC7A1 (cationic amino acid transporter 1, CAT1), SLC7A3 (CAT3), SLC7A5 (large neutral amino acid transporter 1, LAT1), SLC16A1 (monocarboxylate transporter 1, MCT1, and SLC16A2 (MCT8).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2022}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2023}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2035}, properties:{annotationPublicationtype:["Research"], evidence:"The gene encoding the aging marker advanced glycosylation end-product specific receptor (AGER; receptor for advanced glycosylation end-product, RAGE) was increased. Finally, mucins were also altered including two MUC1 transcripts (tva was reduced and tvb increased) (Fig. 3C).", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:67}, end: {_id:2037}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, the expression levels(median signal intensity, MSI) of CD57, a marker for terminal differentiation, among CD8 TEMRA showed a trend to be increased(p = 0.0663) in PD (Fig. 1g).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationTechnique:["Cytometry by Time of Flight (CyTOF)"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:2037}, properties:{annotationPublicationtype:["Research"], evidence:"CD8+ NKT also expressed higher levels of CD57 (Fig. 1k).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["mature natural killer cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationTechnique:["Cytometry by Time of Flight (CyTOF)"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2048}, properties:{annotationPublicationtype:["Research"], evidence:"Highly encouragingly, circulating GZMA was significantly elevated in iPD, especially in females (Fig. 2j), while the levels of both GZMB and perforin were comparable between iPD and HC (Fig. 2k, l).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["mature natural killer cell", "CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationGender:["Female"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2052}, properties:{annotationPublicationtype:["Research"], evidence:"The frequency of GZMB-expressing cells was selectively enhanced only in TEM and TEMRA of iPD vs HC.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell", "effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2053}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, the frequency of GZMK expressing cells was reduced in TEM and TEMRA (Fig. 5h).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell", "effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2054}, properties:{annotationPublicationtype:["Research"], evidence:"Although the frequency of PRF1- expressing cells was not significantly changed in CD8 subsets, the MFI of PRF1 still showed a trend to be augmented in iPD vs HC among total CD8 T cells, TEM and TEMRA (Fig. 5l).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell", "central memory CD8-positive, alpha-beta T cell", "CD8-positive, alpha-beta T cell", "effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2055}, properties:{annotationPublicationtype:["Research"], evidence:"As expected, a higher expression of CCR7, CD27, CD28, IL7R and SELL/CD62L was observed in CD8 Tn and TCM compared with the later-differentiated ones (i.e., CD8 TEM and TEMRA) (Fig. 6c).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["central memory CD8-positive, alpha-beta T cell", "CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2056}, properties:{annotationPublicationtype:["Research"], evidence:"As expected, a higher expression of CCR7, CD27, CD28, IL7R and SELL/CD62L was observed in CD8 Tn and TCM compared with the later-differentiated ones (i.e., CD8 TEM and TEMRA) (Fig. 6c).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["central memory CD8-positive, alpha-beta T cell", "CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2057}, properties:{annotationPublicationtype:["Research"], evidence:"As expected, a higher expression of CCR7, CD27, CD28, IL7R and SELL/CD62L was observed in CD8 Tn and TCM compared with the later-differentiated ones (i.e., CD8 TEM and TEMRA) (Fig. 6c).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["central memory CD8-positive, alpha-beta T cell", "CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2058}, properties:{annotationPublicationtype:["Research"], evidence:"As expected, a higher expression of CCR7, CD27, CD28, IL7R and SELL/CD62L was observed in CD8 Tn and TCM compared with the later-differentiated ones (i.e., CD8 TEM and TEMRA) (Fig. 6c).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["central memory CD8-positive, alpha-beta T cell", "CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2059}, properties:{annotationPublicationtype:["Research"], evidence:"As expected, a higher expression of CCR7, CD27, CD28, IL7R and SELL/CD62L was observed in CD8 Tn and TCM compared with the later-differentiated ones (i.e., CD8 TEM and TEMRA) (Fig. 6c).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["central memory CD8-positive, alpha-beta T cell", "CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2060}, properties:{annotationPublicationtype:["Research"], evidence:"THEMIS was among the most upregulated genes in CD8 TEMRA of iPD (Fig. 6j).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2052}, properties:{annotationPublicationtype:["Research"], evidence:"The analysis of differentially-expressed genes (DEG) in iPD vs HC further demonstrated that the genes involved in NK-mediated cytotoxicity, such as GZMB, PRF1 and FCGR3A, were among the most upregulated ones in C1(Fig. 6p).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2054}, properties:{annotationPublicationtype:["Research"], evidence:"The analysis of differentially-expressed genes (DEG) in iPD vs HC further demonstrated that the genes involved in NK-mediated cytotoxicity, such as GZMB, PRF1 and FCGR3A, were among the most upregulated ones in C1(Fig. 6p).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:1537}, properties:{annotationPublicationtype:["Research"], evidence:"The analysis of differentially-expressed genes (DEG) in iPD vs HC further demonstrated that the genes involved in NK-mediated cytotoxicity, such as GZMB, PRF1 and FCGR3A, were among the most upregulated ones in C1(Fig. 6p).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2064}, properties:{annotationPublicationtype:["Research"], evidence:"Several MHC type II molecules (e.g., HLA-DRB1, HLA-DQA1 and HLA-DQB1), known CD8 T-cell activation markers as well as another NK cytotoxic effector molecule (KLRD1) and leukocyte transendothelial migration and adhesion molecules (ITGB2 and ITGAL) were upregulated in C0 and, to a lesser extent in C1, of CD8 TEMRA (Fig. 6p). Together, these scRNA-seq data support that the cytotoxic pathways are enhanced in CD8 TEMRA from early-to-mid stage iPD vs HC. Similar pathways enriched for the upregulated genes in iPD vs HC were observed in CD8 TEM (Supplementary Fig. 6G–I).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2065}, properties:{annotationPublicationtype:["Research"], evidence:"Several MHC type II molecules (e.g., HLA-DRB1, HLA-DQA1 and HLA-DQB1), known CD8 T-cell activation markers as well as another NK cytotoxic effector molecule (KLRD1) and leukocyte transendothelial migration and adhesion molecules (ITGB2 and ITGAL) were upregulated in C0 and, to a lesser extent in C1, of CD8 TEMRA (Fig. 6p). Together, these scRNA-seq data support that the cytotoxic pathways are enhanced in CD8 TEMRA from early-to-mid stage iPD vs HC. Similar pathways enriched for the upregulated genes in iPD vs HC were observed in CD8 TEM (Supplementary Fig. 6G–I).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:1288}, properties:{annotationPublicationtype:["Research"], evidence:"Several MHC type II molecules (e.g., HLA-DRB1, HLA-DQA1 and HLA-DQB1), known CD8 T-cell activation markers as well as another NK cytotoxic effector molecule (KLRD1) and leukocyte transendothelial migration and adhesion molecules (ITGB2 and ITGAL) were upregulated in C0 and, to a lesser extent in C1, of CD8 TEMRA (Fig. 6p). Together, these scRNA-seq data support that the cytotoxic pathways are enhanced in CD8 TEMRA from early-to-mid stage iPD vs HC. Similar pathways enriched for the upregulated genes in iPD vs HC were observed in CD8 TEM (Supplementary Fig. 6G–I).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2067}, properties:{annotationPublicationtype:["Research"], evidence:"Several MHC type II molecules (e.g., HLA-DRB1, HLA-DQA1 and HLA-DQB1), known CD8 T-cell activation markers as well as another NK cytotoxic effector molecule (KLRD1) and leukocyte transendothelial migration and adhesion molecules (ITGB2 and ITGAL) were upregulated in C0 and, to a lesser extent in C1, of CD8 TEMRA (Fig. 6p). Together, these scRNA-seq data support that the cytotoxic pathways are enhanced in CD8 TEMRA from early-to-mid stage iPD vs HC. Similar pathways enriched for the upregulated genes in iPD vs HC were observed in CD8 TEM (Supplementary Fig. 6G–I).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2068}, properties:{annotationPublicationtype:["Research"], evidence:"Several MHC type II molecules (e.g., HLA-DRB1, HLA-DQA1 and HLA-DQB1), known CD8 T-cell activation markers as well as another NK cytotoxic effector molecule (KLRD1) and leukocyte transendothelial migration and adhesion molecules (ITGB2 and ITGAL) were upregulated in C0 and, to a lesser extent in C1, of CD8 TEMRA (Fig. 6p). Together, these scRNA-seq data support that the cytotoxic pathways are enhanced in CD8 TEMRA from early-to-mid stage iPD vs HC. Similar pathways enriched for the upregulated genes in iPD vs HC were observed in CD8 TEM (Supplementary Fig. 6G–I).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2069}, properties:{annotationPublicationtype:["Research"], evidence:"Several MHC type II molecules (e.g., HLA-DRB1, HLA-DQA1 and HLA-DQB1), known CD8 T-cell activation markers as well as another NK cytotoxic effector molecule (KLRD1) and leukocyte transendothelial migration and adhesion molecules (ITGB2 and ITGAL) were upregulated in C0 and, to a lesser extent in C1, of CD8 TEMRA (Fig. 6p). Together, these scRNA-seq data support that the cytotoxic pathways are enhanced in CD8 TEMRA from early-to-mid stage iPD vs HC. Similar pathways enriched for the upregulated genes in iPD vs HC were observed in CD8 TEM (Supplementary Fig. 6G–I).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:2070}, properties:{annotationPublicationtype:["Research"], evidence:"Our volcano plot (Supplementary Fig. 6G) showed that, AOAH (acyloxyacyl hydrolase), a lysosomal enzyme known to detoxify LPS64 and several established cytotoxic molecules (GZMH, NKG7 and KLRG1), were substantially upregulated in CD8 TEM of iPD vs HC.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2071}, properties:{annotationPublicationtype:["Research"], evidence:"Our volcano plot (Supplementary Fig. 6G) showed that, AOAH (acyloxyacyl hydrolase), a lysosomal enzyme known to detoxify LPS64 and several established cytotoxic molecules (GZMH, NKG7 and KLRG1), were substantially upregulated in CD8 TEM of iPD vs HC.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2072}, properties:{annotationPublicationtype:["Research"], evidence:"Our volcano plot (Supplementary Fig. 6G) showed that, AOAH (acyloxyacyl hydrolase), a lysosomal enzyme known to detoxify LPS64 and several established cytotoxic molecules (GZMH, NKG7 and KLRG1), were substantially upregulated in CD8 TEM of iPD vs HC.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2073}, properties:{annotationPublicationtype:["Research"], evidence:"Our volcano plot (Supplementary Fig. 6G) showed that, AOAH (acyloxyacyl hydrolase), a lysosomal enzyme known to detoxify LPS64 and several established cytotoxic molecules (GZMH, NKG7 and KLRG1), were substantially upregulated in CD8 TEM of iPD vs HC.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2052}, properties:{annotationPublicationtype:["Research"], evidence:"C0 expressed high levels of both cytotoxic molecules (GZMB, GZMH and GNLY) and the terminal-differentiation-related transcription factor ZEB2, indicative of a more terminally-differentiated status (Supplementary Fig. 6K).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2071}, properties:{annotationPublicationtype:["Research"], evidence:"C0 expressed high levels of both cytotoxic molecules (GZMB, GZMH and GNLY) and the terminal-differentiation-related transcription factor ZEB2, indicative of a more terminally-differentiated status (Supplementary Fig. 6K).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2074}, properties:{annotationPublicationtype:["Research"], evidence:"C0 expressed high levels of both cytotoxic molecules (GZMB, GZMH and GNLY) and the terminal-differentiation-related transcription factor ZEB2, indicative of a more terminally-differentiated status (Supplementary Fig. 6K).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2075}, properties:{annotationPublicationtype:["Research"], evidence:"C0 expressed high levels of both cytotoxic molecules (GZMB, GZMH and GNLY) and the terminal-differentiation-related transcription factor ZEB2, indicative of a more terminally-differentiated status (Supplementary Fig. 6K).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2076}, properties:{annotationPublicationtype:["Research"], evidence:"C2 showed an expression profile reminiscent of NK-like cells (including KLRC2, KLRC3, TYROBP/DAP12, LYN and IKZF2/HELIOS).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C2"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2077}, properties:{annotationPublicationtype:["Research"], evidence:"C2 showed an expression profile reminiscent of NK-like cells (including KLRC2, KLRC3, TYROBP/DAP12, LYN and IKZF2/HELIOS).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C2"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2078}, properties:{annotationPublicationtype:["Research"], evidence:"C2 showed an expression profile reminiscent of NK-like cells (including KLRC2, KLRC3, TYROBP/DAP12, LYN and IKZF2/HELIOS).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C2"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2079}, properties:{annotationPublicationtype:["Research"], evidence:"C2 showed an expression profile reminiscent of NK-like cells (including KLRC2, KLRC3, TYROBP/DAP12, LYN and IKZF2/HELIOS).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C2"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2080}, properties:{annotationPublicationtype:["Research"], evidence:"C2 showed an expression profile reminiscent of NK-like cells (including KLRC2, KLRC3, TYROBP/DAP12, LYN and IKZF2/HELIOS).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C2"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2048}, properties:{annotationPublicationtype:["Research"], evidence:"The more-active cluster C0 was characterized by high levels of cytotoxic or proinflammatory effector molecules (e.g., GZMA and CCL5), while the resting cluster C1 was devoid of the expression of those effector molecules.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:968}, properties:{annotationPublicationtype:["Research"], evidence:"The more-active cluster C0 was characterized by high levels of cytotoxic or proinflammatory effector molecules (e.g., GZMA and CCL5), while the resting cluster C1 was devoid of the expression of those effector molecules.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2086}, properties:{annotationPublicationtype:["Research"], evidence:"The integrin ITGA4,known to have a higher expression in CD8 TEM compared to TCM, was highly expressed in C0 (Fig. 7f).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2087}, properties:{annotationPublicationtype:["Research"], evidence:"The less-active C1 also expressed the TCR inhibitory docking adapter (GAB2) and the transcription factor KLF7 that is highly expressed in CD8 Tn (Fig. 7f).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2088}, properties:{annotationPublicationtype:["Research"], evidence:"The less-active C1 also expressed the TCR inhibitory docking adapter (GAB2) and the transcription factor KLF7 that is highly expressed in CD8 Tn (Fig. 7f).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:1820}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, C1 overexpressed the antigen-specific memory T-cell marker CD40LG in iPD vs HC (Fig. 7f), again indicative of C1 as a quiescent TCM subset.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2089}, properties:{annotationPublicationtype:["Research"], evidence:"Meanwhile, MAP3K1/MEKK1, the negative regulator of virus-specific CD8T cells, was mainly expressed in C1, especially for iPD (Fig. 7f).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:2060}, properties:{annotationPublicationtype:["Research"], evidence:"Meanwhile, THEMIS was upregulated in both clusters of CD8 TCM of iPD (Supplementary Fig. 7A).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1", "C0"], annotationCell:["central memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2090}, properties:{annotationPublicationtype:["Research"], evidence:"Several critical transcription factors (ID3, LEF1 and ETS1) that favor more the memory T-cell development were also upregulated (Fig. 7f, g, Supplementary Fig. 7A).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2091}, properties:{annotationPublicationtype:["Research"], evidence:"Several critical transcription factors (ID3, LEF1 and ETS1) that favor more the memory T-cell development were also upregulated (Fig. 7f, g, Supplementary Fig. 7A).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2092}, properties:{annotationPublicationtype:["Research"], evidence:"Several critical transcription factors (ID3, LEF1 and ETS1) that favor more the memory T-cell development were also upregulated (Fig. 7f, g, Supplementary Fig. 7A).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2093}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, our DEG analysis showed that three out of five somatic linker histone H1 family genes (HIST1H1C/H1.2, HIST1H1D/H1.3 and HIST1H1E/H1.4) 75 and several other histone genes showed a substantial upregulation in CD8 TCM of iPD (Fig. 7g).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2094}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, our DEG analysis showed that three out of five somatic linker histone H1 family genes (HIST1H1C/H1.2, HIST1H1D/H1.3 and HIST1H1E/H1.4) 75 and several other histone genes showed a substantial upregulation in CD8 TCM of iPD (Fig. 7g).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2095}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, our DEG analysis showed that three out of five somatic linker histone H1 family genes (HIST1H1C/H1.2, HIST1H1D/H1.3 and HIST1H1E/H1.4) 75 and several other histone genes showed a substantial upregulation in CD8 TCM of iPD (Fig. 7g).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2091}, properties:{annotationPublicationtype:["Research"], evidence:"The volcano plot shows that the early-differentiation transcription factor LEF174 was among the most highly-upregulated genes in total CD8 Tn of iPD vs HC (Supplementary Fig. 7C).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2097}, properties:{annotationPublicationtype:["Research"], evidence:"More precisely, RUNX1 and RUNX2, reported to favor CD8 terminal differentiation78, were upregulated in CD8 Tn of iPD vs HC (Supplementary Fig. 7E, ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2098}, properties:{annotationPublicationtype:["Research"], evidence:"More precisely, RUNX1 and RUNX2, reported to favor CD8 terminal differentiation78, were upregulated in CD8 Tn of iPD vs HC (Supplementary Fig. 7E, ", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2098}, properties:{annotationPublicationtype:["Research"], evidence:"Our clustering analysis identified two clusters in CD8 Tn (Supplementary Fig. 7G). C0, the main cluster (>95% of CD8 Tn), expressed RUNX2, while C1 expressed the effector molecule CCL5 and more abundantly the other two markers (e.g., FYN and ITGB1/CD29) that are highly expressed in memory CD8 T cells relative to CD8 Tn", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:968}, properties:{annotationPublicationtype:["Research"], evidence:"Our clustering analysis identified two clusters in CD8 Tn (Supplementary Fig. 7G). C0, the main cluster (>95% of CD8 Tn), expressed RUNX2, while C1 expressed the effector molecule CCL5 and more abundantly the other two markers (e.g., FYN and ITGB1/CD29) that are highly expressed in memory CD8 T cells relative to CD8 Tn", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], annotationCell:["central memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2104}, properties:{annotationPublicationtype:["Research"], evidence:"Our clustering analysis identified two clusters in CD8 Tn (Supplementary Fig. 7G). C0, the main cluster (>95% of CD8 Tn), expressed RUNX2, while C1 expressed the effector molecule CCL5 and more abundantly the other two markers (e.g., FYN and ITGB1/CD29) that are highly expressed in memory CD8 T cells relative to CD8 Tn", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], annotationCell:["central memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2105}, properties:{annotationPublicationtype:["Research"], evidence:"Our clustering analysis identified two clusters in CD8 Tn (Supplementary Fig. 7G). C0, the main cluster (>95% of CD8 Tn), expressed RUNX2, while C1 expressed the effector molecule CCL5 and more abundantly the other two markers (e.g., FYN and ITGB1/CD29) that are highly expressed in memory CD8 T cells relative to CD8 Tn", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1"], annotationCell:["central memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2091}, properties:{annotationPublicationtype:["Research"], evidence:"The DEG analysis within different clusters also showed that LEF1 and THEMIS were upregulated in CD8 Tn of iPD vs HC.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationTechnique:["differentially-expressed gene analysis"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2060}, properties:{annotationPublicationtype:["Research"], evidence:"The DEG analysis within different clusters also showed that LEF1 and THEMIS were upregulated in CD8 Tn of iPD vs HC.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationTechnique:["differentially-expressed gene analysis"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2093}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, similar to the scenario in other CD8 subsets, several members of the linker histone H1 family genes showed a substantial increase in both clusters of CD8 Tn, while CNOT6L was still among the most downregulated genes (Supplementary Fig. 7H).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1", "C0"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2094}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, similar to the scenario in other CD8 subsets, several members of the linker histone H1 family genes showed a substantial increase in both clusters of CD8 Tn, while CNOT6L was still among the most downregulated genes (Supplementary Fig. 7H).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1", "C0"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2095}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, similar to the scenario in other CD8 subsets, several members of the linker histone H1 family genes showed a substantial increase in both clusters of CD8 Tn, while CNOT6L was still among the most downregulated genes (Supplementary Fig. 7H).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C1", "C0"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:640}, end: {_id:2118}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Furthermore, exposure of human brain endothelial cells to 10% serum from recovered individuals and individuals with long COVID resulted in the upregulation of ICAM1, VCAM1 and TNF transcripts compared to sera from unaffected individuals.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:2231}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Furthermore, exposure of human brain endothelial cells to 10% serum from recovered individuals and individuals with long COVID resulted in the upregulation of ICAM1, VCAM1 and TNF transcripts compared to sera from unaffected individuals.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:974}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Furthermore, exposure of human brain endothelial cells to 10% serum from recovered individuals and individuals with long COVID resulted in the upregulation of ICAM1, VCAM1 and TNF transcripts compared to sera from unaffected individuals.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:1135}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While each of these microglial states was detectable in both control mice and mice following mild respiratory SARS-CoV-2 infection, post-COVID mice exhibited an increased abundance of the chemokine-enriched microglia (Figure 3B), a small but striking subpopulation of cells characterized by expression of several chemokines and cytokines like Tnf, Il1a, and Il1b (Figures 3C and S4B; Table 3), consistent with an inflammatory reactive response.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1377}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While each of these microglial states was detectable in both control mice and mice following mild respiratory SARS-CoV-2 infection, post-COVID mice exhibited an increased abundance of the chemokine-enriched microglia (Figure 3B), a small but striking subpopulation of cells characterized by expression of several chemokines and cytokines like Tnf, Il1a, and Il1b (Figures 3C and S4B; Table 3), consistent with an inflammatory reactive response.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1379}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While each of these microglial states was detectable in both control mice and mice following mild respiratory SARS-CoV-2 infection, post-COVID mice exhibited an increased abundance of the chemokine-enriched microglia (Figure 3B), a small but striking subpopulation of cells characterized by expression of several chemokines and cytokines like Tnf, Il1a, and Il1b (Figures 3C and S4B; Table 3), consistent with an inflammatory reactive response.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2351}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While each of these microglial states was detectable in both control mice and mice following mild respiratory SARS-CoV-2 infection, post-COVID mice exhibited an increased abundance of the chemokine-enriched microglia (Figure 3B), a small but striking subpopulation of cells characterized by expression of several chemokines and cytokines like Tnf, Il1a, and Il1b (Figures 3C and S4B; Table 3), consistent with an inflammatory reactive response.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2352}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We also found transcriptional changes within the homeostatic microglia cluster in post-COVID mice compared with controls, with increased expression of genes commonly upregulated in inflammation and involved in antigen processing and presentation, like B2m, H2-D1, H2-K1, as well as the cell surface glycoprotein Cd300lf (Figures 3D, 3E, and S4C).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2353}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We also found transcriptional changes within the homeostatic microglia cluster in post-COVID mice compared with controls, with increased expression of genes commonly upregulated in inflammation and involved in antigen processing and presentation, like B2m, H2-D1, H2-K1, as well as the cell surface glycoprotein Cd300lf (Figures 3D, 3E, and S4C).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2354}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We also found transcriptional changes within the homeostatic microglia cluster in post-COVID mice compared with controls, with increased expression of genes commonly upregulated in inflammation and involved in antigen processing and presentation, like B2m, H2-D1, H2-K1, as well as the cell surface glycoprotein Cd300lf (Figures 3D, 3E, and S4C).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2355}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We also found transcriptional changes within the homeostatic microglia cluster in post-COVID mice compared with controls, with increased expression of genes commonly upregulated in inflammation and involved in antigen processing and presentation, like B2m, H2-D1, H2-K1, as well as the cell surface glycoprotein Cd300lf (Figures 3D, 3E, and S4C).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2356}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"The homeostatic microglia cluster in post-COVID mice exhibit downregulation of characteristic microglial genes such as Trem2 and Sall3, as well as Adrb1, a gene known to be downregulated in lipid-droplet-accumulating microglia (LDAM) in aging white matter (Marschallinger et al., 2020; Figure 3E).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2357}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"The homeostatic microglia cluster in post-COVID mice exhibit downregulation of characteristic microglial genes such as Trem2 and Sall3, as well as Adrb1, a gene known to be downregulated in lipid-droplet-accumulating microglia (LDAM) in aging white matter (Marschallinger et al., 2020; Figure 3E).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2358}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"The homeostatic microglia cluster in post-COVID mice exhibit downregulation of characteristic microglial genes such as Trem2 and Sall3, as well as Adrb1, a gene known to be downregulated in lipid-droplet-accumulating microglia (LDAM) in aging white matter (Marschallinger et al., 2020; Figure 3E).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["Microglia", "White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["Single-cell RNA sequencing"], annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:466}, end: {_id:473}, properties:{annotationPublicationtype:["Review"], evidence:"Potential roles for this protein are in preventing protein aggregation and/or promoting mitophagy [167–169]. Parkin has also been suggested to function as a transcription factor, regulating p53 expression [170] independent of its ligase activity", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:453}, end: {_id:1858}, properties:{annotationPublicationtype:["Review"], evidence:"For instance, leucine-rich repeated kinase 2 (LRRK2), which regulates Rab-GTPases and is involved in endolysosomal regulation, has a strong relation to the innate immune system (reviewed in [13,14]).", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:2246}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, we and others have shown that glycoprotein A repetitions predominant [GARP, also known as leucine-rich repeat protein 32 (LRRC32)] is important for the suppressor function and the regulation of FOXP3 expression in human Tregs.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:15}, end: {_id:160}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:15}, end: {_id:161}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:176}, end: {_id:177}, properties:{annotationPublicationtype:["Review"], evidence:"Central to the innate immune network are microglia (Perry 2011). They secrete both anti- and proinflammatory cytokines and chemokines together with other factors that regulate not only adaptive immunity, but also neural function and neural homeostasis.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:176}, end: {_id:179}, properties:{annotationPublicationtype:["Review"], evidence:"Central to the innate immune network are microglia (Perry 2011). They secrete both anti- and proinflammatory cytokines and chemokines together with other factors that regulate not only adaptive immunity, but also neural function and neural homeostasis.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:15}, end: {_id:187}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:15}, end: {_id:161}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:188}, end: {_id:187}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:188}, end: {_id:161}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:206}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:177}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia and monocytes in PD brains and CFS secrete proinflammatory and neurotoxic cytokines and chemokines that disrupt the BBB and attract lymphocytes to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid", "Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:236}, end: {_id:179}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia and monocytes in PD brains and CFS secrete proinflammatory and neurotoxic cytokines and chemokines that disrupt the BBB and attract lymphocytes to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid", "Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:16}, end: {_id:600}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia have also been shown to induce astrocytes to release neurotoxic mediators, leading to further neuronal damage.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", annotationAnatomy:["skeletal muscle tissue"], citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:142}, end: {_id:177}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:142}, end: {_id:179}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:1454}, end: {_id:177}, properties:{annotationPublicationtype:["Review"], evidence:"In fact, α-syn fibrils are able to induce the TLR2-NFkB signaling pathway in glial cells, resulting in microglia activation and release of proinflammatory cytokines [119, 120].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationProteinType:["fibril"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:4}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Raised levels of proinflammatory cytokines and inducible nitric oxide synthase have also been detected in these brain regions, providing evidence of a local inflammatory reaction", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:104}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Raised levels of proinflammatory cytokines and inducible nitric oxide synthase have also been detected in these brain regions, providing evidence of a local inflammatory reaction", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:178}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"Central to the innate immune network are microglia (Perry 2011). They secrete both anti- and proinflammatory cytokines and chemokines together with other factors that regulate not only adaptive immunity, but also neural function and neural homeostasis.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:4}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"Central to the innate immune network are microglia (Perry 2011). They secrete both anti- and proinflammatory cytokines and chemokines together with other factors that regulate not only adaptive immunity, but also neural function and neural homeostasis.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:178}, end: {_id:181}, properties:{annotationPublicationtype:["Review"], evidence:"Central to the innate immune network are microglia (Perry 2011). They secrete both anti- and proinflammatory cytokines and chemokines together with other factors that regulate not only adaptive immunity, but also neural function and neural homeostasis.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:4}, end: {_id:181}, properties:{annotationPublicationtype:["Review"], evidence:"Central to the innate immune network are microglia (Perry 2011). They secrete both anti- and proinflammatory cytokines and chemokines together with other factors that regulate not only adaptive immunity, but also neural function and neural homeostasis.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:286}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, Treg control microglia function by suppressing reactive oxygen species production and NFκB activation via mechanisms that modulate redox enzymes, cell migration, and phagocytosis .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:329}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, Treg control microglia function by suppressing reactive oxygen species production and NFκB activation via mechanisms that modulate redox enzymes, cell migration, and phagocytosis .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:330}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, Treg control microglia function by suppressing reactive oxygen species production and NFκB activation via mechanisms that modulate redox enzymes, cell migration, and phagocytosis .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:119}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, Treg control microglia function by suppressing reactive oxygen species production and NFκB activation via mechanisms that modulate redox enzymes, cell migration, and phagocytosis .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:563}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Metabolites secreted from gut bacteria that have been proposed to impact glial biology and neuroinflammation include short chain fatty acids and tryptophan metabolites [18].Microbiome metabolites have been shown to induce microglia activation and motor deficits in α-synuclein transgenic mice.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["α-synuclein transgenic mice"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:564}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Metabolites secreted from gut bacteria that have been proposed to impact glial biology and neuroinflammation include short chain fatty acids and tryptophan metabolites [18].Microbiome metabolites have been shown to induce microglia activation and motor deficits in α-synuclein transgenic mice.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["α-synuclein transgenic mice"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:564}, end: {_id:1335}, properties:{annotationPublicationtype:["Review"], evidence:"Other products of microbial metabolism, such as short-chain fatty acids (SCFAs), tryptophan metabolites and the amyloid curli, can have an impact of neuronal activity and modulate neuroinflammation [36–38].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:564}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Other products of microbial metabolism, such as short-chain fatty acids (SCFAs), tryptophan metabolites and the amyloid curli, can have an impact of neuronal activity and modulate neuroinflammation [36–38].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:195}, end: {_id:1355}, properties:{annotationPublicationtype:["Review"], evidence:"While at rest, they are involved in synaptic pruning and remodeling thereby regulating brain connectivity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:195}, end: {_id:1356}, properties:{annotationPublicationtype:["Review"], evidence:"While at rest, they are involved in synaptic pruning and remodeling thereby regulating brain connectivity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:729}, end: {_id:1853}, properties:{annotationPublicationtype:["Review"], evidence:"The reduction in myelinating oligodendrocytes causes loss of myelin and, ultimately, alters cognitive function and neural circuit dynamics (Steadman et al., 2020).", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:2235}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Dendritic cells (DCs) are the key antigen presenting cells (APCs) within the CNS. Since the first discovery of DCs in the CNS,28 they have been considered as major players in the development and maintenance of CNS inflammation.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:1583}, end: {_id:2237}, properties:{annotationPublicationtype:["Review"], evidence:"Under healthy conditions, astrocytes serve as supporters of normal neuronal functioning. Similar to microglia, activated astrocytes respond to various harmful conditions, including inflammation, stroke, brain tumors, and neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2303}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, treatment with erythropoietin modulates the immune balance in both the peripheral nervous system and the inflamed spinal cord by promoting the expansion of Tregs, by inhibiting Th17 polarization, and by abrogating proliferation of the antigenpresenting DCs in EAE (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Encephalomyelitis, Autoimmune, Experimental"], annotationMeshanatomy:["Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1017}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, a relative deficiency in ADAMTS13 activity was previously described in inflammatory conditions with high levels of IL-6, as found in patients with SARS-CoV-2 infection64. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:2160}, properties:{annotationPublicationtype:["Research"], evidence:"The density of NM-containing and TH-immunoreactive neurons was decreased in COVID-19 and PD(D) brain donors compared with age-matched controls (NM+: −58%, p = 0.008% and −71%, p < 0.001, respectively; TH+: −44%, p = 0.035; −64%, p < 0.002). The percentage area of TH-immunoreactivity threads was also decreased in COVID-19 and PD(D) donors (TH+ −55%, p = 0.006; 60%, p = 0.006, respectively) (cohort 2, Figures 7G and 7H).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:67}, end: {_id:2160}, properties:{annotationPublicationtype:["Research"], evidence:"The density of NM-containing and TH-immunoreactive neurons was decreased in COVID-19 and PD(D) brain donors compared with age-matched controls (NM+: −58%, p = 0.008% and −71%, p < 0.001, respectively; TH+: −44%, p = 0.035; −64%, p < 0.002). The percentage area of TH-immunoreactivity threads was also decreased in COVID-19 and PD(D) donors (TH+ −55%, p = 0.006; 60%, p = 0.006, respectively) (cohort 2, Figures 7G and 7H).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:22}, end: {_id:20}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:22}, end: {_id:21}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:98}, end: {_id:97}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:98}, end: {_id:95}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:98}, end: {_id:21}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:225}, end: {_id:224}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:254}, end: {_id:97}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:255}, end: {_id:97}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:423}, end: {_id:266}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:423}, end: {_id:422}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:488}, end: {_id:486}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:488}, end: {_id:487}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:490}, end: {_id:486}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:490}, end: {_id:489}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:523}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:524}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:527}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:530}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:532}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:610}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:615}, end: {_id:614}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:615}, end: {_id:603}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:617}, end: {_id:612}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:624}, end: {_id:601}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:625}, end: {_id:607}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:632}, end: {_id:146}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:633}, end: {_id:243}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:776}, end: {_id:775}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1032}, end: {_id:1031}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1035}, end: {_id:1034}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1048}, end: {_id:1047}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1052}, end: {_id:1047}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1079}, end: {_id:607}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1084}, end: {_id:1081}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1084}, end: {_id:1083}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1093}, end: {_id:607}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1093}, end: {_id:1090}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1106}, end: {_id:1098}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1107}, end: {_id:1101}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1108}, end: {_id:1104}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:1268}, end: {_id:896}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1269}, end: {_id:775}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1269}, end: {_id:896}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1272}, end: {_id:1264}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1387}, end: {_id:1384}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1387}, end: {_id:1386}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1441}, end: {_id:1436}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1441}, end: {_id:1196}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1447}, end: {_id:1445}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1447}, end: {_id:1446}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1792}, end: {_id:1791}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1792}, end: {_id:1790}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2248}, end: {_id:2246}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2248}, end: {_id:196}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2269}, end: {_id:2268}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2281}, end: {_id:2279}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2281}, end: {_id:2280}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2324}, end: {_id:2321}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2324}, end: {_id:2322}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2324}, end: {_id:2323}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:1683}, end: {_id:1684}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the MX1 gene displayed the highest log fold change in expression (.6-fold), which was accompanied by a 25% decline in promoter methylation. ISG20 and ZCCHC3 also became hypomethylated at their promoters during SARS-CoV-2 infection.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1623}, end: {_id:1685}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the MX1 gene displayed the highest log fold change in expression (.6-fold), which was accompanied by a 25% decline in promoter methylation. ISG20 and ZCCHC3 also became hypomethylated at their promoters during SARS-CoV-2 infection.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1623}, end: {_id:1686}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the MX1 gene displayed the highest log fold change in expression (.6-fold), which was accompanied by a 25% decline in promoter methylation. ISG20 and ZCCHC3 also became hypomethylated at their promoters during SARS-CoV-2 infection.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1189}, end: {_id:1176}, properties:{annotationPublicationtype:["Research"], evidence:"In keeping with the central role of Q in the recognition sequence, the mutation p.Gln231Ala in the human NEMO sequence prevented cleavage by Mpro at this site (Fig. 3f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1189}, end: {_id:1178}, properties:{annotationPublicationtype:["Research"], evidence:"In keeping with the central role of Q in the recognition sequence, the mutation p.Gln231Ala in the human NEMO sequence prevented cleavage by Mpro at this site (Fig. 3f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["mass spectrometry"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1227}, properties:{annotationPublicationtype:["Research"], evidence:"NEMO deficiency led to interruptions and the disintegration of occludin-positive tight junctions, which was prevented by RIPK3 deficiency (Fig. 6e).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1227}, properties:{annotationPublicationtype:["Research"], evidence:"RIPK3 deficiency did not counteract the effect of NEMO ablation on IgG transcytosis (Fig. 6f). Therefore, we conclude that RIPK3 deficiency improves the BBB tightness of NemobeKO mice mainly by preventing endothelial cell death and rescuing tight junctions.", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1369}, end: {_id:1373}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:145}, end: {_id:144}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:210}, end: {_id:151}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:684}, end: {_id:728}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:879}, end: {_id:881}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2412}, end: {_id:926}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2412}, end: {_id:928}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2412}, end: {_id:930}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:942}, end: {_id:937}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:942}, end: {_id:939}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:942}, end: {_id:941}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:684}, end: {_id:1127}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1460}, end: {_id:1468}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:684}, end: {_id:1477}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:258}, end: {_id:1713}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:258}, end: {_id:1714}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:258}, end: {_id:1715}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:257}, end: {_id:1716}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:257}, end: {_id:1717}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:257}, end: {_id:1718}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2415}, end: {_id:1719}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_LOCATED_ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:2415}, end: {_id:1720}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2415}, end: {_id:1721}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1760}, end: {_id:1754}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:194}, end: {_id:1827}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2272}, end: {_id:2271}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:283}, end: {_id:2283}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2424}, end: {_id:2393}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_LOCATED_ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:77}, end: {_id:79}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:81}, end: {_id:79}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:7}, end: {_id:111}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to widespread apoptosis, evidence is accumulating that synaptic loss is also prominent in neurodegenerative diseases such as AD", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:159}, end: {_id:164}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:10}, end: {_id:190}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], annotationCell:["brain microvascular endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:14}, end: {_id:190}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, innate immunity regulates lymphocyte infiltration into the CNS. Cytokines, such as IL-1β and TNF-α, secreted by activated glia or endothelial cells increase BBB permeability (Desai et al. 2007), and the expression of cellular adhesion molecules (such as E-selectin) on microvascular endothelial cells are up-regulated (Wong et al. 1999), together increase permeability of the BBB and increase homing, extravasation, and activation of lymphocytes.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], annotationCell:["brain microvascular endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1387}, end: {_id:1370}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:79}, end: {_id:78}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:88}, end: {_id:87}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:111}, end: {_id:110}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:232}, end: {_id:231}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:250}, end: {_id:210}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:908}, end: {_id:907}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1139}, end: {_id:1138}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1244}, end: {_id:1243}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2259}, end: {_id:1915}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:23}, end: {_id:170}, properties:{annotationPublicationtype:["Review"], evidence:"The engagement of TLRs leads to translocation of nuclear factor-κ light-chain enhancer of activated B cells (NF-κB) and AP-1 to the nucleus where they induce transcription of a broad range of innate immune proteins.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:423}, end: {_id:198}, properties:{annotationPublicationtype:["Review"], evidence:"Impaired FasL-Fas interactions result in unchecked T cell activation and proliferation. An extreme example manifests itself in autoimmune lymphoproliferative syndrome caused by unchecked T cell proliferation [113].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:423}, end: {_id:424}, properties:{annotationPublicationtype:["Review"], evidence:"Impaired FasL-Fas interactions result in unchecked T cell activation and proliferation. An extreme example manifests itself in autoimmune lymphoproliferative syndrome caused by unchecked T cell proliferation [113].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1337}, end: {_id:1335}, properties:{annotationPublicationtype:["Review"], evidence:"Other products of microbial metabolism, such as short-chain fatty acids (SCFAs), tryptophan metabolites and the amyloid curli, can have an impact of neuronal activity and modulate neuroinflammation [36–38].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1347}, end: {_id:1348}, properties:{annotationPublicationtype:["Review"], evidence:"To this regard, it is worth noting that GABA receptors have been found not only in the CNS but also in the ENS, where they could transduce signals regulating gastric motility and secretion.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Enteric Nervous System", "Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1347}, end: {_id:1349}, properties:{annotationPublicationtype:["Review"], evidence:"To this regard, it is worth noting that GABA receptors have been found not only in the CNS but also in the ENS, where they could transduce signals regulating gastric motility and secretion.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Enteric Nervous System", "Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1441}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, DJ-1 was shown to suppress NFkB signaling by directly interacting with its p65 subunit [110] and to mitigate inflammation mediated by the STING pathway", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:1441}, end: {_id:1420}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, DJ-1 was shown to suppress NFkB signaling by directly interacting with its p65 subunit [110] and to mitigate inflammation mediated by the STING pathway", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:616}, end: {_id:603}, properties:{annotationPublicationtype:["Research"], evidence:"ThT fluorescence studies quantitatively showed that SDCs, especially SDC3 and SDC4 significantly (p<0.05) facilitate the fibrillation of Aβ1–42 (Fig. 2a).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:616}, end: {_id:603}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells with relatively low surface HS expression, SDC3 and SDC4 induce the fibrillation of Aβ1–42 even after 1h of incubation, as shown by increased ThT fluorescence of Aβ1–42-treated SDC3 and 4 transfectants.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["fluorescent labeling method"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:616}, end: {_id:603}, properties:{annotationPublicationtype:["Research"], evidence:"Simultaneous scanning electron microscopy studies also confirmed the fibrillation triggering effect of SDCs - especially SDC3 and SDC4 - on surface attached Aβ1–42 (Fig. 2b).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours", "6 hours", "1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:616}, end: {_id:603}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy also showed increased number of fibrillar Aβ1–42 assemblies on SDC3 and SDC4 overexpressing cells, even after 1h incubation.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["1 hour"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy", "fluorescent labeling method"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:616}, end: {_id:603}, properties:{annotationPublicationtype:["Research"], evidence:"Scanning electron microscopy studies also confirmed the inhibitory effect of undersulfation as fibrillary assemblies of Aβ1–42 were reduced due to NaClO3 treatment (Fig. 6d).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:616}, end: {_id:603}, properties:{annotationPublicationtype:["Research"], evidence:"In SH-SY5Y cells, SDC3 overexpression resulted in increased HS expression, along with increased cellular uptake and fibrillation of Aβ1–42 (Fig. 8a–e).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy", "flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"30718543"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:52}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Mitochondria are induced to produce more ROS by TNF-a via a second messenger component(s), perhaps a membrane component, such as arachidonate [80] or ceramide [81].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:53}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Mitochondria are induced to produce more ROS by TNF-a via a second messenger component(s), perhaps a membrane component, such as arachidonate [80] or ceramide [81].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:1344}, end: {_id:149}, properties:{annotationPublicationtype:["Review"], evidence:"In support of these observations, transplantation of fecal microbiota from healthy donors as well as butyrate supplementation improved dopamine deficiency and motor impairment in different animal models of PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1338}, end: {_id:149}, properties:{annotationPublicationtype:["Review"], evidence:"In support of these observations, transplantation of fecal microbiota from healthy donors as well as butyrate supplementation improved dopamine deficiency and motor impairment in different animal models of PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:789}, end: {_id:57}, properties:{annotationPublicationtype:["Research"], evidence:"The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict OSTOX, increased NO production, and decreased Gpx and ANTIOX, whereas increased PBT levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID’s increased OSTOX/ANTIOX ratio.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:319}, end: {_id:1734}, properties:{annotationPublicationtype:["Research"], evidence:"We also found a positive correlation between medullary microgliosis and hospitalization time, as described in detail in the following paragraphs (Fig. 5f).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:1734}, end: {_id:195}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, in the COVID-19 cohort hospitalization time was positively correlated to microglial density in the medulla (r = 0.44; p = 0.044), but not with microglial density in the pons and midbrain (Fig. 5f).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36781876"}}, {start: {_id:1887}, end: {_id:1003}, properties:{annotationPublicationtype:["Review"], evidence:"Those with a high risk showed higher neutrophil and lower (CD4+) lymphocyte fractions compared with those with a low risk.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:257}, end: {_id:1892}, properties:{annotationPublicationtype:["Review"], evidence:"Another study confirmed the decrease in naïve CD8 T cells and the increase in late-differentiated CD4 T cells during PD [108]. Naïve CD8 T cells in blood were positively correlated with the severity of autonomic dysfunction and psychiatric complications, and negatively with the severity of RBD [108].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:4}, properties:{annotationPublicationtype:["Review"], evidence:"Among earlier observations that stand out as pointing toward the need to consider inflammatory processes as important include: (1) Colton's demonstrations that cytokine-activated microglia produce ROS [3,4]; (2) that, in contrast to normal brain, proinflammatory cytokines are prevalent in Alzheimer's brains [5–7]; (3) the early indications that anti-inflammatory therapeutics may delay on-set of Alzheimer's disease [8]; and (4) the early demonstrations that complement and classic markers of immune-mediated damage are expressed in neurodegenerative brains [9,10].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:30}, properties:{annotationPublicationtype:["Review"], evidence:"They cite many studies that have shown that several markers of inflammation (major histocompatibility complex, acute phase reactants, complement proteins, cytokines, etc.) have been shown to be significantly increased in the Alzheimer's brain but importantly in most cases the complimentary anti-inflammatory component is also increasingly present [14].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:31}, properties:{annotationPublicationtype:["Review"], evidence:"They cite many studies that have shown that several markers of inflammation (major histocompatibility complex, acute phase reactants, complement proteins, cytokines, etc.) have been shown to be significantly increased in the Alzheimer's brain but importantly in most cases the complimentary anti-inflammatory component is also increasingly present [14].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:4}, properties:{annotationPublicationtype:["Review"], evidence:"They cite many studies that have shown that several markers of inflammation (major histocompatibility complex, acute phase reactants, complement proteins, cytokines, etc.) have been shown to be significantly increased in the Alzheimer's brain but importantly in most cases the complimentary anti-inflammatory component is also increasingly present [14].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:0}, end: {_id:4}, properties:{annotationPublicationtype:["Review"], evidence:"Head trauma is also known to cause the induction of a large amount of cytokines [70].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:49}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, an acute injury will bring on much higher levels of ROS, cytokines, and toxic gene products than that normally noted in the chronic condition; but in the acute condition these levels will soon drop back to background levels.However, in the chronic condition, the levels are not as high but are continuously present and keep building slowly with time", annotationDiseaseCondition:["acute"], citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:49}, end: {_id:4}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, an acute injury will bring on much higher levels of ROS, cytokines, and toxic gene products than that normally noted in the chronic condition; but in the acute condition these levels will soon drop back to background levels.However, in the chronic condition, the levels are not as high but are continuously present and keep building slowly with time", annotationDiseaseCondition:["acute"], citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:50}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, an acute injury will bring on much higher levels of ROS, cytokines, and toxic gene products than that normally noted in the chronic condition; but in the acute condition these levels will soon drop back to background levels.However, in the chronic condition, the levels are not as high but are continuously present and keep building slowly with time", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:50}, end: {_id:4}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, an acute injury will bring on much higher levels of ROS, cytokines, and toxic gene products than that normally noted in the chronic condition; but in the acute condition these levels will soon drop back to background levels.However, in the chronic condition, the levels are not as high but are continuously present and keep building slowly with time", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:67}, end: {_id:68}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to forming peroxynitrite, nitric oxide will also become oxidized to form nitrite; and even though it is less direct proof, significantly elevated levels of nitrite in cerebrospinal fluid has been found in patients having Parkinson's disease [99], although see Kupier et al. [100], as well as those having AIDS dementia [101].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:18}, end: {_id:68}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to forming peroxynitrite, nitric oxide will also become oxidized to form nitrite; and even though it is less direct proof, significantly elevated levels of nitrite in cerebrospinal fluid has been found in patients having Parkinson's disease [99], although see Kupier et al. [100], as well as those having AIDS dementia [101].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Acquired Immunodeficiency Syndrome"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:67}, end: {_id:4}, properties:{annotationPublicationtype:["Review"], evidence:"Raised levels of proinflammatory cytokines and inducible nitric oxide synthase have also been detected in these brain regions, providing evidence of a local inflammatory reaction", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:67}, end: {_id:104}, properties:{annotationPublicationtype:["Review"], evidence:"Raised levels of proinflammatory cytokines and inducible nitric oxide synthase have also been detected in these brain regions, providing evidence of a local inflammatory reaction", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:67}, end: {_id:242}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:244}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:245}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to a variety of antibodies directed against globally expressed tissue antigens such as heat shock protein (HSP)-65 and HSP-70 (Fiszer et al. 1996), PD patients also show brain-associated autoantibodies including those directed against, GM1, S100B, glial fibrillar acidic protein (GFAP), NGF, neurofilament, myelin basic protein, tau, Aβ, and neuronal calcium channels, as well as α-syn and its modified and fibriliary forms.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:145}, properties:{annotationPublicationtype:["Review"], evidence:"In PD patients, approximately 4% of the pigmented neurons contained Lewy bodies and all pigmented, Lewy body-containing neurons showed detectable IgG and α-syn within inclusions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:231}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, levels of antibodies to α-syn and catecholamine-derived melanin (neuromelanin) are increased in PD patients with antineuromelanin immunoglobulin binding shown to be more active in early disease.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:276}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to T cells that express α and β chains of the T-cell receptor (TCRαβ+ T cells), elevated frequencies of T-cell populations expressing γ and δ chains of the T-cell receptor (TCRγδ+T cells) also have been found in the CSF of PD patients (Fiszer et al. 1994b) and are thought to play a regulatory role in CNS inflammation.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:277}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to T cells that express α and β chains of the T-cell receptor (TCRαβ+ T cells), elevated frequencies of T-cell populations expressing γ and δ chains of the T-cell receptor (TCRγδ+T cells) also have been found in the CSF of PD patients (Fiszer et al. 1994b) and are thought to play a regulatory role in CNS inflammation.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:145}, properties:{annotationPublicationtype:["Review"], evidence:"During disease, dopaminergic neurons accumulate α-synuclein together with other misfolded proteins seen as intracellular Lewy body inclusions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:696}, end: {_id:729}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis is a syndrome of multifocal demyelination, typically occurring weeks after an infection, which generally presents with focal neurological symptoms, often with encephalopathy.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:752}, properties:{annotationPublicationtype:["Review"], evidence:"Two patients had the Miller Fisher variant of Guillain-Barré syndrome, with ophthalmoplegia, ataxia, and areflexia;46, 47 one also had loss of smell and taste, and was positive for anti-GD1b-IgG. One patient had bilateral and one patient unilateral abducens palsy,46, 47 and another had an acute vestibular syndrome with horizontal nystagmus and oscillopsia.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:683}, properties:{annotationPublicationtype:["Review"], evidence:"Endothelial cells of lung blood vessels can be activated by the high levels of pro-inflammatory cytokines (IL-1, IL-6 and TNF) and ferritin in severe COVID-19 (ref.60).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:67}, end: {_id:556}, properties:{annotationPublicationtype:["Review"], evidence:"In parallel, we and others recently reported increased levels of Lactobacillus, Christensenella and Akkermansia in stool samples from PD patients", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1346}, properties:{annotationPublicationtype:["Review"], evidence:"In parallel, we and others recently reported increased levels of Lactobacillus, Christensenella and Akkermansia in stool samples from PD patients", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:557}, properties:{annotationPublicationtype:["Review"], evidence:"In parallel, we and others recently reported increased levels of Lactobacillus, Christensenella and Akkermansia in stool samples from PD patients", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:558}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, our study also highlighted a higher abundance of Bifidobacteria but only in constipated PD cases, thus suggesting a link between microbiota composition and intestinal non-motor symptoms in PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Constipation"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1351}, properties:{annotationPublicationtype:["Review"], evidence:"Of note, also pathogens that belong to the families Enterococcaceae and Enterobacteriacee significantly increased in fecal samples from PD patients, and this positively correlated with disease duration and severity [44, 45].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1352}, properties:{annotationPublicationtype:["Review"], evidence:"Of note, also pathogens that belong to the families Enterococcaceae and Enterobacteriacee significantly increased in fecal samples from PD patients, and this positively correlated with disease duration and severity [44, 45].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:319}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, microgliosis is a typical histopathological hallmark of PD that was discovered as early as in 1988", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:319}, properties:{annotationPublicationtype:["Review"], evidence:"In support of the latter hypothesis, PET studies using the 11C-(R)-PK11195 ligand that specifically binds to active microglia revealed that microgliosis can be observed during the early stages of the disease", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["early onset"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:640}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Strikingly, we observed abundant infection in astrocytes, as indicated by the presence of viral N protein, S RNA, and dsRNA, with 90% of infected cells expressing glial fibrillary acidic protein (GFAP) or Aquaporin 4 (AQP4) throughout the outer subventricular zone (SVZ) of primary cortical tissue (Fig. 1B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1477}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Astrocytes adjacent to infected vasculature were also frequently infected (SI Appendix, Fig. 2D), suggesting a potential hematologic means of viral spread in the cortex.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"35858406", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1477}, properties:{annotationCellCulture:["human stem cell derived cortical organoid cultures"], annotationPublicationtype:["Research"], evidence:"Together, experiments utilizing primary and organoid cortical cultures suggest SARS-CoV-2 can readily infect, replicate, and propagate in astrocytes in the developing human cortex.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We investigated the impact of SARS-CoV-2 on cellular stress by evaluating the abundance of endoplasmic reticulum stress and the unfolded protein response gene ARCN1. ARCN1 is lowly expressed in developing human cortex tissue, but after infection by SARS-CoV-2, we found a 15% increase in expression, exclusively in infected cells coexpressing dsRNA.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We exposed the CD147- or DPP4-expressing organoids to SARS-CoV-2 for 2 h. We observed a significant increase in SARS-CoV-2 N+ cells with DPP4 overexpression and an increase in dsRNA+ cells in both DPP4- and CD147-overexpressing conditions (SI Appendix, Fig. 13C). Taken together with the loss of function and inhibition studies, these findings indicate that DPP4 and CD147 are sufficient to mediate SARS-CoV-2 infection and suggest that DPP4 may promote viral entry, while CD147 may promote viral replication.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1566}, end: {_id:57}, properties:{annotationPublicationtype:["Research"], evidence:"We found that 23.0% of the variance in the somatic HAMD score (regression #2) was explained by the cumulative effects of lowered Gpx and zinc, increased NO and CRP and vaccination with AstraZeneca or Pfizer.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1704}, properties:{annotationPublicationtype:["Research"], evidence:"Diabetic nephropathy and steatohepatitis were observed in ten cases (23%) and five cases (12%), respectively.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36517603"}}, {start: {_id:67}, end: {_id:1003}, properties:{annotationPublicationtype:["Review"], evidence:"Those with a high risk showed higher neutrophil and lower (CD4+) lymphocyte fractions compared with those with a low risk.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:1909}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, autoantibodies against the neuroprotective compound stress-inducible phosphoprotein-1 (STIP1) and specific B cell STIP1 epitopes have been reported in PD [129].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:2038}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, another cytotoxic cell type, natural killer T cells (NKT) also exhibited a late-differentiated state, as reflected by an increased frequency of CD8+ NKT (Fig. 1h), among total NKT26, especially in women.", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationTechnique:["Cytometry by Time of Flight (CyTOF)"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2066}, properties:{annotationPublicationtype:["Research"], evidence:"Several MHC type II molecules (e.g., HLA-DRB1, HLA-DQA1 and HLA-DQB1), known CD8 T-cell activation markers as well as another NK cytotoxic effector molecule (KLRD1) and leukocyte transendothelial migration and adhesion molecules (ITGB2 and ITGAL) were upregulated in C0 and, to a lesser extent in C1, of CD8 TEMRA (Fig. 6p). Together, these scRNA-seq data support that the cytotoxic pathways are enhanced in CD8 TEMRA from early-to-mid stage iPD vs HC. Similar pathways enriched for the upregulated genes in iPD vs HC were observed in CD8 TEM (Supplementary Fig. 6G–I).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCluster:["C0"], annotationCell:["effector memory CD8-positive, alpha-beta T cell, terminally differentiated"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:1146}, end: {_id:194}, properties:{annotationPublicationtype:["Research"], evidence:"The presence of T-B lymphocytes as a whole (sum of scores) was similar in the lungs and kidneys (Figure 2A; Table 3), albeit with a significantly greater presence of T lymphocytes in the lungs (p = 0.020; Figure 2B).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:443}, end: {_id:444}, properties:{annotationPublicationtype:["Review"], evidence:"However, germ-line mutant LRRK2 transgenic mice do not completely replicate PD-like phenotypes or show spontaneous DA neuron degeneration [154-157]. However, these mouse models do show behavioral alterations and impaired dopamine release in the nigrostriatal system.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["nigrostriatal tract"], citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:466}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"However, Parkin-deficient animals have interesting inflammation-related phenotypes, suggesting that inflammatory stimuli could be this secondary insult.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:823}, end: {_id:822}, properties:{annotationPublicationtype:["Research"], evidence:"These cultures exhibit neuronal outgrowths as long-range axonal fibers expressing mature neuronal markers of MAP2, Tau, synapsin-1, and PSD95.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:243}, end: {_id:822}, properties:{annotationPublicationtype:["Research"], evidence:"These cultures exhibit neuronal outgrowths as long-range axonal fibers expressing mature neuronal markers of MAP2, Tau, synapsin-1, and PSD95.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:824}, end: {_id:822}, properties:{annotationPublicationtype:["Research"], evidence:"These cultures exhibit neuronal outgrowths as long-range axonal fibers expressing mature neuronal markers of MAP2, Tau, synapsin-1, and PSD95.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:825}, end: {_id:822}, properties:{annotationPublicationtype:["Research"], evidence:"These cultures exhibit neuronal outgrowths as long-range axonal fibers expressing mature neuronal markers of MAP2, Tau, synapsin-1, and PSD95.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:325}, end: {_id:833}, properties:{annotationPublicationtype:["Research"], evidence:"Staining for SARS-CoV-2-positive cells revealed that most of the virus-positive cells were TUNEL-positive. Besides, we also noticed that some SARS-CoV-2-positive cells were also positive for caspase-3, a protease that specifies programmed cell death.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["Terminal deoxynucleotidyl transferase dUTP nick end labeling"], citationRef:"32876341"}}, {start: {_id:453}, end: {_id:170}, properties:{annotationPublicationtype:["Review"], evidence:"For instance, leucine-rich repeated kinase 2 (LRRK2), which regulates Rab-GTPases and is involved in endolysosomal regulation, has a strong relation to the innate immune system (reviewed in [13,14]).", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:582}, end: {_id:1862}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 or Parkin deficiency in myeloid cells (macrophages/microglia) enhances the NLRP3 inflammasome response [25]. Moreover, PINK1 has been associated with the function of regulatory T cells (Tregs) [26] and the antiviral response in macrophages [27].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Macrophages"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:582}, end: {_id:1490}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 or Parkin deficiency in myeloid cells (macrophages/microglia) enhances the NLRP3 inflammasome response [25]. Moreover, PINK1 has been associated with the function of regulatory T cells (Tregs) [26] and the antiviral response in macrophages [27].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Macrophages"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1109}, end: {_id:2029}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:2030}, end: {_id:2029}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:2031}, end: {_id:2029}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:2184}, end: {_id:770}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2164}, end: {_id:770}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2185}, end: {_id:1026}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2186}, end: {_id:1026}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2187}, end: {_id:1026}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1018}, end: {_id:2188}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2189}, end: {_id:2188}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:35}, end: {_id:2188}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Next, we performed gene ontology (GO) analysis. In the recovered cohort and the cohort without brain fog, upregulated terms included those related to the coagulation system, such as blood coagulation (for example, F13A1, PROS1), platelet activation (for example, F2R, PF4, PF4V1), platelet degranulation (for example, SELP, VCL, CLU) as well as megakaryocyte development, immunoglobulin production and complement activation (Extended Data Fig. 7d,e and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2333}, end: {_id:2334}, properties:{annotationPublicationtype:["Research"], evidence:"Among the host genes examined, ACTR2 (endosomal entry), ATP6AP2 (spike protein cleavage, endosomal acidification and processing), ERMP1 (ER), and CHST14 (Golgi) showed higher expression levels in ApoE4 astrocytes than that in ApoE3 astrocytes (Figures 3E and 3F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["gene expression assay", "real-time PCR "], annotationCellline:["AG14048 cell"], citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1402}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin also suppresses inflammation by degrading TRAF2/6 and preventing the activation of NFkB and JNK signaling pathways", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1404}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin also suppresses inflammation by degrading TRAF2/6 and preventing the activation of NFkB and JNK signaling pathways", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:449}, end: {_id:450}, properties:{annotationPublicationtype:["Review"], evidence:"BMDMs from R144C-LRRK2 mutant mice have reduced LC3-II expression, a marker of autophagy [158].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:611}, end: {_id:243}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:243}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:243}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:243}, properties:{annotationPublicationtype:["Research"], evidence:"Thus scanning electron microscopy revealed that the high number of fibrils on the cell surface of fibril-treated cells at the start (i.e. 10 min) of the incubation period was reduced at 3h, suggesting the onset of intense internalization.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["scanning electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:922}, end: {_id:325}, properties:{annotationPublicationtype:["Research"], evidence:"As seen in Table 2, the % of cells with identifiable spike subunit or caspase-3 was significantly less than for the full length S1 subunit (p < 0.001).", annotationPublicationstatus:["Published"], citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationSection:["Results"], annotationCustomCellline:["HUVEC cell line"], annotationConcentration:["70 ng/ ml"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", citationRef:"33360731"}}, {start: {_id:922}, end: {_id:934}, properties:{annotationPublicationtype:["Research"], evidence:"Note the significant decrease in MFSD2a and increase in nNOS in the mice brains exposed to the full length S1 subunit, but not in the other mice (Table 1 and Fig. 4) (p < 0.001).", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["immunohistochemistry"], citationRef:"33360731"}}, {start: {_id:775}, end: {_id:611}, properties:{annotationPublicationtype:["Research"], evidence:"These analyses revealed significantly decreased the expression of all four SDC isoforms (i.e., SDC1–4) in ACE2 overexpressing ACE2-293T cells (Figure 2C,F).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["293T cell overexpressing ACE2"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:775}, end: {_id:608}, properties:{annotationPublicationtype:["Research"], evidence:"These analyses revealed significantly decreased the expression of all four SDC isoforms (i.e., SDC1–4) in ACE2 overexpressing ACE2-293T cells (Figure 2C,F).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["293T cell overexpressing ACE2"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:775}, end: {_id:601}, properties:{annotationPublicationtype:["Research"], evidence:"These analyses revealed significantly decreased the expression of all four SDC isoforms (i.e., SDC1–4) in ACE2 overexpressing ACE2-293T cells (Figure 2C,F).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["293T cell overexpressing ACE2"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:775}, end: {_id:607}, properties:{annotationPublicationtype:["Research"], evidence:"These analyses revealed significantly decreased the expression of all four SDC isoforms (i.e., SDC1–4) in ACE2 overexpressing ACE2-293T cells (Figure 2C,F).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["293T cell overexpressing ACE2"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1436}, end: {_id:1417}, properties:{annotationPublicationtype:["Review"], evidence:"In particular, DJ-1 KO mice display a significant increase in Rikenella and Alistipes, accompanied by higher levels of malonate in stool and serum, and elevated expression of fecal inflammatory proteins calprotectin and MCP-1.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1359}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"All PRKN-positive patients had negative IP/RT-QuIC results. ", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["immunoprecipitation-based real-time quaking-induced conversion"], citationRef:"37248302"}}, {start: {_id:775}, end: {_id:1927}, properties:{annotationPublicationtype:["Research"], evidence:"A ~6-fold increase in the ACE2 expression with a ~30% reduced HS expression in the ACE2-293T cells (Figure 1B,E) resulted in a modestly (yet significantly, i.e., p < 0.01) increased WT SCV2 cellular uptake, an unchanged Delta cellular uptake, and a significantly reduced Omicron cellular uptake, highlightingthe increased importance of HS in the variants, especially for Omicron's cellular entry(Figure 2A–E).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationSection:["Results"], annotationCustomCellline:["ACE2-293T cell"], annotationSarsCov2Variant:["wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:2100}, end: {_id:2101}, properties:{annotationPublicationtype:["Research"], evidence:"Concurrently, RUNX3, known to suppress the expression of both RUNX1 and RUNX2 genes and terminal differentiation79, was slightly reduced in CD8 Tn (Supplementary Fig. 7F).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:2100}, end: {_id:2102}, properties:{annotationPublicationtype:["Research"], evidence:"Concurrently, RUNX3, known to suppress the expression of both RUNX1 and RUNX2 genes and terminal differentiation79, was slightly reduced in CD8 Tn (Supplementary Fig. 7F).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Validation Cohort"], citationRef:"37985656"}}, {start: {_id:2308}, end: {_id:2309}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, midkine, which is also known as neurite-growth-promoting factor 2 in humans and is encoded by the gene for MDK, a heparin-binding growth factor, has been shown to decrease the Treg population in vitro in a dose-dependent manner by suppression of signal transducer and activator of transcription 5 (STAT5) phosphorylation263 (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1337}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Other products of microbial metabolism, such as short-chain fatty acids (SCFAs), tryptophan metabolites and the amyloid curli, can have an impact of neuronal activity and modulate neuroinflammation [36–38].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:283}, end: {_id:331}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, CD4+CD25+CD127lowFOXP3+CD39+ Tregs play an important role in constraining pathogenic Th17 cells and are impaired in MS patients; this in turn leads to an inability to control Th17-mediated neurodegenerative diseases.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2303}, end: {_id:2304}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, treatment with erythropoietin modulates the immune balance in both the peripheral nervous system and the inflamed spinal cord by promoting the expansion of Tregs, by inhibiting Th17 polarization, and by abrogating proliferation of the antigenpresenting DCs in EAE (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Encephalomyelitis, Autoimmune, Experimental"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:4}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"However, it now seems clear that iNOS is expressed in human macrophages and is induced by cytokines [89,90].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], annotationCell:["macrophage"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:6}, end: {_id:218}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, reactive oxygen species produced by activated microglia increases nitration of α-syn and neuronal cell death (Shavali et al. 2006); and in turn, immune T cells that recognize nitrated α-syn (N-α-syn) enhance the neurotoxic activities of microglia in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of nigrostriatal degeneration . Activated T cells and B cells are then able to enter the CNS more readily and migrate to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", annotationDisease:["Parkinson's disease 1"], citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:307}, properties:{annotationPublicationtype:["Review"], evidence:" In the brain, Treg promote neurotrophic support by inducing astrocytes to increase expression of brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) (Benner et al. 2004; Reynolds et al. 2007), and may promote glutamate clearance.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:308}, properties:{annotationPublicationtype:["Review"], evidence:" In the brain, Treg promote neurotrophic support by inducing astrocytes to increase expression of brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) (Benner et al. 2004; Reynolds et al. 2007), and may promote glutamate clearance.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:317}, end: {_id:320}, properties:{annotationPublicationtype:["Review"], evidence:"This study showed that adoptively transferred Treg attenuated microgliosis and astrogliosis, increased expression of BDNF and GDNF expression, and down-regulated proinflammatory cytokines, oxidative stress, and viral replication, whereas effector CD4+ T cells were not therapeutic.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:317}, end: {_id:321}, properties:{annotationPublicationtype:["Review"], evidence:"This study showed that adoptively transferred Treg attenuated microgliosis and astrogliosis, increased expression of BDNF and GDNF expression, and down-regulated proinflammatory cytokines, oxidative stress, and viral replication, whereas effector CD4+ T cells were not therapeutic.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:364}, end: {_id:379}, properties:{annotationPublicationtype:["Review"], evidence:"Endothelial upregulation of ICAM-1 is also present in MPTP-induced rodent and nonhuman primate PD models [55, 56]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:392}, end: {_id:393}, properties:{annotationPublicationtype:["Review"], evidence:"A transient decrease in tyrosine hydroxylase(TH) expression in the SN was also observed [93]. This virus can also induce alpha-synuclein phosphorylation and aggregation [94].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:194}, end: {_id:268}, properties:{annotationPublicationtype:["Review"], evidence:"A more activated, cytotoxic T cell response is suggested by decreased CD4:CD8 ratios and a shift to more IFN−G versus IL-4-producing T cells in PD patients [101–103].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:415}, properties:{annotationPublicationtype:["Review"], evidence:"In this model, these lymphocytes have increased expression of LFA-1, an integrin that binds endothelial adhesion molecules, to allow for diapedesis across the BBB [42].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationCell:["lymphocyte"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:146}, properties:{annotationPublicationtype:["Review"], evidence:"The level of alpha-synuclein protein increases after LPS stimulation of monocytes and lymphocytes [138], suggesting it may have some regulatory role in inflammatory responses.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Monocytes", "Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"In microglia, LRRK2 expression can be detected upon in vivo activation with LPS and is upregulated by ex vivo LPS treatment.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:550}, end: {_id:230}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:552}, end: {_id:230}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:555}, end: {_id:146}, properties:{annotationPublicationtype:["Review"], evidence:"Even common gastrointestinal infections, such as norovirus, induce upregulation of α-synuclein in the gastrointestinal tract, potentially in an effort to rally an immune response.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Our Western blots using anti-ACE2 antibodies recognized ACE2 in organoid extracts only at higher exposure conditions.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["western blot"], source:"wp4-cbm-comorbidity", annotationCustomAnatomy:["induced pluripotent stem cells derived brain organoids"], pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32876341"}}, {start: {_id:684}, end: {_id:834}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, TUNEL-positive cells in un-exposed control organoids (which could be after programmed cell death) did not contain pT231Tau suggesting that this different Tau phosphorylation pattern is associated with SARS-CoV-2 entry (Fig 3Ciii). Thus, it appears that Tau is aberrantly phosphorylated in response to the viral-induced stress, which may elicit further cell death programs that remains to be elucidated.", citationTitle:"EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"32876341", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["Terminal deoxynucleotidyl transferase dUTP nick end labeling"], citationRef:"32876341"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Immunohistology confirmed expression of ACE2 at a much higher level in CPOs than in hippocampal organoids.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Infected cells identified by SARS-CoV-2 nucleoprotein immunostaining also showed high levels of ACE2 expression, consistent with ACE2 being a critical cell entry receptor for SARS-CoV-2 (Figure S3C).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:684}, end: {_id:847}, properties:{annotationPublicationtype:["Research"], evidence:"We validated the upregulation of p38 signaling by immunostaining of the phosphorylated form of p38 in infected cells (Figures S4C and S4D). Interestingly, quantification showed elevated levels of phospho-p38 in nearby uninfected cells, although to a lesser degree than in infected cells, suggesting a substantial non-cell-autonomous effect .", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:891}, properties:{annotationPublicationtype:["Research"], evidence:"Similarly, the co-entry factors TMPRSS2 and TMPRSS4 were most abundant in ChP cells with high levels of lipoprotein expression.", annotationCellType:["lipoprotein-expressing cells"], citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:892}, properties:{annotationPublicationtype:["Research"], evidence:"Similarly, the co-entry factors TMPRSS2 and TMPRSS4 were most abundant in ChP cells with high levels of lipoprotein expression.", annotationCellType:["lipoprotein-expressing cells"], citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"To explore this timing further, and to examine whether protein levels displayed a similar pattern, we performed immunoblotting for both ACE2 and APOJ, an abundant CSF lipoprotein present in various-sized lipoprotein particles (Wang and Eckel, 2014). We could detect both APOJ and ACE2 in ChP organoid lysates with increasing abundance over time.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoblot"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:35}, properties:{annotationPublicationtype:["Research"], evidence:"To explore this timing further, and to examine whether protein levels displayed a similar pattern, we performed immunoblotting for both ACE2 and APOJ, an abundant CSF lipoprotein present in various-sized lipoprotein particles (Wang and Eckel, 2014). We could detect both APOJ and ACE2 in ChP organoid lysates with increasing abundance over time.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoblot"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Next, to validate the observed differences in expression of ACE2 in neuronal and ChP cells, we performed immunostaining of organoids containing cortical (Figure S1D) or ChP identities (Figure 1I). Consistent with scRNA-seq data, the ChP epithelial tissue, marked by the serotonin receptor HTR2C, showed sparse but strong positive signal for ACE2 compared to cortex.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Together, these findings indicate that ACE2 is expressed in cells of the ChP, but no specific expression of ACE2 is present in neuronal progenitors or neurons.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:891}, properties:{annotationPublicationtype:["Research"], evidence:"Expression of TMPRSS2 was also detected by immunostaining in the membrane of ChP epithelial cells from organoids.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:894}, properties:{annotationPublicationtype:["Research"], evidence:"We found enriched expression of DPP4 (dipeptidyl peptidase 4) and ANPEP (alanyl aminopeptidase), which both encode for known receptors of human CoVs (Qi et al., 2020) and were similarly enriched in the lipoprotein-producing subcluster.", annotationCellType:["lipoprotein-expressing cells"], citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"33113348"}}, {start: {_id:684}, end: {_id:895}, properties:{annotationPublicationtype:["Research"], evidence:"We found enriched expression of DPP4 (dipeptidyl peptidase 4) and ANPEP (alanyl aminopeptidase), which both encode for known receptors of human CoVs (Qi et al., 2020) and were similarly enriched in the lipoprotein-producing subcluster.", annotationCellType:["lipoprotein-expressing cells"], citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["bioinformatics method"], annotationDisease:["COVID-19"], citationRef:"33113348"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Further supporting this claim, confocal imaging of infected cells immunostained for ACE2 showed positive signal on the membrane of SARS-CoV-2-infected ChP cells.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Again, this infection matched ACE2 expression, with infected cells co-staining for the receptor (Figure 4A) in the ChP epithelium, whereas stromal cells of the ChP were uninfected (Figure S4A).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:887}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed expression of APOA1 and abundant lipid vesicles in cells of the ChP epithelium infected with SARS-CoV-2 (Figures 4B and 4C), whereas these cells were absent from cortical neuronal regions (Figure S4B).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:1128}, properties:{annotationPublicationtype:["Research"], evidence:"In hamsters, although we did not detect clear SARS-CoV-2-S RNA by FISH, ACE2 can be slightly found in blood vessels, meninges, choroid plexus, and ependyma.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Meninges", "Ependyma", "Blood Vessels", "Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1132}, properties:{annotationPublicationtype:["Research"], evidence:"The expression of Iba1, a marker for microglia, was evidence of microglial cell activation and proliferation in K18-hACE2 mice infected with SARS-CoV-2 (Fig. 2a, b).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationMouseStrain:["K18-hACE2 mice"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1141}, properties:{annotationPublicationtype:["Research"], evidence:"Here, the level of MMP9 expression was remarkably increased in the cerebral vessels compared to mock-treated animals (Fig. 3e, g). These results provide a clue that SARS-CoV-2 infection could damage BBB via MMP9-mediated BMs disruption.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Arteries"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1141}, properties:{annotationHourspostinfection:["48 hours"], annotationPublicationtype:["Research"], evidence:"Moreover, both the mRNA and protein levels of MMP9 were increased in the BMEC BBB models at 48 hpi compared with the mock group (Fig. 5k–m).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1164}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, immunoblots of NEMO in brain lysates of SARS-CoV-2-infected and control patients indicated that NEMO was cleaved in some of the infected patients (Extended Data Fig. 5c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["western blot"], annotationMeshanatomy:["Brain", "Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:115}, end: {_id:1384}, properties:{annotationPublicationtype:["Review"], evidence:"The expression and kinase activity of LRRK2 were increased in LPS-treated lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:115}, end: {_id:1388}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:115}, end: {_id:1389}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:1505}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"More than 50% of infected cells expressed the reactive marker Synemin (SYNM) (27, 28), and the number of SYNM+ cells increased by 20% postinfection compared to controls.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1506}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:" Another marker of reactivity, Vimentin (VIM) (29), trended toward increased intensity after SARS-CoV-2 exposure in infected astrocytes.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1507}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We observed that more than 75% of infected cells expressed EGFR, and total abundance of EGFR doubled after SARS-CoV-2 infection compared to control conditions.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1505}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Organoid-derived astrocytes also exhibit some reactive characteristics in response to infection, with approx 70% of organoid-derived infected cells expressing SYNM and 33% expressing EGFR (Fig. 4D).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1507}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Organoid-derived astrocytes also exhibit some reactive characteristics in response to infection, with approx 70% of organoid-derived infected cells expressing SYNM and 33% expressing EGFR (Fig. 4D).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1508}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"We investigated the impact of SARS-CoV-2 on cellular stress by evaluating the abundance of endoplasmic reticulum stress and the unfolded protein response gene ARCN1. ARCN1 is lowly expressed in developing human cortex tissue, but after infection by SARS-CoV-2, we found a 15% increase in expression, exclusively in infected cells coexpressing dsRNA.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"To evaluate ACE2 RNA abundance in cortical tissue, we utilized fluorescent in situ hybridization of an ACE2 RNA probe, using lung tissue as a positive control (Fig. 5A). Although we observed robust expression of ACE2 throughout the lung, as well as modest expression in vascular cells (SI Appendix, Fig. 2D), it was absent in cortical astrocytes.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels", "Lung"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["nucleic acid hybridization-based method"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:891}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:" Additionally, SARS-CoV proteases TMPRSS2, FURIN, and CTSB express modest RNA levels across cortical tissue samples, but infected astrocytes have abundant protein of all three proteases.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1511}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:" Additionally, SARS-CoV proteases TMPRSS2, FURIN, and CTSB express modest RNA levels across cortical tissue samples, but infected astrocytes have abundant protein of all three proteases.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1512}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:" Additionally, SARS-CoV proteases TMPRSS2, FURIN, and CTSB express modest RNA levels across cortical tissue samples, but infected astrocytes have abundant protein of all three proteases.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1158}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"While we observed higher expression of CD147 in GFAP+ astrocytes than NEUN+ neurons, DPP4 had similar levels of expression in both cell types (Fig. 6B and SI Appendix, Figs. 9B and 14). We observed ACE2 expression along blood vessels but found no expression in adult cortical cell types.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:775}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"While we observed higher expression of CD147 in GFAP+ astrocytes than NEUN+ neurons, DPP4 had similar levels of expression in both cell types (Fig. 6B and SI Appendix, Figs. 9B and 14). We observed ACE2 expression along blood vessels but found no expression in adult cortical cell types.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1516}, properties:{annotationPublicationtype:["Research"], evidence:"Compared with K562, L929 and RAW cells exhibited slightly increased SDC1 yet significantly decreased SDC3 expression (Figure 3A–C)", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCellline:["L929 cell", "RAW 264.7 cell"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:1517}, properties:{annotationPublicationtype:["Research"], evidence:"Compared with K562, L929 cells showed higher SDC2 expression, although the increase was not statistically significant (p > 0.05).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCellline:["L929 cell"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:1518}, properties:{annotationPublicationtype:["Research"], evidence:"SDC4 expression of RAW and L929 was significantly higher than that of K562, but the increase (~4.5-fold) was more definite in L929 cells.", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCellline:["L929 cell", "RAW 264.7 cell"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:1518}, properties:{annotationPublicationtype:["Research"], evidence:"According to the Human Protein Atlas, SDC4 expression is highest in the liver, the lung, and the brain, while the heart muscle shows medium and the spleen exhibits modest SDC4 expression (Supplementary Table S1).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Brain", "Liver", "Heart"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationCondition:["Heat-inactivated"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["ELISA"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], evidence:"As revealed by TNF-α-specific ELISA analyses, internalized SARS-CoV-2 particles significantly raised tissue TNF-α concentrations in all organs (brain, heart, liver, lung, and spleen).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Spleen", "Liver", "Brain", "Heart"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationCondition:["Heat-inactivated"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["ELISA"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], evidence:"As shown in Figure 9, inactivated virus particles triggered the highest TNF-α concentrations in the heart, followed by the lung, spleen, liver, and brain.", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Spleen", "Liver", "Brain", "Heart"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationCondition:["Heat-inactivated"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["ELISA"], citationRef:"35886958"}}, {start: {_id:684}, end: {_id:1503}, properties:{annotationPublicationtype:["Research"], evidence:"At 24hpi, a strong signal for the viral nucleocapsid protein (NP) was observed mainly in the periphery of the infected organoids, whereas at 72hpi, we observed NP staining in cellular cytoplasm or processes of infected cells.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1069}, properties:{annotationPublicationtype:["Research"], evidence:"Cleaved caspase3 (CASP3) staining indicated a pronounced increase in early cell death-related events in infected organoids as compared to mock-treated organoids.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:324}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"While module B was largely comprised of genes encoding for cytosolic ribosomal proteins (Supplementary Fig. 7a, b), we detected several interferon-stimulated genes (ISGs) in module A (Fig. 6b, Supplementary Table 3). Accordingly, IHC validation of ISG15 protein showed a general increase in interferon response in organoids at 72hpi as well as a specific upregulation in IBA1+ cells, compared to control mock organoids.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:183}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Nonetheless, we detected no clear upregulation of pro-inflammatory cytokines in microglia or microglial subclusters (Supplementary Fig. 7d, e), at either 24hpi or at 72hpi, although several pathogen sensors and upstream effectors of interferon signaling were upregulated including nuclear factor kappa B (NFKB1).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:241}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1543}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1545}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1546}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1550}, properties:{annotationHourspostinfection:["24 hours"], annotationPublicationtype:["Research"], evidence:"At 24hpi, we observed an enrichment of metallothioneins, similar to what we observed in astrocytes at 72hpi, whereas genes involved in viral defense response, regulation of reactive oxygen species, and ECM organization, were enriched at 72hpi.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1553}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"In addition to choroid plexus, a differential expression analysis showed significant increase in expression of matrix metalloproteases and ECM-regulatory enzymes at 72hpi in microglia, astrocytes and perivascular cells, whereas endothelial cells reduced expression levels of solute carrier SLC2A1 (Fig. 7g), all in agreement with signaling that promotes compromised CNS barriers.", annotationCustomCell:["perivascular cell"], citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Choroid Plexus", "Microglia", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", citationType:"PubMed", annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1556}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Accordingly, by IHC we validated increased MMP14 protein expression by PDGFRB+ (pericytes) as well as GFAP+ cells within 72hpi organoids (Fig. 7h, i).", annotationCustomCell:["GFAP+ cells", "PDGFRB+ pericytes"], citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1069}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, the immunostaining revealed a significant increase in cell death measured by both cleaved caspase 3 (CC3) by 20% and TUNEL immunostainings by 30%, accompanied by a 15% increase in the amount of SARS-CoV-2+ cells in virus-infected BCO when compared to non-infected controls (Fig 1J, ​,1K,1K, and ​and1M).1M). Treatment with SOF significantly decreased both SARS-CoV-2 viral protein levels and viral-induced cell death.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", citationType:"PubMed", annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationBioassay:["immunolabeling method"], annotationDisease:["COVID-19"], citationRef:"36327326"}}, {start: {_id:319}, end: {_id:293}, properties:{annotationPublicationtype:["Review"], evidence:"CD4 has also been observed in areas with microgliosis in postmortem human brains, especially in PDD [37].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:684}, end: {_id:2148}, properties:{annotationPublicationtype:["Research"], evidence:"Western blotting further validated the upregulation of P21 and downregulation of LMNB1 at the protein level .", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["western blot"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Western blotting confirmed that SARS-CoV-2 infection increases total α-Syn expression and SARS-CoV-2 infected SNCA 4 copy iPSC-derived DA neurons showed the highest α-Syn expression (Figure S4F).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["western blot"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:1583}, end: {_id:44}, properties:{annotationPublicationtype:["Review"], evidence:"Astrocytes also generate high levels of inducible nitric oxide synthase during CNS infections, epilepsy, EAE, and MS.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshdisease:["Central Nervous System Infections", "Encephalomyelitis, Autoimmune, Experimental", "Multiple Sclerosis", "Epilepsy"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2255}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"CD46-costimulated human conventional CD4+ T cells can induce a Tr1 phenotype with considerable amounts of IL10 production.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2300}, end: {_id:2301}, properties:{annotationPublicationtype:["Review"], evidence:"17β-Estradiol (also known as E2) can exert a protective effect against EAE by upregulating the expression of Foxp3 in Tregs via the α-receptor Esr1.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2302}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Treatment with glucocorticoids in patients with MS during relapse significantly increased the percentage of Tregs and plasma IL10 and the FOXP3/CD3 ratio in peripheral blood", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Multiple Sclerosis"], annotationMeshanatomy:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2302}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"Treatment with glucocorticoids in patients with MS during relapse significantly increased the percentage of Tregs and plasma IL10 and the FOXP3/CD3 ratio in peripheral blood", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Multiple Sclerosis"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, oral administration with purified zwitterionic capsular polysaccharide A of Bacteroides fragilis protects mice against EAE prophylactically and therapeutically by inducing the conversion of naive CD4+ T cells into IL10-producing Foxp3+ Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1463}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"Cytoplasmic release of damaged mitochondria DNA (mtDNA) is an important DAMP that initiates multiple inflammatory pathways, including STING, NLRP3 inflammasome and NFKB signaling [133].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:276}, end: {_id:278}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, a large proportion of the TCRγδ+ T cells also express CD25, suggesting these CSF-obtained T cells are preferentially activated in PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:288}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:290}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:294}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:278}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:296}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:298}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:247}, end: {_id:248}, properties:{annotationPublicationtype:["Review"], evidence:"In one study, IgG reacted with 30% of the dopaminergic neurons within the nigra, and yielded positive correlations with numbers of MHC II+ and CD64+ (FcγRI) reactive microglia, yet yielded a negative correlation with disease duration.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1441}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, DJ-1 was shown to suppress NFkB signaling by directly interacting with its p65 subunit [110] and to mitigate inflammation mediated by the STING pathway", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:141}, end: {_id:670}, properties:{annotationPublicationtype:["Review"], evidence:"Thus, both peripheral and central induction of the NLRP3 inflammasome can directly induce or aggravate neurodegenerative processes that lead to functional impairment in AD [25] or strongly contribute to the spreading of pathology and thus the progression of the disease.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:1841}, end: {_id:2169}, properties:{annotationPublicationtype:["Research"], evidence:"Six participants with brain fog showed mild-to-moderate cognitive impairment on the Montreal Cognitive Assessment (MOCA) test (score 18–25) along with deficits in recall, executive functioning and word finding.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:670}, properties:{annotationPublicationtype:["Research"], evidence:"Six participants with brain fog showed mild-to-moderate cognitive impairment on the Montreal Cognitive Assessment (MOCA) test (score 18–25) along with deficits in recall, executive functioning and word finding.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2389}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:267}, end: {_id:269}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:270}, end: {_id:272}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:8}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Among earlier observations that stand out as pointing toward the need to consider inflammatory processes as important include: (1) Colton's demonstrations that cytokine-activated microglia produce ROS [3,4]; (2) that, in contrast to normal brain, proinflammatory cytokines are prevalent in Alzheimer's brains [5–7]; (3) the early indications that anti-inflammatory therapeutics may delay on-set of Alzheimer's disease [8]; and (4) the early demonstrations that complement and classic markers of immune-mediated damage are expressed in neurodegenerative brains [9,10].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:149}, end: {_id:152}, properties:{annotationPublicationtype:["Review"], evidence:"Progressive degeneration of dopaminergic neurons in the substantia nigra (SN) pars compacta and their projections into the caudate nucleus leads to substantial decreases in dopamine levels, which manifest as resting tremor, bradykinesia, rigidity, and gait dysfunction.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:149}, end: {_id:153}, properties:{annotationPublicationtype:["Review"], evidence:"Progressive degeneration of dopaminergic neurons in the substantia nigra (SN) pars compacta and their projections into the caudate nucleus leads to substantial decreases in dopamine levels, which manifest as resting tremor, bradykinesia, rigidity, and gait dysfunction.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:149}, end: {_id:154}, properties:{annotationPublicationtype:["Review"], evidence:"Progressive degeneration of dopaminergic neurons in the substantia nigra (SN) pars compacta and their projections into the caudate nucleus leads to substantial decreases in dopamine levels, which manifest as resting tremor, bradykinesia, rigidity, and gait dysfunction.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:149}, end: {_id:155}, properties:{annotationPublicationtype:["Review"], evidence:"Progressive degeneration of dopaminergic neurons in the substantia nigra (SN) pars compacta and their projections into the caudate nucleus leads to substantial decreases in dopamine levels, which manifest as resting tremor, bradykinesia, rigidity, and gait dysfunction.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Thus, Treg have the capacity to keep the disorder in check during the asymptomatic phase, whereas Teff can accelerate disease progression.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:317}, end: {_id:318}, properties:{annotationPublicationtype:["Review"], evidence:"This study showed that adoptively transferred Treg attenuated microgliosis and astrogliosis, increased expression of BDNF and GDNF expression, and down-regulated proinflammatory cytokines, oxidative stress, and viral replication, whereas effector CD4+ T cells were not therapeutic.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:283}, end: {_id:207}, properties:{annotationPublicationtype:["Review"], evidence:"Up-regulation of the antiviral ubiquitin-like protein, interferon-stimulated gene 15 (ISG15) was concordant with the decrease in viral release from MP , and implicating caspase-3 and granzyme/perforin pathways in MP killing. Finally, it was shown that Treg induce the phenotypic switch of MP from the neurotoxic MI phenotype to the more neurotrophic M2 phenotype with the down-regulation of iNOS and up-regulation of arginase 1.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:412}, end: {_id:409}, properties:{annotationPublicationtype:["Review"], evidence:"Lymphocytes from PD patients display an increased incidence of micronuclei, single strand DNA breaks, and oxidized purine bases [109]. Interestingly,levodopa treatment seems to reduce this DNA damage in peripheral blood lymphocytes [110].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:283}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Adoptive transfer of ex vivo differentiated regulatory T cells into MPTP-induced mice attenuated neurodegeneration [67].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:6}, end: {_id:454}, properties:{annotationPublicationtype:["Review"], evidence:"IFN-gamma stimulation of immune cells results in upregulation of LRRK2 expression, which was shown to activate the NF-κB pathway, to be important for production of microbicidal reactive oxygen species during phagocytosis, and to colocalize near pathogens during intracellular infection [160]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:478}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"One such example is that adoptive transfer of T cells from a copaxone-immunized animal showed protection against neurodegeneration in an MPTP model [178].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:478}, end: {_id:264}, properties:{annotationPublicationtype:["Review"], evidence:"Copaxone, also known as glatiramer acetate,is used in the treatment of multiple sclerosis.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:283}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Adoptive transfer of Tregs also attenuated neurodegeneration in an MPTP model [67]. ", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:482}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"In a rotenone rat PD model, colchicine showed benefit in preventing neurodegeneration [187].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10116"], annotationSection:["Full Text"], annotationRatType:["rotenone rat PD model"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:492}, end: {_id:264}, properties:{annotationPublicationtype:["Review"], evidence:"The drug, natalizumab has been successful in the treatment of multiple sclerosis [190].  As an antibody against the alpha 4 integrin, this antibody blocks the recruitment of T cells to sites of inflammation. By blocking activation and recruitment of T cells in PD, neuroinflammation could be dampened to prevent subsequent neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:496}, end: {_id:497}, properties:{annotationPublicationtype:["Review"], evidence:"Intravenous immunoglobulin (IVIG) has been effective in treating diseases that are mediated by pathogenic antibody responses such as erythroblastosis fetalis, autoimmune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:496}, end: {_id:498}, properties:{annotationPublicationtype:["Review"], evidence:"Intravenous immunoglobulin (IVIG) has been effective in treating diseases that are mediated by pathogenic antibody responses such as erythroblastosis fetalis, autoimmune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:496}, end: {_id:499}, properties:{annotationPublicationtype:["Review"], evidence:"Intravenous immunoglobulin (IVIG) has been effective in treating diseases that are mediated by pathogenic antibody responses such as erythroblastosis fetalis, autoimmune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:540}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, 13 089 patients with IBD were exposed to anti-TNF therapy on or after the IBD index date. We observed a markedly lower PD incidence rate (0.08 per 1000 patient-years)among patients with IBD who were exposed to anti-TNF therapy compared with patients with IBD who were not exposed to anti-TNF therapy (0.76 per 1000 patient-years)(Table 3)", citationTitle:"JAMA Neurol. 2018 Aug 1;75(8):939-946. doi:10.1001/jamaneurol.2018.0605.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Inflammatory Bowel Diseases"], source:"wp4-cbm-comorbidity", pmid:"29710331", citationType:"PubMed", citationRef:"29710331"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:541}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Of the six categories of immunosuppressants, two were clearly associated with a lower risk of PD: Corticosteroids (RR = 0.80; 95% CI 0.77–0.83) and IMDH inhibitors (RR = 0.64; 95% CI 0.51–0.79).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:542}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Of the six categories of immunosuppressants, two were clearly associated with a lower risk of PD: Corticosteroids (RR = 0.80; 95% CI 0.77–0.83) and IMDH inhibitors (RR = 0.64; 95% CI 0.51–0.79).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:543}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"The other classes of immunosuppressants were not as clearly inversely associated with PD risk, although those taking methotrexate had a borderline lower risk of PD (RR = 0.84; 95% CI 0.74–0.95).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:542}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"When we considered medications within the IMDH inhibitor category, each was consistently associated with a lower risk of PD. Mycophenolate was associated with the lowest risk of PD (RR = 0.55; 95% CI 0.31–0.98), although the number of patients taking this drug was small, and the CIs were relatively wide.", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:544}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"When we considered medications within the IMDH inhibitor category, each was consistently associated with a lower risk of PD. Mycophenolate was associated with the lowest risk of PD (RR = 0.55; 95% CI 0.31–0.98), although the number of patients taking this drug was small, and the CIs were relatively wide.", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:545}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Within the corticosteroid category, the steroids most strongly associated with PD were those used commonly for long-term immunosuppression: Prednisone (RR = 0.81; 95% CI 0.78–0.85); dexamethasone (RR = 0.76; 95% CI 0.66–0.88); methylprednisolone (RR = 0.80; 95% CI 0.76–0.84).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:365}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Within the corticosteroid category, the steroids most strongly associated with PD were those used commonly for long-term immunosuppression: Prednisone (RR = 0.81; 95% CI 0.78–0.85); dexamethasone (RR = 0.76; 95% CI 0.66–0.88); methylprednisolone (RR = 0.80; 95% CI 0.76–0.84).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:546}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"Within the corticosteroid category, the steroids most strongly associated with PD were those used commonly for long-term immunosuppression: Prednisone (RR = 0.81; 95% CI 0.78–0.85); dexamethasone (RR = 0.76; 95% CI 0.66–0.88); methylprednisolone (RR = 0.80; 95% CI 0.76–0.84).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:540}, end: {_id:314}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, patients with inflammatory bowel disease have a higher incidence of PD [37–40], which is substantially reduced by early exposure to anti-inflammatory anti-tumor necrosis factor therapy.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:577}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, general immunosuppressive and anti-inflammatory treatments reduce the risk of developing PD [43]. Taken together, systemic inflammation itself, and several chronic conditions that feature increased inflammation, might be considered facilitators of PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:578}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, general immunosuppressive and anti-inflammatory treatments reduce the risk of developing PD [43]. Taken together, systemic inflammation itself, and several chronic conditions that feature increased inflammation, might be considered facilitators of PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:365}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Examination showed hyporeflexia and a sensory level at T10. He was treated with dexamethasone and intravenous immunoglobulin, and was discharged for rehabilitation.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:739}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Examination showed hyporeflexia and a sensory level at T10. He was treated with dexamethasone and intravenous immunoglobulin, and was discharged for rehabilitation.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:541}, end: {_id:696}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis and myelitis, usually considered post-infectious diseases, are treated typically with corticosteroids or other immunotherapies.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:740}, end: {_id:735}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis and myelitis, usually considered post-infectious diseases, are treated typically with corticosteroids or other immunotherapies.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:771}, end: {_id:772}, properties:{annotationPublicationtype:["Review"], evidence:"Immediate anticoagulation with low-molecular-weight heparin has been recommended for patients with COVID-19, to reduce the risk of thrombotic disease.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:959}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"We showed that camostat or EK1 peptide inhibited viral infection, confirming that pseudovirus entry is mediated by the spike protein and is dependent on TMPRSS2 function (Figure 2C). ", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:960}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"We showed that camostat or EK1 peptide inhibited viral infection, confirming that pseudovirus entry is mediated by the spike protein and is dependent on TMPRSS2 function (Figure 2C). ", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:963}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"We then tested the inhibitory activities of nafamostat in Calu-3 cells infected with a patient derived isolate of SARS-CoV-2, whereby our results showed that nafamostat significantly reduced SARS-CoV-2 infection (Figures S1J–S1K) as observed in LORGs.", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33631122", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], annotationCellline:["Calu-3 cell"], citationRef:"33631122"}}, {start: {_id:1042}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Studies of heparin treatment of COVID-19 have shown positive results103,106(Supplementary Table 1), and this is now one of a growing number of agents available to manage COVID-19 either as a prophylactic or therapeutic regimen108 (Table 1).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1046}, end: {_id:998}, properties:{annotationPublicationtype:["Review"], evidence:"Among 35 patients admitted to the ICU with COVID-19, eculizumab treatment improved 15-day survival and hypoxia compared with patients treated with standard care alone148. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["patients admitted to the ICU"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1054}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"In a report from Italy, a patient with severe COVID-19-related ARDS was safely and successfully treated with the compstatin-based complement C3 inhibitor AMY-101 (ref.149). ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1147}, end: {_id:1146}, properties:{annotationPublicationtype:["Research"], evidence:"Because of pneumonia, more SARS-CoV-2-infected patients were ventilated than controls (Supplementary Table 2). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34675436", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1147}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"All patients were very critically ill, with acute respiratory distress syndrome and mechanical ventilation, associated with acute kidney failure and refractory shock", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:1452}, end: {_id:219}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast, specific inhibition of GCase in mice resulted in α-syn neuropathology and inflammation, as revealed by elevated GFAP levels that are indicative of astrogliosis", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:90}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"It was shown that regular intake of nonsteroidal anti-inflammatory drugs (NSAID) was associated with a reduced risk for PD [153].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:1573}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1592}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Both inhibitors produced dose-related inhibition of SARS-CoV-2 infection of astrocytes, with EG01377 displaying slightly higher potency than EG00229 (Fig. S1D)", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1593}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Both inhibitors produced dose-related inhibition of SARS-CoV-2 infection of astrocytes, with EG01377 displaying slightly higher potency than EG00229 (Fig. S1D)", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1595}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Tetrandrine, a calcium channel blocker and inhibitor of the TPCN2 gene product, also produced dose-dependent inhibition of SARS-CoV-2 infection (Fig. S1D). Fifty percent cell death was observed at the highest drug concentration (20 mM), but at lower, nontoxic doses, viral infection was inhibited in a dose-related manner (Fig. S1E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], annotationConcentration:["0.8 mM", "0.032 mM", "0.16 mM", "0.0064 mM", "4 mM"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:2152}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, these three drug candidates also blocked virus infection in MEL-1-derived DA neurons (Figures S6A–S6C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, these three drug candidates also blocked virus infection in MEL-1-derived DA neurons (Figures S6A–S6C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, these three drug candidates also blocked virus infection in MEL-1-derived DA neurons (Figures S6A–S6C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Together, this suggests that riluzole, metformin, and imatinib prevent SARS-CoV-2 infection induced DA neuron senescence by blocking SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Together, this suggests that riluzole, metformin, and imatinib prevent SARS-CoV-2 infection induced DA neuron senescence by blocking SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Together, this suggests that riluzole, metformin, and imatinib prevent SARS-CoV-2 infection induced DA neuron senescence by blocking SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2166}, end: {_id:1841}, properties:{annotationPublicationtype:["Research"], evidence:"Patients with brain fog had a higher mean age (53.7 versus 42.7) and were more likely to be hospitalized and require oxygen therapy; therefore, age, sex, comorbidities and severity of infection were included in the statistical model to identify differences between groups (Supplementary Table 1).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:283}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, adoptive transfer of Tregs significantly protects the progress of myelin oligodendrocyte glycoprotein (MOG)-induced EAE.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:2292}, properties:{annotationPublicationtype:["Review"], evidence:"Treatment with a blocker of AII production induces abundant Foxp3+Tregs with sufficient potency to reverse paralytic EAE.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2295}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"The repetitive administration of pertussis toxin, the major virulence factor of Bordetella pertussis, promotes the development of Tregs and prevents mice from developing EAE.2", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2300}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"17β-Estradiol (also known as E2) can exert a protective effect against EAE by upregulating the expression of Foxp3 in Tregs via the α-receptor Esr1.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2307}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of VIP to EAE mice significantly ameliorates the progression of the disease by inducing the expansion of Tregs both in the periphery and in the nervous system262 (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Peripheral Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:264}, properties:{annotationPublicationtype:["Review"], evidence:"A natural antioxidant, C-phycocyanin, has also been found to induce Tregs in vitro from the peripheral blood of MS patients and consequently ameliorates the disease progress; C-phycocyanin can also ameliorate EAE clinical symptoms in Lewis rats.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2312}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"A natural antioxidant, C-phycocyanin, has also been found to induce Tregs in vitro from the peripheral blood of MS patients and consequently ameliorates the disease progress; C-phycocyanin can also ameliorate EAE clinical symptoms in Lewis rats.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10116"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:872}, properties:{annotationPublicationtype:["Review"], evidence:"As has recently been shown, the adoptive transfer of CD3-activated Tregs attenuates astrogliosis and microglial inflammation with concomitant neuroprotection in a murine model of HIV-1-associated neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2327}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, oral administration with purified zwitterionic capsular polysaccharide A of Bacteroides fragilis protects mice against EAE prophylactically and therapeutically by inducing the conversion of naive CD4+ T cells into IL10-producing Foxp3+ Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2337}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"These results together indicate that remdesivir could effectively inhibit SARS-CoV-2 infection and rescue disease phenotypes in neurons and astrocytes and therefore can be used to manage neurological infection by SARS-CoV-2.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["neuron", "astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["AG14048 cell"], annotationDisease:["COVID-19"], citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:173}, end: {_id:202}, properties:{annotationPublicationtype:["Review"], evidence:"The engagement of TLRs leads to translocation of nuclear factor-κ light-chain enhancer of activated B cells (NF-κB) and AP-1 to the nucleus where they induce transcription of a broad range of innate immune proteins.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:601}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"As Fig. 1. shows, internalization of Aβ1–42 was highest in SDC3 transfectants at every time points.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"SDC4 transfectants surpassed WT K562 cells in uptake of Aβ1–42 after 6h of incubation, while SDC2 bested K562 cells in uptake and attachment of Aβ1–42 only at 18h.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["6 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:607}, end: {_id:613}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, uptake of Trf, the marker of clathrin-mediated endocytosis, was higher in K562 cells than in SDC1, 2 and 3 transfectants, while SDC4 exhibited slightly higher Trf uptake levels than WT K562 cells.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["K 562 cell"], pmid:"30718543", citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy studies then revealed ThT labeled fibrillar structures inside of Aβ1–42 treated cells, especially in SDC3 and SDC4 transfectants, suggesting while triggering Aβ1–42 fibrillation, SDCs also mediate the intracellular translocation of Aβ1–42 oligomers (Fig. 2c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method", "confocal microscopy"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy studies then revealed ThT labeled fibrillar structures inside of Aβ1–42 treated cells, especially in SDC3 and SDC4 transfectants, suggesting while triggering Aβ1–42 fibrillation, SDCs also mediate the intracellular translocation of Aβ1–42 oligomers (Fig. 2c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method", "confocal microscopy"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:611}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, all SDC transfectants exhibited higher uptake of Aβ1–42 at 18h (p<0.01).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:608}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, all SDC transfectants exhibited higher uptake of Aβ1–42 at 18h (p<0.01).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, all SDC transfectants exhibited higher uptake of Aβ1–42 at 18h (p<0.01).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, all SDC transfectants exhibited higher uptake of Aβ1–42 at 18h (p<0.01).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Among SDC transfectants, the neuron specific SDC3 internalized Aβ1–42 the most and Trf the least (Fig. 3a–d).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method", "flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:601}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"In SH-SY5Y cells, SDC3 overexpression resulted in increased HS expression, along with increased cellular uptake and fibrillation of Aβ1–42 (Fig. 8a–e).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy", "flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:607}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, WT SDC4 transfectants exhibited the most significant (p<0.05) increase in α-syn and tau fibril uptake (Fig. 3f,g). ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:607}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, WT SDC4 transfectants exhibited the most significant (p<0.05) increase in α-syn and tau fibril uptake (Fig. 3f,g). ", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:635}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, mutants with a truncated ectodomain containing only the HSA with the HS chains increased fibril internalization at an extent similar to SDC4 transfectants, thus confirming the significance of polyanionic HS chains in the interactions with α-syn or tau fibrils.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:635}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, mutants with a truncated ectodomain containing only the HSA with the HS chains increased fibril internalization at an extent similar to SDC4 transfectants, thus confirming the significance of polyanionic HS chains in the interactions with α-syn or tau fibrils.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", annotationProteinType:["fibril"], pmid:"31719623", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"31719623"}}, {start: {_id:601}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 overexpression – either in differentiated or undifferentiated SH-SY5Y cells - induced increased HS expression, along with increased internalization of both fibrils (Fig. 4a,b).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 overexpression – either in differentiated or undifferentiated SH-SY5Y cells - induced increased HS expression, along with increased internalization of both fibrils (Fig. 4a,b).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:607}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Uptake studies showed that while at 1h of incubation the cellular uptake of monomeric α-syn and tau were lower in the SDC overexpressing lines, at 18h, when fibril are already formed due to SDCs, SDC overexpression also triggered higher amount of α-syn or tau uptake (Fig. 6a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:611}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:611}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:608}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed ThT-labeled aggregates intracellularly 18h after treatment with monomeric α-syn or tau, especially in SDC transfectants, suggesting once SDCs trigger the formation of α-syn or tau fibrils, they also mediate the intracellular translocation of the fibrils (Fig. 6h).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationProteinType:["fibril"], annotationCellline:["K 562 cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpressing SDC3 in SH-SY5Y cells, either differentiated or undifferentiated, induced lower uptake of α-syn or tau monomers at 1h (Fig. 8a,c), but significantly (p<0.05) higher at 18h of incubation, when fibrils are already formed, as revealed by both ThT fluorescence and electron microscopic studies (Fig. 8a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpressing SDC3 in SH-SY5Y cells, either differentiated or undifferentiated, induced lower uptake of α-syn or tau monomers at 1h (Fig. 8a,c), but significantly (p<0.05) higher at 18h of incubation, when fibrils are already formed, as revealed by both ThT fluorescence and electron microscopic studies (Fig. 8a–f).", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "flow cytometry"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:628}, properties:{annotationPublicationtype:["Research"], evidence:"Electron microscopy also revealed widespread presence of mature fibrils on SDC3 overexpressing SH-SY5Y cells at 18h (Fig. 8c–e), while confocal microscopic studies showed higher number of ThT-labeled aggregates in SDC3 transfectants at the same time point (Fig. 8f), suggesting that while inducing fibrillation, SDC3 also facilitate the uptake of fibrillar α-syn or tau.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:601}, end: {_id:629}, properties:{annotationPublicationtype:["Research"], evidence:"Electron microscopy also revealed widespread presence of mature fibrils on SDC3 overexpressing SH-SY5Y cells at 18h (Fig. 8c–e), while confocal microscopic studies showed higher number of ThT-labeled aggregates in SDC3 transfectants at the same time point (Fig. 8f), suggesting that while inducing fibrillation, SDC3 also facilitate the uptake of fibrillar α-syn or tau.", citationTitle:"Sci Rep. 2019 Nov 12;9(1):16543. doi:10.1038/s41598-019-53038-z.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"31719623", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["laser scanning confocal microscope", "electron microscopy"], annotationProteinType:["fibril"], annotationCellline:["SH-SY5Y cell"], citationRef:"31719623"}}, {start: {_id:607}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry analyses revealed increased uptake of SARS-CoV-2 into SDC transfectants (Figure 1A–C).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["flow cytometry", "confocal microscopy", "transfection method"], annotationCellline:["K 562 cell"], citationRef:"34069441"}}, {start: {_id:607}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Among SDCs, SDC4 increased SARS-CoV-2 uptake the most (p < 0.01) (incubating the cells with the AF 488-labeled secondary antibodies did not result in any statistically significant difference in cellular fluorescence of applied WT K562 cells and SDC transfectants, showing that no unspecific binding influenced the detected difference in fluorescence intensities of SARS-CoV-2-treated cells (Supplementary Figure S4).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["flow cytometry", "confocal microscopy", "transfection method"], annotationCellline:["K 562 cell"], citationRef:"34069441"}}, {start: {_id:607}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Treating WT K562 cells and SDC transfectants with the SARS-CoV-2 pseudovirus (SARS-CoV-2 PSV), a recombinant pseudotyped lentiviral particle carrying the SARS-CoV-2 spike protein and encoding the red fluorescent protein (RFP) as a reporter gene [29,66,67,68], delivered similar results as uptake studies with the heat-inactivated SARS-CoV-2.", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["reporter gene assay", "flow cytometry", "confocal microscopy", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:607}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, SDC transfectants all increased SARS-CoV-2 PSV-mediated RFP transduction (Figure 1D–F).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["reporter gene assay", "flow cytometry", "confocal microscopy", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:607}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to PSV-treated WT K562 cells, the increase in RFP transduction was significant (p < 0.05) only in the case of SDC4 transfectants (Figure 1F).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["reporter gene assay", "flow cytometry", "confocal microscopy", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:607}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"PSV studies thus showed that besides facilitating SARS-CoV-2 uptake, SDC4-mediated cellular entry also maintains the biological activity (i.e., the gene transduction ability) of the virus.", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["reporter gene assay", "flow cytometry", "confocal microscopy", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:607}, end: {_id:1091}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry analyses revealed increased uptake of spikeS1 into SDC lines (Figure 6A–C).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:607}, end: {_id:1091}, properties:{annotationPublicationtype:["Research"], evidence:"Among SDCs, SDC4 significantly increased the uptake of spikeS1 (p < 0.01) (incubating the cells with the fluorescently labeled anti-His tag antibodies without spikeS1 pretreatment did not induce any difference in fluorescence among the applied K562 cells and SDC transfectants, showing that no unspecific binding influenced the detected fluorescence intensities in spikeS1-treated cells (Supplementary Figure S11)).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:607}, end: {_id:1091}, properties:{annotationPublicationtype:["Research"], evidence:"Increased SDC4 expression, with unaffected ACE2 levels, resulted in increased cellular uptake of spikeS1 (Figure 8C–G). Namely, overexpression of SDC4 increased spikeS1 entry from a low level of WT A549 cells by almost twofold (Figure 8C–E).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["flow cytometry", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["A549 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:775}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT A549 cells, SARS-CoV-2 treatment of ACE2 and SDC4 KO cells resulted in significantly reduced virus uptake (Figure 10C,D,F).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "transfection method"], annotationCellline:["A549 cell"], annotationCelllineType:["ACE2-/-"], citationRef:"34069441"}}, {start: {_id:607}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT A549 cells, SARS-CoV-2 treatment of ACE2 and SDC4 KO cells resulted in significantly reduced virus uptake (Figure 10C,D,F).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "transfection method"], annotationCellline:["A549 cell"], annotationCelllineType:["SDC4-/-"], citationRef:"34069441"}}, {start: {_id:775}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ACE2 knockdown, the effect of SDC4 KO exerted a significantly (p < 0.01) more pronounced inhibitory effect on SARS-CoV-2 internalization (Figure 10D,F), suggesting a substantial role is played by SDC4 in SARS-CoV-2 uptake.", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "transfection method"], annotationCellline:["A549 cell"], annotationCelllineType:["ACE2-/-"], citationRef:"34069441"}}, {start: {_id:607}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ACE2 knockdown, the effect of SDC4 KO exerted a significantly (p < 0.01) more pronounced inhibitory effect on SARS-CoV-2 internalization (Figure 10D,F), suggesting a substantial role is played by SDC4 in SARS-CoV-2 uptake.", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry", "transfection method"], annotationCellline:["A549 cell"], annotationCelllineType:["SDC4-/-"], citationRef:"34069441"}}, {start: {_id:611}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Flow cytometry studies of ApoE-treated SDC transfectants showed that SDC overexpression increased the cellular uptake of ApoEs in an isoform-dependent manner: among SDCs, neuronal SDC3 increased ApoE internalization the best (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:611}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Among ApoEs, SDCs increased ApoE2 and ApoE3 uptake most effectively, while SDCs' effect on increasing ApoE4 uptake was lower (Figure 1A,B).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to ApoE-treated WT K562 cells, the overall cellular fluorescence of FITC-ApoE-treated SDC transfectants also increased, indicating that SDC overexpression increased both the cellular binding and the uptake of ApoEs (Figure 1C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:611}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:611}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:608}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:607}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"In line with the flow cytometry measurement, confocal microscopy studies also revealed the more intense intracellular fluorescence of FITC-ApoE2- and ApoE3-treated SDC transfectants, while, compared to the other ApoE isoforms, the uptake of ApoE4 remained relatively modest (Figure 1D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"When immunoprecipitated with SDC3 from extracts of ApoE-treated SDC3 transfectants, ApoE2 exhibited the strongest band, followed by ApoE3 and 4 (Figure 2D and Supplementary Figure S4A), thus confirming the previously detected differences in the internalization efficacy of the ApoE isoforms (ApoE2 ≥ ApoE3 > ApoE4, as shown in Figure 1).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoprecipitation"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"When immunoprecipitated with SDC3 from extracts of ApoE-treated SDC3 transfectants, ApoE2 exhibited the strongest band, followed by ApoE3 and 4 (Figure 2D and Supplementary Figure S4A), thus confirming the previously detected differences in the internalization efficacy of the ApoE isoforms (ApoE2 ≥ ApoE3 > ApoE4, as shown in Figure 1).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoprecipitation"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"When immunoprecipitated with SDC3 from extracts of ApoE-treated SDC3 transfectants, ApoE2 exhibited the strongest band, followed by ApoE3 and 4 (Figure 2D and Supplementary Figure S4A), thus confirming the previously detected differences in the internalization efficacy of the ApoE isoforms (ApoE2 ≥ ApoE3 > ApoE4, as shown in Figure 1).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoprecipitation"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Following immunoprecipitation with SDC3 from extracts of ApoE-treated differentiated SH-SY5Y cells, ApoE2 exhibited the strongest band, followed by ApoE3 and 4 (Figure 3C and Supplementary Figure S4B), further confirming the previously revealed differences in the internalization efficacy of the ApoE isoforms.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoprecipitation"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Following immunoprecipitation with SDC3 from extracts of ApoE-treated differentiated SH-SY5Y cells, ApoE2 exhibited the strongest band, followed by ApoE3 and 4 (Figure 3C and Supplementary Figure S4B), further confirming the previously revealed differences in the internalization efficacy of the ApoE isoforms.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoprecipitation"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Following immunoprecipitation with SDC3 from extracts of ApoE-treated differentiated SH-SY5Y cells, ApoE2 exhibited the strongest band, followed by ApoE3 and 4 (Figure 3C and Supplementary Figure S4B), further confirming the previously revealed differences in the internalization efficacy of the ApoE isoforms.", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["immunoprecipitation"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1099}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpressing SDC3 in differentiated SH-SY5Y cells increased uptake for all ApoE isoforms (Figure 4A–C). Among ApoEs, ApoE2 exhibited the highest internalization efficacy, while ApoE4 the lowest (Figure 4C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1102}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpressing SDC3 in differentiated SH-SY5Y cells increased uptake for all ApoE isoforms (Figure 4A–C). Among ApoEs, ApoE2 exhibited the highest internalization efficacy, while ApoE4 the lowest (Figure 4C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:601}, end: {_id:1105}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpressing SDC3 in differentiated SH-SY5Y cells increased uptake for all ApoE isoforms (Figure 4A–C). Among ApoEs, ApoE2 exhibited the highest internalization efficacy, while ApoE4 the lowest (Figure 4C).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:775}, end: {_id:1126}, properties:{annotationPublicationtype:["Research"], evidence:"The co-localization of SARS-CoV-2-S with ACE2 in the vessels and cells suggests the role of ACE2 as the entry receptor for SARS-CoV-2 invading the brain by passing through the BBB.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34489403", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34489403"}}, {start: {_id:775}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Overexpression of ACE2 in 293T-ACE2 cells increased the internalization of the WT spike.", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationConcentration:["50 nM"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["293T cell overexpressing ACE2"], citationRef:"35054983"}}, {start: {_id:611}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, both SDC1 and SDC4 increased PSV-mediated gene (i.e., RFP transduction) either for the WT or Delta PSVs. However, the rate of SDC-mediated increase was higher for the Delta PSV (Figure 5A–D).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:607}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, both SDC1 and SDC4 increased PSV-mediated gene (i.e., RFP transduction) either for the WT or Delta PSVs. However, the rate of SDC-mediated increase was higher for the Delta PSV (Figure 5A–D).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:611}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, both SDC1 and SDC4 increased PSV-mediated gene (i.e., RFP transduction) either for the WT or Delta PSVs. However, the rate of SDC-mediated increase was higher for the Delta PSV (Figure 5A–D).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:607}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, both SDC1 and SDC4 increased PSV-mediated gene (i.e., RFP transduction) either for the WT or Delta PSVs. However, the rate of SDC-mediated increase was higher for the Delta PSV (Figure 5A–D).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:582}, end: {_id:1395}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 is involved in the recruitment of cytosolic Parkin to damaged mitochondria ", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1518}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Cellular internalization of inactivated SARS-CoV-2 in RAW cells was slightly lower than in K562, yet L929 fibroblasts—whose SDC4 expression was highest among the three lines—exhibited significantly increased SARS-CoV-2 uptake (Figure 4D–F).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCellline:["L929 cell"], citationRef:"35886958"}}, {start: {_id:1518}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Compared with stable SDC4 transfectants (created in K562 cells) with ~20-fold SDC4 expression (Supplementary Figure S2), the cellular uptake of SARS-CoV-2 in L929 cells was significantly lower (Figure 4D–F).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCellline:["L929 cell"], citationRef:"35886958"}}, {start: {_id:1518}, end: {_id:1519}, properties:{annotationPublicationtype:["Research"], evidence:"Cellular internalization of the spike protein (incubated at a concentration of 50 nM for 3 h at 37 °C) exhibited a pattern similar to the heat-inactivated SARS-CoV-2 particles (Figure 4E,G).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCellline:["L929 cell"], citationRef:"35886958"}}, {start: {_id:1518}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Reducing the SDC4 expression of L929 and RAW cells with knockdown (KD) reduced the cellular uptake of the virus (Figure 4A–D). That is, a ~70% decrease in SDC4 expression resulted in a ~50% reduction in SARS-CoV-2 uptake in the applied murine cell lines (Figure 5B–D).", citationTitle:"Int J Mol Sci. 2022 Jul 9;23(14):7609. doi: 10.3390/ijms23147609.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35886958", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["flow cytometry", "western blot"], annotationCellline:["L929 cell", "RAW 264.7 cell"], annotationCelllineType:["Sdc4-/-"], citationRef:"35886958"}}, {start: {_id:775}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"A ~6-fold increase in the ACE2 expression with a ~30% reduced HS expression in the ACE2-293T cells (Figure 1B,E) resulted in a modestly (yet significantly, i.e., p < 0.01) increased WT SCV2 cellular uptake, an unchanged Delta cellular uptake, and a significantly reduced Omicron cellular uptake, highlightingthe increased importance of HS in the variants, especially for Omicron's cellular entry(Figure 2A–E).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationSection:["Results"], annotationCustomCellline:["ACE2-293T cell"], annotationSarsCov2Variant:["wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:611}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:608}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:601}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:607}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["wild type"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:611}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:608}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:601}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:607}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:611}, end: {_id:1928}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:608}, end: {_id:1928}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:601}, end: {_id:1928}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:607}, end: {_id:1928}, properties:{annotationPublicationtype:["Research"], evidence:"Imaging flow cytometry revealed that while SDC overexpression generally amplified the cellular entry of all viral particles, specific variations between the virus strains were observed (Figure 3A–E).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Omicron"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:611}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"The Delta variant showed the most pronounced increase in cellular entry in the cells overexpressing SDC1, 2, and 4, while the Omicron entered the SDC4 transfectants the most. This suggests that while the Delta variant exhibited evenly enhanced cellular uptake in all SDC transfectants, the Omicron variant predominantly favored SDC4 overexpression.", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:608}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"The Delta variant showed the most pronounced increase in cellular entry in the cells overexpressing SDC1, 2, and 4, while the Omicron entered the SDC4 transfectants the most. This suggests that while the Delta variant exhibited evenly enhanced cellular uptake in all SDC transfectants, the Omicron variant predominantly favored SDC4 overexpression.", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:607}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"The Delta variant showed the most pronounced increase in cellular entry in the cells overexpressing SDC1, 2, and 4, while the Omicron entered the SDC4 transfectants the most. This suggests that while the Delta variant exhibited evenly enhanced cellular uptake in all SDC transfectants, the Omicron variant predominantly favored SDC4 overexpression.", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"37762442"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:5}, end: {_id:72}, properties:{annotationPublicationtype:["Review"], evidence:"Data from human studies support the idea that a reduction in CD200 expression is associated with microglial activation.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:198}, end: {_id:268}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence of increased mutual coexpression of CD4 and CD8 by CD45R0+ T cells, increased expression of CD25 (α chain of the high-affinity IL-2 receptor) and TNF-α receptors, and diminished expression of IFN-γ receptors suggest that these T-cell subsets from PD patients are indeed activated.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:637}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"More interestingly, the loss of IL10 is only associated with costimulation by CD46, but not by CD28.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:380}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"Positive correlations between disease duration and the microglial/macrophage activation marker CD68 and between MHC-II expression and amount of alpha-synuclein deposition in the SN of post-mortem human brain sections have been reported [57].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2}, end: {_id:21}, properties:{annotationPublicationtype:["Review"], evidence:"It should also be pointed out that experimentally it has been shown that brain ischemia causes enhanced formation of b-amyloid precursor protein [25].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:67}, end: {_id:375}, properties:{annotationPublicationtype:["Review"], evidence:"In vivo evidence for increased blood brain permeability has been revealed through PET measurement of ligand uptake by the molecular efflux pump, Pglycoprotein, and increased albumin in the CSF of PD patients [51, 52].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["cerebrospinal fluid"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:376}, properties:{annotationPublicationtype:["Review"], evidence:"In vivo evidence for increased blood brain permeability has been revealed through PET measurement of ligand uptake by the molecular efflux pump, Pglycoprotein, and increased albumin in the CSF of PD patients [51, 52].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["cerebrospinal fluid"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:405}, properties:{annotationPublicationtype:["Review"], evidence:"Within the CD4 T cell compartment, PD patients have an increase in CD45RO+ T cells, which represent an activated and/or memory T cell population [104].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:313}, end: {_id:437}, properties:{annotationPublicationtype:["Review"], evidence:"CD4 T cells from people with the autoimmune disorder systemic lupus erythematosus have a 5-fold increase in alpha-synuclein expression that correlates with higher basal levels of autophagy [139].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Lupus Erythematosus, Systemic"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:506}, properties:{annotationPublicationtype:["Research"], evidence:"While residue aa39 is highly phosphorylated in PD patients 24, Y39 phosphorylation was not required for antigenic response. The response was primarily polarized towards IL-5 in PD (71% IL-5 and 29% IFNγ; Fig. 2d). This polarization was PD specific, and the relatively rare HC responses were not similarly polarized (46% IL-5 and 54% IFNγ ).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:77}, end: {_id:230}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:640}, end: {_id:575}, properties:{annotationPublicationtype:["Review"], evidence:"Unexpectedly, acute cerebrovascular disease is also emerging as an important complication, with cohort studies reporting stroke in 2–6% of patients hospitalised with COVID-19. So far, 96 patients with stroke have been described, who frequently had vascular events in the context of a pro-inflammatory hypercoagulable state with elevated C-reactive protein, D-dimer, and ferritin.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:81}, end: {_id:575}, properties:{annotationPublicationtype:["Review"], evidence:"Thrombocytopenia with elevated D-dimer and C-reactive protein in severe COVID-19 and stroke are consistent with a virus-associated microangiopathic process.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:575}, properties:{annotationPublicationtype:["Review"], evidence:"Thrombocytopenia with elevated D-dimer and C-reactive protein in severe COVID-19 and stroke are consistent with a virus-associated microangiopathic process.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:775}, properties:{annotationPublicationtype:["Research"], evidence:"Correspondingly, ACE2 was detectable in olfactory mucosa by means of immunohistochemistry, while we found no reliable ACE2 immunoreactivity in the parenchyma of the CNS, namely, in the olfactory bulb and medulla oblongata (Supplementary Fig. 1).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Olfactory Mucosa"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:1009}, properties:{annotationPublicationtype:["Review"], evidence:"The occurrence of a COVID-19-specific coagulopathy is suggested by elevated levels of fibrinogen, von Willebrand factor (VWF) and the fibrin degradation product D-dimer in the blood, whereas patients generally show minor or no changes in prothrombin time (a measure of time to clot), activated partial thromboplastin time (coagulation time), antithrombin levels, activated protein C levels and platelet count", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1009}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, increased levels of the endothelial adhesion protein VWF were reported both in patients admitted to the ICU and in non-critically ill patients34,35,61,62, and this increase seems to be associated with a mild reduction in the activity of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13), a metalloproteinase that regulates the size of VWF multimers63. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], annotationDiseaseSeverity:["non-critically ill patients", "patients admitted to the ICU"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1012}, properties:{annotationPublicationtype:["Review"], evidence:"In support of this, there is increasing evidence that COVID-19 is a disease of the endothelium35 that results in elevated levels of PAI1 and VWF, increased platelet activation and a state of hypercoagulability, with consequent venous, arterial and microvascular thrombosis.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1009}, properties:{annotationPublicationtype:["Review"], evidence:"In support of this, there is increasing evidence that COVID-19 is a disease of the endothelium35 that results in elevated levels of PAI1 and VWF, increased platelet activation and a state of hypercoagulability, with consequent venous, arterial and microvascular thrombosis.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1069}, properties:{annotationPublicationtype:["Research"], evidence:"We observed abundant Iba1+ immune cells in the olfactory mucosa of all four patients (Table S4, Fig. 8B, D and E), and apoptotic cells (cleaved caspase-3 positive) were observed in the samples of all these patients (Fig. 8D and E, Table S4).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Olfaction Disorders"], annotationBioassay:["immunofluorescent labeling"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1076}, properties:{annotationPublicationtype:["Research"], evidence:"We observed abundant Iba1+ immune cells in the olfactory mucosa of all four patients (Table S4, Fig. 8B, D and E), and apoptotic cells (cleaved caspase-3 positive) were observed in the samples of all these patients (Fig. 8D and E, Table S4).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Olfaction Disorders"], annotationBioassay:["immunofluorescent labeling"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:126}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], evidence:"Increased Aβ plaque load was also associated with elevated TNF-α concentrations in APPSWE-Tau mice’s brain samples, as shown by ELISA measurements (Figure 3A). ", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["ELISA"], citationRef:"35328830"}}, {start: {_id:640}, end: {_id:575}, properties:{annotationPublicationtype:["Research"], evidence:"The LC group was differentiated from controls by increased body temperature and CRP and lowered SpO2, Gpx and ANTIOX values.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:575}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1031}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:575}, properties:{annotationPublicationtype:["Research"], evidence:"Nevertheless, in the present study, we detected that the patient group with Long COVID showed increased CRP levels compared with control levels, indicating a mild inflammatory response.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:896}, properties:{annotationPublicationtype:["Research"], evidence:"We validated our ddPCR results by ISH for SARS-CoV-2 spike RNA in respiratory and non-respiratory tissues in selected early, mid and late cases across >35 cell types and hyaline membranes (Figs.2 and 3, Extended Data Table  Table33 and Supplementary Data 3).", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationTechnique:["In situ hybridization"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:640}, end: {_id:1709}, properties:{annotationPublicationtype:["Case Report"], evidence:"The perivascular region from the patient showed immune cell infiltrates, fibrinogen leakage, increased PECAM-1 expression, and CD68 infiltrates (Figure 1A).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:67}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Positive results for serum IP/RT-QuIC for patients with PD in the first, second and external cohorts were 210/221 (95%), 34/34 (100%) and 15/20 (75%), respectively (Table 2 and Extended Data Table 4). ", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["immunoprecipitation-based real-time quaking-induced conversion"], citationRef:"37248302"}}, {start: {_id:1741}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Seventeen of 26 patients with MSA parkinsonian variant (MSA-P) and eight of 13 patients with MSA cerebellar variant (MSA-C) were positive (Supplementary Table 6).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["immunoprecipitation-based real-time quaking-induced conversion"], citationRef:"37248302"}}, {start: {_id:1742}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"Seventeen of 26 patients with MSA parkinsonian variant (MSA-P) and eight of 13 patients with MSA cerebellar variant (MSA-C) were positive (Supplementary Table 6).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["immunoprecipitation-based real-time quaking-induced conversion"], citationRef:"37248302"}}, {start: {_id:1743}, end: {_id:146}, properties:{annotationPublicationtype:["Research"], evidence:"In the external cohort, two non-synucleinopathy patients had negative results, whereas the patient with PDD had positive results (Extended Data Table 2).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", citationRef:"37248302"}}, {start: {_id:220}, end: {_id:393}, properties:{annotationPublicationtype:["Research"], evidence:"MSA seed injection resulted in a more rapid development of phosphorylated α-synuclein pathology by 6 months than PD seed injection.", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Corpus Striatum", "Brain"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMeshdisease:["Multiple System Atrophy"], annotationCellline:["HEK293"], annotationDurationAfterInjection:["6 months"], citationRef:"37248302"}}, {start: {_id:67}, end: {_id:280}, properties:{annotationPublicationtype:["Research"], evidence:"The results of IP/RT-QuIC of the brain samples were all positive (Supplementary Fig. 6a and Supplementary Table 12a), and the forming rate was over 1,000 relative fluorescence units (RFU) per hour.", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Corpus Striatum", "Brain"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["immunoprecipitation-based real-time quaking-induced conversion"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationCellline:["HEK293"], annotationDurationAfterInjection:["12 months", "6 months"], citationRef:"37248302"}}, {start: {_id:1750}, end: {_id:280}, properties:{annotationPublicationtype:["Research"], evidence:"The results of IP/RT-QuIC of the brain samples were all positive (Supplementary Fig. 6a and Supplementary Table 12a), and the forming rate was over 1,000 relative fluorescence units (RFU) per hour.", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Corpus Striatum", "Brain"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["immunoprecipitation-based real-time quaking-induced conversion"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationCellline:["HEK293"], annotationDurationAfterInjection:["12 months", "6 months"], citationRef:"37248302"}}, {start: {_id:640}, end: {_id:1761}, properties:{annotationPublicationtype:["Research"], evidence:"However at a short distance from the hemorrhagic foci, both antibodies labelled numerous inclusions in endothelial cells of apparently spared vessels (Fig. 3. a, b). ", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1762}, properties:{annotationPublicationtype:["Research"], evidence:"However at a short distance from the hemorrhagic foci, both antibodies labelled numerous inclusions in endothelial cells of apparently spared vessels (Fig. 3. a, b). ", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", citationRef:"37283933"}}, {start: {_id:640}, end: {_id:14}, properties:{annotationPublicationtype:["Research"], evidence:"TNF, IL-6, and CCL7 remained persistently elevated in all inflammatory PASC (clusters 4 + 5) over time when compared to non-inflammatory PASC or individuals who were infected but recovered (Fig. 3F)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:13}, properties:{annotationPublicationtype:["Research"], evidence:"TNF, IL-6, and CCL7 remained persistently elevated in all inflammatory PASC (clusters 4 + 5) over time when compared to non-inflammatory PASC or individuals who were infected but recovered (Fig. 3F)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1007}, properties:{annotationPublicationtype:["Research"], evidence:"TNF, IL-6, and CCL7 remained persistently elevated in all inflammatory PASC (clusters 4 + 5) over time when compared to non-inflammatory PASC or individuals who were infected but recovered (Fig. 3F)", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1799}, properties:{annotationPublicationtype:["Research"], evidence:"In inflammatory PASC cluster 5, we also noted a protein signature suggestive of persistent type I interferon signaling including elevation of proteins that are induced by type I IFNs during acute SARS-CoV-2 infection (SAMD9L, DDX58, MNDA, and LAMP3)28,29.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1674}, properties:{annotationPublicationtype:["Research"], evidence:"In inflammatory PASC cluster 5, we also noted a protein signature suggestive of persistent type I interferon signaling including elevation of proteins that are induced by type I IFNs during acute SARS-CoV-2 infection (SAMD9L, DDX58, MNDA, and LAMP3)28,29.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1800}, properties:{annotationPublicationtype:["Research"], evidence:"In inflammatory PASC cluster 5, we also noted a protein signature suggestive of persistent type I interferon signaling including elevation of proteins that are induced by type I IFNs during acute SARS-CoV-2 infection (SAMD9L, DDX58, MNDA, and LAMP3)28,29.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1801}, properties:{annotationPublicationtype:["Research"], evidence:"In inflammatory PASC cluster 5, we also noted a protein signature suggestive of persistent type I interferon signaling including elevation of proteins that are induced by type I IFNs during acute SARS-CoV-2 infection (SAMD9L, DDX58, MNDA, and LAMP3)28,29.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:268}, properties:{annotationPublicationtype:["Research"], evidence:"Two important observations emerge from this analysis: First, IFN-γ is both the most highly expressed cytokine in cluster 4 and the most highly differentially expressed protein overall in this cluster.Similarly, many of the top 50 most differentially expressed proteins in cluster 4 are the cytokines, chemokines, or cytokine/chemokine receptor subunits highlighted above (Fig. 4A, upper portion). Cluster 4 participants also showed increased levels of cell surface receptors linked to inflammation (CD74) or inflammation-associated checkpoint molecules (CD5, TIM-3 (HAVCR2), PDCD1, and CD83).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1803}, properties:{annotationPublicationtype:["Research"], evidence:"Two important observations emerge from this analysis: First, IFN-γ is both the most highly expressed cytokine in cluster 4 and the most highly differentially expressed protein overall in this cluster.Similarly, many of the top 50 most differentially expressed proteins in cluster 4 are the cytokines, chemokines, or cytokine/chemokine receptor subunits highlighted above (Fig. 4A, upper portion). Cluster 4 participants also showed increased levels of cell surface receptors linked to inflammation (CD74) or inflammation-associated checkpoint molecules (CD5, TIM-3 (HAVCR2), PDCD1, and CD83).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1804}, properties:{annotationPublicationtype:["Research"], evidence:"Two important observations emerge from this analysis: First, IFN-γ is both the most highly expressed cytokine in cluster 4 and the most highly differentially expressed protein overall in this cluster.Similarly, many of the top 50 most differentially expressed proteins in cluster 4 are the cytokines, chemokines, or cytokine/chemokine receptor subunits highlighted above (Fig. 4A, upper portion). Cluster 4 participants also showed increased levels of cell surface receptors linked to inflammation (CD74) or inflammation-associated checkpoint molecules (CD5, TIM-3 (HAVCR2), PDCD1, and CD83).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1805}, properties:{annotationPublicationtype:["Research"], evidence:"Two important observations emerge from this analysis: First, IFN-γ is both the most highly expressed cytokine in cluster 4 and the most highly differentially expressed protein overall in this cluster.Similarly, many of the top 50 most differentially expressed proteins in cluster 4 are the cytokines, chemokines, or cytokine/chemokine receptor subunits highlighted above (Fig. 4A, upper portion). Cluster 4 participants also showed increased levels of cell surface receptors linked to inflammation (CD74) or inflammation-associated checkpoint molecules (CD5, TIM-3 (HAVCR2), PDCD1, and CD83).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1806}, properties:{annotationPublicationtype:["Research"], evidence:"Two important observations emerge from this analysis: First, IFN-γ is both the most highly expressed cytokine in cluster 4 and the most highly differentially expressed protein overall in this cluster.Similarly, many of the top 50 most differentially expressed proteins in cluster 4 are the cytokines, chemokines, or cytokine/chemokine receptor subunits highlighted above (Fig. 4A, upper portion). Cluster 4 participants also showed increased levels of cell surface receptors linked to inflammation (CD74) or inflammation-associated checkpoint molecules (CD5, TIM-3 (HAVCR2), PDCD1, and CD83).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1807}, properties:{annotationPublicationtype:["Research"], evidence:"Two important observations emerge from this analysis: First, IFN-γ is both the most highly expressed cytokine in cluster 4 and the most highly differentially expressed protein overall in this cluster.Similarly, many of the top 50 most differentially expressed proteins in cluster 4 are the cytokines, chemokines, or cytokine/chemokine receptor subunits highlighted above (Fig. 4A, upper portion). Cluster 4 participants also showed increased levels of cell surface receptors linked to inflammation (CD74) or inflammation-associated checkpoint molecules (CD5, TIM-3 (HAVCR2), PDCD1, and CD83).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1808}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we noted that in cluster 5, cytokines, chemokines, and their receptors were less prominent but two of the three most highly differentially expressed proteins overall were annexin-11 (ANXA11) and annexin-3(ANXA3) (Fig. 4A, lower portion).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1809}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we noted that in cluster 5, cytokines, chemokines, and their receptors were less prominent but two of the three most highly differentially expressed proteins overall were annexin-11 (ANXA11) and annexin-3(ANXA3) (Fig. 4A, lower portion).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1807}, properties:{annotationPublicationtype:["Research"], evidence:"Second, we noted that in cluster 5, cytokines, chemokines, and their receptors were less prominent but two of the three most highly differentially expressed proteins overall were annexin-11 (ANXA11) and annexin-3(ANXA3) (Fig. 4A, lower portion).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1810}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1031}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1811}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1812}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1813}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1799}, properties:{annotationPublicationtype:["Research"], evidence:"The presence of SAMD9L and MNDA among the top differentially expressed proteins highlights the prominence of the type-I interferon signature noted above and may be indicative of a role for sustained type I IFNs in driving persistent neutrophil activation35", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1800}, properties:{annotationPublicationtype:["Research"], evidence:"The presence of SAMD9L and MNDA among the top differentially expressed proteins highlights the prominence of the type-I interferon signature noted above and may be indicative of a role for sustained type I IFNs in driving persistent neutrophil activation35", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:655}, end: {_id:241}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, COVID-19 patients with pre-existing neurological syndromes such as Guillain–Barré syndrome exhibit impairment in amyloid processing along with increased biomarkers of neurodegenerative diseases in their cerebrospinal fluid (CSF), including neuroinflammatory cytokines, glial fibrillary acidic protein and neuronal injury markers (Guasp et al., 2022; Jarius et al., 2022; Kanberg et al., 2020; Pilotto et al., 2021; Ziff et al., 2022; Visser et al., 2022 preprint).", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1851}, end: {_id:775}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, an increase in soluble ACE2 levels has been detected in patients with cardiovascular and inflammatory conditions, in those with COVID-19 and in the aging population, indicating convergence to the ACE2–renin–angiotensin system (Batlle et al., 2022; Verdecchia et al., 2020). ", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:67}, end: {_id:453}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 is highly expressed in neutrophils, monocytes, and B cells and has a lower expression in microglia [15,16].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["B-Lymphocytes", "Monocytes", "Neutrophils"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:73}, properties:{annotationPublicationtype:["Review"], evidence:"Translocator protein 18 (TSPO) PET signal, which denotes the innate inflammatory response, is seen in the brains of both people with PD and those with rapid eye movement (REM) sleep behavioral disorder (RBD), considered indicative of a prodromal PD [41,42].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1867}, end: {_id:73}, properties:{annotationPublicationtype:["Review"], evidence:"Translocator protein 18 (TSPO) PET signal, which denotes the innate inflammatory response, is seen in the brains of both people with PD and those with rapid eye movement (REM) sleep behavioral disorder (RBD), considered indicative of a prodromal PD [41,42].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1880}, properties:{annotationPublicationtype:["Review"], evidence:"Similarly, upregulation of proteins associated with transmigration (CCR2 and CD11b) occurred in RBD and early PD, suggesting an increase in migratory capacity early in PD [73,79].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Prodromal Symptoms"], annotationTimeline:["early stage"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1881}, properties:{annotationPublicationtype:["Review"], evidence:"Similarly, upregulation of proteins associated with transmigration (CCR2 and CD11b) occurred in RBD and early PD, suggesting an increase in migratory capacity early in PD [73,79].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Prodromal Symptoms"], annotationTimeline:["early stage"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:268}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["less than 2 years"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:999}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1925}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"However, females (both humans and mice) showed higher repair of oxidative DNA damage in response to α-syn compared with males [152] and higher levels of the anti-inflammatory angiotensin 2 receptor [153].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1926}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"However, females (both humans and mice) showed higher repair of oxidative DNA damage in response to α-syn compared with males [152] and higher levels of the anti-inflammatory angiotensin 2 receptor [153].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:640}, end: {_id:214}, properties:{annotationPublicationtype:["Research"], evidence:"Immunostaining showed accumulation of p-a-Syn (cohort 1, Figure 7F) in COVID-19 samples compared with the expression in non-COVID-19 samples, which indicates a potential link of PD phenotypes within the substantia nigra of COVID-19 patients despite the lack of acute clinical symptoms specific to midbrain dysfunction.34", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2287}, end: {_id:296}, properties:{annotationPublicationtype:["Review"], evidence:"Patients with RR-MS have a strikingly reduced number of CD39 Tregs in the blood; this might contribute to the defects of Tregs in MS.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1326}, end: {_id:1331}, properties:{annotationPublicationtype:["Review"], evidence:"In turn, this results in a leakage of microbial-derived products and inflammatory mediators into the bloodstream, through which they can cross the blood-brain barrier (BBB) and finally reach the brain [34] (Fig. 1).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1326}, end: {_id:1333}, properties:{annotationPublicationtype:["Review"], evidence:"In turn, this results in a leakage of microbial-derived products and inflammatory mediators into the bloodstream, through which they can cross the blood-brain barrier (BBB) and finally reach the brain [34] (Fig. 1).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:70}, end: {_id:1331}, properties:{annotationPublicationtype:["Review"], evidence:"In turn, this results in a leakage of microbial-derived products and inflammatory mediators into the bloodstream, through which they can cross the blood-brain barrier (BBB) and finally reach the brain [34] (Fig. 1).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:70}, end: {_id:1333}, properties:{annotationPublicationtype:["Review"], evidence:"In turn, this results in a leakage of microbial-derived products and inflammatory mediators into the bloodstream, through which they can cross the blood-brain barrier (BBB) and finally reach the brain [34] (Fig. 1).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:836}, end: {_id:1772}, properties:{annotationPublicationtype:["Research"], evidence:"Our results reveal not only the presence of mCardinal in both fused neurons but also the movement of mitochondria between them (Fig. 3, C to E, and movie S3).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1267}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Unlike DX600, which left the cellular uptake of the spike proteins unaffected, heparin reduced the WT and Delta spike uptake in 293T and 293T-ACE2 cells, as shown by data obtained with imaging flow cytometry (Figure 3A–H).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationConcentration:["50 nM"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["293T cell", "293T cell overexpressing ACE2"], citationRef:"35054983"}}, {start: {_id:1267}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Unlike DX600, which left the cellular uptake of the spike proteins unaffected, heparin reduced the WT and Delta spike uptake in 293T and 293T-ACE2 cells, as shown by data obtained with imaging flow cytometry (Figure 3A–H).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationConcentration:["50 nM"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["293T cell", "293T cell overexpressing ACE2"], citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:1138}, end: {_id:1140}, properties:{annotationPublicationtype:["Research"], evidence:"The expression of collagen IV, a major component of BMs, was measured by IHC and found to be significantly decreased in the cerebral vessels of infected animals, compared to the mock group.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebral Arteries"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10036", "10090"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"34489403"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_COMPONENT]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:874}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, homeostatic microglial marker TMEM119 was consistently expressed in our cohort (Fig. 5a–d), even though it is known to be downregulated upon microglial activation in various neuropathological conditions25.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:2343}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"In the same mice, serum CCL11 levels were elevated at 7 days post-infection and—in contrast to persistent elevation in CSF—normalized in serum by 7 weeks post-infection (Figures 1D, 1E, ​1E,S6C,S6C, and S6D; Table S1). ", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Serum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:46}, properties:{annotationPublicationtype:["Review"], evidence:"Of direct pertinence are the demonstrations that brain microvessels isolated from Alzheimer's disease brains showed significantly elevated nitric oxide synthase activity [34], as well as enhanced levels of protein oxidation products [35].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microvessels"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:7}, end: {_id:64}, properties:{annotationPublicationtype:["Review"], evidence:"Utilizing an antibody directed to nitrotyrosine it has been shown that there are significantly elevated levels of this reaction product in Alzheimer's disease brains [96] and in amyotrophic lateral sclerosis [97].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:65}, end: {_id:64}, properties:{annotationPublicationtype:["Review"], evidence:"Utilizing an antibody directed to nitrotyrosine it has been shown that there are significantly elevated levels of this reaction product in Alzheimer's disease brains [96] and in amyotrophic lateral sclerosis [97].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:77}, end: {_id:80}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:81}, end: {_id:80}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:67}, end: {_id:257}, properties:{annotationPublicationtype:["Review"], evidence:"Early autopsy evidence within the SN of PD patients showed increased numbers of CD8+ T cells in close proximity to activated microglia and degenerating neurons.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, both CD4+ and CD8+ T cells have been discovered within the SN of PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:257}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, both CD4+ and CD8+ T cells have been discovered within the SN of PD patients.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:263}, properties:{annotationPublicationtype:["Review"], evidence:"A greater loss of naive helper CD4+ T cells (CD45RA+) and either unchanged or increased levels of effector/memory helper T-cell subset (CD29+ or CD45R0+) have also been observed.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:267}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:270}, properties:{annotationPublicationtype:["Review"], evidence:"Increased frequencies of activated CD4+ T cells expressing Fas (Hisanaga et al. 2001) and increased IFN-γ-producing Th1 cells, decreased IL-4-producing Th2 cells, and a decrease in CD4+CD25+ T cells have been found in the peripheral blood of PD patients (Baba et al. 2005), whereas circulating IL-15, RANTES, and IL-10 are significantly elevated in PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Blood"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:145}, properties:{annotationPublicationtype:["Review"], evidence:"PD pathology is characterized by chronic neuroinflammation, Lewy body inclusions, and loss of dopamine-producing (DA) neurons in the substantia nigra parts compacta (SNpc) of the midbrain [4, 6]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", annotationAnatomy:["midbrain"], citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:263}, properties:{annotationPublicationtype:["Review"], evidence:"Compared to people with other neurologic diseases, individuals with PD have increased memory T cells but decreased naive T cells [88].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:411}, properties:{annotationPublicationtype:["Review"], evidence:"Lymphocytes from PD patients display an increased incidence of micronuclei, single strand DNA breaks, and oxidized purine bases [109]. Interestingly,levodopa treatment seems to reduce this DNA damage in peripheral blood lymphocytes [110].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:556}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have reported changes in gut microbiota in PD, including increases in Lactobacillus, Akkermansia, and Bifidobacterium, and decreases in Prevotella, Blautia and Faecalibacterium.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:557}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have reported changes in gut microbiota in PD, including increases in Lactobacillus, Akkermansia, and Bifidobacterium, and decreases in Prevotella, Blautia and Faecalibacterium.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:558}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have reported changes in gut microbiota in PD, including increases in Lactobacillus, Akkermansia, and Bifidobacterium, and decreases in Prevotella, Blautia and Faecalibacterium.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:66}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, numerous studies demonstrate that mitochondrial dysfunction results in the chronic production of reactive oxygen species, leading to oxidative stress, and promoting both misfolding of α-synuclein and directly causing neurodegeneration.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:640}, end: {_id:647}, properties:{annotationPublicationtype:["Review"], evidence:"While on intensive care units, patients showed agitation, confusion, and corticospinal tract signs such as enhanced tendon reflexes and clonus.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:682}, properties:{annotationPublicationtype:["Review"], evidence:"Unexpectedly, acute cerebrovascular disease is also emerging as an important complication, with cohort studies reporting stroke in 2–6% of patients hospitalised with COVID-19. So far, 96 patients with stroke have been described, who frequently had vascular events in the context of a pro-inflammatory hypercoagulable state with elevated C-reactive protein, D-dimer, and ferritin.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:683}, properties:{annotationPublicationtype:["Review"], evidence:"Unexpectedly, acute cerebrovascular disease is also emerging as an important complication, with cohort studies reporting stroke in 2–6% of patients hospitalised with COVID-19. So far, 96 patients with stroke have been described, who frequently had vascular events in the context of a pro-inflammatory hypercoagulable state with elevated C-reactive protein, D-dimer, and ferritin.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:728}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, some case reports have appeared, including a woman with encephalopathy with imaging changes consistent with acute necrotising encephalopathy (figure 2C, D)37 and a fatal case in which viral particles were found in endothelial cells and neural tissue, although there was no indication of whether this was associated with inflammation.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:696}, end: {_id:730}, properties:{annotationPublicationtype:["Review"], evidence:"Acute disseminated encephalomyelitis is a syndrome of multifocal demyelination, typically occurring weeks after an infection, which generally presents with focal neurological symptoms, often with encephalopathy.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:730}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological symptoms started at a median of 7 days (range −7 to 24) after respiratory or systemic features (figure 1), although two patients developed febrile illness 7 days after the onset of Guillain-Barré syndrome;45, 68 on hospital admission, one had a positive swab for SARS-CoV-2 and the other had lymphocytopenia and thrombocytopenia, which are characteristic for SARS-CoV-2 infection.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:730}, properties:{annotationPublicationtype:["Review"], evidence:"Three patients had diarrhoea before the onset of neurological disease.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:746}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:729}, properties:{annotationPublicationtype:["Review"], evidence:"Four of these patients had facial nerve involvement, five had dysphagia, and eight developed respiratory failure. Three had autonomic complications, one with hypertension and two with sphincter dysfunction. Electrophysiological studies were done in 12 patients and were consistent with demyelinating disease in eight and axonal disease in four patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:81}, end: {_id:768}, properties:{annotationPublicationtype:["Review"], evidence:"Concurrent deep vein thrombosis and pulmonary embolism have been found in other stroke patients.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:682}, properties:{annotationPublicationtype:["Review"], evidence:"Blood D-dimer concentration was raised in many patients with COVID-19, consistent with a pro-inflammatory, coagulopathic state in the setting of critical illness.51, 52, 53, 54, 55, 77, 92, 95, 96 Positive lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein-1 antibodies have also been reported in COVID-19-associated stroke,52, 77 although these can be raised in other critical illnesses, including infections.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:655}, end: {_id:782}, properties:{annotationPublicationtype:["Review"], evidence:"By comparison with other viruses, it would not be surprising to see immune-mediated disease, such as Guillain-Barré syndrome, and direct anterior horn cell viral damage, which causes acute flaccid myelitis, might also be expected.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:783}, end: {_id:782}, properties:{annotationPublicationtype:["Review"], evidence:"By comparison with other viruses, it would not be surprising to see immune-mediated disease, such as Guillain-Barré syndrome, and direct anterior horn cell viral damage, which causes acute flaccid myelitis, might also be expected.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:81}, end: {_id:682}, properties:{annotationPublicationtype:["Review"], evidence:"Thrombocytopenia with elevated D-dimer and C-reactive protein in severe COVID-19 and stroke are consistent with a virus-associated microangiopathic process.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:682}, properties:{annotationPublicationtype:["Review"], evidence:"Thrombocytopenia with elevated D-dimer and C-reactive protein in severe COVID-19 and stroke are consistent with a virus-associated microangiopathic process.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:789}, properties:{annotationPublicationtype:["Research"], evidence:"All ten patients developed fever and had at least two respiratory symptoms or signs (cough, shortness of breath, reduced oxygen saturations, or pleuritic chest pain) during their early presentation.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"32844161", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32844161"}}, {start: {_id:640}, end: {_id:75}, properties:{annotationPublicationtype:["Research"], evidence:"Florid acute bronchopneumonia and ventilator-associated pneumonia were not noted in this series, although mild interstitial neutrophilic inflammation (three [30%] of ten patients) and patchy acute bronchopneumonia (three [30%] patients) were observed. Interstitial macrophages were prominent.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:258}, properties:{annotationPublicationtype:["Research"], evidence:"We noted that lymphocytes in the lung were predominantly CD4-positive T cells.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:800}, properties:{annotationPublicationtype:["Research"], evidence:" A single patient (11%) had a right atrial thrombus. Pericarditis was identified in two patients (22%); one patient showed florid fibrinous pericarditis containing fungal hyphae (PM5), while the other showed only microscopic acute pericarditis (appendix p 22, figure 3 ).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:805}, properties:{annotationPublicationtype:["Research"], evidence:"Plasma cells were variably prominent, and sinusoidal histiocytes showed phagocytosis of red blood cells and other cells to varying extents.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:806}, properties:{annotationPublicationtype:["Research"], evidence:"Medullary areas showed prominence of plasma cells, and histiocytes were prominent in the sinuses.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney Medulla"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:807}, properties:{annotationPublicationtype:["Research"], evidence:"Medullary areas showed prominence of plasma cells, and histiocytes were prominent in the sinuses.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:806}, properties:{annotationPublicationtype:["Research"], evidence:"Bone marrow samples showed reactive changes with trilineage hyperplasia, and prominence of plasma cells and histiocytes were a common finding.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Bone Marrow"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:807}, properties:{annotationPublicationtype:["Research"], evidence:"Bone marrow samples showed reactive changes with trilineage hyperplasia, and prominence of plasma cells and histiocytes were a common finding.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Bone Marrow"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:2}, end: {_id:866}, properties:{annotationPublicationtype:["Research"], evidence:"13 brains (30%) showed gross macroscopic abnormalities (fresh  territorial ischaemic lesions in six patients, older territorial  ischaemic lesions in five patients, grey matter heterotopia in one  patient with trisomy 21, and cerebellar metastasis of a non-small cell  lung carcinoma in one patient; table).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:879}, properties:{annotationPublicationtype:["Research"], evidence:"Cytotoxic T lymphocytes could be seen in small amounts(up to 49 cells  per HPF) in the frontal cortex and basal ganglia, but their presence  was more pronounced in the brainstem, where they were mostly  concentrated in perivascular regions but were also observed in the  parenchyma as clusters in close vicinity to IBA-1-positive microglia  (figures 1, 4).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain Stem", "Parenchymal Tissue"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:881}, properties:{annotationPublicationtype:["Research"], evidence:"Infiltration of the meningeal compartments by cytotoxic T lymphocytes  was seen in 34 (79%) patients (moderate in six patients and mild in 28  patients; table, figure 4), with an enrichment of IBA-1-postive,  CD68-positive, and TMEM119-negative perivascular and meningeal  macrophages (figure 2).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:882}, properties:{annotationPublicationtype:["Research"], evidence:"Infiltration of the meningeal compartments by cytotoxic T lymphocytes  was seen in 34 (79%) patients (moderate in six patients and mild in 28  patients; table, figure 4), with an enrichment of IBA-1-postive,  CD68-positive, and TMEM119-negative perivascular and meningeal  macrophages (figure 2).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Meninges"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:883}, properties:{annotationPublicationtype:["Research"], evidence:"Infiltration of the meningeal compartments by cytotoxic T lymphocytes  was seen in 34 (79%) patients (moderate in six patients and mild in 28  patients; table, figure 4), with an enrichment of IBA-1-postive,  CD68-positive, and TMEM119-negative perivascular and meningeal  macrophages (figure 2).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Meninges"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:884}, properties:{annotationPublicationtype:["Research"], evidence:"Infiltration of the meningeal compartments by cytotoxic T lymphocytes  was seen in 34 (79%) patients (moderate in six patients and mild in 28  patients; table, figure 4), with an enrichment of IBA-1-postive,  CD68-positive, and TMEM119-negative perivascular and meningeal  macrophages (figure 2).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Meninges"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:319}, properties:{annotationPublicationtype:["Research"], evidence:"The olfactory bulb showed a high degree of astrogliosis and  microgliosis, but only minor infiltration by cytotoxic T  lymphocytes(figures 1, 4).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Olfactory Bulb"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:881}, properties:{annotationPublicationtype:["Research"], evidence:"Cases 2, 16, 21, and 41 showed more brainstem inflammation(in terms of  infiltration by cytotoxic CD8-positive T cells or activation of  microglia) than all others (figure 4).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain Stem"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:911}, properties:{annotationPublicationtype:["Research"], evidence:"The hematoxylin and eosin findings revealed two differences: 1) Microvessels of the brain of COVID-19 patients showed perivascular edema as defined by a zone of edema at least 50 μm in size around a capillary. 2) Less commonly, microvessels in the COVID-19 cases had endothelial cells that were degenerated, mummified, and detached, showed focal basement membrane duplication, and/or microthrombi.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationTechnique:["Hematoxylin and eosin staining"], annotationSpecies:["9606"], annotationSection:["Results"], citationRef:"33360731"}}, {start: {_id:640}, end: {_id:937}, properties:{annotationPublicationtype:["Research"], evidence:"With an added SARS-CoV-2 annotation, SARS-CoV-2 transcript reads were localized to a variety of cell clusters (Fig. 3 A), demonstrating the widespread infectivity of SARS-CoV-2 in neurons, radial glia, and neuronal progenitor cells.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Organoids"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["rna-seq method"], annotationCustomCellline:["induced human neural progenitor cell"], citationRef:"33433624"}}, {start: {_id:640}, end: {_id:939}, properties:{annotationPublicationtype:["Research"], evidence:"With an added SARS-CoV-2 annotation, SARS-CoV-2 transcript reads were localized to a variety of cell clusters (Fig. 3 A), demonstrating the widespread infectivity of SARS-CoV-2 in neurons, radial glia, and neuronal progenitor cells.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Organoids"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["rna-seq method"], annotationCustomCellline:["induced human neural progenitor cell"], citationRef:"33433624"}}, {start: {_id:640}, end: {_id:941}, properties:{annotationPublicationtype:["Research"], evidence:"With an added SARS-CoV-2 annotation, SARS-CoV-2 transcript reads were localized to a variety of cell clusters (Fig. 3 A), demonstrating the widespread infectivity of SARS-CoV-2 in neurons, radial glia, and neuronal progenitor cells.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Organoids"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["rna-seq method"], annotationCustomCellline:["induced human neural progenitor cell"], citationRef:"33433624"}}, {start: {_id:640}, end: {_id:683}, properties:{annotationPublicationtype:["Review"], evidence:"Increased levels of ferritin have also been observed among patients with COVID-19, similar to what is observed in macrophage activation syndrome", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1002}, end: {_id:683}, properties:{annotationPublicationtype:["Review"], evidence:"Increased levels of ferritin have also been observed among patients with COVID-19, similar to what is observed in macrophage activation syndrome", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:883}, properties:{annotationPublicationtype:["Review"], evidence:"With regard to inflammatory cells, large numbers of CD68+ macrophages were observed in the alveoli of patients who died from COVID-19-associated pneumonia, and SARS-CoV-2 proteins were detected in CD68+ alveolar macrophages", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Pneumonia"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:75}, properties:{annotationPublicationtype:["Review"], evidence:"Analysis of the bronchoalveolar fluid of patients with severe or critical COVID-19 showed a higher percentage of macrophages and neutrophils and a lower proportion of myeloid dendritic cells, plasmacytoid dendritic cells and T cells than that of patients with moderate disease", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1003}, properties:{annotationPublicationtype:["Review"], evidence:"Analysis of the bronchoalveolar fluid of patients with severe or critical COVID-19 showed a higher percentage of macrophages and neutrophils and a lower proportion of myeloid dendritic cells, plasmacytoid dendritic cells and T cells than that of patients with moderate disease", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:682}, properties:{annotationPublicationtype:["Review"], evidence:"The occurrence of a COVID-19-specific coagulopathy is suggested by elevated levels of fibrinogen, von Willebrand factor (VWF) and the fibrin degradation product D-dimer in the blood, whereas patients generally show minor or no changes in prothrombin time (a measure of time to clot), activated partial thromboplastin time (coagulation time), antithrombin levels, activated protein C levels and platelet count", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:958}, properties:{annotationPublicationtype:["Review"], evidence:"Alveolar damage, vessel wall oedema, hyaline thrombi, microhaemorrhage and diffuse thrombosis of peripheral small vessels have emerged as key features of COVID-19 contributing to respiratory failure6,8,46 (Fig. 2).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1015}, properties:{annotationPublicationtype:["Review"], evidence:"Alveolar damage, vessel wall oedema, hyaline thrombi, microhaemorrhage and diffuse thrombosis of peripheral small vessels have emerged as key features of COVID-19 contributing to respiratory failure6,8,46 (Fig. 2).", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:907}, properties:{annotationPublicationtype:["Review"], evidence:"Higher numbers of circulating endothelial cells were described in patients with COVID-19, especially among those admitted to the ICU, and the presence of circulating endothelial cells positively correlated with platelet and lymphocyte counts and with the classical endothelial marker soluble vascular cell adhesion molecule 1 (sVCAM1)65.", annotationCellType:["Circulating"], citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["patients admitted to the ICU"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1021}, properties:{annotationPublicationtype:["Review"], evidence:"Higher numbers of circulating endothelial cells were described in patients with COVID-19, especially among those admitted to the ICU, and the presence of circulating endothelial cells positively correlated with platelet and lymphocyte counts and with the classical endothelial marker soluble vascular cell adhesion molecule 1 (sVCAM1)65.", annotationCellType:["Circulating"], citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["patients admitted to the ICU"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:402}, properties:{annotationPublicationtype:["Review"], evidence:"Higher numbers of circulating endothelial cells were described in patients with COVID-19, especially among those admitted to the ICU, and the presence of circulating endothelial cells positively correlated with platelet and lymphocyte counts and with the classical endothelial marker soluble vascular cell adhesion molecule 1 (sVCAM1)65.", annotationCellType:["Circulating"], citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung", "Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["patients admitted to the ICU"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:907}, properties:{annotationPublicationtype:["Review"], evidence:"This was recently confirmed by another report from Italy,showing that patients with COVID-19 had increased circulating endothelial cells and higher plasma levels of soluble intercellular adhesion molecule 1 (sICAM1) and sVCAM1, further supporting the concept of endothelial dysfunction in COVID-19 (ref.66).", annotationCellType:["Circulating"], citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", annotationProteinType:["Soluble"], pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1027}, properties:{annotationPublicationtype:["Review"], evidence:"From a clinical standpoint, two phenotypes are described67,78. Patients with 'type L' have high lung compliance, lower lung weight as estimated by computed tomography scan and poor response to positive end-expiratory pressure.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationDiseaseType:["type L"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationTechnique:["computed tomography scan"], annotationSpecies:["9606"], annotationSection:["Full Text"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1028}, properties:{annotationPublicationtype:["Review"], evidence:"From a clinical standpoint, two phenotypes are described67,78. Patients with 'type L' have high lung compliance, lower lung weight as estimated by computed tomography scan and poor response to positive end-expiratory pressure.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationDiseaseType:["type L"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationTechnique:["computed tomography scan"], annotationSpecies:["9606"], annotationSection:["Full Text"], citationRef:"33824483"}}, {start: {_id:668}, end: {_id:1029}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, ARDS can be considered as a NETopathy81; higher levels of NETs were described in the plasma and bronchoalveolar fluid of patients with transfusion-associated and pneumonia-related ARDS compared with those without ARDS82–84.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationDiseaseType:["pneumonia-related", "transfusion-associated"], annotationMeshanatomy:["Plasma"], annotationSpecimen:["Bronchoalveolar Lavage Fluid"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1029}, properties:{annotationPublicationtype:["Review"], evidence:"NETs are markers of disease severity in patients with SARS-CoV-2 infection80,85. Compared with controls, patients with COVID-19 have higher levels of serum85 or plasma80myeloperoxidase (MPO)–DNA complexes, which are biomarkers of circulating NET fragments, and further increases were found in those patients requiring invasive mechanical ventilation", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationDiseaseType:["patients requiring invasive mechanical ventilation"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Serum", "Plasma"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1029}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, neutrophils isolated from patients with COVID-19 showed elevated NET release at baseline similar to phorbol myristate acetate (PMA)-stimulated neutrophils from healthy donors, indicating that the COVID-19 plasma environment promotes NET formation80", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neutrophils"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1144}, properties:{annotationPublicationtype:["Research"], evidence:"We noted an increase in thin collagen IV-positive strings lacking CD34 staining (Fig. 1a,b).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Frontal Lobe"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"Counting revealed a significant increase in string vessels in patients with SARS-CoV-2 (Fig. 1c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Frontal Lobe"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1148}, properties:{annotationPublicationtype:["Research"], evidence:"A similar finding was observed in K18-hACE2 mice, which express the human angiotensin-converting enzyme 2 (hACE2) receptor, under the control of the keratin 18 promoter. In this model, SARS-CoV-2 infection induced the formation of string vessels in a time-dependent manner (Fig. 1g,h and Supplementary Fig. 1b). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["10090"], annotationTimeline:["Day 7 post infection"], annotationMouseType:["mouse expressing human angiotensin-converting enzyme 2 under the control of the keratin 18 promoter"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1144}, properties:{annotationPublicationtype:["Research"], evidence:"A similar finding was observed in K18-hACE2 mice, which express the human angiotensin-converting enzyme 2 (hACE2) receptor, under the control of the keratin 18 promoter. In this model, SARS-CoV-2 infection induced the formation of string vessels in a time-dependent manner (Fig. 1g,h and Supplementary Fig. 1b). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["10090"], annotationTimeline:["Day 7 post infection"], annotationMouseType:["mouse expressing human angiotensin-converting enzyme 2 under the control of the keratin 18 promoter"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1242}, properties:{annotationPublicationtype:["Research"], evidence:"Histological brain analysis showed reactive gliosis, congestion and cortical neuron eosinophilic degeneration, and axonal disruption in all six cases (Fig. 6)", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1247}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1248}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1249}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1251}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:67}, end: {_id:195}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, we also demonstrated, by means of single-nuclei sequencing, a specific upregulation of microglia in the midbrain tissue from sporadic PD (sPD) patients compared to controls", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["sporadic"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["Single-nucleus RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:640}, end: {_id:57}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1574}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1701}, properties:{annotationPublicationtype:["Research"], evidence:"Of 44 cases, 38 were determined to have died from COVID-19, and of these, 35 (92.1%) had either acute pneumonia or diffuse alveolar damage at the time of death (Supplementary Data 2).", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36517603"}}, {start: {_id:640}, end: {_id:1710}, properties:{annotationPublicationtype:["Case Report"], evidence:"Numerous neurons were found to be surrounded by microglial cells in the brain of the patient, considered to represent neuronophagia (Panel E), and the number of the CD68+ microglial nodules was significantly increased compared with control tissues (Panel F).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1711}, properties:{annotationPublicationtype:["Case Report"], evidence:"Numerous neurons were found to be surrounded by microglial cells in the brain of the patient, considered to represent neuronophagia (Panel E), and the number of the CD68+ microglial nodules was significantly increased compared with control tissues (Panel F).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1713}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1714}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1715}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1716}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1717}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1718}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1719}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1720}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1721}, properties:{annotationPublicationtype:["Case Report"], evidence:"Panel G shows lymphocytic infiltrates (CD3+, CD4+, and CD8+) in the parenchyma (top row), perivascular region (middle row), and meninges (bottom row).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1728}, properties:{annotationPublicationtype:["Research"], evidence:"Small vessel thromboses were detected in nine COVID-19 patients at the level of the pons, deep cerebellar nuclei and cerebral cortex, with one patient presenting small vessel thromboses in multiple sites.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Cerebellar Nuclei", "Cerebral Cortex", "Pons"], source:"wp4-cbm-comorbidity", pmid:"36781876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1728}, properties:{annotationPublicationtype:["Research"], evidence:"In all COVID-19 cases, CD61 immunoperoxidase staining revealed platelet-rich microthrombi in small parenchymal vessels, with no evidence of arachnoid of meningeal vessels being involved, as seen in Fig. 1d. ", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1728}, properties:{annotationPublicationtype:["Research"], evidence:"In line with previous findings in literature, CNS microthromboses appear to be peculiar to the COVID-19 cohort, with no control subject presenting either fibrin- or platelet-enriched microthrombi in the CNS or other organs regardless of the cause of death.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"36781876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1710}, properties:{annotationPublicationtype:["Research"], evidence:"Microglial nodules associated with perineuronal HLA-DR +/TMEM119+/CD68+ cells were suggestive of neuronophagia in 18 COVID-19 subjects (Fig. 6a–h) and were identified at the level of the substantia nigra (N = 14), dorsal motor nucleus of the vagus (N = 12), medullary reticular formation (N = 9), area postrema(N = 6) and basal ganglia (N = 5); no microglial nodules were found in control cases, regardless of cause of death. ", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Basal Ganglia", "Medulla Oblongata", "Area Postrema", "Reticular Formation"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1736}, properties:{annotationPublicationtype:["Research"], evidence:"Morphometrical quantification of CD206+ perivascular cells revealed statistically significant differences between groups, with COVID-19 subjects presenting higher densities of pro-inflammatory macrophages in both medulla and midbrain (Fig. 7c, d).", annotationCustomCell:["CD206+ perivascular cell"], citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["midbrain"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:319}, properties:{annotationPublicationtype:["Research"], evidence:"At the level of the medulla oblongata, a topographically defined pattern of microgliosis was detected, as seen in Fig. 8a–c. ", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1739}, properties:{annotationPublicationtype:["Research"], evidence:"Welch one-way ANOVA of individual counting fields (FOVs) (Fig. 8d)revealed statistically significant differences (p < 0.001) in TMEM119+/CD68+ activated microglial cell densities between the medullary tegmentum (T, FOV-13; 216.84 ± 52.26 microglia/mm2) and the ventral medulla (pes, P, FOV4–6; 156.09 ± 35.16microglia/mm2).", annotationCustomCell:["TMEM119+/CD68+ activated microglial cell"], citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationAnatomy:["midbrain tegmentum"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:319}, properties:{annotationPublicationtype:["Research"], evidence:"When comparing microglial densities between COVID-19 patients and the control cohort, statistically significant differences were found when considering overall medullary microgliosis, as well as single anatomical compartments (Fig. 8f).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:319}, properties:{annotationPublicationtype:["Research"], evidence:"This anatomically segregated pattern of inflammation targeting mainly the substantia nigra, but also part of the preacqueductal tegmentum, indicates an increasing dorsal-to-ventral gradient of microgliosis which affects the gray matter of the midbrain, sparing counting fields falling within the cerebral peduncle (FOV5–6).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Gray Matter"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["midbrain tegmentum"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1740}, properties:{annotationPublicationtype:["Research"], evidence:"Indeed, subjects with detectable viral genomic sequences and antigens (RT-PCR+/IHC+) were characterized by higher microglial densities in the medullary (p = 0.017) and midbrain tegmentum (p = 0.0074) when compared to negative (RT-PCR−/IHC−) COVID-19 subjects, as seen in Figs. 8h and 10g. ", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationCell:["midbrain tegmentum"], annotationMeshanatomy:["Medulla Oblongata"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1754}, properties:{annotationPublicationtype:["Research"], evidence:"In the biopsy samples, multiple well-delineated foci of CD163 positive macrophages were observed in the white matter (Fig. 1. q, t, u, v).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["White Matter", "Brain"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["magnetic resonance imaging", "biopsy"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1756}, properties:{annotationPublicationtype:["Research"], evidence:"In the foci, numerous and large axonal swellings were seen and white matter was vacuolized (Fig. 1. x). ", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["magnetic resonance imaging"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1759}, properties:{annotationPublicationtype:["Research"], evidence:"Some recent blood extravasation (Fig. 1. r) and a few siderophages were observed.", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["hematoxylin staining"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1760}, properties:{annotationPublicationtype:["Research"], evidence:"The most conspicuous lesions were small foci rich in CD163 positive macrophages centered by a small caliber arteriole (Fig. 2. a, b, c) associated with swollen axons and vacuolization of the surrounding white matter (Fig. 2. d, e).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["Axons"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["hematoxylin-eosin staining"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1756}, properties:{annotationPublicationtype:["Research"], evidence:"The most conspicuous lesions were small foci rich in CD163 positive macrophages centered by a small caliber arteriole (Fig. 2. a, b, c) associated with swollen axons and vacuolization of the surrounding white matter (Fig. 2. d, e).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshanatomy:["White Matter", "Brain"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["hematoxylin-eosin staining"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1029}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1827}, properties:{annotationPublicationtype:["Review"], evidence:"Postmortem analyses of COVID-19 patients' brain tissue revealed T-cell infiltration and microglial activation, and injured neurons and astrocytes (Kanberg et al., 2020; Schwabenland et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:640}, end: {_id:1828}, properties:{annotationPublicationtype:["Review"], evidence:"Postmortem analyses of COVID-19 patients' brain tissue revealed T-cell infiltration and microglial activation, and injured neurons and astrocytes (Kanberg et al., 2020; Schwabenland et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1829}, end: {_id:1835}, properties:{annotationPublicationtype:["Review"], evidence:"For example, a meta-analysis of ~10,000 COVID-19 studies revealed the persistence of headache in between 8% and 15% of patients in the first 6 months after SARS-CoV-2 infection (Fernández-de-las-Peñas et al., 2021), and two independent patient cohort studies reported partial taste and smell disorders in 40% of patients (Lechien et al., 2020; Leedman et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["6 months after acute infection"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:655}, end: {_id:1828}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, COVID-19 patients with pre-existing neurological syndromes such as Guillain–Barré syndrome exhibit impairment in amyloid processing along with increased biomarkers of neurodegenerative diseases in their cerebrospinal fluid (CSF), including neuroinflammatory cytokines, glial fibrillary acidic protein and neuronal injury markers (Guasp et al., 2022; Jarius et al., 2022; Kanberg et al., 2020; Pilotto et al., 2021; Ziff et al., 2022; Visser et al., 2022 preprint).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDisease:["COVID-19"], citationRef:"37458167"}}, {start: {_id:67}, end: {_id:1878}, properties:{annotationPublicationtype:["Review"], evidence:"Some studies in PD cohorts show an increase of classical monocytes [77,78], and the monocytic distribution appears to evolve, since people with RBD or early PD (<5 years from diagnosis) showed increased classical monocytes, while in late-stage disease (>5 years) the intermediate monocytes were the cells increased [73,79].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1879}, properties:{annotationPublicationtype:["Review"], evidence:"Some studies in PD cohorts show an increase of classical monocytes [77,78], and the monocytic distribution appears to evolve, since people with RBD or early PD (<5 years from diagnosis) showed increased classical monocytes, while in late-stage disease (>5 years) the intermediate monocytes were the cells increased [73,79].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Prodromal Symptoms"], annotationTimeline:["more than 5 years from diagnosis"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1882}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, people with PD had increased monocyte numbers in the CSF [80]. However, the antigen-presenting (HLA-DR) and phagocytic capacity (CD163) of blood monocytes increased with time, becoming significant at later PD stages [73,79]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1003}, properties:{annotationPublicationtype:["Review"], evidence:"Analyses of blood from people with PD showed increased neutrophils and decreased lymphocytes many years before diagnosis, thus associating a higher NLR with PD risk [56,5", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["many years before diagnosis"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:1885}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, the relevance of the increased NLR is true in iPD and genetic GBA-PD, but not in those with genetic LRRK2-PD, supporting a differential immune response in these PD subtypes [90]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the decrease in total T cells, the percentage of activated (HLA-DR+) T cells (CD8 and CD4) are increased in the blood and CSF in PD [105].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:257}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the decrease in total T cells, the percentage of activated (HLA-DR+) T cells (CD8 and CD4) are increased in the blood and CSF in PD [105].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid", "Blood"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:331}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["less than 2 years"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:270}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["less than 2 years"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1891}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:258}, properties:{annotationPublicationtype:["Review"], evidence:"Another study confirmed the decrease in naïve CD8 T cells and the increase in late-differentiated CD4 T cells during PD [108]. Naïve CD8 T cells in blood were positively correlated with the severity of autonomic dysfunction and psychiatric complications, and negatively with the severity of RBD [108].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1896}, properties:{annotationPublicationtype:["Review"], evidence:"scRNAseq of T cells from people with PD revealed clonal expansion of cytotoxic CD4 T cells and bias in terminal effector memory CD8 cells, which showed enrichment of certain genes associated with trans-endothelial migration [101].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["T-Lymphocytes"], annotationCell:["CD4-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1897}, properties:{annotationPublicationtype:["Review"], evidence:"scRNAseq of T cells from people with PD revealed clonal expansion of cytotoxic CD4 T cells and bias in terminal effector memory CD8 cells, which showed enrichment of certain genes associated with trans-endothelial migration [101].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["effector memory CD8-positive, alpha-beta T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1901}, properties:{annotationPublicationtype:["Review"], evidence:"Besides T cells, people with PD also have a reduced number of B cells [119,120]. Additionally, the B cell compartment during PD shows decreased naïve B cells and increased unswitched memory B cells [107,121].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1903}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1906}, properties:{annotationPublicationtype:["Review"], evidence:"Increased α-syn autoantibodies in the CSF of people with PD have been reported [124], although it is suggested that those α-syn autoantibodies with high affinity are decreased in the blood [125] and CSF [126] as the disease progresses.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1906}, properties:{annotationPublicationtype:["Review"], evidence:"Similarly, neuromelanin autoantibodies are found in people with PD and decrease as the disease progresses [131].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1918}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"In terms of sex immune dimorphism during PD, more naïve T cells and fewer resting NK cells have been reported in females (vs. males) [147]. Metabolomics studies in blood revealed a sex-associated pattern during de novo PD, with males showing a significantly different profile versus control, but not females [148].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1919}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"In terms of sex immune dimorphism during PD, more naïve T cells and fewer resting NK cells have been reported in females (vs. males) [147]. Metabolomics studies in blood revealed a sex-associated pattern during de novo PD, with males showing a significantly different profile versus control, but not females [148].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1882}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"When addressing monocytes in people with PD, disease-associated changes differed between sexes [79,82], with females showing the most robust transcriptomic changes [149], but with males showing higher numbers of monocytes compared with females [147].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1252}, end: {_id:158}, properties:{annotationPublicationtype:["Review"], evidence:"Proliferative-phase DAD shows interstitial lymphocytic infiltrates, squamous metaplasia (replacement of alveolar epithelium with squamous epithelium), syncytial multinucleated giant cells (fusions of uninuclear cells such as monocytes and/or macrophages or epithelial cells) and reactive type II pneumocyte (AT2) hyperplasia (reactive proliferation of a specific type of pulmonary epithelial cell.)", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1252}, end: {_id:1934}, properties:{annotationPublicationtype:["Review"], evidence:"Proliferative-phase DAD shows interstitial lymphocytic infiltrates, squamous metaplasia (replacement of alveolar epithelium with squamous epithelium), syncytial multinucleated giant cells (fusions of uninuclear cells such as monocytes and/or macrophages or epithelial cells) and reactive type II pneumocyte (AT2) hyperplasia (reactive proliferation of a specific type of pulmonary epithelial cell.)", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1252}, end: {_id:1935}, properties:{annotationPublicationtype:["Review"], evidence:"Proliferative-phase DAD shows interstitial lymphocytic infiltrates, squamous metaplasia (replacement of alveolar epithelium with squamous epithelium), syncytial multinucleated giant cells (fusions of uninuclear cells such as monocytes and/or macrophages or epithelial cells) and reactive type II pneumocyte (AT2) hyperplasia (reactive proliferation of a specific type of pulmonary epithelial cell.)", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1945}, properties:{annotationPublicationtype:["Review"], evidence:"COVID-19 autopsy lungs revealed endothelial injury, microangiopathy (injury of capillaries with thickening and weakening of the vessel walls) and intussusceptive angiogenesis (an aberrant blood vessel neoformation), and perivascular inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1948}, properties:{annotationPublicationtype:["Review"], evidence:"In addition to changes to the endothelium, autopsy tissues showed increased microthrombi in both venous and arterial vessels and multifocal acute infarctions.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Veins", "Arteries"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1950}, properties:{annotationPublicationtype:["Review"], evidence:"In autopsy specimens, renal histomorphological alterations include acute tubular necrosis, thrombotic microangiopathy, interstitial inflammation and fibrosis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:1956}, end: {_id:730}, properties:{annotationPublicationtype:["Review"], evidence:"The most recent autopsy related to Lassa virus infection was published 40 years ago62, although 100,000 to 300,000 infections are estimated to occur annually, with case fatality rates ranging from 15% to 70% (ref. 63). Clinical manifestations of this fatal disease can include acute kidney injury, neurological complications and haemorrhage.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:178}, properties:{annotationPublicationtype:["Research"], evidence:"Remarkably, the same transcriptional signatures identified in SARS-CoV-2 infected DA neurons in vitro (Figures S3I, S3J, S3K, and 3C) were observed in COVID-19 autopsy samples, including the induction of chemokine/cytokine (cohort 1, Figure 7A), inflammation (cohort 1, Figure 7B), senescence-associated (cohort 1, Figure 7C) genes, and SASP associated genes (cohort 1, Figure 7D).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:640}, end: {_id:4}, properties:{annotationPublicationtype:["Research"], evidence:"Remarkably, the same transcriptional signatures identified in SARS-CoV-2 infected DA neurons in vitro (Figures S3I, S3J, S3K, and 3C) were observed in COVID-19 autopsy samples, including the induction of chemokine/cytokine (cohort 1, Figure 7A), inflammation (cohort 1, Figure 7B), senescence-associated (cohort 1, Figure 7C) genes, and SASP associated genes (cohort 1, Figure 7D).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:1841}, end: {_id:2172}, properties:{annotationPublicationtype:["Research"], evidence:"While standard diagnostic MRI scans showed no clinically relevant pathological findings in any participant, DCE-MRI imaging revealed significantly increased whole-brain leakage in patients with long COVID with brain fog (Fig. 2d–f), with an increased percentage of brain volume with leaky blood vessels in the cohort with brain fog compared to the cohort without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:264}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast, in another study, Tregs were detectable in all the CSF samples, and Tregs with a CD45R high CD95 high phenotype previously shown to be highly apoptosis sensitive were enriched in the CSF compared with the peripheral blood of the MS patients.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:551}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Substantial changes in the composition of the microbiota are associated with IBDs, and changes in the individual species of microbial flora can shape the induction of T cell subsets, including Th17 and Tregs in the intestine.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:551}, end: {_id:331}, properties:{annotationPublicationtype:["Review"], evidence:"Substantial changes in the composition of the microbiota are associated with IBDs, and changes in the individual species of microbial flora can shape the induction of T cell subsets, including Th17 and Tregs in the intestine.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:640}, end: {_id:75}, properties:{annotationPublicationtype:["Research"], evidence:"In the lung, H&E revealed severe congestion, diffuse alveolar damage, and interstitial pneumonia presenting as septal infiltrate shown in the middle of the image (A); SARS-CoV-2 positivity is evident in alveolar pneumocytes showing cytopathic features (B) and in the bronchiolar ciliated epithelium (B); diffuse interstitial macrophages detected by CD68 antibody (C, arrowheads); T-lymphocyte (D) and B-lymphocyte (E) infiltrates are revealed by CD3 and CD20 reactions, respectively; CD42b marks several microthrombi in capillary and interstitial vessels characterized by a rosary crown feature (F).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:158}, properties:{annotationPublicationtype:["Research"], evidence:"In the lung, H&E revealed severe congestion, diffuse alveolar damage, and interstitial pneumonia presenting as septal infiltrate shown in the middle of the image (A); SARS-CoV-2 positivity is evident in alveolar pneumocytes showing cytopathic features (B) and in the bronchiolar ciliated epithelium (B); diffuse interstitial macrophages detected by CD68 antibody (C, arrowheads); T-lymphocyte (D) and B-lymphocyte (E) infiltrates are revealed by CD3 and CD20 reactions, respectively; CD42b marks several microthrombi in capillary and interstitial vessels characterized by a rosary crown feature (F).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2368}, properties:{annotationPublicationtype:["Research"], evidence:"In the kidney, H&E labeled acute glomerular alterations in the lower part of the image and inflammatory infiltrates at the top (G); SARS-CoV-2 immunoreactivity detectable in some vascular endothelial cells (H, arrows); occasional foci of macrophages detected by the CD68 antibody (I, arrowheads); as in the lung, T-lymphocyte (J) and B-lymphocyte (K) infiltrates are revealed by CD3 and CD20 reactions, respectively; occasional microthrombi in the glomerular capillary are marked by CD42b antibody (L).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2369}, properties:{annotationPublicationtype:["Research"], evidence:"In the kidney, H&E labeled acute glomerular alterations in the lower part of the image and inflammatory infiltrates at the top (G); SARS-CoV-2 immunoreactivity detectable in some vascular endothelial cells (H, arrows); occasional foci of macrophages detected by the CD68 antibody (I, arrowheads); as in the lung, T-lymphocyte (J) and B-lymphocyte (K) infiltrates are revealed by CD3 and CD20 reactions, respectively; occasional microthrombi in the glomerular capillary are marked by CD42b antibody (L).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:158}, properties:{annotationPublicationtype:["Research"], evidence:"In the kidney, H&E labeled acute glomerular alterations in the lower part of the image and inflammatory infiltrates at the top (G); SARS-CoV-2 immunoreactivity detectable in some vascular endothelial cells (H, arrows); occasional foci of macrophages detected by the CD68 antibody (I, arrowheads); as in the lung, T-lymphocyte (J) and B-lymphocyte (K) infiltrates are revealed by CD3 and CD20 reactions, respectively; occasional microthrombi in the glomerular capillary are marked by CD42b antibody (L).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2372}, properties:{annotationPublicationtype:["Research"], evidence:"In the heart, H&E stained parenchymal dissociation and myocyte vacuolization in the upper part of the image (M); rare SARS-CoV-2 traces observed in the endocardium (N, arrows); occasional foci of interstitial macrophages labeled by the CD68 antibody (O, arrowheads), rare subepicardial T-lymphocyte (P, arrows) and B-lymphocyte (Q, arrowheads) infiltrates revealed by CD3 and CD20 reactions in the upper and lower parts of the images, respectively; CD42b antibody marks focal and sporadic capillary microthrombi (R).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:158}, properties:{annotationPublicationtype:["Research"], evidence:"In the heart, H&E stained parenchymal dissociation and myocyte vacuolization in the upper part of the image (M); rare SARS-CoV-2 traces observed in the endocardium (N, arrows); occasional foci of interstitial macrophages labeled by the CD68 antibody (O, arrowheads), rare subepicardial T-lymphocyte (P, arrows) and B-lymphocyte (Q, arrowheads) infiltrates revealed by CD3 and CD20 reactions in the upper and lower parts of the images, respectively; CD42b antibody marks focal and sporadic capillary microthrombi (R).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:1756}, properties:{annotationPublicationtype:["Research"], evidence:"In the brain, H&E revealed diffuse neuronal loss and cortical edema characterized by spongiosis (S); very rare SARS-CoV-2-positive cells detected in the pons (T); amoeboid microglial cells and several microglial nodules identified by the CD68 antibody, mainly in the brainstem (U); rare T and B lymphocytes are observed in the perivascular spaces (V) and in some nodules (W); frequent capillary microthrombi are observed in the brainstem (X).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:495}, properties:{annotationPublicationtype:["Research"], evidence:"In the brain, H&E revealed diffuse neuronal loss and cortical edema characterized by spongiosis (S); very rare SARS-CoV-2-positive cells detected in the pons (T); amoeboid microglial cells and several microglial nodules identified by the CD68 antibody, mainly in the brainstem (U); rare T and B lymphocytes are observed in the perivascular spaces (V) and in some nodules (W); frequent capillary microthrombi are observed in the brainstem (X).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["perivascular space"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:194}, properties:{annotationPublicationtype:["Research"], evidence:"In the brain, H&E revealed diffuse neuronal loss and cortical edema characterized by spongiosis (S); very rare SARS-CoV-2-positive cells detected in the pons (T); amoeboid microglial cells and several microglial nodules identified by the CD68 antibody, mainly in the brainstem (U); rare T and B lymphocytes are observed in the perivascular spaces (V) and in some nodules (W); frequent capillary microthrombi are observed in the brainstem (X).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["perivascular space"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:248}, properties:{annotationPublicationtype:["Research"], evidence:"In the brain, H&E revealed diffuse neuronal loss and cortical edema characterized by spongiosis (S); very rare SARS-CoV-2-positive cells detected in the pons (T); amoeboid microglial cells and several microglial nodules identified by the CD68 antibody, mainly in the brainstem (U); rare T and B lymphocytes are observed in the perivascular spaces (V) and in some nodules (W); frequent capillary microthrombi are observed in the brainstem (X).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain Stem"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:2369}, properties:{annotationPublicationtype:["Research"], evidence:"The lung samples showed: (1) severe capillary congestion, edema, and DAD with cytopathic alterations in type-2 pneumocytes; (2) SARS-CoV-2 positivity in alveolar pneumocytes of five cases, ubiquitous alveolar macrophages, interstitial pneumonia with fibrosis and moderate to severe inflammatory septal infiltrates (mainly T-lymphocytes, present in all cases), and frequent superimposed bacterial infection; and (3) microthrombi and frequent clots inside the vessels in seven cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pulmonary capillary"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2369}, properties:{annotationPublicationtype:["Research"], evidence:"Findings from the kidneys included: (1) congestion and acute glomerular alterations in three cases; (2) SARS-CoV-2 positivity in the tubular epithelium and the capillary endothelium in three cases, and moderate to severe inflammatory infiltrates (T-lymphocytes and B-lymphocytes in the majority of cases, while macrophages were quite rare in all but one case); and (3) microthrombi and clots in two cases.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationCell:["macrophage", "T cell", "B cell"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2369}, properties:{annotationPublicationtype:["Research"], evidence:"The heart samples revealed: (1) hypoxic myocytic injuries; (2) sporadic SARS-CoV-2 traces in the endothelial and endocardial cells of one case, perivascular–parenchymal inflammatory infiltrates (prominent only in two cases) characterized by predominant macrophages with no evidence of T-lymphocytes and rare B-lymphocytes; and (3) relevant microthrombi in only one case.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:75}, properties:{annotationPublicationtype:["Research"], evidence:"The heart samples revealed: (1) hypoxic myocytic injuries; (2) sporadic SARS-CoV-2 traces in the endothelial and endocardial cells of one case, perivascular–parenchymal inflammatory infiltrates (prominent only in two cases) characterized by predominant macrophages with no evidence of T-lymphocytes and rare B-lymphocytes; and (3) relevant microthrombi in only one case.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2369}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Pons"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2380}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Blood Vessels", "Frontal Lobe", "Pons"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2144}, properties:{annotationPublicationtype:["Research"], evidence:"The heart samples presented with myocardiosclerosis, lipofuscin deposits, and fatty infiltrates.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2387}, properties:{annotationPublicationtype:["Research"], evidence:"The heart samples presented with myocardiosclerosis, lipofuscin deposits, and fatty infiltrates.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2393}, properties:{annotationPublicationtype:["Research"], evidence:"The heart had relevant inflammatory foci in only two cases, characterized by the presence of macrophages (Figure 1O), the substantial absence of lymphocytes, and very rare SARS-CoV-2 traces in the endothelium–endocardium (Figure 1N).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36231087", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["H&E staining"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:164}, end: {_id:163}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:190}, end: {_id:189}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:256}, end: {_id:97}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:278}, end: {_id:274}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:288}, end: {_id:287}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:290}, end: {_id:289}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:294}, end: {_id:293}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:296}, end: {_id:295}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:298}, end: {_id:297}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:406}, end: {_id:405}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:408}, end: {_id:266}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:873}, end: {_id:382}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:875}, end: {_id:874}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1152}, end: {_id:1151}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1154}, end: {_id:1153}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1157}, end: {_id:1156}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1159}, end: {_id:1158}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1317}, end: {_id:1312}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1528}, end: {_id:1527}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1530}, end: {_id:1529}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:2239}, end: {_id:2238}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2261}, end: {_id:487}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2262}, end: {_id:489}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2265}, end: {_id:2264}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2267}, end: {_id:2266}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2350}, end: {_id:2349}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:1109}, end: {_id:1110}, properties:{annotationPublicationtype:["Research"], evidence:"Cellular viability was also measured during the uptake studies: the ApoE treatment of both WT and SDC3-overexpressing SH-SY5Y cells left cellular viability unaffected (Supplementary Figure S6).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:896}, end: {_id:1110}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, neither spike protein affected cellular viability at the applied concentration of 50 nM (Supplementary Figure S3).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationSection:["Results"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["293T cell", "293T cell overexpressing ACE2"], annotationConcentration:["50 nM"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1264}, end: {_id:1110}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, neither spike protein affected cellular viability at the applied concentration of 50 nM (Supplementary Figure S3).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationSection:["Results"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["293T cell", "293T cell overexpressing ACE2"], annotationConcentration:["50 nM"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:896}, end: {_id:1110}, properties:{annotationPublicationtype:["Research"], evidence:"As shown in Supplementary Figure S7, neither the WT nor the Delta spike affected the viability after 4 h of incubation at the applied concentration", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationCustomCellline:["K-562 cell overexpressing SDC"], annotationSarsCov2Variant:["Delta", "wild type"], annotationCellline:["K-562 cell"], citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:509}, end: {_id:530}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:523}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:524}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:527}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:532}, properties:{annotationPublicationtype:["Research"], evidence:"Extended Data Fig. 3 shows that T cells lines specific for the α-syn epitopes were activated by antigen presenting cells pulsed with native or PFF protein in 7/12 and 11/12 cases. There was significantly higher response to native α-syn (p=0.004) and PFF α-syn (p=0.0005) than media alone. Thus, T cells can respond to α-syn epitopes arising from natural processing of extracellular native α-syn, which is present in blood, and the fibrilized α-syn associated with PD", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:608}, end: {_id:610}, properties:{annotationPublicationtype:["Research"], evidence:"SDC4 transfectants surpassed WT K562 cells in uptake of Aβ1–42 after 6h of incubation, while SDC2 bested K562 cells in uptake and attachment of Aβ1–42 only at 18h.", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"30718543", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"30718543"}}, {start: {_id:601}, end: {_id:617}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells, extracellular attachment of Aβ1–42 was also increased on SDC3 and 4 transfectants (p<0.05 and p<0.01, respectively), while in case of Trf, extracellular attachment to SDC3 transfectants was significantly (p<0.01) reduced (Fig. 3c,d).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescent labeling method"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:1436}, end: {_id:1447}, properties:{annotationPublicationtype:["Review"], evidence:"In particular, DJ-1 KO mice display a significant increase in Rikenella and Alistipes, accompanied by higher levels of malonate in stool and serum, and elevated expression of fecal inflammatory proteins calprotectin and MCP-1.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2299}, end: {_id:460}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of a secreted phospholipase A2- IID-Fc fusion protein, which is selectively produced by Tregs, inhibits disease development in murine models of colitis and MS via promoting the differentiation of Tregs and mediating Treg function", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2299}, end: {_id:264}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of a secreted phospholipase A2- IID-Fc fusion protein, which is selectively produced by Tregs, inhibits disease development in murine models of colitis and MS via promoting the differentiation of Tregs and mediating Treg function", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:62}, end: {_id:59}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__REACTANTS]->(end) SET r += row.properties;
UNWIND [{start: {_id:789}, end: {_id:1563}, properties:{annotationPublicationtype:["Research"], evidence:"The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict OSTOX, increased NO production, and decreased Gpx and ANTIOX, whereas increased PBT levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID’s increased OSTOX/ANTIOX ratio.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:385}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Certain antigens or environmental exposures could synergize with a person's MHCII genome to put them at risk for developing PD.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1316}, end: {_id:126}, properties:{annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationPublicationtype:["Research"], evidence:"In our studies, 12-month-old APPSWE-Tau mice, compared with wild type (WT) C57BL/6 mice, exhibited significantly increased amyloid plaque load (Figure 2A–C).", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", citationRef:"35328830"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1369}, end: {_id:1370}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1371}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1372}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2239}, end: {_id:14}, properties:{annotationPublicationtype:["Review"], evidence:"Astrocytes express high levels of Tolllike receptor-3 (TLR3) but low levels of other TLRs, leading to pro-inflammatory responses by producing tumor necrosis factor (TNF), interleukin 6 (IL6), and other cytokines.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2239}, end: {_id:13}, properties:{annotationPublicationtype:["Review"], evidence:"Astrocytes express high levels of Tolllike receptor-3 (TLR3) but low levels of other TLRs, leading to pro-inflammatory responses by producing tumor necrosis factor (TNF), interleukin 6 (IL6), and other cytokines.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:432}, end: {_id:430}, properties:{annotationPublicationtype:["Review"], evidence:"These immunoglobulins induced perivascular inflammation,microgliosis, and loss of TH+ neurons in the SN that was dependent on expression of the Fc receptor [127].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Parkinson Disease"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2299}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of a secreted phospholipase A2- IID-Fc fusion protein, which is selectively produced by Tregs, inhibits disease development in murine models of colitis and MS via promoting the differentiation of Tregs and mediating Treg function", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:164}, end: {_id:165}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:164}, end: {_id:166}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:164}, end: {_id:167}, properties:{annotationPublicationtype:["Review"], evidence:"When cytokines such as interleukin (IL)-1 and tumor necrosis factor (TNF)-α are secreted by activated glia in the brain, or are present in circulating blood, permeability of the BBB is increased and the expression of cellular adhesion molecules (such as selectins) on microvascular endothelial cells are up-regulated (Wong et al. 1999). Activated T cells and B cells are then able to extravasate and migrate to the site of neuronal injury in increased numbers.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:406}, end: {_id:407}, properties:{annotationPublicationtype:["Review"], evidence:"Within the CD4 T cell compartment, PD patients have an increase in CD45RO+ T cells, which represent an activated and/or memory T cell population [104].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:2350}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While microglial/macrophage reactivity was evident in white matter by increased expression of the marker CD68, overall numbers of microglia were largely unchanged (Figure S2 ).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["BALB/c", "CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:2350}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While microglial/macrophage reactivity was evident in white matter by increased expression of the marker CD68, overall numbers of microglia were largely unchanged (Figure S2 ).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["BALB/c", "CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:837}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in cells with low ACE2 expression, viral infection can be enhanced by additional host factors, such as the extracellular protease BSG (also known as CD147), the transmembrane receptor NRP1 (Cantuti-Castelvetri et al., 2020), lectins (Lempp et al., 2021), or HAVCR1 phosphatidylserine receptors such TIM-1 (also known as TIMELESS) and AXL (Bohan et al., 2021; Wang et al., 2021b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:108}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:112}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:221}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:343}, end: {_id:342}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:388}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:421}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:449}, end: {_id:448}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:570}, end: {_id:569}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:585}, end: {_id:584}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:586}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:597}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:635}, end: {_id:634}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:705}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1081}, end: {_id:1080}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1083}, end: {_id:1082}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1085}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1087}, end: {_id:1086}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1092}, end: {_id:1080}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1092}, end: {_id:1082}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1098}, end: {_id:1096}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__VARIANT]->(end) SET r += row.properties;
UNWIND [{start: {_id:1098}, end: {_id:1097}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1101}, end: {_id:1100}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1101}, end: {_id:1097}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1104}, end: {_id:1100}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1104}, end: {_id:1103}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1188}, end: {_id:1187}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1201}, end: {_id:1200}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1256}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1257}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1258}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1259}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1260}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1261}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1262}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1264}, end: {_id:1263}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1313}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1315}, end: {_id:1314}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1358}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1359}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1360}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__VARIANT]->(end) SET r += row.properties;
UNWIND [{start: {_id:1368}, end: {_id:1367}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1422}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1457}, end: {_id:584}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1627}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1256}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1628}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1629}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1630}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1631}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1632}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1633}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1634}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1635}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1258}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1636}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1637}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1638}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1639}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1640}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1641}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__VARIANT]->(end) SET r += row.properties;
UNWIND [{start: {_id:1655}, end: {_id:1642}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1643}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1644}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1645}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1646}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1647}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1648}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1649}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1650}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1262}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1651}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1652}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1653}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1655}, end: {_id:1654}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1849}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2243}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2288}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__VARIANT]->(end) SET r += row.properties;
UNWIND [{start: {_id:1984}, end: {_id:1983}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1990}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1997}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1999}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2013}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2019}, end: {_id:107}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2033}, end: {_id:2032}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2035}, end: {_id:2034}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__VARIANT]->(end) SET r += row.properties;
UNWIND [{start: {_id:10}, end: {_id:27}, properties:{annotationPublicationtype:["Review"], evidence:"IL-1b activates astrocytes to form much higher levels of not only b-amyloid precursor protein but also S100b peptide mediator which then promotes neurite growth leading to dystrophic neurites [19].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:26}, end: {_id:27}, properties:{annotationPublicationtype:["Review"], evidence:"IL-1b activates astrocytes to form much higher levels of not only b-amyloid precursor protein but also S100b peptide mediator which then promotes neurite growth leading to dystrophic neurites [19].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:10}, end: {_id:28}, properties:{annotationPublicationtype:["Review"], evidence:"That is, after a large inflammatory insult a severely weakened state requires recovery and a large rise in the proinflammatory cytokine IL-1b in the brain causes 'sickness behavior, leading to sleep' and 'diminished likelihood of confrontation with predators and facilitating recovery'[13].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:14}, end: {_id:128}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, a study published in 2009 demonstrated that both acute and chronic systemic inflammation are associated with raised levels of serum tnF, which in turn is associated with accelerated, delirium-independent cognitive decline in patients with AD", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:221}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Although most cases of PD have no family history of disease, point mutations in the gene encoding α-syn (SNCA; OMIM 163890) are linked to autosomal-dominant parkinsonism (PARK1, OMIM 168601) (Polymeropoulos et al. 1996, 1997; Kruger et al. 1998; Zarranz et al. 2004), as are duplications and triplications of the SNCA gene (PARK4, OMIM 605543) (Singleton et al. 2003; Chartier-Harlin et al. 2004), all of which present increased aggregation of α-syn.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", annotationDisease:["Parkinson's disease 1"], citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:343}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Multiple genetic polymorphisms have been associated with sporadic PD through genome-wide association studies (GWAS) (Table 1) [9].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:388}, end: {_id:390}, properties:{annotationPublicationtype:["Review"], evidence:"A GWAS identified polymorphism in the LRRK2 gene is associated with Crohn's disease. Mutations in this gene give rise to an autosomal dominant form of PD (see below).", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:146}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Signs of synergy between inflammation and alpha-synuclein-induced degeneration have been observed in numerous cell culture and animal model studies as discussed previously.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:230}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Several triggers of PD have already been proposed and include pathogens, environmental toxins as well as head trauma.Potential outcomes of triggering events may include long term gut dysfunction [6], chronic inflammation in critical tissues [7], or the direct misfolding of α-synuclein into pathogenic conformers.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:585}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GBA) have an incomplete penetrance with 28–74% (G2019S LRRK2 mutation) [48] and 2–30% [49, 50] of patients developing PD, respectively.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:586}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GBA) have an incomplete penetrance with 28–74% (G2019S LRRK2 mutation) [48] and 2–30% [49, 50] of patients developing PD, respectively.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:585}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 variants are the leading heritable form of PD [47]. Mutations in LRRK2 associated with PD elevate LRRK2 kinase activity and decrease GTPase activity.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:388}, end: {_id:589}, properties:{annotationPublicationtype:["Review"], evidence:"Macrophages, monocytes, and neutrophils express high levels of LRRK2, implying that it contributes to defense against pathogens [51]. Therefore, people with LRRK2 variants might be more susceptible to viral or bacterial infections, including ones that have been postulated to trigger PD.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:388}, end: {_id:590}, properties:{annotationPublicationtype:["Review"], evidence:"Macrophages, monocytes, and neutrophils express high levels of LRRK2, implying that it contributes to defense against pathogens [51]. Therefore, people with LRRK2 variants might be more susceptible to viral or bacterial infections, including ones that have been postulated to trigger PD.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:388}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"A recent study, for instance, demonstrated that LRRK2 activity regulates Mycobacterium tuberculosis replication by affecting phagosome maturation in macrophages [52], and LRRK2 mutations may trigger PD pathogenesis via a dysregulation of responses to such bacteria.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:388}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The targets of the LRRK2 kinase, and cell model experiments, suggest that mutations can also alter vesicular trafficking, mitochondrial function, protein synthesis, cytoskeletal dynamics [57], and autophagy–functions that, when impaired, may facilitate PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:597}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Genome-wide studies in PD have identified several polymorphisms that are adjacent to genes involved in lysosomal function and autophagy. For example, multiple mutations in different loci of the GBA gene, that encodes a lysosomal enzyme, have been identified.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:920}, end: {_id:923}, properties:{annotationPublicationtype:["Research"], evidence:"The mice injected with the S2 subunit showed no behavioral changes; the mice injected with the S1 subunit had significantly increased thirst (consumed 11 g of hydrogel/mouse at day 1 versus 3 g/mouse for sham injected) and showed stress related behavior that included eating the plastic support in their cages.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], citationRef:"33360731"}}, {start: {_id:920}, end: {_id:924}, properties:{annotationPublicationtype:["Research"], evidence:"The mice injected with the S2 subunit showed no behavioral changes; the mice injected with the S1 subunit had significantly increased thirst (consumed 11 g of hydrogel/mouse at day 1 versus 3 g/mouse for sham injected) and showed stress related behavior that included eating the plastic support in their cages.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationAge:["9 months"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationMouseStrain:["C57BL/6"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], citationRef:"33360731"}}, {start: {_id:1201}, end: {_id:1202}, properties:{annotationPublicationtype:["Research"], evidence:"In these experiments, levels of the HA-tagged p.Cys145Ala-Mpro were higher than those of Mpro, probably reflecting a better cell viability with the mutated protease. In support of this concept, the number of GFP-positive hCMEC/D3 cells dropped when Mpro-HA but not p.Cys145Ala-Mpro-HA were co-transfected (Fig. 4g).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["western blot"], annotationCustomCellline:["hCMEC/D3 cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:388}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Mutations in LRRK2 can cause autosomal dominant PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal dominant"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:933}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:372}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1194}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-treated R1141G LRRK2 transgenic mice showed increased secretion of pro-inflammatory TNFα, IL-1b and IL-6, as well as a decreased expression of anti-inflammatory IL-10", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:372}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1366}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1380}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1381}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1382}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1383}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1384}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1358}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Mutations in the PARK6 gene encoding PINK1 can cause autosomal recessive PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1359}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Mutations in the PARK2 gene encoding Parkin also cause autosomal recessive PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1422}, end: {_id:1421}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, it was shown that intestinal infection/dysfunction in PINK1-KO mice and PINK1-mutant flies also leads to neuroinflammation and neurotoxicity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Pink1-/-"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1422}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, it was shown that intestinal infection/dysfunction in PINK1-KO mice and PINK1-mutant flies also leads to neuroinflammation and neurotoxicity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Pink1-/-"], citationRef:"35674870"}}, {start: {_id:1422}, end: {_id:63}, properties:{annotationPublicationtype:["Review"], evidence:"More recently, it was shown that intestinal infection/dysfunction in PINK1-KO mice and PINK1-mutant flies also leads to neuroinflammation and neurotoxicity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Pink1-/-"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1360}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Mutations in DJ-1 cause autosomal recessive PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:597}, end: {_id:1448}, properties:{annotationPublicationtype:["Review"], evidence:"Biallelic homozygous and compound heterozygous mutations in the GBA gene are known to cause Gaucher Disease, whereas individuals with heterozygous GBA mutations have a risk to develop PD which is 5 to 20 times higher compared to non-carriers", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:241}, end: {_id:1544}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1543}, end: {_id:1544}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1031}, end: {_id:207}, properties:{annotationPublicationtype:["Research"], evidence:"Nonetheless, our study demonstrates that a persistent imbalance between oxidative stress toxicity and reduced ANTIOX is a key component of Long COVID and that increased aldehyde, neutrophil-associated MPO, protein carbonyl, and NO production are the major neurotoxic pathways, which, when combined with decreased ANTIOX, may have a variety of detrimental effects as reviewed before.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:575}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1589}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"Further supporting a requirement for endocytosis, the knockdown of cathepsin L (CTSL) also inhibited infection (Fig. 2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1158}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in cells with low ACE2 expression, viral infection can be enhanced by additional host factors, such as the extracellular protease BSG (also known as CD147), the transmembrane receptor NRP1 (Cantuti-Castelvetri et al., 2020), lectins (Lempp et al., 2021), or HAVCR1 phosphatidylserine receptors such TIM-1 (also known as TIMELESS) and AXL (Bohan et al., 2021; Wang et al., 2021b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1824}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in cells with low ACE2 expression, viral infection can be enhanced by additional host factors, such as the extracellular protease BSG (also known as CD147), the transmembrane receptor NRP1 (Cantuti-Castelvetri et al., 2020), lectins (Lempp et al., 2021), or HAVCR1 phosphatidylserine receptors such TIM-1 (also known as TIMELESS) and AXL (Bohan et al., 2021; Wang et al., 2021b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1825}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in cells with low ACE2 expression, viral infection can be enhanced by additional host factors, such as the extracellular protease BSG (also known as CD147), the transmembrane receptor NRP1 (Cantuti-Castelvetri et al., 2020), lectins (Lempp et al., 2021), or HAVCR1 phosphatidylserine receptors such TIM-1 (also known as TIMELESS) and AXL (Bohan et al., 2021; Wang et al., 2021b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1826}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in cells with low ACE2 expression, viral infection can be enhanced by additional host factors, such as the extracellular protease BSG (also known as CD147), the transmembrane receptor NRP1 (Cantuti-Castelvetri et al., 2020), lectins (Lempp et al., 2021), or HAVCR1 phosphatidylserine receptors such TIM-1 (also known as TIMELESS) and AXL (Bohan et al., 2021; Wang et al., 2021b).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1156}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Studies based on publicly available transcriptome databases revealed that one of the most likely enhancers of direct viral infection in the brain is NRP1, which is highly expressed in multiple neuron and glial cell types, including astrocytes and microglia (Cantuti-Castelvetri et al., 2020; Daly et al., 2020; Lonsdale et al., 2013).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Microglia", "Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1849}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, carrying the Alzheimer’s disease risk allele APOE ɛ4 (Kuo et al., 2020; Wang et al., 2021c) or being of an advanced age (González-García et al., 2021) increase the risk of severe COVID-19.", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1849}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, carrying the Alzheimer’s disease risk allele APOE ɛ4 (Kuo et al., 2020; Wang et al., 2021c) or being of an advanced age (González-García et al., 2021) increase the risk of severe COVID-19.", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDiseaseSeverity:["severe"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:388}, end: {_id:389}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 mutations are also associated with Crohn’s disease, strongly linking gastrointestinal inflammation with PD (reviewed in [21]).", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1369}, end: {_id:1134}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1374}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1375}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1376}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1377}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1378}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:1379}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1369}, end: {_id:446}, properties:{annotationPublicationtype:["Review"], evidence:"mRNA levels of the pro-inflammatory cytokines TNF, IL-1, IL-12, CCL4, CXCL1, CCL3L1 were also increased, suggesting an upstream regulation by LRRK2", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:624}, end: {_id:616}, properties:{annotationPublicationtype:["Research"], evidence:"Scanning electron microscopy studies also confirmed the inhibitory effect of undersulfation as fibrillary assemblies of Aβ1–42 were reduced due to NaClO3 treatment (Fig. 6d).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["scanning electron microscopy"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:1774}, end: {_id:1335}, properties:{annotationPublicationtype:["Research"], evidence:"Every neuron that fused with glial cells presented a complete loss in neuronal activity (fig. S12, E to G).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:2269}, end: {_id:2270}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs either inhibit the activation of DCs by binding LAG3 to MHC II or restrict the access of effector T cells via elongating the interaction between Neuropilin-1 (Nrp1) expressed on Tregs and immature DCs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:70}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Evoking the concept of neuroinflammatory processes can also explain the observed increased presence of proinflammatory cytokines in Alzheimer's brains [5–7,107,108].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:89}, properties:{annotationPublicationtype:["Review"], evidence:"Interest in activated microglia as contributors to the progression of chronic neurodegeneration, rather than simply being a consequence of the pathology, was first proposed in AD", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", annotationDiseaseCondition:["chronic"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], citationRef:"20234358"}}, {start: {_id:140}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"However, when an adaptive immune response continues unchecked in the brain, the proinflammatory innate microglial response leads to the accumulation of neurotoxins and eventual neurodegeneration. What drives such responses are misfolded and nitrated proteins.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:142}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Ingress of lymphocytes and chronic activation of glial cells directly affect neurodegeneration.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:15}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Ingress of lymphocytes and chronic activation of glial cells directly affect neurodegeneration.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Aberrant proteins (e.g., modified α-synuclein) activate microglia and engage the adaptive immune system, causing neuroinflammation and neurodegeneration in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Aberrant proteins (e.g., modified α-synuclein) activate microglia and engage the adaptive immune system, causing neuroinflammation and neurodegeneration in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:139}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Aberrant proteins (e.g., modified α-synuclein) activate microglia and engage the adaptive immune system, causing neuroinflammation and neurodegeneration in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:139}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Aberrant proteins (e.g., modified α-synuclein) activate microglia and engage the adaptive immune system, causing neuroinflammation and neurodegeneration in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:156}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"Peripheral immune responses can trigger inflammation and exacerbation of CNS degeneration in several neurodegenerative diseases such as Alzheimer's disease (AD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), stroke, and prion-mediated diseases and particularly PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Prion Diseases", "Multiple Sclerosis", "Alzheimer Disease", "Stroke", "Amyotrophic Lateral Sclerosis", "Parkinson Disease"], annotationMeshanatomy:["Peripheral Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:156}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Peripheral immune responses can trigger inflammation and exacerbation of CNS degeneration in several neurodegenerative diseases such as Alzheimer's disease (AD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), stroke, and prion-mediated diseases and particularly PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Prion Diseases", "Multiple Sclerosis", "Alzheimer Disease", "Stroke", "Amyotrophic Lateral Sclerosis", "Parkinson Disease"], annotationMeshanatomy:["Peripheral Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:207}, properties:{annotationPublicationtype:["Review"], evidence:"However, during chronic inflammation, the neurotoxic effects of microglia are proposed to eventually out-compete the neurotrophic effects, thus increasing neurodegeneration.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:208}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence abounds for the involvement of misfolded proteins in the pathology of neurodegenerative diseases, as well as in the activation of microglia and antigen-presenting cells (APCs) that function to induce the adaptive immune arm.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:207}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, reactive oxygen species produced by activated microglia increases nitration of α-syn and neuronal cell death (Shavali et al. 2006); and in turn, immune T cells that recognize nitrated α-syn (N-α-syn) enhance the neurotoxic activities of microglia in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of nigrostriatal degeneration . Activated T cells and B cells are then able to enter the CNS more readily and migrate to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationDisease:["Parkinson's disease 1"], citationRef:"22315722"}}, {start: {_id:281}, end: {_id:207}, properties:{annotationPublicationtype:["Review"], evidence:"An influx of α-syn-specific Th1 or Th17 effector T cells into the brain during PD could increase the inflammatory phenotype and neurotoxic response of microglia near dopaminergic neurons by increasing the concentration of proinflammatory molecules in the SN.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:282}, end: {_id:207}, properties:{annotationPublicationtype:["Review"], evidence:"An influx of α-syn-specific Th1 or Th17 effector T cells into the brain during PD could increase the inflammatory phenotype and neurotoxic response of microglia near dopaminergic neurons by increasing the concentration of proinflammatory molecules in the SN.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:352}, end: {_id:353}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, the identification of 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) was critical in recognizing the loss of these neurons as the cause of motor symptoms in disease [10, 11].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:359}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Many mechanisms of neuronal dysfunction have been implicated in PD pathogenesis, including proteasome-mediated protein degradation, mitochondrial dysfunction, and oxidative stress [28].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:39}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Many mechanisms of neuronal dysfunction have been implicated in PD pathogenesis, including proteasome-mediated protein degradation, mitochondrial dysfunction, and oxidative stress [28].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:227}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"The drug, natalizumab has been successful in the treatment of multiple sclerosis [190].  As an antibody against the alpha 4 integrin, this antibody blocks the recruitment of T cells to sites of inflammation. By blocking activation and recruitment of T cells in PD, neuroinflammation could be dampened to prevent subsequent neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:39}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:17}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:568}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"In principle, pesticides could trigger PD pathogenesis via several possible mechanisms, including inhibiting mitochondrial complex I, inducing oxidative stress, stimulating inflammation, and causing α-synuclein fibrillization.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:223}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Intravenous injection of the neurotoxin MPTP (e.g., through use of the synthetic analgesic drug MPPP when accidentally contaminated with MPTP) causes rapid death of nigral dopamine neurons and, consequently, PD symptoms.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:17}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, general immunosuppressive and anti-inflammatory treatments reduce the risk of developing PD [43]. Taken together, systemic inflammation itself, and several chronic conditions that feature increased inflammation, might be considered facilitators of PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:39}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, numerous studies demonstrate that mitochondrial dysfunction results in the chronic production of reactive oxygen species, leading to oxidative stress, and promoting both misfolding of α-synuclein and directly causing neurodegeneration.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:99}, end: {_id:48}, properties:{annotationPublicationtype:["Review"], evidence:"However, in PD, activated microglia are believed to have a deleterious effect on neurons and emit harmful levels of cytokines. This induces a vicious, self-propagating chronic neuroinflammatory state that contributes to the neurodegenerative process.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:16}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia have also been shown to induce astrocytes to release neurotoxic mediators, leading to further neuronal damage.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", annotationAnatomy:["skeletal muscle tissue"], citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:17}, end: {_id:681}, properties:{annotationPublicationtype:["Review"], evidence:"Encephalitis is the inflammation of the brain parenchyma, usually caused by an infection or the body's immune defences.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:209}, end: {_id:1406}, properties:{annotationPublicationtype:["Review"], evidence:"Several studies have suggested that wild type PINK1 inhibits peripheral inflammation [92], and both PINK1 and Parkin repress mitochondrial antigen presentation thereby preventing adaptive inflammation", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Mitochondria"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1576}, end: {_id:207}, properties:{annotationPublicationtype:["Research"], evidence:"Nonetheless, our study demonstrates that a persistent imbalance between oxidative stress toxicity and reduced ANTIOX is a key component of Long COVID and that increased aldehyde, neutrophil-associated MPO, protein carbonyl, and NO production are the major neurotoxic pathways, which, when combined with decreased ANTIOX, may have a variety of detrimental effects as reviewed before.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1580}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:39}, end: {_id:1575}, properties:{annotationPublicationtype:["Research"], evidence:"In addition, ~60% of the variance in the severity of the neuropsychiatric symptoms is explained by the cumulative effects of decreased SpO2 and increased PBT (thus, the severity of the acute infectious phase) coupled with increased CRP and OSTOX/ANTIOX ratio. Most notably was the impact of MDA and NO and decreased Gpx and zinc, although PCs and MPO, as well as decreased TAC, all contribute to neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1871}, end: {_id:1345}, properties:{annotationPublicationtype:["Review"], evidence:"Increased monocytic activation and reduced cytotoxicity in NK cells, which was associated with worse motor performance, have been described in peripheral blood mononuclear cells (PBMCs) from persons with PD [58].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Leukocytes, Mononuclear"], annotationCell:["natural killer cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:17}, end: {_id:668}, properties:{annotationPublicationtype:["Review"], evidence:"The exact mechanism underlying the induction of ARDS by SARS-CoV-2 remains unclear, but it has been proposed to be a consequence of hyperinflammatory conditions in the lungs associated with the presence of viral RNA.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:120}, end: {_id:123}, properties:{annotationPublicationtype:["Review"], evidence:"This switch in microglial phenotype was associated with exaggerated symptoms of sickness behavior such as fever and reduced mobility, increased neuronal loss, and an increase in disease progression", annotationDiseaseCondition:["chronic"], annotationPublicationstatus:["Published"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationSection:["Full Text"], annotationMeshdisease:["Prion Diseases"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:151}, end: {_id:149}, properties:{annotationPublicationtype:["Review"], evidence:"Progressive degeneration of dopaminergic neurons in the substantia nigra (SN) pars compacta and their projections into the caudate nucleus leads to substantial decreases in dopamine levels, which manifest as resting tremor, bradykinesia, rigidity, and gait dysfunction.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:145}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"In PD, LBs are associated with activated microglia and dopaminergic neuronal death. LBs are comprised mostly of α-syn, ubiquitin, and neurofilament (Goldman et al. 1983; Spillantini et al. 1997, 1998; Jellinger 2007) and posttranslationally modified forms of α-syn have an increased propensity to aggregate.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:317}, end: {_id:319}, properties:{annotationPublicationtype:["Review"], evidence:"This study showed that adoptively transferred Treg attenuated microgliosis and astrogliosis, increased expression of BDNF and GDNF expression, and down-regulated proinflammatory cytokines, oxidative stress, and viral replication, whereas effector CD4+ T cells were not therapeutic.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:283}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"In the MPTP mouse model, Treg control microglia function by suppressing reactive oxygen species production and NFκB activation via mechanisms that modulate redox enzymes, cell migration, and phagocytosis .", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:115}, end: {_id:149}, properties:{annotationPublicationtype:["Review"], evidence:"Within a week after direct LPS injection into the SN of mice, significant decreases in dopamine and dopamine metabolite levels (>60%) in the striatum and in tyrosine hydroxylase immunostain-positive(TH+) neuron number in the SN are detectable. These changes are detectable even a year after the injection[34, 35].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationTimeline:["1 year after injection"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["10090"], annotationAnatomy:["striatum"], citationRef:"24275605"}}, {start: {_id:412}, end: {_id:411}, properties:{annotationPublicationtype:["Review"], evidence:"Lymphocytes from PD patients display an increased incidence of micronuclei, single strand DNA breaks, and oxidized purine bases [109]. Interestingly,levodopa treatment seems to reduce this DNA damage in peripheral blood lymphocytes [110].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"DA neuron loss and behavioral deficits caused by both chronic and acute MPTP administration are attenuated in RAG2 knockout mice that lack both T and B cells [55, 112].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:430}, end: {_id:319}, properties:{annotationPublicationtype:["Review"], evidence:"These immunoglobulins induced perivascular inflammation,microgliosis, and loss of TH+ neurons in the SN that was dependent on expression of the Fc receptor [127].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10116"], annotationMeshdisease:["Parkinson Disease"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:115}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"Chronic peripheral low dose LPS intraperitoneal administration in Parkin-/- mice triggers fine-motor deficits and loss of DA neurons in the SN [173].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], annotationMouseType:["PRKN -/- mice"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:494}, end: {_id:495}, properties:{annotationPublicationtype:["Review"], evidence:"Rituximab is an example of a B cell depleting antibody that has shown some effectiveness in autoimmune diseases where antibodies are known to play a pathogenic role [192].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:1046}, end: {_id:866}, properties:{annotationPublicationtype:["Review"], evidence:"Four patients with COVID-19 receiving eculizumab intravenously showed a prompt reduction in C-reactive protein levels and an improvement of the lesions observed through chest computed tomography scan147.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", annotationTechnique:["computed tomography scan"], citationRef:"33824483"}}, {start: {_id:684}, end: {_id:1142}, properties:{annotationHourspostinfection:["48 hours"], annotationPublicationtype:["Research"], evidence:"In BBB models from hamster, the TEER was decreased slightly at 48 hpi compared to the mock-treated group (Fig. ​(Fig.5a).5a).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1504}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"However, there was an increase in the overall number of TUNEL+ apoptotic cells in cultures exposed to SARS-CoV-2 (Fig. 3D). Although we observed no change in astrocyte cell death, there was an overall decrease in the number of neurons .", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1514}, end: {_id:1473}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"To probe the functional role of DPP4 in infectivity, organotypic slice cultures were treated with the DPP4 inhibitor Vildagliptin for 24 h prior to and throughout the duration of infection. As before, there was robust infection in GFAP+ astrocytes in virally exposed samples after 72 h. However, in tissue samples treated with the DPP4 inhibitor, there was a 35% reduction in the number of SARS-CoV-2 N+ cells and a 60% reduction in dsRNA+ cells (SI Appendix, Fig. 12E). Additionally, there was a 70% reduction in the number of cells expressing ARCN1 after DPP4 inhibition, indicating decreased activation of cellular stress.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:1514}, end: {_id:1515}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"To probe the functional role of DPP4 in infectivity, organotypic slice cultures were treated with the DPP4 inhibitor Vildagliptin for 24 h prior to and throughout the duration of infection. As before, there was robust infection in GFAP+ astrocytes in virally exposed samples after 72 h. However, in tissue samples treated with the DPP4 inhibitor, there was a 35% reduction in the number of SARS-CoV-2 N+ cells and a 60% reduction in dsRNA+ cells (SI Appendix, Fig. 12E). Additionally, there was a 70% reduction in the number of cells expressing ARCN1 after DPP4 inhibition, indicating decreased activation of cellular stress.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:684}, end: {_id:1521}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with this upregulation in microglia, and the extensive initiation of neuronal apoptosis and decreased postsynaptic density in infected organoids, neurons at 72hpi downregulated the expression of ‘don’t-eat-me’ signals such as CD46 and CD200.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1696}, end: {_id:684}, properties:{annotationPublicationtype:["Research"], evidence:"We then treated BCOs with incremental doses of SOF and found that SOF was able to reduce intracellular SARS-CoV-2 RNA levels in a dose-response manner.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:1696}, end: {_id:684}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, the amount of retrieved infectious viruses was significantly reduced upon SOF treatment (a 5-fold decrease in the supernatant and by 75% for the intracellular viral RNA), further supporting both the ability of BCOs to allow productive replication of SARS-CoV-2 and SOF as an inhibitor of viral growth.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:684}, end: {_id:1700}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, we show that SARS-CoV-2 rapidly decreased the number of excitatory synapses in neurons within seven days post-infection, revealing a potential novel mechanism for the associated neurological symptoms with COVID-19.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2152}, end: {_id:2150}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, these three drugs also decreased lysosomal accumulation compared with DMSO-treated cells (Figures 4K and 4L).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:2150}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, these three drugs also decreased lysosomal accumulation compared with DMSO-treated cells (Figures 4K and 4L).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:2150}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, these three drugs also decreased lysosomal accumulation compared with DMSO-treated cells (Figures 4K and 4L).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2290}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Blocking the production of the octapeptide angiotensin II (AII) or inhibiting AII signaling suppresses autoreactive Th1 and Th17 cells and promotes antigen-specific Foxp3+Tregs with an inhibition of the canonical nuclear factor κ-B (NFKB) transcription factor complex and an activation of the alternative NFKB pathway.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2290}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Treatment with a blocker of AII production induces abundant Foxp3+Tregs with sufficient potency to reverse paralytic EAE.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2318}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Dopamine has been shown to downregulate Treg function.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:543}, end: {_id:2360}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"This loss of myelin persisted until at least 7 weeks following mild respiratory SARS-CoV-2 infection and was similar in magnitude to the loss of myelinated axons seen 4 weeks (Figures 6J, ​J,S7J,S7J, and S7K) and 6 months (Figures 6K, ​K,S7J,S7J, and S7K) after methotrexate chemotherapy exposure.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["6 months post treatment", "4 weeks post treatment"], annotationMeshanatomy:["White Matter", "Corpus Callosum"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["transmission electron microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:59}, end: {_id:57}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:59}, end: {_id:58}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:262}, properties:{annotationPublicationtype:["Review"], evidence:"A greater loss of naive helper CD4+ T cells (CD45RA+) and either unchanged or increased levels of effector/memory helper T-cell subset (CD29+ or CD45R0+) have also been observed.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:1340}, properties:{annotationPublicationtype:["Review"], evidence:" Accordingly, reduced levels of the SCFA acetate, propionate and butyrate were detected in the stool of PD patients compared to age-matched controls and paralleled by a decreased amount of SCFA-producing bacteria, in particular from the families Prevotellaceae and Lachnospiracae", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1341}, properties:{annotationPublicationtype:["Review"], evidence:" Accordingly, reduced levels of the SCFA acetate, propionate and butyrate were detected in the stool of PD patients compared to age-matched controls and paralleled by a decreased amount of SCFA-producing bacteria, in particular from the families Prevotellaceae and Lachnospiracae", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1338}, properties:{annotationPublicationtype:["Review"], evidence:" Accordingly, reduced levels of the SCFA acetate, propionate and butyrate were detected in the stool of PD patients compared to age-matched controls and paralleled by a decreased amount of SCFA-producing bacteria, in particular from the families Prevotellaceae and Lachnospiracae", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1342}, properties:{annotationPublicationtype:["Review"], evidence:" Accordingly, reduced levels of the SCFA acetate, propionate and butyrate were detected in the stool of PD patients compared to age-matched controls and paralleled by a decreased amount of SCFA-producing bacteria, in particular from the families Prevotellaceae and Lachnospiracae", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1343}, properties:{annotationPublicationtype:["Review"], evidence:" Accordingly, reduced levels of the SCFA acetate, propionate and butyrate were detected in the stool of PD patients compared to age-matched controls and paralleled by a decreased amount of SCFA-producing bacteria, in particular from the families Prevotellaceae and Lachnospiracae", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1566}, end: {_id:1573}, properties:{annotationPublicationtype:["Research"], evidence:"We found that 23.0% of the variance in the somatic HAMD score (regression #2) was explained by the cumulative effects of lowered Gpx and zinc, increased NO and CRP and vaccination with AstraZeneca or Pfizer.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:67}, end: {_id:402}, properties:{annotationPublicationtype:["Review"], evidence:"Those with a high risk showed higher neutrophil and lower (CD4+) lymphocyte fractions compared with those with a low risk.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:2042}, properties:{annotationPublicationtype:["Research"], evidence:"In the blood of iPD, we observed a lower frequency of CXCR3+ and CCR4+ cells and their corresponding expression levels (geometric mean, MFI) among total CD8 T cells, whereas CCR6 showed no difference (Supplementary Fig. 4A, B).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], annotationSpecimen:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:67}, end: {_id:2043}, properties:{annotationPublicationtype:["Research"], evidence:"In the blood of iPD, we observed a lower frequency of CXCR3+ and CCR4+ cells and their corresponding expression levels (geometric mean, MFI) among total CD8 T cells, whereas CCR6 showed no difference (Supplementary Fig. 4A, B).", citationTitle:"Nat Commun. 2023 Nov 20;14(1):7461.doi: 10.1038/s41467-023-43053-0.", annotationPublicationstatus:["Published"], annotationDiseaseType:["idiopathy"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], annotationSpecimen:["Blood"], source:"wp4-cbm-comorbidity", pmid:"37985656", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], annotationCohort:["Discovery Cohort"], citationRef:"37985656"}}, {start: {_id:2287}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"The frequency and the suppressive capability of the CD4+CD25+CD127lowFOXP3+CD39+ Tregs are significantly lower in RR-MS than in healthy controls.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2287}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, CD4+CD25+CD127lowFOXP3+CD39+ Tregs play an important role in constraining pathogenic Th17 cells and are impaired in MS patients; this in turn leads to an inability to control Th17-mediated neurodegenerative diseases.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:7}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Larbi et al. reported that Tregs are reduced in mild AD.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationDiseaseSeverity:["Mild"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:65}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, Tregs have been reported to be significantly reduced in patients with ALS compared with normal controls.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:65}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore,significantly reduced CD25 high Tregs in sporadic ALS patients have been observed at a less severe stage but not at a more severe stage of the disease suggesting their early recruitment into the CNS area affected by primary neurodegeneration.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Amyotrophic Lateral Sclerosis"], annotationDiseaseSeverity:["less severe"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:412}, end: {_id:639}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, our analyses revealed a significant correlation between low LED (<1000 mg/day) and T cell responses against α-syn (Fig. 6e).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:789}, end: {_id:1564}, properties:{annotationPublicationtype:["Research"], evidence:"The second major finding of this study is that decreased SpO2 levels during the acute phase of COVID-19 significantly predict OSTOX, increased NO production, and decreased Gpx and ANTIOX, whereas increased PBT levels during the acute phase predict increased CRP and decreased zinc and antioxidant levels in Long COVID. As a result, both decreased SpO2 and higher body temperature contribute to Long COVID’s increased OSTOX/ANTIOX ratio.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1111}, end: {_id:1110}, properties:{annotationPublicationtype:["Research"], evidence:"Cellular viability was also measured during the uptake studies: the ApoE treatment of both WT and SDC3-overexpressing SH-SY5Y cells left cellular viability unaffected (Supplementary Figure S6).", annotationPublicationstatus:["Published"], citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationSection:["Results"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:233}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Since 1988, when McGeer and colleagues found HLA-DR-positive (activated) microglia phagocytosing-free neuromelanin in post mortem PD SN (McGeer et al. 1988a), activated microglial consistently have been observed in PD patients, whereas others have shown higher expression levels of polymorphic major histocompatibility complex (MHC) class II (MHC II) molecules, HLA-DR and HLA-DQ, expressed by monocytes in the CSF and peripheral blood of PD patients compared with controls.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Cerebrospinal Fluid", "Blood"], annotationCell:["T cell"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], citationRef:"22315722"}}, {start: {_id:233}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Increased susceptibility to PD owing to MHC II molecules could reflect increased neuroinflammation associated with up-regulation of those molecules or alternatively, could represent immune responses to self- or weak nonself-antigens.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1088}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"The next steps showed that ACE2 and SDCs colocalize during SARS-CoV-2 uptake, suggesting that ACE2 and SDCs collaborate in mediating SARS-CoV-2 internalization (Figure 5C,D).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["flow cytometry", "confocal microscopy", "transfection method"], source:"wp4-cbm-comorbidity", pmid:"34069441", annotationCellline:["A549 cell"], citationType:"PubMed", citationRef:"34069441"}}, {start: {_id:1113}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings [16], SDC3 overexpression increased the cellular uptake of Aβ1–42 at both 3 and 18 h of incubation (Figure 6A–D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1121}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings [16], SDC3 overexpression increased the cellular uptake of Aβ1–42 at both 3 and 18 h of incubation (Figure 6A–D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1115}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings [16], SDC3 overexpression increased the cellular uptake of Aβ1–42 at both 3 and 18 h of incubation (Figure 6A–D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1116}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings [16], SDC3 overexpression increased the cellular uptake of Aβ1–42 at both 3 and 18 h of incubation (Figure 6A–D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings [16], SDC3 overexpression increased the cellular uptake of Aβ1–42 at both 3 and 18 h of incubation (Figure 6A–D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1112}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted various effects on Aβ1–42 uptake: at 3 h ApoE2 increased Aβ1–42 internalization, while ApoE4 reduced it (Figure 6A,C).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1115}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted various effects on Aβ1–42 uptake: at 3 h ApoE2 increased Aβ1–42 internalization, while ApoE4 reduced it (Figure 6A,C).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1116}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted various effects on Aβ1–42 uptake: at 3 h ApoE2 increased Aβ1–42 internalization, while ApoE4 reduced it (Figure 6A,C).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1113}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"This effect of ApoEs on Aβ1–42 uptake was reversed at 18 h of incubation: ApoE4 increased Aβ1–42 uptake, while ApoE2 and 3 reduced it (Figure 6B,D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"This effect of ApoEs on Aβ1–42 uptake was reversed at 18 h of incubation: ApoE4 increased Aβ1–42 uptake, while ApoE2 and 3 reduced it (Figure 6B,D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1114}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed an increased presence of ThT-labeled aggregates at 18 h in WT and SDC3-overexpressing differentiated SH-SY5Y cells, which was reduced in the case of samples pretreated with ApoE2. ApoE4, on the other hand, increased the number of ThT-labeled aggregates, indicating the increased presence of Aβ1–42 aggregates (Figure 6E,F).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1117}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed an increased presence of ThT-labeled aggregates at 18 h in WT and SDC3-overexpressing differentiated SH-SY5Y cells, which was reduced in the case of samples pretreated with ApoE2. ApoE4, on the other hand, increased the number of ThT-labeled aggregates, indicating the increased presence of Aβ1–42 aggregates (Figure 6E,F).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1222}, end: {_id:1225}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, Ripk3 deletion abrogated endothelial proliferation (Fig. 6a). Ripk3 deletion also normalized survival, brain weight and body weight of mice with a NEMO deficiency in brain endothelial cells and reduced the extravasation of IgG and albumin into the parenchyma, showing that disruption of the BBB was mitigated (Fig. 6b,c and Extended Data Fig. 9c–f). Consequentially, Nemo deletion did not activate microglia or astrocytes in the absence of RIPK3 (Fig. 6d).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1226}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, Ripk3 deletion abrogated endothelial proliferation (Fig. 6a). Ripk3 deletion also normalized survival, brain weight and body weight of mice with a NEMO deficiency in brain endothelial cells and reduced the extravasation of IgG and albumin into the parenchyma, showing that disruption of the BBB was mitigated (Fig. 6b,c and Extended Data Fig. 9c–f). Consequentially, Nemo deletion did not activate microglia or astrocytes in the absence of RIPK3 (Fig. 6d).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1222}, end: {_id:1225}, properties:{annotationPublicationtype:["Research"], evidence:"RIPK3 deficiency did not counteract the effect of NEMO ablation on IgG transcytosis (Fig. 6f). Therefore, we conclude that RIPK3 deficiency improves the BBB tightness of NemobeKO mice mainly by preventing endothelial cell death and rescuing tight junctions.", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1270}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells lacking SDC1 and 4 (thus, WT K562 cells could be considered as SDC1 or SDC4 KO lines), SDC1 or SDC4 overexpression increased the cellular uptake of the WT spike and its Delta variant (Figure 4A–C).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1271}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells lacking SDC1 and 4 (thus, WT K562 cells could be considered as SDC1 or SDC4 KO lines), SDC1 or SDC4 overexpression increased the cellular uptake of the WT spike and its Delta variant (Figure 4A–C).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["wild type"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1270}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells lacking SDC1 and 4 (thus, WT K562 cells could be considered as SDC1 or SDC4 KO lines), SDC1 or SDC4 overexpression increased the cellular uptake of the WT spike and its Delta variant (Figure 4A–C).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}, {start: {_id:1271}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to WT K562 cells lacking SDC1 and 4 (thus, WT K562 cells could be considered as SDC1 or SDC4 KO lines), SDC1 or SDC4 overexpression increased the cellular uptake of the WT spike and its Delta variant (Figure 4A–C).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1271}, end: {_id:1265}, properties:{annotationPublicationtype:["Research"], evidence:"The most efficient transduction was achieved with Delta PSV on SDC4 transfectants, showing that SDC4 enhances Delta cellular entry the most (Figure 5C,D).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["K-562 cell overexpressing SDC"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:62}, end: {_id:61}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PRODUCTS]->(end) SET r += row.properties;
UNWIND [{start: {_id:699}, end: {_id:702}, properties:{annotationPublicationtype:["Review"], evidence:"Headache, neck stiffness, and seizures were described among 22 children (median age 36 months; range 0·8–72 months) with suspected CNS infection and coronavirus IgM antibodies in their serum, CSF, or both.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid", "Serum"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:115}, end: {_id:1387}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:684}, end: {_id:1774}, properties:{annotationPublicationtype:["Research"], evidence:"Every neuron that fused with glial cells presented a complete loss in neuronal activity (fig. S12, E to G).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:283}, end: {_id:2269}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs either inhibit the activation of DCs by binding LAG3 to MHC II or restrict the access of effector T cells via elongating the interaction between Neuropilin-1 (Nrp1) expressed on Tregs and immature DCs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2290}, end: {_id:23}, properties:{annotationPublicationtype:["Review"], evidence:"Blocking the production of the octapeptide angiotensin II (AII) or inhibiting AII signaling suppresses autoreactive Th1 and Th17 cells and promotes antigen-specific Foxp3+Tregs with an inhibition of the canonical nuclear factor κ-B (NFKB) transcription factor complex and an activation of the alternative NFKB pathway.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:0}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"Perhaps the risk factors that have the most obvious relationship to inflammatory processes include head trauma, transient ischemias, and microvascular defects", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:2}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"Perhaps the risk factors that have the most obvious relationship to inflammatory processes include head trauma, transient ischemias, and microvascular defects", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationDiseaseType:["transient"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:3}, end: {_id:1}, properties:{annotationPublicationtype:["Review"], evidence:"Perhaps the risk factors that have the most obvious relationship to inflammatory processes include head trauma, transient ischemias, and microvascular defects", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:36}, end: {_id:18}, properties:{annotationPublicationtype:["Review"], evidence:"In a prospective study, it has been observed that clinical dementia in neuropathologically diagnosed Alzheimer's disease was much more prevalent in individuals who had experienced brain infarction than those who had not [24].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:36}, end: {_id:18}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, in this very careful Nun study, Snowden et al. [24] clearly demonstrated that even though neuropathologically the senile plaques characteristic of Alzheimer's disease were present, there was a much more significant tendency toward clinical manifestations of dementia if the brain had experienced infarction.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:2}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"This study also noted a strong association with atherosclerosis of the circle of Willis and brain infarcts [24], which, therefore, lends support to the inclusion of not only transient ischemias but also microvascular defects as risk factors in neurodegenerative processes.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationDiseaseType:["transient"], annotationMeshanatomy:["Circle of Willis"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], citationRef:"10381209"}}, {start: {_id:38}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"This study also noted a strong association with atherosclerosis of the circle of Willis and brain infarcts [24], which, therefore, lends support to the inclusion of not only transient ischemias but also microvascular defects as risk factors in neurodegenerative processes.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], annotationMeshanatomy:["Circle of Willis"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:77}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:81}, end: {_id:37}, properties:{annotationPublicationtype:["Review"], evidence:"Acute injury to the brain, such as a traumatic brain injury or stroke, will lead to the rapid degeneration of neurons and neuronal processes, and subsequently will lead to the generation of DAMPs, which in turn could activate microglia.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:130}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:131}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:132}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:133}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:134}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:135}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:130}, end: {_id:128}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:131}, end: {_id:128}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:132}, end: {_id:128}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:133}, end: {_id:128}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:134}, end: {_id:128}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:135}, end: {_id:128}, properties:{annotationPublicationtype:["Review"], evidence:"Also of note is the fact that many of the risk factors for AD, such as obesity, smoking, diabetes,atherosclerosis and periodontitis,are associated with chronic systemic inflammation", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:136}, end: {_id:137}, properties:{annotationPublicationtype:["Research"], evidence:"While there was no evidence for an increase in the risk of developing PD in relation to an increasing number of influenza attacks prior to the index date, the risk of developing PS was statistically significantly increased (OR 2.00, 95% CI 1.45–2.75) for patients with three or more recorded influenza infections prior to the index date, as compared to those with no recorded infection (Table 2).", annotationDiseaseCondition:["previous influenza infections"], citationTitle:"Influenza Other Respir Viruses. 2011 Sep;5(5):328-33. doi: 10.1111/j.1750-2659.2011.00232.x.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"21668692", citationType:"PubMed", citationRef:"21668692"}}, {start: {_id:136}, end: {_id:137}, properties:{annotationPublicationtype:["Research"], evidence:"For patients with PS, the OR was also highest for those with a recent influenza infection (1–29 days ago; OR 3.03, 95% CI 1.94–4.74,P < 0.0001); the risk decreased gradually to 1.20 (95% CI 1.12–1.29, P < 0.0001) for those with a last influenza infection recorded more than 2 years ago (Table 2)", annotationDiseaseCondition:["previous influenza infections"], citationTitle:"Influenza Other Respir Viruses. 2011 Sep;5(5):328-33. doi: 10.1111/j.1750-2659.2011.00232.x.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"21668692", citationType:"PubMed", citationRef:"21668692"}}, {start: {_id:136}, end: {_id:137}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, the OR of developing PS was 1.45 (95% CI 1.25–1.68, P < 0.0001) for patients with one or more previous influenza infections with complications, as compared to those with no recorded infection, and it was particularly high for patients who had such an infection within 30 days prior to the diagnosis of a PS (OR 5.30, 95% CI 1.83–15.3, P < 0.01) (Table 2).", annotationDiseaseCondition:["previous influenza infections"], citationTitle:"Influenza Other Respir Viruses. 2011 Sep;5(5):328-33. doi: 10.1111/j.1750-2659.2011.00232.x.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"21668692", citationType:"PubMed", citationRef:"21668692"}}, {start: {_id:219}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"Abnormal species of α-syn found in PD patients are also present in LBs of other synucleinopathy-affected brains, including AD and multiple-system atrophy (MSA).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:219}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Abnormal species of α-syn found in PD patients are also present in LBs of other synucleinopathy-affected brains, including AD and multiple-system atrophy (MSA).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:219}, end: {_id:220}, properties:{annotationPublicationtype:["Review"], evidence:"Abnormal species of α-syn found in PD patients are also present in LBs of other synucleinopathy-affected brains, including AD and multiple-system atrophy (MSA).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:136}, properties:{annotationPublicationtype:["Review"], evidence:"Positive associations of PD with influenza, toxoplasmosis, and autoimmunity have been reported while non-steroidal anti-inflammatory drugs decrease risk for PD [16–24]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:358}, properties:{annotationPublicationtype:["Review"], evidence:"Positive associations of PD with influenza, toxoplasmosis, and autoimmunity have been reported while non-steroidal anti-inflammatory drugs decrease risk for PD [16–24]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:136}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Immune responses to infections are also implicated in PD through association with influenza, toxoplasmosis, and Epstein-Barr Virus (EBV) [21, 23, 92].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:358}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Immune responses to infections are also implicated in PD through association with influenza, toxoplasmosis, and Epstein-Barr Virus (EBV) [21, 23, 92].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:391}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Immune responses to infections are also implicated in PD through association with influenza, toxoplasmosis, and Epstein-Barr Virus (EBV) [21, 23, 92].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:500}, properties:{annotationPublicationtype:["Research"], evidence:"Overall, H. pylori infection was significantly associated with a 1.59-fold (95% CI: 1.37-1.85) increased risk of PD.", citationTitle:"Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12398. Epub 2017 Jun 9.", annotationPublicationstatus:["Published"], annotationSection:["Discussion"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28598012", citationType:"PubMed", citationRef:"28598012"}}, {start: {_id:314}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"We found a statistically significant 28% increase in the incidence of PD among patients with IBD compared with the unaffected matched controls, after adjusting for age and sex(Table 2,Figure)", citationTitle:"JAMA Neurol. 2018 Aug 1;75(8):939-946. doi:10.1001/jamaneurol.2018.0605.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"29710331", citationType:"PubMed", citationRef:"29710331"}}, {start: {_id:458}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"The increased rate of PD was observed equally among patients with CD (adjusted IRR, 1.26; 95% CI, 1.03-1.53;P = .02) and among those with UC (adjusted IRR, 1.31; 95% CI, 1.14-1.51; P < .001; Table 2)", citationTitle:"JAMA Neurol. 2018 Aug 1;75(8):939-946. doi:10.1001/jamaneurol.2018.0605.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"29710331", citationType:"PubMed", citationRef:"29710331"}}, {start: {_id:539}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"The increased rate of PD was observed equally among patients with CD (adjusted IRR, 1.26; 95% CI, 1.03-1.53;P = .02) and among those with UC (adjusted IRR, 1.31; 95% CI, 1.14-1.51; P < .001; Table 2)", citationTitle:"JAMA Neurol. 2018 Aug 1;75(8):939-946. doi:10.1001/jamaneurol.2018.0605.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"29710331", citationType:"PubMed", citationRef:"29710331"}}, {start: {_id:314}, end: {_id:67}, properties:{annotationGender:["Male"], annotationPublicationtype:["Research"], evidence:"Compared with non-IBD controls, a greater proportion of men with IBD developed PD (0.34% vs 0.25%).", citationTitle:"JAMA Neurol. 2018 Aug 1;75(8):939-946. doi:10.1001/jamaneurol.2018.0605.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Inflammatory Bowel Diseases"], source:"wp4-cbm-comorbidity", pmid:"29710331", citationType:"PubMed", citationRef:"29710331"}}, {start: {_id:553}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Gastrointestinal dysfunction and hyposmia are core features of PD, often occurring years to decades before the emergence of motor symptoms [10]. Their involvement in the early symptoms of PD, together with the findings of α-synuclein aggregates in these tissues [9], indicate that the gastrointestinal tract and olfactory system might be trigger sites in PD pathogenesis.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:554}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Gastrointestinal dysfunction and hyposmia are core features of PD, often occurring years to decades before the emergence of motor symptoms [10]. Their involvement in the early symptoms of PD, together with the findings of α-synuclein aggregates in these tissues [9], indicate that the gastrointestinal tract and olfactory system might be trigger sites in PD pathogenesis.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:549}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Gastrointestinal dysfunction and hyposmia are core features of PD, often occurring years to decades before the emergence of motor symptoms [10]. Their involvement in the early symptoms of PD, together with the findings of α-synuclein aggregates in these tissues [9], indicate that the gastrointestinal tract and olfactory system might be trigger sites in PD pathogenesis.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:562}, properties:{annotationPublicationtype:["Review"], evidence:"However, unmedicated patients with rapid eye movement (REM) sleep behavior disorder, who exhibit a high conversion rate to PD, display similar changes in the gut microbiota.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:549}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, α-synuclein-overexpressing mice exposed to the microbiota from PD patients display exacerbated motor dysfunction compared to those that received microbiota from healthy donors, supporting perturbation of gut microbiota as a potential PD trigger.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:551}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, α-synuclein-overexpressing mice exposed to the microbiota from PD patients display exacerbated motor dysfunction compared to those that received microbiota from healthy donors, supporting perturbation of gut microbiota as a potential PD trigger.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:579}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"PD patients have reduced mitochondrial complex I activity in the substantia nigra, skeletal muscles, and platelets.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:640}, end: {_id:719}, properties:{annotationPublicationtype:["Research"], evidence:"Clinically documented COVID-19-associated neurological alterations included impaired consciousness (n=5), intraventricular hemorrhage (n=2), headache (n=2) and behavioral changes (n=2); acute cerebral ischemia was reported for 2 individuals, while neuropathological postmortem workup revealed acute infarcts in 6 individuals (Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:900}, properties:{annotationPublicationtype:["Research"], evidence:"Clinically documented COVID-19-associated neurological alterations included impaired consciousness (n=5), intraventricular hemorrhage (n=2), headache (n=2) and behavioral changes (n=2); acute cerebral ischemia was reported for 2 individuals, while neuropathological postmortem workup revealed acute infarcts in 6 individuals (Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:642}, properties:{annotationPublicationtype:["Research"], evidence:"Clinically documented COVID-19-associated neurological alterations included impaired consciousness (n=5), intraventricular hemorrhage (n=2), headache (n=2) and behavioral changes (n=2); acute cerebral ischemia was reported for 2 individuals, while neuropathological postmortem workup revealed acute infarcts in 6 individuals (Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:901}, properties:{annotationPublicationtype:["Research"], evidence:"Clinically documented COVID-19-associated neurological alterations included impaired consciousness (n=5), intraventricular hemorrhage (n=2), headache (n=2) and behavioral changes (n=2); acute cerebral ischemia was reported for 2 individuals, while neuropathological postmortem workup revealed acute infarcts in 6 individuals (Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:654}, properties:{annotationPublicationtype:["Research"], evidence:"Clinically documented COVID-19-associated neurological alterations included impaired consciousness (n=5), intraventricular hemorrhage (n=2), headache (n=2) and behavioral changes (n=2); acute cerebral ischemia was reported for 2 individuals, while neuropathological postmortem workup revealed acute infarcts in 6 individuals (Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:767}, properties:{annotationPublicationtype:["Research"], evidence:"Clinically documented COVID-19-associated neurological alterations included impaired consciousness (n=5), intraventricular hemorrhage (n=2), headache (n=2) and behavioral changes (n=2); acute cerebral ischemia was reported for 2 individuals, while neuropathological postmortem workup revealed acute infarcts in 6 individuals (Supplementary Table 2).", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:650}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1057}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:787}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:788}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1058}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:121}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:736}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:642}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1059}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1060}, properties:{annotationPublicationtype:["Research"], evidence:"Their prominent symptom was recent loss of olfactory function (sudden for 6 patients but progressive for case #1) and was accompanied with taste changes (except case #3) and at least one symptom belonging to the clinical spectrum of COVID-19, such as diarrhea, cough, dyspnea, conjunctivitis, fever, fatigue, headache, muscle pain, laryngitis or a sore throat (Fig. S1A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1061}, properties:{annotationPublicationtype:["Research"], evidence:"Other otolaryngologic symptoms were rhinorrhea for 4 patients, not concomitant with smell loss, nasal irritation for 2 patients and hyperacusis for case #1.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1062}, properties:{annotationPublicationtype:["Research"], evidence:"Other otolaryngologic symptoms were rhinorrhea for 4 patients, not concomitant with smell loss, nasal irritation for 2 patients and hyperacusis for case #1.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1063}, properties:{annotationPublicationtype:["Research"], evidence:"Other otolaryngologic symptoms were rhinorrhea for 4 patients, not concomitant with smell loss, nasal irritation for 2 patients and hyperacusis for case #1.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:650}, properties:{annotationPublicationtype:["Research"], evidence:"Taste changes were characterized in the 6 patients by dysgeusia where they had a reduced acuity for sweet taste, had a bad taste in the mouth, reduced or increased acuity for bitter, reduced acuity for salt or sour were reported in 4 out of the 6 patients with dysgeusia.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:651}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:650}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:121}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:736}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1057}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:787}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:788}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:642}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1059}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1060}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1070}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1071}, properties:{annotationPublicationtype:["Research"], evidence:"The four patients with long-lasting/relapsing loss of smell had been diagnosed with COVID-19 between January and March 2020, based on their initial clinical assessment, including sudden anosmia at disease onset, accompanied with taste changes (except case #8) and at least one clinical sign related to COVID-19, such as fever, fatigue, diarrhea, cough, dyspnea, headache, muscle pain, laryngitis, sore throat, but also paresthesia and vertigo in some patients (Fig. 8A).", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1061}, properties:{annotationPublicationtype:["Research"], evidence:"Other otolaryngologic symptoms were rhinorrhea for two patients, not concomitant with smell loss and nasal irritation for three patients.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1062}, properties:{annotationPublicationtype:["Research"], evidence:"Other otolaryngologic symptoms were rhinorrhea for two patients, not concomitant with smell loss and nasal irritation for three patients.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1072}, properties:{annotationPublicationtype:["Research"], evidence:"Nasal obstruction was reported in patient #10.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1073}, properties:{annotationPublicationtype:["Research"], evidence:"Neurological signs were stereotypical crises of wriggling nose, left intercostal and non-specific arm pain (case #8), paresthesia (case #9) and vertigo (case #10). ", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1074}, properties:{annotationPublicationtype:["Research"], evidence:"Neurological signs were stereotypical crises of wriggling nose, left intercostal and non-specific arm pain (case #8), paresthesia (case #9) and vertigo (case #10). ", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], annotationMeshanatomy:["Intercostal Muscles"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1075}, properties:{annotationPublicationtype:["Research"], evidence:"Neurological signs were stereotypical crises of wriggling nose, left intercostal and non-specific arm pain (case #8), paresthesia (case #9) and vertigo (case #10). ", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1070}, properties:{annotationPublicationtype:["Research"], evidence:"Neurological signs were stereotypical crises of wriggling nose, left intercostal and non-specific arm pain (case #8), paresthesia (case #9) and vertigo (case #10). ", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:650}, properties:{annotationPublicationtype:["Research"], evidence:"Two patients complained of bad taste (Table S2). Reduced or increased acuity for bitter, reduced acuity for salt or sour were reported by the two patients with dysgeusia", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:391}, end: {_id:264}, properties:{annotationPublicationtype:["Research"], evidence:"Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus.", citationTitle:"Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.", annotationPublicationstatus:["Published"], annotationSection:["Abstract"], annotationSpecies:["9606"], annotationMeshdisease:["Multiple Sclerosis"], source:"wp4-cbm-comorbidity", pmid:"35025605", citationType:"PubMed", citationRef:"35025605"}}, {start: {_id:640}, end: {_id:668}, properties:{annotationPublicationtype:["Research"], evidence:"All patients were very critically ill, with acute respiratory distress syndrome and mechanical ventilation, associated with acute kidney failure and refractory shock", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:1353}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Last but not the least, Helicobacter pylori infection has been also associated to an increased risk to develop PD.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1362}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Recent studies suggested that α-syn aggregation at nerve terminals as well as its capability to leave the cell into exosomes can trigger neuroinflammation and could be used as a potential biomarker for early PD diagnosis and a prognostic tool for disease progression", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Central Nervous System", "Nerve Endings"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:640}, end: {_id:37}, properties:{annotationPublicationtype:["Research"], evidence:"Additionally, the levels of genes involved in DNA demethylation, proinflammatory responses, apoptosis, p38 MAPK signaling, and neurodegenerative signaling like that found in Parkinson's disease and amyotrophic lateral sclerosis were also increased (Fig. 5C and Fig. S5F).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1705}, properties:{annotationPublicationtype:["Research"], evidence:"Diabetic nephropathy and steatohepatitis were observed in ten cases (23%) and five cases (12%), respectively.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36517603"}}, {start: {_id:18}, end: {_id:1722}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"At 1–5 years preceding NDD diagnosis, 15 replicated pairings had significant associations, with hazard ratios ranging from 2.24(PD and influenza and pneumonia) to 24.14 (dementia and viral encephalitis).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:136}, end: {_id:7}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"For both pairs (influenza/Alzheimer's and Bell's palsy/dementia), the HR was higher before NDD diagnosis.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1727}, end: {_id:18}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"For both pairs (influenza/Alzheimer's and Bell's palsy/dementia), the HR was higher before NDD diagnosis.", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:640}, end: {_id:1}, properties:{annotationPublicationtype:["Research"], evidence:"Interestingly, INCOV participants from cluster E predominantly exhibited an acute WHO ordinal score of ≥3 reflecting the association between more severe acute disease and persistent inflammation37 (Fig. 5D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationSpecimen:["Plasma"], source:"wp4-cbm-comorbidity", pmid:"37296110", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:786}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1839}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1840}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:1566}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:65}, end: {_id:1829}, properties:{annotationPublicationtype:["Review"], evidence:"Along with female sex and older age, low socioeconomic status, smoking, obesity and a large panel of other comorbidities, i.e. chronic obstructive pulmonary disease, prostatic hyperplasia, fibromyalgia, depression or multiple sclerosis, among others, have also been associated with a higher long-term risk of long COVID (Subramanian et al., 2022; Thompson et al., 2022).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1122}, end: {_id:1929}, properties:{annotationPublicationtype:["Review"], evidence:"In the literature, viraemia is not only predictive of patient survival but is also associated with worse respiratory disease severity, increased markers of inflammation, and increased pulmonary viral RNA load.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:134}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"In line with this, microscopic evaluations of the hearts of deceased patients revealed features consistent with pre-existing hypertensive or atherosclerotic disease.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:748}, end: {_id:640}, properties:{annotationPublicationtype:["Review"], evidence:"In line with this, microscopic evaluations of the hearts of deceased patients revealed features consistent with pre-existing hypertensive or atherosclerotic disease.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1246}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1312}, end: {_id:372}, properties:{annotationPublicationtype:["Research"], evidence:"As shown in Figure 4C,D, increased SDC3 concentrations in the brain and the liver correlated well with blood TNF-α concentrations, suggesting a cause and effect relationship between TNF-α and SDC3 expression, as shown in previous in vitro studies.", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Liver", "Brain", "Blood"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["ELISA"], citationRef:"35328830"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:625}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Compared to K562 cells, WT SDC4 transfectants exhibited the most significant (p<0.01) increase in Aβ1–42 uptake (Fig. 7b,c).", citationTitle:"Sci Rep. 2019 Feb 4;9(1):1393. doi:10.1038/s41598-018-37476-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"30718543", annotationCellline:["K 562 cell"], citationType:"PubMed", citationRef:"30718543"}}, {start: {_id:1084}, end: {_id:954}, properties:{annotationPublicationtype:["Research"], evidence:"Namely, deleting both the CBD and the HSA with HS chains reduced cellular uptake of SARS-CoV-2, as shown by the markedly reduced intracellular fluorescence detected in Si4 mutants (Figure 3B–D).", citationTitle:"Int J Mol Sci. 2021 May 19;22(10):5336. doi:10.3390/ijms22105336.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"34069441", citationType:"PubMed", annotationCondition:["Heat-inactivated"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["fluorescence method", "flow cytometry"], annotationCellline:["K 562 cell"], citationRef:"34069441"}}, {start: {_id:1268}, end: {_id:1077}, properties:{annotationPublicationtype:["Research"], evidence:"Heparin's effect on lowering the cellular uptake of Delta was slightly higher than on WT spike, suggesting the increased importance of polyanionic HS chains in the interactions with the more positively charged Delta spike (Figure 3A–F,H).", citationTitle:"Int J Mol Sci. 2022 Jan 12;23(2):796. doi: 10.3390/ijms23020796.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationSarsCov2Variant:["Delta"], annotationCustomCellline:["293T cell", "293T cell overexpressing ACE2"], source:"wp4-cbm-comorbidity", pmid:"35054983", citationType:"PubMed", citationRef:"35054983"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:109}, end: {_id:105}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:332}, end: {_id:283}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:332}, end: {_id:331}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:333}, end: {_id:283}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:333}, end: {_id:267}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:366}, end: {_id:364}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:366}, end: {_id:365}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:368}, end: {_id:364}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:368}, end: {_id:8}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:370}, end: {_id:8}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:370}, end: {_id:369}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:385}, end: {_id:384}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:547}, end: {_id:542}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:547}, end: {_id:541}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:571}, end: {_id:565}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:962}, end: {_id:959}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:962}, end: {_id:960}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:964}, end: {_id:959}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:964}, end: {_id:963}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:964}, end: {_id:960}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:1218}, end: {_id:1217}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1221}, end: {_id:1217}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1233}, end: {_id:1232}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1270}, end: {_id:626}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1271}, end: {_id:626}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1369}, end: {_id:115}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1699}, end: {_id:1696}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1699}, end: {_id:684}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1877}, end: {_id:1876}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1877}, end: {_id:4}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:145}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In PD, LBs are associated with activated microglia and dopaminergic neuronal death. LBs are comprised mostly of α-syn, ubiquitin, and neurofilament (Goldman et al. 1983; Spillantini et al. 1997, 1998; Jellinger 2007) and posttranslationally modified forms of α-syn have an increased propensity to aggregate.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:592}, end: {_id:591}, properties:{annotationPublicationtype:["Review"], evidence:"A recent study, for instance, demonstrated that LRRK2 activity regulates Mycobacterium tuberculosis replication by affecting phagosome maturation in macrophages [52], and LRRK2 mutations may trigger PD pathogenesis via a dysregulation of responses to such bacteria.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:1736}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The transition of macrophages from the M1 to M2 stage is an indication of inflammatory pathology,1 and a high M1/M2 macrophage ratio has significant implications for CNS injury.62 An altered M1/M2 equilibrium promotes CNS inflammation, and an imbalance toward M1 promotes relapsing EAE", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2240}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The transition of macrophages from the M1 to M2 stage is an indication of inflammatory pathology,1 and a high M1/M2 macrophage ratio has significant implications for CNS injury.62 An altered M1/M2 equilibrium promotes CNS inflammation, and an imbalance toward M1 promotes relapsing EAE", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1211}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated FADD"], citationRef:"34675436"}}, {start: {_id:1211}, end: {_id:1216}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated FADD"], citationRef:"34675436"}}, {start: {_id:1221}, end: {_id:1219}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated Ripk3"], citationRef:"34675436"}}, {start: {_id:1233}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"The RIPK1 inhibitor abrogated Mpro-induced string vessel formation (Fig. 7c,d) and normalized body weight gain that was impaired by Mpro expression in brain endothelial cells (Extended Data Fig. 10). ", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMouseType:["Mouse with inactivated Ripk3"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:5}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Among earlier observations that stand out as pointing toward the need to consider inflammatory processes as important include: (1) Colton's demonstrations that cytokine-activated microglia produce ROS [3,4]; (2) that, in contrast to normal brain, proinflammatory cytokines are prevalent in Alzheimer's brains [5–7]; (3) the early indications that anti-inflammatory therapeutics may delay on-set of Alzheimer's disease [8]; and (4) the early demonstrations that complement and classic markers of immune-mediated damage are expressed in neurodegenerative brains [9,10].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"The enhanced oxidative damage to brain noted with increasing age [62], and especially so in neurodegenerative diseases, is most likely due to several factors, including altered mitochondrial production of ROS [54,55, 65]; but it is likely that the increased oxidative damage is also due in part to the increased prevalence of inflammatory conditions where microglia and other brain cells are 'activated' to produce increased ROS. ", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Neurodegenerative Diseases"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:17}, end: {_id:64}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, if inflammatory processes occur in the living brain, and more so under neurodegenerative conditions, it should be possible to measure higher levels of nitrotyrosine in these brains", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:5}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, reactive oxygen species produced by activated microglia increases nitration of α-syn and neuronal cell death (Shavali et al. 2006); and in turn, immune T cells that recognize nitrated α-syn (N-α-syn) enhance the neurotoxic activities of microglia in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of nigrostriatal degeneration . Activated T cells and B cells are then able to enter the CNS more readily and migrate to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", annotationDisease:["Parkinson's disease 1"], citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:57}, properties:{annotationPublicationtype:["Review"], evidence:"Aggregated α-syn activates microglia (Zhang et al. 2005), which have been shown to produce nitric oxide and superoxide in mice and inducible nitric oxide synthase (iNOS) in humans, which increases nitration of α-syn and perpetuates the proinflammatory innate immune response in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:58}, properties:{annotationPublicationtype:["Review"], evidence:"Aggregated α-syn activates microglia (Zhang et al. 2005), which have been shown to produce nitric oxide and superoxide in mice and inducible nitric oxide synthase (iNOS) in humans, which increases nitration of α-syn and perpetuates the proinflammatory innate immune response in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:17}, end: {_id:356}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, inflammation is a key pathogenic process in models of PD that often precedes detectable neuronal injury and degeneration.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:5}, end: {_id:356}, properties:{annotationPublicationtype:["Review"], evidence:"These activated microglia are associated with damaged neurons and Lewy body pathology [74]. In vivo PET imaging of PD patients demonstrates that microglial activation is concentrated in the SN and also occurs throughout the diseased CNS.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra", "Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:5}, end: {_id:145}, properties:{annotationPublicationtype:["Review"], evidence:"These activated microglia are associated with damaged neurons and Lewy body pathology [74]. In vivo PET imaging of PD patients demonstrates that microglial activation is concentrated in the SN and also occurs throughout the diseased CNS.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra", "Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:5}, end: {_id:383}, properties:{annotationPublicationtype:["Review"], evidence:"PET studies have also correlated microglial activation in the human midbrain with increased motor score on the Unified Parkinson's Disease Rating Scale (UPDRS) [80].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Mesencephalon"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:119}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"IFN-gamma stimulation of immune cells results in upregulation of LRRK2 expression, which was shown to activate the NF-κB pathway, to be important for production of microbicidal reactive oxygen species during phagocytosis, and to colocalize near pathogens during intracellular infection [160]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:222}, end: {_id:574}, properties:{annotationPublicationtype:["Review"], evidence:"For example, pathogen-induced (trigger) inflammation in the gut resulting in localized α-synuclein accumulation and aggregation in enteric nerves [11] may not promote PD until years later, after an age-related decline in cellular energy homeostasis and lysosomal function (facilitators) has set in, which in turn could enable the propagation of α-synuclein aggregates to the brainstem.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:47}, end: {_id:1915}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"The common genomic signature of aging in human PBMCs includes decreases in T cell functions and -> in cytotoxic effector cells (NK and memory CD8) and monocyte cell functions, which appear to be more pronounced in males [145].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:47}, end: {_id:1916}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"The common genomic signature of aging in human PBMCs includes decreases in T cell functions and -> in cytotoxic effector cells (NK and memory CD8) and monocyte cell functions, which appear to be more pronounced in males [145].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:47}, end: {_id:1917}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"The common genomic signature of aging in human PBMCs includes decreases in T cell functions and -> in cytotoxic effector cells (NK and memory CD8) and monocyte cell functions, which appear to be more pronounced in males [145].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:17}, end: {_id:2235}, properties:{annotationPublicationtype:["Review"], evidence:"In the healthy CNS, DCs are rarely detected. However, in response to local inflammation induced by autoimmunity, infection,trauma, or neurodegeneration, DCs accumulate significantly in the brain and spinal cord.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Brain", "Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:13}, end: {_id:32}, properties:{annotationPublicationtype:["Review"], evidence:"Other anti-inflammatory mediators that have been shown to increase when the corresponding inflammatory agent is increased include: (1) IL-10, which is thought to counteract IL-6 [20]; (2) CD59, the membrane inhibitor of reactive lysis [21]; and (3) SP-40,40 which has clusterin activity [22].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:2288}, end: {_id:292}, properties:{annotationPublicationtype:["Review"], evidence:"For instance, two independent groups have shown that the CD58 risk allele results in the downregulation of FOXP3 and consequently causes the dysfunction of Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:127}, end: {_id:74}, properties:{annotationPublicationtype:["Review"], evidence:"According to epidemiological evidence, a single bout of delirium can accelerate cognitive decline in patients with AD", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:67}, end: {_id:259}, properties:{annotationPublicationtype:["Review"], evidence:"Peripheral immune aberrations, particularly in lymphocyte subsets, are abundant in PD patients. Total numbers of lymphocytes have been shown to be diminished by 17%, whereas CD19+ B cells are diminished as much as 35% and CD3+ T cells are diminished by 22%. Among CD3+ T cells, numbers of CD4+ T cells have been shown to be diminished by 31%, whereas numbers of CD8+ T cells are not significantly changed.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"As disease evolves, these responses emerge from a well-regulated neuroprotective state to loss of regulatory function and disease.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"People with PD have significant BBB dysfunction, which is discussed below. The use of anti-inflammatory drugs in neurotoxin animal models such as MPTP and 6-hydroxydopamine (6-OHDA) also attenuates DA neuron loss [44].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:404}, properties:{annotationPublicationtype:["Review"], evidence:"A more activated, cytotoxic T cell response is suggested by decreased CD4:CD8 ratios and a shift to more IFN−G versus IL-4-producing T cells in PD patients [101–103].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:548}, properties:{annotationPublicationtype:["Review"], evidence:"In idiopathic PD, the triggers are thought to act decades before the loss of nigrostriatal dopaminergic signaling has reached levels necessary for the onset of clinical motor symptoms", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:71}, end: {_id:74}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, neuroinflammation is a predictive indicator in the development of non-motor symptoms and cognitive decline [69, 70], further illuminating its role as an aggravator and potential therapeutic target.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", annotationAnatomy:["skeletal muscle tissue"], citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:675}, end: {_id:74}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, ventilation-induced hypercapnia has been experimentally shown to lead to cognitive impairment in a NLRP3 inflammasome-interleukin-1β-dependent manner [23].", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:416}, properties:{annotationPublicationtype:["Research"], evidence:"The hematoxylin and eosin findings revealed two differences: 1) Microvessels of the brain of COVID-19 patients showed perivascular edema as defined by a zone of edema at least 50 μm in size around a capillary. 2) Less commonly, microvessels in the COVID-19 cases had endothelial cells that were degenerated, mummified, and detached, showed focal basement membrane duplication, and/or microthrombi.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationTechnique:["Hematoxylin and eosin staining"], annotationSpecies:["9606"], annotationSection:["Results"], citationRef:"33360731"}}, {start: {_id:640}, end: {_id:1011}, properties:{annotationPublicationtype:["Review"], evidence:"Apart from a state of hypercoagulability in the lungs of patients with ARDS, a hypofibrinolytic state in the alveolar space was observed in COVID-19-related ARDS due to increased levels of fibrinolytic inhibitors", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Respiratory Distress Syndrome, Adult"], annotationMeshanatomy:["Pulmonary Alveoli"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:551}, end: {_id:1327}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, modifications in the composition of microorganisms that populate the gut, also known as dysbiosis, may lead to dysregulated TLR signaling, persistent production of proinflammatory cytokines and disruption of the gut epithelial barrier.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, quantitative imaging analysis of sPD and control midbrain sections revealed a reduction in microglial branching exclusively in the SN of PD patients ", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["sporadic"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:640}, end: {_id:1491}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Relatively fewer genes were downregulated, but those that decreased were involved in fundamental cellular processes including cholesterol biosynthesis, calcium transport, cell size, and morphology.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1492}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Relatively fewer genes were downregulated, but those that decreased were involved in fundamental cellular processes including cholesterol biosynthesis, calcium transport, cell size, and morphology.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1493}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Relatively fewer genes were downregulated, but those that decreased were involved in fundamental cellular processes including cholesterol biosynthesis, calcium transport, cell size, and morphology.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1564}, properties:{annotationPublicationtype:["Research"], evidence:"The LC group was differentiated from controls by increased body temperature and CRP and lowered SpO2, Gpx and ANTIOX values.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", citationType:"PubMed", annotationSection:["Results"], annotationBioassay:["ELISA"], annotationDisease:["COVID-19"], citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1564}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, the ANTIOX index was significantly lower in both patient groups as compared with controls and also in the total Long COVID group as compared with controls (F=17.46, df=1/154, p<0.001).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1564}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1610}, properties:{annotationPublicationtype:["Research"], evidence:"Several different classes of genes were downregulated after SARS-CoV-2 infection, including those involved in cell-cell communication, cell junction organization, ion and fatty acid homeostasis, and solute carrier (SLC)-mediated transmembrane transport(Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1611}, properties:{annotationPublicationtype:["Research"], evidence:"Several different classes of genes were downregulated after SARS-CoV-2 infection, including those involved in cell-cell communication, cell junction organization, ion and fatty acid homeostasis, and solute carrier (SLC)-mediated transmembrane transport(Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1612}, properties:{annotationPublicationtype:["Research"], evidence:"Several different classes of genes were downregulated after SARS-CoV-2 infection, including those involved in cell-cell communication, cell junction organization, ion and fatty acid homeostasis, and solute carrier (SLC)-mediated transmembrane transport(Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1613}, properties:{annotationPublicationtype:["Research"], evidence:"Several different classes of genes were downregulated after SARS-CoV-2 infection, including those involved in cell-cell communication, cell junction organization, ion and fatty acid homeostasis, and solute carrier (SLC)-mediated transmembrane transport(Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:855}, properties:{annotationPublicationtype:["Research"], evidence:"Several different classes of genes were downregulated after SARS-CoV-2 infection, including those involved in cell-cell communication, cell junction organization, ion and fatty acid homeostasis, and solute carrier (SLC)-mediated transmembrane transport(Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Fibrinogen and IgG IHC were positive in the lesions, evidencing blood-brain barrier leakage (Fig. 2. h).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37283933", annotationAnatomy:["perivascular space"], citationType:"PubMed", annotationTechnique:["hematoxylin-eosin staining"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1847}, properties:{annotationPublicationtype:["Review"], evidence:"Researchers have observed a significant and progressive reduction in COVID-19 patients’ gray matter in the parahippocampal gyrus, the entorhinal cortex and the hippocampus after SARS-CoV-2 infection (Di Stadio et al., 2022; Douaud et al., 2022; Griffanti et al., 2021). These regions relate to olfaction and memory function.", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:640}, end: {_id:1848}, properties:{annotationPublicationtype:["Review"], evidence:"Researchers have observed a significant and progressive reduction in COVID-19 patients’ gray matter in the parahippocampal gyrus, the entorhinal cortex and the hippocampus after SARS-CoV-2 infection (Di Stadio et al., 2022; Douaud et al., 2022; Griffanti et al., 2021). These regions relate to olfaction and memory function.", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:655}, end: {_id:1850}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, COVID-19 patients with pre-existing neurological syndromes such as Guillain–Barré syndrome exhibit impairment in amyloid processing along with increased biomarkers of neurodegenerative diseases in their cerebrospinal fluid (CSF), including neuroinflammatory cytokines, glial fibrillary acidic protein and neuronal injury markers (Guasp et al., 2022; Jarius et al., 2022; Kanberg et al., 2020; Pilotto et al., 2021; Ziff et al., 2022; Visser et al., 2022 preprint).", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:640}, end: {_id:1854}, properties:{annotationPublicationtype:["Review"], evidence:"Yet, common phenotypes emerge upon analysis of short-term SARS-CoV-2 infection in brain organoids, including increased apoptosis, increased oxidative stress in neurons, myelin disregulation and synapsis loss due to microglial activation (Mesci et al., 2022; Samudyata et al., 2022; Song et al., 2021a).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], annotationCustomDisease:["short-term SARS-CoV-2 infection"], citationRef:"37458167"}}, {start: {_id:640}, end: {_id:1855}, properties:{annotationPublicationtype:["Review"], evidence:"Yet, common phenotypes emerge upon analysis of short-term SARS-CoV-2 infection in brain organoids, including increased apoptosis, increased oxidative stress in neurons, myelin disregulation and synapsis loss due to microglial activation (Mesci et al., 2022; Samudyata et al., 2022; Song et al., 2021a).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], annotationCustomDisease:["short-term SARS-CoV-2 infection"], citationRef:"37458167"}}, {start: {_id:67}, end: {_id:1857}, properties:{annotationPublicationtype:["Review"], evidence:"The causes of iPD remain elusive, although several pathological processes are associated with its progression. Mitochondrial dysfunction, impaired proteostasis, calcium dysregulation, and chronic inflammation have been extensively shown in PD animal models and people with PD (reviewed in [5])", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1866}, properties:{annotationPublicationtype:["Review"], evidence:"However, PD-associated transcriptomic profiles in microglia and peripheral monocytes from people with PD are not identical (e.g., upregulation of the S100 family of genes was seen in both, while oxidative phosphorylation (OXPHOS) genes were upregulated in monocytes but downregulated in microglia) [39].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1871}, properties:{annotationPublicationtype:["Review"], evidence:"Increased monocytic activation and reduced cytotoxicity in NK cells, which was associated with worse motor performance, have been described in peripheral blood mononuclear cells (PBMCs) from persons with PD [58].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Leukocytes, Mononuclear"], annotationCell:["natural killer cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1884}, properties:{annotationPublicationtype:["Review"], evidence:"Although both classical and intermediate monocytes from people with PD show transcriptomic alterations, this was more pronounced in intermediate monocytes, which showed dysregulation of proteasomal and mitochondrial genes [39].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["intermediate monocyte"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1888}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, analyses of PBMCs showed decreased senescence of CD8 cells in people with late-onset PD compared with those with early-onset PD [58].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationTimeline:["late onset"], annotationMeshanatomy:["Leukocytes, Mononuclear", "CD8-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1894}, properties:{annotationPublicationtype:["Review"], evidence:"Supporting the idea that chronic inflammation is important in PD, studies showed that people with PD have a reduced immunoregulatory compartment and Tregs of less regulatory-suppressive capacity, which was associated with an increase in proinflammatory effector T cells [81,109].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:186}, properties:{annotationPublicationtype:["Review"], evidence:"By contrast, CD4 T cells from people with PD showed decreased migratory capacity in vitro associated with mitochondrial dysfunction [112]. Interestingly, transcriptomic analysis of CD4 T cells upon in vitro activation suggests that mitochondrial dysfunction and defective DNA repair mechanisms contribute to T cell-related PD pathogenesis [106].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1898}, properties:{annotationPublicationtype:["Review"], evidence:"By contrast, CD4 T cells from people with PD showed decreased migratory capacity in vitro associated with mitochondrial dysfunction [112]. Interestingly, transcriptomic analysis of CD4 T cells upon in vitro activation suggests that mitochondrial dysfunction and defective DNA repair mechanisms contribute to T cell-related PD pathogenesis [106].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:7}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"In the CON NVU model, barrier integrity of BCECs was significantly increased by NSCs (p = 0.02; TEER = 2674 ± 670 Ω*cm2) compared to BCEC mono-cultures (TEER= 2299 ± 123 Ω*cm2) (Fig. 1G). The supporting effect was suppressed in the LOAD NVU model.", citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationModel:["isogenic model of the neurovascular unit"], annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", citationRef:"37907966"}}, {start: {_id:1841}, end: {_id:74}, properties:{annotationPublicationtype:["Research"], evidence:"Six participants with brain fog showed mild-to-moderate cognitive impairment on the Montreal Cognitive Assessment (MOCA) test (score 18–25) along with deficits in recall, executive functioning and word finding.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Stratifying the cohort into recovered, long COVID without brain fog and long COVID with brain fog revealed significantly increased BBB permeability in the cohort with brain fog compared to recovered patients and patients with long COVID without brain fog.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationDisease:["COVID-19"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Region of interest analysis identified significantly increased leakage in the right and left temporal lobes (TLs) and right and left frontal cortex.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationCustomAnatomy:["left frontal cortex", "right frontal cortex"], annotationAnatomy:["right temporal lobe", "left temporal lobe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Stratifying the groups according to recovered, long COVID or brain fog revealed significantly increased BBB permeability in the group with brain fog only in the right and left TL and right and left frontal cortex.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationCustomAnatomy:["left frontal cortex", "right frontal cortex"], annotationAnatomy:["right temporal lobe", "left temporal lobe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2173}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Comparing all individuals with previous COVID infection to unaffected controls revealed volumetric deficits predominantly in the FLs and TLs and increases in the lateral ventricles and occipital lobes (OLs), while group-wise comparisons of macrostructures revealed decreased GBV in patients with brain fog along with significantly reduced cerebral WM volume in both hemispheres in the recovered and brain fog cohorts along with reduced cerebellar WM volume in the recovered, long COVID and brain fog cohorts.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2177}, properties:{annotationPublicationtype:["Research"], evidence:"When comparing groups, there was reduced thickness in the frontal pole in the recovered, long COVID and brain fog cohorts; the superior frontal gyrus in the cohorts with long COVID and brain fog; the middle temporal gyrus in the cohort with brain fog only; and the superior temporal gyrus in the cohort with brain fog only.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2177}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"When comparing groups, there was reduced thickness in the frontal pole in the recovered, long COVID and brain fog cohorts; the superior frontal gyrus in the cohorts with long COVID and brain fog; the middle temporal gyrus in the cohort with brain fog only; and the superior temporal gyrus in the cohort with brain fog only.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:640}, end: {_id:2178}, properties:{annotationPublicationtype:["Research"], evidence:"When comparing groups, there was reduced thickness in the frontal pole in the recovered, long COVID and brain fog cohorts; the superior frontal gyrus in the cohorts with long COVID and brain fog; the middle temporal gyrus in the cohort with brain fog only; and the superior temporal gyrus in the cohort with brain fog only.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2178}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"When comparing groups, there was reduced thickness in the frontal pole in the recovered, long COVID and brain fog cohorts; the superior frontal gyrus in the cohorts with long COVID and brain fog; the middle temporal gyrus in the cohort with brain fog only; and the superior temporal gyrus in the cohort with brain fog only.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2179}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"When comparing groups, there was reduced thickness in the frontal pole in the recovered, long COVID and brain fog cohorts; the superior frontal gyrus in the cohorts with long COVID and brain fog; the middle temporal gyrus in the cohort with brain fog only; and the superior temporal gyrus in the cohort with brain fog only.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2180}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"When comparing groups, there was reduced thickness in the frontal pole in the recovered, long COVID and brain fog cohorts; the superior frontal gyrus in the cohorts with long COVID and brain fog; the middle temporal gyrus in the cohort with brain fog only; and the superior temporal gyrus in the cohort with brain fog only.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Frontal Lobe", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:2242}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"For instance, the loss of BBB integrity, the so-called ‘leakiness’ in the spinal cord, is common to EAE.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2361}, end: {_id:1624}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Hippocampal neurogenesis was deficient at both 7-day and 7-week time points, consistent with the persistent hippocampal microglial/macrophage reactivity (Figures 7N and 7O).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:4}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"It is difficult to prove this notion, but it is known that proinflammatory cytokines do mediate increased formation of ROS.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:53}, end: {_id:6}, properties:{annotationPublicationtype:["Review"], evidence:"Ceramide has been shown to mediate increased ROS formation in liver mitochondria.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:157}, end: {_id:158}, properties:{annotationPublicationtype:["Review"], evidence:"Although fewer activated T cells infiltrate the normal CNS than other tissues (Yeager et al. 2000), this may be owing to the low level of adhesion molecules expressed on endothelial cells under normal conditions (Hickey 2001), whereas increased expression of adhesion molecules leads to increased lymphocyte infiltration.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:302}, end: {_id:300}, properties:{annotationPublicationtype:["Review"], evidence:"For example, TGF-β, IL-2, IL-10, and all-trans retinoic acid are known to polarize T cells to iTreg (Zheng et al. 2007, 2008; Khattar et al. 2009; Lee et al. 2009b), whereas histone deacetylase inhibitors are known to increase proliferation and suppressor activity of Treg.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:303}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"For example, TGF-β, IL-2, IL-10, and all-trans retinoic acid are known to polarize T cells to iTreg (Zheng et al. 2007, 2008; Khattar et al. 2009; Lee et al. 2009b), whereas histone deacetylase inhibitors are known to increase proliferation and suppressor activity of Treg.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:354}, end: {_id:356}, properties:{annotationPublicationtype:["Review"], evidence:"MPP+ inhibits cellular respiration by direct inhibition of the mitochondrial transport chain leading to neuronal injury and death [12].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:365}, end: {_id:210}, properties:{annotationPublicationtype:["Review"], evidence:"The anti-inflammatory effects of dexamethasone in the MPTP mouse model protect against DA neuron loss [42, 43].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:319}, properties:{annotationPublicationtype:["Review"], evidence:"In those individuals exposed to MPTP through the use of contaminated heroin, microgliosis is present even years after exposure [75].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:364}, end: {_id:257}, properties:{annotationPublicationtype:["Review"], evidence:"CD8 T cells are seen in greater amounts than CD4 T cells in the acute MPTP neurotoxin model", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:691}, end: {_id:780}, properties:{annotationPublicationtype:["Review"], evidence:"Immunohistochemical staining showed that SARS-CoV in the brain was associated with elevated expression of the cytokine, monokine induced by gamma interferon (known as MIG or CXCL9), and with infiltration of monocytes and macrophages plus T cells. These findings are consistent with viral CNS entry triggering the infiltration of immune cells and the release of cytokines and chemokines, which contribute to tissue damage.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:684}, end: {_id:897}, properties:{annotationPublicationtype:["Research"], evidence:"We also observed expression of APOA1 and abundant lipid vesicles in cells of the ChP epithelium infected with SARS-CoV-2 (Figures 4B and 4C), whereas these cells were absent from cortical neuronal regions (Figure S4B).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:958}, properties:{annotationPublicationtype:["Research"], evidence:"Most infarcts showed signs of tissue damage and localized cell death, and positive viral staining was present predominantly around the edges of the infarct and to a lesser degree within the center.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["White Matter"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:1037}, end: {_id:1029}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, neutrophils isolated from patients with COVID-19 showed elevated NET release at baseline similar to phorbol myristate acetate (PMA)-stimulated neutrophils from healthy donors, indicating that the COVID-19 plasma environment promotes NET formation80", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neutrophils"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:684}, end: {_id:1029}, properties:{annotationPublicationtype:["Review"], evidence:"The virus itself is also reported to directly activate neutrophils towards NETosis, promoting epithelial cell death89.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neutrophils"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:684}, end: {_id:1554}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"In addition to choroid plexus, a differential expression analysis showed significant increase in expression of matrix metalloproteases and ECM-regulatory enzymes at 72hpi in microglia, astrocytes and perivascular cells, whereas endothelial cells reduced expression levels of solute carrier SLC2A1 (Fig. 7g), all in agreement with signaling that promotes compromised CNS barriers.", annotationCustomCell:["perivascular cell"], citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Choroid Plexus", "Microglia", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", citationType:"PubMed", annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"36198765"}}, {start: {_id:1593}, end: {_id:1594}, properties:{annotationPublicationtype:["Research"], evidence:"At the highest dose tested, 20 mM, EG00229 produced moderate cell toxicity, which was not observed with EG10377 (Fig. S1E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], annotationConcentration:["20 mM"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:684}, end: {_id:1775}, properties:{annotationPublicationtype:["Research"], evidence:"The intracellular Ca2+ concentration increased within the bridges (fig. S14, C to E), forming Ca2+ peaks that reflected the patterns of neuronal activity (fig. S14, F and G).", citationTitle:"Sci Adv. 2023 Jun 9;9(23):eadg2248. doi: 10.1126/sciadv.adg2248. Epub 2023 Jun 7.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Intracellular Space", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37285437", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37285437"}}, {start: {_id:684}, end: {_id:1935}, properties:{annotationPublicationtype:["Review"], evidence:"Although the exact link between viral infections and ARDS is not fully understood, certain alterations can be attributed to direct viral cytopathic effects, in particular, syncytial multinucleated giant cells and reactive AT2 hyperplasia.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:684}, end: {_id:4}, properties:{annotationPublicationtype:["Research"], evidence:"Further analysis of RNA-seq data of purified hPSC-derived DA neurons using NURR1-GFP in mock-infected or SARS-CoV-2-infected conditions identified robust induction of chemokine/cytokine transcripts and inflammation-related genes (Figures S3I and S3J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2144}, properties:{annotationPublicationtype:["Research"], evidence:"Transmission EM detected lipofuscin in SARS-CoV-2 infected DA neurons, another senescence-associated marker of DA neurons1.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["transmission electron microscopy"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:2150}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover, SARS-CoV-2 infected DA neurons showed additional senescence-associated phenotypes, including increased accumulation of lysosomes as indicated by LysoTracker staining  (Figure 3K), mitochondrial dysfunction as indicated by EM and MitoTracker staining (Figures 3L and 3M), and increased protein oxidation as indicated by ROS staining (Figure 3N).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationTechnique:["LysoTracker staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2150}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with the data of H9 hESC-derived DA neurons, MEL-1 hESC-derived DA neurons also showed increased β-gal staining and lysosomal accumulation upon SARS-CoV-2 infection (Figures S3M and S3N).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2150}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 infection increased both the percentage of β-gal+ cells (Figure S4D) and lysosomal accumulation (Figure S4E) in all iPSC-derived DA neurons.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:684}, end: {_id:2150}, properties:{annotationPublicationtype:["Research"], evidence:"However, the percentage of β-gal+ cells (Figure S4D) and lysosomal accumulation (Figure S4E) increased progressively along with the copy number of SNCA both in mock condition and upon SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:1736}, end: {_id:2241}, properties:{annotationPublicationtype:["Review"], evidence:"The transition of macrophages from the M1 to M2 stage is an indication of inflammatory pathology,1 and a high M1/M2 macrophage ratio has significant implications for CNS injury.62 An altered M1/M2 equilibrium promotes CNS inflammation, and an imbalance toward M1 promotes relapsing EAE", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2290}, end: {_id:267}, properties:{annotationPublicationtype:["Review"], evidence:"Blocking the production of the octapeptide angiotensin II (AII) or inhibiting AII signaling suppresses autoreactive Th1 and Th17 cells and promotes antigen-specific Foxp3+Tregs with an inhibition of the canonical nuclear factor κ-B (NFKB) transcription factor complex and an activation of the alternative NFKB pathway.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2290}, end: {_id:331}, properties:{annotationPublicationtype:["Review"], evidence:"Blocking the production of the octapeptide angiotensin II (AII) or inhibiting AII signaling suppresses autoreactive Th1 and Th17 cells and promotes antigen-specific Foxp3+Tregs with an inhibition of the canonical nuclear factor κ-B (NFKB) transcription factor complex and an activation of the alternative NFKB pathway.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2295}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"The repetitive administration of pertussis toxin, the major virulence factor of Bordetella pertussis, promotes the development of Tregs and prevents mice from developing EAE.2", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2300}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of E2 at pregnancy levels enhances the frequency of Tregs cells in EAE models", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2302}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Treatment with glucocorticoids in patients with MS during relapse significantly increased the percentage of Tregs and plasma IL10 and the FOXP3/CD3 ratio in peripheral blood", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Multiple Sclerosis"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2303}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, treatment with erythropoietin modulates the immune balance in both the peripheral nervous system and the inflamed spinal cord by promoting the expansion of Tregs, by inhibiting Th17 polarization, and by abrogating proliferation of the antigenpresenting DCs in EAE (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Encephalomyelitis, Autoimmune, Experimental"], annotationMeshanatomy:["Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2307}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Administration of VIP to EAE mice significantly ameliorates the progression of the disease by inducing the expansion of Tregs both in the periphery and in the nervous system262 (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["Peripheral Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2312}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"A natural antioxidant, C-phycocyanin, has also been found to induce Tregs in vitro from the peripheral blood of MS patients and consequently ameliorates the disease progress; C-phycocyanin can also ameliorate EAE clinical symptoms in Lewis rats.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:478}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"A 6-month treatment of glatiramer acetate in patients with RR-MS reconstituted naive Tregs and increased total Treg numbers with a concomitant reversion of the Treg defect266 (Figure 3(b)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Multiple Sclerosis, Relapsing-Remitting"], annotationTimeline:["6 months treatment"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2314}, end: {_id:2315}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, inhibition of Foxp3 expression by nitric oxide has been observed in MBP-primed murine T cells via soluble guanylyl-cyclase-mediated production of cGMP.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2326}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, the spore-forming component of indigenous intestinal microbiota, particularly, Clostridium species, has been shown to promote the induction of colonic Tregs.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2327}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, oral administration with purified zwitterionic capsular polysaccharide A of Bacteroides fragilis protects mice against EAE prophylactically and therapeutically by inducing the conversion of naive CD4+ T cells into IL10-producing Foxp3+ Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:673}, end: {_id:679}, properties:{annotationPublicationtype:["Review"], evidence:"The recent finding showing that NLRP3-driven and interleukin-1β-mediated modulation of phosphokinases and phosphatases largely accounts for the pathological formation of neurofibrillary tangles in murine models of tauopathy raises the concern that COVID-19 patients are likely to experience an induction or strong aggravation of neurodegenerative processes.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Tauopathies"], source:"wp4-cbm-comorbidity", pmid:"32498691", citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:2281}, end: {_id:2283}, properties:{annotationPublicationtype:["Review"], evidence:"Signaling of the chemokine CCL25 through its receptor CCR9 induces Tregs to migrate to the intestine in a chronic ileitis mouse model.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:145}, end: {_id:148}, properties:{annotationPublicationtype:["Review"], evidence:"Pathologically, the disease is characterized by the cytoplasmic accumulation of proteinaceous aggregates called Lewy bodies (LBs), which are mainly comprised of α-synuclein (α-syn) and ubiquitin.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS_COMPONENTS]->(end) SET r += row.properties;
UNWIND [{start: {_id:101}, end: {_id:100}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:103}, end: {_id:102}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:437}, end: {_id:436}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:441}, end: {_id:440}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1161}, end: {_id:1160}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1472}, end: {_id:1471}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1501}, end: {_id:1471}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1709}, end: {_id:1708}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1761}, end: {_id:727}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1762}, end: {_id:727}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2277}, end: {_id:2276}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__LOCATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:505}, end: {_id:507}, properties:{annotationPublicationtype:["Research"], evidence:"We identified two antigenic regions in α-syn, the first near the N terminus, composed of aa31GKTKEGVLYVGSKTK aa45 and aa32KTKEGVLYVGSKTKE aa46 (referred to as the Y39 region) (Fig 1a), which elicited an apparent Class II restricted IL-5 and IFNγ response (Fig 1b–d).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:505}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"We identified two antigenic regions in α-syn, the first near the N terminus, composed of aa31GKTKEGVLYVGSKTK aa45 and aa32KTKEGVLYVGSKTKE aa46 (referred to as the Y39 region) (Fig 1a), which elicited an apparent Class II restricted IL-5 and IFNγ response (Fig 1b–d).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:507}, properties:{annotationPublicationtype:["Research"], evidence:"We identified two antigenic regions in α-syn, the first near the N terminus, composed of aa31GKTKEGVLYVGSKTK aa45 and aa32KTKEGVLYVGSKTKE aa46 (referred to as the Y39 region) (Fig 1a), which elicited an apparent Class II restricted IL-5 and IFNγ response (Fig 1b–d).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"We identified two antigenic regions in α-syn, the first near the N terminus, composed of aa31GKTKEGVLYVGSKTK aa45 and aa32KTKEGVLYVGSKTKE aa46 (referred to as the Y39 region) (Fig 1a), which elicited an apparent Class II restricted IL-5 and IFNγ response (Fig 1b–d).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:518}, end: {_id:507}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:507}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:518}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:516}, end: {_id:507}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:519}, end: {_id:507}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:516}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:519}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"The immune responses to aa39 and aa129 region epitopes, including a second cohort of 19  PD and 12 HC assayed for response to additional phosphorylated and nitrated modifications  (Extended Data Fig 1), were different between PD and HC for secretion of both IFNγ (two-tailed Mann-Whitney test, p<0.05) and IL-5 (two-tailed Mann-Whitney test, p<0.001), and combined responses (two-tailed Mann-Whitney test, p<0.001) (Fig. 2a–c). ", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:518}, end: {_id:507}, properties:{annotationPublicationtype:["Research"], evidence:"While residue aa39 is highly phosphorylated in PD patients 24, Y39 phosphorylation was not required for antigenic response. The response was primarily polarized towards IL-5 in PD (71% IL-5 and 29% IFNγ; Fig. 2d). This polarization was PD specific, and the relatively rare HC responses were not similarly polarized (46% IL-5 and 54% IFNγ ).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:509}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"While residue aa39 is highly phosphorylated in PD patients 24, Y39 phosphorylation was not required for antigenic response. The response was primarily polarized towards IL-5 in PD (71% IL-5 and 29% IFNγ; Fig. 2d). This polarization was PD specific, and the relatively rare HC responses were not similarly polarized (46% IL-5 and 54% IFNγ ).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:521}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"Approximately 0.2% of CD3+ T cells responded to the α-syn peptides. Of the responsive T cells, ~50% produced IL-4 and 50% produced IFNγ, with no detectable IL-10 or IL-17 production.", annotationCustomCell:["CD3-positive T-lymphocyte"], citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:521}, end: {_id:272}, properties:{annotationPublicationtype:["Research"], evidence:"Approximately 0.2% of CD3+ T cells responded to the α-syn peptides. Of the responsive T cells, ~50% produced IL-4 and 50% produced IFNγ, with no detectable IL-10 or IL-17 production.", annotationCustomCell:["CD3-positive T-lymphocyte"], citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}, {start: {_id:146}, end: {_id:272}, properties:{annotationPublicationtype:["Research"], evidence:"The results indicated that IFNγ and IL-4 were produced primarily by CD4+ T cells, while IL-10 is produced by both CD4+ and CD8+ T cells (Fig. 5a–c), consistent with the previously reported data9. Boolean gating of cytokine responses revealed that the majority of responses were from unique T cells producing one of the three cytokines, IFNγ, IL-4, or IL-10 (Fig. 5d), although some cells produced both IFNγ and IL-4.", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:146}, end: {_id:269}, properties:{annotationPublicationtype:["Research"], evidence:"The results indicated that IFNγ and IL-4 were produced primarily by CD4+ T cells, while IL-10 is produced by both CD4+ and CD8+ T cells (Fig. 5a–c), consistent with the previously reported data9. Boolean gating of cytokine responses revealed that the majority of responses were from unique T cells producing one of the three cytokines, IFNγ, IL-4, or IL-10 (Fig. 5d), although some cells produced both IFNγ and IL-4.", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:146}, end: {_id:638}, properties:{annotationPublicationtype:["Research"], evidence:"The results indicated that IFNγ and IL-4 were produced primarily by CD4+ T cells, while IL-10 is produced by both CD4+ and CD8+ T cells (Fig. 5a–c), consistent with the previously reported data9. Boolean gating of cytokine responses revealed that the majority of responses were from unique T cells producing one of the three cytokines, IFNγ, IL-4, or IL-10 (Fig. 5d), although some cells produced both IFNγ and IL-4.", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["CD4-Positive T-Lymphocytes"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:174}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Cell debris and foreign matter within the CNS engage toll-like receptors (TLRs), which are expressed by microglia, astrocytes, oligodendrocytes, as well as by neurons (Lv et al. 2011; Zurolo et al. 2011). Engagement of TLRs activates signaling cascades that result in proinflammatory cytokine and chemokine production and in effects on the brain directly or indirectly through glial or BBB function.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Microglia", "Astrocytes"], annotationCell:["oligodendrocyte"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:174}, end: {_id:175}, properties:{annotationPublicationtype:["Review"], evidence:"Cell debris and foreign matter within the CNS engage toll-like receptors (TLRs), which are expressed by microglia, astrocytes, oligodendrocytes, as well as by neurons (Lv et al. 2011; Zurolo et al. 2011). Engagement of TLRs activates signaling cascades that result in proinflammatory cytokine and chemokine production and in effects on the brain directly or indirectly through glial or BBB function.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Neurons", "Microglia", "Astrocytes"], annotationCell:["oligodendrocyte"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:238}, end: {_id:240}, properties:{annotationPublicationtype:["Review"], evidence:"Nitrated α-syn in turn amplifies activation of microglia and antigen-presenting cells that correspondingly up-regulate both humoral and cell-mediated responses to nitrated α-syn in the MPTP model.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:326}, end: {_id:106}, properties:{annotationPublicationtype:["Review"], evidence:"Up-regulation of the antiviral ubiquitin-like protein, interferon-stimulated gene 15 (ISG15) was concordant with the decrease in viral release from MP , and implicating caspase-3 and granzyme/perforin pathways in MP killing. Finally, it was shown that Treg induce the phenotypic switch of MP from the neurotoxic MI phenotype to the more neurotrophic M2 phenotype with the down-regulation of iNOS and up-regulation of arginase 1.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:361}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The bacterial endotoxin, lipopolysaccharide (LPS),directly activates TLR4 receptors on microglia (and other innate immune cells) to initiate an inflammatory response", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:371}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In a mouse model, expression of wild-type alpha-synuclein under the direction of the Thy1 promoter resulted in microglial activation and TNFalpha expression in the striatum at 1 month of age and progression to the SN at 5-6 months of age [46].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationAge:["1 month"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["10090"], annotationAnatomy:["striatum"], citationRef:"24275605"}}, {start: {_id:456}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, LRRK2 inhibition and knockdown in microglia attenuated LPS-induced inflammatory signaling as measured by cytokine secretion, microglial chemotaxis, and morphologic remodeling [161].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:456}, end: {_id:455}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, LRRK2 inhibition and knockdown in microglia attenuated LPS-induced inflammatory signaling as measured by cytokine secretion, microglial chemotaxis, and morphologic remodeling [161].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:456}, end: {_id:335}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, LRRK2 inhibition and knockdown in microglia attenuated LPS-induced inflammatory signaling as measured by cytokine secretion, microglial chemotaxis, and morphologic remodeling [161].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:481}, end: {_id:639}, properties:{annotationPublicationtype:["Research"], evidence:"We found a positive correlation between age and T cell reactivity to α-syn, with patients older than 70 years having more frequent responses (p = 0.0177 Fisher's exact test, Fig. 6a). ", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:481}, end: {_id:639}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, our analyses revealed a significant correlation between low LED (<1000 mg/day) and T cell responses against α-syn (Fig. 6e).", citationTitle:"Nat Commun. 2020; 11: 1875. doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"32313102", citationType:"PubMed", citationRef:"32313102"}}, {start: {_id:674}, end: {_id:677}, properties:{annotationPublicationtype:["Review"], evidence:"Given the above cytokine findings in COVID-19 patients and in particular the rise of interleukin-1β and interleukin-18, it seems highly likely that COVID-19 patients suffer from NLRP3 inflammasome activation. This activation and the subsequent increased activity of proinflammatory immune pathways are likely to exert a negative impact on cerebral homeostasis and function.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:674}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"This conclusion is based on not only epidemiological evidence but also on experiments that showed that systemic, NLRP3 inflammasome-mediated inflammation adversely affects beneficial immune functions in the brain and thereby causes the pathological accumulation of neurodegeneration-associated peptides such as fibrillar amyloid-β.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:953}, end: {_id:774}, properties:{annotationPublicationtype:["Research"], evidence:"We detected significant inhibition of SARS-CoV-2 infection upon pretreatment with ACE2 antibody compared with isotype control, indicating the requirement of ACE2 for infection of brain organoids (Fig. 6, B and F; and Fig. S2 C).", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Organoids"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:1206}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"NEMO deletion induced endothelial cell death as detected by the TUNEL reaction or by staining for active caspase-3 (Fig. 5c–e). Most of them were observed in higher-order capillaries (Fig. 5f and Extended Data Fig. 8), suggesting that capillaries are particularly susceptible to NEMO deficiency", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1205}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Finally, Nemo deletion led to a significant vessel rarefaction in the brain (Fig. 6a) and to a BBB disruption (Fig. 6c,f and Supplementary Fig. 5c)", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1390}, end: {_id:1326}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:24}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is known to regulate oxidative stress and maintain mitochondrial function within the cell and, together with PINK1, was originally shown to provide neuroprotection by activating the NFkB transcription factor that regulates immune response among others", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1273}, end: {_id:774}, properties:{annotationPublicationtype:["Research"], evidence:"The gene delivery studies with red fluorescent proteins (RFPs) encoding PSVs bearing the spike proteins of the respective strains (WT SCV2, Delta, or Omicron) showed that SDC4 KD decreased the cellular entry and gene delivery of all PSVs (Figure 6).", citationTitle:"Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], source:"wp4-cbm-comorbidity", pmid:"37762442", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"37762442"}}, {start: {_id:1939}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Independent studies have shown that SARS-CoV-2 can infect blood monocytes through an antibody-opsonized virus, which in turn may lead to inflammasome  activation and systemic inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood"], annotationCell:["monocyte"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:2228}, end: {_id:2230}, properties:{annotationPublicationtype:["Research"], evidence:"We next examined immunovascular interactions in PBMCs isolated from patients with COVID-19 and found increased adhesion of PBMCs to human brain endothelial cells in the cohort with long COVID compared to unaffected individuals, which was heightened in the presence of TNF and only modestly affected by blocking antibodies against ICAM-1 and VCAM-1.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell", "peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2229}, end: {_id:2230}, properties:{annotationPublicationtype:["Research"], evidence:"We next examined immunovascular interactions in PBMCs isolated from patients with COVID-19 and found increased adhesion of PBMCs to human brain endothelial cells in the cohort with long COVID compared to unaffected individuals, which was heightened in the presence of TNF and only modestly affected by blocking antibodies against ICAM-1 and VCAM-1.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell", "peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:98}, end: {_id:99}, properties:{annotationPublicationtype:["Review"], evidence:"By contrast, complexes of Aβ, SAP and C1q complement protein stimulate increased cytokine synthesis", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:225}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, reactive oxygen species produced by activated microglia increases nitration of α-syn and neuronal cell death (Shavali et al. 2006); and in turn, immune T cells that recognize nitrated α-syn (N-α-syn) enhance the neurotoxic activities of microglia in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of nigrostriatal degeneration . Activated T cells and B cells are then able to enter the CNS more readily and migrate to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationDisease:["Parkinson's disease 1"], citationRef:"22315722"}}, {start: {_id:233}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Global loss of MHC-II in a mouse model is protective against neurodegeneration, microglial activation, and T cell infiltration when human alpha-synuclein is virally overexpressed in the SN", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:233}, end: {_id:227}, properties:{annotationPublicationtype:["Review"], evidence:"Global loss of MHC-II in a mouse model is protective against neurodegeneration, microglial activation, and T cell infiltration when human alpha-synuclein is virally overexpressed in the SN", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:233}, end: {_id:227}, properties:{annotationPublicationtype:["Review"], evidence:"In both PD patients and animal models, infiltration of T cells into the SN has been demonstrated [55, 72, 73].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:233}, end: {_id:227}, properties:{annotationPublicationtype:["Review"], evidence:"In conjunction with HLA-DR expression on microglia, T cell infiltration has been shown in post-mortem brain sections from PD patients.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:400}, end: {_id:401}, properties:{annotationPublicationtype:["Review"], evidence:"MHC-I molecules activate CD8 T cells by presenting cytosolic peptides processed through the proteasome pathway(Fig. 2).", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:776}, end: {_id:774}, properties:{annotationPublicationtype:["Review"], evidence:"The angiotensin converting enzyme 2 receptor, to which SARS-CoV-2 binds for entry into cells,100 is found in brain vascular endothelium and smooth muscle.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:23}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Not only aggregation, but also the overexpression and post-translational modifications (e.g. nitration) of α-syn are linked to sustained microglial activation [61–66], an effect likely mediated by the NFkB and MAPK signaling pathways", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:203}, end: {_id:205}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:204}, end: {_id:205}, properties:{annotationPublicationtype:["Review"], evidence:"Once activated, microglia secrete both neurotrophic and neurotoxic factors (Zhang and Fedoroff 1996; Glezer et al. 2007); proinflammatory cytokines including IL-1α, IL-1β, and TNF-α (Giulian et al. 1986; Sawada et al. 1989); and neurotrophins including nerve growth factor (NGF) and neurotrophin 3 (NT-3).", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:IS_A]->(end) SET r += row.properties;
UNWIND [{start: {_id:17}, end: {_id:466}, properties:{annotationPublicationtype:["Review"], evidence:"Current evidence demonstrates that inflammation regulates Parkin expression and that Parkin is involved in PD-implicated pathways in neurons.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1436}, end: {_id:1437}, properties:{annotationPublicationtype:["Review"], evidence:"RNA sequencing analysis in the midbrain of DJ-1 KO mice also allowed to identify several genes potentially involved in neuroinflammation (e.g. Parp-1, Mmp8, Hmgn1, IL-1, Nfkbid), most of which were significantly upregulated[109•]", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Mesencephalon"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1436}, end: {_id:1438}, properties:{annotationPublicationtype:["Review"], evidence:"RNA sequencing analysis in the midbrain of DJ-1 KO mice also allowed to identify several genes potentially involved in neuroinflammation (e.g. Parp-1, Mmp8, Hmgn1, IL-1, Nfkbid), most of which were significantly upregulated[109•]", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Mesencephalon"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1436}, end: {_id:1439}, properties:{annotationPublicationtype:["Review"], evidence:"RNA sequencing analysis in the midbrain of DJ-1 KO mice also allowed to identify several genes potentially involved in neuroinflammation (e.g. Parp-1, Mmp8, Hmgn1, IL-1, Nfkbid), most of which were significantly upregulated[109•]", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Mesencephalon"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1436}, end: {_id:1374}, properties:{annotationPublicationtype:["Review"], evidence:"RNA sequencing analysis in the midbrain of DJ-1 KO mice also allowed to identify several genes potentially involved in neuroinflammation (e.g. Parp-1, Mmp8, Hmgn1, IL-1, Nfkbid), most of which were significantly upregulated[109•]", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Mesencephalon"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1436}, end: {_id:1440}, properties:{annotationPublicationtype:["Review"], evidence:"RNA sequencing analysis in the midbrain of DJ-1 KO mice also allowed to identify several genes potentially involved in neuroinflammation (e.g. Parp-1, Mmp8, Hmgn1, IL-1, Nfkbid), most of which were significantly upregulated[109•]", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Mesencephalon"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:388}, end: {_id:389}, properties:{annotationPublicationtype:["Review"], evidence:"A GWAS identified polymorphism in the LRRK2 gene is associated with Crohn's disease. Mutations in this gene give rise to an autosomal dominant form of PD (see below).", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:466}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Current evidence demonstrates that inflammation regulates Parkin expression and that Parkin is involved in PD-implicated pathways in neurons.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:705}, end: {_id:680}, properties:{annotationPublicationtype:["Review"], evidence:"Neurological complications have also been described for other respiratory viruses, particularly seasonal and pandemic influenza.3 These complications include acute necrotising encephalopathy (associated with mutations in the RANBP2 gene), acute infantile encephalopathy, and acute haemorrhagic leukoencephalopathy and myelopathy in adults.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:221}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The inheritance of specific gene mutations in autosomal dominant (e.g. SNCA, LRRK2) and autosomal recessive (e.g. PINK1, PRKN, DJ-1) manner has been associated with the development of familial PD.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["familial", "autosomal dominant"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:388}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The inheritance of specific gene mutations in autosomal dominant (e.g. SNCA, LRRK2) and autosomal recessive (e.g. PINK1, PRKN, DJ-1) manner has been associated with the development of familial PD.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["familial", "autosomal dominant"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1358}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The inheritance of specific gene mutations in autosomal dominant (e.g. SNCA, LRRK2) and autosomal recessive (e.g. PINK1, PRKN, DJ-1) manner has been associated with the development of familial PD.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["familial", "autosomal dominant"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1359}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The inheritance of specific gene mutations in autosomal dominant (e.g. SNCA, LRRK2) and autosomal recessive (e.g. PINK1, PRKN, DJ-1) manner has been associated with the development of familial PD.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["familial", "autosomal dominant"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:1360}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"The inheritance of specific gene mutations in autosomal dominant (e.g. SNCA, LRRK2) and autosomal recessive (e.g. PINK1, PRKN, DJ-1) manner has been associated with the development of familial PD.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["familial", "autosomal dominant"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:221}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"Duplication, triplication and point mutations in SNCA, the gene which codes for α-syn, are equally linked with late and early onset PD", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late onset", "early onset"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:453}, end: {_id:314}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, it was speculated that the same LRRK2 gene that is also associated with inflammatory bowel disease [154] may modulate inflammatory pathways related to neurodegeneration.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:1358}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"PTEN-induced serine/threonine kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin, mutations of which are associated with recessive familial PD, are both involved in mitochondrial antigen presentation, and their dysfunction may lead to an inflammatory response [24].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1359}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"PTEN-induced serine/threonine kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin, mutations of which are associated with recessive familial PD, are both involved in mitochondrial antigen presentation, and their dysfunction may lead to an inflammatory response [24].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:2286}, end: {_id:2242}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, adoptive transfer of Tregs significantly protects the progress of myelin oligodendrocyte glycoprotein (MOG)-induced EAE.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2343}, end: {_id:669}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Notably, CSF levels of CCL11, a chemokine associated with cognitive impairment in aging (Villeda et al., 2011), were further increased at 7 weeks compared with 7 days post-infection (Figures 1J and 1K; Table S1).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1450}, end: {_id:1362}, properties:{annotationPublicationtype:["Review"], annotationGeneType:["GBA-/-"], evidence:"Knocking down GBA leads to α-syn aggregation, which in turn further impinges on GCase activity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:18}, end: {_id:19}, properties:{annotationPublicationtype:["Review"], evidence:"This cytokine circuit cascade [15–17] is a condition observed in the brains of HIV-induced demented individuals [15,16] and is manifest to various degrees with specific uniqueness in several other neurodegenerative conditions.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["HIV Infections"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:37}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"Therefore, viewed from this perspective the observed increased oxidative damage found in several neurodegenerative conditions, i.e., see a review of Alzheimer's disease [29], would be an expected consequence.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:41}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"The results of much research have demonstrated that oxidative damage to brain occurs as a result of stroke [36,38,56,57] or head trauma [58–61].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:0}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"The results of much research have demonstrated that oxidative damage to brain occurs as a result of stroke [36,38,56,57] or head trauma [58–61].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:48}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"It is proposed here that inflammatory processes contribute significantly to the enhanced oxidative damage observed in the chronic phase of neurodegenerative disease processes. ", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Neurodegenerative Diseases"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:49}, end: {_id:82}, properties:{annotationPublicationtype:["Review"], evidence:"The synthesis of proinflammatory cytokines and other inflammatory mediators is rapidly induced following acute injury, and these molecules contribute to the demise of neurons in the penumbra", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:49}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"The synthesis of proinflammatory cytokines and other inflammatory mediators is rapidly induced following acute injury, and these molecules contribute to the demise of neurons in the penumbra", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:168}, end: {_id:169}, properties:{annotationPublicationtype:["Review"], evidence:"Whereas acute neuroinflammation is beneficial to regaining homeostasis and normal function of the CNS after injury or infection, chronic neuroinflammation is damaging to the CNS and may initiate or amplify neurodegeneration associated with HIV-1 encephalitis, AD, or PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Alzheimer Disease", "Parkinson Disease"], annotationDisease:["viral encephalitis"], citationRef:"22315722"}}, {start: {_id:48}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"However, during chronic inflammation, the neurotoxic effects of microglia are proposed to eventually out-compete the neurotrophic effects, thus increasing neurodegeneration.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:207}, end: {_id:226}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, reactive oxygen species produced by activated microglia increases nitration of α-syn and neuronal cell death (Shavali et al. 2006); and in turn, immune T cells that recognize nitrated α-syn (N-α-syn) enhance the neurotoxic activities of microglia in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of nigrostriatal degeneration . Activated T cells and B cells are then able to enter the CNS more readily and migrate to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationDisease:["Parkinson's disease 1"], citationRef:"22315722"}}, {start: {_id:207}, end: {_id:227}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, reactive oxygen species produced by activated microglia increases nitration of α-syn and neuronal cell death (Shavali et al. 2006); and in turn, immune T cells that recognize nitrated α-syn (N-α-syn) enhance the neurotoxic activities of microglia in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of nigrostriatal degeneration . Activated T cells and B cells are then able to enter the CNS more readily and migrate to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationDisease:["Parkinson's disease 1"], citationRef:"22315722"}}, {start: {_id:71}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"Increased susceptibility to PD owing to MHC II molecules could reflect increased neuroinflammation associated with up-regulation of those molecules or alternatively, could represent immune responses to self- or weak nonself-antigens.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:67}, end: {_id:377}, properties:{annotationPublicationtype:["Review"], evidence:"Increased proliferation of blood vessels or endothelial cells also occurs in PD [54]. ", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Blood Vessels", "Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:67}, end: {_id:410}, properties:{annotationPublicationtype:["Review"], evidence:"Lymphocytes from PD patients display an increased incidence of micronuclei, single strand DNA breaks, and oxidized purine bases [109]. Interestingly,levodopa treatment seems to reduce this DNA damage in peripheral blood lymphocytes [110].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:551}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"While all the aforementioned studies have focused on the gut microbiome, it is possible that analogous changes in the nasal microbiome trigger α-synuclein aggregation in the olfactory bulb.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Olfactory Bulb"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:551}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Thus, gut dysbiosis and/or small intestinal bacterial overgrowth, along with increased intestinal permeability, can cause systemic inflammation, which could spread to the CNS through systemic circulation and several neural pathways.", annotationPublicationstatus:["Published"], citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, colon biopsies from PD patients exhibit increased mRNA levels for pro-inflammatory cytokines and glial markers, indicative of enteric inflammation.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:67}, end: {_id:15}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, colon biopsies from PD patients exhibit increased mRNA levels for pro-inflammatory cytokines and glial markers, indicative of enteric inflammation.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Colon"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:71}, end: {_id:15}, properties:{annotationPublicationtype:["Review"], evidence:"Neuroinflammation has been closely linked with neurodegenerative diseases and is often characterized by the activation of glial cells and the overexpression of pro-inflammatory mediators.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:71}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Neuroinflammation has been closely linked with neurodegenerative diseases and is often characterized by the activation of glial cells and the overexpression of pro-inflammatory mediators.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:659}, properties:{annotationPublicationtype:["Review"], evidence:"COVID-19 is associated with a severe innate immune response and sustained rise of systemic cytokine levels.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:640}, end: {_id:660}, properties:{annotationPublicationtype:["Review"], evidence:"COVID-19 is associated with a severe innate immune response and sustained rise of systemic cytokine levels.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:717}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"Encephalitis is the inflammation of the brain parenchyma, usually caused by an infection or the body's immune defences.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 can cause damage to endothelial cells, activating inflammatory and thrombotic pathways.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:770}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 can cause damage to endothelial cells, activating inflammatory and thrombotic pathways.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"A vasculitis process similar to that for varicella zoster virus, in which viral replication in the cerebral arterial wall triggers local inflammation,is also plausible; endothelial infection by SARS-CoV-2 with inflammation and apoptosis of endothelial cells has been shown in kidney, heart, bowel, and lung at autopsy,but cerebral vessels have not yet been investigated.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract", "Lung", "Kidney", "Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:785}, properties:{annotationPublicationtype:["Review"], evidence:"A vasculitis process similar to that for varicella zoster virus, in which viral replication in the cerebral arterial wall triggers local inflammation,is also plausible; endothelial infection by SARS-CoV-2 with inflammation and apoptosis of endothelial cells has been shown in kidney, heart, bowel, and lung at autopsy,but cerebral vessels have not yet been investigated.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract", "Lung", "Kidney", "Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32622375", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"32622375"}}, {start: {_id:640}, end: {_id:793}, properties:{annotationPublicationtype:["Research"], evidence:"Mild or moderate lymphocyte inflammation was present in all ten patients, although focal lymphocyte cuffing of small vessels was noted in six patients (60%).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lymphocytes"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"PM1 and PM2 were the two patients with the highest active viral load detected in the heart.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:119}, properties:{annotationPublicationtype:["Research"], evidence:"Lymphocyte depletion involving specific compartments and increased phagocytosis were prominent findings (appendix p 24, figure 4 ).", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:119}, properties:{annotationPublicationtype:["Research"], evidence:"Increased phagocytosis of other cells was identified in the sinusoidal macrophages of the red pulp of the spleen (in four [57%] of seven patients), sinus histiocytes of hilar lymph nodes (in three [50%] of six), and bone marrow (four [50%] of eight). Phagocytosis was identified in at least one of these organs in six (67%) of nine patients.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Bone Marrow", "Spleen", "Lymph Nodes"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:808}, properties:{annotationPublicationtype:["Research"], evidence:"A necrotising granuloma was noted in a single hilar lymph node in one patient, and acid-fast bacilli were noted on Ziehl Neelson staining.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lymph Nodes"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:818}, properties:{annotationPublicationtype:["Research"], evidence:"Mild T-cell infiltration was noted around blood vessels and capillaries in all five patients, but B cells were absent.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"Viral RNA was present in respiratory tract samples, including lung, of all five cases analysed. In addition, two of three patients had detectable viral RNA in the nasal epithelium and four of five patients in the trachea.", citationTitle:"Lancet Microbe. 2020 Oct;1(6):e245-e253. doi: 10.1016/S2666-5247(20)30115-4. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Nose", "Trachea"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"32844161", citationType:"PubMed", annotationTechnique:["histological analysis"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDiseaseSeverity:["Severe"], annotationDisease:["COVID-19"], citationRef:"32844161"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"Diffuse activation of microglia, with occasional microglial  nodules,was pronounced in the brainstem and cerebellum. Additionally,  we found distinct positive staining for HLA-DR in subpial and  subependymal regions, a pattern not commonly observed in classic  encephalitis.", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain Stem", "Cerebellum"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"Cases 2, 16, 21, and 41 showed more brainstem inflammation(in terms of  infiltration by cytotoxic CD8-positive T cells or activation of  microglia) than all others (figure 4).", citationTitle:"Lancet Neurol. 2020 Nov;19(11):919-929. doi: 10.1016/S1474-4422(20)30308-2. Epub 2020 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain Stem"], source:"wp4-cbm-comorbidity", pmid:"33031735", citationType:"PubMed", citationRef:"33031735"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"A correlate of this HLA-DR-positive, presumably myeloid-driven inflammatory response was found in the CSF, where levels of inflammatory mediators such as interleukin (IL)-6, IL-18, CC-chemokine ligand 2 (CCL2) and soluble intercellular adhesion molecule-1 (sICAM-1) were found to be increased (Supplementary Fig. 4a)30.", citationTitle:"Nat Neurosci. 2021 Feb;24(2):168-175. doi: 10.1038/s41593-020-00758-5. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Cerebrospinal Fluid"], source:"wp4-cbm-comorbidity", pmid:"33257876", citationType:"PubMed", citationRef:"33257876"}}, {start: {_id:640}, end: {_id:909}, properties:{annotationPublicationtype:["Research"], evidence:"The hematoxylin and eosin findings revealed two differences: 1) Microvessels of the brain of COVID-19 patients showed perivascular edema as defined by a zone of edema at least 50 μm in size around a capillary. 2) Less commonly, microvessels in the COVID-19 cases had endothelial cells that were degenerated, mummified, and detached, showed focal basement membrane duplication, and/or microthrombi.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationTechnique:["Hematoxylin and eosin staining"], annotationSpecies:["9606"], annotationSection:["Results"], citationRef:"33360731"}}, {start: {_id:640}, end: {_id:910}, properties:{annotationPublicationtype:["Research"], evidence:"The hematoxylin and eosin findings revealed two differences: 1) Microvessels of the brain of COVID-19 patients showed perivascular edema as defined by a zone of edema at least 50 μm in size around a capillary. 2) Less commonly, microvessels in the COVID-19 cases had endothelial cells that were degenerated, mummified, and detached, showed focal basement membrane duplication, and/or microthrombi.", citationTitle:"Ann Diagn Pathol. 2021 Apr:51:151682. doi: 10.1016/j.anndiagpath.2020.151682.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain", "Microvessels"], source:"wp4-cbm-comorbidity", pmid:"33360731", citationType:"PubMed", annotationTechnique:["Hematoxylin and eosin staining"], annotationSpecies:["9606"], annotationSection:["Results"], citationRef:"33360731"}}, {start: {_id:668}, end: {_id:99}, properties:{annotationPublicationtype:["Review"], evidence:"This event has been referred to as a cytokine storm18,19, although recent evidence suggests that cytokine levels in patients with COVID-19 are lower than those reported in patients with non-COVID-19 ARDS, sepsis, influenza virus infection and chimeric antigen receptor (CAR) T cell-induced cytokine release syndrome20,21. ", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1000}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 has been shown to trigger the IL-1/IL-6 pathway to a larger extent than other coronaviruses", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1001}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 has been shown to trigger the IL-1/IL-6 pathway to a larger extent than other coronaviruses", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"However, the striking finding in COVID-19 compared with SARS-CoV is the more extensive viral infection within the lungs, which results in more diffuse inflammation involving the pulmonary vessels", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Blood Vessels", "Lung"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:785}, properties:{annotationPublicationtype:["Review"], evidence:"SARS-CoV-2 directly infects vascular endothelial cells and leads to cellular damage and apoptosis, thus decreasing the antithrombotic activity of the normal endothelium7,55.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Endothelial Cells"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:653}, end: {_id:1024}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, endothelial dysfunction is recognized as a risk factor of microvascular dysfunction through a shift towards vasoconstriction, by promoting ischaemia, inflammation and a procoagulant state69", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:653}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, endothelial dysfunction is recognized as a risk factor of microvascular dysfunction through a shift towards vasoconstriction, by promoting ischaemia, inflammation and a procoagulant state69", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:653}, end: {_id:1025}, properties:{annotationPublicationtype:["Review"], evidence:"In addition, endothelial dysfunction is recognized as a risk factor of microvascular dysfunction through a shift towards vasoconstriction, by promoting ischaemia, inflammation and a procoagulant state69", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1026}, properties:{annotationPublicationtype:["Review"], evidence:"Lastly, platelet activation within the microvasculature is increased in patients with severe COVID-19 and is associated with poor outcomes70,71.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Lung", "Microvessels"], annotationDiseaseSeverity:["Severe"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1023}, end: {_id:1026}, properties:{annotationPublicationtype:["Review"], evidence:"All of these elements support the hypothesis that endothelial dysfunction, or endotheliopathy35,75, and platelet activation are key features of COVID-19-associated coagulopathy and may mediate the damage leading to severe disease.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"33824483", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:1026}, properties:{annotationPublicationtype:["Review"], evidence:"In support of this, there is increasing evidence that COVID-19 is a disease of the endothelium35 that results in elevated levels of PAI1 and VWF, increased platelet activation and a state of hypercoagulability, with consequent venous, arterial and microvascular thrombosis.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:640}, end: {_id:833}, properties:{annotationPublicationtype:["Research"], evidence:"Altogether these results show that a variety of cell types are infected in the olfactory neuroepithelium of patients with COVID-19, leading to increased cell death through apoptosis. Among them, the loss of mature OSN might be critically relevant in the context of the anosmia.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], annotationMeshanatomy:["Olfactory Mucosa"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:352}, properties:{annotationPublicationtype:["Research"], evidence:"Altogether these results show that a variety of cell types are infected in the olfactory neuroepithelium of patients with COVID-19, leading to increased cell death through apoptosis. Among them, the loss of mature OSN might be critically relevant in the context of the anosmia.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], annotationMeshanatomy:["Olfactory Nerve"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:872}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"While the overall coverage of vessels by pericytes was slightly lowered (Fig. 5i), the number of microglia increased and they exhibited an activated morphology (Fig. 5j). The astrogliosis marker glial fibrillary acidic protein (GFAP) was strongly upregulated, indicating an inflammatory response (Fig. 5k).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:640}, end: {_id:1250}, properties:{annotationPublicationtype:["Research"], evidence:"Other findings included edema (5 cases), discrete perivascular hemorrhages (5), cerebral small vessel disease (3), perivascular hemosiderin deposits (3), Alzheimer type II glia (3), abundant corpora amylacea (3), foci of ischemic area (1), foci of periventricular encephalitis (1), fibrin thrombi (1) and periventricular vascular ectasia (1) (Fig. 6).", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:819}, properties:{annotationPublicationtype:["Research"], evidence:"Other autopsy findings included typical COVID-19 pneumonia (diffuse alveolar damage, pneumocyte cytopathic changes, fibrin thrombi and increased megakaryocytes in septal vessels), acute tubular necrosis and visceral congestion.", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["pneumocyte"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:640}, end: {_id:1250}, properties:{annotationPublicationtype:["Research"], evidence:"Other autopsy findings included typical COVID-19 pneumonia (diffuse alveolar damage, pneumocyte cytopathic changes, fibrin thrombi and increased megakaryocytes in septal vessels), acute tubular necrosis and visceral congestion.", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}, {start: {_id:551}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, modifications in the composition of microorganisms that populate the gut, also known as dysbiosis, may lead to dysregulated TLR signaling, persistent production of proinflammatory cytokines and disruption of the gut epithelial barrier.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1453}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Based on recent studies, the cell-to-cell spreading of α-syn aggregates, and in particular the fibrillar forms of α-syn, can trigger an inflammatory response that contributes to PD progression [68, 119].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationProteinType:["fibril"], citationRef:"35674870"}}, {start: {_id:1453}, end: {_id:1454}, properties:{annotationPublicationtype:["Review"], evidence:"In fact, α-syn fibrils are able to induce the TLR2-NFkB signaling pathway in glial cells, resulting in microglia activation and release of proinflammatory cytokines [119, 120].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationProteinType:["fibril"], citationRef:"35674870"}}, {start: {_id:67}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Despite the early findings, few studies have convincingly shown increased inflammation in sporadic PD patients compared to healthy individuals [14, 139–141], and no inflammatory blood marker has been recommended as a potential biomarker for PD.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["sporadic"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:17}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:170}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1490}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Differential gene expression analysis revealed an increase in expression for genes involved in inflammation, the innate immune response, and the defense response to viral infection (Fig. 3 B).", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Among the top upregulated genes were those implicated in inflammation, injury response, and microglial activation (DGE_VolcanoPlot) (Fig. 3B, Right). Microglia markers and activation genes—including TREM2, CD4, SPP1, ITGAX—were also increased in infected cortical tissue.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Additionally, many indicators of inflammation, cytokine secretion, and immune activation had increased expression.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:455}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Additionally, many indicators of inflammation, cytokine secretion, and immune activation had increased expression.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:156}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Additionally, many indicators of inflammation, cytokine secretion, and immune activation had increased expression.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"In addition to an increase in inflammatory and reactivity gene expression in microglia, there was an increased abundance of CD14, IFITM3, and TREM2 protein in infected astrocytes.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["microglial cell"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:774}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Focusing on infected samples only, we identified the top genes with high correlation (R > 0.8) and anti-correlation (R < −0.8) to SARS-CoV-2 E and N gene levels (Materials and Methods). The top genes were involved in viral response and entry, type I interferon (IFN) signaling, IFN-gamma signaling, Major Histocompatibility Complex (MHC) activation, and interleukin 4 signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:947}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Focusing on infected samples only, we identified the top genes with high correlation (R > 0.8) and anti-correlation (R < −0.8) to SARS-CoV-2 E and N gene levels (Materials and Methods). The top genes were involved in viral response and entry, type I interferon (IFN) signaling, IFN-gamma signaling, Major Histocompatibility Complex (MHC) activation, and interleukin 4 signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1283}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Focusing on infected samples only, we identified the top genes with high correlation (R > 0.8) and anti-correlation (R < −0.8) to SARS-CoV-2 E and N gene levels (Materials and Methods). The top genes were involved in viral response and entry, type I interferon (IFN) signaling, IFN-gamma signaling, Major Histocompatibility Complex (MHC) activation, and interleukin 4 signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1499}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Focusing on infected samples only, we identified the top genes with high correlation (R > 0.8) and anti-correlation (R < −0.8) to SARS-CoV-2 E and N gene levels (Materials and Methods). The top genes were involved in viral response and entry, type I interferon (IFN) signaling, IFN-gamma signaling, Major Histocompatibility Complex (MHC) activation, and interleukin 4 signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1500}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Focusing on infected samples only, we identified the top genes with high correlation (R > 0.8) and anti-correlation (R < −0.8) to SARS-CoV-2 E and N gene levels (Materials and Methods). The top genes were involved in viral response and entry, type I interferon (IFN) signaling, IFN-gamma signaling, Major Histocompatibility Complex (MHC) activation, and interleukin 4 signaling.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:820}, properties:{annotationCellCulture:["Primary organotypic cortical slice cultures"], annotationPublicationtype:["Research"], evidence:"Moreover, infected SARS-CoV-2 S+ VIM+ astrocytes expressed DPP4 and CD147 but not ACE2 (Fig. 6C). The high abundance of VIM in infected cells suggests both specific astrocyte tropism as well as reactivity in adult tissue. Together with our observations in infected organoids and developing tissue, these data suggest tropism of SARS-CoV-2 for astrocytes in both developing and adult human cortex. Furthermore, the capacity for viral propagation can occur independent of ACE2 and is mediated, in part, by CD147 and DPP4.", citationTitle:"Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. doi: 10.1073/pnas.2122236119. Epub 2022 Jul 12.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], annotationMeshanatomy:["Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35858406", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"35858406"}}, {start: {_id:640}, end: {_id:1561}, properties:{annotationPublicationtype:["Research"], evidence:"The LC group was differentiated from controls by increased body temperature and CRP and lowered SpO2, Gpx and ANTIOX values.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1561}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:39}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:1576}, properties:{annotationPublicationtype:["Research"], evidence:"The current study’s first major finding is that (a) Long COVID is associated with decreased ANTIOX, including Gpx, and a mild inflammatory process; and (b) 31.7% of Long COVID patients belong to a cluster characterized by decreased SpO2, antioxidant levels, zinc, and Gpx, and increased body temperature, CRP, and OSTOX (increased MPO, NOx, MDA, and (PCs)).", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Hierarchical clustering revealed that SARS-CoV-2 induced increased transcription of inflammatory chemokines, including CCL3 and CXCL3 (Fig. S2A and B), indicating the activation of an intrinsic inflammatory response.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1606}, properties:{annotationPublicationtype:["Research"], evidence:"Pathway analysis revealed the activation of genes involved in chromatin modification (CHD1, H2BC5, H2AC12, and INO80) as well as genes mediating cell activation and apoptosis (Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:106}, properties:{annotationPublicationtype:["Research"], evidence:"Pathway analysis revealed the activation of genes involved in chromatin modification (CHD1, H2BC5, H2AC12, and INO80) as well as genes mediating cell activation and apoptosis (Fig. 4E).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1623}, properties:{annotationPublicationtype:["Research"], evidence:"In this regard, DNA methylation profiling of SARS-CoV-2-infected brain organoids also revealed the hypermethylation of numerous genes involved in neurogenesis, axonogenesis, and synaptic transmission (Fig. 4F and Fig. S3 and S4)", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1683}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the MX1 gene displayed the highest log fold change in expression (.6-fold), which was accompanied by a 25% decline in promoter methylation. ISG20 and ZCCHC3 also became hypomethylated at their promoters during SARS-CoV-2 infection.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:1623}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the MX1 gene displayed the highest log fold change in expression (.6-fold), which was accompanied by a 25% decline in promoter methylation. ISG20 and ZCCHC3 also became hypomethylated at their promoters during SARS-CoV-2 infection.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 RNA was detected in 84 distinct anatomical locations and body fluids (Supplementary Data 1b–d), with a significantly (P<0.0001 for all) higher burden detected in respiratory compared with non-respiratory tissues among early (2.04±0.10 log10[N gene copies] per nanogram of RNA), mid (1.36±0.12 log10[N gene copies] per nanogram of RNA) and late (0.67±0.11 log10[N gene copies] per nanogram of RNA.", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Respiratory System"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"We detected SARS-CoV-2 RNA in perimortem plasma of 11 early and 1 mid case (Supplementary Data 1b,d).", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Plasma"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"SARS-CoV-2 RNA was detected in central nervous system (CNS) tissue in 10/11 cases (90.9%), including across most brain regions evaluated in 5/6 late cases, including P42 who died at D230 (Fig.1).", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"We detected SARS-CoV-2 subgenomic RNA across all tissue groups and multiple fluid types, including plasma, pleural fluid and vitreous humour (Supplementary Data 1a–c).", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Plasma", "Vitreous Body"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["pleural fluid"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"We observed SARS-CoV-2 RNA and protein in hypothalamus and cerebellum of an early case (P38) and cervical spinal cord and basal ganglia of late cases (P42 and P40, respectively), with a pattern consistent with neuronal staining (Fig.3).", citationTitle:"Nature. 2022 Dec;612(7941):758-763. doi: 10.1038/s41586-022-05542-y. Epub 2022 Dec 14.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hypothalamus", "Basal Ganglia", "Cerebellum"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"36517603", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationAnatomy:["cervical spinal cord"], annotationDisease:["COVID-19"], citationRef:"36517603"}}, {start: {_id:640}, end: {_id:1707}, properties:{annotationPublicationtype:["Case Report"], evidence:"The perivascular region from the patient showed immune cell infiltrates, fibrinogen leakage, increased PECAM-1 expression, and CD68 infiltrates (Figure 1A).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:16}, properties:{annotationPublicationtype:["Case Report"], evidence:"The perivascular region had astrocyte activation (Panel D).", citationTitle:"Neurology. 2023 Mar 28;100(13):624-628.doi: 10.1212/WNL.0000000000201682.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Temporal Lobe"], source:"wp4-cbm-comorbidity", pmid:"36526429", citationType:"PubMed", annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Drug Resistant Epilepsy"], annotationBioassay:["immunofluorescent labeling"], citationRef:"36526429"}}, {start: {_id:640}, end: {_id:1729}, properties:{annotationPublicationtype:["Research"], evidence:"Some of these subjects (#7, #9, #11, #17, #18) also displayed endothelial cell immunoreactivity in small vessels of the cerebral cortex (subject #11), deep cerebellar nuclei (#17–18) hippocampus (#7)(Fig. 4) and midbrain (#9) (Fig. 2j); small vessel thromboses,perivascular extravasation and hemorrhagic injury were found within affected regions of these cases.", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Hippocampus", "Cerebellar Nuclei", "Cerebral Cortex", "Microvessels"], annotationCell:["midbrain"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"In 23 COVID-19 subjects parenchymal microglia displayed an activated phenotype with characteristic thorny ramifications or amoeboid morphology (Fig. 5a, b).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1730}, properties:{annotationPublicationtype:["Research"], evidence:"In 23 COVID-19 subjects parenchymal microglia displayed an activated phenotype with characteristic thorny ramifications or amoeboid morphology (Fig. 5a, b).", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Parenchymal Tissue", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"36781876", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], annotationDisease:["COVID-19"], citationRef:"36781876"}}, {start: {_id:640}, end: {_id:1735}, properties:{annotationPublicationtype:["Research"], evidence:"Moreover,moderate to severe infiltration of CD68+/TMEM119− cells was found in 23 subjects; given their prominent perivascular localization, these were likely monocyte-derived macrophages", citationTitle:"NPJ Parkinsons Dis. 2023 Feb 13;9(1):25. doi: 10.1038/s41531-023-00467-3.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["immunohistochemistry"], source:"wp4-cbm-comorbidity", pmid:"36781876", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36781876"}}, {start: {_id:219}, end: {_id:222}, properties:{annotationPublicationtype:["Research"], evidence:"The forming rates of IP/RT-QuIC results were significantly higher in patients with synucleinopathy than in controls or non-synucleinopathy patients (P<0.001), but the comparison among patients with PD, DLB and MSA did not reveal significant results (Fig. 1a).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", citationRef:"37248302"}}, {start: {_id:640}, end: {_id:1757}, properties:{annotationPublicationtype:["Research"], evidence:"At the periphery of the lesions, apoptotic nuclei and occasional glial nuclear alterations, reminiscent of Creutzfeldt-Peters cells, were seen (Fig. 1. y).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["magnetic resonance imaging"], citationRef:"37283933"}}, {start: {_id:640}, end: {_id:1758}, properties:{annotationPublicationtype:["Research"], evidence:"At the periphery of the lesions, apoptotic nuclei and occasional glial nuclear alterations, reminiscent of Creutzfeldt-Peters cells, were seen (Fig. 1. y).", citationTitle:"Free Neuropathol. 2023 Feb 10:4:4-1. doi: 10.17879/freeneuropathology-2023-4584.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"37283933", citationType:"PubMed", annotationTechnique:["magnetic resonance imaging"], citationRef:"37283933"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:947}, properties:{annotationPublicationtype:["Research"], evidence:"Two of the clusters (4 & 5) showed marked enrichment for inflammatory modules including type I and type II interferon signaling, TNF signaling, NFκB signaling, and several others, while clusters 1, 2, and 3 lacked a distinct inflammatory protein signature.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1776}, properties:{annotationPublicationtype:["Research"], evidence:"Two of the clusters (4 & 5) showed marked enrichment for inflammatory modules including type I and type II interferon signaling, TNF signaling, NFκB signaling, and several others, while clusters 1, 2, and 3 lacked a distinct inflammatory protein signature.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1777}, properties:{annotationPublicationtype:["Research"], evidence:"Two of the clusters (4 & 5) showed marked enrichment for inflammatory modules including type I and type II interferon signaling, TNF signaling, NFκB signaling, and several others, while clusters 1, 2, and 3 lacked a distinct inflammatory protein signature.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1454}, properties:{annotationPublicationtype:["Research"], evidence:"Two of the clusters (4 & 5) showed marked enrichment for inflammatory modules including type I and type II interferon signaling, TNF signaling, NFκB signaling, and several others, while clusters 1, 2, and 3 lacked a distinct inflammatory protein signature.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1778}, properties:{annotationPublicationtype:["Research"], evidence:"Two of the clusters (4 & 5) showed marked enrichment for inflammatory modules including type I and type II interferon signaling, TNF signaling, NFκB signaling, and several others, while clusters 1, 2, and 3 lacked a distinct inflammatory protein signature.", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationSpecimen:["Serum"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1776}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1454}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1788}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1777}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1000}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1524}, properties:{annotationPublicationtype:["Research"], evidence:"Within cluster 4, multiple pathways associated with type II interferon (IFN-γ) signaling (Type II IFN signaling, IL-27, TID (aka: Chaperones modulating interferon signaling)), were among those most highly enriched (Fig. 2B, Supplemental Data S7). Canonical NF-κB signaling and NF-κB activating cytokine pathways(IL-18, TNF, IL-1 were enriched in both clusters 4 and 5 (Fig. 2C). In addition, cluster 5 was also enriched for proteins associated with IFN-α signaling (Fig. 2D).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1776}, properties:{annotationPublicationtype:["Research"], evidence:"To strengthen this observation, we extended our analysis to include all proteins that are part of IFN-γ related signaling modules and show that over time, the differences between inflammatory PASC vs. non-inflammatory PASC and the recovered COVID groups are even more distinct (Fig. 3D and Supplemental Fig. S10A).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1777}, properties:{annotationPublicationtype:["Research"], evidence:"To strengthen this observation, we extended our analysis to include all proteins that are part of IFN-γ related signaling modules and show that over time, the differences between inflammatory PASC vs. non-inflammatory PASC and the recovered COVID groups are even more distinct (Fig. 3D and Supplemental Fig. S10A).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1454}, properties:{annotationPublicationtype:["Research"], evidence:"To strengthen this observation, we extended our analysis to include all proteins that are part of IFN-γ related signaling modules and show that over time, the differences between inflammatory PASC vs. non-inflammatory PASC and the recovered COVID groups are even more distinct (Fig. 3D and Supplemental Fig. S10A).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1788}, properties:{annotationPublicationtype:["Research"], evidence:"To strengthen this observation, we extended our analysis to include all proteins that are part of IFN-γ related signaling modules and show that over time, the differences between inflammatory PASC vs. non-inflammatory PASC and the recovered COVID groups are even more distinct (Fig. 3D and Supplemental Fig. S10A).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1793}, properties:{annotationPublicationtype:["Research"], evidence:"To strengthen this observation, we extended our analysis to include all proteins that are part of IFN-γ related signaling modules and show that over time, the differences between inflammatory PASC vs. non-inflammatory PASC and the recovered COVID groups are even more distinct (Fig. 3D and Supplemental Fig. S10A).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:19}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to elevated cytokine levels, there is evidence for persistent inflammatory cytokine signaling based on the enrichment of proteins involved in TNF signaling, the IL-18 pathway, and the NF-κB canonical signaling pathway (Fig. 3G and Supplemental Fig. S10B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1777}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to elevated cytokine levels, there is evidence for persistent inflammatory cytokine signaling based on the enrichment of proteins involved in TNF signaling, the IL-18 pathway, and the NF-κB canonical signaling pathway (Fig. 3G and Supplemental Fig. S10B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1454}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to elevated cytokine levels, there is evidence for persistent inflammatory cytokine signaling based on the enrichment of proteins involved in TNF signaling, the IL-18 pathway, and the NF-κB canonical signaling pathway (Fig. 3G and Supplemental Fig. S10B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1788}, properties:{annotationPublicationtype:["Research"], evidence:"In addition to elevated cytokine levels, there is evidence for persistent inflammatory cytokine signaling based on the enrichment of proteins involved in TNF signaling, the IL-18 pathway, and the NF-κB canonical signaling pathway (Fig. 3G and Supplemental Fig. S10B).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1802}, properties:{annotationPublicationtype:["Research"], evidence:"Similarly, ssGSEA analysis showed enrichment for the pathway associated with regulation of IFN-α signaling in inflammatory PASC that followed a similar kinetic (Fig. 3I and supplemental Fig. S10C).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1814}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:1815}, properties:{annotationPublicationtype:["Research"], evidence:"Pairing this with the presence of neutrophil granule proteins including MMP8(neutrophil collagenase) and MPO, the neutrophil serine protease inhibitor SERPINB1, and multiple components of the membrane/vesicle trafficking machinery (SNAP23, STX8, SNAP29) among the 50 most differentially expressed proteins in cluster 5 suggests persistent neutrophil activation, degranulation, and possibly generation of neutrophil extracellular traps (NETosis).", citationTitle:"Nat Commun. 2023 Jun 9;14(1):3417. doi: 10.1038/s41467-023-38682-4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37296110", citationType:"PubMed", citationRef:"37296110"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Postmortem analyses of COVID-19 patients' brain tissue revealed T-cell infiltration and microglial activation, and injured neurons and astrocytes (Kanberg et al., 2020; Schwabenland et al., 2021).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:655}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, COVID-19 patients with pre-existing neurological syndromes such as Guillain–Barré syndrome exhibit impairment in amyloid processing along with increased biomarkers of neurodegenerative diseases in their cerebrospinal fluid (CSF), including neuroinflammatory cytokines, glial fibrillary acidic protein and neuronal injury markers (Guasp et al., 2022; Jarius et al., 2022; Kanberg et al., 2020; Pilotto et al., 2021; Ziff et al., 2022; Visser et al., 2022 preprint).", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:640}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Yet, common phenotypes emerge upon analysis of short-term SARS-CoV-2 infection in brain organoids, including increased apoptosis, increased oxidative stress in neurons, myelin disregulation and synapsis loss due to microglial activation (Mesci et al., 2022; Samudyata et al., 2022; Song et al., 2021a).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], annotationCustomDisease:["short-term SARS-CoV-2 infection"], citationRef:"37458167"}}, {start: {_id:640}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"Yet, common phenotypes emerge upon analysis of short-term SARS-CoV-2 infection in brain organoids, including increased apoptosis, increased oxidative stress in neurons, myelin disregulation and synapsis loss due to microglial activation (Mesci et al., 2022; Samudyata et al., 2022; Song et al., 2021a).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], annotationCustomDisease:["short-term SARS-CoV-2 infection"], citationRef:"37458167"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Yet, common phenotypes emerge upon analysis of short-term SARS-CoV-2 infection in brain organoids, including increased apoptosis, increased oxidative stress in neurons, myelin disregulation and synapsis loss due to microglial activation (Mesci et al., 2022; Samudyata et al., 2022; Song et al., 2021a).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], annotationCustomDisease:["short-term SARS-CoV-2 infection"], citationRef:"37458167"}}, {start: {_id:640}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, SARS-CoV-2 infection in brain organoids increased the number of reactive astrocytes adjacent to infected ones, increasing neuronal cell death in the vicinity probably due to a local inflammatory reaction (Andrews et al., 2022) (Fig. 4).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDisease:["COVID-19"], citationRef:"37458167"}}, {start: {_id:640}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, SARS-CoV-2 infection in brain organoids increased the number of reactive astrocytes adjacent to infected ones, increasing neuronal cell death in the vicinity probably due to a local inflammatory reaction (Andrews et al., 2022) (Fig. 4).", citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"37458167", citationType:"PubMed", annotationDiseaseCondition:["acute"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationDisease:["COVID-19"], citationRef:"37458167"}}, {start: {_id:67}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"The concept of neuroinflammation in PD was initially proposed based on the presence of responsive microglia in PD postmortem brains, as revealed by upregulated human leukocyte antigen (HLA)- DR (major histocompatibility complex; MHC-II) and CD68 [29,30]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1866}, properties:{annotationPublicationtype:["Review"], evidence:"However, PD-associated transcriptomic profiles in microglia and peripheral monocytes from people with PD are not identical (e.g., upregulation of the S100 family of genes was seen in both, while oxidative phosphorylation (OXPHOS) genes were upregulated in monocytes but downregulated in microglia) [39].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"Proinflammatory cytokines are also increased in the brain tissue of PD mouse models [49,50].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:236}, properties:{annotationPublicationtype:["Review"], evidence:"Increased monocytic activation and reduced cytotoxicity in NK cells, which was associated with worse motor performance, have been described in peripheral blood mononuclear cells (PBMCs) from persons with PD [58].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Leukocytes, Mononuclear"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1883}, properties:{annotationPublicationtype:["Review"], evidence:"Although both classical and intermediate monocytes from people with PD show transcriptomic alterations, this was more pronounced in intermediate monocytes, which showed dysregulation of proteasomal and mitochondrial genes [39].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["intermediate monocyte"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:186}, properties:{annotationPublicationtype:["Review"], evidence:"scRNAseq of T cells from people with PD revealed clonal expansion of cytotoxic CD4 T cells and bias in terminal effector memory CD8 cells, which showed enrichment of certain genes associated with trans-endothelial migration [101].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1866}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, Parkin and LRRK2 were downregulated in CD4 and upregulated in CD8 memory T cells in the responder group. However, other enriched pathways were shared across both memory T cell types, such as OXPHOS and TNF signaling, which are well-known PD-associated neurotoxic mechanisms [118].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["CD4-positive, alpha-beta memory T cell", "CD8-positive, alpha-beta memory T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1777}, properties:{annotationPublicationtype:["Review"], evidence:"Notably, Parkin and LRRK2 were downregulated in CD4 and upregulated in CD8 memory T cells in the responder group. However, other enriched pathways were shared across both memory T cell types, such as OXPHOS and TNF signaling, which are well-known PD-associated neurotoxic mechanisms [118].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["CD4-positive, alpha-beta memory T cell", "CD8-positive, alpha-beta memory T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1902}, properties:{annotationPublicationtype:["Review"], evidence:"B cells from people with PD showed clonal expansion and higher expression of MHCII genes compared with healthy controls [121]. Moreover, a proinflammatory B cell bias is supported by the decrease in regulatory and anti-inflammatory B cells [109,122] as well as by the increase in TNF [107,121,122] and GM-CSF-producing B cells in people with PD [122]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"The second study found a common over-representation of genes associated with mitochondrial dysfunction, oxidative stress, and inflammation in PD, but with the genes involved differing between sexes [142].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The second study found a common over-representation of genes associated with mitochondrial dysfunction, oxidative stress, and inflammation in PD, but with the genes involved differing between sexes [142].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:67}, end: {_id:1898}, properties:{annotationGender:["Female"], annotationPublicationtype:["Review"], evidence:"However, females (both humans and mice) showed higher repair of oxidative DNA damage in response to α-syn compared with males [152] and higher levels of the anti-inflammatory angiotensin 2 receptor [153].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606", "10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Studies employing Syrian hamsters exhibit often mild to moderate disease courses with a pulmonary pathology resembling COVID-19, that is, respiratory tract and lung pathology, alveolar and perivascular oedema and endotheliitis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10036"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1252}, end: {_id:1932}, properties:{annotationPublicationtype:["Review"], evidence:"The initial exudative phase is characterized by hyaline membrane formation (deposits along the alveolar walls composed of fibrin, mucopolysaccharides and cell debris), cell death, pulmonary oedema and inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1252}, end: {_id:106}, properties:{annotationPublicationtype:["Review"], evidence:"The initial exudative phase is characterized by hyaline membrane formation (deposits along the alveolar walls composed of fibrin, mucopolysaccharides and cell debris), cell death, pulmonary oedema and inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1252}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The initial exudative phase is characterized by hyaline membrane formation (deposits along the alveolar walls composed of fibrin, mucopolysaccharides and cell debris), cell death, pulmonary oedema and inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:1252}, end: {_id:836}, properties:{annotationPublicationtype:["Review"], evidence:"Proliferative-phase DAD shows interstitial lymphocytic infiltrates, squamous metaplasia (replacement of alveolar epithelium with squamous epithelium), syncytial multinucleated giant cells (fusions of uninuclear cells such as monocytes and/or macrophages or epithelial cells) and reactive type II pneumocyte (AT2) hyperplasia (reactive proliferation of a specific type of pulmonary epithelial cell.)", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Lung"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:445}, properties:{annotationPublicationtype:["Review"], evidence:"Other studies have investigated lung damage in depth by employing imaging flow-cytometry approaches, and have revealed that SARS-CoV-2 primarily infects alveolar epithelial cells. It is here that a local hyperinflammatory cell state is induced, predominantly mediated by macrophages.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationBioassay:["flow cytometry"], annotationMeshanatomy:["Lung", "Alveolar Epithelial Cells"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:445}, properties:{annotationPublicationtype:["Review"], evidence:"These data revealed the loss of alveolar type I (AT1) and AT2 cells and the aberrant activation of monocyte-derived macrophages and alveolar macrophages in the lungs with a specific cytokine profile.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1947}, properties:{annotationPublicationtype:["Review"], evidence:"COVID-19 autopsy lungs revealed endothelial injury, microangiopathy (injury of capillaries with thickening and weakening of the vessel walls) and intussusceptive angiogenesis (an aberrant blood vessel neoformation), and perivascular inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"COVID-19 autopsy lungs revealed endothelial injury, microangiopathy (injury of capillaries with thickening and weakening of the vessel walls) and intussusceptive angiogenesis (an aberrant blood vessel neoformation), and perivascular inflammation.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:322}, properties:{annotationPublicationtype:["Review"], evidence:"Investigating viral tropism using autopsies revealed high viral copy  numbers in the lung compared to relatively low copy numbers in all other organs examined.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:1122}, end: {_id:799}, properties:{annotationPublicationtype:["Review"], evidence:"In the literature, viraemia is not only predictive of patient survival but is also associated with worse respiratory disease severity, increased markers of inflammation, and increased pulmonary viral RNA load.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lung"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In autopsy specimens, renal histomorphological alterations include acute tubular necrosis, thrombotic microangiopathy, interstitial inflammation and fibrosis.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Kidney"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:799}, properties:{annotationPublicationtype:["Review"], evidence:"The latter are associated with SARS-CoV-2-dependent coagulation activation extending to the myocardium, or ACE2-mediated damage caused by low to moderate viral RNA loads in the heart.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:186}, properties:{annotationPublicationtype:["Review"], evidence:"Histopathological changes in the brain include the recruitment of immune cells and immune activation in the brain stem and olfactory bulbs, as well as in the choroid plexus and the blood–brain barrier, including vascular alterations.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain Stem", "Choroid Plexus", "Olfactory Bulb", "Blood-Brain Barrier"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:1955}, properties:{annotationPublicationtype:["Review"], evidence:"Histopathological changes in the brain include the recruitment of immune cells and immune activation in the brain stem and olfactory bulbs, as well as in the choroid plexus and the blood–brain barrier, including vascular alterations.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain Stem", "Choroid Plexus", "Olfactory Bulb", "Blood-Brain Barrier"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:99}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, COVID-19-induced cytokines alone were shown to be sufficient for significant disturbances to the neuronal expression signature in the absence of detectable SARS-CoV-2.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:7}, end: {_id:1959}, properties:{annotationPublicationtype:["Research"], evidence:"We found no changes in hiPSCs and PCs but a LOAD-dependent decrease in telomere length in ACs, BCECs, and NSCs, thus integrating a disease-related molecular phenotype for LOAD in our isogenic in vitro model of the NVU.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], annotationMeshanatomy:["Neural Stem Cells"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], citationRef:"37907966"}}, {start: {_id:640}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"Remarkably, the same transcriptional signatures identified in SARS-CoV-2 infected DA neurons in vitro (Figures S3I, S3J, S3K, and 3C) were observed in COVID-19 autopsy samples, including the induction of chemokine/cytokine (cohort 1, Figure 7A), inflammation (cohort 1, Figure 7B), senescence-associated (cohort 1, Figure 7C) genes, and SASP associated genes (cohort 1, Figure 7D).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Remarkably, the same transcriptional signatures identified in SARS-CoV-2 infected DA neurons in vitro (Figures S3I, S3J, S3K, and 3C) were observed in COVID-19 autopsy samples, including the induction of chemokine/cytokine (cohort 1, Figure 7A), inflammation (cohort 1, Figure 7B), senescence-associated (cohort 1, Figure 7C) genes, and SASP associated genes (cohort 1, Figure 7D).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:640}, end: {_id:2156}, properties:{annotationPublicationtype:["Research"], evidence:"Remarkably, the same transcriptional signatures identified in SARS-CoV-2 infected DA neurons in vitro (Figures S3I, S3J, S3K, and 3C) were observed in COVID-19 autopsy samples, including the induction of chemokine/cytokine (cohort 1, Figure 7A), inflammation (cohort 1, Figure 7B), senescence-associated (cohort 1, Figure 7C) genes, and SASP associated genes (cohort 1, Figure 7D).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:640}, end: {_id:2173}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"Comparing all individuals with previous COVID infection to unaffected controls revealed volumetric deficits predominantly in the FLs and TLs and increases in the lateral ventricles and occipital lobes (OLs), while group-wise comparisons of macrostructures revealed decreased GBV in patients with brain fog along with significantly reduced cerebral WM volume in both hemispheres in the recovered and brain fog cohorts along with reduced cerebellar WM volume in the recovered, long COVID and brain fog cohorts.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Lateral Ventricles", "Occipital Lobe"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2175}, properties:{annotationDiseaseStage:["recovered"], annotationPublicationtype:["Research"], evidence:"There was a significantly increased CSF volume in the cohort with brain fog only.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:7}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Sustained inflammation is observed in many of the neurodegenerative diseases including AD, PD, and amyotrophic lateral sclerosis (ALS).", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:67}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Sustained inflammation is observed in many of the neurodegenerative diseases including AD, PD, and amyotrophic lateral sclerosis (ALS).", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:65}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Sustained inflammation is observed in many of the neurodegenerative diseases including AD, PD, and amyotrophic lateral sclerosis (ALS).", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2236}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In the healthy CNS, DCs are rarely detected. However, in response to local inflammation induced by autoimmunity, infection,trauma, or neurodegeneration, DCs accumulate significantly in the brain and spinal cord.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:454}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In the healthy CNS, DCs are rarely detected. However, in response to local inflammation induced by autoimmunity, infection,trauma, or neurodegeneration, DCs accumulate significantly in the brain and spinal cord.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:141}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In the healthy CNS, DCs are rarely detected. However, in response to local inflammation induced by autoimmunity, infection,trauma, or neurodegeneration, DCs accumulate significantly in the brain and spinal cord.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:81}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"Under healthy conditions, astrocytes serve as supporters of normal neuronal functioning. Similar to microglia, activated astrocytes respond to various harmful conditions, including inflammation, stroke, brain tumors, and neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:89}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"Under healthy conditions, astrocytes serve as supporters of normal neuronal functioning. Similar to microglia, activated astrocytes respond to various harmful conditions, including inflammation, stroke, brain tumors, and neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:551}, end: {_id:198}, properties:{annotationPublicationtype:["Review"], evidence:"Substantial changes in the composition of the microbiota are associated with IBDs, and changes in the individual species of microbial flora can shape the induction of T cell subsets, including Th17 and Tregs in the intestine.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"As hypothesized, we found increased microglial/macrophage reactivity in subcortical white matter, as assessed by IBA1 and CD68 co-positivity (Figure 2 )", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["BALB/c", "CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"As hypothesized, we found increased microglial/macrophage reactivity in subcortical white matter, as assessed by IBA1 and CD68 co-positivity (Figure 2 )", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["BALB/c", "CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While microglial/macrophage reactivity was evident in white matter by increased expression of the marker CD68, overall numbers of microglia were largely unchanged (Figure S2 ).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["BALB/c", "CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"While microglial/macrophage reactivity was evident in white matter by increased expression of the marker CD68, overall numbers of microglia were largely unchanged (Figure S2 ).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["BALB/c", "CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["24-73"], evidence:" Similar to the mouse model, humans with COVID exhibit robustly elevated CD68+ microglial/macrophage reactivity in subcortical white matter compared with cortical gray matter and compared with individuals without SARS-CoV-2 infection (Figures 2M, 2N, and S3A).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["24-73"], evidence:" Similar to the mouse model, humans with COVID exhibit robustly elevated CD68+ microglial/macrophage reactivity in subcortical white matter compared with cortical gray matter and compared with individuals without SARS-CoV-2 infection (Figures 2M, 2N, and S3A).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["White Matter"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Examining the mouse hippocampus following mild respiratory COVID, we found robustly increased microglial/macrophage reactivity in hippocampal white matter at 7 days post-infection (Figures 4A and 4B) that persists until at least 7 weeks post-infection (Figures 4C and 4D).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Examining the mouse hippocampus following mild respiratory COVID, we found robustly increased microglial/macrophage reactivity in hippocampal white matter at 7 days post-infection (Figures 4A and 4B) that persists until at least 7 weeks post-infection (Figures 4C and 4D).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:1624}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Consistent with previous observations that reactive microglia/macrophages can inhibit hippocampal neurogenesis (Monje et al., 2003), a stark decrease in new neuron generation was evident, as assessed by Doublecortin-positive cell quantification, at 7 days post-infection (Figures 4E and 4F) and persisted until at least 7 weeks post-infection (Figures 4G and 4H).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We found the same pattern of white matter-selective microglial/macrophage reactivity in the subcortical and hippocampal white matter (Figures 7H and 7I) at 7 days post-infection.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"We found the same pattern of white matter-selective microglial/macrophage reactivity in the subcortical and hippocampal white matter (Figures 7H and 7I) at 7 days post-infection.", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"In contrast, microglial/macrophage reactivity persisted at 7 weeks in hippocampal white matter (Figure 7K), a finding that is consistent with the persistently elevated CSF CCL11 levels (Figure 7F), which we demonstrate above specifically increases reactivity of hippocampal microglia/macrophages (Figures 5F and 5G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:2361}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"In contrast, microglial/macrophage reactivity persisted at 7 weeks in hippocampal white matter (Figure 7K), a finding that is consistent with the persistently elevated CSF CCL11 levels (Figure 7F), which we demonstrate above specifically increases reactivity of hippocampal microglia/macrophages (Figures 5F and 5G).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:640}, end: {_id:2370}, properties:{annotationPublicationtype:["Research"], evidence:"In the heart, H&E stained parenchymal dissociation and myocyte vacuolization in the upper part of the image (M); rare SARS-CoV-2 traces observed in the endocardium (N, arrows); occasional foci of interstitial macrophages labeled by the CD68 antibody (O, arrowheads), rare subepicardial T-lymphocyte (P, arrows) and B-lymphocyte (Q, arrowheads) infiltrates revealed by CD3 and CD20 reactions in the upper and lower parts of the images, respectively; CD42b antibody marks focal and sporadic capillary microthrombi (R).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:2371}, properties:{annotationPublicationtype:["Research"], evidence:"In the heart, H&E stained parenchymal dissociation and myocyte vacuolization in the upper part of the image (M); rare SARS-CoV-2 traces observed in the endocardium (N, arrows); occasional foci of interstitial macrophages labeled by the CD68 antibody (O, arrowheads), rare subepicardial T-lymphocyte (P, arrows) and B-lymphocyte (Q, arrowheads) infiltrates revealed by CD3 and CD20 reactions in the upper and lower parts of the images, respectively; CD42b antibody marks focal and sporadic capillary microthrombi (R).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Heart"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:119}, properties:{annotationPublicationtype:["Research"], evidence:"The neuropathological hallmarks were: (1) diffuse cortical edema due to extreme hypoxia with cortical swelling, spongiosis, and severe neuronal rarefaction in the cerebral cortex and hippocampus; (2) very limited traces of SARS-CoV-2 antigens in pontine neurons of one case, perivascular and parenchymal inflammatory infiltrates characterized by the enhancement of CD68-positive amoeboid cells (activated microglia), which are more abundant in the pons (all cases) than in the frontal cortex, with a tendency to nodular aggregation and neuronophagia, and very scant B–T lymphocytes as vascular cuffing or inside few nodules; and (3) frequent microthrombi in the frontal lobe (eight cases) and pons (six cases) with rare ischemic rarefaction of the surrounding tissue.", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:126}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"The brain samples showed different degrees of atrophy and AD pathology (six cases showing cortical neuritic plaques associated with microglial activation and astrogliosis with reactive astrocytes), and small-vessel disease (SVD), including enlarged perivascular spaces, arteriolosclerosis, myelin loss, hemosiderin leakage, and microbleeds (five cases).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}, {start: {_id:640}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], evidence:"On the other hand, the significantly greater microglial activation in the pons of COVID-19 cases (Figure 4B), associated with traces of viral antigen (Figure 1T), emerged as a specific topographical phenomenon within the brain (p = 0.017; Figure 4B).", citationTitle:"Cells. 2022 Oct 4;11(19):3124. doi: 10.3390/cells11193124.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Pons"], source:"wp4-cbm-comorbidity", pmid:"36231087", citationType:"PubMed", annotationTechnique:["H&E staining"], annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"36231087"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:146}, properties:{annotationPublicationtype:["Review"], evidence:"Parkinson’s disease (PD) is characterized by the cardinal signs of the movement disorder such as tremor and postural instability, as well as the histopathological hallmarks of alpha-synuclein (α-syn) accumulation and loss of dopaminergic neurons in the substantia nigra (SN).", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:196}, end: {_id:197}, properties:{annotationPublicationtype:["Review"], evidence:"Of the antiinflammatory cytokines produced by T cells, macrophages, and microglia, TGF-β modulates injurious responses to the brain (Finch et al. 1993) and suppresses proinflammatory microglia and T-cell responses, and as such may represent a neuroprotective host response.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:146}, end: {_id:435}, properties:{annotationPublicationtype:["Review"], evidence:"In microglia, alpha-synuclein has been shown to have a homeostatic role.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:146}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The level of alpha-synuclein protein increases after LPS stimulation of monocytes and lymphocytes [138], suggesting it may have some regulatory role in inflammatory responses.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Monocytes", "Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:461}, end: {_id:463}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly for adaptive immunity, LRRK2 inhibits the nuclear translocation of NFAT, a master regulator of transcriptional activation in T cells [164].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:466}, end: {_id:438}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, genetic loss of Parkin in mice and Drosophila models has been shown to increase susceptibility to infection. This effect on immune function was shown to be related to Parkin's role in autophagy [177].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:477}, end: {_id:438}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, genetic loss of Parkin in mice and Drosophila models has been shown to increase susceptibility to infection. This effect on immune function was shown to be related to Parkin's role in autophagy [177].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["7227"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:453}, end: {_id:593}, properties:{annotationPublicationtype:["Review"], evidence:"The targets of the LRRK2 kinase, and cell model experiments, suggest that mutations can also alter vesicular trafficking, mitochondrial function, protein synthesis, cytoskeletal dynamics [57], and autophagy–functions that, when impaired, may facilitate PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:453}, end: {_id:594}, properties:{annotationPublicationtype:["Review"], evidence:"The targets of the LRRK2 kinase, and cell model experiments, suggest that mutations can also alter vesicular trafficking, mitochondrial function, protein synthesis, cytoskeletal dynamics [57], and autophagy–functions that, when impaired, may facilitate PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:453}, end: {_id:595}, properties:{annotationPublicationtype:["Review"], evidence:"The targets of the LRRK2 kinase, and cell model experiments, suggest that mutations can also alter vesicular trafficking, mitochondrial function, protein synthesis, cytoskeletal dynamics [57], and autophagy–functions that, when impaired, may facilitate PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:453}, end: {_id:438}, properties:{annotationPublicationtype:["Review"], evidence:"The targets of the LRRK2 kinase, and cell model experiments, suggest that mutations can also alter vesicular trafficking, mitochondrial function, protein synthesis, cytoskeletal dynamics [57], and autophagy–functions that, when impaired, may facilitate PD pathogenesis.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Gastrointestinal Tract"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:851}, end: {_id:852}, properties:{annotationPublicationtype:["Research"], evidence:"Upregulation of many vascular remodeling genes (Figure 4D), such as NPPB and VCAN, suggests that infected choroid plexus cells could signal the vasculature to promote leukocyte invasion (Shechter et al., 2013).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:853}, end: {_id:852}, properties:{annotationPublicationtype:["Research"], evidence:"Upregulation of many vascular remodeling genes (Figure 4D), such as NPPB and VCAN, suggests that infected choroid plexus cells could signal the vasculature to promote leukocyte invasion (Shechter et al., 2013).", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}, {start: {_id:146}, end: {_id:1361}, properties:{annotationPublicationtype:["Review"], evidence:"In the brain, the function of α-syn is to aid neurotransmission via the regulation of the synaptic vesicles and synaptic membranes [59].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late onset", "early onset"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}, {start: {_id:582}, end: {_id:1392}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 phosphorylates ubiquitin, regulates mitochondrial quality control and plays a key role in mitophagy (the removal of damaged mitochondria from cells). ", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:582}, end: {_id:472}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 phosphorylates ubiquitin, regulates mitochondrial quality control and plays a key role in mitophagy (the removal of damaged mitochondria from cells). ", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:466}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is known to regulate oxidative stress and maintain mitochondrial function within the cell and, together with PINK1, was originally shown to provide neuroprotection by activating the NFkB transcription factor that regulates immune response among others", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:466}, end: {_id:1398}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin is known to regulate oxidative stress and maintain mitochondrial function within the cell and, together with PINK1, was originally shown to provide neuroprotection by activating the NFkB transcription factor that regulates immune response among others", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:582}, end: {_id:170}, properties:{annotationPublicationtype:["Review"], evidence:"Accordingly, PINK1 deficiency triggers an innate immune response mediated by mitochondrial dysfunction and a dysregulation in anti-microbial defense mechanisms ", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1423}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"DJ-1 has multiple neuroprotective functions, including the regulation of oxidative stress [106], but the link with inflammation is less clear.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["autosomal recessive"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1545}, end: {_id:119}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1546}, end: {_id:119}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"Subcluster AS-2, comprising of cells sampled at 72hpi, showed elevated levels of GFAP and STAT3, indicative of reactive astrogliosis [45], along with phagocytosis related genes such as MEGF8 and ABCA1 (Fig. 7c, Supplementary Fig. 8d).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:388}, end: {_id:1776}, properties:{annotationPublicationtype:["Review"], evidence:"Moreover, LRRK2 mutations can lead to an abnormal type-II interferon (IFN) response, potentially resulting in brain inflammation [20].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1922}, end: {_id:1923}, properties:{annotationGender:["Male"], annotationPublicationtype:["Review"], evidence:"Males were affected earlier motorically by Nurr1 deficiency [151] and male MPTP-intoxicated monkeys showed higher inflammation markers [43].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:2155}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Real-time quantitative PCR analysis showed a decrease in the senescence-pathway associated gene IGFBP7 and an upregulation of LMNB1 for each of the three drugs (Figure 4J).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:301}, end: {_id:377}, properties:{annotationPublicationtype:["Review"], evidence:"IL2 is also important for the proliferation and survival of Tregs.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1244}, properties:{annotationPublicationtype:["Research"], evidence:"Histological brain analysis showed reactive gliosis, congestion and cortical neuron eosinophilic degeneration, and axonal disruption in all six cases (Fig. 6)", citationTitle:"Insights Imaging. 2022 Jan 15;13(1):7. doi: 10.1186/s13244-021-01144-w.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["immunohistochemistry"], annotationMeshanatomy:["Brain", "Cerebral Cortex"], source:"wp4-cbm-comorbidity", pmid:"35032223", citationType:"PubMed", citationRef:"35032223"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:247}, end: {_id:67}, properties:{annotationPublicationtype:["Review"], evidence:"In one study, IgG reacted with 30% of the dopaminergic neurons within the nigra, and yielded positive correlations with numbers of MHC II+ and CD64+ (FcγRI) reactive microglia, yet yielded a negative correlation with disease duration.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:61}, end: {_id:60}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:1201}, end: {_id:1145}, properties:{annotationPublicationtype:["Research"], evidence:"The inactive p.Cys145Ala-Mpro had no effect on string vessels or vascular density. In line with a detrimental effect of Mpro on endothelial cell survival, there were less HA-positive vessels after expression of Mpro-HA in comparison to p.Cys145Ala-Mpro-HA (Supplementary Fig. 4c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["western blot"], citationRef:"34675436"}}, {start: {_id:1201}, end: {_id:1148}, properties:{annotationPublicationtype:["Research"], evidence:"The inactive p.Cys145Ala-Mpro had no effect on string vessels or vascular density. In line with a detrimental effect of Mpro on endothelial cell survival, there were less HA-positive vessels after expression of Mpro-HA in comparison to p.Cys145Ala-Mpro-HA (Supplementary Fig. 4c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["western blot"], citationRef:"34675436"}}, {start: {_id:1201}, end: {_id:1203}, properties:{annotationPublicationtype:["Research"], evidence:"The inactive p.Cys145Ala-Mpro had no effect on string vessels or vascular density. In line with a detrimental effect of Mpro on endothelial cell survival, there were less HA-positive vessels after expression of Mpro-HA in comparison to p.Cys145Ala-Mpro-HA (Supplementary Fig. 4c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["western blot"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:CAUSES_NO_CHANGE]->(end) SET r += row.properties;
UNWIND [{start: {_id:5}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The microglia in brain are analogous to resident macrophages capable of being activated to produce cell mediators, (i.e., such as the cytokines IL-1b, IL-6, TNF-a, etc.), which in turn activate other cell populations, e.g., glia and astrocytes, to subsequently produce other cell mediators that then additionally activate microglia and other cellular populations, therefore, perpetuating and amplifying the inflammatory cascade.", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:138}, end: {_id:139}, properties:{annotationPublicationtype:["Review"], evidence:"However, when an adaptive immune response continues unchecked in the brain, the proinflammatory innate microglial response leads to the accumulation of neurotoxins and eventual neurodegeneration. What drives such responses are misfolded and nitrated proteins.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:139}, end: {_id:140}, properties:{annotationPublicationtype:["Review"], evidence:"However, when an adaptive immune response continues unchecked in the brain, the proinflammatory innate microglial response leads to the accumulation of neurotoxins and eventual neurodegeneration. What drives such responses are misfolded and nitrated proteins.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:208}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence abounds for the involvement of misfolded proteins in the pathology of neurodegenerative diseases, as well as in the activation of microglia and antigen-presenting cells (APCs) that function to induce the adaptive immune arm.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:208}, end: {_id:209}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence abounds for the involvement of misfolded proteins in the pathology of neurodegenerative diseases, as well as in the activation of microglia and antigen-presenting cells (APCs) that function to induce the adaptive immune arm.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence abounds for the involvement of misfolded proteins in the pathology of neurodegenerative diseases, as well as in the activation of microglia and antigen-presenting cells (APCs) that function to induce the adaptive immune arm.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:209}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"Evidence abounds for the involvement of misfolded proteins in the pathology of neurodegenerative diseases, as well as in the activation of microglia and antigen-presenting cells (APCs) that function to induce the adaptive immune arm.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:222}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Aggregated α-syn activates microglia (Zhang et al. 2005), which have been shown to produce nitric oxide and superoxide in mice and inducible nitric oxide synthase (iNOS) in humans, which increases nitration of α-syn and perpetuates the proinflammatory innate immune response in PD.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:5}, end: {_id:239}, properties:{annotationPublicationtype:["Review"], evidence:"Nitrated α-syn in turn amplifies activation of microglia and antigen-presenting cells that correspondingly up-regulate both humoral and cell-mediated responses to nitrated α-syn in the MPTP model.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:252}, end: {_id:119}, properties:{annotationPublicationtype:["Review"], evidence:"Opsonization of cells or damaged neurons with antibody, targets the cells for phagocytosis and degradation by phagocytic macrophages, and also can activate the complement system, a major mediator of immune/inflammatory reactions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:252}, end: {_id:253}, properties:{annotationPublicationtype:["Review"], evidence:"Opsonization of cells or damaged neurons with antibody, targets the cells for phagocytosis and degradation by phagocytic macrophages, and also can activate the complement system, a major mediator of immune/inflammatory reactions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:253}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"Opsonization of cells or damaged neurons with antibody, targets the cells for phagocytosis and degradation by phagocytic macrophages, and also can activate the complement system, a major mediator of immune/inflammatory reactions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:253}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Opsonization of cells or damaged neurons with antibody, targets the cells for phagocytosis and degradation by phagocytic macrophages, and also can activate the complement system, a major mediator of immune/inflammatory reactions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:281}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"An influx of α-syn-specific Th1 or Th17 effector T cells into the brain during PD could increase the inflammatory phenotype and neurotoxic response of microglia near dopaminergic neurons by increasing the concentration of proinflammatory molecules in the SN.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:282}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"An influx of α-syn-specific Th1 or Th17 effector T cells into the brain during PD could increase the inflammatory phenotype and neurotoxic response of microglia near dopaminergic neurons by increasing the concentration of proinflammatory molecules in the SN.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:306}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"Treg can also inhibit the adaptive immune system indirectly by suppressing antigen presentation by APCs.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:327}, end: {_id:106}, properties:{annotationPublicationtype:["Review"], evidence:"Up-regulation of the antiviral ubiquitin-like protein, interferon-stimulated gene 15 (ISG15) was concordant with the decrease in viral release from MP , and implicating caspase-3 and granzyme/perforin pathways in MP killing. Finally, it was shown that Treg induce the phenotypic switch of MP from the neurotoxic MI phenotype to the more neurotrophic M2 phenotype with the down-regulation of iNOS and up-regulation of arginase 1.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:223}, end: {_id:334}, properties:{annotationPublicationtype:["Review"], evidence:"In an attempt to clear and digest cellular debris, microglia and blood-borne macrophages infiltrate sites of neuronal injury and death and convert to a proinflammatory activated state.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:223}, end: {_id:335}, properties:{annotationPublicationtype:["Review"], evidence:"In an attempt to clear and digest cellular debris, microglia and blood-borne macrophages infiltrate sites of neuronal injury and death and convert to a proinflammatory activated state.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:209}, end: {_id:336}, properties:{annotationPublicationtype:["Review"], evidence:"Misfolded and modified α-synuclein species draining from these sites also have the capability to activate antigen-presenting cells in peripheral lymphoid tissues inducing effector neurotoxic T-cell responses. This normally serves to facilitate debris clearance and repair functions.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphoid Tissue"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:337}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"Once modified protein species enters the peripheral lymphoid tissues, activate antigen-presenting cells, and are presented as neoepitopes, adaptive immune responses are induced.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:352}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Neuronal death can induce inflammation by releasing apoptotic and necrotic cellular factors that are recognized by innate immune cells", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:17}, end: {_id:99}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, inflammation can induce neuronal death through the production of neurotoxic cytokines or direct neuronal injury", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:99}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Conversely, inflammation can induce neuronal death through the production of neurotoxic cytokines or direct neuronal injury", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:162}, end: {_id:373}, properties:{annotationPublicationtype:["Review"], evidence:"Increased BBB permeability could allow for increased influx of peripheral adaptive immune cells which could then be activated by inflamed microglia as they are the primary innate immune cell of the CNS", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:5}, end: {_id:374}, properties:{annotationPublicationtype:["Review"], evidence:"Increased BBB permeability could allow for increased influx of peripheral adaptive immune cells which could then be activated by inflamed microglia as they are the primary innate immune cell of the CNS", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:17}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Some of the earliest evidence for inflammation in PD is from identification of chronic microglial activation in post-mortem brains.", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:119}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"Neuronal death can occur in response to cytokines such as TNFalpha, to ligation of death receptors such as Fas, and to toxicity of reactive oxygen species, as well as phagocytosis [59, 66].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:180}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"These studies provide provocative evidence that an adaptive immune response could induce PD-related neurologic dysfunction initiated solely by inflammation.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:5}, end: {_id:165}, properties:{annotationPublicationtype:["Review"], evidence:"In the intranigral AAV-human-alpha-synuclein overexpression mouse model, B and T lymphocyte infiltration in the SN persists after peak of microglial activation suggesting that adaptive immune cells propagate inflammation in this model as well [45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], annotationMouseType:["AAV-human-alpha-synuclein overexpression mouse"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:5}, end: {_id:166}, properties:{annotationPublicationtype:["Review"], evidence:"In the intranigral AAV-human-alpha-synuclein overexpression mouse model, B and T lymphocyte infiltration in the SN persists after peak of microglial activation suggesting that adaptive immune cells propagate inflammation in this model as well [45].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], annotationMouseType:["AAV-human-alpha-synuclein overexpression mouse"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:17}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"For example, pathogen-induced (trigger) inflammation in the gut resulting in localized α-synuclein accumulation and aggregation in enteric nerves [11] may not promote PD until years later, after an age-related decline in cellular energy homeostasis and lysosomal function (facilitators) has set in, which in turn could enable the propagation of α-synuclein aggregates to the brainstem.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:17}, end: {_id:222}, properties:{annotationPublicationtype:["Review"], evidence:"At the molecular level, inflammatory mediators are known to promote α-synuclein misfolding and aggregation [34]. Importantly, there are also emerging, compelling links between inflammation and the spread of α-synuclein pathology, which could explain how systemic inflammation facilitates the propagation of α-synuclein pathology from peripheral tissues to central nervous system.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:209}, end: {_id:285}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, mutations in genes known to cause familial PD have been directly or indirectly implicated in causing mitochondrial dysfunction. For example, PINK1 and Parkin actively inhibit mitochondrial-derived vesicle formation and mitochondrial antigen presentation; thus mutation of these genes in autosomal recessive Parkinson’s disease may result in excessive antigen presentation that provokes an autoimmune response.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:5}, end: {_id:99}, properties:{annotationPublicationtype:["Review"], evidence:"However, in PD, activated microglia are believed to have a deleterious effect on neurons and emit harmful levels of cytokines. This induces a vicious, self-propagating chronic neuroinflammatory state that contributes to the neurodegenerative process.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neurons"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:5}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia have also been shown to induce astrocytes to release neurotoxic mediators, leading to further neuronal damage.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30342839", annotationAnatomy:["skeletal muscle tissue"], citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:156}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Encephalitis is the inflammation of the brain parenchyma, usually caused by an infection or the body's immune defences.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Parenchymal Tissue", "Brain"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:5}, end: {_id:17}, properties:{annotationPublicationtype:["Research"], evidence:"While the overall coverage of vessels by pericytes was slightly lowered (Fig. 5i), the number of microglia increased and they exhibited an activated morphology (Fig. 5j). The astrogliosis marker glial fibrillary acidic protein (GFAP) was strongly upregulated, indicating an inflammatory response (Fig. 5k).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1324}, end: {_id:1322}, properties:{annotationPublicationtype:["Review"], evidence:"Among these, pathogen-associated molecular patterns (PAMPs), including, e.g. bacterial lipopolysaccharides (LPS), peptidoglycans, CpG oligonucleotides and viral double-stranded RNAs (dsRNAs), can trigger the innate immune system by acting as ligands for the corresponding pattern recognition receptors (PRRs) on the surface of host cells", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1365}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Not only aggregation, but also the overexpression and post-translational modifications (e.g. nitration) of α-syn are linked to sustained microglial activation [61–66], an effect likely mediated by the NFkB and MAPK signaling pathways", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Central Nervous System"], annotationSpecimen:["Feces"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1454}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"In fact, α-syn fibrils are able to induce the TLR2-NFkB signaling pathway in glial cells, resulting in microglia activation and release of proinflammatory cytokines [119, 120].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Neuroglia"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationProteinType:["fibril"], citationRef:"35674870"}}, {start: {_id:1609}, end: {_id:99}, properties:{annotationPublicationtype:["Research"], evidence:"NOD2, a member of the Nod-like receptor (NLR) family of intracellular sensors of pathogen/microbe-associated molecular patterns,was upregulated, promoting NF-kB and mitogen-activated protein kinase (MAPK) activation, which in turn stimulated the production of proinflammatory cytokines and chemokines(Fig. 4D). ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1609}, end: {_id:175}, properties:{annotationPublicationtype:["Research"], evidence:"NOD2, a member of the Nod-like receptor (NLR) family of intracellular sensors of pathogen/microbe-associated molecular patterns,was upregulated, promoting NF-kB and mitogen-activated protein kinase (MAPK) activation, which in turn stimulated the production of proinflammatory cytokines and chemokines(Fig. 4D). ", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:285}, end: {_id:1864}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, in PINK1-knockout mice, gut infection resulted in dopaminergic degeneration mediated by cytotoxic CD8+ T cells (Tc), which was induced by an autoimmune mechanism [28].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMouseType:["PINK1 -/-"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:5}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The concept of neuroinflammation in PD was initially proposed based on the presence of responsive microglia in PD postmortem brains, as revealed by upregulated human leukocyte antigen (HLA)- DR (major histocompatibility complex; MHC-II) and CD68 [29,30]. ", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:445}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Other studies have investigated lung damage in depth by employing imaging flow-cytometry approaches, and have revealed that SARS-CoV-2 primarily infects alveolar epithelial cells. It is here that a local hyperinflammatory cell state is induced, predominantly mediated by macrophages.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationBioassay:["flow cytometry"], annotationMeshanatomy:["Lung", "Alveolar Epithelial Cells"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", citationRef:"37798476"}}, {start: {_id:2233}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"However, under injury and pathological conditions including specific pathogen invasion and abnormal protein accumulation, microglia become ‘activated’ and promote adaptive immune responses for various neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshdisease:["Neurodegenerative Diseases"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:5}, end: {_id:180}, properties:{annotationPublicationtype:["Review"], evidence:"However, under injury and pathological conditions including specific pathogen invasion and abnormal protein accumulation, microglia become ‘activated’ and promote adaptive immune responses for various neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshdisease:["Neurodegenerative Diseases"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:17}, end: {_id:16}, properties:{annotationPublicationtype:["Review"], evidence:"Under healthy conditions, astrocytes serve as supporters of normal neuronal functioning. Similar to microglia, activated astrocytes respond to various harmful conditions, including inflammation, stroke, brain tumors, and neurodegenerative diseases.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:222}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs have been found to mediate neuroprotection through the suppression of microglial stimulation,including that by aggregated nitrated α-synuclein in an animal model of PD.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:5}, end: {_id:74}, properties:{annotationPublicationtype:["Review"], evidence:"In patients with Alzheimer disease (AD), initial studies suggest that the 11C-R-PK11195 signal correlates inversely with cognitive function.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:5}, end: {_id:74}, properties:{annotationPublicationtype:["Review"], evidence:"Furthermore, as cognitive function declines over time, the C-R-PK11195 signal increases without a change in the signal from the Pet ligand Pittsburgh compound B (C-PIB), which binds to amyloid.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:162}, end: {_id:228}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, increased BBB permeability is found in both AD and PD, allowing for increased lymphocytic ingress.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Alzheimer Disease", "Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:162}, end: {_id:142}, properties:{annotationPublicationtype:["Review"], evidence:"Activated microglia and monocytes in PD brains and CFS secrete proinflammatory and neurotoxic cytokines and chemokines that disrupt the BBB and attract lymphocytes to the site of neuronal injury.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Cerebrospinal Fluid", "Brain"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:1624}, end: {_id:5}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Considering the number of newly generated hippocampal neurons as a function of the reactive microglial load, we found an inverse correlation between neurogenesis and reactive microglia/macrophages in the hippocampus (Figure S6A).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:1624}, end: {_id:445}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["8 week old"], evidence:"Considering the number of newly generated hippocampal neurons as a function of the reactive microglial load, we found an inverse correlation between neurogenesis and reactive microglia/macrophages in the hippocampus (Figure S6A).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationDiseaseType:["mild COVID"], annotationTimeline:["7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female", "Male"], annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationDisease:["COVID-19"], citationRef:"35768006"}}, {start: {_id:5}, end: {_id:1624}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Hippocampal neurogenesis was deficient at both 7-day and 7-week time points, consistent with the persistent hippocampal microglial/macrophage reactivity (Figures 7N and 7O).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}, {start: {_id:445}, end: {_id:1624}, properties:{annotationPublicationtype:["Research"], annotationAgeGroup:["6 to 12 week old"], evidence:"Hippocampal neurogenesis was deficient at both 7-day and 7-week time points, consistent with the persistent hippocampal microglial/macrophage reactivity (Figures 7N and 7O).", citationTitle:"Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.", annotationPublicationstatus:["Published"], annotationTimeline:["7 weeks post-infection", "7 days post-infection"], annotationMeshanatomy:["White Matter", "Dentate Gyrus"], source:"wp4-cbm-comorbidity", pmid:"35768006", citationType:"PubMed", annotationMouseStrain:["CD-1"], annotationGender:["Female"], annotationSection:["Results"], annotationSpecies:["10090"], annotationDisease:["swine influenza"], citationRef:"35768006"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:2220}, end: {_id:2190}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2221}, end: {_id:2190}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2222}, end: {_id:180}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2223}, end: {_id:180}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2224}, end: {_id:2219}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2225}, end: {_id:2219}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2226}, end: {_id:2219}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2330}, end: {_id:2331}, properties:{annotationPublicationtype:["Research"], evidence:"Among the host genes examined, ACTR2 (endosomal entry), ATP6AP2 (spike protein cleavage, endosomal acidification and processing), ERMP1 (ER), and CHST14 (Golgi) showed higher expression levels in ApoE4 astrocytes than that in ApoE3 astrocytes (Figures 3E and 3F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["gene expression assay", "real-time PCR "], annotationCellline:["AG14048 cell"], citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:403}, end: {_id:408}, properties:{annotationPublicationtype:["Review"], evidence:"Naive CD4 T cells have increased Fas expression, which may explain why their frequency is decreased [102]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:283}, end: {_id:278}, properties:{annotationPublicationtype:["Review"], evidence:"However, others have shown that Tregs might inhibit the proliferation of conventional CD4+ T cells by competing for the consumption of IL2, because Tregs express a higher level of the IL-2Rα chain (also known as CD25)", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:2311}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs and naive conventional CD4+ T cells from healthy people have recently been shown to express equal numbers of voltage-gated K(V)1.3 channels, although Tregs have a greater membrane surface and, consequently, lower channel density than naive conventional CD4+ T cells.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:258}, end: {_id:2311}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs and naive conventional CD4+ T cells from healthy people have recently been shown to express equal numbers of voltage-gated K(V)1.3 channels, although Tregs have a greater membrane surface and, consequently, lower channel density than naive conventional CD4+ T cells.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:202}, end: {_id:201}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:462}, end: {_id:201}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:606}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:613}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:628}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:629}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:828}, end: {_id:827}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:831}, end: {_id:827}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:954}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1077}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1091}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1099}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1102}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1105}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1126}, end: {_id:1125}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1192}, end: {_id:201}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1197}, end: {_id:201}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1213}, end: {_id:1125}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1215}, end: {_id:1125}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1225}, end: {_id:1224}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__TO_LOCATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1226}, end: {_id:1224}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1265}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1331}, end: {_id:1330}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1333}, end: {_id:1330}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1395}, end: {_id:1394}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1463}, end: {_id:1462}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1519}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1772}, end: {_id:1771}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1928}, end: {_id:605}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2320}, end: {_id:2319}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__TO_LOCATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:114}, end: {_id:7}, properties:{annotationPublicationtype:["Review"], evidence:"A notable feature of these mice, and of triple transgenic mice that carry tau genes bearing frontotemporal dementia-causing mutations, in addition to the hAPP and PS1 genes, is the lack of widespread and catastrophic neurodegeneration typical of AD", annotationDiseaseCondition:["chronic"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Frontotemporal Dementia"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:503}, end: {_id:67}, properties:{annotationPublicationtype:["Research"], evidence:"While ~15% of HC carried DRB1*15:01/DRB5*01:01 alleles, ~1/3 of PD carried these alleles (difference between PD and HC, p=0.036 and 0.022 for DRB1*15:01/DRB5*01:01), indicating association of HLA DR allelic variants with PD in our cohort (Supplemental Table 3).", citationTitle:"Nature. 2017 Jun 29;546(7660):656-661. doi: 10.1038/nature22815. Epub 2017 Jun 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"28636593", citationType:"PubMed", citationRef:"28636593"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:668}, end: {_id:670}, properties:{annotationPublicationtype:["Review"], evidence:"In keeping with this, the most frequent clinical presentation of COVID-19 is the development of acute respiratory distress syndrome (ARDS) [16], the latter being, along with chronic ventilation, highly associated with subsequent cognitive decline, executive dysfunction, and reduced quality of life, often persisting months and years after hospital discharge [17] reviewed in [18]. ", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:264}, end: {_id:1235}, properties:{annotationPublicationtype:["Research"], evidence:"MS risk was lower among CMV-positive than among CMV-negative individuals (Fig. 2D), consistent with a previous report and with suggestions that the immune response to CMV attenuates the adverse effects of EBV", citationTitle:"Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Multiple Sclerosis"], source:"wp4-cbm-comorbidity", pmid:"35025605", citationType:"PubMed", citationRef:"35025605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:238}, end: {_id:237}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1732}, end: {_id:1731}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:1588}, end: {_id:1522}, properties:{annotationPublicationtype:["Research"], evidence:"The effective knockdown of TPCN2, TMPRSS2, DPP4, and CD147 was similarly achieved (Fig. 2C), but only TPCN2 knockdown inhibited SARS-CoV-2 infection in astrocytes (Fig. 2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1411}, end: {_id:2297}, properties:{annotationPublicationtype:["Review"], evidence:"Intramuscular treatment of IFN-β − 1α in RRMS subjects significantly increased both the percentage of NK cells and FOXP3 mRNA expression compared with untreated RR-MS and healthy controls.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Multiple Sclerosis, Relapsing-Remitting"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1388}, end: {_id:1370}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1389}, end: {_id:1370}, properties:{annotationPublicationtype:["Review"], evidence:"LPS-dependent activation of TLR signaling pathway, increase in LRRK2/TRAF6 interaction and increased phosphorylation of both MAPK and IkB were reduced upon treatment with a LRRK2 inhibitor, leading to reduced TNFα secretion and thus confirming the involvement of LRRK2 in the generation of pro-inflammatory responses in lymphoblasts", annotationCustomCell:["lymphoblast"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:544}, end: {_id:542}, properties:{annotationPublicationtype:["Research"], evidence:"When we considered medications within the IMDH inhibitor category, each was consistently associated with a lower risk of PD. Mycophenolate was associated with the lowest risk of PD (RR = 0.55; 95% CI 0.31–0.98), although the number of patients taking this drug was small, and the CIs were relatively wide.", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:545}, end: {_id:541}, properties:{annotationPublicationtype:["Research"], evidence:"Within the corticosteroid category, the steroids most strongly associated with PD were those used commonly for long-term immunosuppression: Prednisone (RR = 0.81; 95% CI 0.78–0.85); dexamethasone (RR = 0.76; 95% CI 0.66–0.88); methylprednisolone (RR = 0.80; 95% CI 0.76–0.84).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:365}, end: {_id:541}, properties:{annotationPublicationtype:["Research"], evidence:"Within the corticosteroid category, the steroids most strongly associated with PD were those used commonly for long-term immunosuppression: Prednisone (RR = 0.81; 95% CI 0.78–0.85); dexamethasone (RR = 0.76; 95% CI 0.66–0.88); methylprednisolone (RR = 0.80; 95% CI 0.76–0.84).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}, {start: {_id:546}, end: {_id:541}, properties:{annotationPublicationtype:["Research"], evidence:"Within the corticosteroid category, the steroids most strongly associated with PD were those used commonly for long-term immunosuppression: Prednisone (RR = 0.81; 95% CI 0.78–0.85); dexamethasone (RR = 0.76; 95% CI 0.66–0.88); methylprednisolone (RR = 0.80; 95% CI 0.76–0.84).", citationTitle:"Ann Clin Transl Neurol. 2018 May 31;5(7):870-875. doi: 10.1002/acn3.580.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"30009205", citationType:"PubMed", citationRef:"30009205"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:IS_A]->(end) SET r += row.properties;
UNWIND [{start: {_id:453}, end: {_id:1859}, properties:{annotationPublicationtype:["Review"], evidence:"For instance, leucine-rich repeated kinase 2 (LRRK2), which regulates Rab-GTPases and is involved in endolysosomal regulation, has a strong relation to the innate immune system (reviewed in [13,14]).", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:292}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"The suboptimal suppressive function of Tregs in MS has been found to be related to decreased FOXP3 expression in Tregs from RR-MS patients", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Multiple Sclerosis, Relapsing-Remitting"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:292}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"For instance, two independent groups have shown that the CD58 risk allele results in the downregulation of FOXP3 and consequently causes the dysfunction of Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:7}, end: {_id:2024}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:2002}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1962}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}, {start: {_id:7}, end: {_id:1992}, properties:{annotationPublicationtype:["Research"], evidence:"Transcripts involved in lipid metabolism were significantly altered including APOE, two APOE receptors (low density lipoprotein receptor-related protein 1, LRP1 and LRP8), and the gene encoding the lipolysis-stimulated lipoprotein receptor (LSR). Two intermediate filaments (KRT19, VIM) were significantly upregulated.", annotationCustomCell:["brain capillary endothelial-like cells"], citationTitle:"Fluids Barriers CNS. 2023 Oct 31;20(1):78. doi: 10.1186/s12987-023-00471-y.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late-onset Alzheimers disease"], source:"wp4-cbm-comorbidity", pmid:"37907966", citationType:"PubMed", annotationModel:["isogenic model of the neurovascular unit"], annotationSection:["Results"], annotationBioassay:["quantitative PCR"], citationRef:"37907966"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:563}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Metabolites secreted from gut bacteria that have been proposed to impact glial biology and neuroinflammation include short chain fatty acids and tryptophan metabolites [18].Microbiome metabolites have been shown to induce microglia activation and motor deficits in α-synuclein transgenic mice.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["α-synuclein transgenic mice"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:564}, end: {_id:71}, properties:{annotationPublicationtype:["Review"], evidence:"Metabolites secreted from gut bacteria that have been proposed to impact glial biology and neuroinflammation include short chain fatty acids and tryptophan metabolites [18].Microbiome metabolites have been shown to induce microglia activation and motor deficits in α-synuclein transgenic mice.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["α-synuclein transgenic mice"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:563}, end: {_id:549}, properties:{annotationPublicationtype:["Review"], evidence:"Metabolites secreted from gut bacteria that have been proposed to impact glial biology and neuroinflammation include short chain fatty acids and tryptophan metabolites [18].Microbiome metabolites have been shown to induce microglia activation and motor deficits in α-synuclein transgenic mice.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["α-synuclein transgenic mice"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}, {start: {_id:564}, end: {_id:549}, properties:{annotationPublicationtype:["Review"], evidence:"Metabolites secreted from gut bacteria that have been proposed to impact glial biology and neuroinflammation include short chain fatty acids and tryptophan metabolites [18].Microbiome metabolites have been shown to induce microglia activation and motor deficits in α-synuclein transgenic mice.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["α-synuclein transgenic mice"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", citationRef:"30342839"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1114}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings [16], SDC3 overexpression increased the cellular uptake of Aβ1–42 at both 3 and 18 h of incubation (Figure 6A–D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1114}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"ApoEs exerted various effects on Aβ1–42 uptake: at 3 h ApoE2 increased Aβ1–42 internalization, while ApoE4 reduced it (Figure 6A,C).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["3 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1116}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"This effect of ApoEs on Aβ1–42 uptake was reversed at 18 h of incubation: ApoE4 increased Aβ1–42 uptake, while ApoE2 and 3 reduced it (Figure 6B,D).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["flow cytometry"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1112}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed an increased presence of ThT-labeled aggregates at 18 h in WT and SDC3-overexpressing differentiated SH-SY5Y cells, which was reduced in the case of samples pretreated with ApoE2. ApoE4, on the other hand, increased the number of ThT-labeled aggregates, indicating the increased presence of Aβ1–42 aggregates (Figure 6E,F).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationTimeline:["18 hours"], source:"wp4-cbm-comorbidity", pmid:"34209175", annotationCellline:["SH-SY5Y cell"], citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1115}, end: {_id:606}, properties:{annotationPublicationtype:["Research"], evidence:"Confocal microscopy also showed an increased presence of ThT-labeled aggregates at 18 h in WT and SDC3-overexpressing differentiated SH-SY5Y cells, which was reduced in the case of samples pretreated with ApoE2. ApoE4, on the other hand, increased the number of ThT-labeled aggregates, indicating the increased presence of Aβ1–42 aggregates (Figure 6E,F).", citationTitle:"Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["confocal microscopy"], annotationTimeline:["18 hours"], annotationCustomCellline:["SH-SY5Y cell overexpressing SDC3"], source:"wp4-cbm-comorbidity", pmid:"34209175", citationType:"PubMed", citationRef:"34209175"}}, {start: {_id:1190}, end: {_id:1192}, properties:{annotationPublicationtype:["Research"], evidence:"When expressed in human brain endothelial hCMEC/D3 cells, Mpro prevented the nuclear translocation of the NF-κB subunit p65, reflecting its activation in response to IL-1β (Fig. 4a). Mpro also abolished the stimulation of NF-κB-mediated gene transcription by IL-1β, which we investigated in hCMEC/D3 cells and mouse brain endothelial bEnd.3 cells using luciferase reporter gene assays (Fig. 4b, c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationConcentration:["0.25 µg/ml"], annotationCustomCellline:["hCMEC/D3 cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1195}, end: {_id:1197}, properties:{annotationPublicationtype:["Research"], evidence:"When expressed in human brain endothelial hCMEC/D3 cells, Mpro prevented the nuclear translocation of the NF-κB subunit p65, reflecting its activation in response to IL-1β (Fig. 4a). Mpro also abolished the stimulation of NF-κB-mediated gene transcription by IL-1β, which we investigated in hCMEC/D3 cells and mouse brain endothelial bEnd.3 cells using luciferase reporter gene assays (Fig. 4b, c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationConcentration:["0.25 µg/ml"], source:"wp4-cbm-comorbidity", annotationCellline:["bEnd.3 cell"], pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1211}, end: {_id:1213}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["western blot"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated FADD"], citationRef:"34675436"}}, {start: {_id:1211}, end: {_id:1215}, properties:{annotationPublicationtype:["Research"], evidence:"FADD deficiency did not ameliorate the consequences of Nemo deletion but enhanced the damage (Extended Data Fig. 9b–f).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["western blot"], annotationMouseType:["inducible Ikbkg (Nemo) deletion with inactivated FADD"], citationRef:"34675436"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1317}, end: {_id:126}, properties:{annotationPublicationtype:["Research"], evidence:"SDC3 expression of blood-derived monocytes showed a positive correlation (r = 0.81) with Aβ plaque deposition in the brain, showing that SDC3 on monocytes is a good indicator of amyloid pathology in the brain (Figure 6C).", citationTitle:"Int J Mol Sci. 2022 Mar 21;23(6):3407. doi: 10.3390/ijms23063407.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["monocyte"], annotationAge:["12 months"], source:"wp4-cbm-comorbidity", pmid:"35328830", citationType:"PubMed", annotationMouseStrain:["STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc/Tac"], annotationSpecies:["10090"], annotationSection:["Results"], citationRef:"35328830"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1362}, end: {_id:1451}, properties:{annotationPublicationtype:["Review"], annotationGeneType:["GBA-/-"], evidence:"Knocking down GBA leads to α-syn aggregation, which in turn further impinges on GCase activity", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:REGULATES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1029}, end: {_id:1039}, properties:{annotationPublicationtype:["Review"], evidence:"Indeed, NETs participate in acute lung injury by inducing macrophage release of IL-1β, which in turn can increase NET formation95,96.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:57}, end: {_id:1566}, properties:{annotationPublicationtype:["Research"], evidence:"OSTOX was associated with depression HAMD, NO with somatic HAMD HAMA and FF, MDA predicted somatic FF and OSTOX/ANTIOX predicted the neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:57}, end: {_id:1567}, properties:{annotationPublicationtype:["Research"], evidence:"OSTOX was associated with depression HAMD, NO with somatic HAMD HAMA and FF, MDA predicted somatic FF and OSTOX/ANTIOX predicted the neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:57}, end: {_id:1565}, properties:{annotationPublicationtype:["Research"], evidence:"OSTOX was associated with depression HAMD, NO with somatic HAMD HAMA and FF, MDA predicted somatic FF and OSTOX/ANTIOX predicted the neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1574}, end: {_id:1565}, properties:{annotationPublicationtype:["Research"], evidence:"OSTOX was associated with depression HAMD, NO with somatic HAMD HAMA and FF, MDA predicted somatic FF and OSTOX/ANTIOX predicted the neuropsychiatric symptoms.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Results"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1726}, end: {_id:264}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Viral encephalitis and viral and other specified intestinal infections were significant and replicated for both AD and dementia; the varicella-zoster virus was significant and replicated for both MS and VAS (as a note, varicella-zoster virus is referred to as Zoster [herpes zoster] in the FinnGen and UKB coding system).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:1726}, end: {_id:1724}, properties:{annotationEthnicity:["European"], annotationPublicationtype:["Research"], evidence:"Viral encephalitis and viral and other specified intestinal infections were significant and replicated for both AD and dementia; the varicella-zoster virus was significant and replicated for both MS and VAS (as a note, varicella-zoster virus is referred to as Zoster [herpes zoster] in the FinnGen and UKB coding system).", citationTitle:"Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"36669485", citationType:"PubMed", annotationCohort:["FinnGen"], citationRef:"36669485"}}, {start: {_id:331}, end: {_id:353}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:1891}, end: {_id:1345}, properties:{annotationPublicationtype:["Review"], evidence:"This is in agreement with another study describing an increase in Th17, cytotoxic IFNγ-CD8, and Th2 cells in de novo PD (<2 years) [107]. People with PD showed a decrease in naïve CD8 and CD4 T cells, and an increase in both Th17 and central memory CD4 cells; these -> were associated with worse motor impairments [107].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationCell:["CD8-positive, alpha-beta cytotoxic T cell"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:120}, end: {_id:122}, properties:{annotationPublicationtype:["Review"], evidence:"This switch in microglial phenotype was associated with exaggerated symptoms of sickness behavior such as fever and reduced mobility, increased neuronal loss, and an increase in disease progression", annotationDiseaseCondition:["chronic"], annotationPublicationstatus:["Published"], citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationSection:["Full Text"], annotationMeshdisease:["Prion Diseases"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}, {start: {_id:283}, end: {_id:285}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Treg are an important subset of CD4+ T cells that are known to maintain self-tolerance, prevent autoimmunity, and regulate immune homeostasis by attenuating excessive inflammation caused by pathogens or injury. They are identified by the expression of CD4 and CD25 cell-surface markers and by the transcription factor forkhead box P3 (FoxP3) in mice (Hall et al. 1990; Fontenot et al. 2003; Hori et al. 2003), and the expression of FOXP3, CD4, CD25, CD39, CD49d, and a lack of CD127 in human.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:305}, properties:{annotationPublicationtype:["Review"], evidence:"In vitro studies have shown that Treg can suppress Teff responses via cell-to-cell contact (Cederbom et al. 2000) and soluble factors.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:283}, end: {_id:306}, properties:{annotationPublicationtype:["Review"], evidence:"Treg can also inhibit the adaptive immune system indirectly by suppressing antigen presentation by APCs.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:317}, end: {_id:70}, properties:{annotationPublicationtype:["Review"], evidence:"This study showed that adoptively transferred Treg attenuated microgliosis and astrogliosis, increased expression of BDNF and GDNF expression, and down-regulated proinflammatory cytokines, oxidative stress, and viral replication, whereas effector CD4+ T cells were not therapeutic.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:317}, end: {_id:39}, properties:{annotationPublicationtype:["Review"], evidence:"This study showed that adoptively transferred Treg attenuated microgliosis and astrogliosis, increased expression of BDNF and GDNF expression, and down-regulated proinflammatory cytokines, oxidative stress, and viral replication, whereas effector CD4+ T cells were not therapeutic.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:317}, end: {_id:322}, properties:{annotationPublicationtype:["Review"], evidence:"This study showed that adoptively transferred Treg attenuated microgliosis and astrogliosis, increased expression of BDNF and GDNF expression, and down-regulated proinflammatory cytokines, oxidative stress, and viral replication, whereas effector CD4+ T cells were not therapeutic.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", annotationTechnique:["Adoptive Transfer"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMouseType:["HIV-1 encephalitic mice"], citationRef:"22315722"}}, {start: {_id:283}, end: {_id:323}, properties:{annotationPublicationtype:["Review"], evidence:"Treg inhibit release of viral particles from HIV-1-infected human mononuclear phagocytes (MP), kill infected cells, and induce phenotypic changes in MP.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["HIV Infections"], annotationCell:["mononuclear phagocyte"], annotationMeshanatomy:["Brain", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:354}, end: {_id:355}, properties:{annotationPublicationtype:["Review"], evidence:"MPP+ inhibits cellular respiration by direct inhibition of the mitochondrial transport chain leading to neuronal injury and death [12].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:365}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"The anti-inflammatory effects of dexamethasone in the MPTP mouse model protect against DA neuron loss [42, 43].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:394}, end: {_id:396}, properties:{annotationPublicationtype:["Review"], evidence:"Japanese Encephalitis Virus (JEV) has also induced a post-encephalitic parkinsonism with similar neuropathologic features and locomotor dysfunction as that seen in people with sporadic PD [95]", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:412}, end: {_id:410}, properties:{annotationPublicationtype:["Review"], evidence:"Lymphocytes from PD patients display an increased incidence of micronuclei, single strand DNA breaks, and oxidized purine bases [109]. Interestingly,levodopa treatment seems to reduce this DNA damage in peripheral blood lymphocytes [110].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Lymphocytes"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:430}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"These immunoglobulins induced perivascular inflammation,microgliosis, and loss of TH+ neurons in the SN that was dependent on expression of the Fc receptor [127].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", annotationSpecies:["10116"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["perivascular space"], citationRef:"24275605"}}, {start: {_id:194}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"The adoptively transferred T cells accumulate in the SN, suppress microglial activation, and are correlated with an increase in neurotrophic factors [180]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:482}, end: {_id:483}, properties:{annotationPublicationtype:["Review"], evidence:"Colchicine blocks mitosis and thereby preventing the proliferation of rapidly dividing cells such as activated immune cells.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:482}, end: {_id:484}, properties:{annotationPublicationtype:["Review"], evidence:"Colchicine blocks mitosis and thereby preventing the proliferation of rapidly dividing cells such as activated immune cells.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:492}, end: {_id:227}, properties:{annotationPublicationtype:["Review"], evidence:"The drug, natalizumab has been successful in the treatment of multiple sclerosis [190].  As an antibody against the alpha 4 integrin, this antibody blocks the recruitment of T cells to sites of inflammation. By blocking activation and recruitment of T cells in PD, neuroinflammation could be dampened to prevent subsequent neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:494}, end: {_id:285}, properties:{annotationPublicationtype:["Review"], evidence:"Rituximab is an example of a B cell depleting antibody that has shown some effectiveness in autoimmune diseases where antibodies are known to play a pathogenic role [192].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:684}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Together, these transcriptome analyses suggest that SARS-CoV-2 infection of choroid plexus cells leads to viral RNA production and inflammatory cellular responses with a concomitant compromise of normal barrier and secretory functions as well as increased cell death.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. doi: 10.1016/j.stem.2020.09.016. Epub 2020 Sep 21.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"33010822", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33010822"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"We next examined the impact of SARS-CoV-2 infection on the function of the ChP epithelium, specifically its role as an integral part of the blood-CNS barrier. We observed a striking effect on tight junctions, labeled by claudin-5, as early as 2 days post-infection (Figure 4F), with increasing disruption by 4 days post-infection suggesting a potential breakdown of barrier integrity.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationDayspostinfection:["4 days"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Taken together, these data suggest that SARS-CoV-2 is capable of infecting ChP epithelial cells, leading to a breakdown of barrier integrity.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:684}, end: {_id:955}, properties:{annotationPublicationtype:["Research"], evidence:"In many instances, the expression of the virus coincided with a disruption in the normal vascular topology expected in the cortex, with an important loss of the normal enrichment in radially oriented vessels in upper layers.", citationTitle:"J Exp Med. 2021 Mar 1; 218(3) doi: 10.1084/jem.20202135", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["10090"], annotationMeshanatomy:["Cerebral Cortex"], annotationCustomCellline:["induced human neural progenitor cell"], source:"wp4-cbm-comorbidity", pmid:"33433624", citationType:"PubMed", citationRef:"33433624"}}, {start: {_id:960}, end: {_id:322}, properties:{annotationPublicationtype:["Research"], evidence:"Next, we compared these results with a lung epithelial cell line, Calu-3, and obtained similar results whereby EK1 peptide or TMPRSS2 inhibitors, camostat and nafamostat, repressed viral infection, which was further reduced when both classes of inhibitors were combined (Figure S1I).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], source:"wp4-cbm-comorbidity", pmid:"33631122", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:959}, end: {_id:322}, properties:{annotationPublicationtype:["Research"], evidence:"Next, we compared these results with a lung epithelial cell line, Calu-3, and obtained similar results whereby EK1 peptide or TMPRSS2 inhibitors, camostat and nafamostat, repressed viral infection, which was further reduced when both classes of inhibitors were combined (Figure S1I).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], source:"wp4-cbm-comorbidity", pmid:"33631122", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:963}, end: {_id:322}, properties:{annotationPublicationtype:["Research"], evidence:"Next, we compared these results with a lung epithelial cell line, Calu-3, and obtained similar results whereby EK1 peptide or TMPRSS2 inhibitors, camostat and nafamostat, repressed viral infection, which was further reduced when both classes of inhibitors were combined (Figure S1I).", citationTitle:"Stem Cell Reports. 2021 Mar 9;16(3):437-445. doi: 10.1016/j.stemcr.2021.02.005.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["luciferase enzyme activity assay"], source:"wp4-cbm-comorbidity", pmid:"33631122", annotationCellline:["Calu-3 cell"], citationType:"PubMed", citationRef:"33631122"}}, {start: {_id:1044}, end: {_id:1045}, properties:{annotationPublicationtype:["Review"], evidence:"Liu et al. demonstrated that dipyridamole can suppress SARS-CoV-2 replication in vitro and improve lung pathology in an animal model of viral pneumonia through a type I interferon response125. This drug was tested in 14 patients and led to an improvement in clinical status compared with controls125.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:684}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"These data indicate that SARS-CoV-2 may infect brain endothelial cells, leading to increased vascular permeability, which supports the probability that SARS-CoV-2 crosses the BBB.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34489403", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34489403"}}, {start: {_id:684}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"The co-localization of SARS-CoV-2-S with ACE2 in the vessels and cells suggests the role of ACE2 as the entry receptor for SARS-CoV-2 invading the brain by passing through the BBB.", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"34489403", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"34489403"}}, {start: {_id:684}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"To assess BBB integrity, we administered Evans blue dye (EBD) by i.p. injection in both mock-treated and SARS-CoV-2-infected hamsters at 6 dpi and evaluated its leakage into the brain, which is a classic method for evaluating BBB integrity. Compared with the mock-treated hamsters, infected animals displayed visible leakage of the EBD in the cortex (Fig. ​(Fig.3a).3a).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["10036"], source:"wp4-cbm-comorbidity", pmid:"34489403", annotationDisease:["COVID-19"], citationType:"PubMed", annotationTechnique:["Evan's blue dye test"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"But the permeability to NaFl was increased in both BBB models at 48 hpi (Fig. ​(Fig.5c5c).", citationTitle:"Signal Transduct Target Ther. 2021 Sep 6;6(1):337. doi: 10.1038/s41392-021-00719-9.", annotationPublicationstatus:["Published"], annotationCell:["microvascular endothelial cell"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"34489403", citationType:"PubMed", annotationSpecies:["10036", "10090"], annotationSection:["Results"], annotationDisease:["COVID-19"], citationRef:"34489403"}}, {start: {_id:684}, end: {_id:1310}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our findings from spatial transcriptomics of brain vessels and their microenvironment in fatal COVID-19 (Figure 1), we detected that genes responsible for the innate immune response and type I interferon response were significantly upregulated. Moreover, genes that regulate phosphorus-dependent metabolic and ATP-generating pathways were significantly downregulated (Figures 3B–3D), which is in accord with studies in SARS-CoV-2-infected lung organoids.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:684}, end: {_id:945}, properties:{annotationPublicationtype:["Research"], evidence:"Intriguingly, SARS-CoV-2 infection of endothelial cells consistently resulted in downregulation of metabolic pathways and upregulation of a cellular interferon response.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["RNA-seq gene expression profiling assay"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:963}, end: {_id:774}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, all antibodies and nafamostat could significantly (p < 0.0001) diminish virus uptake by hiPS-BCECs.", annotationCustomCell:["human induced pluripotent stem cell derived brain capillary endothelial-like cell"], citationTitle:"Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"35063125", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationDisease:["COVID-19"], citationRef:"35063125"}}, {start: {_id:564}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"Most SCFAs have anti-inflammatory properties (e.g. butyrate, valerate) and contribute to maintain the integrity of intestinal barrier; as a consequence, a low abundance of SCFA-producing bacteria may cause leakiness of the gut epithelium thus promoting the passage of intestinal pathogens into the bloodstream and systemic inflammation [39, 40].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1452}, end: {_id:17}, properties:{annotationPublicationtype:["Review"], evidence:"In contrast, specific inhibition of GCase in mice resulted in α-syn neuropathology and inflammation, as revealed by elevated GFAP levels that are indicative of astrogliosis", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:684}, end: {_id:1523}, properties:{annotationPublicationtype:["Research"], evidence:"In line with our previous findings in 2D models [20], this revealed a baseline uptake of postsynaptic structures (indicated by PSD-95) in microglia residing in brain organoids", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Microglia", "Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1523}, properties:{annotationPublicationtype:["Research"], evidence:"In infected organoids (MOI 0.3, 72hpi), the total numbers of Iba1+ cells were slightly increased but did not reach significance (Supplementary Fig. 3a) while we observed a clear increase in CD68+ cells (Supplementary Fig. 3b) and a threefold increase in uptake of synaptic structures in microglia (Fig. 4d, e).", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:162}, properties:{annotationHourspostinfection:["72 hours"], annotationPublicationtype:["Research"], evidence:"In addition to choroid plexus, a differential expression analysis showed significant increase in expression of matrix metalloproteases and ECM-regulatory enzymes at 72hpi in microglia, astrocytes and perivascular cells, whereas endothelial cells reduced expression levels of solute carrier SLC2A1 (Fig. 7g), all in agreement with signaling that promotes compromised CNS barriers.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1557}, properties:{annotationHourspostinfection:["24 hours"], annotationPublicationtype:["Research"], evidence:"Further, astrocytes, pericytes and choroid plexus-related cells were observed to downregulate VEGF signaling, a potent inducer of BBB permeability, at 24hpi but then at 72hpi instead display an upregulation, coinciding with increased signaling for leukocyte chemotaxis and activation in astrocytes, as well as antigen processing and presentation in choroid plexus.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Pericytes", "Choroid Plexus", "Astrocytes"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:684}, end: {_id:595}, properties:{annotationPublicationtype:["Research"], evidence:"Further, a partial translational inhibition could be observed in microglia (module B), as well as most of the other cell types. We also observed downregulation of the ROS metabolism across cell types, which can lead to dysregulation of the antioxidant cellular systems and result in oxidative stress.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:684}, end: {_id:1560}, properties:{annotationPublicationtype:["Research"], evidence:"Further, a partial translational inhibition could be observed in microglia (module B), as well as most of the other cell types. We also observed downregulation of the ROS metabolism across cell types, which can lead to dysregulation of the antioxidant cellular systems and result in oxidative stress.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1696}, end: {_id:322}, properties:{annotationPublicationtype:["Research"], evidence:"We then treated BCOs with incremental doses of SOF and found that SOF was able to reduce intracellular SARS-CoV-2 RNA levels in a dose-response manner.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:1696}, end: {_id:322}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, the amount of retrieved infectious viruses was significantly reduced upon SOF treatment (a 5-fold decrease in the supernatant and by 75% for the intracellular viral RNA), further supporting both the ability of BCOs to allow productive replication of SARS-CoV-2 and SOF as an inhibitor of viral growth.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36327326"}}, {start: {_id:1696}, end: {_id:1697}, properties:{annotationPublicationtype:["Research"], evidence:"Notably, the immunostaining revealed a significant increase in cell death measured by both cleaved caspase 3 (CC3) by 20% and TUNEL immunostainings by 30%, accompanied by a 15% increase in the amount of SARS-CoV-2+ cells in virus-infected BCO when compared to non-infected controls (Fig 1J, ​,1K,1K, and ​and1M).1M). Treatment with SOF significantly decreased both SARS-CoV-2 viral protein levels and viral-induced cell death.", citationTitle:"PLoS Biol. 2022 Nov 3;20(11):e3001845. doi: 10.1371/journal.pbio.3001845.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36327326", citationType:"PubMed", annotationSpecies:["9606"], annotationDayspostinfection:["7 days"], annotationBioassay:["immunolabeling method"], annotationDisease:["COVID-19"], citationRef:"36327326"}}, {start: {_id:729}, end: {_id:74}, properties:{annotationPublicationtype:["Review"], evidence:"The reduction in myelinating oligodendrocytes causes loss of myelin and, ultimately, alters cognitive function and neural circuit dynamics (Steadman et al., 2020).", annotationDiseaseCondition:["acute"], citationTitle:"Dis Model Mech. 2023 Jul 1;16(7):dmm050049. doi: 10.1242/dmm.050049.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"37458167", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"37458167"}}, {start: {_id:194}, end: {_id:199}, properties:{annotationPublicationtype:["Review"], evidence:"Additionally, pharmacological strategies to modify monocytes [60], decrease T cells, or enhance Treg capacity [61–63] are neuroprotective in animal/PD models, with the latter already examined in an early small safety clinical trial [64].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:2152}, end: {_id:2156}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the genes involved in SASP phenotype (Figure 4N) and senescence pathway (Figures S5F–S5H) were downregulated in riluzole, metformin, or imatinib treated DA neurons in the presence of SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:2156}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the genes involved in SASP phenotype (Figure 4N) and senescence pathway (Figures S5F–S5H) were downregulated in riluzole, metformin, or imatinib treated DA neurons in the presence of SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:2156}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the genes involved in SASP phenotype (Figure 4N) and senescence pathway (Figures S5F–S5H) were downregulated in riluzole, metformin, or imatinib treated DA neurons in the presence of SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the genes involved in SASP phenotype (Figure 4N) and senescence pathway (Figures S5F–S5H) were downregulated in riluzole, metformin, or imatinib treated DA neurons in the presence of SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the genes involved in SASP phenotype (Figure 4N) and senescence pathway (Figures S5F–S5H) were downregulated in riluzole, metformin, or imatinib treated DA neurons in the presence of SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:1888}, properties:{annotationPublicationtype:["Research"], evidence:"Importantly, the genes involved in SASP phenotype (Figure 4N) and senescence pathway (Figures S5F–S5H) were downregulated in riluzole, metformin, or imatinib treated DA neurons in the presence of SARS-CoV-2 infection.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"At 48 hpi, real-time quantitative PCR analysis demonstrated that riluzole, metformin, and imatinib all decreased viral RNA (Figure 5A), a finding further validated by immunostaining using an antibody against the SARS-CoV-2 nucleocapsid protein (Figures 5B and 5C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR", "immunolabeling method"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"At 48 hpi, real-time quantitative PCR analysis demonstrated that riluzole, metformin, and imatinib all decreased viral RNA (Figure 5A), a finding further validated by immunostaining using an antibody against the SARS-CoV-2 nucleocapsid protein (Figures 5B and 5C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR", "immunolabeling method"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"At 48 hpi, real-time quantitative PCR analysis demonstrated that riluzole, metformin, and imatinib all decreased viral RNA (Figure 5A), a finding further validated by immunostaining using an antibody against the SARS-CoV-2 nucleocapsid protein (Figures 5B and 5C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["quantitative PCR", "immunolabeling method"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with pre-treatment, the candidate drugs significantly decreased both replicating viral RNA (Figure 5D) and the percentage of SARS-N+ cells (Figures 5E and 5F) when applied at the post-infection time point.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2153}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with pre-treatment, the candidate drugs significantly decreased both replicating viral RNA (Figure 5D) and the percentage of SARS-N+ cells (Figures 5E and 5F) when applied at the post-infection time point.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2154}, end: {_id:799}, properties:{annotationPublicationtype:["Research"], evidence:"Consistent with pre-treatment, the candidate drugs significantly decreased both replicating viral RNA (Figure 5D) and the percentage of SARS-N+ cells (Figures 5E and 5F) when applied at the post-infection time point.", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}, {start: {_id:2152}, end: {_id:2157}, properties:{annotationPublicationtype:["Research"], evidence:"GSEA identified the downregulation of fatty acid biosynthesis pathway in riluzole-treated condition (Figures 6B and 6C).", citationTitle:"Cell Stem Cell. 2024 Feb 1;31(2):196-211.e6. doi: 10.1016/j.stem.2023.12.012. Epub 2024 Jan 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"38237586", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["gene list enrichment analysis"], annotationCellline:["human induced pluripotent stem cell line cell"], annotationDisease:["COVID-19"], citationRef:"38237586"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:283}, end: {_id:2254}, properties:{annotationPublicationtype:["Review"], evidence:"However, others have shown that Tregs might inhibit the proliferation of conventional CD4+ T cells by competing for the consumption of IL2, because Tregs express a higher level of the IL-2Rα chain (also known as CD25)", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2290}, end: {_id:2291}, properties:{annotationPublicationtype:["Review"], evidence:"Blocking the production of the octapeptide angiotensin II (AII) or inhibiting AII signaling suppresses autoreactive Th1 and Th17 cells and promotes antigen-specific Foxp3+Tregs with an inhibition of the canonical nuclear factor κ-B (NFKB) transcription factor complex and an activation of the alternative NFKB pathway.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2303}, end: {_id:2305}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, treatment with erythropoietin modulates the immune balance in both the peripheral nervous system and the inflamed spinal cord by promoting the expansion of Tregs, by inhibiting Th17 polarization, and by abrogating proliferation of the antigenpresenting DCs in EAE (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Encephalomyelitis, Autoimmune, Experimental"], annotationMeshanatomy:["Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2303}, end: {_id:2306}, properties:{annotationPublicationtype:["Review"], evidence:"Interestingly, treatment with erythropoietin modulates the immune balance in both the peripheral nervous system and the inflamed spinal cord by promoting the expansion of Tregs, by inhibiting Th17 polarization, and by abrogating proliferation of the antigenpresenting DCs in EAE (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Encephalomyelitis, Autoimmune, Experimental"], annotationMeshanatomy:["Spinal Cord"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"However, Treg suppressive activity is intensified in AD and PD patients with age, whereas the increase of suppressive activity does not reach significance for the non-affected elderly individuals compared with the young groups", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs have been found to mediate neuroprotection through the suppression of microglial stimulation,including that by aggregated nitrated α-synuclein in an animal model of PD.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:283}, end: {_id:5}, properties:{annotationPublicationtype:["Review"], evidence:"As has recently been shown, the adoptive transfer of CD3-activated Tregs attenuates astrogliosis and microglial inflammation with concomitant neuroprotection in a murine model of HIV-1-associated neurodegeneration.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2337}, end: {_id:1757}, properties:{annotationPublicationtype:["Research"], evidence:"Treatment with remdesivir reduced fragmented nuclei in ApoE4 astrocytes significantly (Figures 4H and S4F).", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationCell:["astrocyte"], source:"wp4-cbm-comorbidity", pmid:"33450186", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationCellline:["AG14048 cell"], annotationDisease:["COVID-19"], citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:381}, end: {_id:382}, properties:{annotationPublicationtype:["Review"], evidence:"Positive correlations between disease duration and the microglial/macrophage activation marker CD68 and between MHC-II expression and amount of alpha-synuclein deposition in the SN of post-mortem human brain sections have been reported [57].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:2300}, end: {_id:1806}, properties:{annotationPublicationtype:["Review"], evidence:"E2 can also suppress EAE by the upregulation of programmed death 1 (PD1) expression in Tregs.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:503}, end: {_id:501}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:503}, end: {_id:502}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__GENE]->(end) SET r += row.properties;
UNWIND [{start: {_id:480}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"The use of a dominant-negative inhibitor of TNFα (DN-TNF) in PD animal models suggests that anti-TNF biological agents may also be of clinical value to delay or attenuate nigral DA neuron degeneration. Administration of soluble DN-TNF via osmotic pump or lentiviral overexpression in the SN shows protection in 6-OHDA models [182, 183]. Even delayed lentiviral overexpression of DN-TNF in the SN can be protective against progressive DA neuron loss [184].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:144}, end: {_id:143}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:151}, end: {_id:150}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:728}, end: {_id:727}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:881}, end: {_id:880}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:926}, end: {_id:925}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:928}, end: {_id:927}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:930}, end: {_id:929}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:937}, end: {_id:936}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:939}, end: {_id:938}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:941}, end: {_id:940}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1127}, end: {_id:936}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1468}, end: {_id:1467}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1477}, end: {_id:1471}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1713}, end: {_id:1712}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1714}, end: {_id:1708}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1715}, end: {_id:880}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1716}, end: {_id:1712}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1717}, end: {_id:1708}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1718}, end: {_id:880}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1719}, end: {_id:1712}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__LOCATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:1720}, end: {_id:1708}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1721}, end: {_id:880}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1754}, end: {_id:1753}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1827}, end: {_id:925}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2271}, end: {_id:100}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2283}, end: {_id:2282}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2393}, end: {_id:2392}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__LOCATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:160}, end: {_id:159}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:161}, end: {_id:14}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:187}, end: {_id:10}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:206}, end: {_id:205}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:269}, end: {_id:268}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:272}, end: {_id:271}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:507}, end: {_id:506}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:638}, end: {_id:32}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1370}, end: {_id:372}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1371}, end: {_id:1194}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1372}, end: {_id:933}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1412}, end: {_id:1411}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1413}, end: {_id:1380}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1415}, end: {_id:1414}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1416}, end: {_id:1382}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1418}, end: {_id:1417}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:1419}, end: {_id:1381}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2256}, end: {_id:196}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2299}, end: {_id:2298}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__PROTEIN]->(end) SET r += row.properties;
UNWIND [{start: {_id:62}, end: {_id:63}, properties:{annotationPublicationtype:["Review"], evidence:"The mechanism of nitric oxide-mediated toxicity to neurons has not been completely established, but strong evidence [91] indicates that this involves the action of peroxynitrite, which is readily formed from the reaction of NO with superoxide [92,93]", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Mitochondria", "Liver"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1165}, end: {_id:1148}, properties:{annotationPublicationtype:["Research"], evidence:"When mice received AAV-BR1-Mpro 2 weeks before, we observed an increased number of string vessels and a decreased vascular density in their brains (Fig. 4j–l).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["western blot"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1165}, end: {_id:1203}, properties:{annotationPublicationtype:["Research"], evidence:"When mice received AAV-BR1-Mpro 2 weeks before, we observed an increased number of string vessels and a decreased vascular density in their brains (Fig. 4j–l).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Results"], annotationBioassay:["western blot"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1436}, end: {_id:1442}, properties:{annotationPublicationtype:["Review"], evidence:"In particular, DJ-1 KO mice display a significant increase in Rikenella and Alistipes, accompanied by higher levels of malonate in stool and serum, and elevated expression of fecal inflammatory proteins calprotectin and MCP-1.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1436}, end: {_id:1443}, properties:{annotationPublicationtype:["Review"], evidence:"In particular, DJ-1 KO mice display a significant increase in Rikenella and Alistipes, accompanied by higher levels of malonate in stool and serum, and elevated expression of fecal inflammatory proteins calprotectin and MCP-1.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1436}, end: {_id:1444}, properties:{annotationPublicationtype:["Review"], evidence:"In particular, DJ-1 KO mice display a significant increase in Rikenella and Alistipes, accompanied by higher levels of malonate in stool and serum, and elevated expression of fecal inflammatory proteins calprotectin and MCP-1.", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecimen:["Feces", "Serum"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], annotationMouseType:["Park7-/-"], citationRef:"35674870"}}, {start: {_id:1055}, end: {_id:110}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["viral encephalitis"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1539}, end: {_id:110}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["viral encephalitis"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:1540}, end: {_id:110}, properties:{annotationPublicationtype:["Research"], evidence:"Consequently, we observed increased microglial expression of genes associated with microglia-mediated phagocytosis [41–44], such as CD68 (in line with the observed increase of CD68+ cells), TREM2, ITGB5, CD47, MSR1, CALR, as well as genes previously identified to be directly involved in synapse elimination in the aftermath of viral encephalitis, such as C3, C3AR1 and FCGR3A.", citationTitle:"Mol Psychiatry. 2022 Oct;27(10):3939-3950. doi: 10.1038/s41380-022-01786-2. Epub 2022 Oct 5.", annotationPublicationstatus:["Published"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"36198765", annotationDisease:["viral encephalitis"], citationType:"PubMed", citationRef:"36198765"}}, {start: {_id:280}, end: {_id:1751}, properties:{annotationPublicationtype:["Research"], evidence:"The significant loss of GST-pi-positive oligodendrocytes in mouse brains 1year after MSA seed injection (Extended Data Fig. 4) suggests that MSA seeds may induce oligodendrocyte degeneration.", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Corpus Striatum", "Brain"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationSpecies:["10090"], annotationSection:["Results"], annotationMeshdisease:["Multiple System Atrophy"], annotationCellline:["HEK293"], annotationDurationAfterInjection:["12 months"], citationRef:"37248302"}}, {start: {_id:295}, end: {_id:2271}, properties:{annotationPublicationtype:["Review"], evidence:"Tregs can inhibit the costimulatory capability of DCs by CD39-mediated inactivation of extracellular ATP, which is an inducer of DC activation.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:2308}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Recently, midkine, which is also known as neurite-growth-promoting factor 2 in humans and is encoded by the gene for MDK, a heparin-binding growth factor, has been shown to decrease the Treg population in vitro in a dose-dependent manner by suppression of signal transducer and activator of transcription 5 (STAT5) phosphorylation263 (Figure 3(a)).", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:224}, end: {_id:283}, properties:{annotationPublicationtype:["Review"], evidence:"Reynolds et al. have shown Th17-mediated nigrostriatal dopaminergic neurodegeneration with Treg dysfunction in an animal model of PD immunized by nitrated α-synuclein.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationMeshanatomy:["Dopaminergic Neurons"], source:"wp4-cbm-comorbidity", pmid:"22899644", annotationAnatomy:["nigrostriatal tract"], citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:896}, end: {_id:78}, properties:{annotationPublicationtype:["Research"], evidence:"Again, a more dramatic decrease in neurite number was observed in spike+ ApoE4 neurons compared to mock-treated or spike– ApoE4 neurons (p < 0.001) than the decrease in spike+ ApoE3 neurons compared to mock-treated or spike– ApoE3 neurons (p < 0.01), although adirect comparison of the neurite length and number between the ApoE3 and ApoE4 neurons (mock, spike–, and spike+) did not reach a statistically significant difference.", citationTitle:"Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5. doi:10.1016/j.stem.2020.12.018. Epub 2021 Jan 4.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationCell:["neuron"], source:"wp4-cbm-comorbidity", annotationCellline:["AG14048 cell"], pmid:"33450186", citationType:"PubMed", citationRef:"33450186"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1264}, end: {_id:1626}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Delta"], citationRef:"36314791"}}, {start: {_id:1264}, end: {_id:1622}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Delta"], citationRef:"36314791"}}, {start: {_id:1655}, end: {_id:1626}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Omicron"], citationRef:"36314791"}}, {start: {_id:1655}, end: {_id:1622}, properties:{annotationPublicationtype:["Research"], evidence:"Of note, the Delta and Omicron variants, although less infectious in the brain organoids, also induced similar levels of interferon activation, inflammation, and downregulation of AQP4 (Fig. S2E), arguing for retention of neurotoxic potential.", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["real-time PCR "], annotationSarsCov2Variant:["Omicron"], citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:640}, end: {_id:1064}, properties:{annotationPublicationtype:["Research"], evidence:"Taste changes were characterized in the 6 patients by dysgeusia where they had a reduced acuity for sweet taste, had a bad taste in the mouth, reduced or increased acuity for bitter, reduced acuity for salt or sour were reported in 4 out of the 6 patients with dysgeusia.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1066}, properties:{annotationPublicationtype:["Research"], evidence:"Taste changes were characterized in the 6 patients by dysgeusia where they had a reduced acuity for sweet taste, had a bad taste in the mouth, reduced or increased acuity for bitter, reduced acuity for salt or sour were reported in 4 out of the 6 patients with dysgeusia.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1067}, properties:{annotationPublicationtype:["Research"], evidence:"Taste changes were characterized in the 6 patients by dysgeusia where they had a reduced acuity for sweet taste, had a bad taste in the mouth, reduced or increased acuity for bitter, reduced acuity for salt or sour were reported in 4 out of the 6 patients with dysgeusia.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1068}, properties:{annotationPublicationtype:["Research"], evidence:"Three patients (#2, #4 and #15) were unable to discriminate between different food flavors such as meat and fish.", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1066}, properties:{annotationPublicationtype:["Research"], evidence:"Two patients complained of bad taste (Table S2). Reduced or increased acuity for bitter, reduced acuity for salt or sour were reported by the two patients with dysgeusia", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:640}, end: {_id:1067}, properties:{annotationPublicationtype:["Research"], evidence:"Two patients complained of bad taste (Table S2). Reduced or increased acuity for bitter, reduced acuity for salt or sour were reported by the two patients with dysgeusia", citationTitle:"Sci Transl Med. 2021 Jun 2;13(596):eabf8396. doi: 10.1126/scitranslmed.abf8396.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshdisease:["Olfaction Disorders"], source:"wp4-cbm-comorbidity", pmid:"33941622", citationType:"PubMed", citationRef:"33941622"}}, {start: {_id:67}, end: {_id:1350}, properties:{annotationPublicationtype:["Review"], evidence:"Importantly, GABAergic dysfunctions have been reported both in prodromal PD (mostly linked to gastrointestinal symptoms) and at later disease stages, but GABA contribution to neurodegeneration is still debated, as demonstrated by multiple studies showing controversial results", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationDiseaseType:["late onset", "prodromal"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:67}, end: {_id:1465}, properties:{annotationPublicationtype:["Review"], evidence:"Another study observed a defective meningeal lymphatic drainage in sporadic PD patients [144], known to impair clearance of toxic CSF waste from the brain leading to an aggravated inflammatory response [145].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}, {start: {_id:640}, end: {_id:1564}, properties:{annotationPublicationtype:["Research"], evidence:"Nonetheless, our study demonstrates that a persistent imbalance between oxidative stress toxicity and reduced ANTIOX is a key component of Long COVID and that increased aldehyde, neutrophil-associated MPO, protein carbonyl, and NO production are the major neurotoxic pathways, which, when combined with decreased ANTIOX, may have a variety of detrimental effects as reviewed before.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:640}, end: {_id:39}, properties:{annotationPublicationtype:["Research"], evidence:"Nonetheless, our study demonstrates that a persistent imbalance between oxidative stress toxicity and reduced ANTIOX is a key component of Long COVID and that increased aldehyde, neutrophil-associated MPO, protein carbonyl, and NO production are the major neurotoxic pathways, which, when combined with decreased ANTIOX, may have a variety of detrimental effects as reviewed before.", citationTitle:"Mol Psychiatry. 2023 Feb;28(2):564-578. doi: 10.1038/s41380-022-01836-9. Epub 2022 Oct 24.", annotationPublicationstatus:["Published"], annotationDiseaseType:["Long COVID"], annotationSection:["Discussions"], annotationTimeline:["3-4 months post infection"], source:"wp4-cbm-comorbidity", pmid:"36280755", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"36280755"}}, {start: {_id:1122}, end: {_id:1053}, properties:{annotationPublicationtype:["Review"], evidence:"In the literature, viraemia is not only predictive of patient survival but is also associated with worse respiratory disease severity, increased markers of inflammation, and increased pulmonary viral RNA load.", citationTitle:"Nat Microbiol. 2023 Nov;8(11):1986-1994. doi: 10.1038/s41564-023-01488-7. Epub 2023 Oct 5.", annotationPublicationstatus:["Published"], annotationCell:["endothelial cell"], annotationSpecimen:["post-mortem specimen"], source:"wp4-cbm-comorbidity", pmid:"37798476", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationAnatomy:["secondary pulmonary lobule"], citationRef:"37798476"}}, {start: {_id:640}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"Given the significantly increased serum concentrations of S100β, our data indicated that active and acute SARS-CoV-2 infection is associated with potential BBB dysfunction in individuals with neurological impairment.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], source:"wp4-cbm-comorbidity", pmid:"38388736", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"38388736"}}, {start: {_id:651}, end: {_id:162}, properties:{annotationPublicationtype:["Research"], evidence:"There was no association between BBB permeability and anosmia status, duration of anosmia, Q-SIT or MOCA scores (Extended Data Fig. 5a–c and Supplementary Table 3); however, regional BBB permeability in the right and left TLs was correlated with the duration of anosmia (Extended Data Fig. 5a,b).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["9606"], annotationBioassay:["imaging method"], annotationAnatomy:["right temporal lobe", "left temporal lobe"], annotationDisease:["COVID-19"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2190}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:180}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:1841}, end: {_id:2219}, properties:{annotationPublicationtype:["Research"], evidence:"Pathways related to immunoglobulin, production, defense responses and B cell activation were among those downregulated, including immunoglobulin production (IGKV1–12, IGKV1–17), adaptive immune response (for example, CX3CR1, FCGR1BP) and B cell activation (HDAC9, CD180, MNDA) (Extended Data Fig. ​Fig.77 and Supplementary Tables 4 and 5–12).", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationCell:["peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Mental Fatigue"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:2287}, end: {_id:162}, properties:{annotationPublicationtype:["Review"], evidence:"As the migratory capability across the intact BBB is impaired in RR-MS, a broader functional deficiency of Tregs might contribute to the development of early CNS lesions.", citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:7}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"However, Treg suppressive activity is intensified in AD and PD patients with age, whereas the increase of suppressive activity does not reach significance for the non-affected elderly individuals compared with the young groups", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}, {start: {_id:67}, end: {_id:156}, properties:{annotationPublicationtype:["Review"], evidence:"However, Treg suppressive activity is intensified in AD and PD patients with age, whereas the increase of suppressive activity does not reach significance for the non-affected elderly individuals compared with the young groups", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:466}, end: {_id:1402}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin also suppresses inflammation by degrading TRAF2/6 and preventing the activation of NFkB and JNK signaling pathways", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:466}, end: {_id:1404}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin also suppresses inflammation by degrading TRAF2/6 and preventing the activation of NFkB and JNK signaling pathways", annotationPublicationstatus:["Published"], citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:2258}, end: {_id:2259}, properties:{annotationPublicationtype:["Review"], evidence:"Expression of granzyme B in Tregs has been found in a tumor microenvironment, and these Tregs can kill NK cells in a granzyme-Bdependent manner.", annotationPublicationstatus:["Published"], citationTitle:"Wiley Interdiscip Rev Syst Biol Med . 2013 Mar-Apr;5(2):153-80. doi: 10.1002/wsbm.1187. Epub 2012 Aug 15.", annotationSection:["Full Text"], annotationMeshanatomy:["T-Lymphocytes, Regulatory"], source:"wp4-cbm-comorbidity", pmid:"22899644", citationType:"PubMed", citationRef:"22899644"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1036}, end: {_id:1029}, properties:{annotationPublicationtype:["Review"], evidence:"MPO–DNA complexes and thrombin–antithrombin complexes were positively correlated in patients with COVID-19, and the anticoagulant dabigatran or complement targeting inhibited NETosis86, further suggesting a central role for NETs in the immunothrombotic milieu.", citationTitle:"Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"33824483", citationType:"PubMed", citationRef:"33824483"}}, {start: {_id:1887}, end: {_id:402}, properties:{annotationPublicationtype:["Review"], evidence:"Those with a high risk showed higher neutrophil and lower (CD4+) lymphocyte fractions compared with those with a low risk.", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:NEGATIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:86}, end: {_id:88}, properties:{annotationPublicationtype:["Review"], evidence:"Wallerian degeneration in the CNS is accompanied by the activation of microglia along the degenerating fiber tracts and, over time, foam cells, which are responsible for the removal of degenerating axons and myelin, become evident.", citationTitle:"Nat Rev Neurol. 2010 Apr;6(4):193-201. doi: 10.1038/nrneurol.2010.17. Epub 2010 Mar 16.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"20234358", citationType:"PubMed", citationRef:"20234358"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:ASSOCIATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:218}, end: {_id:238}, properties:{annotationPublicationtype:["Review"], evidence:"Nitrated α-syn in turn amplifies activation of microglia and antigen-presenting cells that correspondingly up-regulate both humoral and cell-mediated responses to nitrated α-syn in the MPTP model.", citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationChemicalTreatment:["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine"], annotationPublicationstatus:["Published"], annotationSpecies:["10090"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:453}, end: {_id:24}, properties:{annotationPublicationtype:["Review"], evidence:"IFN-gamma stimulation of immune cells results in upregulation of LRRK2 expression, which was shown to activate the NF-κB pathway, to be important for production of microbicidal reactive oxygen species during phagocytosis, and to colocalize near pathogens during intracellular infection [160]", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:388}, end: {_id:587}, properties:{annotationPublicationtype:["Review"], evidence:"LRRK2 variants are the leading heritable form of PD [47]. Mutations in LRRK2 associated with PD elevate LRRK2 kinase activity and decrease GTPase activity.", citationTitle:"Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra", "Blood Platelets"], source:"wp4-cbm-comorbidity", pmid:"30342839", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], annotationAnatomy:["skeletal muscle tissue"], citationRef:"30342839"}}, {start: {_id:672}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:" In keeping with this, the coronavirus ORF3a protein has been shown to induce NLRP3 inflammasome activity.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:10}, end: {_id:1193}, properties:{annotationPublicationtype:["Research"], evidence:"When expressed in human brain endothelial hCMEC/D3 cells, Mpro prevented the nuclear translocation of the NF-κB subunit p65, reflecting its activation in response to IL-1β (Fig. 4a). Mpro also abolished the stimulation of NF-κB-mediated gene transcription by IL-1β, which we investigated in hCMEC/D3 cells and mouse brain endothelial bEnd.3 cells using luciferase reporter gene assays (Fig. 4b, c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationConcentration:["0.25 µg/ml"], annotationCustomCellline:["hCMEC/D3 cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:1194}, end: {_id:1198}, properties:{annotationPublicationtype:["Research"], evidence:"When expressed in human brain endothelial hCMEC/D3 cells, Mpro prevented the nuclear translocation of the NF-κB subunit p65, reflecting its activation in response to IL-1β (Fig. 4a). Mpro also abolished the stimulation of NF-κB-mediated gene transcription by IL-1β, which we investigated in hCMEC/D3 cells and mouse brain endothelial bEnd.3 cells using luciferase reporter gene assays (Fig. 4b, c).", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationConcentration:["0.25 µg/ml"], source:"wp4-cbm-comorbidity", annotationCellline:["bEnd.3 cell"], pmid:"34675436", citationType:"PubMed", citationRef:"34675436"}}, {start: {_id:146}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:"Other studies have shown an activation of NLRP3 inflammasome in distinct α-syn PD models, including primary monocytes and primary microglia exposed to fibrillar α-syn, mouse striatum subjected to 6-OHDA treatment, α-syn pre-formed fibrils (PFF)-injected mice, post-mortem SN sections from PD brains and also blood and CSF samples from PD patients [68, 69, 70•].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Substantia Nigra"], annotationSpecimen:["Cerebrospinal Fluid", "Blood"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], annotationProteinType:["fibrillar"], citationRef:"35674870"}}, {start: {_id:14}, end: {_id:2228}, properties:{annotationPublicationtype:["Research"], evidence:"We next examined immunovascular interactions in PBMCs isolated from patients with COVID-19 and found increased adhesion of PBMCs to human brain endothelial cells in the cohort with long COVID compared to unaffected individuals, which was heightened in the presence of TNF and only modestly affected by blocking antibodies against ICAM-1 and VCAM-1.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell", "peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}, {start: {_id:14}, end: {_id:2229}, properties:{annotationPublicationtype:["Research"], evidence:"We next examined immunovascular interactions in PBMCs isolated from patients with COVID-19 and found increased adhesion of PBMCs to human brain endothelial cells in the cohort with long COVID compared to unaffected individuals, which was heightened in the presence of TNF and only modestly affected by blocking antibodies against ICAM-1 and VCAM-1.", citationTitle:"Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Erratum in: Nat Neurosci. 2024 Apr 16;:", annotationPublicationstatus:["Published"], annotationDiseaseType:["long COVID"], annotationMeshanatomy:["Blood Vessels", "Brain"], annotationCell:["endothelial cell", "peripheral blood mononuclear cell"], source:"wp4-cbm-comorbidity", pmid:"38388736", citationType:"PubMed", annotationSpecies:["9606"], annotationSection:["Results"], annotationBioassay:["bioinformatics method"], citationRef:"38388736"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1205}, end: {_id:1206}, properties:{annotationPublicationtype:["Research"], evidence:"NEMO deletion induced endothelial cell death as detected by the TUNEL reaction or by staining for active caspase-3 (Fig. 5c–e). Most of them were observed in higher-order capillaries (Fig. 5f and Extended Data Fig. 8), suggesting that capillaries are particularly susceptible to NEMO deficiency", citationTitle:"Nat Neurosci. 2021 Nov;24(11):1522-1533. doi: 10.1038/s41593-021-00926-1.", annotationPublicationstatus:["Published"], annotationMeshanatomy:["Brain"], annotationCell:["endothelial cell"], source:"wp4-cbm-comorbidity", pmid:"34675436", citationType:"PubMed", annotationSection:["Results"], annotationSpecies:["10090"], annotationBioassay:["confocal microscopy"], annotationMouseType:["inducible Ikbkg (Nemo) deletion"], citationRef:"34675436"}}, {start: {_id:1861}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 or Parkin deficiency in myeloid cells (macrophages/microglia) enhances the NLRP3 inflammasome response [25]. Moreover, PINK1 has been associated with the function of regulatory T cells (Tregs) [26] and the antiviral response in macrophages [27].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Myeloid Cells"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}, {start: {_id:474}, end: {_id:674}, properties:{annotationPublicationtype:["Review"], evidence:"PINK1 or Parkin deficiency in myeloid cells (macrophages/microglia) enhances the NLRP3 inflammasome response [25]. Moreover, PINK1 has been associated with the function of regulatory T cells (Tregs) [26] and the antiviral response in macrophages [27].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Myeloid Cells"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1410}, end: {_id:1372}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1410}, end: {_id:1412}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1410}, end: {_id:1413}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1410}, end: {_id:1415}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1410}, end: {_id:1416}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1410}, end: {_id:1418}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}, {start: {_id:1410}, end: {_id:1419}, properties:{annotationPublicationtype:["Review"], evidence:"When subjected to exhaustive exercise, both PINK1- and Parkin-deficient mice trigger the pro-inflammatory cGAS-STING mediated Type-1 interferon response to foreign DNA [95•], resulting in increased serum levels of IL-6, IFN-β1, IL-12(p70), IL-13, CXCL1, CCL2 and CCL4", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:DECREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:47}, end: {_id:46}, properties:{annotationPublicationtype:["Review"], evidence:"Careful studies on Alzheimer's disease brains versus age-matched controls clearly demonstrate that protein oxidative damage products in brain increases with age but much more rapidly in those that have Alzheimer's disease [62].", citationTitle:"Free Radic Biol Med. 1999 May;26(9-10):1346-55. doi: 10.1016/s0891-5849(98)00293-7.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"10381209", citationType:"PubMed", citationRef:"10381209"}}, {start: {_id:249}, end: {_id:248}, properties:{annotationPublicationtype:["Review"], evidence:"This pattern of antibody reactivity was consistent with activated microglia and destruction of dopaminergic neurons in PD.", annotationPublicationstatus:["Published"], citationTitle:"Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381. doi: 10.1101/cshperspect.a009381.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"22315722", citationType:"PubMed", citationRef:"22315722"}}, {start: {_id:17}, end: {_id:356}, properties:{annotationPublicationtype:["Review"], evidence:"This inflammatory response could induce neuronal injury (if not already present) that in turn could propagate a positive-feedback cycle of neuronal injury and inflammation in the development of PD [32].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:770}, end: {_id:682}, properties:{annotationPublicationtype:["Review"], evidence:"Blood D-dimer concentration was raised in many patients with COVID-19, consistent with a pro-inflammatory, coagulopathic state in the setting of critical illness.51, 52, 53, 54, 55, 77, 92, 95, 96 Positive lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein-1 antibodies have also been reported in COVID-19-associated stroke,52, 77 although these can be raised in other critical illnesses, including infections.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:47}, end: {_id:893}, properties:{annotationPublicationtype:["Research"], evidence:"Examination of apolipoproteins revealed their enrichment in the major adult ChP cluster, which exhibited much higher levels than cells of the embryonic ChP.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Choroid Plexus"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:47}, end: {_id:893}, properties:{annotationPublicationtype:["Research"], evidence:"Furthermore, we examined a previously published proteomic dataset of CSF-like fluid from ChP organoids spanning day 32 to day 146 (Pellegrini et al., 2020), which revealed increasing secretion of lipoproteins with age.", citationTitle:"Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationMeshanatomy:["Cerebrospinal Fluid", "Choroid Plexus", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"33113348", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"33113348"}}, {start: {_id:222}, end: {_id:1745}, properties:{annotationPublicationtype:["Research"], evidence:"The results of Pearson’s chi-square tests showed a significant positive correlation between the results of the IP/RT-QuIC and delayed heart-to-mediastinum (H/M) ratio with 123I-metaiodobenzylguanidine (MIBG) cardiac scintigraphy in patients with PD (Supplementary Table 8a) but not in patients with MSA (Supplementary Table 8b).", citationTitle:"Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. ", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Results"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"37248302", citationType:"PubMed", annotationTechnique:["cardiac scintigraphy"], citationRef:"37248302"}}, {start: {_id:74}, end: {_id:1885}, properties:{annotationPublicationtype:["Review"], evidence:"Another study, in which people with PD were divided according to cognitive performance, showed that those with mild cognitive impairment had a higher level of lymphocytes (i.e., lower NLR) compared with those with normal cognition [92].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:480}, end: {_id:352}, properties:{annotationPublicationtype:["Review"], evidence:"The use of a dominant-negative inhibitor of TNFα (DN-TNF) in PD animal models suggests that anti-TNF biological agents may also be of clinical value to delay or attenuate nigral DA neuron degeneration. Administration of soluble DN-TNF via osmotic pump or lentiviral overexpression in the SN shows protection in 6-OHDA models [182, 183]. Even delayed lentiviral overexpression of DN-TNF in the SN can be protective against progressive DA neuron loss [184].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:POSITIVE_CORRELATION]->(end) SET r += row.properties;
UNWIND [{start: {_id:474}, end: {_id:418}, properties:{annotationPublicationtype:["Review"], evidence:"Parkin knockout animals do not have loss of DA neurons in the SN and do not have increased vulnerability to MPTP, yet they do show non-motor behavioral changes related to changes in the nigrostriatal pathway [171, 172].", annotationPublicationstatus:["Published"], citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationSection:["Full Text"], annotationMeshanatomy:["Substantia Nigra"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:481}, end: {_id:418}, properties:{annotationPublicationtype:["Review"], evidence:"In mice expressing human alpha-synuclein under the platelet-derived growth factor promoter, administration of an anti-alpha-synuclein antibody improves behavioral performance and promoted degradation of accumulated alpha-synuclein [185, 186].", citationTitle:"J Parkinsons Dis. 2013;3(4):493-514.doi: 10.3233/JPD-130250.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["10090"], source:"wp4-cbm-comorbidity", pmid:"24275605", citationType:"PubMed", citationRef:"24275605"}}, {start: {_id:674}, end: {_id:678}, properties:{annotationPublicationtype:["Review"], evidence:"This conclusion is based on not only epidemiological evidence but also on experiments that showed that systemic, NLRP3 inflammasome-mediated inflammation adversely affects beneficial immune functions in the brain and thereby causes the pathological accumulation of neurodegeneration-associated peptides such as fibrillar amyloid-β.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshanatomy:["Brain"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:674}, end: {_id:141}, properties:{annotationPublicationtype:["Review"], evidence:"Thus, both peripheral and central induction of the NLRP3 inflammasome can directly induce or aggravate neurodegenerative processes that lead to functional impairment in AD [25] or strongly contribute to the spreading of pathology and thus the progression of the disease.", citationTitle:"Alzheimers Res Ther. 2020 Jun 4;12(1):69. 10.1186/s13195-020-00640-3.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32498691", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32498691"}}, {start: {_id:759}, end: {_id:760}, properties:{annotationPublicationtype:["Review"], evidence:"Muscle injury associated with raised creatine kinase affected 23 (11%) of 214 patients in the Wuhan series. Rhabdomyolysis due to COVID-19 has also been reported.", citationTitle:"Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], source:"wp4-cbm-comorbidity", pmid:"32622375", annotationDisease:["COVID-19"], citationType:"PubMed", citationRef:"32622375"}}, {start: {_id:1587}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"The siRNAs specific for NRP1, but not AXL, strongly inhibited the infection of astrocytes by SARS-CoV-2, as assessed by the reduced expression of viral nucleocapsid (N) mRNA (Fig. 2D).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1587}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"However. treatment of primary astrocytes with a neutralizing anti-ACE2 antibody did not significantly impair SARS-CoV-2 infection, while treatment with anti-NRP1 antibody strongly and significantly blocked infection (Fig. 2E and Fig. S1C).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], annotationMeshanatomy:["Brain", "Astrocytes", "Organoids"], source:"wp4-cbm-comorbidity", pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}, {start: {_id:1591}, end: {_id:640}, properties:{annotationPublicationtype:["Research"], evidence:"In contrast, the anti-ACE2 antibodies significantly blocked SARS-CoV-2 infection of Vero-E6 cells, while anti-NRP1 antibodies did not (Fig. 2F).", citationTitle:"mBio. 2022 Dec 20;13(6):e0230822. doi: 10.1128/mbio.02308-22. ", annotationPublicationstatus:["Published"], annotationSection:["Results"], annotationSpecies:["9606"], source:"wp4-cbm-comorbidity", annotationCellline:["VERO 76 cell"], pmid:"36314791", citationType:"PubMed", citationRef:"36314791"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:67}, end: {_id:1865}, properties:{annotationPublicationtype:["Review"], evidence:"However, PD-associated transcriptomic profiles in microglia and peripheral monocytes from people with PD are not identical (e.g., upregulation of the S100 family of genes was seen in both, while oxidative phosphorylation (OXPHOS) genes were upregulated in monocytes but downregulated in microglia) [39].", citationTitle:"Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005.", annotationPublicationstatus:["Published"], annotationSection:["Full Text"], annotationSpecies:["9606"], annotationMeshanatomy:["Monocytes", "Microglia"], source:"wp4-cbm-comorbidity", pmid:"37598092", citationType:"PubMed", citationRef:"37598092"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
UNWIND [{start: {_id:1266}, end: {_id:626}, properties:{source:"wp4-cbm-comorbidity"}}, {start: {_id:2311}, end: {_id:2310}, properties:{source:"wp4-cbm-comorbidity"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:HAS__ABUNDANCE]->(end) SET r += row.properties;
UNWIND [{start: {_id:1463}, end: {_id:1420}, properties:{annotationPublicationtype:["Review"], evidence:"Cytoplasmic release of damaged mitochondria DNA (mtDNA) is an important DAMP that initiates multiple inflammatory pathways, including STING, NLRP3 inflammasome and NFKB signaling [133].", citationTitle:"Curr Neurol Neurosci Rep. 2022 Aug;22(8):427-440. doi: 10.1007/s11910-022-01207-5. Epub 2022 Jun 8.", annotationPublicationstatus:["Published"], annotationSpecies:["9606"], annotationSection:["Full Text"], annotationMeshdisease:["Parkinson Disease"], source:"wp4-cbm-comorbidity", pmid:"35674870", citationType:"PubMed", annotationTechnique:["RNA sequencing"], citationRef:"35674870"}}] AS row
MATCH (start:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.start._id})
MATCH (end:`UNIQUE IMPORT LABEL`{`UNIQUE IMPORT ID`: row.end._id})
CREATE (start)-[r:INCREASES]->(end) SET r += row.properties;
:commit
:begin
MATCH (n:`UNIQUE IMPORT LABEL`)  WITH n LIMIT 20000 REMOVE n:`UNIQUE IMPORT LABEL` REMOVE n.`UNIQUE IMPORT ID`;
:commit
:begin
DROP CONSTRAINT UNIQUE_IMPORT_NAME;
:commit
